Citrus Sinensis ID: 022347
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 298 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.738 | 0.564 | 0.469 | 2e-54 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.697 | 0.227 | 0.401 | 3e-40 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.697 | 0.222 | 0.428 | 4e-39 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.687 | 0.154 | 0.426 | 5e-38 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.718 | 0.185 | 0.382 | 8e-36 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.731 | 0.162 | 0.382 | 1e-34 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.744 | 0.191 | 0.346 | 2e-34 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.728 | 0.264 | 0.394 | 2e-34 | |
| Q54XQ2 | 1125 | RGS domain-containing ser | no | no | 0.724 | 0.192 | 0.395 | 6e-34 | |
| Q80XI6 | 850 | Mitogen-activated protein | yes | no | 0.691 | 0.242 | 0.366 | 6e-34 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 212 bits (540), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 108/230 (46%), Positives = 146/230 (63%), Gaps = 10/230 (4%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN 74
+ RA LE +F EV ++SR+ H N+V+F+ ACK P + I+TE + +LR YL P
Sbjct: 123 ETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPY 182
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 134
L + L ALDI+R M+ LH+ G+IHRDLK +NLLL D+ +K+ADFG + ET
Sbjct: 183 SLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLN-DEMRVKVADFGTSCLETQCR 241
Query: 135 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
GTYRWMAPE+ ++K Y KVDVYSFGIVLWEL T LPF+GM+ +Q
Sbjct: 242 EAKGNMGTYRWMAPEMI--------KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQ 293
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
AA+A A K+ RP LP P LA +++ CW E+P+ RP FS I+ +L +
Sbjct: 294 AAFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKY 343
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (418), Expect = 3e-40, Method: Composition-based stats.
Identities = 88/219 (40%), Positives = 136/219 (62%), Gaps = 11/219 (5%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F +E+ ++SR++H N+V + AC P + +TE LPG SL L S + K+++ +
Sbjct: 705 FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHS-KKIKMNMQLYKK 763
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
A+ IA+ M+ LH +G+IHRD+K NLLL + ++K+ DFGL++ ++ + MT G+
Sbjct: 764 LAIQIAQGMNYLHLSGVIHRDIKSLNLLLD-EHMNVKICDFGLSKLKSKSTEMTKSIGSP 822
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
WM+PEL GE Y KVDVY+FGI+LWEL T LP+ G+ ++Q A A K
Sbjct: 823 IWMSPELL------MGED--YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKS 874
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
RP +P L+ ++Q+CW +DP RPSF++I+ +LN
Sbjct: 875 LRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLN 913
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (409), Expect = 4e-39, Method: Compositional matrix adjust.
Identities = 96/224 (42%), Positives = 137/224 (61%), Gaps = 16/224 (7%)
Query: 23 GRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHV 80
F EV +M R++H N+V FLGA + P + IVTE LP SL Y + RP + +D
Sbjct: 709 AEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSL--YRILHRPKSHIDERR 766
Query: 81 ALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
+ ALD+A M+CLH + I+HRDLK NLL+ + ++K+ DFGL+R + T + +
Sbjct: 767 RIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVD-NNWNVKVGDFGLSRLKHNTFLSSK 825
Query: 139 ET-GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
T GT WMAPE+ LR + N K DVYSFG++LWEL T RLP+ GM+ +Q
Sbjct: 826 STAGTPEWMAPEV-----LR---NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVG 877
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
A F++ R +P+++ P + I+ CW DPNLRPSF+Q+ +L
Sbjct: 878 AVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 5e-38, Method: Composition-based stats.
Identities = 95/223 (42%), Positives = 126/223 (56%), Gaps = 18/223 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN------KLDL 78
F EV ++ ++H NLV G +P M IV E LP +L + L+ +P+ KLD
Sbjct: 1117 FKAEVELLGSLQHPNLVTCYGYSLNP-MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDS 1174
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
+ L A DIAR M LH IIHRDLK NLL+ ++K+AD G+ARE + T+ MT
Sbjct: 1175 TLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMD-KHFNIKIADLGIARETSFTQTMTT 1233
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
GT W APE+ LR + YN K DVYS+ IVL+ELLT P++G+ + A
Sbjct: 1234 -IGTVAWTAPEI-----LRH---ESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGIL 1284
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
A K RP LP++ P+ +V CW EDPN RPSF +I L
Sbjct: 1285 VASKGLRPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 150 bits (380), Expect = 8e-36, Method: Composition-based stats.
Identities = 90/235 (38%), Positives = 126/235 (53%), Gaps = 21/235 (8%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN- 74
DE E RFIREV + + H N+V F+GAC P I+TE + G SL Y + PN
Sbjct: 887 DEEQFKE-RFIREVQNLKKGNHQNIVMFIGACYKP-ACIITEYMAGGSL--YNILHNPNS 942
Query: 75 -----KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129
K + L A D+A + LH+ I+HRDL N+LL + ++K++DFGL+RE
Sbjct: 943 STPKVKYSFPLVLKMATDMALGLLHLHSITIVHRDLTSQNILLD-ELGNIKISDFGLSRE 1001
Query: 130 ETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
++ MT G RW PEL + HY+ KVDVY F +V+WE+LT +P
Sbjct: 1002 KSREGSMTMTNGGICNPRWRPPELTKNL-------GHYSEKVDVYCFSLVVWEILTGEIP 1054
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
F + QA+ A+ RP +PE P+L ++ CW DPN RP F+ I+ L
Sbjct: 1055 FSDLDGSQASAQVAYAGLRPPIPEYCDPELKLLLTQCWEADPNDRPPFTYIVNKL 1109
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (370), Expect = 1e-34, Method: Composition-based stats.
Identities = 91/238 (38%), Positives = 139/238 (58%), Gaps = 20/238 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSL 64
+K + N ++DE+ FI+EV+ + + H N+V F+GAC DP I TE L G SL
Sbjct: 1083 IKILKNESISNDEK------FIKEVSSLIKSHHPNVVTFMGACIDP-PCIFTEYLQGGSL 1135
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
L ++ KL+ + D++ M+ LH+ ++HRDL N+LL + K++K+ADF
Sbjct: 1136 YDVL-HIQKIKLNPLMMYKMIHDLSLGMEHLHSIQMLHRDLTSKNILLD-EFKNIKIADF 1193
Query: 125 GLAREETVTEMMTAETGTY-RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
GLA T+++ MT T RW +PEL + YN KVDVYSFG+V++E+ T
Sbjct: 1194 GLA--TTLSDDMTLSGITNPRWRSPELTKGLV--------YNEKVDVYSFGLVVYEIYTG 1243
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
++PFEG+ +A AAF++ RP +P D L ++ CW DP+ RPSF++I+ L
Sbjct: 1244 KIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLRKLITKCWASDPSQRPSFTEILTEL 1301
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (368), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 86/248 (34%), Positives = 128/248 (51%), Gaps = 26/248 (10%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNK 75
D+ + ++E + +KH+N+ G C + + +V E G SL + L K
Sbjct: 177 DDMQRMRDNVLQEAKLFWALKHENIAALRGVCLNTKLCLVMEYARGGSLNRILA----GK 232
Query: 76 LDLHVALNFALDIARAMDCLHANG---IIHRDLKPDNLLLTP-------DQKSLKLADFG 125
+ V +N+A+ IAR M+ LH IIHRDLK N+L+ QK+LK+ DFG
Sbjct: 233 IPPDVLVNWAIQIARGMNYLHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQKTLKITDFG 292
Query: 126 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
LARE T+ M+A GTY WM PE+ S T Y+ DV+S+G++LWEL+T
Sbjct: 293 LAREMYNTQRMSA-AGTYAWMPPEVISVST--------YSKFSDVWSYGVLLWELITGET 343
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
P++G L AY A +P+ +++SCW DP+ RP F +I++ L +
Sbjct: 344 PYKGFDPLSVAYGVAVNTLTLPIPKTCPETWGALMKSCWQTDPHKRPGFKEILKQLESIA 403
Query: 246 ---FTLRP 250
FTL P
Sbjct: 404 CSKFTLTP 411
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 145 bits (367), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 92/233 (39%), Positives = 138/233 (59%), Gaps = 16/233 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVAL 82
F+REV +M R++H N+V F+GA + P + IVTE L SL + L S +LD L
Sbjct: 593 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 652
Query: 83 NFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMT-A 138
+ A D+A+ M+ LH I+HRDLK NLL+ D+K ++K+ DFGL+R + T + + +
Sbjct: 653 SMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLV--DKKYTVKVCDFGLSRLKASTFLSSKS 710
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
GT WMAPE+ LR + N K DVYSFG++LWEL T + P+ ++ Q A
Sbjct: 711 AAGTPEWMAPEV-----LRD---EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 762
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251
FK R +P +++P +A I++ CW +P RPSF+ I+ +L + + PP
Sbjct: 763 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 815
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XQ2|RCKA_DICDI RGS domain-containing serine/threonine-protein kinase A OS=Dictyostelium discoideum GN=rckA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (364), Expect = 6e-34, Method: Composition-based stats.
Identities = 93/235 (39%), Positives = 130/235 (55%), Gaps = 19/235 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F REV +MS KHDNL + LGA + D +TE SL YL R N + L+
Sbjct: 884 FKREVALMSIFKHDNLARCLGAGQYDDKYFHLTEYCHNGSLFSYLRDQR-NNISFGQRLH 942
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
FAL IAR M LH+ IIHRDLK N+LLT K +K+ DFG +R MT GT
Sbjct: 943 FALGIARGMRYLHSMSIIHRDLKSMNILLTKRLK-IKIVDFGTSRVANKYN-MTTHVGTQ 1000
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
WMAPE++++ T Y NKVDVYS+ I+L+E+ T + ++ +N+ K
Sbjct: 1001 AWMAPEIFTSRT--------YTNKVDVYSYAIILFEIFTRKSAYDENANINIP-NMVMKG 1051
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPES 258
RP LP+D+ ++ I++ CW + P+ RPSF +I+ L + ++ PSV S
Sbjct: 1052 ERPELPKDMQTSISNIIKKCWQQKPSNRPSFIKIVAYLESIIY------PSVSNS 1100
|
Serine/threonine kinase involved in negative regulation of chemotaxis. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q80XI6|M3K11_MOUSE Mitogen-activated protein kinase kinase kinase 11 OS=Mus musculus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (364), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 84/229 (36%), Positives = 121/229 (52%), Gaps = 23/229 (10%)
Query: 27 REVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E + + + H N++ C ++P + +V E G L + L R + HV +N+A
Sbjct: 164 QEARLFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWA 220
Query: 86 LDIARAMDCLHANG---IIHRDLKPDN-LLLTP------DQKSLKLADFGLAREETVTEM 135
+ IAR M LH +IHRDLK +N LLL P + K+LK+ DFGLARE T
Sbjct: 221 VQIARGMHYLHCEALVPVIHRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQ 280
Query: 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
M+A GTY WMAPE+ T +G DV+SFG++LWELLT +P+ G+ L
Sbjct: 281 MSA-AGTYAWMAPEVIKASTFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAV 331
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
AY A +P A ++ CW +DP+ RP F+ I++ L A
Sbjct: 332 AYGVAVNKLTLPIPSTCPEPFAQLMADCWAQDPHRRPDFASILQQLEAL 380
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 298 | ||||||
| 255584255 | 367 | protein kinase atn1, putative [Ricinus c | 0.973 | 0.790 | 0.886 | 1e-152 | |
| 225439671 | 374 | PREDICTED: serine/threonine-protein kina | 0.979 | 0.780 | 0.843 | 1e-146 | |
| 297735553 | 337 | unnamed protein product [Vitis vinifera] | 0.979 | 0.866 | 0.843 | 1e-146 | |
| 224139346 | 356 | predicted protein [Populus trichocarpa] | 0.973 | 0.814 | 0.852 | 1e-144 | |
| 356532165 | 370 | PREDICTED: serine/threonine-protein kina | 0.973 | 0.783 | 0.856 | 1e-141 | |
| 388513773 | 360 | unknown [Medicago truncatula] | 0.959 | 0.794 | 0.829 | 1e-139 | |
| 357506577 | 326 | Protein kinase, putative [Medicago trunc | 0.993 | 0.907 | 0.816 | 1e-139 | |
| 357506575 | 363 | Protein kinase, putative [Medicago trunc | 0.973 | 0.798 | 0.835 | 1e-138 | |
| 449439809 | 373 | PREDICTED: serine/threonine-protein kina | 0.979 | 0.782 | 0.820 | 1e-138 | |
| 449521717 | 373 | PREDICTED: serine/threonine-protein kina | 0.979 | 0.782 | 0.820 | 1e-138 |
| >gi|255584255|ref|XP_002532865.1| protein kinase atn1, putative [Ricinus communis] gi|223527377|gb|EEF29519.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1398), Expect = e-152, Method: Compositional matrix adjust.
Identities = 257/290 (88%), Positives = 273/290 (94%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VLNRGST +ERA LE RF REVNMMSRVKHDNLVKF+GACK+PLMVIVTELLPGMSLRK
Sbjct: 77 KVLNRGSTCEERAALENRFAREVNMMSRVKHDNLVKFIGACKEPLMVIVTELLPGMSLRK 136
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL+ +RPN+ DL +ALNFALDIARAMDCLHANGIIHRDLKPDNLLLT +QKS+KLADFGL
Sbjct: 137 YLIGIRPNQPDLRLALNFALDIARAMDCLHANGIIHRDLKPDNLLLTANQKSVKLADFGL 196
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP
Sbjct: 197 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 256
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP LPED SPDLAFI+QSCWVEDPNLRPSFSQIIRMLNAFLF
Sbjct: 257 FEGMSNLQAAYAAAFKQERPSLPEDTSPDLAFIIQSCWVEDPNLRPSFSQIIRMLNAFLF 316
Query: 247 TLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKN 296
TL PPS SVPES T+EAAA+SNG ++EFSARARGKFAFLRQLFTAKR +N
Sbjct: 317 TLSPPSTSVPESSTHEAAASSNGTVSEFSARARGKFAFLRQLFTAKRARN 366
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439671|ref|XP_002270753.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1351), Expect = e-146, Method: Compositional matrix adjust.
Identities = 247/293 (84%), Positives = 269/293 (91%), Gaps = 1/293 (0%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL+RGSTS+ERA LEGRF REVNMMSRVKH+NLVKF+GACKDPLMVIVTELLPGMSLRK
Sbjct: 82 KVLHRGSTSEERAALEGRFAREVNMMSRVKHENLVKFIGACKDPLMVIVTELLPGMSLRK 141
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL S+RP ++D+HVAL+FALDIARAM+CLHANGIIHRDLKPDNLLLT +QKS+KLADFGL
Sbjct: 142 YLTSIRPKRMDIHVALSFALDIARAMECLHANGIIHRDLKPDNLLLTANQKSVKLADFGL 201
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV WELLTNR+P
Sbjct: 202 AREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVFWELLTNRMP 261
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP LPEDISPDLAFI+QSCWVEDPN+RPSFSQIIRMLN F F
Sbjct: 262 FEGMSNLQAAYAAAFKQERPSLPEDISPDLAFIIQSCWVEDPNMRPSFSQIIRMLNTFHF 321
Query: 247 TLRPPSPS-VPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 298
+ PP S + ESDTN AA +SNG MTE SAR RGKF+FLRQLF AKRT+N Q
Sbjct: 322 KVTPPPSSLLEESDTNGAAMSSNGTMTELSARTRGKFSFLRQLFAAKRTRNSQ 374
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735553|emb|CBI18047.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1348), Expect = e-146, Method: Compositional matrix adjust.
Identities = 247/293 (84%), Positives = 269/293 (91%), Gaps = 1/293 (0%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL+RGSTS+ERA LEGRF REVNMMSRVKH+NLVKF+GACKDPLMVIVTELLPGMSLRK
Sbjct: 45 KVLHRGSTSEERAALEGRFAREVNMMSRVKHENLVKFIGACKDPLMVIVTELLPGMSLRK 104
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL S+RP ++D+HVAL+FALDIARAM+CLHANGIIHRDLKPDNLLLT +QKS+KLADFGL
Sbjct: 105 YLTSIRPKRMDIHVALSFALDIARAMECLHANGIIHRDLKPDNLLLTANQKSVKLADFGL 164
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV WELLTNR+P
Sbjct: 165 AREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVFWELLTNRMP 224
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP LPEDISPDLAFI+QSCWVEDPN+RPSFSQIIRMLN F F
Sbjct: 225 FEGMSNLQAAYAAAFKQERPSLPEDISPDLAFIIQSCWVEDPNMRPSFSQIIRMLNTFHF 284
Query: 247 TLRPPSPS-VPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 298
+ PP S + ESDTN AA +SNG MTE SAR RGKF+FLRQLF AKRT+N Q
Sbjct: 285 KVTPPPSSLLEESDTNGAAMSSNGTMTELSARTRGKFSFLRQLFAAKRTRNSQ 337
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139346|ref|XP_002323067.1| predicted protein [Populus trichocarpa] gi|222867697|gb|EEF04828.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 515 bits (1327), Expect = e-144, Method: Compositional matrix adjust.
Identities = 249/292 (85%), Positives = 275/292 (94%), Gaps = 2/292 (0%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL+ G+TS+ERA LE RF REVNMMSRVKH+NLVKF+GACKDP MVIVTELLPGMSLRK
Sbjct: 63 KVLHPGTTSEERAALEDRFAREVNMMSRVKHENLVKFIGACKDPFMVIVTELLPGMSLRK 122
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YLVS+RP +LDL+VA+NFALD+ARAMDCLHANGIIHRDLKPDNLLLT +QKS+KLADFGL
Sbjct: 123 YLVSIRPKQLDLYVAINFALDVARAMDCLHANGIIHRDLKPDNLLLTANQKSVKLADFGL 182
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+P
Sbjct: 183 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMP 242
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP LPED+SPDLAFI+QSCWVEDPNLRPSF+QIIRMLNAFLF
Sbjct: 243 FEGMSNLQAAYAAAFKQERPALPEDVSPDLAFIMQSCWVEDPNLRPSFNQIIRMLNAFLF 302
Query: 247 --TLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKN 296
+ P+PS+PESDTNEAA++SNG +TEFS+R RGKFAFLRQLFTAK+T+N
Sbjct: 303 TLSPPSPTPSLPESDTNEAASSSNGTITEFSSRTRGKFAFLRQLFTAKKTRN 354
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532165|ref|XP_003534644.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1304), Expect = e-141, Method: Compositional matrix adjust.
Identities = 250/292 (85%), Positives = 267/292 (91%), Gaps = 2/292 (0%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL+RGSTS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRK
Sbjct: 79 KVLHRGSTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRK 138
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL S+RP LDL VA+NFALDIARAMD LHANGIIHRDLKPDNLLLT DQKS+KLADFGL
Sbjct: 139 YLTSIRPKLLDLDVAINFALDIARAMDWLHANGIIHRDLKPDNLLLTADQKSVKLADFGL 198
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+P
Sbjct: 199 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMP 258
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RPG+P+DISP+LAF++QSCWVEDPNLRPSFSQIIRMLNAFLF
Sbjct: 259 FEGMSNLQAAYAAAFKQERPGIPDDISPELAFVIQSCWVEDPNLRPSFSQIIRMLNAFLF 318
Query: 247 TLRPPSPSVPESDTN--EAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKN 296
TL PPSP +P N E A TSNG +TEFSAR RGKF FLRQLF++KRTKN
Sbjct: 319 TLSPPSPPLPVPPDNEPEVATTSNGTITEFSARNRGKFGFLRQLFSSKRTKN 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388513773|gb|AFK44948.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1291), Expect = e-139, Method: Compositional matrix adjust.
Identities = 239/288 (82%), Positives = 260/288 (90%), Gaps = 2/288 (0%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL RG+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRK
Sbjct: 72 KVLQRGTTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRK 131
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL S+RP LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGL
Sbjct: 132 YLTSIRPKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGL 191
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+P
Sbjct: 192 AREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMP 251
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP +P+DISPDLAF++QSCWVEDPNLRPSFSQIIRMLN FLF
Sbjct: 252 FEGMSNLQAAYAAAFKQERPKIPDDISPDLAFVIQSCWVEDPNLRPSFSQIIRMLNEFLF 311
Query: 247 TLRPPSPSVPESDTNEAAATS--NGAMTEFSARARGKFAFLRQLFTAK 292
TL P P +PE D AAT+ NGA+TEFSAR +GKFAF RQLF++K
Sbjct: 312 TLSPLFPPLPEPDNEPKAATTSNNGAITEFSARNKGKFAFFRQLFSSK 359
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506577|ref|XP_003623577.1| Protein kinase, putative [Medicago truncatula] gi|355498592|gb|AES79795.1| Protein kinase, putative [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1286), Expect = e-139, Method: Compositional matrix adjust.
Identities = 249/305 (81%), Positives = 270/305 (88%), Gaps = 9/305 (2%)
Query: 1 MGKFMKE-------VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 53
M KF+KE VL RG+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMV
Sbjct: 22 MEKFIKEDQIVAIKVLQRGTTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMV 81
Query: 54 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 113
IVTELLPGMSLRKYL S+RP LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT
Sbjct: 82 IVTELLPGMSLRKYLTSIRPKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLT 141
Query: 114 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173
+QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF
Sbjct: 142 ANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 201
Query: 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
GIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P+DISPDLAF++QSCWVEDPNLRPS
Sbjct: 202 GIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPKIPDDISPDLAFVIQSCWVEDPNLRPS 261
Query: 234 FSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS--NGAMTEFSARARGKFAFLRQLFTA 291
FSQIIRMLN FLFTL P SP +PE D AAT+ NGA+TEFSAR +GKFAFLRQLF++
Sbjct: 262 FSQIIRMLNEFLFTLSPLSPPLPEPDNEPKAATTSNNGAITEFSARNKGKFAFLRQLFSS 321
Query: 292 KRTKN 296
KR KN
Sbjct: 322 KRIKN 326
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506575|ref|XP_003623576.1| Protein kinase, putative [Medicago truncatula] gi|355498591|gb|AES79794.1| Protein kinase, putative [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1281), Expect = e-138, Method: Compositional matrix adjust.
Identities = 244/292 (83%), Positives = 265/292 (90%), Gaps = 2/292 (0%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL RG+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRK
Sbjct: 72 KVLQRGTTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRK 131
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL S+RP LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGL
Sbjct: 132 YLTSIRPKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGL 191
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+P
Sbjct: 192 AREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMP 251
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP +P+DISPDLAF++QSCWVEDPNLRPSFSQIIRMLN FLF
Sbjct: 252 FEGMSNLQAAYAAAFKQERPKIPDDISPDLAFVIQSCWVEDPNLRPSFSQIIRMLNEFLF 311
Query: 247 TLRPPSPSVPESDTNEAAATS--NGAMTEFSARARGKFAFLRQLFTAKRTKN 296
TL P SP +PE D AAT+ NGA+TEFSAR +GKFAFLRQLF++KR KN
Sbjct: 312 TLSPLSPPLPEPDNEPKAATTSNNGAITEFSARNKGKFAFLRQLFSSKRIKN 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439809|ref|XP_004137678.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1279), Expect = e-138, Method: Compositional matrix adjust.
Identities = 242/295 (82%), Positives = 266/295 (90%), Gaps = 3/295 (1%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL+RGST +ERA LE RF REVNMMSRVKH+NLVKF+GACK+PLMVIVTELLPGMSLRK
Sbjct: 79 KVLHRGSTPEERAALESRFAREVNMMSRVKHENLVKFIGACKEPLMVIVTELLPGMSLRK 138
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL++ R +LD +A+NFALD+ARAMDCLHANGIIHRDLKPDNLLLT +Q+S+KLADFGL
Sbjct: 139 YLMNNRKQQLDPRMAINFALDVARAMDCLHANGIIHRDLKPDNLLLTANQRSVKLADFGL 198
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+P
Sbjct: 199 AREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMP 258
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP +P DISP+LAFIVQSCWVEDPN+RPSFSQIIRMLNA+LF
Sbjct: 259 FEGMSNLQAAYAAAFKQERPSIPGDISPELAFIVQSCWVEDPNMRPSFSQIIRMLNAYLF 318
Query: 247 TL---RPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 298
TL SPS P+SDT E A TSN A+TEFS+RARGKF FLRQLF AKR KN Q
Sbjct: 319 TLPPPSQSSPSSPKSDTTETATTSNSAITEFSSRARGKFGFLRQLFAAKRAKNSQ 373
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521717|ref|XP_004167876.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1279), Expect = e-138, Method: Compositional matrix adjust.
Identities = 242/295 (82%), Positives = 266/295 (90%), Gaps = 3/295 (1%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+VL+RGST +ERA LE RF REVNMMSRVKH+NLVKF+GACK+PLMVIVTELLPGMSLRK
Sbjct: 79 KVLHRGSTPEERAALESRFAREVNMMSRVKHENLVKFIGACKEPLMVIVTELLPGMSLRK 138
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL++ R +LD +A+NFALD+ARAMDCLHANGIIHRDLKPDNLLLT +Q+S+KLADFGL
Sbjct: 139 YLMNNRKQQLDPRMAINFALDVARAMDCLHANGIIHRDLKPDNLLLTANQRSVKLADFGL 198
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AREE+VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+P
Sbjct: 199 AREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMP 258
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP +P DISP+LAFIVQSCWVEDPN+RPSFSQIIRMLNA+LF
Sbjct: 259 FEGMSNLQAAYAAAFKQERPSIPGDISPELAFIVQSCWVEDPNMRPSFSQIIRMLNAYLF 318
Query: 247 TL---RPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 298
TL SPS P+SDT E A TSN A+TEFS+RARGKF FLRQLF AKR KN Q
Sbjct: 319 TLPPPSQSSPSSPKSDTTETATTSNSAITEFSSRARGKFGFLRQLFAAKRAKNSQ 373
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 298 | ||||||
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.963 | 0.861 | 0.745 | 2.2e-112 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.818 | 0.685 | 0.644 | 2.4e-83 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.808 | 0.682 | 0.652 | 1.7e-82 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.838 | 0.722 | 0.625 | 2.5e-81 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.828 | 0.609 | 0.494 | 2.1e-61 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.791 | 0.625 | 0.439 | 9.5e-50 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.765 | 0.554 | 0.430 | 1.4e-48 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.765 | 0.553 | 0.430 | 5.4e-47 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.741 | 0.420 | 0.402 | 8.1e-44 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.708 | 0.366 | 0.436 | 1.1e-41 |
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
Identities = 217/291 (74%), Positives = 241/291 (82%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+V+NRGS D+++ LE RF+REVNMMSRV+H NLVKF+GACKDPLMVIVTELLPGMSLRK
Sbjct: 45 KVVNRGSKPDQQSSLESRFVREVNMMSRVQHHNLVKFIGACKDPLMVIVTELLPGMSLRK 104
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL S+RP L L +AL+FALDIARA+ CLHANGIIHRDLKPDNLLLT + KS+KLADFGL
Sbjct: 105 YLTSIRPQLLHLPLALSFALDIARALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGL 164
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AR YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+P
Sbjct: 165 AREESVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMP 224
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK RP +PE ISP LAFIVQSCWVEDPN+RPSFSQIIR+LN FL
Sbjct: 225 FEGMSNLQAAYAAAFKQERPVMPEGISPSLAFIVQSCWVEDPNMRPSFSQIIRLLNEFLL 284
Query: 247 TLRPPSPS-VPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKN 296
TL PP P +PE+ TN T+ A+TEFS R +GKFAF+RQLF AKR N
Sbjct: 285 TLTPPPPQPLPETATNR---TNGRAITEFSIRPKGKFAFIRQLFAAKRNIN 332
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 835 (299.0 bits), Expect = 2.4e-83, P = 2.4e-83
Identities = 158/245 (64%), Positives = 195/245 (79%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+++ RG + +E A + RF RE+ M+S+V+H NLVKF+GACK+P+MVIVTELL G +LRK
Sbjct: 53 KIIKRGESPEEIAKRDNRFAREIAMLSKVQHKNLVKFIGACKEPMMVIVTELLLGGTLRK 112
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YLVSLRP +LD+ +A+ FALDIARAM+CLH++GIIHRDLKP+NL+L+ D K++KLADFGL
Sbjct: 113 YLVSLRPKRLDIRLAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGL 172
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AR YRWMAPELYSTVTLRQGEKKHYN+KVD YSF IVLWEL+ N+LP
Sbjct: 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLP 232
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK+ RP ED+ DL IV SCW EDPN RP+F++II+ML +L
Sbjct: 233 FEGMSNLQAAYAAAFKNLRPSA-EDLPGDLEMIVTSCWKEDPNERPNFTEIIQMLLRYLT 291
Query: 247 TLRPP 251
T+ P
Sbjct: 292 TVSAP 296
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 827 (296.2 bits), Expect = 1.7e-82, P = 1.7e-82
Identities = 158/242 (65%), Positives = 193/242 (79%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+++ RG + +E A E RF REV+M+SRV+H NLVKF+GACK+P+MVIVTELL G +LRK
Sbjct: 53 KIVKRGESPEEIAKRESRFAREVSMLSRVQHKNLVKFIGACKEPIMVIVTELLLGGTLRK 112
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YLVSLRP LD+ VA+ +ALDIARAM+CLH++G+IHRDLKP++L+LT D K++KLADFGL
Sbjct: 113 YLVSLRPGSLDIRVAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGL 172
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AR YRWMAPELYSTVTLR GEKKHYN+KVD YSF IVLWEL+ N+LP
Sbjct: 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLP 232
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK+ RP +D+ DLA IV SCW EDPN RP+F++II+ML L
Sbjct: 233 FEGMSNLQAAYAAAFKNVRPSA-DDLPKDLAMIVTSCWKEDPNDRPNFTEIIQMLLRCLS 291
Query: 247 TL 248
T+
Sbjct: 292 TI 293
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 816 (292.3 bits), Expect = 2.5e-81, P = 2.5e-81
Identities = 157/251 (62%), Positives = 193/251 (76%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
++++RG T +E A + RF+REV M+SRV+H NLVKF+GACK+P+MVIVTELL G +LRK
Sbjct: 47 KIVHRGETPEEIAKRDSRFLREVEMLSRVQHKNLVKFIGACKEPVMVIVTELLQGGTLRK 106
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL++LRP L+ VA+ FALDIAR M+CLH++GIIHRDLKP+NLLLT D K++KLADFGL
Sbjct: 107 YLLNLRPACLETRVAIGFALDIARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGL 166
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AR YRWMAPELYSTVTLR GEKKHYN+KVD YSF IVLWELL N+LP
Sbjct: 167 AREESLTEMMTAETGTYRWMAPELYSTVTLRLGEKKHYNHKVDAYSFAIVLWELLHNKLP 226
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
FEGMSNLQAAYAAAFK+ RP E + +L IV SCW EDPN RP+F+ II +L +L
Sbjct: 227 FEGMSNLQAAYAAAFKNVRPSA-ESLPEELGDIVTSCWNEDPNARPNFTHIIELLLNYLS 285
Query: 247 TLRPPSPSVPE 257
+ P ++P+
Sbjct: 286 KVGSPISAIPQ 296
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 2.1e-61, P = 2.1e-61
Identities = 124/251 (49%), Positives = 175/251 (69%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+F REV ++S+ +H+N+V+F+GAC +P ++I+TEL+ G +L+K+++S+RP LDL ++++
Sbjct: 116 KFQREVLLLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSIS 175
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXY 143
FALDIAR M+ L+ANGIIHRDLKP N+LLT DQK +KLADFGLAR Y
Sbjct: 176 FALDIARGMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREETKGFMTFEAGT-Y 234
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
RWMAPEL+S TL GEKKHY++KVDVYSF IV WELLTN+ PF+G +N+ AYAA+ K+
Sbjct: 235 RWMAPELFSYDTLEIGEKKHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAAS-KN 293
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE-SDTNE 262
RP + E++ + I+QSCW E+P+ RP F +I L L +L + + S N
Sbjct: 294 QRPSV-ENLPEGVVSILQSCWAENPDARPEFKEITYSLTNLLRSLSSDTDATSSNSKANI 352
Query: 263 AAATSNGAMTE 273
A S ++ +
Sbjct: 353 ATEDSTSSLVQ 363
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 9.5e-50, P = 9.5e-50
Identities = 105/239 (43%), Positives = 154/239 (64%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
+++ G TS + +F +EV ++S +KH+N+V+F+GAC +P ++IVTEL+ G +L++
Sbjct: 76 KIVQPGKTSAVSIQDKQQFQKEVLVLSSMKHENIVRFVGACIEPQLMIVTELVRGGTLQR 135
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
++++ RP+ LDL V+L+FALDI+RAM+ LH+ GIIHRDL P N+L+T D K +KLADFGL
Sbjct: 136 FMLNSRPSPLDLKVSLSFALDISRAMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGL 195
Query: 127 ARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
AR YRWMAPE+ S LR GEKKHY+ K+DVYSF ++ W LLTN+ P
Sbjct: 196 AREKTLGGMTCEAGT-YRWMAPEVCSREPLRIGEKKHYDQKIDVYSFALIFWSLLTNKTP 254
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
F + ++ Y + RP L +I ++ I++ CW D R F I L + L
Sbjct: 255 FSEIPSISIPYFVN-QGKRPSL-SNIPDEVVPILECCWAADSKTRLEFKDITISLESLL 311
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 1.4e-48, P = 1.4e-48
Identities = 103/239 (43%), Positives = 152/239 (63%)
Query: 7 EVLNRGSTSDERA-LLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM-VIVTELLPGMSL 64
++L R S E+A +E +F +EV+M++ +KH N+V+F+GAC+ P++ IVTE G S+
Sbjct: 157 KILERPENSPEKAQFMEQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV 216
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
R++L + + L +A+ ALD+AR M +H IHRDLK DNLL++ D KS+K+ADF
Sbjct: 217 RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLISAD-KSIKIADF 275
Query: 125 GLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
G+AR YRWMAPE+ + + YN KVDVYSFGIVLWEL+T
Sbjct: 276 GVARIEVQTEGMTPETGTYRWMAPEMI--------QHRAYNQKVDVYSFGIVLWELITGL 327
Query: 185 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
LPF+ M+ +QAA+A + RP +P D P L+ I+ CW +P +RP F +++++L A
Sbjct: 328 LPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLEA 386
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 5.4e-47, P = 5.4e-47
Identities = 103/239 (43%), Positives = 150/239 (62%)
Query: 7 EVLNRGSTSDERA-LLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM-VIVTELLPGMSL 64
++L R ++ E+A LE +F +EV+M++ +KH N+V+F+GAC P++ IVTE G S+
Sbjct: 158 KLLERSDSNPEKAQALEQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSV 217
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
R++L + + L +A+ ALD+AR M +H IHRDLK DNLL++ D +S+K+ADF
Sbjct: 218 RQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLISAD-RSIKIADF 276
Query: 125 GLARXXXXXXXXXXXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
G+AR YRWMAPE+ + + Y KVDVYSFGIVLWEL+T
Sbjct: 277 GVARIEVQTEGMTPETGTYRWMAPEMI--------QHRPYTQKVDVYSFGIVLWELITGL 328
Query: 185 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
LPF+ M+ +QAA+A + RP +P D P L I+ CW DP +RP F++I+ +L A
Sbjct: 329 LPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLEA 387
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 8.1e-44, P = 8.1e-44
Identities = 93/231 (40%), Positives = 141/231 (61%)
Query: 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLD 77
A LE +F +EV ++SR+ H N++KF+GA KDP + ++T+ LP SLR +L L
Sbjct: 249 ARLEKQFTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLP 308
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXX 137
L + FA+DIAR M+ +H+ IIHRDLKP+N+L+ ++ LK+ADFG+A
Sbjct: 309 LKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLID-EEFHLKIADFGIACEEEYCDMLA 367
Query: 138 XXXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
YRWMAPE+ ++K + K DVYSFG+VLWE++ +P+E M+ +QAA+
Sbjct: 368 DDPGTYRWMAPEMI--------KRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAF 419
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
A K+ RP +P D + +++ CW P+ RP F QI+++L F +L
Sbjct: 420 AVVHKNIRPAIPGDCPVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFAISL 470
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 1.1e-41, P = 1.1e-41
Identities = 97/222 (43%), Positives = 131/222 (59%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
LE F +EV +M +V+H N+V+F+GAC K P + IVTE +PG S+ YL + L
Sbjct: 328 LEKEFAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQK-GVFKLP 386
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXX 139
A+DI + M LH N IIHRDLK NLL+ + + +K+ADFG+AR
Sbjct: 387 TLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQTGVMTAE 445
Query: 140 XXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
YRWMAPE+ E K Y++K DV+S+GIVLWELLT +LP+E M+ LQAA
Sbjct: 446 TGTYRWMAPEVI--------EHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGV 497
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
K RP +P++ P LA +++ W D RP FS+II L
Sbjct: 498 VQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDFSEIIEQL 539
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00037482001 | SubName- Full=Chromosome chr8 scaffold_88, whole genome shotgun sequence; (337 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 298 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-67 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-66 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-63 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-63 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-39 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-36 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-35 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-35 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-34 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-34 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-33 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-32 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-32 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-32 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-31 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-30 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-30 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-29 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-29 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-28 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-27 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-26 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-26 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-25 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-25 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-24 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-23 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-21 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-21 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-21 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-20 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-18 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-17 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-17 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-16 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-11 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-06 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 6e-04 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 5e-67
Identities = 85/238 (35%), Positives = 132/238 (55%), Gaps = 18/238 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
L ++ + F+RE +M ++ H N+VK LG C ++ ++IV E +PG L
Sbjct: 35 TLKEDASEQQIEE----FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLD 90
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL RP +L L L+FAL IAR M+ L + IHRDL N L+ + +K++DFGL
Sbjct: 91 YLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGL 149
Query: 127 AREETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN- 183
+R+ + + G RWMAPE +L++G+ + +K DV+SFG++LWE+ T
Sbjct: 150 SRDLYDDDYYKVKGGKLPIRWMAPE-----SLKEGK---FTSKSDVWSFGVLLWEIFTLG 201
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
P+ GMSN + K R P + P+L ++ CW EDP RP+FS+++ +L
Sbjct: 202 EEPYPGMSNAE-VLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 7e-66
Identities = 82/240 (34%), Positives = 128/240 (53%), Gaps = 23/240 (9%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
L ++ + F+RE +M ++ H N+VK LG C ++ + IV E + G L
Sbjct: 35 TLKEDASEQQIEE----FLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLS 90
Query: 67 YLVSLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
YL RP L ++ L+FAL IAR M+ L + IHRDL N L+ + +K++DF
Sbjct: 91 YLRKNRPK---LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDF 146
Query: 125 GLAREETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
GL+R+ + G RWMAPE +L++G+ + +K DV+SFG++LWE+ T
Sbjct: 147 GLSRDLYDDDYYRKRGGKLPIRWMAPE-----SLKEGK---FTSKSDVWSFGVLLWEIFT 198
Query: 183 N-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
P+ GMSN + R P + P+L ++ CW EDP RP+FS+++ +L
Sbjct: 199 LGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 1e-63
Identities = 74/220 (33%), Positives = 114/220 (51%), Gaps = 14/220 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
R +RE+ ++ ++KH N+V+ +D + +V E G L L +L A
Sbjct: 43 RILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEAR 100
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 142
+ I A++ LH+ GI+HRDLKP+N+LL D +KLADFGLAR+ E +T GT
Sbjct: 101 FYLRQILSALEYLHSKGIVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGT 159
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+MAPE+ K Y VD++S G++L+ELLT + PF G L + K
Sbjct: 160 PEYMAPEVLL--------GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 211
Query: 203 HARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
P P DISP+ +++ V+DP R + + ++
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 2e-63
Identities = 82/240 (34%), Positives = 126/240 (52%), Gaps = 22/240 (9%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
L G++ +ER F+ E ++M ++ H N+V+ LG C +PL IVTE +PG L
Sbjct: 35 TLKEGASEEERE----EFLEEASIMKKLSHPNIVRLLGVCTQGEPLY-IVTEYMPGGDLL 89
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+L KL L L AL IA+ M+ L + +HRDL N L+T + +K++DFG
Sbjct: 90 DFLRK-HGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVT-ENLVVKISDFG 147
Query: 126 LAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
L+R+ + G +WMAPE L+ G+ + +K DV+SFG++LWE+ T
Sbjct: 148 LSRDIYEDDYYRKRGGGKLPIKWMAPES-----LKDGK---FTSKSDVWSFGVLLWEIFT 199
Query: 183 N-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
P+ GMSN + R PE+ +L ++ CW DP RP+FS+++ L
Sbjct: 200 LGEQPYPGMSNEE-VLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 2e-61
Identities = 80/230 (34%), Positives = 124/230 (53%), Gaps = 24/230 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP-------NK 75
F++E +M ++ H N+V+ LG C ++PL +V E + G L YL RP +
Sbjct: 43 FLKEARVMKKLGHPNVVRLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKST 101
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
L L L+FA+ IA+ M+ L + +HRDL N L+ D +K++DFGL+R+ +
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDY 160
Query: 136 MTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMS 191
+TG RWMAPE +L+ G + +K DV+SFG++LWE+ T P+ G+S
Sbjct: 161 YRKKTGGKLPIRWMAPE-----SLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212
Query: 192 NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
N + K R PE +L ++ SCW DP RP+FS+++ L
Sbjct: 213 NEE-VLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 9e-58
Identities = 81/241 (33%), Positives = 123/241 (51%), Gaps = 23/241 (9%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMS 63
+K + R S + RE+ ++ R+ H N+V+ + A +D + +V E G
Sbjct: 29 VKILKKRSEKSKKDQ----TARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGD 84
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L YL P L A AL I R ++ LH+NGIIHRDLKP+N+LL + +K+AD
Sbjct: 85 LFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENG-VVKIAD 141
Query: 124 FGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
FGLA++ + +T GT +MAPE+ L G Y KVDV+S G++L+ELLT
Sbjct: 142 FGLAKKLLKSSSSLTTFVGTPWYMAPEV-----LLGG--NGYGPKVDVWSLGVILYELLT 194
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPED------ISPDLAFIVQSCWVEDPNLRPSFSQ 236
+ PF G N+ + P L D S + +++ C +DP+ RP+ +
Sbjct: 195 GKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEE 253
Query: 237 I 237
I
Sbjct: 254 I 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 6e-57
Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 43/223 (19%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLH 79
L +RE+ ++ ++ H N+VK G +D + +V E G SL+ L KL
Sbjct: 34 LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSED 92
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
L L I ++ LH+NGIIHRDLKP+N+LL D +KLADFGL++ T + +
Sbjct: 93 EILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152
Query: 140 T-GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
GT +MAPE+ K +Y+ K D++S G++L+EL
Sbjct: 153 IVGTPAYMAPEVLL-------GKGYYSEKSDIWSLGVILYEL------------------ 187
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
P+L +++ +DP RPS +I+ L
Sbjct: 188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-47
Identities = 75/245 (30%), Positives = 116/245 (47%), Gaps = 26/245 (10%)
Query: 2 GKFM--KEV-LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV---IV 55
G+ M K V L+ S + AL RE+ ++S ++H N+V++ G+ +D I
Sbjct: 25 GELMAVKSVELSGDSEEELEALE-----REIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79
Query: 56 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 115
E + G SL L KL V + I + LH+NGI+HRD+K N+L+ D
Sbjct: 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137
Query: 116 QKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
+KLADFG A+ + E + GT WMAPE+ +R E Y D++S
Sbjct: 138 GV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-----IRGEE---YGRAADIWS 188
Query: 173 FGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
G + E+ T + P+ + N AA Y P +PE +S + ++ C DP R
Sbjct: 189 LGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKR 248
Query: 232 PSFSQ 236
P+ +
Sbjct: 249 PTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 68/240 (28%), Positives = 120/240 (50%), Gaps = 18/240 (7%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMS 63
+KE+ + ER + EV ++ ++ H N++K+ + ++ + IV E G
Sbjct: 30 LKEIDLSNMSEKERE----DALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85
Query: 64 LRKYLVSLRPNKLDL--HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
L + + + L++ + + A+ LH+ I+HRD+KP N+ LT + +KL
Sbjct: 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL-VKL 144
Query: 122 ADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
DFG+++ + ++ GT +++PEL + K YN K D++S G VL+EL
Sbjct: 145 GDFGISKVLSSTVDLAKTVVGTPYYLSPELC--------QNKPYNYKSDIWSLGCVLYEL 196
Query: 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
T + PFEG + L+ A P +P S +L +V S +DP RPS +QI++
Sbjct: 197 CTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-38
Identities = 77/232 (33%), Positives = 122/232 (52%), Gaps = 21/232 (9%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E A+ E FI E +M ++ H NLV+ G C K + IVTE + L YL R K
Sbjct: 38 EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGK 96
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
L L+ D+ AM+ L +NG IHRDL N L+ + +K++DFGLAR + +
Sbjct: 97 LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG-EDNVVKVSDFGLAR-YVLDDQ 154
Query: 136 MTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 191
T+ GT +W PE++ +++K DV+SFG+++WE+ + ++P+E S
Sbjct: 155 YTSSQGTKFPVKWAPPEVFD--------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
Query: 192 NLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
N + +A ++ RP L ++ I+ SCW E P RP+F +++ L
Sbjct: 207 NSEVVESVSAGYRLYRPKL---APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-36
Identities = 72/216 (33%), Positives = 113/216 (52%), Gaps = 18/216 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL-HVAL 82
I E+ ++ + KH N+VK+ G+ KD L IV E G SL+ L+ L +A
Sbjct: 45 INEIQILKKCKHPNIVKYYGSYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLTESQIAY 102
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 142
++ + ++ LH+NGIIHRD+K N+LLT D + +KL DFGL+ + + T+ GT
Sbjct: 103 -VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGT 160
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + K Y+ K D++S GI EL + P+ + ++A + A
Sbjct: 161 PYWMAPEVIN--------GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN 212
Query: 203 HARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
PGL PE S + ++ C ++P RP+ Q
Sbjct: 213 GP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-36
Identities = 76/225 (33%), Positives = 119/225 (52%), Gaps = 20/225 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F+ E ++M+ ++H NLV+ LG +PL IVTE + SL YL S + L L
Sbjct: 47 FLAEASVMTTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQL 105
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 142
FALD+ M+ L +HRDL N+L++ + K++DFGLA+E + + ++G
Sbjct: 106 GFALDVCEGMEYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQ----DSGK 160
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LR +K ++ K DV+SFGI+LWE+ + R+P+ + L+
Sbjct: 161 LPVKWTAPE-----ALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPH 211
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
K R PE P++ +++ CW DP RP+F Q+ L
Sbjct: 212 VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 85/241 (35%), Positives = 122/241 (50%), Gaps = 30/241 (12%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLR 72
S L+ +F++E ++ + H N+VK +G C K P+ IV EL+PG SL +L R
Sbjct: 29 STLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY-IVMELVPGGSLLTFL---R 84
Query: 73 PNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
K L V L +LD A M+ L + IHRDL N L+ + LK++DFG++REE
Sbjct: 85 KKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG-ENNVLKISDFGMSREE 143
Query: 131 TVTEMMTAETGT----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 185
+ T G +W APE L G Y ++ DV+S+GI+LWE +
Sbjct: 144 E-GGIYTVSDGLKQIPIKWTAPE-----ALNYGR---YTSESDVWSYGILLWETFSLGDT 194
Query: 186 PFEGMSNLQA--AYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ GMSN Q + ++ P L PE+I ++ CW DP RPSFS+I L
Sbjct: 195 PYPGMSNQQTRERIESGYRMPAPQLCPEEIYR----LMLQCWAYDPENRPSFSEIYNELQ 250
Query: 243 A 243
Sbjct: 251 I 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (328), Expect = 2e-35
Identities = 73/246 (29%), Positives = 115/246 (46%), Gaps = 22/246 (8%)
Query: 24 RFIREVNMMSRVKH-DNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSL-RPNKLDLHV 80
RF+RE+ +++ + H N+VK +D + +V E + G SL L + R L
Sbjct: 43 RFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-------ETVT 133
AL I A++ LH+ GIIHRD+KP+N+LL D + +KL DFGLA+ ++
Sbjct: 103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162
Query: 134 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+ + GT +MAPE+ L + ++ D++S GI L+ELLT PFEG N
Sbjct: 163 ALPSTSVGTPGYMAPEV-----LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
A + K ++ L+ + + S +++ L A R S
Sbjct: 218 S-ATSQTLKIILELPTPSLASPLSPSNP------ELISKAASDLLKKLLAKDPKNRLSSS 270
Query: 254 SVPESD 259
S D
Sbjct: 271 SDLSHD 276
|
Length = 384 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 75/248 (30%), Positives = 121/248 (48%), Gaps = 31/248 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRK 66
+N ++ ER +E F+ E ++M ++V+ LG P +V++ EL+ L+
Sbjct: 44 VNENASMRER--IE--FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM-ELMAKGDLKS 98
Query: 67 YLVSLRPNK--------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 118
YL S RP L + A +IA M L A +HRDL N ++ D +
Sbjct: 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-T 157
Query: 119 LKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFG+ R+ T+ RWMAPE +L+ G + K DV+SFG+
Sbjct: 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-----SLKDG---VFTTKSDVWSFGV 209
Query: 176 VLWELLT-NRLPFEGMSNLQA-AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
VLWE+ T P++G+SN + + H LPE+ L +++ CW +P +RP+
Sbjct: 210 VLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD--LPENCPDKLLELMRMCWQYNPKMRPT 267
Query: 234 FSQIIRML 241
F +I+ L
Sbjct: 268 FLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-35
Identities = 70/231 (30%), Positives = 105/231 (45%), Gaps = 32/231 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD---LHVA 81
F++E +M + H+NL++ G +++VTEL P SL L LR + L +
Sbjct: 43 FLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSL---LDRLRKDALGHFLISTL 99
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 141
++A+ IA M L + IHRDL N+LL D K +K+ DFGL R E
Sbjct: 100 CDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-VKIGDFGLMRALPQNEDH----- 153
Query: 142 TYR----------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190
Y W APE T T +++ DV+ FG+ LWE+ T P+ G+
Sbjct: 154 -YVMEEHLKVPFAWCAPESLRTRT--------FSHASDVWMFGVTLWEMFTYGEEPWAGL 204
Query: 191 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
S Q + R PE D+ ++ CW +P RP+F+ + L
Sbjct: 205 SGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
I E+ +M KH N+V + + + +V E + G SL +++ +++
Sbjct: 63 INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYV 121
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
++ + ++ LH+ +IHRD+K DN+LL+ D S+KLADFG A + T + GT
Sbjct: 122 CREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTP 180
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
WMAPE+ +K Y KVD++S GI+ E+ P+ L+A + K
Sbjct: 181 YWMAPEVIK--------RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK- 231
Query: 204 ARPGLP-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
G+P E SP+ + C V+DP RPS ++++
Sbjct: 232 ---GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-34
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 21/233 (9%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNK 75
+ A + F+RE ++M+++ H +V+ +G CK +++V EL P L KYL R
Sbjct: 34 EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK-RREI 92
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TE 134
+ A +A M L + +HRDL N+LL ++ K++DFG++R ++
Sbjct: 93 PVSDL-KELAHQVAMGMAYLESKHFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSD 150
Query: 135 MMTAETG---TYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 188
A T +W APE Y +++K DV+S+G+ LWE + P+
Sbjct: 151 YYRATTAGRWPLKWYAPECINYGK----------FSSKSDVWSYGVTLWEAFSYGAKPYG 200
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
M + A R PE+ ++ I+ SCW P RP+FS++
Sbjct: 201 EMKGAEVI-AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-34
Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E +M+ V H ++V+ LG C + ++T+L+P L Y+ + + N + LN+
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNW 114
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE-ETVTEMMTAETGT 142
+ IA+ M L ++HRDL N+L+ TP +K+ DFGLA+ + + AE G
Sbjct: 115 CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMA E ++ Y +K DV+S+G+ +WEL+T P+EG+
Sbjct: 173 VPIKWMALE-----SILHRI---YTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDL 223
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
K R P + D+ ++ CW+ D RP+F ++I +
Sbjct: 224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-34
Identities = 72/243 (29%), Positives = 118/243 (48%), Gaps = 24/243 (9%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMS 63
+KE+ R +D + + E E+ ++ +KH NLVK+ G + I E G +
Sbjct: 30 VKEI--RIQDNDPKTIKEIA--DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L + L R LD HV + L + + LH++GI+HRD+KP N+ L +KL D
Sbjct: 86 LEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD-HNGVIKLGD 142
Query: 124 FG----LAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
FG L T E + + GT +MAPE+ G+ K + D++S G V+
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI-----TGGKGKGHGRAADIWSLGCVVL 197
Query: 179 ELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPE--DISPD-LAFIVQSCWVEDPNLRPSF 234
E+ T + P+ + N Q + H +P +P+ +SP+ F+ + C DP RP+
Sbjct: 198 EMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEGKDFLDR-CLESDPKKRPTA 255
Query: 235 SQI 237
S++
Sbjct: 256 SEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 73/223 (32%), Positives = 117/223 (52%), Gaps = 26/223 (11%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F++E +M +KH NLV+ LG C ++P I+TE + +L YL +++ V L
Sbjct: 49 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 108
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT- 142
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R +MT +T T
Sbjct: 109 MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSR------LMTGDTYTA 161
Query: 143 -------YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQ 194
+W APE + ++ K DV++FG++LWE+ T + P+ G+ +L
Sbjct: 162 HAGAKFPIKWTAPESLAYNK--------FSIKSDVWAFGVLLWEIATYGMSPYPGI-DLS 212
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
Y K R PE P + ++++CW +P+ RPSF++I
Sbjct: 213 QVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 20/230 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMS 63
MK VL + + + + E N++SR+ H +VK A + + +V E PG
Sbjct: 23 MK-VLKKKKIIKRKEVE--HTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L +L + A +A +I A++ LH+ GII+RDLKP+N+LL +KL D
Sbjct: 80 LFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD-ADGHIKLTD 136
Query: 124 FGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
FGLA+E +E T GT ++APE V L +G Y VD +S G++L+E+L
Sbjct: 137 FGLAKEL-SSEGSRTNTFCGTPEYLAPE----VLLGKG----YGKAVDWWSLGVLLYEML 187
Query: 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
T + PF + + Y PE +SP+ ++ +DP R
Sbjct: 188 TGKPPFYA-EDRKEIY-EKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 37/254 (14%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L +G+T E+ F++E ++MS H N+VK LG C +P +I+ EL+ G L
Sbjct: 34 LRKGATDQEKK----EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM-ELMEGGDLLS 88
Query: 67 YLVSLRPNK-----LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--- 118
YL R + L L L+ LD+A+ L IHRDL N L++
Sbjct: 89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148
Query: 119 -LKLADFGLAREETVTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174
+K+ DFGLAR+ ++ E RWMAPE +L G+ + + DV+SFG
Sbjct: 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE-----SLLDGK---FTTQSDVWSFG 200
Query: 175 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPN 229
+++WE+LT + P+ ++N + +H G PE+ + ++ +CW +DP+
Sbjct: 201 VLMWEILTLGQQPYPALNNQEV-----LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPS 255
Query: 230 LRPSFSQIIRMLNA 243
RP+F +I +L
Sbjct: 256 ERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 77/249 (30%), Positives = 124/249 (49%), Gaps = 30/249 (12%)
Query: 2 GKF--MKEVL--NRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVI 54
G F +KEV + G T E LE +E+ ++S+++H N+V++LG + D L I
Sbjct: 25 GDFFAVKEVSLADDGQTGQEAVKQLE----QEIALLSKLQHPNIVQYLGTEREEDNLY-I 79
Query: 55 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114
EL+PG SL K L V + I ++ LH +HRD+K N+L+
Sbjct: 80 FLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT 137
Query: 115 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174
+ +KLADFG+A++ + G+ WMAPE V +QG Y D++S G
Sbjct: 138 N-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE----VIAQQGG---YGLAADIWSLG 189
Query: 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQSCWVEDPNL 230
+ E+ T + P+ S L+ AA FK R P +P+ +S + + C DP+L
Sbjct: 190 CTVLEMATGKPPW---SQLEG-VAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSL 245
Query: 231 RPSFSQIIR 239
RP+ ++++
Sbjct: 246 RPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 76/228 (33%), Positives = 114/228 (50%), Gaps = 22/228 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +++HD LV+ C ++P+ IVTE + SL +L S KL L +
Sbjct: 48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLV 106
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 142
+ A IA M L + IHRDL N+L+ + K+ADFGLAR E TA G
Sbjct: 107 DMAAQIAEGMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLARLIEDDE-YTAREGA 164
Query: 143 ---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
+W APE Y T+ K DV+SFGI+L E++T R+P+ GM+N +
Sbjct: 165 KFPIKWTAPEAANYGRFTI----------KSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
+ P P + +L ++ CW +DP RP+F + L +
Sbjct: 215 EQVERGYRMP-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 73/218 (33%), Positives = 111/218 (50%), Gaps = 22/218 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F+ E +M +++H L++ C ++P + IVTEL+ SL +YL L L +
Sbjct: 48 FLAEAQIMKKLRHPKLIQLYAVCTLEEP-IYIVTELMKYGSLLEYLQGGAGRALKLPQLI 106
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 142
+ A +A M L A IHRDL N+L+ + K+ADFGLAR ++ A G
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLAR-VIKEDIYEAREGA 164
Query: 143 ---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196
+W APE LY+ ++ K DV+SFGI+L E++T R+P+ GM+N +
Sbjct: 165 KFPIKWTAPEAALYNRFSI----------KSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+ P P +L I+ CW EDP+ RP+F
Sbjct: 215 QQVDQGYRMP-CPPGCPKELYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-32
Identities = 75/218 (34%), Positives = 120/218 (55%), Gaps = 19/218 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F+ E ++M++++H NLV+ LG + + IVTE + SL YL S + L L
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 142
F+LD+ AM+ L AN +HRDL N+L++ D + K++DFGL +E + T+ +TG
Sbjct: 106 KFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQ----DTGK 160
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+W APE LR+ K ++ K DV+SFGI+LWE+ + R+P+ + L+
Sbjct: 161 LPVKWTAPE-----ALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPR 211
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K + P+ P + +++ CW D RPSF Q+
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-32
Identities = 70/232 (30%), Positives = 116/232 (50%), Gaps = 20/232 (8%)
Query: 13 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSL 71
T E LE E+ ++ ++H+ +V++ G +D + I E +PG S++ L +
Sbjct: 43 ETKKEVNALEC----EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY 98
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REE 130
L V + I ++ LH+N I+HRD+K N+L ++KL DFG + R +
Sbjct: 99 GA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRLQ 155
Query: 131 TV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
T+ M + TGT WM+PE+ S GE Y K DV+S G + E+LT + P+
Sbjct: 156 TICSSGTGMKSVTGTPYWMSPEVIS------GEG--YGRKADVWSVGCTVVEMLTEKPPW 207
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ A + A + P LP +SPD ++ +VE+ RPS +++R
Sbjct: 208 AEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-32
Identities = 74/232 (31%), Positives = 119/232 (51%), Gaps = 21/232 (9%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN 74
E A+ E FI E +M ++ H LV+ G C + PL IVTE + L YL R
Sbjct: 38 EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY-IVTEFMENGCLLNYLRQ-RQG 95
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 134
KL + L+ D+ M+ L N IHRDL N L++ +K++DFG+ R E
Sbjct: 96 KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE 154
Query: 135 MMTAETGTY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMS 191
++ + +W PE+++ Y++K DV+SFG+++WE+ T ++PFE S
Sbjct: 155 YTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
Query: 192 NLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
N + + F+ RP L S + ++ SCW E P RP+F++++R +
Sbjct: 207 NYEVVEMISRGFRLYRPKLA---SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 78/247 (31%), Positives = 123/247 (49%), Gaps = 42/247 (17%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP-----NKL 76
+ E+ MM + KH N++ LG C + PL V+V E +LR +L + RP +
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPD 120
Query: 77 DLHVA---------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
D ++FA +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIADFGLA 179
Query: 128 REETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R+ + T +WMAPE L+ V Y ++ DV+SFG++LWE+ T
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLLWEIFTL 230
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
P+ G+ FK + G P++ + +L +++ CW E P+ RP+F Q++
Sbjct: 231 GGSPYPGI-----PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285
Query: 239 RMLNAFL 245
L+ L
Sbjct: 286 EDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 71/236 (30%), Positives = 114/236 (48%), Gaps = 19/236 (8%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR 72
+ L + F +EV + R++H +L+ C +P+ I+TEL+ SL +L S
Sbjct: 39 KSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPE 97
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EE 130
L + ++ A +A M L IHRDL N+L+ + K+ADFGLAR +E
Sbjct: 98 GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKE 156
Query: 131 TVTEMMTAETGT-YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 188
V ++++ Y+W APE S ++ K DV+SFGI+L+E+ T ++P+
Sbjct: 157 DV--YLSSDKKIPYKWTAPEAAS--------HGTFSTKSDVWSFGILLYEMFTYGQVPYP 206
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
GM+N Y R P ++ I+ CW +P RPSF + L+
Sbjct: 207 GMNN-HEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-30
Identities = 79/238 (33%), Positives = 119/238 (50%), Gaps = 37/238 (15%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
L+ +F+ E ++ + H N+VK +G C + P+ IV EL+PG +L LR K +L
Sbjct: 35 LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIY-IVMELVPGGD---FLSFLRKKKDEL 90
Query: 79 HVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
+ FALD A M L + IHRDL N L+ + LK++DFG++R+E
Sbjct: 91 KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG-ENNVLKISDFGMSRQE------ 143
Query: 137 TAETGTY----------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 185
+ G Y +W APE L G Y+++ DV+S+GI+LWE +
Sbjct: 144 --DDGIYSSSGLKQIPIKWTAPE-----ALNYGR---YSSESDVWSYGILLWETFSLGVC 193
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
P+ GM+N QA K R P+ D+ ++Q CW P RP FS++ + L A
Sbjct: 194 PYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 16/223 (7%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+F++E +M + H ++VK +G + + IV EL P LR YL + LDL +
Sbjct: 53 KFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLIL 111
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGT 142
++ ++ A+ L + +HRD+ N+L+ +PD +KL DFGL+R A G
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESYYKASKGK 169
Query: 143 Y--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 199
+WMAPE ++ R+ + + DV+ FG+ +WE+L PF+G+ N
Sbjct: 170 LPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGR 220
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
R +P + P L ++ CW DP+ RP F+++ L+
Sbjct: 221 IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 43/246 (17%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ + H+N+VK+ G C+ P + ++ E LP SLR YL R ++L
Sbjct: 53 FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRL 111
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 141
L F+ I + MD L + IHRDL N+L+ + +K++DFGLA+ ++ +
Sbjct: 112 LLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAK------VLPEDKD 164
Query: 142 TY----------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----NRLPF 187
Y W APE T +++ DV+SFG+ L+EL T ++ P
Sbjct: 165 YYYVKEPGESPIFWYAPECLRTSK--------FSSASDVWSFGVTLYELFTYGDPSQSPP 216
Query: 188 EGMSNLQAAYAAAFKHAR--------PGLPE-DISPDLAF-IVQSCWVEDPNLRPSFSQI 237
+ R LP PD + +++ CW +P RPSF+ +
Sbjct: 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
Query: 238 IRMLNA 243
I +++
Sbjct: 277 ILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-30
Identities = 74/231 (32%), Positives = 121/231 (52%), Gaps = 22/231 (9%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
L+ +F++E ++ + H N+V+ +G C K P+ IV EL+ G +L + P +L +
Sbjct: 36 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGP-RLKV 93
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
+ + A M+ L + IHRDL N L+T ++ LK++DFG++REE + + A
Sbjct: 94 KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEE--DGVYA 150
Query: 139 ETGTYR-----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
TG + W APE L G Y+++ DV+SFGI+LWE + +P+ +SN
Sbjct: 151 STGGMKQIPVKWTAPE-----ALNYGR---YSSESDVWSFGILLWEAFSLGAVPYANLSN 202
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
Q A + R PE + +++ CW DP RPSFS + + L +
Sbjct: 203 QQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-30
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E ++ + H LV + + M +V +LL G LR +L + K +
Sbjct: 48 LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFW 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTY 143
+I A++ LH+ GIIHRD+KPDN+LL D++ + + DF +A + T + T+ +GT
Sbjct: 106 ICEIVLALEYLHSKGIIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDTLTTSTSGTP 163
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFK 202
+MAPE+ + Y+ VD +S G+ +E L + P+ G S ++ A +
Sbjct: 164 GYMAPEVLCR--------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE 215
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
A P S + + DP R +
Sbjct: 216 TADVLYPATWSTEAIDAINKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-30
Identities = 69/220 (31%), Positives = 115/220 (52%), Gaps = 20/220 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
++E++++ +KH N+VK++G+ + + I+ E SLR+ + + +
Sbjct: 46 IMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAV 103
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGT 142
+ + + + LH G+IHRD+K N+L T D +KLADFG+A + V++ + GT
Sbjct: 104 YVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGT 162
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE V G + D++S G + ELLT P+ +L AA F+
Sbjct: 163 PYWMAPE----VIEMSG----ASTASDIWSLGCTVIELLTGNPPY---YDLNPM-AALFR 210
Query: 203 HA---RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P LPE ISP+L + C+ +DPNLRP+ Q+++
Sbjct: 211 IVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 69/220 (31%), Positives = 115/220 (52%), Gaps = 17/220 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E +M+++ H NLV+ LG + IV EL+ +L +L + + + L F
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 143
+LD+A M+ L + ++HRDL N+L++ D + K++DFGLAR M +
Sbjct: 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVA-KVSDFGLAR----VGSMGVDNSKLP 160
Query: 144 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 201
+W APE L+ + +++K DV+S+G++LWE+ + R P+ MS L+
Sbjct: 161 VKWTAPE-----ALKHKK---FSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVE 211
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
K R PE D+ ++ SCW +P RPSF ++ L
Sbjct: 212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 24/241 (9%)
Query: 13 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLV- 69
T DE E F RE++M ++ H N+V+ LG C +P ++ E L+++L
Sbjct: 45 KTKDENLQSE--FRRELDMFRKLSHKNVVRLLGLCREAEP-HYMILEYTDLGDLKQFLRA 101
Query: 70 ------SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L+P L + IA MD L +HRDL N L++ Q+ +K++
Sbjct: 102 TKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS-SQREVKVSL 160
Query: 124 FGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
L+++ +E + RW+APE +++ + ++ K DV+SFG+++WE+
Sbjct: 161 LSLSKDVYNSEYYKLRNALIPLRWLAPE-----AVQEDD---FSTKSDVWSFGVLMWEVF 212
Query: 182 TN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
T LPF G+S+ + +PE L ++ CW +P RPSFS+++
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272
Query: 241 L 241
L
Sbjct: 273 L 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 2e-29
Identities = 61/172 (35%), Positives = 92/172 (53%), Gaps = 16/172 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLG-ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE++++ +KH N+VK L + + +V E M L+KYL RP L ++ +
Sbjct: 46 LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYL-DKRPGPLSPNLIKSI 103
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGT- 142
+ R + H++ I+HRDLKP N+L+ D LKLADFGLAR + T E T
Sbjct: 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHEVVTL 162
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
YR APE+ G KHY+ VD++S G + E++T + F G S +
Sbjct: 163 WYR--APEIL------LGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-29
Identities = 72/231 (31%), Positives = 114/231 (49%), Gaps = 29/231 (12%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M +++H LV+ + I+TE + SL +L + KL ++ ++
Sbjct: 48 FLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 143
A IA M + IHRDL+ N+L++ + K+ADFGLAR E E +
Sbjct: 108 AAQIAEGMAFIERKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 144 -RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS------NL 193
+W APE Y T T+ K DV+SFGI+L E++T R+P+ GM+ NL
Sbjct: 167 IKWTAPEAINYGTFTI----------KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
+ Y R P++ +L +++ CW E P RP+F + +L F
Sbjct: 217 ERGY-------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 75/235 (31%), Positives = 120/235 (51%), Gaps = 21/235 (8%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLR 72
T E A+ E FI E +M ++ H LV+ G C + + +V E + L YL + R
Sbjct: 35 TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR 94
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 132
K L LD+ M L ++ +IHRDL N L+ +Q +K++DFG+ R +
Sbjct: 95 -GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTR-FVL 151
Query: 133 TEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFE 188
+ T+ TGT +W +PE++S Y++K DV+SFG+++WE+ + + P+E
Sbjct: 152 DDQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
Query: 189 GMSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
SN + A F+ +P L S + ++Q CW E P RPSFS ++ L
Sbjct: 204 NRSNSEVVETINAGFRLYKPRL---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 27/247 (10%)
Query: 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGM 62
KE+ T E+ L + EVN++ +KH N+V++ D + IV E G
Sbjct: 31 KEIDYGNMTEKEKQQL----VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGG 86
Query: 63 SLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH-----ANGIIHRDLKPDNLLLTPD 115
L + + + + ++ + A+ H N ++HRDLKP N+ L
Sbjct: 87 DLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-A 145
Query: 116 QKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173
++KL DFGLA+ + A+T GT +M+PE + Y+ K D++S
Sbjct: 146 NNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPEQLN--------HMSYDEKSDIWSL 196
Query: 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
G +++EL PF + LQ A R +P S +L +++S DP+ RPS
Sbjct: 197 GCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IPYRYSSELNEVIKSMLNVDPDKRPS 255
Query: 234 FSQIIRM 240
+++++
Sbjct: 256 TEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLV 69
R ++S++ ++E +E+ +M+R+ H ++++ LGA C+D + E + G S+ L
Sbjct: 37 RNTSSEQEEVVE-ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS 95
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129
V +N+ + R + LH N IIHRD+K NLL+ + L++ADFG A
Sbjct: 96 KYGA--FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153
Query: 130 ETVTEMMTAE-----TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
E GT +MAPE+ LR GE+ Y DV+S G V+ E+ T +
Sbjct: 154 LAAKGTGAGEFQGQLLGTIAFMAPEV-----LR-GEQ--YGRSCDVWSVGCVIIEMATAK 205
Query: 185 LPFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQSCWVEDPNLRP 232
P+ A FK A P +PE +SP L + C P RP
Sbjct: 206 PPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 77/251 (30%), Positives = 115/251 (45%), Gaps = 38/251 (15%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L GS+ +R F+ E ++M + H N+++ G P+M I+TE + SL K
Sbjct: 40 LKAGSSDKQRL----DFLTEASIMGQFDHPNIIRLEGVVTKSRPVM-IITEYMENGSLDK 94
Query: 67 YLVSLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
+L R N V + IA M L +HRDL N+L+ + K++DF
Sbjct: 95 FL---RENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVC-KVSDF 150
Query: 125 GLAREETVTEMMTAETGTY---------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175
GL+R +E TY RW APE + R + + DV+SFGI
Sbjct: 151 GLSRRLEDSE------ATYTTKGGKIPIRWTAPE---AIAYR-----KFTSASDVWSFGI 196
Query: 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
V+WE+++ P+ MSN Q A R P D L ++ CW +D N RP+F
Sbjct: 197 VMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTF 255
Query: 235 SQIIRMLNAFL 245
SQI+ L+ +
Sbjct: 256 SQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 21/229 (9%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK 75
E ++ E FI E +M ++ H+ LV+ G C K + IVTE + L YL +
Sbjct: 38 EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KR 96
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
L D+ M L + IHRDL N L+ DQ +K++DFGL+R + +
Sbjct: 97 FQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD-DQGCVKVSDFGLSR-YVLDDE 154
Query: 136 MTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
T+ G+ RW PE LYS +++K DV++FG+++WE+ + ++P+E
Sbjct: 155 YTSSVGSKFPVRWSPPEVLLYSK----------FSSKSDVWAFGVLMWEVYSLGKMPYER 204
Query: 190 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+N + + R P S + I+ SCW E RP+F Q++
Sbjct: 205 FNNSETVEKVSQGL-RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 69/235 (29%), Positives = 116/235 (49%), Gaps = 14/235 (5%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMS 63
+K++ T DER + E ++ + H N++++ +D ++IV E PG +
Sbjct: 30 IKQIPVEQMTKDERLAAQN----ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L +Y+ + LD L+F + I A+ +H I+HRDLK N+LL + +K+ D
Sbjct: 86 LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGD 145
Query: 124 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
FG+++ + GT +++PEL E K YN K D+++ G VL+EL +
Sbjct: 146 FGISKILSSKSKAYTVVGTPCYISPELC--------EGKPYNQKSDIWALGCVLYELASL 197
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ FE +NL A + + SPDL ++ S DP+ RP SQI+
Sbjct: 198 KRAFEA-ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 72/226 (31%), Positives = 116/226 (51%), Gaps = 18/226 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E N+M ++HD LV+ K+ + I+TE + SL +L S K+ L ++
Sbjct: 48 FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 107
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
F+ IA M + IHRDL+ N+L++ + K+ADFGLAR E E +
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKF 166
Query: 144 --RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 198
+W APE + + T+ K DV+SFGI+L+E++T ++P+ GMSN A
Sbjct: 167 PIKWTAPEAINFGSFTI----------KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA 216
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
+ P E+ +L I+++CW E RP+F + +L+ F
Sbjct: 217 LQRGYRMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 78/238 (32%), Positives = 122/238 (51%), Gaps = 29/238 (12%)
Query: 15 SDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSL 71
S ER L + E+ +MS + H+N+V LGAC P++VI TE L +L
Sbjct: 79 SSEREAL----MSELKIMSHLGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRK 133
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
R + L L L+F+ +A+ M L + IHRDL N+LLT K +K+ DFGLAR+
Sbjct: 134 RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIM 192
Query: 132 VTEMMTAETGTY---RWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-P 186
+ +WMAPE +++ V Y + DV+S+GI+LWE+ + P
Sbjct: 193 NDSNYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSNP 243
Query: 187 FEGM---SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
+ GM S ++ A+P E ++ I+++CW DP RP+F QI++++
Sbjct: 244 YPGMPVDSKFYKLIKEGYRMAQP---EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 65/244 (26%), Positives = 120/244 (49%), Gaps = 32/244 (13%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHD---NLVKFLGA-CKDPLMVIVTELLPGMS 63
++N + D+ + ++ REV ++S+++ N+ K+ G+ K P + I+ E G S
Sbjct: 33 IINLDTPDDDVSDIQ----REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGS 88
Query: 64 LRKYLVSLRPNKLD-LHVALNFALDIAR----AMDCLHANGIIHRDLKPDNLLLTPDQKS 118
+R + + + ++++ I R A+ +H G+IHRD+K N+L+T
Sbjct: 89 VRTLM---KAGPIAEKYISV-----IIREVLVALKYIHKVGVIHRDIKAANILVTNTGN- 139
Query: 119 LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
+KL DFG+A + + GT WMAPE+ + E K+Y+ K D++S GI +
Sbjct: 140 VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT-------EGKYYDTKADIWSLGITI 192
Query: 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQ 236
+E+ T P+ + +A K P L ++ S L V +C E+P R S +
Sbjct: 193 YEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEE 251
Query: 237 IIRM 240
+++
Sbjct: 252 LLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
EV+++ +KH N+V++LG C D + I E +PG S+ L P L V +
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTK 109
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAE 139
I + LH N ++HRD+K +N++L P+ +KL DFG AR T + M+ +
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA- 198
GT WMAPE+ + + Y K D++S G ++E+ T + P M L A +
Sbjct: 169 HGTPYWMAPEVIN--------ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A + P LP+ S V SC D + RPS Q++R
Sbjct: 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 28/242 (11%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK----FLGACKDPLMVIVTELLP 60
+KEV + ER + E+ +++ V H N++ FL K + IV E P
Sbjct: 30 LKEVDLGSMSQKERE----DAVNEIRILASVNHPNIISYKEAFLDGNK---LCIVMEYAP 82
Query: 61 GMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQK 117
L K + + + + + + R + LH I+HRDLK N+LL D
Sbjct: 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL- 141
Query: 118 SLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
+K+ D G+++ + + M + GT +MAPE++ + Y+ K D++S G +
Sbjct: 142 -VKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWK--------GRPYSYKSDIWSLGCL 190
Query: 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
L+E+ T PFE S +Q + P +P S DL ++S P LRP+ +
Sbjct: 191 LYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDK 249
Query: 237 II 238
I+
Sbjct: 250 IL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 72/243 (29%), Positives = 107/243 (44%), Gaps = 41/243 (16%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------- 74
F RE +++ +H+N+VKF G C DP + +V E + L K+L S P+
Sbjct: 55 FEREAELLTNFQHENIVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113
Query: 75 ----KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
+L L L A+ IA M L + +HRDL N L+ D +K+ DFG++R+
Sbjct: 114 SPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDV 172
Query: 131 TVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 184
T+ T RWM PE +Y T DV+SFG+VLWE+ T +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTES----------DVWSFGVVLWEIFTYGK 222
Query: 185 LPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
P+ G+SN + + G P ++ I+ CW DP R + I
Sbjct: 223 QPWYGLSNEE-----VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277
Query: 241 LNA 243
L
Sbjct: 278 LQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-27
Identities = 66/219 (30%), Positives = 107/219 (48%), Gaps = 16/219 (7%)
Query: 28 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF-A 85
E+ + S +KH N+V++LG+ ++ I E +PG SL L S D + F
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAETG 141
I + LH N I+HRD+K DN+L+ +K++DFG LA TE TG
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TG 171
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAA 200
T ++MAPE+ + +G + Y D++S G + E+ T + PF + QAA +
Sbjct: 172 TLQYMAPEV-----IDKGPRG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P +PE +S + + C+ DP+ R S +++
Sbjct: 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 70/234 (29%), Positives = 109/234 (46%), Gaps = 33/234 (14%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK-------- 75
F +E +MS ++H N+V LG C K+ ++ E L L ++LV P+
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 76 ------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129
LD L+ A+ IA M+ L ++ +HRDL N L+ + ++K++DFGL+R+
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG-EGLTVKISDFGLSRD 173
Query: 130 ETVTE---MMTAETGTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
+ + + RWM PE LY T D++SFG+VLWE+ +
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES----------DIWSFGVVLWEIFSYG 223
Query: 185 L-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
L P+ G SN + + P PED + ++ CW E P RP F I
Sbjct: 224 LQPYYGFSNQEVIEMIRSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 59/221 (26%), Positives = 113/221 (51%), Gaps = 19/221 (8%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E+ + + H N+V++LG + I E +PG S+ L + + + F
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTE 115
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE----TVTEMMTAETGT 142
+ + LH+ GI+HRDLK DNLL+ D K++DFG++++ + M+ + G+
Sbjct: 116 QVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GS 173
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + + Y+ KVD++S G V+ E+ R P+ + A + K
Sbjct: 174 VFWMAPEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227
Query: 203 HARPGLPEDISPDLAFI----VQSCWVEDPNLRPSFSQIIR 239
+ P +P D+S +L+ + + +C+ +P+ RP+ ++++
Sbjct: 228 RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-27
Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 20/240 (8%)
Query: 6 KEV-LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMS 63
KEV L R S + R L E+ ++S ++H N++ + D ++I E G +
Sbjct: 31 KEVNLTRLSEKERRDALN-----EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L +V + + + L + I A+ +H GI+HRD+K N+ LT +KL D
Sbjct: 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGD 144
Query: 124 FGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
FG+++ +E AET GT +M+PEL QG K YN K D+++ G VL+ELL
Sbjct: 145 FGISKILG-SEYSMAETVVGTPYYMSPELC------QGVK--YNFKSDIWALGCVLYELL 195
Query: 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
T + F+ +N + + S +L +V S +DP RP+ +++
Sbjct: 196 TLKRTFDA-TNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 79/243 (32%), Positives = 122/243 (50%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHV- 80
+ E+ MM + KH N++ LGAC PL V+V G +LR+YL + RP +D
Sbjct: 64 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG-NLREYLRARRPPGMDYSFD 122
Query: 81 -------ALNF------ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
L F A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN-VMKIADFGLA 181
Query: 128 REETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R+ + T +WMAPE L+ V Y ++ DV+SFG++LWE+ T
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLLWEIFTL 232
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L I++ CW P+ RP+F Q++ L+
Sbjct: 233 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
Query: 243 AFL 245
L
Sbjct: 292 RVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 68/222 (30%), Positives = 103/222 (46%), Gaps = 25/222 (11%)
Query: 28 EVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E +++S+ + +VK + + +V E LPG L L ++ LD VA +
Sbjct: 43 ERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIA 100
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE------- 139
+I A++ LH+NGIIHRDLKPDN+L+ + LKL DFGL++ V +
Sbjct: 101 EIVLALEYLHSNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 140 --TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
GT ++APE V L QG ++ VD +S G +L+E L PF G + +
Sbjct: 160 RIVGTPDYIAPE----VILGQG----HSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIF 210
Query: 198 A--AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
K P E +S + ++ V DP R I
Sbjct: 211 QNILNGKIEWPEDVE-VSDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 72/245 (29%), Positives = 110/245 (44%), Gaps = 43/245 (17%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR----P 73
F+ E M H N++K +G C K P +++ + L +L+ R P
Sbjct: 48 FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP 107
Query: 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 133
KL L L F +DIA M+ L IHRDL N +L D + +ADFGL++
Sbjct: 108 EKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGLSK----- 161
Query: 134 EMMTAETGTY-----------RWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
+G Y +W+A E L V Y +K DV++FG+ +WE+
Sbjct: 162 ---KIYSGDYYRQGRIAKMPVKWIAIESLADRV---------YTSKSDVWAFGVTMWEIA 209
Query: 182 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
T + P+ G+ N + Y R PED +L ++ SCW DP RP+F+++ +
Sbjct: 210 TRGQTPYPGVENHE-IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
Query: 241 LNAFL 245
L L
Sbjct: 269 LENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 77/243 (31%), Positives = 122/243 (50%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP-------- 73
I E+ MM + KH N++ LGAC PL VIV E +LR+YL + RP
Sbjct: 70 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYN 128
Query: 74 ------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+L ++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA 187
Query: 128 REETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R+ + T +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTL 238
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 239 GGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
Query: 243 AFL 245
L
Sbjct: 298 RIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 16/237 (6%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMS 63
MK++ ER I E +++++ ++++ + + IV E
Sbjct: 30 MKQIDLSKMNRRERE----EAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L K L R L F + I + LH+ I+HRD+K NL L ++K+ D
Sbjct: 86 LHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGD 144
Query: 124 FGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
G+A+ T GT +++PEL E K YN K DV++ G+VL+E T
Sbjct: 145 LGVAKLLSDNTNFANTIVGTPYYLSPELC--------EDKPYNEKSDVWALGVVLYECCT 196
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ PF+ +N A + P + + S LA ++ C +D RP Q++R
Sbjct: 197 GKHPFDA-NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 22/236 (9%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRK 66
V++ DE + +E+ +S+ + + K+ G+ K + I+ E G S
Sbjct: 33 VIDLEEAEDEIEDI----QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD 88
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
L +P KLD ++ ++ LH G IHRD+K N+LL+ ++ +KLADFG+
Sbjct: 89 LL---KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS-EEGDVKLADFGV 144
Query: 127 ARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
+ + T+++ T GT WMAPE+ ++Q Y+ K D++S GI EL
Sbjct: 145 SGQLTSTMSKRNTF-VGTPFWMAPEV-----IKQSG---YDEKADIWSLGITAIELAKGE 195
Query: 185 LPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P + ++ + K+ P L + S V C +DP RPS ++++
Sbjct: 196 PPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 33/240 (13%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN----- 74
E F+ E +MS+ H N+V+ +G + P I+ EL+ G L+ +L RP
Sbjct: 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPS 111
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETV 132
L + L A D+A+ L N IHRD+ N LLT + K+ADFG+AR+
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
Query: 133 TE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 183
M+ +WM PE + + +K DV+SFG++LWE+ +
Sbjct: 172 ASYYRKGGRAMLPI-----KWMPPEAFLDGI--------FTSKTDVWSFGVLLWEIFSLG 218
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
+P+ G +N Q R P+ + I+ CW P RP+F+ I+ +
Sbjct: 219 YMPYPGRTN-QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 68/248 (27%), Positives = 111/248 (44%), Gaps = 31/248 (12%)
Query: 2 GKFM-KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELL 59
GK M + + + + +RE++++ + +V F GA + + I E +
Sbjct: 26 GKIMAVKTIRLEINEAIQK----QILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81
Query: 60 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKS 118
G SL K L ++ ++ + A+ + + + LH IIHRD+KP N+L+ +
Sbjct: 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN-SRGQ 139
Query: 119 LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR-QGEKKHYNNKVDVYSFGIVL 177
+KL DFG++ + V + GT +MAPE R QG Y+ K D++S G+ L
Sbjct: 140 IKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPE-------RIQGN--DYSVKSDIWSLGLSL 189
Query: 178 WELLTNRLPFEGMSNLQAAYAAAF-------KHARPGLPEDI-SPDLAFIVQSCWVEDPN 229
EL T R P+ F P LP SPD V C ++DP
Sbjct: 190 IELATGRFPY---PPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPR 246
Query: 230 LRPSFSQI 237
RPS+ ++
Sbjct: 247 ERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-26
Identities = 75/271 (27%), Positives = 130/271 (47%), Gaps = 51/271 (18%)
Query: 7 EVLNRGSTSDE-RALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMS 63
++L ++S E R LL E N++ +V H +++K GAC PL++IV G S
Sbjct: 36 KMLKENASSSELRDLLS-----EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG-S 89
Query: 64 LRKYLVSLRP----------------------NKLDLHVALNFALDIARAMDCLHANGII 101
LR +L R L + ++FA I+R M L ++
Sbjct: 90 LRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV 149
Query: 102 HRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPE-LYSTVTLR 157
HRDL N+L+ + + +K++DFGL+R EE + +WMA E L+ +
Sbjct: 150 HRDLAARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--- 205
Query: 158 QGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS--NLQAAYAAAFKHARPGLPEDISP 214
Y + DV+SFG++LWE++T P+ G++ L ++ RP E+ S
Sbjct: 206 ------YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP---ENCSE 256
Query: 215 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ ++ +CW ++P+ RP+F+ I + L +
Sbjct: 257 EMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 70/226 (30%), Positives = 105/226 (46%), Gaps = 37/226 (16%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
I+E++++ + +VK+ G+ K+ + IV E S+ D+ N
Sbjct: 46 IKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS-----------DIMKITNK 94
Query: 85 ALD---IA-------RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 134
L IA + ++ LH+N IHRD+K N+LL + KLADFG++ +
Sbjct: 95 TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVS-GQLTDT 152
Query: 135 MMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
M T GT WMAPE V G YNNK D++S GI E+ + P+ +
Sbjct: 153 MAKRNTVIGTPFWMAPE----VIQEIG----YNNKADIWSLGITAIEMAEGKPPYSDIHP 204
Query: 193 LQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
++A + K P L PE SP+ V+ C V+DP RPS Q
Sbjct: 205 MRAIFMIPNKPP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-26
Identities = 73/216 (33%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E +M +++HD LV+ + + IVTE + SL +L L L ++
Sbjct: 48 FLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT-- 142
A +A M + IHRDL+ N+L+ D K+ADFGLAR E TA G
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE-YTARQGAKF 165
Query: 143 -YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 198
+W APE LY T+ K DV+SFGI+L EL+T R+P+ GM+N +
Sbjct: 166 PIKWTAPEAALYGRFTI----------KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+ P P+D L ++ CW +DP RP+F
Sbjct: 216 VERGYRMP-CPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 79/268 (29%), Positives = 125/268 (46%), Gaps = 50/268 (18%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS 70
T +E A L R F+ E ++M ++V+ LG K ++V EL+ L+ YL S
Sbjct: 43 TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 102
Query: 71 LRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
LRP + L + A +IA M L+A +HRDL N ++ D ++K+
Sbjct: 103 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIG 161
Query: 123 DFGLAREETVTEMMTAETGTYR----------WMAPELYSTVTLRQGEKKHYNNKVDVYS 172
DFG+ R+ ET YR WMAPE +L+ G + D++S
Sbjct: 162 DFGMTRD-------IYETDYYRKGGKGLLPVRWMAPE-----SLKDGVFTTSS---DMWS 206
Query: 173 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVED 227
FG+VLWE+ + P++G+SN Q K G P++ + +++ CW +
Sbjct: 207 FGVVLWEITSLAEQPYQGLSNEQV-----LKFVMDGGYLDQPDNCPERVTDLMRMCWQFN 261
Query: 228 PNLRPSFSQIIRMLNAFLFTLRPPSPSV 255
P +RP+F +I+ +L L P P V
Sbjct: 262 PKMRPTFLEIVNLLKD---DLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 66/246 (26%), Positives = 108/246 (43%), Gaps = 42/246 (17%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ ++ + H N++K L + + +V E + L K L+ R L + ++
Sbjct: 46 LREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYK-LIKDRQRGLPESLIKSY 103
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTY 143
+ + + H++GI+HRDLKP+NLL+ + LKLADFGLAR + T T
Sbjct: 104 LYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVT- 161
Query: 144 RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------------- 189
RW APEL + + Y+ VD++S G + ELL+ R F G
Sbjct: 162 RWYRAPEL--LLGDKG-----YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214
Query: 190 -----------MSNLQAAYAAAFKH-ARPGLPE---DISPDLAFIVQSCWVEDPNLRPSF 234
++L Y +F A LP+ + SP ++ DP+ R +
Sbjct: 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274
Query: 235 SQIIRM 240
Q +
Sbjct: 275 EQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 66/222 (29%), Positives = 114/222 (51%), Gaps = 16/222 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVA 81
F+ E++++S KH N+V A + + I+ E G +L ++ L R + +
Sbjct: 49 FMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV 108
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET- 140
L+ A++ LH++ +IHRDLK N+LLT D +KLADFG++ + + + +T
Sbjct: 109 CRQMLE---ALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNK-STLQKRDTF 163
Query: 141 -GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
GT WMAPE+ + T + Y+ K D++S GI L EL P ++ ++
Sbjct: 164 IGTPYWMAPEVVACETFKD---NPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220
Query: 200 AFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
K P L P S ++SC V+DP+ RP+ +++++
Sbjct: 221 L-KSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 77/227 (33%), Positives = 114/227 (50%), Gaps = 21/227 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F+ E N+M ++HD LVK + I+TE + SL +L S +K L ++F
Sbjct: 48 FLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTAETGT 142
+ IA M + IHRDL+ N+L++ SL K+ADFGLAR E E
Sbjct: 108 SAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAK 164
Query: 143 Y--RWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 197
+ +W APE + + T+ K DV+SFGI+L E++T R+P+ GMSN +
Sbjct: 165 FPIKWTAPEAINFGSFTI----------KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
A + P PE+ +L I+ CW P RP+F I +L+ F
Sbjct: 215 ALERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-25
Identities = 74/243 (30%), Positives = 121/243 (49%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E+ MM + KH N++ LGAC PL VIV G +LR+YL + RP ++
Sbjct: 67 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYD 125
Query: 82 LNFALD--------------IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+ D +AR M+ L + IHRDL N+L+T + +K+ADFGLA
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 184
Query: 128 REETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R+ + T +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTL 235
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+
Sbjct: 236 GGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
Query: 243 AFL 245
L
Sbjct: 295 RIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALN 83
+EV MS+ H N+VK+ + + +V L G SL + S P LD +
Sbjct: 47 RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT 106
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAET- 140
++ + ++ LH+NG IHRD+K N+LL D S+K+ADFG++ +
Sbjct: 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 141 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-- 196
GT WMAPE+ + Y+ K D++SFGI EL T P+ S
Sbjct: 166 FVGTPCWMAPEVME-------QVHGYDFKADIWSFGITAIELATGAAPY---SKYPPMKV 215
Query: 197 YAAAFKHARPGLPEDISPDL---AF--IVQSCWVEDPNLRPSFSQIIR 239
++ P L +F ++ C +DP+ RP+ ++++
Sbjct: 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 67/179 (37%), Positives = 95/179 (53%), Gaps = 19/179 (10%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKLD 77
R RE+ M+ KHDN++ L + P + +VTEL+ L K +VS +P D
Sbjct: 45 RVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSD 103
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--M 135
HV + F I R + LH+ GI+HRD+KP NLL+ + LK+ DFGLAR E E
Sbjct: 104 -HVKV-FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKH 160
Query: 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
MT E T + APE+ +HY + VD++S G + ELL R+ F+ S +Q
Sbjct: 161 MTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-24
Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 35/246 (14%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLD 77
+ +E+N++ + H+N+VK+ G C + + ++ E +P SLR YL +KL+
Sbjct: 49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLN 105
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETV 132
L L FA I M LH+ IHRDL N+LL D + +K+ DFGLA+ E
Sbjct: 106 LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYY 164
Query: 133 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-------RL 185
++ + W A E E K DV+SFG+ L+ELLT+
Sbjct: 165 RVREDGDSPVF-WYAVECLK-------ENKFSYAS-DVWSFGVTLYELLTHCDSKQSPPK 215
Query: 186 PFEGMSNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
FE M + + R P++ ++ ++++CW + RP+F +I
Sbjct: 216 KFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
Query: 239 RMLNAF 244
+L
Sbjct: 276 PILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 79/247 (31%), Positives = 118/247 (47%), Gaps = 42/247 (17%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHV- 80
I E+ +M + KH N++ LG C PL VIV E +LR++L + RP D
Sbjct: 64 LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFD 122
Query: 81 -------ALNF------ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
L+F A +AR M+ L + IHRDL N+L+T D +K+ADFGLA
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLA 181
Query: 128 REETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
R + + +WMAPE L+ V Y ++ DV+SFGI++WE+ T
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGILMWEIFTL 232
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
P+ G+ FK R G P + + +L +++ CW P RP+F Q++
Sbjct: 233 GGSPYPGIP-----VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287
Query: 239 RMLNAFL 245
L+ L
Sbjct: 288 EALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-24
Identities = 72/225 (32%), Positives = 108/225 (48%), Gaps = 17/225 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++HD LV + + IVTE + SL +L L L ++
Sbjct: 48 FLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 143
A IA M + IHRDL+ N+L+ D K+ADFGLAR E + +
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL+T R+P+ GM N +
Sbjct: 167 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
+ P P+ L +++ CW +DP+ RP+F I L +
Sbjct: 217 ERGYRMP-CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-24
Identities = 72/243 (29%), Positives = 115/243 (47%), Gaps = 34/243 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F RE+ ++ ++HDN+VK+ G C + +V E LP SLR YL R +LD
Sbjct: 52 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKL 110
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMM 136
L +A I + M+ L + +HRDL N+L+ + + +K+ DFGL + +E
Sbjct: 111 LLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVRE 169
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----NRLP----FE 188
E+ + W APE + E K ++ DV+SFG+VL+EL T + P
Sbjct: 170 PGESPIF-WYAPESLT-------ESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR 220
Query: 189 GMSNLQAAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
M N + + + R P ++ I++ CW DP+ RPSFS++ +
Sbjct: 221 MMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280
Query: 242 NAF 244
A
Sbjct: 281 EAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-24
Identities = 81/246 (32%), Positives = 123/246 (50%), Gaps = 37/246 (15%)
Query: 14 TSDERALLEGR--FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69
T +E A + R F+ E ++M ++V+ LG P +VI+ EL+ L+ YL
Sbjct: 43 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLR 101
Query: 70 SLRPNKLD--------LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
SLRP + L + A +IA M L+AN +HRDL N ++ D ++K+
Sbjct: 102 SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKI 160
Query: 122 ADFGLAREETVTEMMTAETG-----TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
DFG+ R+ + E G RWM+PE +L+ G + DV+SFG+V
Sbjct: 161 GDFGMTRD--IYETDYYRKGGKGLLPVRWMSPE-----SLKDGV---FTTYSDVWSFGVV 210
Query: 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRP 232
LWE+ T P++GMSN Q GL + D PD+ F +++ CW +P +RP
Sbjct: 211 LWEIATLAEQPYQGMSNEQVLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 266
Query: 233 SFSQII 238
SF +II
Sbjct: 267 SFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 4e-24
Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 16/164 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+ E ++ ++H LV G+ +D + +V E +PG L +L + + VA +
Sbjct: 49 LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVARFY 106
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTY 143
A + A++ LH+ I++RDLKP+NLLL +K+ DFG A R + T + GT
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGRTYTL---CGTP 162
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE + L +G Y VD ++ GI+++E+L PF
Sbjct: 163 EYLAPE----IILSKG----YGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-24
Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 49/249 (19%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP--------- 73
F RE +M+ H N+VK LG C P+ ++ + G L ++L P
Sbjct: 55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYG-DLNEFLRHRSPRAQCSLSHS 113
Query: 74 ---------NKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
N L L L A +A M L +HRDL N L+ + +K+A
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIA 172
Query: 123 DFGLAREETVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
DFGL+R + A RWM PE Y+ Y + DV+++G+VL
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN----------RYTTESDVWAYGVVL 222
Query: 178 WELLTNRL-PFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRP 232
WE+ + + P+ GM++ + Y + R G P++ +L +++ CW + P+ RP
Sbjct: 223 WEIFSYGMQPYYGMAHEEVIY-----YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
Query: 233 SFSQIIRML 241
SF+ I R+L
Sbjct: 278 SFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-24
Identities = 69/247 (27%), Positives = 119/247 (48%), Gaps = 20/247 (8%)
Query: 5 MKEV----LNRGSTSDERALLEGRFIREVNMM-SRVKHDNLVKFLGA-CKDPLMVIVTEL 58
+KE+ G ER G + EV ++ +++H N+V++ ++ + IV +L
Sbjct: 31 LKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDL 90
Query: 59 LPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLHANG-IIHRDLKPDNLLLTPD 115
+ G L ++ SL+ K N + + A+ LH I+HRDL P+N++L D
Sbjct: 91 IEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED 150
Query: 116 QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175
K + + DFGLA+++ +T+ GT + PE+ + E Y K DV++FG
Sbjct: 151 DK-VTITDFGLAKQKQPESKLTSVVGTILYSCPEIV------KNEP--YGEKADVWAFGC 201
Query: 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSF 234
+L+++ T + PF + L A P LPE + S D+ ++ SC D RP
Sbjct: 202 ILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LPEGMYSEDVTDVITSCLTPDAEARPDI 260
Query: 235 SQIIRML 241
Q+ M+
Sbjct: 261 IQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-24
Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 33/240 (13%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H N+V+ + D L V V E L G +L + R N+ +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIATVCLAV 124
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---TGT 142
L +A+ LHA G+IHRD+K D++LLT D + +KL+DFG + V++ + GT
Sbjct: 125 L---KALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCAQ--VSKEVPRRKSLVGT 178
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT------NRLPFEGMSNLQAA 196
WMAPE+ S + Y +VD++S GI++ E++ N P + M ++
Sbjct: 179 PYWMAPEVIS--------RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
K+ +SP L + V DP R + ++++ + FL PPS VP
Sbjct: 231 LPPKLKN-----LHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 9e-24
Identities = 69/248 (27%), Positives = 113/248 (45%), Gaps = 36/248 (14%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMS 63
+K++ + + R L RE+ + + +VK GA + IV E + G S
Sbjct: 31 LKKI-HVDGDEEFRKQLL----RELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85
Query: 64 L---RKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSL 119
L K + + L A I + +D LH IIHRD+KP NLL+ +
Sbjct: 86 LADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EV 139
Query: 120 KLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLR-QGEKKHYNNKVDVYSFGIV 176
K+ADFG+++ E T+ + T GT +M+PE R QGE Y+ D++S G+
Sbjct: 140 KIADFGISKVLENTLDQCNTFV-GTVTYMSPE-------RIQGE--SYSYAADIWSLGLT 189
Query: 177 LWELLTNRLPFEGMSNLQAAYAAAFKH----ARPGLPED-ISPDLAFIVQSCWVEDPNLR 231
L E + PF Q ++ + P LP + SP+ + +C +DP R
Sbjct: 190 LLECALGKFPFL--PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKR 247
Query: 232 PSFSQIIR 239
PS +++++
Sbjct: 248 PSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 67/247 (27%), Positives = 107/247 (43%), Gaps = 46/247 (18%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-------VSLRPNKL 76
F++EV ++SR+ N+ + LG C DP + ++ E + L ++L L N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 77 DLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 134
L + L A IA M L + +HRDL N L+ + +K+ADFG++R
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT-IKIADFGMSRN----- 179
Query: 135 MMTAETGTY-----------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 182
+ Y RWMA E ++ G+ + K DV++FG+ LWE+LT
Sbjct: 180 ---LYSSDYYRVQGRAPLPIRWMAWE-----SVLLGK---FTTKSDVWAFGVTLWEILTL 228
Query: 183 -NRLPFEGMSNLQAAYAAAFKHARPGLPE-----DISP-DLAFIVQSCWVEDPNLRPSFS 235
P+E +++ Q A G P D+ ++ CW D RP+F
Sbjct: 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288
Query: 236 QIIRMLN 242
+I L
Sbjct: 289 EIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-23
Identities = 68/239 (28%), Positives = 127/239 (53%), Gaps = 27/239 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNK 75
+R++L+ RE+ ++ ++H+N+V++LG+ D + I E +PG S+ L +
Sbjct: 46 KRSMLDA-LAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GA 102
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTE 134
+ + NF I + ++ LH GIIHRD+K N+L+ D K +K++DFG++++
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV--DNKGGIKISDFGISKKLEANS 160
Query: 135 MMTAETGTYR--------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
+ T T R WMAPE+ ++ Y K D++S G ++ E+LT + P
Sbjct: 161 LSTK-TNGARPSLQGSVFWMAPEVV--------KQTSYTRKADIWSLGCLVVEMLTGKHP 211
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
F + LQA + ++A P +P +IS + ++ + D N RP+ +++ + + FL
Sbjct: 212 FPDCTQLQAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL--LKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-23
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 11/215 (5%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+EV +++++KH N+V F + ++ + IV E G L K + R L++
Sbjct: 48 KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYR 144
+ I+ + +H I+HRD+K N+ L+ + KL DFG+AR+ E+ GT
Sbjct: 108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY 167
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
+++PE+ + + YNNK D++S G VL+EL T + PFEG + Q +
Sbjct: 168 YLSPEIC--------QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF 219
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P P + S DL ++ + P RPS + I++
Sbjct: 220 APISP-NFSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-23
Identities = 70/241 (29%), Positives = 120/241 (49%), Gaps = 18/241 (7%)
Query: 3 KFMKEVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELL 59
+++ + LN R ++ ER E +E ++S++KH N+V + + + D L+ IV
Sbjct: 27 QYVIKKLNLRNASRRERKAAE----QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82
Query: 60 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 119
G L L + L + + + + IA A+ LH I+HRDLK N+ LT +
Sbjct: 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT-RTNII 141
Query: 120 KLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
K+ D G+AR E +M + GT +M+PEL+S K YN K DV++ G ++
Sbjct: 142 KVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVY 193
Query: 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
E+ T + F ++ + + P +P+D SP+L ++ + + P RPS I+
Sbjct: 194 EMATLKHAFNA-KDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
Query: 239 R 239
R
Sbjct: 253 R 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 3e-23
Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 44/236 (18%)
Query: 26 IREVNMMSRVK-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK-LDLHVAL 82
E +++R+ H ++K +D + V E P L +Y+ R LD
Sbjct: 49 KIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTR 105
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+A +I A++ LH+ GIIHRDLKP+N+LL D +K+ DFG A+ +
Sbjct: 106 FYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 141 -------------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
GT +++PEL + +K D+++ G +++++L
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLN--------EKPAGKSSDLWALGCIIYQML 216
Query: 182 TNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
T + PF G + Q + P + PD +++ V DP R
Sbjct: 217 TGKPPFRGSNEYLTFQKILKLEYS-----FPPNFPPDAKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-23
Identities = 81/266 (30%), Positives = 122/266 (45%), Gaps = 40/266 (15%)
Query: 1 MGKFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTEL 58
M +K + S D R F E+ ++ ++ H N++ LGAC+ + + E
Sbjct: 35 MDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89
Query: 59 LPGMSLRKYLVSLRPNKLDLHVA--------------LNFALDIARAMDCLHANGIIHRD 104
P +L +L R + D A L+FA D+AR MD L IHRD
Sbjct: 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 149
Query: 105 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL--YSTVTLRQGEKK 162
L N+L+ + + K+ADFGL+R + V T RWMA E YS
Sbjct: 150 LAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--------- 199
Query: 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFI 219
Y DV+S+G++LWE+++ P+ GM+ L ++ +P +D DL
Sbjct: 200 -YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDL--- 255
Query: 220 VQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ CW E P RPSF+QI+ LN L
Sbjct: 256 MRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-23
Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 38/241 (15%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMS---LRKYLVSLRPNKLD 77
++E ++ + H N++ L C +P V L P M+ L+ +L R + +
Sbjct: 54 LLLQESCLLYGLSHQNILPILHVCIEDGEPPFV----LYPYMNWGNLKLFLQQCRLGEAN 109
Query: 78 LHVALN------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
AL+ A+ IA M LH G+IH+D+ N ++ ++ +K+ D L+R+
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID-EELQVKITDNALSRDLF 168
Query: 132 VTEMMTAETGTYR---WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 187
+ R WMA E +L K Y++ DV+SFG++LWEL+T + P+
Sbjct: 169 PMDYHCLGDNENRPVKWMALE-----SL---VNKEYSSASDVWSFGVLLWELMTLGQTPY 220
Query: 188 EGMSNLQ-AAY-AAAFKHARPGLPEDIS-PDLAFIVQS-CWVEDPNLRPSFSQIIRMLNA 243
+ + AAY ++ A+P I+ PD F V + CW DP RPSFSQ+++ L
Sbjct: 221 VEIDPFEMAAYLKDGYRLAQP-----INCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275
Query: 244 F 244
F
Sbjct: 276 F 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 9e-23
Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F++E +M +++H+ LV+ + + IVTE + SL +L L L ++
Sbjct: 48 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 143
A IA M + +HRDL+ N+L+ + K+ADFGLAR E + +
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFP 166
Query: 144 -RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAA 199
+W APE LY T+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 167 IKWTAPEAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ P P + L ++ CW ++P RP+F L AFL
Sbjct: 217 ERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTF----EYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 66/242 (27%), Positives = 117/242 (48%), Gaps = 30/242 (12%)
Query: 23 GRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP-------- 73
G F +E ++M+ + H N+V LG ++ + ++ E L L ++L+ P
Sbjct: 52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS 111
Query: 74 -------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ LD L+ A+ IA M+ L ++ +H+DL N+L+ +Q +K++D GL
Sbjct: 112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG-EQLHVKISDLGL 170
Query: 127 AREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
+RE + + + RWM PE + G+ +++ D++SFG+VLWE+ +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPE-----AIMYGK---FSSDSDIWSFGVVLWEIFSF 222
Query: 184 RL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
L P+ G SN + + P ED P + ++ CW E P+ RP F I L
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
Query: 243 AF 244
++
Sbjct: 282 SW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 62/181 (34%), Positives = 89/181 (49%), Gaps = 17/181 (9%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYL-- 68
T+D L+ + +RE+ + K +VK+ GA D + I E G SL
Sbjct: 35 TTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK 94
Query: 69 VSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
V R ++ V A + + + LH+ IIHRD+KP N+LLT + +KL DFG++
Sbjct: 95 VKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVS- 152
Query: 129 EETVTEMMTAETGTYRWMAPELYSTVTLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
E V + TGT +MAPE R QG K Y+ DV+S G+ L E+ NR PF
Sbjct: 153 GELVNSLAGTFTGTSFYMAPE-------RIQG--KPYSITSDVWSLGLTLLEVAQNRFPF 203
Query: 188 E 188
Sbjct: 204 P 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 6e-22
Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
LD L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIR-NDS 268
Query: 136 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
G R WMAPE +++ V Y + DV+S+GI+LWE+ + P+ G
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 190 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
M Y + R PE ++ I++SCW DP RP+F QI++++
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-22
Identities = 74/238 (31%), Positives = 117/238 (49%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M +H+N+V+ + D L V++ E L G +L + R N+ +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIAAV---C 122
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYR 144
L + +A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+ + GT
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPY 181
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPEL S + Y +VD++S GI++ E++ P+ L+ A K
Sbjct: 182 WMAPELISRLP--------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMI 228
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +SP L + V DP R + +++++ + FL PPS VP
Sbjct: 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-22
Identities = 72/239 (30%), Positives = 110/239 (46%), Gaps = 33/239 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKD----PLMVIVTELLPGM---SLRKYLVSLR--PN 74
+F++E +M H N++ LG C PL+V LP M LR ++ S P
Sbjct: 42 QFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV-----LPYMKHGDLRNFIRSETHNPT 96
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVT 133
DL + F L +A+ M+ L + +HRDL N +L D+ ++K+ADFGLAR+
Sbjct: 97 VKDL---IGFGLQVAKGMEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDK 151
Query: 134 EMMTAETGT-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
E + T +WMA E T + K DV+SFG++LWEL+T P
Sbjct: 152 EYYSVHNHTGAKLPVKWMALESLQTQK--------FTTKSDVWSFGVLLWELMTRGAPPY 203
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
+ + R PE L ++ SCW P +RP+FS+++ + T
Sbjct: 204 PDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-22
Identities = 69/236 (29%), Positives = 123/236 (52%), Gaps = 21/236 (8%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK 66
++LN T+ +A +E F+ E +M+ + H +LV+ LG C P + +VT+L+P L
Sbjct: 42 KILNE--TTGPKANVE--FMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLD 97
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFG 125
Y+ + N + + LN+ + IA+ M L ++HRDL N+L+ +P+ +K+ DFG
Sbjct: 98 YVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFG 154
Query: 126 LAR-EETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
LAR E + A+ G +WMA E + + ++ DV+S+G+ +WEL+T
Sbjct: 155 LARLLEGDEKEYNADGGKMPIKWMALECI--------HYRKFTHQSDVWSYGVTIWELMT 206
Query: 183 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
P++G+ + K R P + D+ ++ CW+ D + RP F ++
Sbjct: 207 FGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-22
Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 26/228 (11%)
Query: 32 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 91
M + H +V+ LG C + +VT+L P SL ++ R + LD LN+ + IA+
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKG 121
Query: 92 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-------REETVTEMMTAETGTYR 144
M L + ++HR+L N+LL D +++ADFG+A ++ +E T +
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IK 176
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 203
WMA E ++ + Y ++ DV+S+G+ +WE+++ P+ GM K
Sbjct: 177 WMALE---SILFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKG 227
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251
R P+ + D+ ++ CW+ D N+RP+F + + N F R P
Sbjct: 228 ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKE---LANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-22
Identities = 60/184 (32%), Positives = 89/184 (48%), Gaps = 27/184 (14%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKL- 76
R +RE+ ++ ++H+N++ L + P + IVTEL+ L K + S P L
Sbjct: 45 RILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS--PQPLT 101
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETV 132
D H+ F I R + LH+ +IHRDLKP N+L+ + LK+ DFGLAR +E
Sbjct: 102 DDHIQY-FLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDE 159
Query: 133 TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+T T YR APEL Y +D++S G + ELLT + F G
Sbjct: 160 KGFLTEYVVTRWYR--APELL-------LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210
Query: 191 SNLQ 194
+
Sbjct: 211 DYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 8e-22
Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
E ++ H +VK KD + ++ E G L L D + A +
Sbjct: 42 SEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYI 99
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYR 144
+ A + LH GII+RDLKP+NLLL D +KL DFG A++ + GT
Sbjct: 100 ACVVLAFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
++APE+ K Y+ VD +S GI+L+ELLT R PF
Sbjct: 158 YVAPEII--------LNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 12/215 (5%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+EV ++S +KH N+V++ + ++ + IV + G L K + + R L++
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF 107
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYR 144
+ I A+ +H I+HRD+K N+ LT D ++KL DFG+AR T E+ GT
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPY 166
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
+++PE+ E + YNNK D+++ G VL+E+ T + FE N++ + +
Sbjct: 167 YLSPEIC--------ENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGS 217
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P + S DL +V + +P RPS + I+
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-21
Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 27/237 (11%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR----P 73
F+RE M H N++K +G + P+ +++ + L +L+ R P
Sbjct: 48 FLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP 107
Query: 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 133
L L + F +DIA M+ L + IHRDL N +L + ++ +ADFGL+++
Sbjct: 108 FTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSG 166
Query: 134 EMM---TAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 188
+ A +W+A E L V Y DV++FG+ +WE++T + P+
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNV---------YTTHSDVWAFGVTMWEIMTRGQTPYA 217
Query: 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
G+ N + Y K R P D D+ ++ CW +P RPSF + L
Sbjct: 218 GVENSE-IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-21
Identities = 76/236 (32%), Positives = 114/236 (48%), Gaps = 21/236 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
I E+ +M KH N+V +L + D L V V E L G SL + +D
Sbjct: 64 INEILVMRENKHPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTE---TCMDEGQIAA 119
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGT 142
+ +A++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ VT +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 179 PYWMAPEV---VT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T 229
Query: 203 HARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P L PE +S + C D R S ++++ + FL +P S P
Sbjct: 230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
F ++MS++ H +LVK G C ++V E + L +L N + LH L+
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFL-HREKNNVSLHWKLDV 106
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPD------QKSLKLADFGLAREETVTEMMTA 138
A +A A+ L ++H ++ N+L+ +KL+D G+ +T
Sbjct: 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--------ITV 158
Query: 139 ETGTYR-----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 192
+ R W+APE + + D +SFG L E+ +N P +S
Sbjct: 159 LSREERVERIPWIAPECI------RNGQASLTIAADKWSFGTTLLEICSNGEEP---LST 209
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
L ++ F + LP +LA ++ CW DP RPSF I+R LN
Sbjct: 210 LSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 67/254 (26%), Positives = 111/254 (43%), Gaps = 32/254 (12%)
Query: 2 GKFM-KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELL 59
G M K+V++ G+ S R + +RE+ +M + +V F GA + + + E +
Sbjct: 30 GTVMAKKVVHIGAKSSVRK----QILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85
Query: 60 PGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 117
SL + P +++ +A+ + + I+HRD+KP N+L+ +
Sbjct: 86 DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVN-SRG 141
Query: 118 SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
+KL DFG++ E + + GT +M+PE QG K Y K DV+S GI +
Sbjct: 142 QIKLCDFGVS-GELINSIADTFVGTSTYMSPERI------QGGK--YTVKSDVWSLGISI 192
Query: 178 WELLTNRLPF---EGMSNLQAAYAAAF-------KHARPGLP-EDISPDLAFIVQSCWVE 226
EL + PF + Q + P LP D DL V +C ++
Sbjct: 193 IELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLK 252
Query: 227 DPNLRPSFSQIIRM 240
DP RP+ Q+ M
Sbjct: 253 DPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 1e-21
Identities = 71/234 (30%), Positives = 117/234 (50%), Gaps = 25/234 (10%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVS 70
TS E LE E+ ++ + H+ +V++ G +DP+ + I E +PG S++ L S
Sbjct: 44 TSKEVNALEC----EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS 99
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE- 129
L +V + I + LH+N I+HRD+K N+L ++KL DFG ++
Sbjct: 100 Y--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANIL-RDSVGNVKLGDFGASKRL 156
Query: 130 ETV----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
+T+ T M + TGT WM+PE+ S GE Y K D++S G + E+LT +
Sbjct: 157 QTICLSGTGMKSV-TGTPYWMSPEVIS------GEG--YGRKADIWSVGCTVVEMLTEKP 207
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P+ + A + A + P LP +S ++ +VE LRPS +++R
Sbjct: 208 PWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVE-AKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-21
Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVAL 82
++E++++ ++ H N++K+L + ++ + IV EL L + + + K +
Sbjct: 50 LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ + + A++ +H+ I+HRD+KP N+ +T +KL D GL R + ++ A +
Sbjct: 110 KYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLV 167
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAA 199
GT +M+PE + YN K D++S G +L+E+ + PF G NL +
Sbjct: 168 GTPYYMSPERI--------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219
Query: 200 AFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQI 237
K P LP D S +L +V C DP RP S +
Sbjct: 220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 53/171 (30%), Positives = 89/171 (52%), Gaps = 19/171 (11%)
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 141
++++ +AR M+ L + IHRDL N+LL+ + +K+ DFGLAR+ + G
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD-IYKDPDYVRKG 233
Query: 142 TYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195
R WMAPE ++ V Y + DV+SFG++LWE+ + P+ G+ +
Sbjct: 234 DARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDE 283
Query: 196 AYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ K R PE +P++ I+ CW +P RP+FS+++ +L L
Sbjct: 284 EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 67/247 (27%), Positives = 108/247 (43%), Gaps = 43/247 (17%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ + +H +VK L V+V E +P L + L L ++
Sbjct: 47 LREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRD-EERPLPEAQVKSY 104
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT 142
+ + + +HANGI+HRDLKP NLL++ D LK+ADFGLAR E + + + T
Sbjct: 105 MRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPRLYSHQVAT 163
Query: 143 YRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------------ 189
+ APE LY + Y+ VD+++ G + ELL F G
Sbjct: 164 RWYRAPELLYG--------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215
Query: 190 ------------MSNLQAAYAAAFKHARPGLPEDISPDL---AF-IVQSCWVEDPNLRPS 233
+++L F ++P E+I PD A +++ V DP+ R S
Sbjct: 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275
Query: 234 FSQIIRM 240
++ +R
Sbjct: 276 AAEALRH 282
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 77/268 (28%), Positives = 115/268 (42%), Gaps = 58/268 (21%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--L 82
+RE+ ++ +KH N++ L + +V E + L K + + + L A
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVI---KDKSIVLTPADIK 105
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETG 141
++ L R ++ LH+N I+HRDLKP+NLL+ D LKLADFGLAR + MT +
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV-LKLADFGLARSFGSPNRKMTHQVV 164
Query: 142 TYRWM-APEL-YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF------------ 187
T RW APEL + +HY VD++S G + ELL R+PF
Sbjct: 165 T-RWYRAPELLFGA--------RHYGVGVDMWSVGCIFAELL-LRVPFLPGDSDIDQLGK 214
Query: 188 -------------EGMSNLQAAYAAAFKHARPGLPED-----ISPDLAFIVQSCWVEDPN 229
G+++L FK P P S D ++Q +PN
Sbjct: 215 IFEALGTPTEENWPGVTSLP--DYVEFKP-FPPTPLKQIFPAASDDALDLLQRLLTLNPN 271
Query: 230 LRPSFSQIIRMLNAFLFTLRPPSPSVPE 257
R + Q L F+ P P+ P
Sbjct: 272 KRITARQ---ALEHPYFSNDPA-PTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 59/179 (32%), Positives = 93/179 (51%), Gaps = 23/179 (12%)
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
LDL L F+ +A+ MD L + IHRD+ N+LLT D + K+ DFGLAR + + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLAR-DIMNDS 266
Query: 136 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 189
G R WMAPE ++ V Y + DV+S+GI+LWE+ + + P+ G
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCV---------YTVQSDVWSYGILLWEIFSLGKSPYPG 317
Query: 190 M---SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ S ++ +RP P++ I++ CW +P RP+FSQI +++ L
Sbjct: 318 ILVNSKFYKMVKRGYQMSRPDFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 59/178 (33%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 55 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114
V E L G L ++ S + D A +A +I + LH GII+RDLK DN+LL
Sbjct: 74 VMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 115 DQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173
D +K+ADFG+ +E E + GT ++APE+ +G+K YN VD +SF
Sbjct: 132 DGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK--YNESVDWWSF 182
Query: 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
G++L+E+L + PF G + + + RP P IS + + + DP R
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDELFD--SILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNF 84
+E++M+ +H N+V + G+ + + IV E G SL+ Y V+ P
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ------ 102
Query: 85 ALDIA-------RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 137
IA + + LH G IHRD+K N+LLT + +KLADFG++ + T T +
Sbjct: 103 ---IAYVCRETLKGLAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTAT-IAK 157
Query: 138 AET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
++ GT WMAPE+ + V + G Y+ K D+++ GI EL + P + ++A
Sbjct: 158 RKSFIGTPYWMAPEVAA-VERKGG----YDGKCDIWALGITAIELAELQPPMFDLHPMRA 212
Query: 196 AYAAAFKHARPGLPED---ISPDLAFIVQSCWVEDPNLRPS 233
+ + + P +D SP ++ C +DP RP+
Sbjct: 213 LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-21
Identities = 67/233 (28%), Positives = 115/233 (49%), Gaps = 23/233 (9%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVS 70
TS E LE E+ ++ ++HD +V++ G +DP + I E +PG S++ L +
Sbjct: 44 TSKEVNALEC----EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA 99
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
L +V + I + + LH+N I+HRD+K N+L ++KL DFG ++
Sbjct: 100 Y--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRI 156
Query: 131 TVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
M + + TGT WM+PE+ S GE Y K DV+S + E+LT + P
Sbjct: 157 QTICMSGTGIKSVTGTPYWMSPEVIS------GEG--YGRKADVWSVACTVVEMLTEKPP 208
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ + A + A + +P LP+ +S ++ +VE+ RP+ ++R
Sbjct: 209 WAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-21
Identities = 69/233 (29%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVS 70
TS E + LE E+ ++ ++H+ +V++ G +D + I E +PG S++ L +
Sbjct: 44 TSKEVSALEC----EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA 99
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
L V + I M LH+N I+HRD+K N+L ++KL DFG ++
Sbjct: 100 Y--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRL 156
Query: 131 TVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
M + + TGT WM+PE+ S GE Y K DV+S G + E+LT + P
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPEVIS------GEG--YGRKADVWSLGCTVVEMLTEKPP 208
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ + A + A + P LP IS + +VE + RPS +++R
Sbjct: 209 WAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARH-RPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-21
Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 15/215 (6%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E +M+ V + ++ + LG C + ++T+L+P L Y+ + N ++ LN+ +
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQ 117
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTY--R 144
IA+ M+ L ++HRDL N+L+ Q +K+ DFGLA+ E AE G +
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 203
WMA L + Y ++ DV+S+G+ +WEL+T P++G+ + + + K
Sbjct: 177 WMA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKG 227
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
R P + D+ I+ CW+ D + RP F ++I
Sbjct: 228 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-21
Identities = 81/264 (30%), Positives = 121/264 (45%), Gaps = 43/264 (16%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELLP 60
K +KE S +D R F E+ ++ ++ H N++ LGAC++ + I E P
Sbjct: 35 KMLKEF---ASENDHR-----DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86
Query: 61 GMSLRKYLVSLRPNKLDLHVA--------------LNFALDIARAMDCLHANGIIHRDLK 106
+L +L R + D A L FA D+A M L IHRDL
Sbjct: 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLA 146
Query: 107 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL--YSTVTLRQGEKKHY 164
N+L+ + + K+ADFGL+R E V T RWMA E YS Y
Sbjct: 147 ARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV----------Y 195
Query: 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 223
K DV+SFG++LWE+++ P+ GM+ + Y + R P + ++ +++ C
Sbjct: 196 TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEKPRNCDDEVYELMRQC 254
Query: 224 WVEDPNLRPSFSQII----RMLNA 243
W + P RP F+QI RML A
Sbjct: 255 WRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-21
Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 85 ALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
A+ I +A++ LH+ +IHRD+KP N+L+ +KL DFG++ + T + G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCK 167
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
+MAPE + + +K Y+ K DV+S GI + EL T R P++ +
Sbjct: 168 PYMAPERINP----ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223
Query: 204 ARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
P LP + SP+ V C ++ RP++ ++++
Sbjct: 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 51/149 (34%), Positives = 80/149 (53%), Gaps = 11/149 (7%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYR 144
+I A+D LH GII+RD+K +N+LL + + L DFGL++E E A + GT
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFK 202
+MAPE+ +R G H + VD +S G++ +ELLT PF +G N Q+ +
Sbjct: 172 YMAPEV-----IRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL 225
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
++P P+ +S + +Q +DP R
Sbjct: 226 KSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-20
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA- 81
F+ E ++M + H N++ G P+M I+TE + +L +L R N V
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSRPVM-IITEFMENGALDSFL---RQNDGQFTVIQ 107
Query: 82 -LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMT 137
+ IA M L +HRDL N+L+ + K++DFGL+R ++T T
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYT 166
Query: 138 AETG---TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 193
+ G RW APE + R+ + + DV+S+GIV+WE+++ P+ MSN
Sbjct: 167 SSLGGKIPIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMSN- 217
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
Q A + R P D L ++ CW +D N RP F QI+ L+ +
Sbjct: 218 QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 72/237 (30%), Positives = 116/237 (48%), Gaps = 32/237 (13%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
I+EV + +++H N +++ G C ++ +V E Y + + L++H
Sbjct: 63 IKEVRFLQQLRHPNTIEYKG-CYLREHTAWLVME---------YCLGSASDILEVHKKPL 112
Query: 84 FALDIA-------RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
++IA + + LH++ IHRD+K N+LLT + ++KLADFG A ++
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSA---SLVSPA 168
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
+ GT WMAPE V L E Y+ KVDV+S GI EL + P M+ + A
Sbjct: 169 NSFVGTPYWMAPE----VILAMDEG-QYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 197 YAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252
Y A ++ P L D S V SC + P RPS ++++ + F+ RPP+
Sbjct: 224 YHIA-QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK--HRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-20
Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 31/240 (12%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+E+ ++ + H+N+VK+ G C + + ++ E LP SL++YL NK++L L
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLK 113
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET-- 140
+A+ I + MD L + +HRDL N+L+ + + +K+ DFGL + ET E T +
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 141 -GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------NRLPFEG 189
W APE + K Y DV+SFG+ L+ELLT L G
Sbjct: 173 DSPVFWYAPECLI-------QSKFYIAS-DVWSFGVTLYELLTYCDSESSPMTLFLKMIG 224
Query: 190 MSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ Q + G P + ++ +++ CW P+ R +F +I A L
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-20
Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 36/264 (13%)
Query: 1 MGKFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTEL 58
M +K + S D R F E+ ++ ++ H N++ LGAC+ + + E
Sbjct: 23 MDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77
Query: 59 LPGMSLRKYLVSLRPNKLDLHVA--------------LNFALDIARAMDCLHANGIIHRD 104
P +L +L R + D A L+FA D+AR MD L IHRD
Sbjct: 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 137
Query: 105 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL--YSTVTLRQGEKK 162
L N+L+ + + K+ADFGL+R + V T RWMA E YS
Sbjct: 138 LAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--------- 187
Query: 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 221
Y DV+S+G++LWE+++ P+ GM+ + Y + R P + ++ +++
Sbjct: 188 -YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMR 245
Query: 222 SCWVEDPNLRPSFSQIIRMLNAFL 245
CW E P RPSF+QI+ LN L
Sbjct: 246 QCWREKPYERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-20
Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 17/176 (9%)
Query: 27 REVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
REV ++ +++H+N+V A + + +V E + L L+ P L ++
Sbjct: 49 REVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYI 106
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-- 143
+ +A+ H++ IIHRD+KP+N+L++ LKL DFG AR + + Y
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILVSESGV-LKLCDFGFAR--ALRARPASPLTDYVA 163
Query: 144 -RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
RW APEL T +Y VDV++ G ++ ELL F G S++ Y
Sbjct: 164 TRWYRAPELLVGDT-------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-20
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 28/197 (14%)
Query: 60 PGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 117
P + R L++ P + +DL + F+ +A M+ L + +HRDL N+L+ + K
Sbjct: 221 PERTRRDTLINESPALSYMDL---VGFSYQVANGMEFLASKNCVHRDLAARNVLIC-EGK 276
Query: 118 SLKLADFGLAREETVTEMMTAETGTY---RWMAPE-----LYSTVTLRQGEKKHYNNKVD 169
+K+ DFGLAR+ ++ T+ +WMAPE LY+T++ D
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-------------D 323
Query: 170 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 228
V+SFGI+LWE+ T P+ + + Y A + R P S ++ I+Q CW E
Sbjct: 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKF 383
Query: 229 NLRPSFSQIIRMLNAFL 245
+RP FSQ++ ++ L
Sbjct: 384 EIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-20
Identities = 72/246 (29%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRK 66
L +T DE+ L F++EV + H N+++ LG C + P + +V E P L+
Sbjct: 30 LRASATPDEQLL----FLQEVQPYRELNHPNVLQCLGQCIESIPYL-LVLEFCPLGDLKN 84
Query: 67 YLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
YL S R V A ++A + LH IH DL N LT D S+K+ D
Sbjct: 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGD 143
Query: 124 FGLAREETVTE-MMTAETGTY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+GLA E+ + +T + RW+APEL K K +++S G+ +WEL
Sbjct: 144 YGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ-TKKSNIWSLGVTMWEL 202
Query: 181 LTN-RLPFEGMSNLQA-AYAAA---FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
T P+ +S+ Q K +P L S ++Q CW+ DP RP+
Sbjct: 203 FTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAE 261
Query: 236 QIIRML 241
++ +L
Sbjct: 262 EVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-19
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 24/240 (10%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGM 62
K +K N + DE +RE N+M ++ + +V+ +G C+ ++V EL
Sbjct: 28 KILKNDNNDPALKDE-------LLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELG 80
Query: 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
L K+L + + ++ M L +HRDL N+LL Q K++
Sbjct: 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV-TQHYAKIS 137
Query: 123 DFGLAREETVTEMMTAETGT----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
DFGL++ E +W APE + +++K DV+SFG+++W
Sbjct: 138 DFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK--------FSSKSDVWSFGVLMW 189
Query: 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
E + + P++GM + R P+ P++ +++ CW + RP F+ +
Sbjct: 190 EAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-19
Identities = 77/248 (31%), Positives = 120/248 (48%), Gaps = 21/248 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
I E+ +M +K+ N+V FL + D L V++ E L G SL + ++ +
Sbjct: 64 INEILVMKELKNPNIVNFLDSFLVGDELFVVM-EYLAGGSLTDVVTETCMDEAQIAAVCR 122
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGT 142
L +A++ LHAN +IHRD+K DN+LL S+KL DFG + T + + GT
Sbjct: 123 ECL---QALEFLHANQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 179 PYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T 229
Query: 203 HARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 260
+ P L PE +SP + C D R S ++++ + FL +P S P
Sbjct: 230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKPLSSLTPLILA 287
Query: 261 NEAAATSN 268
+ A SN
Sbjct: 288 AKEAMKSN 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 1e-19
Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 53/271 (19%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLP 60
K MK+ S + L E + +R++N +H N+VK D L V E +
Sbjct: 30 KKMKKKFY--SWEECMNLREVKSLRKLN-----EHPNIVKLKEVFRENDELY-FVFEYME 81
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
G +L + + + V + I + + +H +G HRDLKP+NLL++ + +K
Sbjct: 82 G-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVK 139
Query: 121 LADFGLAREETVTEM--MTAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
+ADFGLARE + T T RW APE + LR Y++ VD+++ G ++
Sbjct: 140 IADFGLARE--IRSRPPYTDYVST-RWYRAPE----ILLRST---SYSSPVDIWALGCIM 189
Query: 178 WELLTNRLPFEGMSNL--------------QAAYAAAFKHAR---------PGLPED--- 211
EL T R F G S + + + +K A
Sbjct: 190 AELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI 249
Query: 212 --ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
SP+ +++ DP RP+ SQ ++
Sbjct: 250 PNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 51/261 (19%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGM---SLRKYLVS 70
S++ +++ +RE+ M+ +++H+NLV + + + +V E + L KY
Sbjct: 37 SEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--- 93
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
PN LD + I R ++ H++ IIHRD+KP+N+L++ +KL DFG AR
Sbjct: 94 --PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFAR-- 148
Query: 131 TVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
T+ E+ T T + APEL G+ K Y VD+++ G ++ E+LT F
Sbjct: 149 TLAAPGEVYTDYVATRWYRAPELLV------GDTK-YGRAVDIWAVGCLVTEMLTGEPLF 201
Query: 188 EGMS-------------NLQAAYAAAFKHARPG----LPE------------DISPDLAF 218
G S NL + F+ LPE +S +
Sbjct: 202 PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLD 261
Query: 219 IVQSCWVEDPNLRPSFSQIIR 239
+ + C DP+ RPS SQ++
Sbjct: 262 LAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-19
Identities = 72/231 (31%), Positives = 110/231 (47%), Gaps = 25/231 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA---CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F+ E ++M + H N++ G K P+M IVTE + SL +L R + V
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSK-PVM-IVTEYMENGSLDAFL---RKHDGQFTVI 106
Query: 82 --LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMT 137
+ IA M L G +HRDL N+L+ + K++DFGL+R E+ T
Sbjct: 107 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYT 165
Query: 138 AETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 194
G RW APE + R+ + + DV+S+GIV+WE+++ P+ MSN Q
Sbjct: 166 TRGGKIPIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWEMSN-Q 216
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
A + R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 217 DVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 58/181 (32%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 26 IREVNMMSRVK---HDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKL 76
+RE+ ++ +++ H N+V+ L C P + +V E + L YL L
Sbjct: 46 LREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGL 104
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
+ + R +D LH++ I+HRDLKP N+L+T D + +K+ADFGLAR + +
Sbjct: 105 PPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIYSFEMAL 163
Query: 137 TAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNL 193
T+ T YR APE V L+ Y VD++S G + EL R P F G S
Sbjct: 164 TSVVVTLWYR--APE----VLLQS----SYATPVDMWSVGCIFAELF-RRRPLFRGTSEA 212
Query: 194 Q 194
Sbjct: 213 D 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 30/238 (12%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPN--------- 74
F RE +++ ++H ++V+F G C + +++V E + L ++L S P+
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113
Query: 75 ----KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
+L L L A IA M L + +HRDL N L+ +K+ DFG++R+
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDI 172
Query: 131 TVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 186
T+ T RWM PE ++ R+ + + D++SFG+VLWE+ T + P
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPE---SILYRK-----FTTESDIWSFGVVLWEIFTYGKQP 224
Query: 187 FEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
+ +SN +A R P P++ I+Q CW +P R I L A
Sbjct: 225 WYQLSNTEA--IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 69/247 (27%), Positives = 109/247 (44%), Gaps = 25/247 (10%)
Query: 7 EVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLR 65
+ L G T +R F+ E ++M + H N+++ G K +I+TE + +L
Sbjct: 39 KTLKPGYTEKQRQ----DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALD 94
Query: 66 KYLVSLRPNKLDLHV--ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
KYL R + + + IA M L +HRDL N+L+ K++D
Sbjct: 95 KYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN-SNLECKVSD 150
Query: 124 FGLAR--EETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
FGL+R E+ T G RW APE + + + + DV+SFGIV+WE
Sbjct: 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWE 202
Query: 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+++ P+ MSN A R P D + ++ CW +D RP F I+
Sbjct: 203 VMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
Query: 239 RMLNAFL 245
+L+ L
Sbjct: 262 NLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + K+ G+ KD + I+ E L G S L L P LD
Sbjct: 51 QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATIL 107
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYR 144
+I + +D LH+ IHRD+K N+LL+ + +KLADFG+A + T T++ GT
Sbjct: 108 REILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y++K D++S GI EL P + ++ + K+
Sbjct: 167 WMAPEVI--------KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNN 217
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L + S L V++C ++P+ RP+ ++++
Sbjct: 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 11/168 (6%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+V+ L + + +V E L + L+KY+ S LD + ++
Sbjct: 46 IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
+ + + H++ ++HRDLKP NLL+ + +LKLADFGLAR V T E T
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTL 163
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
+ APE + L + Y+ VD++S G + E++ R F G S
Sbjct: 164 WYRAPE----ILLGS---RQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 37/242 (15%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLR----P 73
F+ E M H N+++ +G C P V++ + L +L+ R P
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP 106
Query: 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA------ 127
L + + F DIA M+ L + IHRDL N +L + ++ +ADFGL+
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNG 165
Query: 128 ---REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 183
R+ + +M +W+A E + + Y K DV+SFG+ +WE+ T
Sbjct: 166 DYYRQGRIAKM------PVKWIAIESLA--------DRVYTTKSDVWSFGVTMWEIATRG 211
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
+ P+ G+ N + Y + R P D L ++ SCW+ +P RPSF + L
Sbjct: 212 QTPYPGVENSE-IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270
Query: 244 FL 245
L
Sbjct: 271 AL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 57/170 (33%), Positives = 92/170 (54%), Gaps = 14/170 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALN 83
IRE++++ ++H N+V ++ + ++ E L M L+KYL SL + +D + +
Sbjct: 47 IREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKS 105
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-KLADFGLAREETV-TEMMTAETG 141
+ I + + H+ ++HRDLKP NLL+ D K + KLADFGLAR + + T E
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHEVV 163
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
T + APE V L G + Y+ VD++S G + E+ T + F G S
Sbjct: 164 TLWYRAPE----VLL--GSPR-YSTPVDIWSIGTIFAEMATKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-19
Identities = 72/238 (30%), Positives = 112/238 (47%), Gaps = 29/238 (12%)
Query: 28 EVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
EV +M H+N+V + D L V V E L G +L + R N+ +
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIATV---C 124
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYR 144
L + RA+ LH G+IHRD+K D++LLT D + +KL+DFG A+ + GT
Sbjct: 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPY 183
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ S + Y +VD++S GI++ E++ P+ LQ A +
Sbjct: 184 WMAPEVISRLP--------YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRI 230
Query: 205 RPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R LP +S L + V +P+ R + ++++ + FL PPS VP
Sbjct: 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-19
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + ++ G+ K + I+ E L G S L L+P L+
Sbjct: 51 QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATIL 107
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYR 144
+I + +D LH+ IHRD+K N+LL+ +Q +KLADFG+A + T T++ GT
Sbjct: 108 REILKGLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y+ K D++S GI EL P + ++ + K++
Sbjct: 167 WMAPEVI--------KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNS 217
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L S V++C +DP RP+ ++++
Sbjct: 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-19
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E+ ++S+ + K+ G+ K + I+ E L G S L LR D
Sbjct: 51 QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA---LDLLRAGPFDEFQIATML 107
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYR 144
+I + +D LH+ IHRD+K N+LL+ +Q +KLADFG+A + T T++ GT
Sbjct: 108 KEILKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
WMAPE+ ++ Y++K D++S GI EL P M ++ + K+
Sbjct: 167 WMAPEVI--------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNN 217
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P L + S + +C +DP+ RP+ ++++
Sbjct: 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-19
Identities = 52/170 (30%), Positives = 90/170 (52%), Gaps = 11/170 (6%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+VK L + + +V E L L+K++ + + + L + ++
Sbjct: 47 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSY 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
+ + + H++ ++HRDLKP NLL+ + +KLADFGLAR V T E T
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTL 164
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+ APE+ K+Y+ VD++S G + E++T R F G S +
Sbjct: 165 WYRAPEILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-19
Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 19/169 (11%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
++ +AR M+ L + IHRDL N+LL+ + +K+ DFGLAR+ + G+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD-IYKDPDYVRKGSA 236
Query: 144 R----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 197
R WMAPE ++ V Y + DV+SFG++LWE+ + P+ G+ + +
Sbjct: 237 RLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QINEEF 286
Query: 198 AAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
K R PE+ +P++ I+ +CW DP RP+FS ++ +L L
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 44/273 (16%)
Query: 4 FMKEVLNRGSTSDE-----RAL----LEGR--FIREVNMMSRVKHDNLVKFLGAC--KDP 50
F+ E N T D+ +AL L R F RE +++ ++H+++VKF G C DP
Sbjct: 22 FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81
Query: 51 LMVIVTELLPGMSLRKYLVSLRPN--------------KLDLHVALNFALDIARAMDCLH 96
L ++V E + L K+L + P+ +L L L+ A IA M L
Sbjct: 82 L-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140
Query: 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYST 153
+ +HRDL N L+ +K+ DFG++R+ T+ T RWM PE +
Sbjct: 141 SQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE---S 196
Query: 154 VTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDI 212
+ R+ + + DV+SFG++LWE+ T + P+ +SN + R +
Sbjct: 197 IMYRK-----FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--IECITQGRVLERPRV 249
Query: 213 SPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNAF 244
P + I+ CW +P R + +I ++L+A
Sbjct: 250 CPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 10/170 (5%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ ++H N+V+ + + +V E L + L+K++ S + + +
Sbjct: 49 IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
I R + H++ ++HRDLKP NLL+ +LKLADFGLAR + T E T
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL 167
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+ APE+ +HY+ VD++S G + E++ + F G S +
Sbjct: 168 WYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 27 REVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+E +++++KH N+V F + + D + IV E G L + + R L +
Sbjct: 47 KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTY 143
+ + + +H ++HRD+K N+ LT + K +KL DFG AR T + A T GT
Sbjct: 107 VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTP 164
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NL-----QAA 196
++ PE++ E YNNK D++S G +L+EL T + PF+ S NL Q +
Sbjct: 165 YYVPPEIW--------ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS 216
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
Y LP S +L +++ + +P RPS + I+
Sbjct: 217 YKP--------LPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 62/187 (33%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL------MVIVTELLPGMSLRKYLVS 70
E R +RE+ ++ R KH+N++ L + P + IV EL+ L K +
Sbjct: 42 EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLI-- 98
Query: 71 LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLA 127
+ L + H+ F I R + +H+ ++HRDLKP NLLL D LK+ DFGLA
Sbjct: 99 -KTQHLSNDHIQY-FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLA 153
Query: 128 R----EETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
R E T +T T RW APE+ K Y +D++S G +L E+L+
Sbjct: 154 RIADPEHDHTGFLTEYVAT-RWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLS 205
Query: 183 NRLPFEG 189
NR F G
Sbjct: 206 NRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 51/149 (34%), Positives = 83/149 (55%), Gaps = 11/149 (7%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYR 144
+I A++ LH GII+RD+K +N+LL + + L DFGL++E E E + GT
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFK 202
+MAP++ +R G+ H + VD +S G++++ELLT PF +G N QA +
Sbjct: 172 YMAPDI-----VRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ P P+++S I+Q ++DP R
Sbjct: 226 KSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 3e-18
Identities = 74/248 (29%), Positives = 119/248 (47%), Gaps = 21/248 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
I E+ +M K+ N+V +L + D L V++ E L G SL + ++ +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCR 123
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 142
L +A++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT
Sbjct: 124 ECL---QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 180 PYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-T 230
Query: 203 HARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 260
+ P L PE +S + C D R S ++++ + FL +P S P
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTPLIAA 288
Query: 261 NEAAATSN 268
+ A +N
Sbjct: 289 AKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-18
Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 25/209 (11%)
Query: 30 NMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
MM + + + K + KD L +V E L G + +L L A + +
Sbjct: 49 IMMIQGESPYVAKLYYSFQSKDYLY-LVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAE 105
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWM 146
+ ++ LH GIIHRD+KP+NLL+ DQ LKL DFGL+R GT ++
Sbjct: 106 VVLGVEDLHQRGIIHRDIKPENLLI--DQTGHLKLTDFGLSR---NGLENKKFVGTPDYL 160
Query: 147 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 206
APE + D +S G V++E L PF + A R
Sbjct: 161 APETI--------LGVGDDKMSDWWSLGCVIFEFLFGYPPFH--AETPDAVFDNILSRRI 210
Query: 207 GLPED----ISPDLAFIVQSCWVEDPNLR 231
PE+ SP+ ++ DP R
Sbjct: 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 17/173 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E ++++ K + LVK L A +D + + E +PG R L +L L A +
Sbjct: 51 ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMA 108
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRW 145
++ A+D LH G IHRDLKP+N L+ D +KL DFGL++ + + G+ +
Sbjct: 109 EMFEAVDALHELGYIHRDLKPENFLI--DASGHIKLTDFGLSKG--IVTYANSVVGSPDY 164
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
MAPE+ +G+ Y+ VD +S G +L+E L PF G S +
Sbjct: 165 MAPEVL------RGKG--YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWE 208
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 10/218 (4%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
++ E+ +++ H +VK LGA D + I+ E PG ++ ++ L + + +
Sbjct: 56 YMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV- 114
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGT 142
+ A+ LH+ IIHRDLK N+LLT D +KLADFG++ + T + + GT
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGT 173
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ T++ Y+ K D++S GI L E+ P ++ ++ A K
Sbjct: 174 PYWMAPEVVMCETMKDTP---YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-K 229
Query: 203 HARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
P L P S + +++ + P RPS +Q++
Sbjct: 230 SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 5e-18
Identities = 57/182 (31%), Positives = 83/182 (45%), Gaps = 41/182 (22%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLV------SLRPNKLDLH 79
IRE+ ++ +++H N+V+ L IVT G S+ Y+V L L
Sbjct: 46 IREIKLLQKLRHPNIVR--------LKEIVTSKGKG-SI--YMVFEYMDHDL--TGLLDS 92
Query: 80 VALNFALD--------IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
+ F + + LH+NGI+HRD+K N+L+ + LKLADFGLAR T
Sbjct: 93 PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLARPYT 151
Query: 132 VTEM--MTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
T T YR PEL G + Y +VD++S G +L EL + F
Sbjct: 152 KRNSADYTNRVITLWYR--PPELL------LGATR-YGPEVDMWSVGCILAELFLGKPIF 202
Query: 188 EG 189
+G
Sbjct: 203 QG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 18/229 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALN 83
I+EV + ++KH N +++ G K+ +V E G + V +P ++++ +
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH 128
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGT 142
AL + + LH++ +IHRD+K N+LLT P Q +KLADFG A + + + GT
Sbjct: 129 GAL---QGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSA---SKSSPANSFVGT 180
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A
Sbjct: 181 PYWMAPEV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 235
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251
+ + + V C + P RP+ ++++R + F+ RP
Sbjct: 236 DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR--HDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-18
Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 14/163 (8%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E ++ V H +++ D + ++ E +PG L YL + + L +A
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYAS 108
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 146
+I A++ LH+ I++RDLKP+N+LL + +KL DFG A++ + + GT ++
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKK--LRDRTWTLCGTPEYL 165
Query: 147 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
APE+ + K +N VD ++ GI+++E+L PF
Sbjct: 166 APEVI--------QSKGHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-18
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 23/173 (13%)
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 141
L+F +AR M+ L + +HRDL N+LL K +K+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 142 TY---RWMAPE-----LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 192
T+ +WMAPE LY+T++ DV+S+GI+LWE+ + P+ GM
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-------------DVWSYGILLWEIFSLGGTPYPGMIV 345
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
Y R P+ + ++ I+ CW +P RPSF + ++ + L
Sbjct: 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-18
Identities = 73/236 (30%), Positives = 116/236 (49%), Gaps = 21/236 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
I E+ +M K+ N+V +L + D L V++ E L G SL + ++ +
Sbjct: 64 INEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCR 122
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGT 142
L +A+D LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT
Sbjct: 123 ECL---QALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 179 PYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T 229
Query: 203 HARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P L PE +S + C D + R S ++++ + FL +P S P
Sbjct: 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-18
Identities = 55/172 (31%), Positives = 91/172 (52%), Gaps = 16/172 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVAL 82
IRE+++M +KH+N+V+ ++ LM +V E + L+KY+ LD +
Sbjct: 46 IREISLMKELKHENIVRLHDVIHTENKLM-LVFEYMDK-DLKKYMDTHGVRGALDPNTVK 103
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETG 141
+F + + + H N ++HRDLKP NLL+ + LKLADFGLAR + + E
Sbjct: 104 SFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVV 162
Query: 142 TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
T + AP+ L + T Y+ +D++S G ++ E++T R F G +N
Sbjct: 163 TLWYRAPDVLLGSRT--------YSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 65/231 (28%), Positives = 115/231 (49%), Gaps = 20/231 (8%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP 73
+DER R E++ ++ H +VK K D ++++ E G L K +
Sbjct: 104 NDERQAAYAR--SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 74 NKL---DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
L + V L F I A+D +H+ ++HRDLK N+ L P +KL DFG +++
Sbjct: 162 EHLPFQEYEVGLLF-YQIVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQY 219
Query: 131 TVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ + ++ ++ GT ++APEL+ E+K Y+ K D++S G++L+ELLT PF
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELW--------ERKRYSKKADMWSLGVILYELLTLHRPF 271
Query: 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+G S + + P P +S + ++ ++P LRP+ Q++
Sbjct: 272 KGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-18
Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 19/180 (10%)
Query: 26 IREVNMMSRVKHDN-LVKFLGA------CKDPLMVIVTELLPGMSLRKYLVSLR---PNK 75
+RE++++ + +V+ L P + +V E L L+K++ S
Sbjct: 48 LREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRP 106
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TE 134
L +F + + + H +G++HRDLKP NLL+ + LK+AD GL R ++ +
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166
Query: 135 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
T E T + APE+ T HY+ VD++S G + E+ + F G S LQ
Sbjct: 167 SYTHEIVTLWYRAPEVLLGST-------HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 17/216 (7%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
E +M+ V + + LG C + +VT+L+P L Y V +++ LN+ +
Sbjct: 59 EAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDY-VRENKDRIGSQDLLNWCVQ 117
Query: 88 IARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG---TY 143
IA+ M L ++HRDL N+L+ +P+ +K+ DFGLAR + E G
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 202
+WMA L + + ++ DV+S+G+ +WEL+T P++G+ + K
Sbjct: 176 KWMA--------LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-K 226
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
R P + D+ I+ CW+ D RP F +++
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 61/187 (32%), Positives = 96/187 (51%), Gaps = 20/187 (10%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI--VTELLPGM 62
+K+++ ST +L R RE+ ++ ++H+N++ PL I VTELL G
Sbjct: 40 IKKIMKPFST----PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT 94
Query: 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
L + L S RP L+ F I R + +H+ G++HRDLKP N+L+ + LK+
Sbjct: 95 DLHRLLTS-RP--LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN-ENCDLKIC 150
Query: 123 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
DFGLAR + MT T + APE+ T + Y+ +VD++S G + E+L
Sbjct: 151 DFGLARIQ--DPQMTGYVSTRYYRAPEIMLTW-------QKYDVEVDIWSAGCIFAEMLE 201
Query: 183 NRLPFEG 189
+ F G
Sbjct: 202 GKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 15/216 (6%)
Query: 28 EVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPN--KLDLHVALNF 84
E ++S++ H +VKF + + I+TE G L L L+ L + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTY 143
+ + + +H I+HRDLK N+ L LK+ DFG++R + ++ T TGT
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTP 169
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
+M+PE QG Y++K D++S G +L+E+ FEG N + +
Sbjct: 170 YYMSPEALK----HQG----YDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEG 220
Query: 204 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P LPE S L I+QS +DP+LRPS ++I+R
Sbjct: 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 68/230 (29%), Positives = 116/230 (50%), Gaps = 18/230 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALN 83
I+EV + R+KH N +++ G ++ +V E G + V +P ++++ +
Sbjct: 73 IKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH 132
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGT 142
AL + + LH++ +IHRD+K N+LLT P Q +KLADFG A ++ + GT
Sbjct: 133 GAL---QGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSA---SIASPANSFVGT 184
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A
Sbjct: 185 PYWMAPEV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 239
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252
+ + S V SC + P RP+ ++++ + F+ RP +
Sbjct: 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM--FVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 24/228 (10%)
Query: 28 EVNMMSRV-KHDNLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLR--PNKLD 77
E N++ + H N+ F GA D + +V EL G S+ + LR +L
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 137
+ R + LH N +IHRD+K N+LLT +KL DFG++ + T
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRR 170
Query: 138 -AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
GT WMAPE+ + + Y+ + DV+S GI EL + P M ++
Sbjct: 171 NTFIGTPYWMAPEV---IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-- 225
Query: 197 YAAAFKHAR---PGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A FK R P L PE+ S + C +++ RP +++
Sbjct: 226 --ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 52/146 (35%), Positives = 87/146 (59%), Gaps = 12/146 (8%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRW 145
++A A+D LH+ GII+RDLKP+N+LL ++ +KL DFGL++E E GT +
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 164
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
MAPE V R+G + D +SFG++++E+LT LPF+G + + K A+
Sbjct: 165 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILK-AK 214
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
G+P+ +SP+ ++++ + +P R
Sbjct: 215 LGMPQFLSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 33/238 (13%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLG-ACKDPLMVIVTELLPGMSLRKYLVSLRPN----- 74
L F E M SR++H N+V LG K+ + ++ L ++LV P+
Sbjct: 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110
Query: 75 -------KLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
K L A ++ IA M+ L ++ ++H+DL N+L+ D+ ++K++D G
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-DKLNVKISDLG 169
Query: 126 LAREETVTE---MMTAETGTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
L RE + +M RWM+PE +Y ++ D++S+G+VLWE+
Sbjct: 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS----------DIWSYGVVLWEV 219
Query: 181 LTNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ L P+ G SN + P P+D + ++ CW E P+ RP F I
Sbjct: 220 FSYGLQPYCGYSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 60/189 (31%), Positives = 96/189 (50%), Gaps = 14/189 (7%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E L G L ++ S +K DL A +A +I + LH+ GI++RDLK DN+L
Sbjct: 71 LFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 112 LTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170
L D +K+ADFG+ +E + + T GT ++APE+ G+K YN VD
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL------LGQK--YNTSVDW 179
Query: 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 230
+SFG++L+E+L + PF G + + + P P ++ + I+ +V +P
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHD--EEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 231 RPSFSQIIR 239
R IR
Sbjct: 238 RLGVKGDIR 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 40/247 (16%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK------- 75
F++EV ++SR+K N+++ LG C +DPL ++TE + L ++L S +
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPL-CMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 76 ----------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+ L+ AL IA M L + +HRDL N L+ + ++K+ADFG
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-ENLTIKIADFG 183
Query: 126 LAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
++R + + RWMA E + G+ + DV++FG+ LWE+L
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWE-----CILMGK---FTTASDVWAFGVTLWEILM 235
Query: 183 --NRLPFEGMSNLQAAYAAA--FKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSF 234
P+ +++ Q A F+ P L ++ CW D RPSF
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 235 SQIIRML 241
S I L
Sbjct: 296 SDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFL--GACKDPLMVIVTELLPGMSLRKYLVSLRPN 74
E RF RE + +R+ H N+V L G L+ V E +PG +LR+ L +
Sbjct: 17 EEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAR---- 128
L L + A+ C H GI+HRDLKP N++++ + K+ DFG+
Sbjct: 77 PAGETGRL--MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPG 134
Query: 129 -EETVTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
+ +T T GT + APE LR GE N+ D+Y++G++ E LT +
Sbjct: 135 VRDADVATLTRTTEVLGTPTYCAPE-----QLR-GEPVTPNS--DLYAWGLIFLECLTGQ 186
Query: 185 LPFEGMSNLQAAY 197
+G S + Y
Sbjct: 187 RVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 6e-17
Identities = 67/247 (27%), Positives = 117/247 (47%), Gaps = 34/247 (13%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------- 74
F RE +++ ++H+++VKF G C DPL ++V E + L K+L + P+
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112
Query: 75 ---KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
+L L+ A IA M L + +HRDL N L+ + +K+ DFG++R+
Sbjct: 113 RPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVY 171
Query: 132 VTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 187
T+ T RWM PE ++ R+ + + DV+S G+VLWE+ T + P+
Sbjct: 172 STDYYRVGGHTMLPIRWMPPE---SIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPW 223
Query: 188 EGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
+SN + R P ++ ++ CW +P++R + I+ +++ L
Sbjct: 224 YQLSNNEV--IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN----IKEIHSLLQ 277
Query: 247 TLRPPSP 253
L SP
Sbjct: 278 NLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 60/175 (34%), Positives = 86/175 (49%), Gaps = 25/175 (14%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC--KDPLM-----VIVTELLPGMSLRKYLVSLRPNKL 76
R RE+ ++ + H+N++ L L +VT L+ G L + + KL
Sbjct: 60 RTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV---KCQKL 115
Query: 77 -DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
D H+ I R + +H+ GIIHRDLKP N+ + D + LK+ DFGLAR +
Sbjct: 116 SDDHIQF-LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARH--TDDE 171
Query: 136 MTAETGTYRW-MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
MT T RW APE + L HYN VD++S G ++ ELLT + F G
Sbjct: 172 MTGYVAT-RWYRAPE----IML---NWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-17
Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 19/182 (10%)
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
L L L + ++ +A+ M+ L + IHRDL N+LL+ + +K+ DFGLAR+
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD- 228
Query: 131 TVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 184
+ G R WMAPE ++ V Y + DV+SFG++LWE+ +
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGA 279
Query: 185 LPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
P+ G+ + + K R P+ +P++ + CW +P+ RP+FS+++ L
Sbjct: 280 SPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
Query: 244 FL 245
L
Sbjct: 339 LL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-17
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVA 81
++ E+++++ H N+VK L A + + I+ E G ++ ++ L RP + + V
Sbjct: 49 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV 108
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAET 140
L+ A++ LH N IIHRDLK N+L T D +KLADFG++ + T T + +
Sbjct: 109 CKQTLE---ALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFI 164
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT WMAPE+ V + + Y+ K DV+S GI L E+ P ++ ++ A
Sbjct: 165 GTPYWMAPEV---VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221
Query: 201 FKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
K P L P S + ++ C ++ + R + +Q+++
Sbjct: 222 -KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-17
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F +MMS++ H +LV G C + +MV E + SL YL N +++
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMV--QEYVKFGSLDTYL-KKNKNLINISWK 102
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKS-----LKLADFGLAREETVTE 134
L A +A A+ L G+ H ++ N+LL D+K+ +KL+D G++ E
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE 162
Query: 135 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNL 193
++ W+ PE ++ + D +SFG LWE+ + P +S L
Sbjct: 163 ILLERI---PWVPPECIE-------NPQNLSLAADKWSFGTTLWEIFSGGDKP---LSAL 209
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
+ F R LP +LA ++ C +P+ RPSF IIR LN
Sbjct: 210 DSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-17
Identities = 71/248 (28%), Positives = 112/248 (45%), Gaps = 26/248 (10%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMS 63
+KE+ S ++ +F+ E ++H NL++ LG C + ++V E P
Sbjct: 27 VKELRVSASVQEQM-----KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81
Query: 64 LRKYLVSLRPNKL---DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
L+ YL S R +L D A +IA + LH N IH DL N LLT D ++K
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVK 140
Query: 121 LADFGLAREETVTEMMTAETGTY---RWMAPELYSTV---TLRQGEKKHYNNKVDVYSFG 174
+ D+GL+ + + + RW+APEL V L + K N V+S G
Sbjct: 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN----VWSLG 196
Query: 175 IVLWELLT-NRLPFEGMSNLQA-AYAA---AFKHARPGLPEDISPDLAFIVQSCWVEDPN 229
+ +WEL P+ +S+ Q Y K +P L +S ++Q CW++ P
Sbjct: 197 VTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PE 255
Query: 230 LRPSFSQI 237
RPS ++
Sbjct: 256 QRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 9e-17
Identities = 59/180 (32%), Positives = 82/180 (45%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P SL + YLV + +L
Sbjct: 61 RAYRELVLMKLVNHKNIIGLLNV-----------FTPQKSLEEFQDVYLV-MELMDANLC 108
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 109 QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 167
Query: 130 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ MMT T + APE V L G Y VD++S G ++ E++ + F G
Sbjct: 168 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMA 147
A+ +H+ +IHRD+K N+LL + +KL DFG ++ T ++ GT ++A
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 148 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 207
PE++ +K Y+ K D++S G++L+ELLT + PF+G N++
Sbjct: 214 PEIW--------RRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDP 264
Query: 208 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
LP ISP++ IV + DP RPS S+++ M LF
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303
|
Length = 496 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 134
+ D A +A +I + LH GII+RDLK DN+LL + +K+ADFG+ + E +
Sbjct: 92 RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCK-EGILG 149
Query: 135 MMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+T T GT ++APE+ + Y VD ++ G++L+E+L + PFEG
Sbjct: 150 GVTTSTFCGTPDYIAPEIL------SYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDE 201
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ + R P +S + I++S ++P R
Sbjct: 202 DELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 9/218 (4%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALN 83
I E++++ + +V F GA + + + E + SL K Y + + V
Sbjct: 47 IMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR 106
Query: 84 FALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 142
+ + + L + IIHRD+KP N+L+ +KL DFG++ V + G
Sbjct: 107 ITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVS-GNLVASLAKTNIGC 164
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAA 200
+MAPE + Q Y + DV+S G+ + E+ R P+ E +N+ A +A
Sbjct: 165 QSYMAPERIKSGGPNQ--NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
P LP S D V C + PN RP+++Q++
Sbjct: 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 29/243 (11%)
Query: 13 STSDERALLEGRFIREVN-MMSRVKHDNLVKFLGA---------CKDPLMVIVTELLPGM 62
ST DE+ + R + +++ +M +VKF GA C + LM I +
Sbjct: 39 STVDEKE--QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME-LMDISLDKF--- 92
Query: 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKL 121
KY+ + + + + A+ +A++ L IIHRD+KP N+LL ++KL
Sbjct: 93 --YKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD-RNGNIKL 149
Query: 122 ADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
DFG++ + + T + G +MAPE R G Y+ + DV+S GI L+E+
Sbjct: 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA-RDG----YDVRSDVWSLGITLYEVA 204
Query: 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQI 237
T + P+ +++ K P L SP + C ++D + RP + ++
Sbjct: 205 TGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264
Query: 238 IRM 240
+
Sbjct: 265 LEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 60/185 (32%), Positives = 86/185 (46%), Gaps = 37/185 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P SL + YLV+
Sbjct: 62 RTYRELRLLKHMKHENVIGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNN 110
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 111 IVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR 168
Query: 129 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+ MT T + APE+ HYN VD++S G ++ ELLT R F
Sbjct: 169 H--TDDEMTGYVATRWYRAPEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFP 219
Query: 189 GMSNL 193
G ++
Sbjct: 220 GTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 12/174 (6%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ M+ ++KH NLV + + + +V E L + + P + H+
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKI 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 144
+A++ H + IHRD+KP+N+L+T Q +KL DFG AR T + R
Sbjct: 106 IWQTLQAVNFCHKHNCIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 145 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
W APEL T Y VDV++ G V ELLT + + G S++ Y
Sbjct: 165 WYRAPELLVGDT-------QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-16
Identities = 50/226 (22%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
+RE +M ++ + +V+ +G C+ +++V E+ G L K+L + +++ + +
Sbjct: 43 MREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELM 101
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETG 141
++ M L +HRDL N+LL +Q K++DFGL++ +++ + +A
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKW 160
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 200
+W APE + R+ ++++ DV+S+GI +WE + + P++ M + +
Sbjct: 161 PLKWYAPE---CINFRK-----FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFI 211
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
+ R P + P++ +++ CW+ RP+F+++ + + +
Sbjct: 212 EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 12/166 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IREV+++ +KH N+V + + +V E L L++YL + N + +H F
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIF 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
+ R + H I+HRDLKP NLL+ ++ LKLADFGLAR ++V T+ + E T
Sbjct: 109 MFQLLRGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTL 167
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ P++ T Y+ +D++ G +L+E+ T R F G
Sbjct: 168 WYRPPDVLLGST-------EYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 64/273 (23%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLP 60
K ++E N+ + +D F++E+ +MSR+K N+++ L C DPL +I TE +
Sbjct: 52 KMLREDANKNARND--------FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMI-TEYME 102
Query: 61 GMSLRKYLVSLRPNK---------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
L ++L P + + + A IA M L + +HRDL N L
Sbjct: 103 NGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162
Query: 112 LTPDQKSLKLADFGLAREETVTEMMTAETGTY-----------RWMAPELYSTVTLRQGE 160
+ + ++K+ADFG++R +G Y RWM+ E ++ L +
Sbjct: 163 VGKNY-TIKIADFGMSR--------NLYSGDYYRIQGRAVLPIRWMSWE---SILLGK-- 208
Query: 161 KKHYNNKVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAA--FKHA-------RPGLP 209
+ DV++FG+ LWE+LT P+ +S+ Q F+ +P L
Sbjct: 209 ---FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPAL- 264
Query: 210 EDISPDLAF-IVQSCWVEDPNLRPSFSQIIRML 241
PD + ++ SCW + RPSF +I L
Sbjct: 265 ---CPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 52/228 (22%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
E+ + R+ +N++K G D P + ++ E LR+ L + L
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFK 122
Query: 80 VALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
L+ A+D + + L+ +++L + L+T + K LK+ GL + +
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK-LKIICHGLEKILSSPPFKNV 181
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
Y + ++ + + Y K D+YS G+VLWE+ T ++PFE ++ +
Sbjct: 182 NFMVYF--SYKMLNDIF------SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
K+ LP D ++ IV++C D RP+ +I+ L+ + F
Sbjct: 234 IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281
|
Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-16
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 22/241 (9%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLV 69
R SD++ F+ E + + H N+V+ G + M+IVTE + +L +L
Sbjct: 42 RAGCSDKQRR---GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL- 97
Query: 70 SLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
R ++ L + +A M L G +H+ L +L+ D K++ F
Sbjct: 98 --RKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRL 154
Query: 128 REETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 184
+E+ + T +G W APE ++ H+++ DV+SFGIV+WE+++
Sbjct: 155 QEDKSEAIYTTMSGKSPVLWAAPE-----AIQYH---HFSSASDVWSFGIVMWEVMSYGE 206
Query: 185 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
P+ MS Q A R P + L ++ CW ++ RP FSQI +L+
Sbjct: 207 RPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
Query: 245 L 245
+
Sbjct: 266 V 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 17/223 (7%)
Query: 28 EVNMMSRV-KHDNLVKFLGA------CKDPLMVIVTELLPGMSLRKYLVSL--RPNKLDL 78
E N++ + H N+VKF G + +V EL G S+ + + L +LD
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MT 137
+ + LH N IIHRD+K +N+LLT + +KL DFG++ + T T +
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQLTSTRLRRN 186
Query: 138 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
GT WMAPE+ + Q Y+ + DV+S GI EL P M ++ +
Sbjct: 187 TSVGTPFWMAPEV---IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243
Query: 198 AAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
++ P L PE + C ++D RPS + ++
Sbjct: 244 KIP-RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 57/175 (32%), Positives = 91/175 (52%), Gaps = 20/175 (11%)
Query: 26 IREVNMMSRVKHDNLVKF----LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+RE+N++ +++H N+V +G+ D + +V E + L+ + +++ L V
Sbjct: 52 LREINILLKLQHPNIVTVKEVVVGSNLDKIY-MVMEYVE-HDLKSLMETMKQPFLQSEVK 109
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET 140
L + + LH N I+HRDLK NLLL ++ LK+ DFGLARE + + T
Sbjct: 110 -CLMLQLLSGVAHLHDNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 141 GT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
T YR APEL G K+ Y+ +D++S G + ELLT + F G S +
Sbjct: 168 VTLWYR--APELL------LGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 15/193 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVAL 82
F E ++M+ +V+ A +D + +V E +PG L + + P K A
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW----AK 145
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ ++ A+D +H+ G+IHRD+KPDN+LL LKLADFG + T M+ +T
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT +++PE+ + QG +Y + D +S G+ L+E+L PF S L Y+
Sbjct: 205 GTPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKI 259
Query: 201 FKHARP-GLPEDI 212
H PED+
Sbjct: 260 MDHKNSLNFPEDV 272
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 8e-16
Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 134
+ DL+ A +A +I + LH+ GII+RDLK DN++L D +K+ADFG+ +E +
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGD 150
Query: 135 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+ GT ++APE+ QG K Y VD +SFG++L+E+L + PF G +
Sbjct: 151 NRASTFCGTPDYIAPEIL------QGLK--YTFSVDWWSFGVLLYEMLIGQSPFHG--DD 200
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ + + P P I+ + I++ + DP R
Sbjct: 201 EDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-16
Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 27/237 (11%)
Query: 28 EVNMMSRVKHDNLVK-FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
EV +M +H N+V+ + + ++ E L G +L + R N+ + L
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL 127
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRW 145
+A+ LH+ G+IHRD+K D++LLT D + +KL+DFG A+ + GT W
Sbjct: 128 ---QALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYW 183
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
MAPE+ S + Y +VD++S GI++ E++ P+ S +Q A K R
Sbjct: 184 MAPEVIS--------RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLR 230
Query: 206 PGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
P ISP L ++ +P R + +++ + FL P VP
Sbjct: 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD--HPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-16
Identities = 58/221 (26%), Positives = 107/221 (48%), Gaps = 15/221 (6%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVAL 82
I+E++++ ++ H N++K+ + +D + IV EL L + + + K +
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETG 141
+ + + A++ +H+ ++HRD+KP N+ +T +KL D GL R + T + G
Sbjct: 110 KYFVQLCSALEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAA 200
T +M+PE + + YN K D++S G +L+E+ + PF G NL +
Sbjct: 169 TPYYMSPE--------RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 220
Query: 201 FKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
+ P LP D S +L +V C DP RP + + +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 51/174 (29%), Positives = 84/174 (48%), Gaps = 29/174 (16%)
Query: 27 REVNMMSRVK-HDNLVKFLGACKDPL---MVIVTELLPGMSL------RKYLVSLRPNKL 76
RE+ + R+ H N+++ + D + +V EL+ M+L RK + ++
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLP--EKRV 102
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
++ + +++D +H NGI HRD+KP+N+L+ LKLADFG R
Sbjct: 103 -----KSYMYQLLKSLDHMHRNGIFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPY 155
Query: 137 TAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
T T RW APE L G +Y K+D+++ G V +E+L+ F G
Sbjct: 156 TEYIST-RWYRAPE----CLLTDG---YYGPKMDIWAVGCVFFEILSLFPLFPG 201
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 45/113 (39%), Positives = 60/113 (53%), Gaps = 20/113 (17%)
Query: 90 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVTEMMTAETGTY 143
+A+ +H+ +IHRDLKP N+LL D + +KLADFGLAR E ++T T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVAT- 175
Query: 144 RWM-APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
RW APE L ST Y VD++S G +L E+L + F G S L
Sbjct: 176 RWYRAPEILLGST---------RYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYR 144
+I A++ LH GI++RD+K +N+LL + + L DFGL++E E + GT
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFK 202
+MAPE+ +G+ H VD +S GI+++ELLT PF EG N Q+ +
Sbjct: 172 YMAPEII------RGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
P P I P+ ++ +DP R
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 61/194 (31%), Positives = 95/194 (48%), Gaps = 15/194 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVAL 82
F E ++M+ + +V+ A +D + +V E +PG L V+L N + A
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL----VNLMSNYDIPEKWAR 145
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ ++ A+D +H+ G IHRD+KPDN+LL LKLADFG + M+ +T
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT +++PE V QG +Y + D +S G+ L+E+L PF S L Y+
Sbjct: 205 GTPDYISPE----VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKI 259
Query: 201 FKHARP-GLPEDIS 213
H P+DI
Sbjct: 260 MDHKNSLTFPDDIE 273
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 26/177 (14%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM----------VIVTELLPGMSLRKYLVSLRP 73
R +RE+ ++ + H+N++ A KD + IV EL+ L + + S +
Sbjct: 50 RTLREIKLLRHLDHENVI----AIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQT 104
Query: 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 133
D H F + R + +H+ ++HRDLKP NLLL + LK+ DFGLAR +
Sbjct: 105 LSDD-HCQY-FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEK 161
Query: 134 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ MT T + APEL + Y +DV+S G + ELL + F G
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCS-------EYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 45/115 (39%), Positives = 62/115 (53%), Gaps = 25/115 (21%)
Query: 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EETVTEM 135
A++ LH GI+HRDLKPDNLL+T +KL DFGL++ E+ E
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 136 MTAET-GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ + GT ++APE V LRQG Y VD ++ GI+L+E L +PF G
Sbjct: 172 LDKQVCGTPEYIAPE----VILRQG----YGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 51/166 (30%), Positives = 88/166 (53%), Gaps = 12/166 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IREV+++ +KH N+V + + +V E L L++YL N +++H F
Sbjct: 52 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
+ R ++ H ++HRDLKP NLL+ ++ LKLADFGLAR +++ T+ + E T
Sbjct: 110 LFQLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTL 168
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ P++ T Y+ ++D++ G + +E+ T R F G
Sbjct: 169 WYRPPDILLGST-------DYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 56/175 (32%), Positives = 86/175 (49%), Gaps = 19/175 (10%)
Query: 26 IREVNMMSRVK---HDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+REV ++ R++ H N+V+ + C ++ + +V E + LR YL + P L
Sbjct: 47 VREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGL 105
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
+ R +D LHAN I+HRDLKP+N+L+T +KLADFGLAR + +
Sbjct: 106 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMAL 164
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
T T + APE+ T Y VD++S G + E+ + F G S
Sbjct: 165 TPVVVTLWYRAPEVLLQST--------YATPVDMWSVGCIFAEMFRRKPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVAL 82
++E++++ ++ H N++K+L + +D + IV EL L + + + K +
Sbjct: 50 VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETG 141
+ + + A++ +H+ ++HRD+KP N+ +T +KL D GL R + T + G
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAA 200
T +M+PE + + YN K D++S G +L+E+ + PF G NL +
Sbjct: 169 TPYYMSPE--------RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI 220
Query: 201 FKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
+ P LP E S L +V C DP+ RP + ++
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ ++ +KH N+V+ D + +V E L+KY S +D + +F
Sbjct: 47 LREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCN-GDIDPEIVKSF 104
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
+ + + H++ ++HRDLKP NLL+ LKLADFGLAR + +AE T
Sbjct: 105 MFQLLKGLAFCHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTL 163
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+ P++ L Y+ +D++S G + EL
Sbjct: 164 WYRPPDVLFGAKL-------YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 16/173 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE +++ +KH N+V + +V E L L++Y+ L +H F
Sbjct: 51 IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDD-CGGGLSMHNVRLF 108
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
+ R + H ++HRDLKP NLL++ ++ LKLADFGLAR ++V ++ + E T
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 144 RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
+ P+ L ST Y+ +D++ G + +E+ T R F G ++++
Sbjct: 168 WYRPPDVLLGST---------EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 62/244 (25%), Positives = 91/244 (37%), Gaps = 55/244 (22%)
Query: 54 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 113
+V E +PG L L+ R + A + ++ A+D +H G IHRD+KPDN+L+
Sbjct: 78 LVMEYMPGGDLMNLLI--RKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 114 PDQKSLKLADFGLA-------------REETVTEMMTAET-----------------GTY 143
D +KLADFGL + GT
Sbjct: 136 AD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
++APE V Y + D +S G++L+E+L PF LQ Y
Sbjct: 195 DYIAPE----VLRGTP----YGLECDWWSLGVILYEMLYGFPPFYS-DTLQETYNKIINW 245
Query: 204 ARP-GLPED--ISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFT------LRPPSP 253
P D +SP+ ++ + DP R SF +I + F P
Sbjct: 246 KESLRFPPDPPVSPEAIDLICRL-LCDPEDRLGSFEEIKS--HPFFKGIDWENLRETKPP 302
Query: 254 SVPE 257
VPE
Sbjct: 303 FVPE 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-15
Identities = 54/164 (32%), Positives = 83/164 (50%), Gaps = 13/164 (7%)
Query: 28 EVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E N++ VKH +V + A + + ++ E L G L +L R A +
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE--REGIFMEDTACFYLS 107
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRW 145
+I+ A++ LH GII+RDLKP+N+LL Q +KL DFGL +E +T GT +
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEY 166
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
MAPE+ R G + VD +S G +++++LT PF
Sbjct: 167 MAPEILM----RSG----HGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-15
Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 20/229 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALN 83
I+EV + +++H N +++ G ++ +V E G + V +P ++++ +
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGT 142
AL + + LH++ +IHRD+K N+LL+ P +KL DFG A ++ GT
Sbjct: 123 GAL---QGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSA---SIMAPANXFVGT 174
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A +
Sbjct: 175 PYWMAPEV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-Q 228
Query: 203 HARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250
+ P L S V SC + P RP+ +++ + F+ RP
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-15
Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 14/150 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+ +I A+D LH+ I++RDLK +NL+L D +K+ DFGL + E +T+ T +T G
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCK-EGITDAATMKTFCG 157
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ + P +S D ++ ++DPN R
Sbjct: 210 EDIK--FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-15
Identities = 42/140 (30%), Positives = 76/140 (54%), Gaps = 10/140 (7%)
Query: 48 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
KD L +++T L+ G L+ ++ ++ A+ +A I ++ LH I++RDLKP
Sbjct: 65 KDDLCLVMT-LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKP 123
Query: 108 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167
+N+LL D +++++D GLA E + + GT +MAPE+ + + Y+
Sbjct: 124 ENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--------QGEVYDFS 174
Query: 168 VDVYSFGIVLWELLTNRLPF 187
VD ++ G L+E++ R PF
Sbjct: 175 VDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 88 IARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 146
I +A+ L G+IHRD+KP N+LL ++KL DFG++ ++ T G +M
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM 181
Query: 147 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 206
APE Y+ + DV+S GI L EL T + P++ + P
Sbjct: 182 APERIDP----PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 207 GLP--EDISPDLAFIVQSCWVEDPNLRPSFSQII 238
LP E SPD V C +D RP + +++
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 37 HDNLVKFLG-------ACKDPLMVI--------VTELLPGMSLRKYLVSLRPNKLDLHVA 81
H N+VKF G D L ++ VT+L+ G R + LH A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAET 140
L + LH N IHRD+K +N+LLT + +KL DFG++ + T T +
Sbjct: 134 L-------MGLQHLHVNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSV 185
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT WMAPE+ + Q Y+ + DV+S GI EL P + ++A +
Sbjct: 186 GTPFWMAPEV---IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242
Query: 201 FKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
++ P L PE S + ++ C +D RP+ S +++
Sbjct: 243 -RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 64/236 (27%), Positives = 108/236 (45%), Gaps = 19/236 (8%)
Query: 14 TSDERALLEGRFIREVNMMSRVKHD-NLVKFLGAC--KDP-----LMVIVTELLPGMSLR 65
T DE E +E+NM+ + H N+ + GA K+P + +V E S+
Sbjct: 42 TGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 97
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+ + + N L +I R + LH + +IHRD+K N+LLT + +KL DFG
Sbjct: 98 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFG 156
Query: 126 LARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
++ + TV T GT WMAPE+ + + Y+ K D++S GI E+
Sbjct: 157 VSAQLDRTVGRRNTF-IGTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEG 212
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P M ++A + A + S ++SC V++ + RP+ Q+++
Sbjct: 213 APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 15/192 (7%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVAL 82
F E ++M+ +V+ A +D + +V E +PG L + + P K A
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----AR 145
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ ++ A+D +H+ G IHRD+KPDN+LL LKLADFG + M+ +T
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT +++PE+ + QG +Y + D +S G+ L+E+L PF S L Y+
Sbjct: 205 GTPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKI 259
Query: 201 FKHARP-GLPED 211
H P+D
Sbjct: 260 MNHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 34/184 (18%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN-- 83
+RE+ ++ ++H N+V+ E++ G L + + + DL L+
Sbjct: 54 LREITLLLNLRHPNIVELK------------EVVVGKHLDSIFLVMEYCEQDLASLLDNM 101
Query: 84 -----------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ET 131
L + R + LH N IIHRDLK NLLLT D+ LK+ADFGLAR
Sbjct: 102 PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGL 160
Query: 132 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
+ MT + T + APEL T Y +D+++ G +L ELL ++ G S
Sbjct: 161 PAKPMTPKVVTLWYRAPELLLGCT-------TYTTAIDMWAVGCILAELLAHKPLLPGKS 213
Query: 192 NLQA 195
++
Sbjct: 214 EIEQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 39/137 (28%), Positives = 78/137 (56%), Gaps = 9/137 (6%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ +V L+ G L+ ++ ++ L++ ++++ I + LH+ I++RD+KP+N+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 112 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171
L DQ + +L+D GLA E + +T GT +MAPE+ +++ Y+ VD +
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--------KEEPYSYPVDWF 178
Query: 172 SFGIVLWELLTNRLPFE 188
+ G ++E++ R PF+
Sbjct: 179 AMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 28 EVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMS--LRKYLVSLRPNKLDLHVALNF 84
E ++ V H ++++ + +V LP S L YL + R L + AL
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL-TKRSRPLPIDQALII 162
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 144
I + LHA IIHRD+K +N+ + D + + D G A+ V GT
Sbjct: 163 EKQILEGLRYLHAQRIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
APE+ + + YN+K D++S GIVL+E+L
Sbjct: 222 TNAPEVLA--------RDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 43/245 (17%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA- 81
F++E+ +MSR+K+ N+++ LG C DPL ++TE + L ++L S R + A
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFL-SQREIESTFTHAN 121
Query: 82 ----------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
L A+ IA M L + +HRDL N L+ + ++K+ADFG++R
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG-NHYTIKIADFGMSRNLY 180
Query: 132 VTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL--LTNRLP 186
+ + RWMA + ++ L + + DV++FG+ LWE+ L P
Sbjct: 181 SGDYYRIQGRAVLPIRWMA---WESILLGK-----FTTASDVWAFGVTLWEMFTLCKEQP 232
Query: 187 FEGMSNLQAAYAAA----------FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
+ +S+ Q + P P SP +++ CW D RP+F++
Sbjct: 233 YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCP---SPVFKLMMR-CWSRDIKDRPTFNK 288
Query: 237 IIRML 241
I L
Sbjct: 289 IHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 12/166 (7%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IREV+++ +KH N+V D + +V E L L++Y+ N + +H F
Sbjct: 52 IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIF 109
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTY 143
I R + H ++HRDLKP NLL+ ++ LKLADFGLAR ++V T+ + E T
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ P+ V L E Y+ ++D++ G + +E+ + R F G
Sbjct: 169 WYRPPD----VLLGSSE---YSTQIDMWGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 55/180 (30%), Positives = 80/180 (44%), Gaps = 29/180 (16%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM--------VIVTELLPGMSLRKYLVSLRPNK 75
R +RE+ ++ KHDN++ A +D L V V L L + S +P
Sbjct: 50 RTLRELKILRHFKHDNII----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP-- 103
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-----E 130
L F + R + +H+ +IHRDLKP NLL+ D L++ DFG+AR
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPT 162
Query: 131 TVTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
MT T RW APEL ++ Y +D++S G + E+L R F G
Sbjct: 163 EHKYFMTEYVAT-RWYRAPELLLSL-------PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 40/112 (35%), Positives = 67/112 (59%), Gaps = 12/112 (10%)
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
A+ +A +IA + LH+ GII+RDLK DN++L + +K+ADFG+ +E + T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKEN-IFGGKTTR 159
Query: 140 T--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
T GT ++APE+ + + Y VD ++FG++L+E+L + PF+G
Sbjct: 160 TFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 37/181 (20%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS--------- 70
R RE+ ++ +KH+N++ L P S+ YLV+
Sbjct: 60 RTYRELRLLKHMKHENVIGLLDV-----------FTPATSIENFNEVYLVTNLMGADLNN 108
Query: 71 -LRPNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ KL D HV + R + +H+ GIIHRDLKP N+ + D + L++ DFGLAR
Sbjct: 109 IVKCQKLSDEHVQF-LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLAR 166
Query: 129 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+ + MT T + APE+ HYN VD++S G ++ ELL + F
Sbjct: 167 Q--ADDEMTGYVATRWYRAPEIMLNWM-------HYNQTVDIWSVGCIMAELLKGKALFP 217
Query: 189 G 189
G
Sbjct: 218 G 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-14
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
RE+ ++ V H N+VK C D + ++ E + G SL ++ D+
Sbjct: 121 REIEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV--- 173
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TA 138
A I + LH I+HRD+KP NLL+ K++K+ADFG++R + + M +
Sbjct: 174 ---ARQILSGIAYLHRRHIVHRDIKPSNLLIN-SAKNVKIADFGVSR--ILAQTMDPCNS 227
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE-GMSNLQAAY 197
GT +M+PE +T L G Y D++S G+ + E R PF G A+
Sbjct: 228 SVGTIAYMSPERINT-DLNHGAYDGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASL 284
Query: 198 AAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A ++ P P S + + C +P R S Q+++
Sbjct: 285 MCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 48/168 (28%), Positives = 89/168 (52%), Gaps = 9/168 (5%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F E +++S + + A +D + +V E PG L L++ ++ D +A
Sbjct: 48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQF 106
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAE--T 140
+ ++ A+ +H G +HRD+KP+N+L+ D+ +KLADFG A T +M+ ++
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPV 164
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
GT ++APE+ + T+ K Y + D +S G++ +E++ R PF
Sbjct: 165 GTPDYIAPEVLT--TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 41/111 (36%), Positives = 70/111 (63%), Gaps = 12/111 (10%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 140
A+ +A +IA + LH+ GII+RDLK DN++L + +K+ADFG+ + E + + +T +T
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCK-ENMWDGVTTKT 160
Query: 141 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
GT ++APE+ + + Y VD ++FG++L+E+L + PFEG
Sbjct: 161 FCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 49/189 (25%), Positives = 78/189 (41%), Gaps = 32/189 (16%)
Query: 26 IREVNMMSRVKHDNLVKF---LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+RE+ ++ R+ HDN+VK LG L V L L + + DL L
Sbjct: 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL---TELNSVYIVQEYMETDLANVL 106
Query: 83 N-----------FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--- 128
F + R + +H+ ++HRDLKP N+ + + LK+ DFGLAR
Sbjct: 107 EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 129 ---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
T YR +P L + +Y +D+++ G + E+LT +
Sbjct: 167 PHYSHKGYLSEGLVTKWYR--SPRLLLSPN-------NYTKAIDMWAAGCIFAEMLTGKP 217
Query: 186 PFEGMSNLQ 194
F G L+
Sbjct: 218 LFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPE 149
+ LH N I++RDLK DNLLL + +K+ADFGL +E T+ GT ++APE
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 150 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ + + Y VD + G++++E+L PF G
Sbjct: 172 VLT--------ETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 36/106 (33%), Positives = 61/106 (57%), Gaps = 12/106 (11%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+ +I A+ LH+ +++RDLK +NL+L D +K+ DFGL +E +++ T +T G
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCG 157
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
T ++APE+ E Y VD + G+V++E++ RLPF
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 33/179 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHV 80
R RE+ +M V H N++ L P SL ++ + + +L
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLNV-----------FTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 81 ALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA 176
Query: 131 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ MMT T + APE V L G Y VD++S G ++ E++ + F G
Sbjct: 177 GTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 27 REVNMMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALN 83
+E+ M+ KH N+V + G+ ++ L I E G SL+ Y V+ ++L +
Sbjct: 55 QEIFMVKECKHCNIVAYFGSYLSREKLW-ICMEYCGGGSLQDIYHVTGPLSELQIAYVCR 113
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGT 142
L + + LH+ G +HRD+K N+LLT D +KLADFG+A + T T + GT
Sbjct: 114 ETL---QGLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGT 169
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
WMAPE+ + V G YN D+++ GI EL + P + ++A + +
Sbjct: 170 PYWMAPEV-AAVEKNGG----YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS 224
Query: 203 HARPGLPED---ISPDLAFIVQSCWVEDPNLRPSFSQII 238
+ +P +D S V+ ++P RP+ +++
Sbjct: 225 NFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 27/180 (15%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ +M+ +KH+N++ + + + +V +++ L+K +V + + V
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKK-VVDRKIRLTESQVKC-I 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------E 129
L I ++ LH +HRDL P N+ + + K+ADFGLAR
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 130 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
E MT++ T + APEL L EK Y+ VD++S G + ELLT + F G
Sbjct: 184 MQRREEMTSKVVTLWYRAPEL-----LMGAEK--YHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 35 VKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL--NFALDIARA 91
++H N+++ LG C + + ++V E L+ YL + ++ + + L A +IA
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 92 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAP 148
+ +H + +H DL N LT D ++K+ D+G+ + + E RW+AP
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 149 ELYSTVTLRQG-----EKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNL----QAAYA 198
EL V G E+ +N V++ G+ LWEL N P+ +S+
Sbjct: 171 EL---VGEFHGGLITAEQTKPSN---VWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
K +P L S ++Q CW+ P R + ++ R+L
Sbjct: 225 QQVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 42/105 (40%), Positives = 60/105 (57%), Gaps = 10/105 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 142
+A +IA A+ LH+ II+RDLKP+N+LL Q + L DFGL +E T+ GT
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE+ LR K+ Y+ VD + G VL+E+L PF
Sbjct: 160 PEYLAPEV-----LR---KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 60/188 (31%), Positives = 89/188 (47%), Gaps = 35/188 (18%)
Query: 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS----- 70
L R RE+ ++ +KH+N++ L P +SL + YLV
Sbjct: 56 LFAKRAYRELRLLKHMKHENVIGLLDV-----------FTPDLSLDRFHDFYLVMPFMGT 104
Query: 71 -----LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
++ KL + + + +HA GIIHRDLKP NL + D + LK+ DFG
Sbjct: 105 DLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFG 163
Query: 126 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
LAR +T +E MT T + APE V L HY VD++S G ++ E+LT +
Sbjct: 164 LAR-QTDSE-MTGYVVTRWYRAPE----VILNW---MHYTQTVDIWSVGCIMAEMLTGKP 214
Query: 186 PFEGMSNL 193
F+G +L
Sbjct: 215 LFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 39/111 (35%), Positives = 68/111 (61%), Gaps = 12/111 (10%)
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 140
A+ +A +I+ + LH GII+RDLK DN++L + +K+ADFG+ +E V + +T T
Sbjct: 103 AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMV-DGVTTRT 160
Query: 141 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
GT ++APE+ + + Y VD +++G++L+E+L + PF+G
Sbjct: 161 FCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 10/106 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 142
+A +I A+ LH GII+RDLK DN+LL + KLADFG+ +E T+ GT
Sbjct: 101 YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGIFNGKTTSTFCGT 159
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
++APE+ ++ Y VD ++ G++L+E+L PFE
Sbjct: 160 PDYIAPEIL--------QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 12/139 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 109
+ +V ++ G LR ++ ++ A + I ++ LH II+RDLKP+N
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPEN 127
Query: 110 LLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168
+LL + +++++D GLA E + T GT +MAPEL QGE+ Y+ V
Sbjct: 128 VLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL------QGEE--YDFSV 178
Query: 169 DVYSFGIVLWELLTNRLPF 187
D ++ G+ L+E++ R PF
Sbjct: 179 DYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 38/118 (32%), Positives = 66/118 (55%), Gaps = 10/118 (8%)
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
R K D + +A ++ A+ LH +G+I+RDLK DN+LL + KLADFG+ +E
Sbjct: 89 RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGI 147
Query: 132 VTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+ + T GT ++APE+ ++ Y VD ++ G++++E++ + PFE
Sbjct: 148 LNGVTTTTFCGTPDYIAPEIL--------QELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 54/175 (30%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 26 IREVNMMSRVKHDNLVKF--LGACKDPLMVIV----TELLPGMSLRKYLVSLRPNKLDLH 79
IRE +++ +KH N+V + K+ L ++ T+L M K+ L P + L
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMD--KHPGGLHPENVKL- 107
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
F + R + +H I+HRDLKP NLL++ D LKLADFGLAR ++V +
Sbjct: 108 ----FLFQLLRGLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSN 162
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
W P V L E Y+ +D++ G + E++ F GM ++Q
Sbjct: 163 EVVTLWYRP---PDVLLGSTE---YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 40/99 (40%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 154
LH+ GIIHRDLKP N+++ D +LK+ DFGLAR MMT T + APE V
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPE----V 193
Query: 155 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
L G Y VD++S G ++ EL+ + F+G ++
Sbjct: 194 ILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 17/223 (7%)
Query: 28 EVNMMSRVKHD-NLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
E+NM+ + H N+ + GA D + +V E S+ + + + N L
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMT 137
+I R + LHA+ +IHRD+K N+LLT + +KL DFG++ + TV T
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNT 180
Query: 138 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
GT WMAPE+ + + Y+ + D++S GI E+ P M ++A +
Sbjct: 181 F-IGTPYWMAPEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236
Query: 198 AAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
++ P L + S ++ C V++ RPS Q+++
Sbjct: 237 LIP-RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 41/95 (43%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 154
+H+ GIIHRDLKP NL + D + LK+ DFGLAR MT T + APE V
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLARHADAE--MTGYVVTRWYRAPE----V 185
Query: 155 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
L HYN VD++S G ++ E+LT + F+G
Sbjct: 186 ILNW---MHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 28/164 (17%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
FI VNMM + +N V FL E + G L +L + VA +
Sbjct: 79 FI--VNMMCSFQDENRVYFL-----------LEFVVGGELFTHLRK--AGRFPNDVAKFY 123
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTY 143
++ A + LH+ II+RDLKP+NLLL D K +K+ DFG A++ V + GT
Sbjct: 124 HAELVLAFEYLHSKDIIYRDLKPENLLL--DNKGHVKVTDFGFAKK--VPDRTFTLCGTP 179
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE+ + K + VD ++ G++L+E + PF
Sbjct: 180 EYLAPEVI--------QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-13
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 15/219 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+E+ MM KH N+V + G+ +D L I E G SL+ P + +A
Sbjct: 55 QEIIMMKDCKHSNIVAYFGSYLRRDKLW-ICMEFCGGGSLQDIYHVTGPLS-ESQIAY-V 111
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTY 143
+ + + + LH+ G +HRD+K N+LLT D +KLADFG++ + T T + GT
Sbjct: 112 SRETLQGLYYLHSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
WMAPE+ + K YN D+++ GI EL + P + ++A + +
Sbjct: 171 YWMAPEVAAV-----ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN 225
Query: 204 ARPGLPED---ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+P +D S V+ ++P RP+ ++++
Sbjct: 226 FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL + E +++ T +T G
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCG 157
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ R P +SP+ ++ +DP R
Sbjct: 210 EEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 18/104 (17%)
Query: 95 LHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR------EETVTEMMTAETGTYRW 145
LH+N ++HRDLKP N+L+ P++ +K+ D GLAR + T YR
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR- 182
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
APEL +HY +D+++ G + ELLT F+G
Sbjct: 183 -APELLLGA-------RHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGAC------KDPLM 52
G+F+ R T +E L IREV ++ ++ H N+V+ C ++ +
Sbjct: 27 GRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+V E + L YL + + + + R +D LH++ ++HRDLKP N+L+
Sbjct: 85 TLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 143
Query: 113 TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
T + +KLADFGLAR + +T+ T + APE+ L Q Y VD++S
Sbjct: 144 TSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEV-----LLQSS---YATPVDLWS 194
Query: 173 FGIVLWELLTNRLPFEGMSNL 193
G + E+ + F G S++
Sbjct: 195 VGCIFAEMFRRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 48/171 (28%), Positives = 88/171 (51%), Gaps = 14/171 (8%)
Query: 26 IREVNMMSRVKHDNLVKF--LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
IRE +++ +KH N+V + K+ L + + L +Y++ P L +
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM--HTDLAQYMIQ-HPGGLHPYNVRL 107
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT 142
F + R + +H I+HRDLKP NLL++ LKLADFGLAR +++ ++ ++E T
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVT 166
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+ P++ T Y++ +D++ G + E+L + F G+S++
Sbjct: 167 LWYRPPDVLLGAT-------DYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 40/112 (35%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTA 138
F I + +H+ ++HRDLKP NLL+ D + LK+ DFGLAR MT
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTE 168
Query: 139 ETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
T RW APE+ + + Y +DV+S G +L ELL + F+G
Sbjct: 169 YVAT-RWYRAPEIMLSF-------QSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 35/180 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLH 79
R RE+ +M V H N++ L P SL + YLV + +L
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNV-----------FTPQKSLEEFQDVYLV-MELMDANLC 109
Query: 80 VALNFALDIAR------AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129
+ LD R M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR
Sbjct: 110 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 168
Query: 130 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ MMT T + APE V L G Y VD++S G ++ E++ +++ F G
Sbjct: 169 AGTSFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 49/144 (34%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V E + G L ++ R KL A ++ +I+ A++ LH GII+RDLK DN+L
Sbjct: 71 LFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL 128
Query: 112 LTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170
L + +KL D+G+ +E T+ GT ++APE+ LR GE Y VD
Sbjct: 129 LDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI-----LR-GED--YGFSVDW 179
Query: 171 YSFGIVLWELLTNRLPFE--GMSN 192
++ G++++E++ R PF+ GMS+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F ++MS+V H +L G C + ++V E + L V LR K + VA
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD---VCLRKEKGRVPVAWK 119
Query: 84 F--ALDIARAMDCLHANGIIHRDLKPDNLLLT------PDQKSLKLADFG-----LAREE 130
A +A A+ L ++H ++ N+LL +KL+D G L+REE
Sbjct: 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 131 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
V + W+APE + D +SFG L E+ F+G
Sbjct: 180 RVERI--------PWIAPECVPGGN-------SLSTAADKWSFGTTLLEIC-----FDGE 219
Query: 191 SNLQAAYAAA---FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
L+ + F + LPE +LA ++ C +P RPSF I+R L
Sbjct: 220 VPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 27 REVNMMSRVKHDNLV---------KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD 77
RE+ +M + H N++ F K+ + +V E +P ++ KY+ N
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHA 166
Query: 78 LHVALN--FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
L + L ++ + RA+ +H+ I HRDLKP NLL+ P+ +LKL DFG A+ +
Sbjct: 167 LPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226
Query: 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+ + + APEL T +Y +D++S G ++ E++ F G S++
Sbjct: 227 SVSYICSRFYRAPELMLGAT-------NYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 41/142 (28%), Positives = 75/142 (52%), Gaps = 10/142 (7%)
Query: 48 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
KD L +++T L+ G L+ ++ ++ D A+ +A +I ++ LH I++RDLKP
Sbjct: 72 KDALCLVLT-LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 108 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167
+N+LL D ++++D GLA E E + GT +MAPE+ + + Y
Sbjct: 131 ENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--------KNERYTFS 181
Query: 168 VDVYSFGIVLWELLTNRLPFEG 189
D + G +++E++ + PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 45/196 (22%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS---------LR 72
+RE+ ++ ++KH N+V + M + P S RK Y+V+ L
Sbjct: 55 LREIKILKKLKHPNVVPLID------MAVER---PDKSKRKRGSVYMVTPYMDHDLSGLL 105
Query: 73 PN---KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR- 128
N KL + L + ++ LH N I+HRD+K N+L+ +Q LK+ADFGLAR
Sbjct: 106 ENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID-NQGILKIADFGLARP 164
Query: 129 -EETVTEMMTAETGT---Y------RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
+ G Y RW PEL GE++ Y VD++ G V
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL------GERR-YTTAVDIWGIGCVF 217
Query: 178 WELLTNRLPFEGMSNL 193
E+ T R +G S++
Sbjct: 218 AEMFTRRPILQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
L+ + + E+ ++ + ++ F GA + + I TE + G SL Y K+ H
Sbjct: 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEH 95
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
V A+ + + + L + I+HRD+KP N+L+ + +KL DFG++ + V +
Sbjct: 96 VLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN-TRGQVKLCDFGVST-QLVNSIAKTY 153
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA- 198
GT +MAPE S GE+ Y DV+S GI EL R P+ + Q +
Sbjct: 154 VGTNAYMAPERIS------GEQ--YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205
Query: 199 -----AAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPS 233
P LP S + C + P RP+
Sbjct: 206 LQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 142
+A ++A A+ LH+ II+RDLKP+N+LL Q + L DFGL +E E T+ GT
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGT 159
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE+ LR K+ Y+ VD + G VL+E+L PF
Sbjct: 160 PEYLAPEV-----LR---KEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 40/105 (38%), Positives = 60/105 (57%), Gaps = 10/105 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGT 142
+A +IA A+ LH+ I++RDLKP+N+LL Q + L DFGL +E ++ T GT
Sbjct: 101 YAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE+ K+ Y+N VD + G VL+E+L PF
Sbjct: 160 PEYLAPEVI--------RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 44/181 (24%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK--YLV---------SLRPN 74
+RE+ ++ +KH+N+V + C+ T+ P + YLV L N
Sbjct: 59 LREIKILQLLKHENVVNLIEICR-------TKATPYNRYKGSFYLVFEFCEHDLAGLLSN 111
Query: 75 KLDLHVALNFAL-DIARAMDCL-------HANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
K + F L +I + M L H N I+HRD+K N+L+T D LKLADFGL
Sbjct: 112 K-----NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGL 165
Query: 127 AR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
AR + + T T + PEL GE + Y +D++ G ++ E+
Sbjct: 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELL------LGE-RDYGPPIDMWGAGCIMAEMW 218
Query: 182 T 182
T
Sbjct: 219 T 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 39/142 (27%), Positives = 75/142 (52%), Gaps = 10/142 (7%)
Query: 48 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
KD L +++T ++ G L+ ++ ++ + AL +A +I ++ LH ++RDLKP
Sbjct: 72 KDALCLVLT-IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKP 130
Query: 108 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167
+N+LL D ++++D GLA + E + GT +MAPE+ + + Y
Sbjct: 131 ENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRYTLS 181
Query: 168 VDVYSFGIVLWELLTNRLPFEG 189
D + G +++E++ + PF G
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 54/166 (32%)
Query: 77 DLHVALN------FALDIAR--------AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
+L L + ++AR A++ LH GI++RDLKP+N+LL + L+
Sbjct: 87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLS 145
Query: 123 DFGLA----------------------REETVTEMMTAET--------GTYRWMAPELYS 152
DF L+ +E + E GT ++APE+ S
Sbjct: 146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS 205
Query: 153 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
+ + VD ++ GI+L+E+L PF+G SN ++
Sbjct: 206 --------GDGHGSAVDWWTLGILLYEMLYGTTPFKG-SNRDETFS 242
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 10/118 (8%)
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
R KL A +A +I A++ LH GII+RDLK DN+LL D +KL D+G+ +E
Sbjct: 89 RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGL 147
Query: 132 VTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
T+ GT ++APE+ +GE+ Y VD ++ G++++E++ R PF+
Sbjct: 148 GPGDTTSTFCGTPNYIAPEIL------RGEE--YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 84 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +E + + T +T
Sbjct: 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKE-GIKDGATMKTFC 157
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 GTPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ R P +SP+ ++ +DP R
Sbjct: 210 MEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-11
Identities = 64/263 (24%), Positives = 116/263 (44%), Gaps = 43/263 (16%)
Query: 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK----FLGACKDPLMVIVTELLPG 61
K + RG E++ L + EVN+M +KH N+V+ FL L +++ E
Sbjct: 44 KAISYRGLKEREKSQL----VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM-EFCDA 98
Query: 62 MSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLH-----ANG--IIHRDLKPDNLLL 112
L + + K++ H ++ + A+ H NG ++HRDLKP N+ L
Sbjct: 99 GDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
Query: 113 TPDQKSL----------------KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 156
+ + + K+ DFGL++ + M + GT + +PEL
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH--- 215
Query: 157 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPD 215
E K Y++K D+++ G +++EL + + PF +N + + K P LP + S +
Sbjct: 216 ---ETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF-SQLISELKRG-PDLPIKGKSKE 270
Query: 216 LAFIVQSCWVEDPNLRPSFSQII 238
L ++++ RPS Q +
Sbjct: 271 LNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 39/110 (35%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAET 140
F + RA+ +H + HRDLKP N+L D K LK+ DFGLAR +T T + +
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDY 166
Query: 141 GTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
RW APEL + + Y +D++S G + E+LT + F G
Sbjct: 167 VATRWYRAPELCGSFFSK------YTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 39/141 (27%), Positives = 75/141 (53%), Gaps = 10/141 (7%)
Query: 48 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107
KD L +++T L+ G L+ ++ + + A+ +A +I ++ LH I++RDLKP
Sbjct: 72 KDALCLVLT-LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKP 130
Query: 108 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167
+N+LL D ++++D GLA + + GT +MAPE+ + + Y
Sbjct: 131 ENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KNERYTFS 181
Query: 168 VDVYSFGIVLWELLTNRLPFE 188
D ++ G +L+E++ + PF+
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 10/105 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 142
+A +IA A+ LH+ I++RDLKP+N+LL Q + L DFGL +E T+ GT
Sbjct: 101 YAAEIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGT 159
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE+ K+ Y+ VD + G VL+E+L PF
Sbjct: 160 PEYLAPEVL--------HKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 46/169 (27%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
AL E R + +VN V + + KD L +++T ++ G L+ ++ ++ D
Sbjct: 47 ALNEKRILEKVNSRFVVS----LAYAYETKDALCLVLT-IMNGGDLKFHIYNMGNPGFDE 101
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
A+ +A ++ ++ L I++RDLKP+N+LL D+ ++++D GLA + E +
Sbjct: 102 QRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRG 160
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
GT +MAPE+ EK Y D + G +++E++ + PF
Sbjct: 161 RVGTVGYMAPEVI------NNEK--YTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
+ + IRE+ ++ +V F GA D + I E + G SL + L + ++
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEE 103
Query: 80 VALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
+ ++ + R + L + I+HRD+KP N+L+ + +KL DFG++ + + M +
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANS 161
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAA 196
GT +M+PE QG HY+ + D++S G+ L EL R P L+A
Sbjct: 162 FVGTRSYMSPERL------QG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213
Query: 197 YAAAFKHARPGLPEDISP 214
+ G P ISP
Sbjct: 214 FGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
R KL A ++ +I+ A++ LH GII+RDLK DN+LL + +KL D+G+ +E
Sbjct: 89 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 147
Query: 132 VTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE-- 188
T+ GT ++APE+ +GE Y VD ++ G++++E++ R PF+
Sbjct: 148 RPGDTTSTFCGTPNYIAPEIL------RGED--YGFSVDWWALGVLMFEMMAGRSPFDIV 199
Query: 189 GMS-----NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
G S N + + +P +S A +++S +DP R
Sbjct: 200 GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 10/180 (5%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP 73
S+E ++ +RE+ M+ +K +N+V+ A + + +V E + L L+ P
Sbjct: 37 SEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMP 94
Query: 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 133
N + ++ + +A+ H N I+HRD+KP+NLL++ + LKL DFG AR ++
Sbjct: 95 NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFAR--NLS 151
Query: 134 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
E A Y +A Y + L G Y VD++S G +L EL + F G S +
Sbjct: 152 EGSNANYTEY--VATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-11
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 10/117 (8%)
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EE 130
R + DL A + ++ A++ LH +I+RDLKP+N+LL Q + L DFGL +
Sbjct: 86 REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNM 144
Query: 131 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+ GT ++APEL Y VD ++ G++L+E+LT PF
Sbjct: 145 KDDDKTNTFCGTPEYLAPELLLGHG--------YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 46/238 (19%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSL-----RKYLVSLRPNKLDL 78
F +MM +V H ++V G C +D ++V E + L RK V P K
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF-- 108
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS------LKLADFG-----LA 127
A +A A+ L ++H ++ N+LL + +KL+D G L+
Sbjct: 109 ----KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS 164
Query: 128 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLP 186
R+E V + W+APE + K+ + D +SFG LWE+ N +P
Sbjct: 165 RQECVERI--------PWIAPECVE-------DSKNLSIAADKWSFGTTLWEICYNGEIP 209
Query: 187 FEG--MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
+ ++ + Y P E LA ++ C DPN RP F I+R +N
Sbjct: 210 LKDKTLAEKERFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 11/99 (11%)
Query: 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 148
A++ LH I++RDLKP+N+LL + L DFGL++ +T+ T T GT ++AP
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAP 165
Query: 149 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
E V L ++K Y VD +S G++++E+ PF
Sbjct: 166 E----VLL---DEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 36/199 (18%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVT-ELLPGMSLRKYLVSLRPN- 74
E LL+ RF+RE + + + H +V C D V T + G +L+ L S+
Sbjct: 41 ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKE 100
Query: 75 --KLDLHVA------LNFALDIARAMDCLHANGIIHRDLKPDNLLL-------------- 112
+L L+ I ++ +H+ G++HRDLKPDN+LL
Sbjct: 101 SLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160
Query: 113 -TPDQKSLKLADFGLAREETVTEMMTAE---TGTYRWMAPELYSTVTLRQGEKKHYNNKV 168
+ L D + MT GT +MAPE L +
Sbjct: 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE-----RLLGVPA---SEST 212
Query: 169 DVYSFGIVLWELLTNRLPF 187
D+Y+ G++L+++LT P+
Sbjct: 213 DIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAP 148
A+D +H G +HRD+KPDN+LL ++LADFG L T GT +++P
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDK-NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 149 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
E+ + + K Y + D +S G+ ++E+L PF
Sbjct: 173 EILQAM---EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 55/224 (24%), Positives = 83/224 (37%), Gaps = 69/224 (30%)
Query: 90 RAMDCLHANGIIHRDLKPDNLLLTPD--------QKSLKLADFGLAREETVTEMMTAETG 141
R ++ LH NG IHR++K ++L++ D L G + + V + T
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG-QKAKVVYDFPQFSTS 170
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA----- 196
W++PEL LRQ + YN K D+YS GI EL T R+PF+ M Q
Sbjct: 171 VLPWLSPEL-----LRQ-DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK 224
Query: 197 -------YAAAF-------KHARPGL--------------------------PEDISPDL 216
F K+++ G+ + SP
Sbjct: 225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF 284
Query: 217 AFIVQSCWVEDPNLRPS---------FSQIIRMLNAFLFTLRPP 251
+V+ C +DP RPS F Q+ + +L PP
Sbjct: 285 QNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 37/184 (20%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK-----YLV---------SL 71
IRE+ ++ ++ H N+V L IVT+ + +K YLV L
Sbjct: 54 IREIKILRQLNHRNIVN--------LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGL 105
Query: 72 RPNKL----DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
+ L + H+ +F + ++ H +HRD+K N+LL ++ +KLADFGLA
Sbjct: 106 LESGLVHFSEDHIK-SFMKQLLEGLNYCHKKNFLHRDIKCSNILLN-NKGQIKLADFGLA 163
Query: 128 R--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
R + T + T + PEL GE++ Y +DV+S G +L EL T +
Sbjct: 164 RLYNSEESRPYTNKVITLWYRPPELL------LGEER-YGPAIDVWSCGCILGELFTKKP 216
Query: 186 PFEG 189
F+
Sbjct: 217 IFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 25/52 (48%), Positives = 40/52 (76%), Gaps = 1/52 (1%)
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
D +A+ + ++A A+D LH +GIIHRDLKPDN+L++ ++ +KL DFGL++
Sbjct: 102 DEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 11/160 (6%)
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG-- 125
L+S ++L +A + ++ A+ +H +HRD+KPDN+LL + ++LADFG
Sbjct: 91 LLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSC 149
Query: 126 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
L + T + GT +++PE+ + G+ Y + D +S G+ ++E+L
Sbjct: 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK---YGPECDWWSLGVCMYEMLYGET 206
Query: 186 PFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQ 221
PF S L Y H P D+S + ++Q
Sbjct: 207 PFYAES-LVETYGKIMNHEERFQFPSHITDVSEEAKDLIQ 245
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 7/138 (5%)
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG-- 125
L+S ++L +A + ++ A+D +H +HRD+KPDN+L+ + ++LADFG
Sbjct: 91 LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSC 149
Query: 126 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
L E T + GT +++PE+ + + K Y + D +S G+ ++E+L
Sbjct: 150 LKLMEDGTVQSSVAVGTPDYISPEILQAM---EDGKGKYGPECDWWSLGVCMYEMLYGET 206
Query: 186 PFEGMSNLQAAYAAAFKH 203
PF S L Y H
Sbjct: 207 PFYAES-LVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 55/177 (31%)
Query: 55 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114
V + +PG + L+ L + DL A + ++ A++ +H G IHRD+KPDN+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDL--ARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136
Query: 115 DQKSLKLADFGL------------------ARE------ETVTEMMTAE----------- 139
D +KL DFGL R+ E +E+
Sbjct: 137 D-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 140 ---------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
GT ++APE V LR G Y D +S G++L+E+L + PF
Sbjct: 196 HQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSL-----RPNKLDLHVA 81
RE++++ + H ++ + A + V M + KY L R L L A
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVC-------MVMPKYKCDLFTYVDRSGPLPLEQA 187
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTA 138
+ + A+ LH GIIHRD+K +N+ L + ++ L DFG A T
Sbjct: 188 ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYG 246
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+GT +PEL + Y K D++S G+VL+E+ + G
Sbjct: 247 WSGTLETNSPELLALDP--------YCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 41/149 (27%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
+A +I ++ +H +++RDLKP N+LL + ++++D GLA + + + A GT+
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM-SNLQAAYAAAFK 202
+MAPE+ L++G Y++ D +S G +L++LL PF + +
Sbjct: 160 GYMAPEV-----LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
LP+ SP+L +++ D N R
Sbjct: 213 TMAVELPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 61/223 (27%)
Query: 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSL 64
E+L + + RA E ++++ + +VK + +D + ++ E LPG +
Sbjct: 37 SEMLEKEQVAHVRA--------ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDM 88
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLAD 123
L+ + + + + A+D +H G IHRD+KPDNLLL D K +KL+D
Sbjct: 89 MTLLM--KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL--DAKGHIKLSD 144
Query: 124 FGL-----------------------AREETVTEMMT---AET-------------GTYR 144
FGL + M + AET GT
Sbjct: 145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPD 204
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE++ + YN + D +S G++++E+L PF
Sbjct: 205 YIAPEVFL--------QTGYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 50/192 (26%)
Query: 35 VKHDNL--VKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 91
V+ D+L VK + +D L + ++ E LPG + L ++ + L + + A
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLA 113
Query: 92 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-------REE-------------T 131
+D +H G IHRD+KPDNLLL + +KL+DFGL R E T
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 132 VTEMMT---AET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175
M + AET GT ++APE++ ++ G YN D +S G+
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGV 224
Query: 176 VLWELLTNRLPF 187
+++E+L PF
Sbjct: 225 IMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 18/163 (11%)
Query: 28 EVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFA 85
E +++ + H V G+ KD + +V E + G ++ LR NK V +A
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIG---GEFFTFLRRNKRFPNDVGCFYA 137
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYR 144
I + L + I++RDLKP+NLLL D +K+ DFG A+ +T T + GT
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRTYTL---CGTPE 193
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
++APE+ V + D ++ GI ++E+L PF
Sbjct: 194 YIAPEILLNVG--------HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 12/115 (10%)
Query: 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 159
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 121 IMHRDVKPSNILVNSRGE-IKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG 172
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 214
HY + D++S G+ L E+ R P A F S
Sbjct: 173 T--HYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESH 223
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 14/168 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
+ + IRE+ ++ +V F GA D + I E + G SL + L + ++
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQ 103
Query: 80 VALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
+ ++ + + + L + I+HRD+KP N+L+ + +KL DFG++ + + M +
Sbjct: 104 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANS 161
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
GT +M+PE QG HY+ + D++S G+ L E+ R P
Sbjct: 162 FVGTRSYMSPERL------QG--THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 68/231 (29%)
Query: 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSL 64
K+VLNR + +A E ++++ ++ +VK + +D + V + +PG +
Sbjct: 37 KDVLNRNQVAHVKA--------ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDM 88
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
L+ R +A + ++ A++ +H G IHRD+KPDN+L+ D +KL DF
Sbjct: 89 MSLLI--RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDF 145
Query: 125 GLA------------------REETVT---------------EMMTAE------------ 139
GL R++++ + T E
Sbjct: 146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLA 205
Query: 140 ---TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
GT ++APE V LR+G Y D +S G++L+E+L + PF
Sbjct: 206 HSLVGTPNYIAPE----VLLRKG----YTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 55/213 (25%)
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA--------REETVTEMMTA 138
D+ A+D +H+ G IHR +K ++LL+ D K L+ + R+ V + +
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKV-VLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ---- 194
W++PE+ L+Q + YN K D+YS GI EL +PF+ M Q
Sbjct: 168 SVKNLPWLSPEV-----LQQ-NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221
Query: 195 ----------------------AAYAAAFKHARPGLPEDI------SPDLAFIVQSCWVE 226
+ ++ +H D S V+ C
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281
Query: 227 DPNLRPSFSQI--------IRMLNAFLFTLRPP 251
DP RPS SQ+ + N L L P
Sbjct: 282 DPESRPSASQLLNHSFFKQCKRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 37/123 (30%), Positives = 60/123 (48%), Gaps = 14/123 (11%)
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR 128
+P +L + + I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR
Sbjct: 101 KPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
Query: 129 EETVTEMMTAETG----TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
A+ T+ + APEL +HY +D+++ G + ELLT+
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSE 213
Query: 185 LPF 187
F
Sbjct: 214 PIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 17/138 (12%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
+A ++ A+D LH GI+ RDL P+N+LL D+ ++L F E V + E
Sbjct: 90 WAAEMVVALDALHREGIVCRDLNPNNILLD-DRGHIQLTYFSRWSE--VEDSCDGEAVEN 146
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 203
+ APE+ G D +S G +L+ELLT G + ++ + H
Sbjct: 147 MYCAPEV--------GGISEETEACDWWSLGAILFELLT------GKTLVECHPSGINTH 192
Query: 204 ARPGLPEDISPDLAFIVQ 221
+PE +S + ++Q
Sbjct: 193 TTLNIPEWVSEEARSLLQ 210
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 37/123 (30%), Positives = 60/123 (48%), Gaps = 14/123 (11%)
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR 128
+P +L + + I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR
Sbjct: 101 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
Query: 129 EETVTEMMTAETG----TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
A+ T+ + APEL +HY +D+++ G + ELLT+
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSE 213
Query: 185 LPF 187
F
Sbjct: 214 PIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 11/114 (9%)
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 134
KL + A++ LH + IIH D+K +N+L + + L D+GL +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 135 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
GT + +PE + + +Y+ D ++ G++ +ELLT + PF+
Sbjct: 165 CY---DGTLDYFSPE--------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 49/173 (28%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ ++ E LPG + L ++ + L + + A+D +H G IHRD+KPDNLL
Sbjct: 76 LYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133
Query: 112 LTPDQKS-LKLADFGLA-------REE----------------TVTEMMTAET------- 140
L D K +KL+DFGL R E + AET
Sbjct: 134 L--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 141 ------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
GT ++APE++ ++ G YN D +S G++++E+L PF
Sbjct: 192 LAYSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 33/104 (31%), Positives = 61/104 (58%), Gaps = 9/104 (8%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
+A +I ++ +H +++RDLKP N+LL + ++++D GLA + + + A GT+
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187
+MAPE+ L++G Y++ D +S G +L++LL PF
Sbjct: 160 GYMAPEV-----LQKGTA--YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 19/111 (17%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKLD 77
R RE +MSR + K V IV E + G L+ + S +L+
Sbjct: 45 RTRREARIMSRAR-----KAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELE 99
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
L + +I R + LH+ GIIH DL N++L+ + + L DFGLA
Sbjct: 100 L------SREIGRLVGKLHSAGIIHGDLTTSNMILSGGK--IYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 18/40 (45%), Positives = 26/40 (65%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
I A+D LH+ GI+HRD+KP N++ + S K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 29/114 (25%), Positives = 50/114 (43%), Gaps = 13/114 (11%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN 74
DE+ L R RE ++++ + + V + +IV E + G L+ L RP+
Sbjct: 38 DEK-LRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEARPD 96
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
++ R + LH GI+H DL N++L+ + + DFGL
Sbjct: 97 ---------LLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR--IYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 31/120 (25%), Positives = 48/120 (40%), Gaps = 25/120 (20%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACK------DP-LMVIVTELLPGMSLRKYL 68
DER E R E ++SR + G DP IV E + G L+ +
Sbjct: 36 DERIRRE-RTRNEARLLSRARK------AGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVI 88
Query: 69 VSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
+ + + + + LH GI+H DL N+++ D+ L L DFGL +
Sbjct: 89 -----EEGNDELLREIGRLVGK----LHKAGIVHGDLTTSNIIVRDDK--LYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 30/83 (36%), Positives = 45/83 (54%), Gaps = 21/83 (25%)
Query: 54 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR--------AMDCLHANGIIHRDL 105
++ E LPG L L+ K D F+ D+ R A++ +H G IHRD+
Sbjct: 78 LIMEFLPGGDLMTMLI-----KYDT-----FSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 106 KPDNLLLTPDQKS-LKLADFGLA 127
KPDN+L+ D+ +KL+DFGL+
Sbjct: 128 KPDNILI--DRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 40/120 (33%), Positives = 57/120 (47%), Gaps = 15/120 (12%)
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLA 122
L YL R L L A + A+D +H GIIHRD+K +N+L+ P+ + L
Sbjct: 246 LYTYL-GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLG 302
Query: 123 DFG---LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFG AR T GT APE+ + G+ Y VD++S G+V++E
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA------GDP--YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 49/252 (19%)
Query: 28 EVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL---RPNKLDLHVALN 83
E+ M +++H N+VK +G C+ + ++ E + G +L + L +L R K+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKI------- 785
Query: 84 FALDIARAMDCLHAN---GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAE 139
A+ IA+A+ LH ++ +L P+ +++ D+ L+L+ GL +T + +A
Sbjct: 786 -AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA- 843
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ----- 194
++APE E K K D+Y FG++L ELLT + P + +
Sbjct: 844 -----YVAPETR--------ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVE 890
Query: 195 -AAYAAAFKH----ARPGLPEDISPDLAFIVQS------CWVEDPNLRPSFSQIIRMLNA 243
A Y + H P + D+S + IV+ C DP RP + +++ L +
Sbjct: 891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
Query: 244 FLFTLRPPSPSV 255
R S V
Sbjct: 951 ---ASRSSSSCV 959
|
Length = 968 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 46/191 (24%), Positives = 76/191 (39%), Gaps = 59/191 (30%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ V + +PG + L+ + DL A + ++ A++ +H G IHRD+KPDN+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDL--ARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 112 LTPDQKSLKLADFGLA------------------REETVTEMMTAE-------------- 139
+ D +KL DFGL R++++
Sbjct: 134 IDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 140 ----------------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
GT ++APE V LR G Y D +S G++L+E+L
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWWSVGVILYEMLVG 244
Query: 184 RLPFEGMSNLQ 194
+ PF + L+
Sbjct: 245 QPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA--REETVTEMMTAETGTYRW 145
+ RA+ LH N IIHRD+K +N+ + + L DFG A + GT
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
APEL + + Y VD++S GIVL+E+ T
Sbjct: 250 NAPELLA--------RDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 60/267 (22%), Positives = 94/267 (35%), Gaps = 81/267 (30%)
Query: 45 GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104
G+ KD +I T + GMS +L +A + +A+D +H G +HR
Sbjct: 84 GSAKD---LICTHFMDGMS-------------ELAIAY-ILQGVLKALDYIHHMGYVHRS 126
Query: 105 LKPDNLLLTPDQK--------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 156
+K ++L++ D K +L + + G R V + W++PE+
Sbjct: 127 VKASHILISVDGKVYLSGLRSNLSMINHG-QRLRVVHDFPKYSVKVLPWLSPEVL----- 180
Query: 157 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA--------------------- 195
Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 181 -QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239
Query: 196 ---------------AYAAAFKHARPGLPED--------ISPDLAFIVQSCWVEDPNLRP 232
+ RP E SP V+ C +P+ RP
Sbjct: 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299
Query: 233 SFSQIIRMLNAFLFTL--RPPSPSVPE 257
S S +LN F R S ++PE
Sbjct: 300 SAST---LLNHSFFKQIKRRASEALPE 323
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 24/66 (36%), Positives = 40/66 (60%), Gaps = 1/66 (1%)
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
M+ +K ++ +K D++V + + LH GI+HRD+KP+NLL+T D + +K+
Sbjct: 292 MAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKI 350
Query: 122 ADFGLA 127
DFG A
Sbjct: 351 IDFGAA 356
|
Length = 507 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 21/77 (27%), Positives = 30/77 (38%), Gaps = 12/77 (15%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
IV E + G L+ L + + LH GI+H DL N +
Sbjct: 411 KTIVMEYIGGKDLKDVL----------EGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFI 460
Query: 112 LTPDQKSLKLADFGLAR 128
+ D+ L L DFGL +
Sbjct: 461 VRDDR--LYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 32/114 (28%), Positives = 42/114 (36%), Gaps = 15/114 (13%)
Query: 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 161
HR K N+LLT D LKL + + Y +MAPE+ + +
Sbjct: 34 HRQAKSGNILLTWD-GLLKLDGSVAFKTPE-----QSRPDPY-FMAPEVIQGQSYTE--- 83
Query: 162 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 215
K D+YS GI L+E L LP+ L A P D S
Sbjct: 84 -----KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNL 132
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 19/74 (25%), Positives = 27/74 (36%), Gaps = 10/74 (13%)
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN----------GIIHRDLKPDNLLLTP 114
R L+ L VA +A + L A ++H DL P NLL+ P
Sbjct: 122 RLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLLVDP 181
Query: 115 DQKSLKLADFGLAR 128
+ + DF A
Sbjct: 182 GGRVTGVIDFEDAG 195
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 298 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.72 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.99 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.3 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.84 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.83 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.81 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.75 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.68 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.62 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.5 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.27 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.74 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.49 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.1 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.04 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.67 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.57 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.12 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.11 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.08 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.8 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.78 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.52 | |
| PLN02236 | 344 | choline kinase | 93.92 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.75 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.73 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.69 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.52 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.49 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.48 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.46 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 92.81 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.34 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.02 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.81 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.48 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 91.39 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=328.43 Aligned_cols=219 Identities=29% Similarity=0.507 Sum_probs=193.7
Q ss_pred HHHHHHHHHHHHHHHHhCCCCcccceeceee-cC-ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 18 RALLEGRFIREVNMMSRVKHDNLVKFLGACK-DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 18 ~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
...+++++.+|+++++.++||+||.+++.|. ++ ...|+||||+||||.+++... +++++...-.++.+++.||.||
T Consensus 117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YL 194 (364)
T KOG0581|consen 117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYL 194 (364)
T ss_pred CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 4456678889999999999999999999984 45 499999999999999999874 6699999999999999999999
Q ss_pred Hh-CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 96 HA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 96 H~-~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|+ ++|+||||||+|||++.. +.|||||||.+...... ...+..||..|||||.+.+ ..|+.++||||||
T Consensus 195 h~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g--------~~Ys~~sDIWSLG 264 (364)
T KOG0581|consen 195 HEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG--------ESYSVKSDIWSLG 264 (364)
T ss_pred hhccCeeeccCCHHHeeeccC-CCEEeccccccHHhhhh-hcccccccccccChhhhcC--------CcCCcccceeccc
Confidence 95 999999999999999954 56999999999875555 5577899999999999976 7899999999999
Q ss_pred HHHHHHHhCCCCCCCC----ChHHHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 175 IVLWELLTNRLPFEGM----SNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
++++||++|+.||... .........+..+.+|.+|.. +|+++++|+..||++||.+|||+.|+++ +.|+....
T Consensus 265 LsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~~~ 342 (364)
T KOG0581|consen 265 LSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKKFE 342 (364)
T ss_pred HHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhhcc
Confidence 9999999999999763 456677777778888999987 9999999999999999999999999999 67766544
Q ss_pred C
Q 022347 250 P 250 (298)
Q Consensus 250 ~ 250 (298)
.
T Consensus 343 ~ 343 (364)
T KOG0581|consen 343 D 343 (364)
T ss_pred c
Confidence 4
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=327.05 Aligned_cols=225 Identities=48% Similarity=0.845 Sum_probs=200.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecC--ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP--LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.|.+|+.+|.+++|||||+++|++.+. .+++||||+++|+|.+++.......+++..++.|+.+|+.|+.|||+.+
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 66899999999999999999999999765 5999999999999999998754567999999999999999999999999
Q ss_pred -CeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 -IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 -ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|+|||||++|||++.+...+||+|||+++..... .......||..|+|||++.+. ...|+.++||||||+++
T Consensus 163 ~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvl 236 (362)
T KOG0192|consen 163 PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVL 236 (362)
T ss_pred CeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHH
Confidence 9999999999999966547999999999866554 344446899999999999741 36899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
|||++|..||.+....+..........++.+|..+++.+..++.+||..||..||++.+++..|+.+........
T Consensus 237 WEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 237 WELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 999999999999988777777777889999999999999999999999999999999999999998877665433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=324.44 Aligned_cols=217 Identities=27% Similarity=0.380 Sum_probs=182.5
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
...+|+++|++|+|||||++++++.. ...|+||||++||.|.+++-.+ +.+.+.....+++|++.|+.|||+.||+|
T Consensus 222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~H 299 (475)
T KOG0615|consen 222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIH 299 (475)
T ss_pred hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCccc
Confidence 35699999999999999999999964 5679999999999999999874 44788888999999999999999999999
Q ss_pred ecCCCCCEEEcCCC--CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+|||+..+. ..+||+|||++...+....+.+.+||+.|.|||++.... ...+..+.|||||||++|-|
T Consensus 300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg-----~~~~~~kVDiWSlGcvLfvc 374 (475)
T KOG0615|consen 300 RDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG-----VEYYPSKVDIWSLGCVLFVC 374 (475)
T ss_pred ccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCC-----eecccchheeeeccceEEEE
Confidence 99999999998552 368999999999988888889999999999999997622 13344589999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
++|.+||.+..........+..+.-. .....++.+..+||.+||..||++|||++++++ +.|+....
T Consensus 375 LsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--hpW~~~~~ 444 (475)
T KOG0615|consen 375 LSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN--HPWFKDAP 444 (475)
T ss_pred eccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--Chhhhccc
Confidence 99999998765544333443333322 233568899999999999999999999999999 77776544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=323.66 Aligned_cols=210 Identities=30% Similarity=0.478 Sum_probs=183.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.++++.+|+++.++|+|||||+++++|+| ++.|||.|+|+.++|..+++. .+.+++.++..++.||+.||.|||+++
T Consensus 61 ~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~ 138 (592)
T KOG0575|consen 61 QREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG 138 (592)
T ss_pred hHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC
Confidence 34567799999999999999999999975 579999999999999999985 467999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+|||||..|+|++.+. .+||+|||+|...... ....+.+||+.|.|||++.. ...+..+||||+||+||
T Consensus 139 IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k--------~gHsfEvDiWSlGcvmY 209 (592)
T KOG0575|consen 139 IIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK--------SGHSFEVDIWSLGCVMY 209 (592)
T ss_pred ceecccchhheeecCcC-cEEecccceeeeecCcccccceecCCCcccChhHhcc--------CCCCCchhhhhhhhHHH
Confidence 99999999999999554 5999999999876644 66778899999999999974 66788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
.||.|++||+..+-.+. +. .+....-.+|..++.+..+||..+|+++|.+|||++++++ +.++
T Consensus 210 tLL~G~PPFetk~vket-y~-~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff 272 (592)
T KOG0575|consen 210 TLLVGRPPFETKTVKET-YN-KIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFF 272 (592)
T ss_pred hhhhCCCCcccchHHHH-HH-HHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhh
Confidence 99999999997643333 22 2344555677899999999999999999999999999998 6666
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=301.51 Aligned_cols=214 Identities=27% Similarity=0.473 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceece-e-ecCc-eeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGA-C-KDPL-MVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~-~-~~~~-~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~ 94 (298)
+-+++...|+.+|++|+|||||+++++ + ++.. ++||||+|++|+|...++..+ .+.+++..+|+++.|++.||..
T Consensus 60 k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~ 139 (375)
T KOG0591|consen 60 KARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYH 139 (375)
T ss_pred HHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHH
Confidence 344577899999999999999999994 4 3444 899999999999999998754 3559999999999999999999
Q ss_pred HHh--CC--CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 95 LHA--NG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 95 LH~--~g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
+|+ .. |.||||||.||+++.+ +.+||+|||+++...... ......|||.||+||.+.+ ..|+++||
T Consensus 140 cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~--------~~Y~~kSD 210 (375)
T KOG0591|consen 140 CHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE--------SGYNFKSD 210 (375)
T ss_pred HhccccccceeeccCcchheEEcCC-CceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc--------CCCCcchh
Confidence 999 45 9999999999999955 579999999999765543 3456789999999999975 88999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
|||+||++|||+.-+.||.+. +...+...+..+..+++| ..+|..+..++..|+..||+.||+...++..+..
T Consensus 211 iWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 211 IWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 999999999999999999987 566677777777777788 6799999999999999999999986555554444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=315.33 Aligned_cols=216 Identities=36% Similarity=0.638 Sum_probs=189.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.|.+|++++++|+|+|||+++++|.. +.+||||||++.|+|.+|+.......+...+.+.++.||++|++||+++++
T Consensus 245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~ 324 (468)
T KOG0197|consen 245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY 324 (468)
T ss_pred hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc
Confidence 3578899999999999999999999965 459999999999999999998556779999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccc--cccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|||||.+.||||+. +..+||+|||+++......... ...-...|.|||.+.. ..++.+|||||||++||
T Consensus 325 IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~--------~~FS~kSDVWSFGVlL~ 395 (468)
T KOG0197|consen 325 IHRDLAARNILVDE-DLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY--------GKFSSKSDVWSFGVLLW 395 (468)
T ss_pred cchhhhhhheeecc-CceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh--------CCcccccceeehhhhHH
Confidence 99999999999994 4579999999999544433322 2223458999999975 78999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 179 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++| |+.||+.+.+.+ ....+..+.+.+.|..+|+++.+++..||..+|++|||++.+...+..+...
T Consensus 396 E~fT~G~~py~~msn~e-v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 396 ELFTYGRVPYPGMSNEE-VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHhccCCCCCCCCCHHH-HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999 999999988754 4566678899999999999999999999999999999999999988876653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=307.30 Aligned_cols=229 Identities=26% Similarity=0.420 Sum_probs=195.0
Q ss_pred CchhhHHHhcCCCCcHHHHHHHHHH--------HHHHHHHHhCC-CCcccceeceeec--CceeEEEecCCCCCHHHHHh
Q 022347 1 MGKFMKEVLNRGSTSDERALLEGRF--------IREVNMMSRVK-HDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLV 69 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~~~~~~~~~--------~~E~~~l~~l~-hp~Iv~~~~~~~~--~~~~lv~e~~~~~sL~~~l~ 69 (298)
||.|++.+-+........+.++++| .||+..|+++. |||||++.+++.+ ..+|+||||| ..+|+++++
T Consensus 23 fGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK 101 (538)
T KOG0661|consen 23 FGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMK 101 (538)
T ss_pred ceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHh
Confidence 5666655554444444444444433 38999999999 9999999999843 3799999999 559999999
Q ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccc
Q 022347 70 SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 149 (298)
Q Consensus 70 ~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE 149 (298)
.+ ++.|++..+..|+.||+.||+|+|++|+.|||+||+|||+.. ...+||+|||+++..........++.|.+|+|||
T Consensus 102 ~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~-~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPE 179 (538)
T KOG0661|consen 102 DR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG-NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPE 179 (538)
T ss_pred hc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc-cceeEecccccccccccCCCcchhhhcccccchH
Confidence 86 788999999999999999999999999999999999999984 4579999999999988888888999999999999
Q ss_pred cccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC----------------------
Q 022347 150 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---------------------- 207 (298)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 207 (298)
++.. ...|+.+.|+|++|||++|+.+-++.|++.++.++.++.+..-+.|.
T Consensus 180 vLLr-------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~ 252 (538)
T KOG0661|consen 180 VLLR-------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVK 252 (538)
T ss_pred Hhhh-------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCC
Confidence 9984 58899999999999999999999999999999988888765444332
Q ss_pred ------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 208 ------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 208 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+....+.++.++|.+||.+||++||||.+.++
T Consensus 253 ~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 253 PSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred CCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 11247788999999999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=309.41 Aligned_cols=216 Identities=28% Similarity=0.527 Sum_probs=182.2
Q ss_pred HHHHHHHHHHHhCCCCcccceecee--ecC-ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGAC--KDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
+.+.+|+.+|++++|||||++++.. .++ .+++.|||+++|+|.+++....+ .+++..+..++.|+++||.|||++|
T Consensus 59 ~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g 137 (313)
T KOG0198|consen 59 ESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG 137 (313)
T ss_pred HHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4578999999999999999999974 333 68999999999999999998665 7999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcc----ccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETV----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+|+||||+|||++..++.+||+|||++..... ........||+.|+|||++.. ......++|||||||
T Consensus 138 ~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGC 210 (313)
T KOG0198|consen 138 IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGC 210 (313)
T ss_pred EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCC
Confidence 999999999999996456799999999876553 223345689999999999963 122335999999999
Q ss_pred HHHHHHhCCCCCCC-CChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 176 VLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 176 il~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
++.||+||+.||.. ................|.+|..++++.++|+.+|+..+|.+||||+++++ +.++...
T Consensus 211 tVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~--hpf~~~~ 282 (313)
T KOG0198|consen 211 TVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE--HPFLKQN 282 (313)
T ss_pred EEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh--Chhhhcc
Confidence 99999999999987 34444455555555667899999999999999999999999999999999 5554443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=300.51 Aligned_cols=229 Identities=30% Similarity=0.472 Sum_probs=189.6
Q ss_pred CchhhHHHhcCCCCcHH---------HHHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhh
Q 022347 1 MGKFMKEVLNRGSTSDE---------RALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVS 70 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~ 70 (298)
||.||++..++...... ..+..+-+..|+.+|+.++|||||.+++++. +++.|+|||||.||+|.+|++.
T Consensus 23 favVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~ 102 (429)
T KOG0595|consen 23 FAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR 102 (429)
T ss_pred eEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH
Confidence 45566555555443311 2234456679999999999999999999985 6789999999999999999997
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC-C----CceEEeccCCCccCccccccccccCccce
Q 022347 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-Q----KSLKLADFGLAREETVTEMMTAETGTYRW 145 (298)
Q Consensus 71 ~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~-~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 145 (298)
+ +.+++..+..++.||+.||++||+++|+||||||+|||++.+ + ..+||.|||+++.........+.+|++.|
T Consensus 103 ~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplY 180 (429)
T KOG0595|consen 103 R--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLY 180 (429)
T ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccc
Confidence 4 469999999999999999999999999999999999999864 1 35899999999988888778888999999
Q ss_pred eccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhh
Q 022347 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCW 224 (298)
Q Consensus 146 ~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 224 (298)
||||++.. ..|+.|+|+||+|+|+|+|++|+.||......+-....... ...+.++...+..+++++...+
T Consensus 181 MAPEV~~~--------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll 252 (429)
T KOG0595|consen 181 MAPEVIMS--------QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLL 252 (429)
T ss_pred cCHHHHHh--------ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHH
Confidence 99999964 88999999999999999999999999987765544433222 2334455667888889999999
Q ss_pred hhCCCCCCCHHHHHH
Q 022347 225 VEDPNLRPSFSQIIR 239 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~ 239 (298)
+.++.+|-+..+...
T Consensus 253 ~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 253 QRNPKDRISFEDFFD 267 (429)
T ss_pred hcCccccCchHHhhh
Confidence 999999998887765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=288.66 Aligned_cols=220 Identities=30% Similarity=0.452 Sum_probs=182.0
Q ss_pred HHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHH
Q 022347 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84 (298)
Q Consensus 6 ~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i 84 (298)
.||+++....+.++ .+....|..+|.+++||.||.++..|++ +.+|+|+||+.||.|...|+. .+.|++..+.-+
T Consensus 55 mKvl~K~~iv~~~e--~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfY 130 (357)
T KOG0598|consen 55 MKVLKKKKIVEKKE--VRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFY 130 (357)
T ss_pred hhhhhhhHhhhhhh--HHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHH
Confidence 45555544443322 2367799999999999999999999975 579999999999999999985 367999999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccC
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
+..|+.||.|||++||+||||||+|||+|.. +.++|+|||++..... .....+.+||+.|+|||++.+ ..
T Consensus 131 laEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~--------~g 201 (357)
T KOG0598|consen 131 LAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG--------KG 201 (357)
T ss_pred HHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhcccCCCccccccCCccccChHHHhc--------CC
Confidence 9999999999999999999999999999955 5699999999985443 345556799999999999976 68
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC----CHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP----SFSQIIR 239 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~~l~~ 239 (298)
|+.++|.||||+++|+|++|.+||.+.+.... ...+.....+..+..++.+.+++++++|..+|++|. ++.++.+
T Consensus 202 y~~~vDWWsLGillYeML~G~pPF~~~~~~~~-~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 202 YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-YDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CCcccchHhHHHHHHHHhhCCCCCcCccHHHH-HHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 99999999999999999999999998765333 333334444556666999999999999999999994 5666554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=301.98 Aligned_cols=215 Identities=28% Similarity=0.520 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 21 LEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
+.+.+.+|+.++++++ ||||++++.++. ....|+||||+.||.|.+++.. .+++.+.++..++.|+++|++|||++
T Consensus 62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~ 139 (370)
T KOG0583|consen 62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR 139 (370)
T ss_pred cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC
Confidence 4456669999999999 999999999984 4569999999999999999987 36699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccC-ccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
||+||||||+||+++.+.+++||+|||++... .......+.+|++.|+|||++.+. ...-+.++||||+|+++
T Consensus 140 gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~------~~Y~g~~aDvWS~GViL 213 (370)
T KOG0583|consen 140 GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGK------GTYSGKAADVWSLGVIL 213 (370)
T ss_pred CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCC------CCcCCchhhhhhhHHHH
Confidence 99999999999999966467999999999977 466677788999999999999761 11235899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCC-cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|.|++|..||.+.+... .... +......+|..+ ++++..|+.+||..+|.+|+++.++++ +.|+..
T Consensus 214 y~ml~G~~PF~d~~~~~-l~~k-i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~--h~w~~~ 280 (370)
T KOG0583|consen 214 YVLLCGRLPFDDSNVPN-LYRK-IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE--HPWFQK 280 (370)
T ss_pred HHHHhCCCCCCCccHHH-HHHH-HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh--Chhhcc
Confidence 99999999999854332 2222 555666778878 999999999999999999999999995 777765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=280.40 Aligned_cols=214 Identities=28% Similarity=0.456 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 16 ~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
++...+++-..||+++|++++|||+|.++.+|. ...+++|+|||+. ++.+-+.. .+..++...+..+++|++.|+.|
T Consensus 39 edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~ 116 (396)
T KOG0593|consen 39 EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHF 116 (396)
T ss_pred CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhh
Confidence 344566778889999999999999999999994 6679999999977 55555555 35679999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
+|+++++||||||+|||++.+ +.+||||||+++... .......+..|.+|+|||++.+ ...|+...||||+
T Consensus 117 cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAi 188 (396)
T KOG0593|consen 117 CHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAI 188 (396)
T ss_pred hhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcc-------cCcCCCcccchhh
Confidence 999999999999999999965 569999999999766 5555667788999999999986 5789999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-------------------CCC----------CCCcHHHHHHHHHhh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-------------------GLP----------EDISPDLAFIVQSCW 224 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~----------~~~~~~l~~li~~~l 224 (298)
||++.||++|.+.|++..+.+++......-+.. +.+ ..++..+.+++..||
T Consensus 189 GCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL 268 (396)
T KOG0593|consen 189 GCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCL 268 (396)
T ss_pred hHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHh
Confidence 999999999999999999888777554322110 111 235667889999999
Q ss_pred hhCCCCCCCHHHHHH
Q 022347 225 VEDPNLRPSFSQIIR 239 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~ 239 (298)
+.||++|++-++++.
T Consensus 269 ~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 269 KMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCccccccHHHHhc
Confidence 999999999999886
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=296.03 Aligned_cols=219 Identities=27% Similarity=0.432 Sum_probs=182.3
Q ss_pred HHHhcCCCCcHHHHHHHHHHHHHHHHHHhC-CCCcccceeceeecC-ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHH
Q 022347 6 KEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83 (298)
Q Consensus 6 ~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 83 (298)
.||+.+.....+++ .+.+.+|-.+|.+| .||.|++++..|+|. .+|+|+||+++|.|.++|+.. +.|++..+..
T Consensus 103 iKVl~K~~Iike~K--vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~ 178 (604)
T KOG0592|consen 103 IKVLDKRYIIKEKK--VKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARF 178 (604)
T ss_pred HhhhhHHHHHhhcc--cchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHH
Confidence 44444433333332 23567899999999 799999999999765 799999999999999999874 6699999999
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--------------ccccccCccceeccc
Q 022347 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--------------MMTAETGTYRWMAPE 149 (298)
Q Consensus 84 i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~~y~aPE 149 (298)
++.+|+.||+|||++|||||||||+|||++.|+ .++|.|||.+....... .....+||..|.+||
T Consensus 179 YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE 257 (604)
T KOG0592|consen 179 YAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE 257 (604)
T ss_pred HHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHH
Confidence 999999999999999999999999999999765 59999999997432211 113468999999999
Q ss_pred cccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCC
Q 022347 150 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (298)
++.. ...+..+|||+||||+|+|+.|++||.+.++.-. ...+....-.+|.++++.+.+|++++|..||.
T Consensus 258 lL~~--------~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--FqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~ 327 (604)
T KOG0592|consen 258 LLND--------SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--FQKIQALDYEFPEGFPEDARDLIKKLLVRDPS 327 (604)
T ss_pred HhcC--------CCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--HHHHHHhcccCCCCCCHHHHHHHHHHHccCcc
Confidence 9975 7788999999999999999999999998765332 22334456678899999999999999999999
Q ss_pred CCCCHHHHHH
Q 022347 230 LRPSFSQIIR 239 (298)
Q Consensus 230 ~Rps~~~l~~ 239 (298)
+|++..+|-+
T Consensus 328 ~Rlt~~qIk~ 337 (604)
T KOG0592|consen 328 DRLTSQQIKA 337 (604)
T ss_pred ccccHHHHhh
Confidence 9999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=307.09 Aligned_cols=219 Identities=29% Similarity=0.555 Sum_probs=189.0
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCC------------CCCCHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP------------NKLDLHVALNFAL 86 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~i~~ 86 (298)
+.+++|++|+.++..|+|||||+++|.| +++-+|+|+|||..|+|.+|+..+.+ .+++..+.+.|+.
T Consensus 531 ~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~ 610 (774)
T KOG1026|consen 531 QARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIAT 610 (774)
T ss_pred HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHH
Confidence 3566899999999999999999999999 56679999999999999999987542 2278899999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccccc---ccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA---ETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
||+.|+.||-++.+|||||-..|+||. ++-.|||+|||+++..-..+.... ..-..+|||||.+.. +.
T Consensus 611 QIAaGM~YLs~~~FVHRDLATRNCLVg-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--------~k 681 (774)
T KOG1026|consen 611 QIAAGMEYLSSHHFVHRDLATRNCLVG-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--------GK 681 (774)
T ss_pred HHHHHHHHHHhCcccccchhhhhceec-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--------Cc
Confidence 999999999999999999999999999 556799999999997554443222 223468999999975 89
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|+++|||||+||++||+++ |..||.+..+.+...... .+...+.|.++|.++.+|+..||+.+|.+||++++|-..|+
T Consensus 682 FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~-~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 682 FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR-AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH-cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 9999999999999999999 999999988866554444 44447889999999999999999999999999999999999
Q ss_pred hhhhcc
Q 022347 243 AFLFTL 248 (298)
Q Consensus 243 ~~~~~~ 248 (298)
.+....
T Consensus 761 ~~~~~s 766 (774)
T KOG1026|consen 761 AWAQAS 766 (774)
T ss_pred HHHhcC
Confidence 887653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=297.92 Aligned_cols=210 Identities=33% Similarity=0.551 Sum_probs=183.4
Q ss_pred HHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
-+.+|+.+|+..+|+|||.+++.| .++.+|+||||++||+|.|.+.. ..+++.++..|+..++.||+|||.+||+|
T Consensus 316 LilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiH 392 (550)
T KOG0578|consen 316 LLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIH 392 (550)
T ss_pred hhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceee
Confidence 466999999999999999999987 56789999999999999999987 45999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+|||.+|||++.++ .+||+|||++....... ...+-.||+.|||||+... ..|+++.||||||++++||+
T Consensus 393 rDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr--------k~YG~KVDIWSLGIMaIEMv 463 (550)
T KOG0578|consen 393 RDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR--------KPYGPKVDIWSLGIMAIEMV 463 (550)
T ss_pred eccccceeEeccCC-cEEEeeeeeeeccccccCccccccCCCCccchhhhhh--------cccCccccchhhhhHHHHHh
Confidence 99999999999665 59999999998765544 3455689999999999864 88999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
-|.+||-..++....+... ..+.+. .++.+|+.+++|+.+||+.|+.+|+++.+||+ +.++...
T Consensus 464 eGEPPYlnE~PlrAlyLIa-~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl~~a 529 (550)
T KOG0578|consen 464 EGEPPYLNENPLRALYLIA-TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE--HPFLKMA 529 (550)
T ss_pred cCCCCccCCChHHHHHHHh-hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc--Chhhhhc
Confidence 9999998877766655544 344443 45779999999999999999999999999999 6666443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=295.83 Aligned_cols=207 Identities=30% Similarity=0.467 Sum_probs=187.7
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCc-eeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..++|+.++++++|||||.+.+.|. ++. ++|||+|++||++.+.+...+...|++..++.|+.|++.|+.|||+.+|+
T Consensus 49 ~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iL 128 (426)
T KOG0589|consen 49 SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVL 128 (426)
T ss_pred HHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 6679999999999999999999984 555 89999999999999999987777799999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+.|||+++++. |+|+|||++....... ...+..||+.|++||++.+ .+|..++|||||||++|||
T Consensus 129 HRDlK~~Nifltk~~~-VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d--------~pYn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 129 HRDLKCANIFLTKDKK-VKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD--------IPYNEKSDIWSLGCCLYEM 199 (426)
T ss_pred cccchhhhhhccccCc-eeecchhhhhhcCCchhhhheecCCCcccCHHHhCC--------CCCCccCcchhhcchHHHH
Confidence 9999999999998876 7999999999877766 6777899999999999976 8899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
++-+++|.+.+- ..+...+......++|..++.+++.++..||+.+|..||++.+++..
T Consensus 200 ~~lk~aF~a~~m-~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 200 CTLKPAFKASNM-SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HhcccccCccch-HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999987654 44555555666788899999999999999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=293.50 Aligned_cols=216 Identities=30% Similarity=0.589 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhC---------------------------
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR--------------------------- 72 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~--------------------------- 72 (298)
+.+.+|+.++.++ +||||+++++++. ++..+++|||+++|+|.+++....
T Consensus 55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (338)
T cd05102 55 KALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134 (338)
T ss_pred HHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccc
Confidence 4688999999999 8999999999884 346899999999999999997532
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCce
Q 022347 73 ---------------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 119 (298)
Q Consensus 73 ---------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~ 119 (298)
...+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.+
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~ 213 (338)
T cd05102 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVV 213 (338)
T ss_pred cccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcE
Confidence 1247788899999999999999999999999999999999955 469
Q ss_pred EEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 022347 120 KLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 195 (298)
Q Consensus 120 ~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~ 195 (298)
+|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+......
T Consensus 214 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~ 285 (338)
T cd05102 214 KICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285 (338)
T ss_pred EEeecccccccccCcchhcccCCCCCccccCcHHhhc--------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH
Confidence 999999987542211 1122345678999998864 567889999999999999997 9999987654444
Q ss_pred HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
.............+..+++.+.+++.+||+.+|.+|||+.++++.|+.++..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4444444445556778899999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=284.34 Aligned_cols=209 Identities=30% Similarity=0.517 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+..++.++||||++++..|. +..+|+||+||.+||+.++++..-+..+++..+..|+++++.||.|||++|.+
T Consensus 69 d~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~I 148 (516)
T KOG0582|consen 69 DALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHI 148 (516)
T ss_pred HHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCce
Confidence 47789999999999999999999984 77899999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-cccc----ccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|||||+.|||++.+ +.|+|+|||.+..... .... ....+++.|+|||++.. ....|+.|+||||||++
T Consensus 149 HRdvKAgnILi~~d-G~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q------~~~GYdfKaDIwSfGIT 221 (516)
T KOG0582|consen 149 HRDVKAGNILIDSD-GTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ------QLHGYDFKADIWSFGIT 221 (516)
T ss_pred ecccccccEEEcCC-CcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh------cccCccchhhhhhhhHH
Confidence 99999999999955 5699999998763222 1111 44579999999999643 34789999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcCC-----CC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARP-----GL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
..|+.+|..||....+.+.+..... +.++ .+ ...++..+++++..||+.||.+|||++++++
T Consensus 222 A~ELA~G~aPf~k~pPmkvLl~tLq-n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 222 ACELAHGHAPFSKYPPMKVLLLTLQ-NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhc-CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 9999999999999888776655442 2222 11 1246778999999999999999999999998
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=286.68 Aligned_cols=244 Identities=26% Similarity=0.408 Sum_probs=196.4
Q ss_pred CchhhHHHhcCCCCcHHH-HHHHH-HH-HHHHHHHHhCCCCcccceeceee---cC---ceeEEEecCCCCCHHHHHhhh
Q 022347 1 MGKFMKEVLNRGSTSDER-ALLEG-RF-IREVNMMSRVKHDNLVKFLGACK---DP---LMVIVTELLPGMSLRKYLVSL 71 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~~-~~~~~-~~-~~E~~~l~~l~hp~Iv~~~~~~~---~~---~~~lv~e~~~~~sL~~~l~~~ 71 (298)
||-||+.++......... ++..+ ++ .+|+++|+.++|||||++..+|. +. ...+||||++. +|.++++..
T Consensus 37 Fg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~ 115 (364)
T KOG0658|consen 37 FGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHY 115 (364)
T ss_pred cceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHH
Confidence 577777766665222111 11111 22 37999999999999999998872 22 46699999955 999999852
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccc
Q 022347 72 --RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 149 (298)
Q Consensus 72 --~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE 149 (298)
....++.-.+.-+.+||++||+|||+.||+||||||.|+|+|.+.+.+||||||+|...........+..+..|+|||
T Consensus 116 ~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPE 195 (364)
T KOG0658|consen 116 TRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPE 195 (364)
T ss_pred hhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHH
Confidence 235688888999999999999999999999999999999999998999999999999877777778889999999999
Q ss_pred cccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC----------------------
Q 022347 150 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---------------------- 207 (298)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 207 (298)
.+.+ ...|+.+.||||.|||+.||+.|++.|.+.+..++....+...+.|.
T Consensus 196 Lifg-------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~ 268 (364)
T KOG0658|consen 196 LIFG-------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAH 268 (364)
T ss_pred HHcC-------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccc
Confidence 9987 47899999999999999999999999999877666555433222221
Q ss_pred -----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 022347 208 -----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 254 (298)
Q Consensus 208 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 254 (298)
+....++++.+|+.++|+++|.+|.++.+++. +.+...++.+...
T Consensus 269 ~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~--h~fFdelr~~~~~ 318 (364)
T KOG0658|consen 269 PWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA--HPFFDELRDPNTK 318 (364)
T ss_pred cceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc--chhhHHhhCcCcc
Confidence 22357889999999999999999999999998 7787777776443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=285.31 Aligned_cols=210 Identities=25% Similarity=0.398 Sum_probs=177.4
Q ss_pred HHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
-..+|+.+|++|.||||+++.+... .+.+|+|+|||++ +|.-++.. ..-.|++.++..++.||++||+|||.+||
T Consensus 162 t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gv 239 (560)
T KOG0600|consen 162 TAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGV 239 (560)
T ss_pred HHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCe
Confidence 4569999999999999999999873 3579999999977 88888765 34569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+|||||.+|||+| +.+.+||+|||+++...... .....+.|.+|+|||++.| ...|+.+.|+||.|||+.
T Consensus 240 lHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~ 311 (560)
T KOG0600|consen 240 LHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILA 311 (560)
T ss_pred eeccccccceEEc-CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHH
Confidence 9999999999999 55679999999999554433 4566788999999999997 478999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCC--------CCC-------------------CCCcHHHHHHHHHhhhhCCCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARP--------GLP-------------------EDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~-------------------~~~~~~l~~li~~~l~~~p~~R 231 (298)
||+.|++.|.+.++.+++.....-.+.| .+| ..++....+|+..+|..||.+|
T Consensus 312 El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR 391 (560)
T KOG0600|consen 312 ELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKR 391 (560)
T ss_pred HHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccc
Confidence 9999999999998877766554322221 111 2467788899999999999999
Q ss_pred CCHHHHHHHHHhhh
Q 022347 232 PSFSQIIRMLNAFL 245 (298)
Q Consensus 232 ps~~~l~~~l~~~~ 245 (298)
.||.+.++ .+++
T Consensus 392 ~tA~~aL~--seyF 403 (560)
T KOG0600|consen 392 GTASSALQ--SEYF 403 (560)
T ss_pred ccHHHHhc--Cccc
Confidence 99999987 5665
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=292.63 Aligned_cols=214 Identities=29% Similarity=0.493 Sum_probs=187.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+.+|+.+|+-+.||||++++++++ ..++|+|.||++||-|.+++... +++++.++.++++||+.|+.|+|..+|+
T Consensus 57 ~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~ic 134 (786)
T KOG0588|consen 57 AGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNIC 134 (786)
T ss_pred cchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcce
Confidence 35669999999999999999999996 45899999999999999999874 5699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|||+||+|+|++..+. +||+|||.+..........+.+|++.|.+||++.| ...-+.++||||-|+|+|.||
T Consensus 135 HRDLKpENlLLd~~~n-IKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G-------~pYdG~~sDVWSCGVILfALL 206 (786)
T KOG0588|consen 135 HRDLKPENLLLDVKNN-IKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSG-------RPYDGRPSDVWSCGVILFALL 206 (786)
T ss_pred eccCCchhhhhhcccC-EeeeccceeecccCCccccccCCCcccCCchhhcC-------CCCCCCccccchhHHHHHHHH
Confidence 9999999999996665 99999999998888888888899999999999987 234467999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
+|+.||++ ++...+... +..+.-.+|..++.++++||.+||..||.+|.|.++|++ +.|+.....
T Consensus 207 tG~LPFdD-dNir~LLlK-V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k--HP~l~g~~~ 271 (786)
T KOG0588|consen 207 TGKLPFDD-DNIRVLLLK-VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK--HPFLSGYTS 271 (786)
T ss_pred hCCCCCCC-ccHHHHHHH-HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh--CchhhcCCC
Confidence 99999985 444444444 345566788999999999999999999999999999999 666654443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=281.21 Aligned_cols=214 Identities=23% Similarity=0.369 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec-----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
..+.|.+|+.++++++||||+++++++.+ ...++||||++||+|.+++... ..+++...+.++.+++.||.||
T Consensus 61 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~l 138 (283)
T PHA02988 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNL 138 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHH
Confidence 44678899999999999999999998744 3688999999999999999763 4688999999999999999999
Q ss_pred HhC-CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 96 HAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 96 H~~-givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|+. +++|+||||+||+++.+ +.++|+|||++...... .....++..|+|||++.+ ....++.++||||||
T Consensus 139 H~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~k~Di~SlG 209 (283)
T PHA02988 139 YKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLND------IFSEYTIKDDIYSLG 209 (283)
T ss_pred HhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhhccc--cccccCcccccCHHHhhh------ccccccchhhhhHHH
Confidence 984 99999999999999965 56999999998753322 223467889999999853 124688999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
+++|+|++|..||.+.+..+...........+..+..+++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 210 vil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 210 VVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 99999999999998776544333333344555666678999999999999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=293.67 Aligned_cols=220 Identities=28% Similarity=0.548 Sum_probs=190.3
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
..+++++--..+++=|++|+|||||.+.|+| +...+|||||||..|-|...++. ...++......|..+|+.|++||
T Consensus 151 AVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YL 228 (904)
T KOG4721|consen 151 AVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYL 228 (904)
T ss_pred hhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHH
Confidence 3444555556789999999999999999999 46689999999999999999987 35688999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|.+.|+|||||.-||||..+ ..|||+|||-+...........+.||..|||||++.. .+++.+.|||||||
T Consensus 229 H~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn--------ePcsEKVDIwSfGV 299 (904)
T KOG4721|consen 229 HLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN--------EPCSEKVDIWSFGV 299 (904)
T ss_pred HHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc--------CCcccccceehhHH
Confidence 99999999999999999955 5799999999987777777778899999999999975 78899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+||||||..||.+.+.....+..-........|..+++.+.-|++.||+..|.+||++.+++.+|..+-+.
T Consensus 300 VLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 300 VLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred HHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 999999999999876655444443333445567888999999999999999999999999999999765443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=268.68 Aligned_cols=223 Identities=24% Similarity=0.383 Sum_probs=186.5
Q ss_pred HHHHHHHHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 16 DERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 16 ~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
+....+.+.-.+|+.+|+++. ||||+++.++|+ +.++++|+|.|+.|.|.||+.+. -.+++....+|+.|+++|+.
T Consensus 60 e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVe 137 (411)
T KOG0599|consen 60 ETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVE 137 (411)
T ss_pred ccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHH
Confidence 345566677789999999996 999999999996 56899999999999999999874 34899999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||..+|||+||||+|||++ ++.+++|+|||+++....+......+||++|+|||.+...-. .....|+...|+|+.
T Consensus 138 ylHa~~IVHRDLKpENILld-dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~--e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 138 YLHARNIVHRDLKPENILLD-DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMY--ENHPGYSKEVDEWAC 214 (411)
T ss_pred HHHHhhhhhcccChhheeec-cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecc--cCCCCccchhhHHHH
Confidence 99999999999999999999 556799999999999888888888899999999999876332 234678889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhh--cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
|+|||.++.|.+||.......-+....... ...+...+++.+..+||.+||+.||.+|.|+++.+. +.+.
T Consensus 215 GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La--Hpff 286 (411)
T KOG0599|consen 215 GVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA--HPFF 286 (411)
T ss_pred HHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc--ChHH
Confidence 999999999999997654433322222111 112334678999999999999999999999999998 4444
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=277.14 Aligned_cols=206 Identities=24% Similarity=0.413 Sum_probs=177.9
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+++|+++++.|+||||++++.+|+ .+...|||||..+|.|+||+.+. +.+++.++..++.||.+|+.|+|+.+++|
T Consensus 99 hIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvH 176 (668)
T KOG0611|consen 99 HIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVH 176 (668)
T ss_pred HHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhcccee
Confidence 5889999999999999999999996 45789999999999999999985 55999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
+|||.+|||+|.|+ ++||.|||++..+.......+++|++-|.+||+.+|. ..-++..|.||||+++|.|+.
T Consensus 177 RDLKLENILLD~N~-NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~-------PY~GPEVDsWsLGvLLYtLVy 248 (668)
T KOG0611|consen 177 RDLKLENILLDQNN-NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGT-------PYKGPEVDSWSLGVLLYTLVY 248 (668)
T ss_pred cccchhheeecCCC-CeeeeccchhhhhccccHHHHhcCCcccCCccccCCC-------CCCCCccchhhHHHHHHHHhh
Confidence 99999999999665 6999999999988888888889999999999999872 334678999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 183 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|.+||++.+-.....+......+ ...-+....-||++||-.||++|.|++++.++..
T Consensus 249 GtMPFDG~Dhk~lvrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 249 GTMPFDGRDHKRLVRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred cccccCCchHHHHHHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 99999998754433333222221 2335667889999999999999999999998653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=288.70 Aligned_cols=232 Identities=29% Similarity=0.455 Sum_probs=194.9
Q ss_pred CchhhHHHhcCCCCc--------HHHHHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhh
Q 022347 1 MGKFMKEVLNRGSTS--------DERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL 71 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~ 71 (298)
||+|||.+....... +..+.-.+++++|+.+|.++++|||.++|+.+ .+..+|++||||.||++.+.++..
T Consensus 26 fG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~ 105 (467)
T KOG0201|consen 26 FGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG 105 (467)
T ss_pred cceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC
Confidence 688887776665444 23333345788999999999999999999988 566899999999999999999862
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceecccc
Q 022347 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPEL 150 (298)
Q Consensus 72 ~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~ 150 (298)
..+.+..+..++.+++.||.|||.++.+|+|||+.||++..+ +.++|+|||.+........ ..+..||+.|||||+
T Consensus 106 --~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEV 182 (467)
T KOG0201|consen 106 --NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEV 182 (467)
T ss_pred --CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechhhccccccccccccchhh
Confidence 335888889999999999999999999999999999999977 5799999999986555433 367789999999999
Q ss_pred ccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 151 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
+.. ..|+.++||||||++.+||++|.+|+.+..+. .....+.+..+|.+...+++.+++|+..||+.||+.
T Consensus 183 I~~--------~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~ 253 (467)
T KOG0201|consen 183 IKQ--------SGYDTKADIWSLGITAIELAKGEPPHSKLHPM-RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEF 253 (467)
T ss_pred hcc--------ccccchhhhhhhhHHHHHHhcCCCCCcccCcc-eEEEeccCCCCCccccccCHHHHHHHHHHhhcCccc
Confidence 974 68999999999999999999999999887763 233344566777777889999999999999999999
Q ss_pred CCCHHHHHHHHHhhhh
Q 022347 231 RPSFSQIIRMLNAFLF 246 (298)
Q Consensus 231 Rps~~~l~~~l~~~~~ 246 (298)
||||.++++ +.+++
T Consensus 254 RpsA~~LLK--h~FIk 267 (467)
T KOG0201|consen 254 RPSAKELLK--HKFIK 267 (467)
T ss_pred CcCHHHHhh--hHHHH
Confidence 999999998 44443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=279.74 Aligned_cols=208 Identities=21% Similarity=0.368 Sum_probs=173.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+.+|+.++++++|+||+++++++. ++..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.|++
T Consensus 45 ~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii 124 (285)
T cd05631 45 AMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124 (285)
T ss_pred HHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 45779999999999999999999884 56799999999999999888764445689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+||+++.+ +.++|+|||++.............++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 125 H~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~ 195 (285)
T cd05631 125 YRDLKPENILLDDR-GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN--------EKYTFSPDWWGLGCLIYEMI 195 (285)
T ss_pred eCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC--------CCCCcccCchhHHHHHHHHH
Confidence 99999999999955 4699999999876543333344578999999999865 57788999999999999999
Q ss_pred hCCCCCCCCChHH--HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 022347 182 TNRLPFEGMSNLQ--AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~ 239 (298)
+|+.||....... .............++..++.++.+|+.+||+.+|.+||+ ++++++
T Consensus 196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 196 QGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 9999998754321 222222233444566779999999999999999999997 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=289.54 Aligned_cols=224 Identities=31% Similarity=0.552 Sum_probs=193.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
+....+|.+|.+++++++||||++++|++. +.-+++|||+|.||+|.++++..+ ..++..+...++.+.+.||+|||+
T Consensus 202 ~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 202 KEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHH
Confidence 344558999999999999999999999984 557999999999999999999743 369999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccc-cccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++++||||-.+|+|++.+ +.+||+|||++.......... ...-...|+|||.+.. ..|+.++||||+|++
T Consensus 281 k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~--------~~~s~kTDV~sfGV~ 351 (474)
T KOG0194|consen 281 KNCIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT--------GIFSFKTDVWSFGVL 351 (474)
T ss_pred CCCcchhHhHHHheecCC-CeEEeCccccccCCcceeeccccccCcceecChhhhcc--------Cccccccchhheeee
Confidence 999999999999999954 458999999998654222222 2234568999999975 689999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+||+++ |..||.+....+........+.+...+...+.++..++..||..+|++||++.++.+.++.+.....++.
T Consensus 352 ~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~ 428 (474)
T KOG0194|consen 352 LWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD 428 (474)
T ss_pred EEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence 999999 8899999888776666667788888899999999999999999999999999999999999887766543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=257.05 Aligned_cols=224 Identities=26% Similarity=0.405 Sum_probs=186.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 18 RALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 18 ~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
++-+.....||++.|+.++||||+.++++|. .+.+-+|+||++ .+|...++. ....++...+..++.+++.||+|||
T Consensus 41 kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H 118 (318)
T KOG0659|consen 41 KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCH 118 (318)
T ss_pred ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHH
Confidence 3334446779999999999999999999994 667899999994 599999987 4467999999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccccc-ccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA-ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
++.|+||||||.|+|++.+ +.+||.|||+++.......... ...|.+|+|||.+.| .+.|+...|+||.||
T Consensus 119 ~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGC 190 (318)
T KOG0659|consen 119 SKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGC 190 (318)
T ss_pred hhhhhcccCCccceEEcCC-CcEEeecccchhccCCCCcccccceeeeeccChHHhcc-------chhcCCcchhhhHHH
Confidence 9999999999999999955 5699999999998776554333 367999999999987 478999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC--------------------------CCCCCcHHHHHHHHHhhhhCCC
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--------------------------LPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~ 229 (298)
|+.||+.|.+-|.+.++.++.......-+.|. +....++++.+|+..||.+||.
T Consensus 191 I~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~ 270 (318)
T KOG0659|consen 191 IFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPK 270 (318)
T ss_pred HHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCch
Confidence 99999999999999888887766544333221 1123566788999999999999
Q ss_pred CCCCHHHHHHHHHhhhhccCCCCC
Q 022347 230 LRPSFSQIIRMLNAFLFTLRPPSP 253 (298)
Q Consensus 230 ~Rps~~~l~~~l~~~~~~~~~~~~ 253 (298)
+|.++.|.++ +.++.+.+.+.+
T Consensus 271 ~Rita~qaL~--~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 271 KRITASQALK--HPYFKSLPLPTP 292 (318)
T ss_pred hcccHHHHhc--chhhhcCCCCCC
Confidence 9999999998 777777555444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.95 Aligned_cols=204 Identities=25% Similarity=0.402 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.++.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ..+++..+..++.|++.||+|||+.||+
T Consensus 40 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~iv 117 (323)
T cd05571 40 AHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVV 117 (323)
T ss_pred HHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 46778999999999999999999885 56799999999999999998753 4689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 118 HrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 188 (323)
T cd05571 118 YRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred eCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccceecCccccChhhhcC--------CCCCccccCcccchhhhhh
Confidence 99999999999955 4699999999875322 222334568999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
++|..||.+.+..... .........++..+++++.+++.+||+.||.+|| ++.++++
T Consensus 189 ltg~~Pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 189 MCGRLPFYNQDHEKLF--ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred hcCCCCCCCCCHHHHH--HHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 9999999876543222 2233345567788999999999999999999999 7999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=261.28 Aligned_cols=209 Identities=29% Similarity=0.434 Sum_probs=178.8
Q ss_pred HHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHH
Q 022347 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84 (298)
Q Consensus 6 ~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i 84 (298)
.|++++.....-+ -.+...+|..+|+.+.||.++.+++.+. .+++|+||||++||.|..+++.. ++|++..+..+
T Consensus 74 mKvL~k~~vVklK--QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFY 149 (355)
T KOG0616|consen 74 MKVLDKQKVVKLK--QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFY 149 (355)
T ss_pred hhhcCHHHHHHHH--HHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc--CCCCchhHHHH
Confidence 4555554433322 2347789999999999999999999886 45899999999999999999863 56999999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCC
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
+.||+.||+|||+.+|++|||||+|||+|+++ .+||+|||++...... ..+.+||+.|+|||.+.. ..+
T Consensus 150 AAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s--------k~y 218 (355)
T KOG0616|consen 150 AAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS--------KGY 218 (355)
T ss_pred HHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecCc--EEEecCCccccChHHhhc--------CCC
Confidence 99999999999999999999999999999765 5999999999875443 456689999999999975 788
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 022347 165 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (298)
..++|.||||+++|||+.|.+||.+.+......+ +......+|..+++++++|+..+|+.|-.+|
T Consensus 219 nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K--I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 219 NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK--ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH--HHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 9999999999999999999999998877443333 3345667889999999999999999999999
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=270.14 Aligned_cols=213 Identities=25% Similarity=0.496 Sum_probs=178.3
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
...+++.+|+.+++.++||||+++++++.+...++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ 115 (257)
T cd05116 38 ALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN 115 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999999999999999999877889999999999999999753 45899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
++|+||||.||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++|+||||+
T Consensus 116 i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 186 (257)
T cd05116 116 FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY--------YKFSSKSDVWSFGV 186 (257)
T ss_pred EeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc--------CCcCchhHHHHHHH
Confidence 9999999999999955 5699999999875433221 112233568999998754 56778999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 176 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
++|++++ |..||...... ...........+..+..+++++.++|.+||+.+|.+||++.+|...|+.+
T Consensus 187 ~l~el~t~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 187 LMWEAFSYGQKPYKGMKGN-EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHhCCCCCCCCCCHH-HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999998 99999876543 33334444455667788999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=274.55 Aligned_cols=214 Identities=30% Similarity=0.566 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFA 85 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~ 85 (298)
..++|.+|+.++++++||||+++++++. +...+++|||+++++|.+++..... ..+++..++.++
T Consensus 51 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 130 (283)
T cd05048 51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130 (283)
T ss_pred HHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHH
Confidence 4557889999999999999999999985 4578999999999999999976322 457889999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.. .
T Consensus 131 ~~l~~al~~lH~~~i~H~dlkp~Nil~~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~ 201 (283)
T cd05048 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------G 201 (283)
T ss_pred HHHHHHHHHHHhCCeeccccccceEEEcCC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc--------C
Confidence 999999999999999999999999999954 569999999987532221 1223345678999998854 5
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++||||||+++|+|++ |..||.+....+ ..........+..+..+++++.+++.+||+.+|.+||++.+++++|
T Consensus 202 ~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 202 KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 67889999999999999998 999998765533 3334444455566778999999999999999999999999999998
Q ss_pred Hhh
Q 022347 242 NAF 244 (298)
Q Consensus 242 ~~~ 244 (298)
+.+
T Consensus 281 ~~~ 283 (283)
T cd05048 281 RSW 283 (283)
T ss_pred hcC
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=269.94 Aligned_cols=215 Identities=22% Similarity=0.541 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
...+++.+|+.++++++||||+++++++.....++||||+++++|.+++... ...+++..++.++.|++.||.|||++|
T Consensus 37 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ 115 (257)
T cd05115 37 SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN 115 (257)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 3456788999999999999999999999877899999999999999998752 356899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
++|+||||+||+++.+ ..++|+|||++........ .....++..|+|||.+.. ..++.++||||||+
T Consensus 116 i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 186 (257)
T cd05115 116 FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGI 186 (257)
T ss_pred eeecccchheEEEcCC-CcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc--------CCCCchhhHHHHHH
Confidence 9999999999999855 5699999999874332211 111223468999998754 55788999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 176 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
++|++++ |..||.+..... .............+...++++.+++.+||..+|++||++.++.+.|+.+.
T Consensus 187 ~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 187 TMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHhcCCCCCcCcCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999996 999998765533 33444455566677788999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=283.44 Aligned_cols=202 Identities=31% Similarity=0.498 Sum_probs=175.1
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
-+.+|+++++.++|||||.++++|+ ..++|+|+||+.| +|..++.. ++.++++.+..++.+++.||.|||+.+|.|
T Consensus 47 ~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilh 123 (808)
T KOG0597|consen 47 NLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILH 123 (808)
T ss_pred HHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 4669999999999999999999996 5689999999966 99999985 577999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+|+||.||++..+ +.+|+||||+++....... .....||+.|||||++.+ ..|+..+|+||||||+||++
T Consensus 124 rd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e--------~pyd~~sDlWslGcilYE~~ 194 (808)
T KOG0597|consen 124 RDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE--------QPYDHTSDLWSLGCILYELY 194 (808)
T ss_pred ccCCcceeeecCC-CceeechhhhhhhcccCceeeeeccCcccccCHHHHcC--------CCccchhhHHHHHHHHHHHh
Confidence 9999999999955 5699999999997665443 455689999999999975 88999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
.|++||....-. ..... +...+...|...+..+..|+..+|..||.+|.++.+++.
T Consensus 195 ~G~PPF~a~si~-~Lv~~-I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 195 VGQPPFYARSIT-QLVKS-ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cCCCCchHHHHH-HHHHH-HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 999999864332 22222 233444556789999999999999999999999999988
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.17 Aligned_cols=213 Identities=32% Similarity=0.531 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC----------------------------
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---------------------------- 72 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~---------------------------- 72 (298)
+.+.+|+.++..+ +||||+++++++. ++..++||||++||+|.+++....
T Consensus 83 ~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (375)
T cd05104 83 EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC 162 (375)
T ss_pred HHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccc
Confidence 4688999999999 8999999999985 557899999999999999996522
Q ss_pred ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 022347 73 ---------------------------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107 (298)
Q Consensus 73 ---------------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~ 107 (298)
...+++..++.++.|++.||+|||+.|++||||||
T Consensus 163 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 242 (375)
T cd05104 163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAA 242 (375)
T ss_pred hhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCch
Confidence 12467888999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh-C
Q 022347 108 DNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 183 (298)
Q Consensus 108 ~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g 183 (298)
+||+++. +..++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |
T Consensus 243 ~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDi~slG~~l~ellt~g 313 (375)
T cd05104 243 RNILLTH-GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLG 313 (375)
T ss_pred hhEEEEC-CCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC--------CCCCCCCCHHHHHHHHHHHHhcC
Confidence 9999995 45699999999875433221 111234567999999864 568889999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 184 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
..||.....................+...+.++.+++.+||+.+|++|||+.++++.|+..
T Consensus 314 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 314 SSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 9999876554444444444444555666789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=269.79 Aligned_cols=212 Identities=33% Similarity=0.591 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~ 126 (263)
T cd05052 47 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126 (263)
T ss_pred HHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 46889999999999999999999984 56789999999999999999775555689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccc--cccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.+ +.++|+|||.+.......... ....+..|+|||.+.+ ..++.++||||||+++|+
T Consensus 127 H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e 197 (263)
T cd05052 127 HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWE 197 (263)
T ss_pred ecccCcceEEEcCC-CcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc--------CCCCchhHHHHHHHHHHH
Confidence 99999999999854 569999999987644322211 1223567999998764 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
|++ |..||.+... ...............+..++.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 198 l~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 198 IATYGMSPYPGIDL-SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHcCCCCCCCCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 998 9999986543 334444444456667788999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.10 Aligned_cols=215 Identities=31% Similarity=0.551 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC---------------------------
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------------------- 72 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------------------- 72 (298)
.+.+.+|+.+++.+ +||||+++++++. .+..++||||+++|+|.+++....
T Consensus 85 ~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 85 REALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred HHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 34688999999999 8999999999985 567999999999999999986421
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEE
Q 022347 73 -----------------------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111 (298)
Q Consensus 73 -----------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil 111 (298)
...+++..++.++.|++.||.|||+.|++||||||+||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil 244 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVL 244 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEE
Confidence 124788889999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCC
Q 022347 112 LTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 187 (298)
Q Consensus 112 ~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~ 187 (298)
++. ...++|+|||++........ .....++..|+|||++.. ..++.++||||||+++|+|++ |+.||
T Consensus 245 ~~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ellt~G~~Pf 315 (374)
T cd05106 245 LTD-GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIFSLGKSPY 315 (374)
T ss_pred EeC-CCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 994 45799999999875432221 112234567999998854 568899999999999999997 99999
Q ss_pred CCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 188 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
.....................+...++++.+++.+||+.+|.+|||+.++++.|+..+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 316 PGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 8765444433444444455566678899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=270.44 Aligned_cols=212 Identities=26% Similarity=0.464 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.|.+|+.++.+++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|+
T Consensus 50 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~i 128 (266)
T cd05064 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGY 128 (266)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 457889999999999999999999984 56899999999999999999763 3468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccccc--ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+|+||||+||+++.+ +.++++|||.+......... ....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 129 iH~dikp~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 199 (266)
T cd05064 129 VHKGLAAHKVLVNSD-LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY--------HHFSSASDVWSFGIVMW 199 (266)
T ss_pred eeccccHhhEEEcCC-CcEEECCCcccccccccchhcccCCCCceeecCHHHHhh--------CCccchhHHHHHHHHHH
Confidence 999999999999955 46999999987653222111 12234568999998864 66788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 179 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
++++ |..||....... .............+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 200 ell~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 200 EVMSYGERPYWDMSGQD-VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHhcCCCCCcCcCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9875 999998765433 2333344445566778999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=263.67 Aligned_cols=238 Identities=24% Similarity=0.374 Sum_probs=189.1
Q ss_pred chhhHHHhcCCCCcHHHHHHHH--HHHHHHHHHHhCC-CCcccceeceeecC-----ceeEEEecCCCCCHHHHHhhhCC
Q 022347 2 GKFMKEVLNRGSTSDERALLEG--RFIREVNMMSRVK-HDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRP 73 (298)
Q Consensus 2 g~~~~~v~~~~~~~~~~~~~~~--~~~~E~~~l~~l~-hp~Iv~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~ 73 (298)
|||+..+-+.......-+.+.+ +.++|+++.=... |||||.++++|++. .+.+|||.++||.|...++++..
T Consensus 76 GkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~ 155 (400)
T KOG0604|consen 76 GKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD 155 (400)
T ss_pred CceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc
Confidence 4555544444444333333333 5668998766664 99999999998542 47899999999999999999888
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC--CceEEeccCCCccCccccccccccCccceeccccc
Q 022347 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 151 (298)
Q Consensus 74 ~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 151 (298)
..|++.++-.|+.||..|+.|||+.+|.||||||+|+|...++ -.+||+|||++..........+.+.|+.|.|||++
T Consensus 156 ~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl 235 (400)
T KOG0604|consen 156 QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL 235 (400)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh
Confidence 8899999999999999999999999999999999999997433 36899999999887766666777889999999998
Q ss_pred cccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhh
Q 022347 152 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--QAAYAAAFKHARPGLP----EDISPDLAFIVQSCWV 225 (298)
Q Consensus 152 ~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~ 225 (298)
.. ..|+..+|+||+|++||-|++|.+||.+.... ....+..+..+--.+| +.+|+...++|+.+|.
T Consensus 236 g~--------eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLk 307 (400)
T KOG0604|consen 236 GP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLK 307 (400)
T ss_pred Cc--------hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhc
Confidence 54 67999999999999999999999999875431 1122233333333343 3578899999999999
Q ss_pred hCCCCCCCHHHHHHHHHhhhhccC
Q 022347 226 EDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 226 ~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
.+|.+|.|+.++++ +.|+...+
T Consensus 308 t~PteRlTI~~~m~--hpwi~~~~ 329 (400)
T KOG0604|consen 308 TEPTERLTIEEVMD--HPWINQYE 329 (400)
T ss_pred CCchhheeHHHhhc--Cchhcccc
Confidence 99999999999998 67765543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.02 Aligned_cols=208 Identities=24% Similarity=0.404 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||+++++|.+++... +.+++..+..++.|++.||+|||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i 122 (291)
T cd05612 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEI 122 (291)
T ss_pred HHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 456889999999999999999999885 55789999999999999999763 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+||+++.+ +.++|+|||++...... .....|++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 123 ~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~l 191 (291)
T cd05612 123 VYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQS--------KGHNKAVDWWALGILIYEM 191 (291)
T ss_pred eecCCCHHHeEECCC-CCEEEEecCcchhccCC--cccccCChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHH
Confidence 999999999999955 46999999998754322 223468899999998864 5578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhhh
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 246 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~~l~~~~~ 246 (298)
++|..||.+....... .. .......++..++..+.+++.+||+.||.+||+ ++++++ +.|+.
T Consensus 192 ~~g~~pf~~~~~~~~~-~~-i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~--h~~~~ 258 (291)
T cd05612 192 LVGYPPFFDDNPFGIY-EK-ILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN--HRWFK 258 (291)
T ss_pred HhCCCCCCCCCHHHHH-HH-HHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc--Ccccc
Confidence 9999999876543322 22 233445667778999999999999999999995 899887 44443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=265.55 Aligned_cols=220 Identities=28% Similarity=0.442 Sum_probs=180.3
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
...++-.+|+++|+.++|+||+.+++.+.. ...|+|+|+| +.+|...++.. ..++...+..+++|++.||.
T Consensus 63 ~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLK 139 (359)
T KOG0660|consen 63 IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLK 139 (359)
T ss_pred HHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcc
Confidence 344577899999999999999999998732 2589999999 77999999863 33999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcc---ccccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|+|+.|++||||||.|++++.+. .+||+|||+++.... ....+.+..|.+|.|||++.. ...|+.+.||
T Consensus 140 yiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDi 211 (359)
T KOG0660|consen 140 YIHSANVIHRDLKPSNLLLNADC-DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDI 211 (359)
T ss_pred hhhcccccccccchhheeeccCC-CEEeccccceeeccccCcccchhcceeeeeecCHHHHhc-------cccccchhhh
Confidence 99999999999999999999665 589999999997643 445567788999999999864 4789999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC---------------------CC--------CCCCCcHHHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---------------------PG--------LPEDISPDLAFIVQ 221 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~--------~~~~~~~~l~~li~ 221 (298)
||+|||+.||++|+..|.+.+...+.......-+. +. +..+.++...+|+.
T Consensus 212 WSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLle 291 (359)
T KOG0660|consen 212 WSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLE 291 (359)
T ss_pred hhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHH
Confidence 99999999999999999887654443322111111 11 11357889999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+||..||.+|+|++|.++ +.++.....++
T Consensus 292 kmL~fdP~kRita~eAL~--hPYl~~~hdp~ 320 (359)
T KOG0660|consen 292 KMLVFDPKKRITAEEALA--HPYLAPYHDPE 320 (359)
T ss_pred HHhccCccccCCHHHHhc--ChhhhhhcCCc
Confidence 999999999999999998 77776665544
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=271.79 Aligned_cols=219 Identities=32% Similarity=0.553 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~ 85 (298)
.+.+.+|+.++.++ +||||+++++++. ++..|+++||+++++|.+++.... ...+++..++.++
T Consensus 46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 125 (297)
T cd05089 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125 (297)
T ss_pred HHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHH
Confidence 45788999999999 6999999999985 557899999999999999997532 1248889999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCC
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 165 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 165 (298)
.|++.||+|||+.|++|+||||+||+++.+ ..++|+|||++..............+..|+|||.+.. ..++
T Consensus 126 ~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~ 196 (297)
T cd05089 126 SDVATGMQYLSEKQFIHRDLAARNVLVGEN-LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------SVYT 196 (297)
T ss_pred HHHHHHHHHHHHCCcccCcCCcceEEECCC-CeEEECCcCCCccccceeccCCCCcCccccCchhhcc--------CCCC
Confidence 999999999999999999999999999855 4699999999864322211122233457999998854 5678
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 166 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 166 ~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
.++||||||+++|+|++ |..||....... .............+..++..+.+++.+||+.+|.+|||++++++.|..+
T Consensus 197 ~~~DvwSlG~il~el~t~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 197 TKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 89999999999999997 999998765433 3333444445556677999999999999999999999999999999888
Q ss_pred hhccCC
Q 022347 245 LFTLRP 250 (298)
Q Consensus 245 ~~~~~~ 250 (298)
+...+.
T Consensus 276 ~~~~~~ 281 (297)
T cd05089 276 LEARKA 281 (297)
T ss_pred HHhhcc
Confidence 765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=278.13 Aligned_cols=204 Identities=24% Similarity=0.404 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+.+|+.++++++||||+++++++. ++..|+||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++
T Consensus 40 ~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iv 117 (323)
T cd05595 40 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVV 117 (323)
T ss_pred HHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 46778999999999999999999885 56799999999999999988753 4689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 118 H~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~el 188 (323)
T cd05595 118 YRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEM 188 (323)
T ss_pred ecCCCHHHEEEcCC-CCEEecccHHhccccCCCCccccccCCcCcCCcccccC--------CCCCchhchhhhHHHHHHH
Confidence 99999999999955 5699999998864322 222234568999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
++|..||...+....... .......++..+++++.+++.+||+.+|.+|| ++.++++
T Consensus 189 l~g~~Pf~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 189 MCGRLPFYNQDHERLFEL--ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HhCCCCCCCCCHHHHHHH--HhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 999999987654332222 22334456778999999999999999999998 8888887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=290.46 Aligned_cols=217 Identities=24% Similarity=0.399 Sum_probs=171.9
Q ss_pred HHHHHHHHHhCCCCcccceeceeec---------CceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHH
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+|+.++++++||||+++++++.. .++++||||++ ++|.+++... ....+++..++.++.|++.||+
T Consensus 106 ~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~ 184 (440)
T PTZ00036 106 KNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184 (440)
T ss_pred HHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence 4479999999999999999887521 14679999996 5888877542 2356899999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||+.||+||||||+||+++.++..++|+|||++.............+++.|+|||++.+ ...++.++|||||
T Consensus 185 yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSl 257 (440)
T PTZ00036 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSL 257 (440)
T ss_pred HHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHH
Confidence 999999999999999999997666799999999986544444445578999999998754 2467889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhc---------------------------CCCCCCCCcHHHHHHHHHhhhh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---------------------------RPGLPEDISPDLAFIVQSCWVE 226 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~ 226 (298)
||++|+|++|..||.+............... ...+|...++++.+||.+||+.
T Consensus 258 Gvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~ 337 (440)
T PTZ00036 258 GCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKY 337 (440)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCC
Confidence 9999999999999987665443332221100 0113345678999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 227 DPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 227 ~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
+|.+|||+.++++ +.|+..++.+
T Consensus 338 dP~~R~ta~e~l~--hp~f~~~~~~ 360 (440)
T PTZ00036 338 EPLKRLNPIEALA--DPFFDDLRDP 360 (440)
T ss_pred ChhHCcCHHHHhC--ChhHHhhhcc
Confidence 9999999999998 6777666543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=277.46 Aligned_cols=204 Identities=25% Similarity=0.376 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++.+++||||+++++++. ++..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+
T Consensus 38 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 115 (312)
T cd05585 38 THTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVI 115 (312)
T ss_pred HHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 46778999999999999999999885 55799999999999999999753 4689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 116 HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el 186 (312)
T cd05585 116 YRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG--------HGYTKAVDWWTLGVLLYEM 186 (312)
T ss_pred eCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccCCcccCCHHHHcC--------CCCCCccceechhHHHHHH
Confidence 99999999999955 4699999999875322 222334568999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS---FSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 239 (298)
++|..||.+...... ... .......++..+++++.+++.+||..||.+||+ +.++++
T Consensus 187 ~tg~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 187 LTGLPPFYDENVNEM-YRK-ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HhCCCCcCCCCHHHH-HHH-HHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 999999987654332 222 233455677889999999999999999999985 566665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=273.30 Aligned_cols=212 Identities=27% Similarity=0.458 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
++..+|+.+|++|.|||||+++.+..+ +.+|+|+|||..|.+...- .+.. +.+.+++.++.+++.||+|||.+
T Consensus 153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q 229 (576)
T KOG0585|consen 153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ 229 (576)
T ss_pred HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc
Confidence 367799999999999999999999844 5799999999988876422 2344 89999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccC------ccccccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE------TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
||+||||||+|+|++.+ +.+||+|||.+... +.........||+.|+|||+..+.. .....+.+.||||
T Consensus 230 giiHRDIKPsNLLl~~~-g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWa 304 (576)
T KOG0585|consen 230 GIIHRDIKPSNLLLSSD-GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWA 304 (576)
T ss_pred CeeccccchhheEEcCC-CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC----Cccccchhhhhhh
Confidence 99999999999999966 67999999999854 2223334468999999999987521 1244567899999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|+++|.++.|+.||-+..... +... +...+..+|. .+...+++||.+||++||++|.+..+|.. +.|..
T Consensus 305 lGVTLYCllfG~~PF~~~~~~~-l~~K-Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~--Hpwvt 376 (576)
T KOG0585|consen 305 LGVTLYCLLFGQLPFFDDFELE-LFDK-IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL--HPWVT 376 (576)
T ss_pred hhhhHHHhhhccCCcccchHHH-HHHH-HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee--cceec
Confidence 9999999999999998654333 2222 3344444444 47899999999999999999999999976 44443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=270.19 Aligned_cols=215 Identities=28% Similarity=0.533 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALD 87 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~q 87 (298)
+.+.+|+.++++++||||+++++++. +...++||||+++++|.+++..... ..+++..++.++.|
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (291)
T cd05094 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131 (291)
T ss_pred HHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHH
Confidence 46889999999999999999999985 5578999999999999999976321 34789999999999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCC
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
++.||+|||++|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..+
T Consensus 132 i~~al~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~ 202 (291)
T cd05094 132 IASGMVYLASQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKF 202 (291)
T ss_pred HHHHHHHHHhCCeeecccCcceEEEccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--------CCC
Confidence 9999999999999999999999999955 569999999987543322 1223345678999998864 567
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+.++||||||+++|+|++ |..||....... .............+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 203 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~ 281 (291)
T cd05094 203 TTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA 281 (291)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 889999999999999998 999997665433 233334444445566788999999999999999999999999999998
Q ss_pred hhhc
Q 022347 244 FLFT 247 (298)
Q Consensus 244 ~~~~ 247 (298)
....
T Consensus 282 ~~~~ 285 (291)
T cd05094 282 LGKA 285 (291)
T ss_pred HHhh
Confidence 7553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=281.15 Aligned_cols=236 Identities=36% Similarity=0.565 Sum_probs=180.2
Q ss_pred CchhhHHHhcCCCCcHHH-----HHH-HHHHHHHHHHHHhCCCCcccceeceee-cC-ceeEEEecCCCCCHHHHHhhhC
Q 022347 1 MGKFMKEVLNRGSTSDER-----ALL-EGRFIREVNMMSRVKHDNLVKFLGACK-DP-LMVIVTELLPGMSLRKYLVSLR 72 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~~-----~~~-~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~-~~~lv~e~~~~~sL~~~l~~~~ 72 (298)
||.||++++.++.....+ ... ..+|.+|+.++.+++|||+++++|||. ++ ..++|+||+++|+|.+++....
T Consensus 88 fg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~ 167 (361)
T KOG1187|consen 88 FGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKK 167 (361)
T ss_pred CeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCC
Confidence 678888887776322111 000 346999999999999999999999995 44 4899999999999999998743
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---CeeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccc-cCccceec
Q 022347 73 PNKLDLHVALNFALDIARAMDCLHANG---IIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE-TGTYRWMA 147 (298)
Q Consensus 73 ~~~~~~~~~~~i~~qi~~al~~LH~~g---ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~-~~~~~y~a 147 (298)
...++|..+++|+.+++.||+|||+.. |+|||||++|||+|.+ ...||+|||++..... ....... .||.+|++
T Consensus 168 ~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~ 246 (361)
T KOG1187|consen 168 GEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLA 246 (361)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCccccceeeecCCCCccCC
Confidence 227899999999999999999999964 9999999999999955 5699999999976544 3333333 79999999
Q ss_pred cccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHH------hhcCCCCC-CCCc--
Q 022347 148 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-----NLQAAYAAAF------KHARPGLP-EDIS-- 213 (298)
Q Consensus 148 PE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~-----~~~~~~~~~~------~~~~~~~~-~~~~-- 213 (298)
||++.. +..+.++||||||++++|+++|+.+.+... ....+..... .-..+.+. ..++
T Consensus 247 PEy~~~--------g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~ 318 (361)
T KOG1187|consen 247 PEYAST--------GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDE 318 (361)
T ss_pred hhhhcc--------CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChH
Confidence 999864 678999999999999999999998776422 1122111111 11223333 3344
Q ss_pred HH---HHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 214 PD---LAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 214 ~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
.. +..+..+|++.+|..||++.+|++.|+...
T Consensus 319 ~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 319 KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 22 557888999999999999999999885443
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=269.98 Aligned_cols=210 Identities=36% Similarity=0.677 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.|.+|++.+++++||||+++++++. .+..++|+||+++|+|.+++.......+++..++.|+.|++.||.|||+.++
T Consensus 45 ~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~i 124 (259)
T PF07714_consen 45 EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNI 124 (259)
T ss_dssp HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 457889999999999999999999996 5568999999999999999998645679999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+|++|+++||+++.+ +.+||+|||++...... ...........|+|||.+.. ..++.++||||||+++
T Consensus 125 iH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~ksDVysfG~~l 195 (259)
T PF07714_consen 125 IHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD--------GEYTKKSDVYSFGMLL 195 (259)
T ss_dssp EEST-SGGGEEEETT-TEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH--------SEESHHHHHHHHHHHH
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc--------cccccccccccccccc
Confidence 999999999999954 57999999998765221 12233346678999999865 4588999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 178 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
||+++ |+.||.+..... .............+..++..+.+++..||..+|.+|||+.++++.|
T Consensus 196 ~ei~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 196 YEILTLGKFPFSDYDNEE-IIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHTTSSGTTTTSCHHH-HHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccccccccccc-ccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 99999 789998875544 3444466666777788999999999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=283.88 Aligned_cols=238 Identities=33% Similarity=0.587 Sum_probs=194.2
Q ss_pred CchhhHHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHH
Q 022347 1 MGKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 80 (298)
+|.|..|+++......+. -+.|++|+.++++-+|.||+-+.|+|....+.||+.+|+|-+|+.+++-. ..+|.+..
T Consensus 414 hGdVAVK~Lnv~~pt~~q---lqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv~-etkfdm~~ 489 (678)
T KOG0193|consen 414 HGDVAVKLLNVDDPTPEQ---LQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCEGSSLYTHLHVQ-ETKFDMNT 489 (678)
T ss_pred ccceEEEEEecCCCCHHH---HHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhccCchhhhhccch-hhhhhHHH
Confidence 366777888887776663 35899999999999999999999999877779999999999999999863 35699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCc---cccccccccCccceeccccccccccc
Q 022347 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET---VTEMMTAETGTYRWMAPELYSTVTLR 157 (298)
Q Consensus 81 ~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~ 157 (298)
.+.|+.|++.|+.|||.++|+|+|||..|||+..+ ..|+|+|||++.... .........+...|+|||++.-
T Consensus 490 ~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRm---- 564 (678)
T KOG0193|consen 490 TIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRM---- 564 (678)
T ss_pred HHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhh----
Confidence 99999999999999999999999999999999955 579999999987432 2233344567889999999973
Q ss_pred cCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 022347 158 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSF 234 (298)
Q Consensus 158 ~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (298)
....+|++.+||||||+++|||++|..||......+.++..-.....+. ...+.++++.+|+..||..++++||.+
T Consensus 565 -qd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F 643 (678)
T KOG0193|consen 565 -QDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLF 643 (678)
T ss_pred -cccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccH
Confidence 2357899999999999999999999999994433333222222212222 234577899999999999999999999
Q ss_pred HHHHHHHHhhhhcc
Q 022347 235 SQIIRMLNAFLFTL 248 (298)
Q Consensus 235 ~~l~~~l~~~~~~~ 248 (298)
.+|+..|..++..+
T Consensus 644 ~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 644 PQLLSKLEELLPSL 657 (678)
T ss_pred HHHHHHHHHhhhcc
Confidence 99999998887753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=276.13 Aligned_cols=214 Identities=26% Similarity=0.471 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
...+++.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (331)
T cd06649 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK 122 (331)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 34567889999999999999999999884 56799999999999999999763 4589999999999999999999986
Q ss_pred -CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 -GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 -givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+|+|+||||+||+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 123 ~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il 192 (331)
T cd06649 123 HQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSL 192 (331)
T ss_pred CCEEcCCCChhhEEEcCC-CcEEEccCccccccccc-ccccCCCCcCcCCHhHhcC--------CCCCchHhHHHHHHHH
Confidence 69999999999999955 46999999998754322 2234468899999999864 5678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHH---------------------------------------------HHHHhhcCCCCC-CC
Q 022347 178 WELLTNRLPFEGMSNLQAAY---------------------------------------------AAAFKHARPGLP-ED 211 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~-~~ 211 (298)
|+|++|+.||...+...... ........+..+ ..
T Consensus 193 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
T cd06649 193 VELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGV 272 (331)
T ss_pred HHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCcc
Confidence 99999999997544321110 000111112211 24
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 212 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 212 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+++++.+|+.+||+.||++|||+.++++ +.|+..
T Consensus 273 ~~~~l~~li~~~L~~~P~~Rpt~~ell~--h~~~~~ 306 (331)
T cd06649 273 FTPDFQEFVNKCLIKNPAERADLKMLMN--HTFIKR 306 (331)
T ss_pred ccHHHHHHHHHHccCCcccCCCHHHHhc--ChHHhh
Confidence 7889999999999999999999999998 555554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.56 Aligned_cols=207 Identities=27% Similarity=0.444 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+|+.+++.++||||+++++++. ++..|+||||++||+|.+++... ....+++..+..++.|++.||.|||+.|
T Consensus 110 ~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ 189 (478)
T PTZ00267 110 AYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK 189 (478)
T ss_pred HHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46778999999999999999999984 66899999999999999988653 2345899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|+||||||+||+++.+ +.++|+|||++....... ......|++.|+|||++.+ ..++.++|||||||+
T Consensus 190 ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~ 260 (478)
T PTZ00267 190 MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER--------KRYSKKADMWSLGVI 260 (478)
T ss_pred EEECCcCHHhEEECCC-CcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC--------CCCCcHHhHHHHHHH
Confidence 9999999999999955 569999999997543322 1234468999999998864 567889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|+|++|..||....... .............+..++.++.+++.+||..+|++||++.+++.
T Consensus 261 l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 261 LYELLTLHRPFKGPSQRE-IMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 999999999998765433 33333334445567778999999999999999999999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=277.17 Aligned_cols=205 Identities=26% Similarity=0.437 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.++.+|+.+++.++||||+++++++. ++..|+||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+
T Consensus 40 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iv 117 (328)
T cd05593 40 AHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIV 117 (328)
T ss_pred HHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 46778999999999999999999885 56799999999999999988753 4689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 118 HrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~el 188 (328)
T cd05593 118 YRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEM 188 (328)
T ss_pred ecccCHHHeEECCC-CcEEEecCcCCccCCCcccccccccCCcCccChhhhcC--------CCCCccCCccccchHHHHH
Confidence 99999999999955 5699999999875322 222334568999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 240 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~ 240 (298)
++|..||...+.... .. ........++..+++++.+++.+||+.+|.+|+ ++.+++++
T Consensus 189 ltG~~Pf~~~~~~~~-~~-~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 189 MCGRLPFYNQDHEKL-FE-LILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred hhCCCCCCCCCHHHH-HH-HhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 999999987554322 22 222344567788999999999999999999997 89999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=281.20 Aligned_cols=216 Identities=31% Similarity=0.536 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC---------------------------
Q 022347 22 EGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------------------- 72 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------------------- 72 (298)
.+.+.+|+.+++++. ||||+++++++. .+..|+||||+++|+|.+++....
T Consensus 84 ~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (400)
T cd05105 84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADEST 163 (400)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccc
Confidence 457889999999996 999999999985 567999999999999999986521
Q ss_pred -------------------------------------------------------------------CCCCCHHHHHHHH
Q 022347 73 -------------------------------------------------------------------PNKLDLHVALNFA 85 (298)
Q Consensus 73 -------------------------------------------------------------------~~~~~~~~~~~i~ 85 (298)
...+++..++.++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~ 243 (400)
T cd05105 164 RSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT 243 (400)
T ss_pred cchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHH
Confidence 1247788889999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++.||.|||+.|++|+||||+||+++.+ ..++|+|||++........ .....++..|+|||.+.+ .
T Consensus 244 ~qi~~aL~~LH~~~ivH~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~ 314 (400)
T cd05105 244 YQVARGMEFLASKNCVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--------N 314 (400)
T ss_pred HHHHHHHHHHHhCCeeCCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--------C
Confidence 999999999999999999999999999954 5699999999875432211 122345678999998864 5
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++||||||+++|+|++ |..||.....................+..++.++.+++.+||+.+|++|||+.++.+.|
T Consensus 315 ~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 315 LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 67889999999999999997 99999875543444444444445566678899999999999999999999999999999
Q ss_pred Hhhhh
Q 022347 242 NAFLF 246 (298)
Q Consensus 242 ~~~~~ 246 (298)
..++.
T Consensus 395 ~~l~~ 399 (400)
T cd05105 395 ESLLP 399 (400)
T ss_pred HHHcC
Confidence 87653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=254.32 Aligned_cols=212 Identities=26% Similarity=0.448 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
....+..++.+|+++-+.|+||||++++++|.+ ...|+++||.++|++...+.+.....+++...+.++.|++.||.|+
T Consensus 61 ~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~ 140 (281)
T KOG0580|consen 61 LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC 140 (281)
T ss_pred HHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh
Confidence 334566689999999999999999999999954 5799999999999999999987778899999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|.++++||||||+|+|++.+ +.+++.|||-+.... .+...+-+||..|.+||+..+ ...+...|+|++|+
T Consensus 141 h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~--------~~hd~~Vd~w~lgv 210 (281)
T KOG0580|consen 141 HLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG--------RGHDKFVDLWSLGV 210 (281)
T ss_pred ccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC-CCCceeeecccccCCHhhcCC--------CCccchhhHHHHHH
Confidence 99999999999999999955 469999999998755 344456689999999999875 77889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
+.||++.|..||++... ... ...+...+..+|..++.++.++|.+|+..+|.+|....+++++
T Consensus 211 l~yeflvg~ppFes~~~-~et-YkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 211 LCYEFLVGLPPFESQSH-SET-YKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHhcCCchhhhhh-HHH-HHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 99999999999998762 333 3334556677789999999999999999999999999999983
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=278.10 Aligned_cols=203 Identities=23% Similarity=0.372 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ..+++..+..++.|++.||+|||+.||
T Consensus 62 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i 139 (329)
T PTZ00263 62 VQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDI 139 (329)
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 346889999999999999999999985 56799999999999999999763 468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+||+++.+ +.++|+|||++...... .....|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 140 vH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 208 (329)
T PTZ00263 140 IYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQS--------KGHGKAVDWWTMGVLLYEF 208 (329)
T ss_pred eecCCCHHHEEECCC-CCEEEeeccCceEcCCC--cceecCChhhcCHHHHcC--------CCCCCcceeechHHHHHHH
Confidence 999999999999955 46999999998754332 223468899999999865 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~ 239 (298)
++|..||.+...... ... .......++..++..+.+++.+||+.||.+||+ +++++.
T Consensus 209 ltg~~pf~~~~~~~~-~~~-i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 209 IAGYPPFFDDTPFRI-YEK-ILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HcCCCCCCCCCHHHH-HHH-HhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 999999987654332 222 233455667778999999999999999999986 688876
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=263.35 Aligned_cols=211 Identities=31% Similarity=0.582 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
....+.+|+.++++++||||+++++++. +...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ 114 (252)
T cd05084 36 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH 114 (252)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4457889999999999999999999984 55789999999999999999753 345899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccc---cccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT---AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++|+||+|+||+++.+ +.++|+|||.+.......... ....+..|+|||.+.+ ..++.++||||||++
T Consensus 115 i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i 185 (252)
T cd05084 115 CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY--------GRYSSESDVWSFGIL 185 (252)
T ss_pred ccccccchheEEEcCC-CcEEECccccCcccccccccccCCCCCCceeecCchhhcC--------CCCChHHHHHHHHHH
Confidence 9999999999999955 469999999987533221111 1122356999998864 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
+|++++ |..||....... .............+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 186 l~e~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 186 LWEAFSLGAVPYANLSNQQ-TREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHhCCCCCccccCHHH-HHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999998 889987655432 23333344455667778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=273.27 Aligned_cols=216 Identities=26% Similarity=0.514 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+++.+|+.+++.++||||+++++++.....++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.|+
T Consensus 52 ~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i 130 (316)
T cd05108 52 ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRL 130 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence 345788999999999999999999999777788999999999999999863 2458899999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccccc---ccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+|+||||+||+++.+ +.++|+|||++......... .....+..|+|||.+.. ..++.++||||||+++
T Consensus 131 iH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slGv~l 201 (316)
T cd05108 131 VHRDLAARNVLVKTP-QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTV 201 (316)
T ss_pred eccccchhheEecCC-CcEEEccccccccccCCCcceeccCCccceeecChHHhcc--------CCCCchhhhHHHHHHH
Confidence 999999999999855 46999999999864432221 12234567999998864 6678899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 178 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+|++ |..||.+..... .............+..++..+.+++.+||..+|.+||++.+++..+......
T Consensus 202 ~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 202 WELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 99998 999998755432 2333334444455667889999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=269.31 Aligned_cols=207 Identities=21% Similarity=0.354 Sum_probs=167.2
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+..|+.++++++||||+++++.+. +...|+||||++|++|.+++.......+++..+..++.|++.||+|||+.|++|
T Consensus 39 ~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 118 (277)
T cd05607 39 MALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118 (277)
T ss_pred HHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 4557999999999999999999885 557899999999999999987655556899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
+||||+||+++.+ +.++|+|||++.............++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 119 ~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~~ 189 (277)
T cd05607 119 RDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE--------EPYSYPVDWFAMGCSIYEMVA 189 (277)
T ss_pred ccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCCCCCccCHHHHcc--------CCCCCchhHHHHHHHHHHHHh
Confidence 9999999999955 5699999999876544333344568889999999864 458889999999999999999
Q ss_pred CCCCCCCCChH---HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 183 NRLPFEGMSNL---QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 183 g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|+.||...... ..................+++++.+++.+||+.+|.+||++.++++
T Consensus 190 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 190 GRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 99999764321 1111222211112222468999999999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.37 Aligned_cols=212 Identities=31% Similarity=0.535 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC------------CCCCCHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------PNKLDLHVALNFALD 87 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~i~~q 87 (298)
..+.+.+|+.++++++||||+++++++. +...++||||+++++|.+++.... ...+++..+..++.|
T Consensus 51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 3468889999999999999999999984 567999999999999999997642 234788999999999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCC
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..+
T Consensus 131 i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~ 201 (280)
T cd05049 131 IASGMVYLASQHFVHRDLATRNCLVGYD-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------RKF 201 (280)
T ss_pred HHHHHHHHhhCCeeccccccceEEEcCC-CeEEECCcccceecccCcceecCCCCcccceecChhhhcc--------CCc
Confidence 9999999999999999999999999955 569999999987432221 1122345678999998864 668
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
+.++||||||+++|+|++ |..||....... .............+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 202 ~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred chhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 889999999999999998 999997765433 23333344444556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=249.64 Aligned_cols=207 Identities=26% Similarity=0.411 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.+-+.|+||||+++.+.+ ++++.|+|+|++.|+.|..-|-.. ..+++..+-..+.||++||.|+|..|||
T Consensus 55 e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~Iv 132 (355)
T KOG0033|consen 55 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIV 132 (355)
T ss_pred HHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCce
Confidence 4677999999999999999999988 567899999999999998776653 4588899999999999999999999999
Q ss_pred eecCCCCCEEEcC--CCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|||+||+|+++.. ++-.+||+|||++.............|+++|+|||++.. .+|+..+|||+-|+|+|-
T Consensus 133 HRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk--------dpy~kpvDiW~cGViLfi 204 (355)
T KOG0033|consen 133 HRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYI 204 (355)
T ss_pred eccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhc--------CCCCCcchhhhhhHHHHH
Confidence 9999999999952 334799999999998776666677899999999999964 789999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHh--hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFK--HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++.|.+||.+.+......+.... ..+++..+.++++.++|+++||..||.+|.|+.|.++
T Consensus 205 LL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 205 LLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 99999999885543332222222 1223345679999999999999999999999999887
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=290.13 Aligned_cols=230 Identities=29% Similarity=0.495 Sum_probs=196.6
Q ss_pred HHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHH
Q 022347 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84 (298)
Q Consensus 6 ~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i 84 (298)
.|.|+.+.++..+ .+|..|..|+.+++|||||++.|+.. ..-.+||+|||++|+|+.|+..+ ++.|+.-+...+
T Consensus 662 IKTLK~Gytekqr----rdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~-DGqftviQLVgM 736 (996)
T KOG0196|consen 662 IKTLKAGYTEKQR----RDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN-DGQFTVIQLVGM 736 (996)
T ss_pred EeeeccCccHHHH----hhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc-CCceEeehHHHH
Confidence 4555555555444 48999999999999999999999985 45688999999999999999874 467999999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-c-cccc--cCccceeccccccccccccCC
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M-MTAE--TGTYRWMAPELYSTVTLRQGE 160 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~-~~~~--~~~~~y~aPE~~~~~~~~~~~ 160 (298)
++.|++|+.||-+.|+|||||...|||++ .+-.+|++|||+++...... . ..+. .-..+|.|||.+..
T Consensus 737 LrGIAsGMkYLsdm~YVHRDLAARNILVN-snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~------- 808 (996)
T KOG0196|consen 737 LRGIASGMKYLSDMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY------- 808 (996)
T ss_pred HHHHHHHhHHHhhcCchhhhhhhhheeec-cceEEEeccccceeecccCCCccccccCCccceeecChhHhhh-------
Confidence 99999999999999999999999999999 55689999999998543332 1 1111 12358999999976
Q ss_pred ccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 161 KKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 161 ~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+.++.+|||||+|++|||.++ |..||-++.+ ++..+.+..+.+.+-|.++|..|++|+..||++|...||.+.+++.
T Consensus 809 -RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 809 -RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred -cccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 899999999999999999988 9999998877 5566777788888889999999999999999999999999999999
Q ss_pred HHHhhhhccCC
Q 022347 240 MLNAFLFTLRP 250 (298)
Q Consensus 240 ~l~~~~~~~~~ 250 (298)
.|++++.....
T Consensus 887 ~lDklIrnP~S 897 (996)
T KOG0196|consen 887 TLDKLIRNPNS 897 (996)
T ss_pred HHHHHhcCchh
Confidence 99999876543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=273.56 Aligned_cols=215 Identities=31% Similarity=0.583 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCC--------------------------
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRP-------------------------- 73 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-------------------------- 73 (298)
+.+.+|+.++.++ +||||+++++++. +...++++||+++++|.+++.....
T Consensus 55 ~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (337)
T cd05054 55 KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134 (337)
T ss_pred HHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccc
Confidence 3577899999999 7999999999873 4578899999999999999864221
Q ss_pred ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceE
Q 022347 74 ---------------------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120 (298)
Q Consensus 74 ---------------------------------~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~ 120 (298)
..+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vk 213 (337)
T cd05054 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVK 213 (337)
T ss_pred cCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEE
Confidence 257899999999999999999999999999999999999965 4699
Q ss_pred EeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 022347 121 LADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 196 (298)
Q Consensus 121 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~ 196 (298)
|+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 214 L~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~ 285 (337)
T cd05054 214 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285 (337)
T ss_pred EeccccchhcccCcchhhccCCCCCccccCcHHhcC--------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH
Confidence 99999997543221 1122344668999998864 678889999999999999998 99999875443433
Q ss_pred HHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
............+...++++.+++.+||+.+|++||++.+++++|+..+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 34444444555667788999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=279.40 Aligned_cols=232 Identities=28% Similarity=0.447 Sum_probs=192.9
Q ss_pred CchhhHHHhcCCCCcHHH--------HHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhh
Q 022347 1 MGKFMKEVLNRGSTSDER--------ALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL 71 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~ 71 (298)
||||||.+-+....-... +.+ ++|.-|+.+|..|+||+|+.+++.| .++.+||+.|||.||.+...+.+.
T Consensus 45 FGKVyKA~nket~~lAAaKvIetkseEEL-EDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL 123 (1187)
T KOG0579|consen 45 FGKVYKAVNKETKLLAAAKVIETKSEEEL-EDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLEL 123 (1187)
T ss_pred chhhhhhhcccchhhhhhhhhcccchhHH-hhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHh
Confidence 799999877644332211 222 3788899999999999999999865 688899999999999999998873
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceecccc
Q 022347 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPEL 150 (298)
Q Consensus 72 ~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~ 150 (298)
+..+++.++.-+++|++.||.|||+.+|+|||||..|||+..+|. ++|.|||.+...... .....++||+.|||||+
T Consensus 124 -~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd-irLADFGVSAKn~~t~qkRDsFIGTPYWMAPEV 201 (1187)
T KOG0579|consen 124 -GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD-IRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEV 201 (1187)
T ss_pred -ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc-EeeecccccccchhHHhhhccccCCcccccchh
Confidence 467999999999999999999999999999999999999998765 999999998654332 33456789999999998
Q ss_pred ccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCC
Q 022347 151 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p 228 (298)
...-. ....+|+.++||||||+++.+|.-+.+|-...+....+.+.... .+|. -|..++..+.+++.+||..||
T Consensus 202 vmCET---~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-ePPTLlqPS~Ws~~F~DfLk~cL~Knp 277 (1187)
T KOG0579|consen 202 VMCET---FKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLLQPSHWSRSFSDFLKRCLVKNP 277 (1187)
T ss_pred eeecc---ccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-CCCcccCcchhhhHHHHHHHHHHhcCC
Confidence 86532 24578999999999999999999999998887776666555433 3333 356799999999999999999
Q ss_pred CCCCCHHHHHH
Q 022347 229 NLRPSFSQIIR 239 (298)
Q Consensus 229 ~~Rps~~~l~~ 239 (298)
..||+++++++
T Consensus 278 ~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 278 RNRPPAAQLLK 288 (1187)
T ss_pred ccCCCHHHHhh
Confidence 99999999998
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.55 Aligned_cols=217 Identities=27% Similarity=0.507 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-----------CCCCCHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-----------PNKLDLHVALNFALDI 88 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~~i~~qi 88 (298)
..+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|+
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql 129 (288)
T cd05093 50 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHH
Confidence 3457889999999999999999999985 567999999999999999997532 1348999999999999
Q ss_pred HHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCC
Q 022347 89 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYN 165 (298)
Q Consensus 89 ~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 165 (298)
+.||+|||++|++||||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++
T Consensus 130 ~~aL~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~ 200 (288)
T cd05093 130 AAGMVYLASQHFVHRDLATRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFT 200 (288)
T ss_pred HHHHHHHHhCCeeecccCcceEEEccC-CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc--------CCCC
Confidence 999999999999999999999999955 5699999999875432211 122234678999998864 5678
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 166 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 166 ~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
.++||||||+++|+|++ |..||....... .............+..++.++.+++.+||+.+|.+|||+.+++..|+.+
T Consensus 201 ~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 201 TESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 89999999999999998 999997765433 2333334444455667889999999999999999999999999999887
Q ss_pred hhc
Q 022347 245 LFT 247 (298)
Q Consensus 245 ~~~ 247 (298)
...
T Consensus 280 ~~~ 282 (288)
T cd05093 280 AKA 282 (288)
T ss_pred HHh
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=265.23 Aligned_cols=213 Identities=32% Similarity=0.542 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++.+. ++..+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i 124 (261)
T cd05072 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124 (261)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 357889999999999999999999874 5578999999999999999976555678999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 125 ~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 195 (261)
T cd05072 125 IHRDLRAANVLVSES-LMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLY 195 (261)
T ss_pred eccccchhhEEecCC-CcEEECCCccceecCCCceeccCCCccceecCCHHHhcc--------CCCChhhhhhhhHHHHH
Confidence 999999999999955 5699999999975433221 122234567999998864 56788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 179 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|++ |..||....... ...........+....++.++.+++.+||..+|++||+++++.+.|+.+
T Consensus 196 ~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 196 EIVTYGKIPYPGMSNSD-VMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHccCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9998 999998755433 2333333344445567889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=269.65 Aligned_cols=209 Identities=23% Similarity=0.387 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
...+.+|+.+++.++||||+++++.+. ++..++||||+++++|.+++.......+++..+..++.|++.||.|||+.|+
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 345778999999999999999999885 5679999999999999998876444569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++||||+|+++|++
T Consensus 124 vH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diws~G~~l~el 194 (285)
T cd05605 124 VYRDLKPENILLDDY-GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN--------ERYTFSPDWWGLGCLIYEM 194 (285)
T ss_pred EecCCCHHHEEECCC-CCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC--------CCCCccccchhHHHHHHHH
Confidence 999999999999954 5699999999876443333334468899999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHH--HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 181 LTNRLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
++|..||.+...... .............+..++..+.+++.+||..||.+|| +++++++
T Consensus 195 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 195 IEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 999999987543221 1112223344455667899999999999999999999 8889977
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=277.16 Aligned_cols=203 Identities=23% Similarity=0.362 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 75 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i 152 (340)
T PTZ00426 75 VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNI 152 (340)
T ss_pred HHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 346789999999999999999999985 55789999999999999999763 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+||+++.+ +.++|+|||++...... .....|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 153 vHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~el 221 (340)
T PTZ00426 153 VYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLN--------VGHGKAADWWTLGIFIYEI 221 (340)
T ss_pred EccCCCHHHEEECCC-CCEEEecCCCCeecCCC--cceecCChhhcCHHHHhC--------CCCCccccccchhhHHHHH
Confidence 999999999999855 56999999998754322 234468999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
++|..||.+.+.... ... .......++..+++.+.+++++||+.+|.+|+ ++.++++
T Consensus 222 l~G~~Pf~~~~~~~~-~~~-i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 222 LVGCPPFYANEPLLI-YQK-ILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred hcCCCCCCCCCHHHH-HHH-HhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 999999987654332 222 23344456778899999999999999999995 8999987
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=271.11 Aligned_cols=213 Identities=30% Similarity=0.536 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-----------------CCCCCHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-----------------PNKLDLHVAL 82 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~~~~~~~~~ 82 (298)
...+|.+|+.++.+++||||+++++++. ++..++||||+++++|.+++.... ...+++..++
T Consensus 62 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05096 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141 (304)
T ss_pred HHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHH
Confidence 3457889999999999999999999984 567899999999999999986532 1236788899
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccC
Q 022347 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQG 159 (298)
Q Consensus 83 ~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 159 (298)
.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||++..
T Consensus 142 ~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------ 214 (304)
T cd05096 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM------ 214 (304)
T ss_pred HHHHHHHHHHHHHHHCCccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc------
Confidence 999999999999999999999999999999955 569999999987543222 1122344678999998864
Q ss_pred CccCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHH--HHh----hcCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 022347 160 EKKHYNNKVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAA--AFK----HARPGLPEDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 160 ~~~~~~~~~Di~slG~il~~ll~--g~~p~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (298)
..++.++||||||+++|+|++ +..||............ ... ......+..++..+.+++.+||+.+|.+|
T Consensus 215 --~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 215 --GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred --CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhC
Confidence 567889999999999999986 56788765543322211 111 11122345678999999999999999999
Q ss_pred CCHHHHHHHHH
Q 022347 232 PSFSQIIRMLN 242 (298)
Q Consensus 232 ps~~~l~~~l~ 242 (298)
||+.++.+.|+
T Consensus 293 Ps~~~i~~~l~ 303 (304)
T cd05096 293 PSFSDIHAFLT 303 (304)
T ss_pred cCHHHHHHHHh
Confidence 99999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=263.64 Aligned_cols=213 Identities=31% Similarity=0.525 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+++|.+|+.++++++||||+++++++. ++..+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.|
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~ 126 (266)
T cd05033 48 QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN 126 (266)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999999884 557899999999999999997633 46899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||++
T Consensus 127 i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Dv~slG~~ 197 (266)
T cd05033 127 YVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIV 197 (266)
T ss_pred cccCCCCcceEEEcCC-CCEEECccchhhcccccccceeccCCCCCccccChhhhcc--------CCCccccchHHHHHH
Confidence 9999999999999955 469999999998654211 1112234568999998864 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|++++ |..||....... ...........+.+..++..+.+++.+||+.+|++||++.++++.|..+
T Consensus 198 l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 198 MWEVMSYGERPYWDMSNQD-VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHccCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999998 999997765433 2333334444455677899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=267.77 Aligned_cols=215 Identities=29% Similarity=0.579 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC----------------------CCCCCHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR----------------------PNKLDLH 79 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~~ 79 (298)
+++.+|+.+++.++||||+++++.+. ++..++++||+.+++|.+++.... ...+++.
T Consensus 48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 127 (290)
T cd05045 48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127 (290)
T ss_pred HHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHH
Confidence 47889999999999999999999884 567899999999999999986521 1347889
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceecccccccccc
Q 022347 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTL 156 (298)
Q Consensus 80 ~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 156 (298)
.++.++.|++.||.|||+.|++||||+|+||+++. ++.++|+|||++........ .....++..|+|||.+.+
T Consensus 128 ~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--- 203 (290)
T cd05045 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--- 203 (290)
T ss_pred HHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc---
Confidence 99999999999999999999999999999999985 45799999999875322211 122234568999998754
Q ss_pred ccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 022347 157 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235 (298)
Q Consensus 157 ~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (298)
..++.++||||||+++|+|++ |..||.+... ...............+..++.++.+++.+||+.+|.+||++.
T Consensus 204 -----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 204 -----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred -----CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 567889999999999999998 9999976553 333344444445556777899999999999999999999999
Q ss_pred HHHHHHHhhhhc
Q 022347 236 QIIRMLNAFLFT 247 (298)
Q Consensus 236 ~l~~~l~~~~~~ 247 (298)
++++.|+.++.+
T Consensus 278 ~i~~~l~~~~~~ 289 (290)
T cd05045 278 DISKELEKMMVK 289 (290)
T ss_pred HHHHHHHHHHhc
Confidence 999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=280.08 Aligned_cols=235 Identities=29% Similarity=0.555 Sum_probs=198.5
Q ss_pred CchhhHHHhcCCCCc------------HHHHHHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHH
Q 022347 1 MGKFMKEVLNRGSTS------------DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYL 68 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l 68 (298)
||.||++|+...... +..-...+.|..|..+++.++|||||+++|+|.+.-.|||||.++-|.|..|+
T Consensus 402 FGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~~~GELr~yL 481 (974)
T KOG4257|consen 402 FGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELAPLGELREYL 481 (974)
T ss_pred ccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecccchhHHHHH
Confidence 688888887665221 11112356899999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccccc--ccCcccee
Q 022347 69 VSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA--ETGTYRWM 146 (298)
Q Consensus 69 ~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~y~ 146 (298)
+.++ ..++......++.||+.||+|||+..+|||||-..|||+. ....+||+|||+++.......... ..-...|+
T Consensus 482 q~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs-Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWm 559 (974)
T KOG4257|consen 482 QQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS-SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWM 559 (974)
T ss_pred Hhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec-Ccceeeecccchhhhccccchhhccccccceeec
Confidence 8754 4588999999999999999999999999999999999999 455799999999997665443332 23346899
Q ss_pred ccccccccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhh
Q 022347 147 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 225 (298)
Q Consensus 147 aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 225 (298)
|||.++. +.++.+||||.||+.|||++. |..||.+..+.+.. .....+.+.++|+++|+.+..++.+||.
T Consensus 560 aPESINf--------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP~P~nCPp~LYslmskcWa 630 (974)
T KOG4257|consen 560 APESINF--------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLPCPPNCPPALYSLMSKCWA 630 (974)
T ss_pred Cccccch--------hcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCCCCCCCChHHHHHHHHHhc
Confidence 9999975 889999999999999999998 99999987665443 2345677889999999999999999999
Q ss_pred hCCCCCCCHHHHHHHHHhhhh
Q 022347 226 EDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 226 ~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++|.+||.+.++...|+..+.
T Consensus 631 yeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 631 YEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCcccCCcHHHHHHHHHHHHH
Confidence 999999999999988877654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=264.99 Aligned_cols=215 Identities=33% Similarity=0.578 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHH
Q 022347 21 LEGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNF 84 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i 84 (298)
..+.+.+|+.++.++ +||||+++++++. ++..+++|||+++++|.+++.... ...+++..++.+
T Consensus 38 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 117 (270)
T cd05047 38 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117 (270)
T ss_pred HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHH
Confidence 345788999999999 7999999999985 567899999999999999997532 124789999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCC
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
+.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++..............+..|+|||.+.. ..+
T Consensus 118 ~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~ 188 (270)
T cd05047 118 AADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVY 188 (270)
T ss_pred HHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCCCCccccchhhhccCCCCccccCChHHHcc--------CCC
Confidence 9999999999999999999999999999954 5699999999864322211122233567999998754 567
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+.++||||||+++|+|++ |..||.+.+.. ..............+...+.++.+++.+||..+|.+|||+.+++..|+.
T Consensus 189 ~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 189 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCccccCHH-HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 889999999999999997 99999765432 2333333344445666788999999999999999999999999999987
Q ss_pred hh
Q 022347 244 FL 245 (298)
Q Consensus 244 ~~ 245 (298)
++
T Consensus 268 ~~ 269 (270)
T cd05047 268 ML 269 (270)
T ss_pred hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=275.11 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... +.+++..+..++.|++.||.|||+.||+
T Consensus 45 ~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iv 122 (323)
T cd05584 45 AHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGII 122 (323)
T ss_pred HHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45778999999999999999999885 56799999999999999998753 4588899999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 123 H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 193 (323)
T cd05584 123 YRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR--------SGHGKAVDWWSLGALMYDM 193 (323)
T ss_pred cCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcccccCCCccccChhhccC--------CCCCCcceecccHHHHHHH
Confidence 99999999999955 46999999998643222 22233468999999999864 4567899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
++|+.||...+..... .. .......++..+++.+.+++.+||+.+|.+|| ++.++++
T Consensus 194 l~G~~pf~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 194 LTGAPPFTAENRKKTI-DK-ILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred hcCCCCCCCCCHHHHH-HH-HHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 9999999876543322 22 22344567778999999999999999999999 8898887
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.15 Aligned_cols=206 Identities=28% Similarity=0.427 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++..++||||+++++++. ++..|+||||++|++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 45 ~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 122 (333)
T cd05600 45 VRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGY 122 (333)
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 346789999999999999999999985 55799999999999999999753 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+||+++.+ +.++|+|||++..... ......+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 123 vH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 191 (333)
T cd05600 123 IHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRG--------KGYDFTVDYWSLGCMLYEF 191 (333)
T ss_pred cccCCCHHHEEECCC-CCEEEEeCcCCccccc--ccCCcccCccccChhHhcC--------CCCCCccceecchHHHhhh
Confidence 999999999999955 4699999999875433 2334568999999999865 5788999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhh---cCCCCC---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKH---ARPGLP---EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
++|..||...+..+......... ..+... ..+++++.+++.+||..+|.+||++.+++++
T Consensus 192 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 192 LCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred hhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 99999998765433322221111 111111 1468999999999999999999999999983
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=261.57 Aligned_cols=214 Identities=30% Similarity=0.544 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
...+++.+|+.++++++||||+++++.+.+...++++||+++++|.+++.......+++..++.++.|++.||+|||+.|
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ 117 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC
Confidence 45568889999999999999999999986688999999999999999998754356899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+
T Consensus 118 i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Di~slG~ 188 (257)
T cd05040 118 FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT--------RTFSHASDVWMFGV 188 (257)
T ss_pred ccccccCcccEEEecC-CEEEeccccccccccccccceecccCCCCCceecCHHHhcc--------cCcCchhhhHHHHH
Confidence 9999999999999966 569999999987543321 1122345678999998864 56788999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 176 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++|+|++ |..||......+..............+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 189 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 189 TLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9999998 999997665544333333233344455678899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=263.35 Aligned_cols=207 Identities=29% Similarity=0.543 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. +...++++||++|++|.+++... ..+++..+..++.|++.||.|||+.|++
T Consensus 49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 126 (263)
T cd06625 49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIV 126 (263)
T ss_pred HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46889999999999999999999985 55799999999999999999763 4588999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccccc----ccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|+||+|+||+++.+ +.++|+|||.+......... ....++..|+|||.+.+ ..++.++||||||+++
T Consensus 127 H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 197 (263)
T cd06625 127 HRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADVWSVGCTV 197 (263)
T ss_pred cCCCCHHHEEEcCC-CCEEEeecccceeccccccccccccCCCcCccccCcceecc--------CCCCchhhhHHHHHHH
Confidence 99999999999954 56999999998643322111 23356788999999865 4578899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
|++++|+.||.+..................++..++..+.+++.+||..+|.+|||+.+++++
T Consensus 198 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 198 VEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 999999999987665555444444445566777899999999999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=255.62 Aligned_cols=217 Identities=28% Similarity=0.369 Sum_probs=180.8
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
--.||+.+|.+++|||||.+..+..+ +..|+|||||+. +|..++...+ .+|...++.-+..|++.|++|||...|
T Consensus 121 tsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wi 198 (419)
T KOG0663|consen 121 TSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWI 198 (419)
T ss_pred hhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhcee
Confidence 35689999999999999999988633 359999999977 9999998743 679999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|||||++|+|++.. +.+||+|||+++.++... .......|.+|+|||++.+ ...|+++.|+||+|||+.|
T Consensus 199 lHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE 270 (419)
T KOG0663|consen 199 LHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAE 270 (419)
T ss_pred EecccchhheeeccC-CcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHH
Confidence 999999999999955 569999999999876653 3445578999999999987 4789999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCC-----------------------------CCCC-CcHHHHHHHHHhhhhCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPG-----------------------------LPED-ISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~-~~~~l~~li~~~l~~~p~ 229 (298)
++++++.|.+....++.......-+.|. ++.. ++....+|+..+|.+||.
T Consensus 271 ~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~ 350 (419)
T KOG0663|consen 271 LLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG 350 (419)
T ss_pred HHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc
Confidence 9999999999887777665543322221 1111 557888999999999999
Q ss_pred CCCCHHHHHHHHHhhhhccCCCC
Q 022347 230 LRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 230 ~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+|.||++.++ +.+....+.+.
T Consensus 351 kR~tA~~~L~--h~~F~e~P~p~ 371 (419)
T KOG0663|consen 351 KRITAEDGLK--HEYFRETPLPI 371 (419)
T ss_pred ccccHHHhhc--ccccccCCCCC
Confidence 9999999998 77777654433
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=262.38 Aligned_cols=208 Identities=32% Similarity=0.600 Sum_probs=171.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.|++
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05114 44 EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFI 122 (256)
T ss_pred HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46889999999999999999999984 557899999999999999987532 3589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccccc--ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||+|+||+++.+ +.++|+|||.+......... ....++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 123 H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s~G~~l~e 193 (256)
T cd05114 123 HRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMWE 193 (256)
T ss_pred ccccCcceEEEcCC-CeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc--------CccchhhhhHHHHHHHHH
Confidence 99999999999954 56999999988754322211 12234567999999864 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
+++ |+.||...+.... ............+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 194 l~~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 194 VFTEGKMPFEKKSNYEV-VEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHcCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999 8999987654333 333444445555667889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.52 Aligned_cols=217 Identities=26% Similarity=0.419 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
...+.+.+|+.+++.++||||+++++++. ++..++||||+++++|.+. ....+..+..++.||+.||.|||+.
T Consensus 114 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~ 187 (353)
T PLN00034 114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRR 187 (353)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567889999999999999999999985 5678999999999998653 2356778889999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++||||||+||+++.+ +.++|+|||++....... ......|+..|+|||.+.... ......+.++|||||||++
T Consensus 188 ~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 188 HIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL---NHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred CEeecCCCHHHEEEcCC-CCEEEcccccceecccccccccccccCccccCcccccccc---ccCcCCCcchhHHHHHHHH
Confidence 99999999999999955 569999999987543321 223456899999999874311 0123445689999999999
Q ss_pred HHHHhCCCCCCCCC--hHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 178 WELLTNRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 178 ~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|+|++|+.||.... ..............+..+..++.++.++|.+||+.+|++|||+.++++ +.|+...
T Consensus 264 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--hp~~~~~ 334 (353)
T PLN00034 264 LEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ--HPFILRA 334 (353)
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--CcccccC
Confidence 99999999997432 222222223333445566778999999999999999999999999998 6666553
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=261.82 Aligned_cols=212 Identities=32% Similarity=0.566 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.+++.++||||+++++++. ....++||||+++++|.+++.......+++..++.++.|++.||.|||+.|+
T Consensus 46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 125 (261)
T cd05148 46 QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125 (261)
T ss_pred HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 346789999999999999999999885 5578999999999999999987555678999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||.+........ .....++..|+|||.+.. ..++.++||||||+++|+
T Consensus 126 ~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~~l~~ 196 (261)
T cd05148 126 IHRDLAARNILVGED-LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH--------GTFSTKSDVWSFGILLYE 196 (261)
T ss_pred eccccCcceEEEcCC-ceEEEccccchhhcCCccccccCCCCceEecCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 999999999999955 5699999999875433221 122334568999998754 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+++ |+.||....... .............+..+++.+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 197 l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 197 MFTYGQVPYPGMNNHE-VYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHcCCCCCCCcCCHHH-HHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 998 899998765433 333333445556677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=267.04 Aligned_cols=214 Identities=33% Similarity=0.568 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|+.+++++ +||||+++++++. .+..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|
T Consensus 82 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 161 (302)
T cd05055 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161 (302)
T ss_pred HHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35788999999999 7999999999985 557999999999999999997644445899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++|+||||+||+++.+ ..++|+|||++........ .....++..|+|||.+.+ ..++.++||||+|++
T Consensus 162 ivH~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvi 232 (302)
T cd05055 162 CIHRDLAARNVLLTHG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIL 232 (302)
T ss_pred eehhhhccceEEEcCC-CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc--------CCCCcHhHHHHHHHH
Confidence 9999999999999854 5699999999875433221 112234678999998864 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|++++ |..||.....................+...++++.+++.+||..+|++|||+.++++.|...
T Consensus 233 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 233 LWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 999998 99999876544433333333344455567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=265.67 Aligned_cols=212 Identities=30% Similarity=0.558 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC---------------CCCCCHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---------------PNKLDLHVALNFAL 86 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~i~~ 86 (298)
+++.+|+.++++++||||+++++++. +...|++|||+++++|.+++.... ...+++..++.++.
T Consensus 52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 131 (283)
T cd05090 52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131 (283)
T ss_pred HHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence 47889999999999999999999874 567899999999999999985322 12478889999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|++.||.|||+.|++|+||||+||+++.+ ..++|+|||++....... ......++..|+|||.+.+ ..
T Consensus 132 ~i~~al~~lH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~ 202 (283)
T cd05090 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------GK 202 (283)
T ss_pred HHHHHHHHHHhcCeehhccccceEEEcCC-CcEEeccccccccccCCcceecccCCCccceecChHHhcc--------CC
Confidence 99999999999999999999999999955 469999999987543221 1222344567999998864 56
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++|+||||+++|+|++ |..||.+... ...............+..+++.+.+++.+||+.+|.+||++.++++.|.
T Consensus 203 ~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 203 FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred CCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 7889999999999999998 9999977544 2333333344445567788999999999999999999999999999887
Q ss_pred hh
Q 022347 243 AF 244 (298)
Q Consensus 243 ~~ 244 (298)
.|
T Consensus 282 ~~ 283 (283)
T cd05090 282 SW 283 (283)
T ss_pred cC
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=260.71 Aligned_cols=212 Identities=29% Similarity=0.522 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+++.+|+.+++++.||||+++++++.....++||||+++++|.+++... ..+++..++.++.|++.||.|||..|+
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i 116 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHF 116 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCe
Confidence 456788999999999999999999998877889999999999999999864 368999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccccc----ccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|+||+|+||+++.+ +.++|+|||.+......... ....++..|+|||.+.+ ..++.++||||||++
T Consensus 117 ~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~ 187 (257)
T cd05060 117 VHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY--------GKFSSKSDVWSYGVT 187 (257)
T ss_pred eccCcccceEEEcCC-CcEEeccccccceeecCCcccccccCccccccccCHHHhcC--------CCCCccchHHHHHHH
Confidence 999999999999854 56999999998754332221 11123457999998864 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|++++ |..||...+... .............+..++..+.+++.+||..+|++|||+.++++.|+..
T Consensus 188 l~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 188 LWEAFSYGAKPYGEMKGAE-VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHcCCCCCcccCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 999998 999998765533 3333334444566777899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.58 Aligned_cols=219 Identities=28% Similarity=0.448 Sum_probs=184.9
Q ss_pred HHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHH
Q 022347 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84 (298)
Q Consensus 6 ~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i 84 (298)
||.-..|+...++. +++.+|+..|.+++|||+|.+.++| .+...|+||||| -||-.|++.-++ +++.+.++..|
T Consensus 57 KKMsySGKQs~EKW---qDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi 131 (948)
T KOG0577|consen 57 KKMSYSGKQSNEKW---QDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAI 131 (948)
T ss_pred eeccccccccHHHH---HHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHH
Confidence 45555666666665 4788999999999999999999998 566789999999 669999887643 67999999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCC
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
+.+.+.||+|||+++.+|||||..|||++ +.+.|||+|||.+.... +...++|||.|||||++... ..+.|
T Consensus 132 ~~gaL~gLaYLHS~~~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~---PAnsFvGTPywMAPEVILAM-----DEGqY 202 (948)
T KOG0577|consen 132 THGALQGLAYLHSHNRIHRDIKAGNILLS-EPGLVKLADFGSASIMA---PANSFVGTPYWMAPEVILAM-----DEGQY 202 (948)
T ss_pred HHHHHHHHHHHHHhhHHhhhccccceEec-CCCeeeeccccchhhcC---chhcccCCccccchhHheec-----ccccc
Confidence 99999999999999999999999999999 55679999999986543 34566899999999999752 45889
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 165 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+-+.||||||+++.++.-.++|+-+++....++-. -.+..|.++ ..++..++.|+..||+.-|.+|||.++++.
T Consensus 203 dgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 203 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCccceeeccchhhhhhhcCCCccCchHHHHHHHH-HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 99999999999999999999999887765554443 344555554 459999999999999999999999999887
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.79 Aligned_cols=206 Identities=25% Similarity=0.426 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|..++.++ +||||+++++++. ++..|+||||++|++|.+++... +.+++..+..++.|++.||.|||+.|+
T Consensus 40 ~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i 117 (329)
T cd05588 40 DWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGI 117 (329)
T ss_pred HHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4677899999998 6999999999985 55789999999999999988653 569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccC-ccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++... ..........|+..|+|||++.+ ..++.++|+||||+++|+
T Consensus 118 vH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~e 188 (329)
T cd05588 118 IYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFE 188 (329)
T ss_pred EecCCCHHHeEECCC-CCEEECcCccccccccCCCccccccCCccccCHHHHcC--------CCCCCccceechHHHHHH
Confidence 999999999999955 46999999998642 22223334578999999999864 567889999999999999
Q ss_pred HHhCCCCCCCCC-------hHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC------HHHHHH
Q 022347 180 LLTNRLPFEGMS-------NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS------FSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~l~~ 239 (298)
|++|+.||.... ................+|..++.++.+++.+||+.||.+|++ +.++++
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 189 MMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 999999996321 111222233344555677889999999999999999999997 677776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=263.66 Aligned_cols=211 Identities=31% Similarity=0.531 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+++.+|+.++++++||||+++++++.++..+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|
T Consensus 46 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H 125 (260)
T cd05067 46 EAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125 (260)
T ss_pred HHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 46889999999999999999999987778999999999999999987655567899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|++
T Consensus 126 ~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~el 196 (260)
T cd05067 126 RDLRAANILVSET-LCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEI 196 (260)
T ss_pred ccccHHhEEEcCC-CCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc--------CCcCcccchHHHHHHHHHH
Confidence 9999999999955 5699999999875442211 112234568999998864 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
++ |..||.+.+... .............+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus 197 ~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 197 VTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HhCCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 98 999998765433 233333444556667788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=265.90 Aligned_cols=214 Identities=27% Similarity=0.482 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFA 85 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~ 85 (298)
..+.+.+|+.+++.++||||+++++++. .+..++++||+++++|.+++.... ...+++..++.++
T Consensus 51 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (283)
T cd05091 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130 (283)
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 4567889999999999999999999985 457899999999999999985321 1347888999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++.||.|||++|++||||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+ .
T Consensus 131 ~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~ 201 (283)
T cd05091 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--------G 201 (283)
T ss_pred HHHHHHHHHHHHcCccccccchhheEecCC-CceEecccccccccccchheeeccCccCCccccCHHHHhc--------C
Confidence 999999999999999999999999999955 4699999999875432221 122345678999998854 5
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++||||||+++|+|++ |..||.+.... ..............+..++.++.+++.+||+.+|.+||++.+++..|
T Consensus 202 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 202 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 67889999999999999998 88898776543 33444444445566788999999999999999999999999999998
Q ss_pred Hhh
Q 022347 242 NAF 244 (298)
Q Consensus 242 ~~~ 244 (298)
+.|
T Consensus 281 ~~~ 283 (283)
T cd05091 281 RTW 283 (283)
T ss_pred hCC
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=261.79 Aligned_cols=212 Identities=33% Similarity=0.540 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..+++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 125 (261)
T cd05068 46 KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125 (261)
T ss_pred HHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46889999999999999999999884 56789999999999999999765445689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccccc--ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||+|+||+++.+ +.++|+|||++......... ........|+|||.+.+ ..++.++|+||||+++|+
T Consensus 126 H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~e 196 (261)
T cd05068 126 HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY--------NRFSIKSDVWSFGILLTE 196 (261)
T ss_pred eccCCcceEEEcCC-CCEEECCcceEEEccCCcccccCCCcCceeccCcccccc--------CCCCchhhHHHHHHHHHH
Confidence 99999999999955 46999999998754422111 11122357999998764 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+++ |+.||.+..... .............+..++..+.+++.+||+.+|.+||++.++.+.|+.+
T Consensus 197 l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 197 IVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 999 999998765433 2333334444455667899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.10 Aligned_cols=213 Identities=30% Similarity=0.502 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+++.+|+.++++++||||+++++.+.+...++||||+++++|.+++.......+++..+..++.|++.||+|||+.|++|
T Consensus 46 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H 125 (262)
T cd05071 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125 (262)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46889999999999999999999887778899999999999999998654456899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccccc--ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||+|+||+++.+ +.++|+|||.+......... ....++..|+|||...+ ..++.++|+||||+++|++
T Consensus 126 ~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~el 196 (262)
T cd05071 126 RDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTEL 196 (262)
T ss_pred cccCcccEEEcCC-CcEEeccCCceeeccccccccccCCcccceecCHhHhcc--------CCCCchhhHHHHHHHHHHH
Confidence 9999999999954 56999999998754332211 12234567999998754 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
++ |..||.+...... ............+..++..+.+++.+||+.+|.+||++.++++.|+.++
T Consensus 197 lt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 197 TTKGRVPYPGMVNREV-LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HcCCCCCCCCCChHHH-HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99 8889987654333 2333333344456678999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=260.07 Aligned_cols=212 Identities=32% Similarity=0.513 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+.+.+|+.++++++||||+++++++.++..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~ 124 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 35688999999999999999999998777889999999999999999765455689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||+|+||+++.+ +.++|+|||.+........ .....++..|+|||...+ ..++.++||||||+++|+
T Consensus 125 H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~~l~e 195 (260)
T cd05069 125 HRDLRAANILVGDN-LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTE 195 (260)
T ss_pred ecccCcceEEEcCC-CeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc--------CCcChHHHHHHHHHHHHH
Confidence 99999999999954 5699999999875432221 112234567999998754 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+++ |..||.+..+... ............+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus 196 l~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 196 LVTKGRVPYPGMVNREV-LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHhCCCCCCCCCCHHHH-HHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 999 8999987654333 33333444555667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=272.01 Aligned_cols=213 Identities=26% Similarity=0.414 Sum_probs=167.0
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.+++.++||||+++++++. +...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+.||+|
T Consensus 49 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 126 (303)
T cd07869 49 TAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILH 126 (303)
T ss_pred hHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 5668999999999999999999985 55789999999 56888888653 356899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ...++.++|||||||++|+|+
T Consensus 127 ~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~ 198 (303)
T cd07869 127 RDLKPQNLLISDT-GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVEMI 198 (303)
T ss_pred CCCCHHHEEECCC-CCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999954 56999999998643322 22234467889999998753 245788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhc-CC------------C---------CC---------CCCcHHHHHHHHHhhhhCCCC
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHA-RP------------G---------LP---------EDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~-~~------------~---------~~---------~~~~~~l~~li~~~l~~~p~~ 230 (298)
+|..||.+..+............ .+ . .+ ..+++.+.+++.+||+.||.+
T Consensus 199 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~ 278 (303)
T cd07869 199 QGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKN 278 (303)
T ss_pred hCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchh
Confidence 99999987655433332221100 00 0 00 124567899999999999999
Q ss_pred CCCHHHHHHHHHhhhhcc
Q 022347 231 RPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 231 Rps~~~l~~~l~~~~~~~ 248 (298)
|||+.++++ +.++...
T Consensus 279 R~s~~~~l~--h~~f~~~ 294 (303)
T cd07869 279 RLSAQAALS--HEYFSDL 294 (303)
T ss_pred ccCHHHHhc--CcccccC
Confidence 999999998 6666554
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.93 Aligned_cols=213 Identities=31% Similarity=0.530 Sum_probs=184.0
Q ss_pred HHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKL--DLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
-+..|+.+.++|+|.|||+++|.+ +++++-|.||-++||||.+++... -+++ .+..+-.+..||++||.|||+..|
T Consensus 618 PLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~I 696 (1226)
T KOG4279|consen 618 PLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKI 696 (1226)
T ss_pred cHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcce
Confidence 577899999999999999999998 567888999999999999999874 3455 788889999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||.+|+|++...+.+||+|||-+..... .....+..||..|||||++.. +.+.|+.++|||||||++.|
T Consensus 697 VHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDq------G~RGYG~aADIWS~GCT~vE 770 (1226)
T KOG4279|consen 697 VHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQ------GPRGYGKAADIWSFGCTMVE 770 (1226)
T ss_pred eeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhcc------CCcCCCchhhhhhccceeEe
Confidence 99999999999999999999999998875443 334566789999999999975 34789999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHH-HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
|.||++||......+.....+ .-...|++|..++.+++.+|.+|+.++|.+||++.+++. ..++
T Consensus 771 MATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~--DpFl 835 (1226)
T KOG4279|consen 771 MATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ--DPFL 835 (1226)
T ss_pred eccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc--Cccc
Confidence 999999998776555433332 334567889999999999999999999999999999998 4444
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=262.75 Aligned_cols=213 Identities=27% Similarity=0.497 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.++..|+.++++++||||+++++++.+...++++||+++|+|.+++... ...+++..++.|+.|++.||.|||+.|++|
T Consensus 54 ~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH 132 (279)
T cd05111 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVH 132 (279)
T ss_pred HHHHHHHHHHhcCCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 4677899999999999999999998777788999999999999999753 346899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 133 ~dlkp~nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~e 203 (279)
T cd05111 133 RNLAARNILLKSD-SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF--------GRYTHQSDVWSYGVTVWE 203 (279)
T ss_pred cccCcceEEEcCC-CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc--------CCcCchhhHHHHHHHHHH
Confidence 9999999999954 569999999997543221 1122345678999998864 567899999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+++ |..||.+.... ..............+..++..+..++.+||..+|.+|||+.++++.|..+..
T Consensus 204 l~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 204 MMSYGAEPYAGMRPH-EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHcCCCCCCCCCCHH-HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 998 99999775432 2222233334445556678899999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=274.94 Aligned_cols=205 Identities=25% Similarity=0.420 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~gi 100 (298)
.++.+|+.++..++||||+++++++. ++..|+||||++|++|.+++... ..+++..+..++.|++.||.|||+ .||
T Consensus 40 ~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~i 117 (325)
T cd05594 40 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNV 117 (325)
T ss_pred HHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 46678999999999999999999885 56799999999999999988753 468999999999999999999997 799
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++||||||+++|+
T Consensus 118 vHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 188 (325)
T cd05594 118 VYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 188 (325)
T ss_pred EecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc--------CCCCCccccccccceeee
Confidence 999999999999955 4699999999864322 222334568999999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 240 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~ 240 (298)
|++|..||.+.+.... . .........++..+++++.+++.+||+.||.+|+ ++.+++++
T Consensus 189 l~tG~~Pf~~~~~~~~-~-~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 189 MMCGRLPFYNQDHEKL-F-ELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred eccCCCCCCCCCHHHH-H-HHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 9999999987654322 2 2223344566778999999999999999999996 89999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=294.14 Aligned_cols=220 Identities=24% Similarity=0.427 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.+.|..|+.++.+++||||++++++|. ...+|+||||+++++|.++|.... ...+++..++.|+.||+.||.|||
T Consensus 56 ~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH 135 (1021)
T PTZ00266 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135 (1021)
T ss_pred HHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 457889999999999999999999873 246899999999999999997632 246999999999999999999999
Q ss_pred hC-------CCeeecCCCCCEEEcCC----------------CCceEEeccCCCccCccccccccccCccceeccccccc
Q 022347 97 AN-------GIIHRDLKPDNLLLTPD----------------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 153 (298)
Q Consensus 97 ~~-------givH~dik~~Nil~~~~----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 153 (298)
+. +|+|+||||+|||++.+ ...++|+|||++.............+++.|+|||++.+
T Consensus 136 s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred hcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc
Confidence 85 49999999999999632 22489999999986554444445578999999999854
Q ss_pred cccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 154 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 154 ~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
....++.++|||||||++|+|++|..||................. ......++.++.+||..||..+|.+||+
T Consensus 216 ------e~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPS 288 (1021)
T PTZ00266 216 ------ETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPS 288 (1021)
T ss_pred ------cCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcC
Confidence 224578899999999999999999999987665544444332222 1112457899999999999999999999
Q ss_pred HHHHHHHHHhhhhccCC
Q 022347 234 FSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~~~ 250 (298)
+.+++. ..++....+
T Consensus 289 a~QlL~--h~~ik~i~~ 303 (1021)
T PTZ00266 289 ALQCLG--YQIIKNVGP 303 (1021)
T ss_pred HHHHhc--cHHHhhcCC
Confidence 999997 455554443
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.48 Aligned_cols=211 Identities=32% Similarity=0.516 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.+.+|+.++++++||||+++++++.+...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++|
T Consensus 46 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H 125 (260)
T cd05070 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125 (260)
T ss_pred HHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46889999999999999999999987777899999999999999998655556899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||+|+||+++. ++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|++
T Consensus 126 ~di~p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l 196 (260)
T cd05070 126 RDLRSANILVGD-GLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred CCCccceEEEeC-CceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc--------CCCcchhhhHHHHHHHHHH
Confidence 999999999995 45699999999875433221 112234557999998754 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
++ |..||.+.+... .............+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 197 ~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 197 VTKGRVPYPGMNNRE-VLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99 899998765433 233333444556677889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=268.01 Aligned_cols=208 Identities=26% Similarity=0.379 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..|+||||++++++..+... ...+++..++.++.|++.||.|||+.|
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ 120 (287)
T cd07848 43 VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND 120 (287)
T ss_pred chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457789999999999999999999884 5679999999988766655432 356899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++
T Consensus 121 i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil 191 (287)
T cd07848 121 IVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG--------APYGKAVDMWSVGCIL 191 (287)
T ss_pred eecCCCCHHHEEEcCC-CcEEEeeccCcccccccccccccccccccccCCcHHHcC--------CCCCCchhHHhHHHHH
Confidence 9999999999999955 469999999987643322 2223467889999999864 5678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhc-------------------C-C----------CCCCCCcHHHHHHHHHhhhhC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHA-------------------R-P----------GLPEDISPDLAFIVQSCWVED 227 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------~-~----------~~~~~~~~~l~~li~~~l~~~ 227 (298)
|+|++|+.||.+............... . + .....++.++.+++.+||+.|
T Consensus 192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~ 271 (287)
T cd07848 192 GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN 271 (287)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCC
Confidence 999999999987654433222111000 0 0 011236788999999999999
Q ss_pred CCCCCCHHHHHH
Q 022347 228 PNLRPSFSQIIR 239 (298)
Q Consensus 228 p~~Rps~~~l~~ 239 (298)
|.+|||++++++
T Consensus 272 P~~R~s~~~~l~ 283 (287)
T cd07848 272 PTDRYLTEQCLN 283 (287)
T ss_pred cccCCCHHHHhc
Confidence 999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=264.59 Aligned_cols=212 Identities=29% Similarity=0.537 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC-------------CCCCHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-------------NKLDLHVALNFAL 86 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~i~~ 86 (298)
..+.+.+|+.+++.++||||+++++++. .+..+++|||+++++|.+++....+ ..+++..++.++.
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 129 (280)
T cd05092 50 ARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129 (280)
T ss_pred HHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHH
Confidence 3457889999999999999999999885 4578999999999999999976432 3478999999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..
T Consensus 130 qi~~al~~LH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~ 200 (280)
T cd05092 130 QIASGMVYLASLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RK 200 (280)
T ss_pred HHHHHHHHHHHCCeecccccHhhEEEcCC-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--------CC
Confidence 99999999999999999999999999954 5699999999864332211 112234578999998864 56
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++||||||+++|+|++ |..||........ ............+..+++.+.+++.+||+.+|.+||++.++++.|+
T Consensus 201 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 201 FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 7889999999999999998 9999977655433 2333344445556778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=259.45 Aligned_cols=207 Identities=28% Similarity=0.482 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.+++.++||||+++++++. +...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.|
T Consensus 42 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (258)
T cd05078 42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG 120 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999985 467899999999999999997633 35899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCc-------eEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKS-------LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
++|+||||+||+++.++.. ++++|||.+...... ....++..|+|||.+.+ ...++.++||||
T Consensus 121 iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~Diws 190 (258)
T cd05078 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIEN-------PQNLSLAADKWS 190 (258)
T ss_pred eecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccC-------CCCCCchhhHHH
Confidence 9999999999999866543 799999988654332 22356778999998863 235688999999
Q ss_pred HHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 173 FGIVLWELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 173 lG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
||+++|++++|. .||........ .. .......++...+.++.+++.+||+.+|++|||++++++.|
T Consensus 191 lG~~l~~l~~g~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 191 FGTTLWEIFSGGDKPLSALDSQKK-LQ--FYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHcCCCCChhhccHHHH-HH--HHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 999999999984 66655443222 11 22334556667788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=260.79 Aligned_cols=208 Identities=26% Similarity=0.389 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+...|-.||+.++||-++.+|..++ +.+.|+|||||+||+|..+.+....+.|+++.+..++..++.||+|||..|||
T Consensus 122 ~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGiv 201 (459)
T KOG0610|consen 122 KRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIV 201 (459)
T ss_pred HHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhcee
Confidence 47778999999999999999999995 67899999999999999999987778899999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-----------------------------------c-------------
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-----------------------------------T------------- 133 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-----------------------------------~------------- 133 (298)
+|||||+|||+..++ .|.|+||+++..... .
T Consensus 202 YRDLKPENILvredG-HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~ 280 (459)
T KOG0610|consen 202 YRDLKPENILVREDG-HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSL 280 (459)
T ss_pred eccCCcceeEEecCC-cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccc
Confidence 999999999999665 599999999752100 0
Q ss_pred ---------cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022347 134 ---------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204 (298)
Q Consensus 134 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 204 (298)
......+||..|+|||++.| ...+.+.|.|+||+++|||+.|..||.+.++.+...+......
T Consensus 281 p~~~aep~~~RSnSFVGThEYlAPEvI~G--------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l 352 (459)
T KOG0610|consen 281 PELVAEPTGARSNSFVGTHEYLAPEVIRG--------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL 352 (459)
T ss_pred hhhhcCCCCccccccccccccccceeeec--------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC
Confidence 00112368889999999986 5567899999999999999999999999988777777665544
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 022347 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPS----FSQIIR 239 (298)
Q Consensus 205 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~ 239 (298)
.-+....++..+++||+++|.+||.+|.- +.+|-+
T Consensus 353 ~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 353 KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 44444468899999999999999999987 888876
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.21 Aligned_cols=236 Identities=31% Similarity=0.528 Sum_probs=199.4
Q ss_pred CchhhHHHhcCCCCcHHHHHHH------HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC
Q 022347 1 MGKFMKEVLNRGSTSDERALLE------GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP 73 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~~~~~~------~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~ 73 (298)
||.||.++-++..-....+.++ ++|..|..+++.++|||+|+++++|. +.-+|||+|||..|+|.+|+.+...
T Consensus 280 YGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr 359 (1157)
T KOG4278|consen 280 YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNR 359 (1157)
T ss_pred ccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhch
Confidence 6788877777765553333333 47999999999999999999999995 6679999999999999999998766
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccccc--ccCccceeccccc
Q 022347 74 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA--ETGTYRWMAPELY 151 (298)
Q Consensus 74 ~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~y~aPE~~ 151 (298)
..++.-..+.++.||.+|+.||..++++||||-..|+|+.. +..+|+.|||+++.+........ ..-...|.|||-+
T Consensus 360 ~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsL 438 (1157)
T KOG4278|consen 360 SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 438 (1157)
T ss_pred hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccc-cceEEeeccchhhhhcCCceecccCccCcccccCcccc
Confidence 77888888999999999999999999999999999999994 46799999999997654433211 1224589999998
Q ss_pred cccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 152 STVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 152 ~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
.. ..++.++|||+||+++||+.| |-.||.+.+- .+.+.....+.+..-|.++++.+.+|++.||++.|.+
T Consensus 439 Ay--------NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsD 509 (1157)
T KOG4278|consen 439 AY--------NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSD 509 (1157)
T ss_pred cc--------cccccchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCccc
Confidence 65 778999999999999999999 9999998664 3445666678888899999999999999999999999
Q ss_pred CCCHHHHHHHHHhhhh
Q 022347 231 RPSFSQIIRMLNAFLF 246 (298)
Q Consensus 231 Rps~~~l~~~l~~~~~ 246 (298)
||++.++-+.++.++.
T Consensus 510 RPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 510 RPSFAEIHQAFETMFS 525 (1157)
T ss_pred CccHHHHHHHHHHHhc
Confidence 9999999998887653
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.40 Aligned_cols=216 Identities=25% Similarity=0.458 Sum_probs=189.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
....+.+|++.++.++|||||++|.+.. ...+|+|.|.-++|+|.|||-.+ ...+.+..+.+++.||+.|+.|+|+..
T Consensus 60 st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH 138 (864)
T KOG4717|consen 60 STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH 138 (864)
T ss_pred hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh
Confidence 4457889999999999999999999984 45799999999999999999653 467999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCC-CcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~~Di~slG~il~ 178 (298)
+|||||||+|+.+...-+-+||.|||++..+.......+.+|+..|-|||++.| ..| .++.||||||+|+|
T Consensus 139 VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLG--------DsYDAPAVDiWSLGVILy 210 (864)
T KOG4717|consen 139 VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLG--------DSYDAPAVDIWSLGVILY 210 (864)
T ss_pred hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhc--------CccCCcchhhhHHHHHHH
Confidence 999999999999988888899999999999888888888999999999999987 334 46889999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
-|++|+.||+..++.+.+-... ...-..|..++.++++||..||..||.+|.+.+++.. ..|+....
T Consensus 211 MLVCGq~PFqeANDSETLTmIm--DCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s--~~Wlq~~D 277 (864)
T KOG4717|consen 211 MLVCGQPPFQEANDSETLTMIM--DCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS--TSWLQAGD 277 (864)
T ss_pred HHHhCCCccccccchhhhhhhh--cccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc--cccccCCC
Confidence 9999999999877665543332 3345678889999999999999999999999999998 66665543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=279.41 Aligned_cols=233 Identities=26% Similarity=0.343 Sum_probs=184.8
Q ss_pred CchhhHHHhcCCCCcHH------HHHHHHHHHHHHHHHHhCC-C-----Ccccceecee-ecCceeEEEecCCCCCHHHH
Q 022347 1 MGKFMKEVLNRGSTSDE------RALLEGRFIREVNMMSRVK-H-----DNLVKFLGAC-KDPLMVIVTELLPGMSLRKY 67 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h-----p~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~ 67 (298)
||+|+|....+....+. +...-.+...|+.+|..|+ | -|+|+++++| ..+++|||+|.+ ..+|.++
T Consensus 199 FGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYel 277 (586)
T KOG0667|consen 199 FGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYEL 277 (586)
T ss_pred cceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHH
Confidence 56666655555333322 2223335567999999997 4 4999999998 467899999999 6699999
Q ss_pred HhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEc-CCCCceEEeccCCCccCccccccccccCcccee
Q 022347 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWM 146 (298)
Q Consensus 68 l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~ 146 (298)
++.++..+++...+..++.||+.||.+||+.||+|+||||+|||+. .+...|||+|||+++.....-. .++.+..|+
T Consensus 278 lK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYR 355 (586)
T KOG0667|consen 278 LKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYR 355 (586)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce--eeeeccccc
Confidence 9999999999999999999999999999999999999999999996 3334799999999998665444 678899999
Q ss_pred ccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC-------------------
Q 022347 147 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG------------------- 207 (298)
Q Consensus 147 aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------------------- 207 (298)
|||++.| ..|+.+.||||||||+.||++|.+.|.+.+..++........+.|+
T Consensus 356 APEVILG--------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~ 427 (586)
T KOG0667|consen 356 APEVILG--------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKG 427 (586)
T ss_pred cchhhcc--------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCC
Confidence 9999997 7899999999999999999999999988776555443322111110
Q ss_pred -------------------------------CC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 208 -------------------------------LP-----------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 208 -------------------------------~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
.| ..-...+.+++.+||+.||.+|+|+.+.++ +.|+
T Consensus 428 ~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~--Hpfl 505 (586)
T KOG0667|consen 428 FPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN--HPFL 505 (586)
T ss_pred ceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc--Cccc
Confidence 11 011235789999999999999999999998 6666
Q ss_pred h
Q 022347 246 F 246 (298)
Q Consensus 246 ~ 246 (298)
.
T Consensus 506 ~ 506 (586)
T KOG0667|consen 506 T 506 (586)
T ss_pred c
Confidence 5
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=271.18 Aligned_cols=204 Identities=28% Similarity=0.417 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+..|..++..+ +||||+++++++. .+..|+||||++|++|.+++... ..+++..+..++.|++.||+|||+.|+
T Consensus 40 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~i 117 (320)
T cd05590 40 ECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGI 117 (320)
T ss_pred HHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4566888888876 6999999999985 45789999999999999988753 469999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++.... .........|++.|+|||++.+ ..++.++||||||+++|+
T Consensus 118 vH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 188 (320)
T cd05590 118 IYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE--------MLYGPSVDWWAMGVLLYE 188 (320)
T ss_pred EeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC--------CCCCCccchhhhHHHHHH
Confidence 999999999999955 469999999986432 2222334568999999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~l~~ 239 (298)
|++|+.||...+.... ... ........+..++.++.+++.+||+.||.+||++ +++++
T Consensus 189 l~~g~~Pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 189 MLCGHAPFEAENEDDL-FEA-ILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HhhCCCCCCCCCHHHH-HHH-HhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 9999999987664332 222 2334455667789999999999999999999998 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=262.47 Aligned_cols=211 Identities=31% Similarity=0.565 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAM 92 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~i~~qi~~al 92 (298)
..++.+|+.+++.++||||+++++++. +...++||||+++++|.+++..... ..+++..++.++.|++.||
T Consensus 53 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (277)
T cd05062 53 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHH
Confidence 346889999999999999999999985 5678999999999999999975321 2357788999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchh
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
.|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|
T Consensus 133 ~~lH~~~~vH~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~D 203 (277)
T cd05062 133 AYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSD 203 (277)
T ss_pred HHHHHCCcccCCcchheEEEcCC-CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--------CCcCchhH
Confidence 99999999999999999999955 5699999999864332221 112244678999998864 56788999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 170 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 170 i~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|||||+++|+|++ |..||...... ..............+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 204 i~slG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 204 VWSFGVVLWEIATLAEQPYQGMSNE-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 9999999999998 78899776543 333333444455667778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=257.97 Aligned_cols=209 Identities=34% Similarity=0.599 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHhCCCCcccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|+.++++++||||+++++++ .++..++++||+++++|.+++.......+++..++.++.|++.||+|||+.|+
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 123 (256)
T cd05082 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4688999999999999999999975 34568999999999999999987555568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.+ +.++|+|||++....... .....+..|+|||++.+ ..++.++||||||+++|+|
T Consensus 124 ~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~~l 192 (256)
T cd05082 124 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred eccccchheEEEcCC-CcEEecCCccceeccccC--CCCccceeecCHHHHcc--------CCCCchhhhHHHHHHHHHH
Confidence 999999999999955 569999999987533222 22234568999998854 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
++ |+.||..... ............+..+..+++.+.+++.+||+.+|++|||+.++++.|+.
T Consensus 193 ~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 193 YSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HhCCCCCCCCCCH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 97 9999976543 23333333444556667889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=258.52 Aligned_cols=210 Identities=34% Similarity=0.600 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++|+||+++++++. ++..++||||+++++|.+++.......+++..++.++.|++.||.|||+.|+
T Consensus 44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i 123 (256)
T cd05039 44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123 (256)
T ss_pred HHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 457889999999999999999999985 6679999999999999999987544468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.+ +.++|+|||.+........ ....+..|+|||.+.. ..++.++|+||||+++|++
T Consensus 124 ~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~--------~~~~~~~Di~slG~il~~l 192 (256)
T cd05039 124 VHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred cchhcccceEEEeCC-CCEEEcccccccccccccc--cCCCcccccCchhhcC--------CcCCcHHHHHHHHHHHHHH
Confidence 999999999999954 5699999999876532222 2334567999998754 5677899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
++ |..||..... ...............+..+++.+.+++.+||..+|.+|||+.++++.|+.
T Consensus 193 ~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 193 YSFGRVPYPRIPL-KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HhcCCCCCCCCCH-HHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 97 9999976643 33333333444555667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=267.20 Aligned_cols=206 Identities=27% Similarity=0.436 Sum_probs=164.0
Q ss_pred HHHHHHHHHHhC---CCCcccceeceee------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRV---KHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 24 ~~~~E~~~l~~l---~hp~Iv~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+|+.+++.+ +||||+++++++. +...++||||++ ++|.+++.......+++..++.++.|++.||.|
T Consensus 47 ~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 125 (290)
T cd07862 47 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125 (290)
T ss_pred HHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 445666666655 6999999999873 246899999995 699999987555668999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+.|++|+||||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++||||||
T Consensus 126 lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG 196 (290)
T cd07862 126 LHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVG 196 (290)
T ss_pred HHHCCeeeCCCCHHHEEEcCC-CCEEEccccceEeccCCcccccccccccccChHHHhC--------CCCCCccchHHHH
Confidence 999999999999999999955 4699999999876544433445568899999999864 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-------------------------CCCCCCcHHHHHHHHHhhhhCCC
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-------------------------GLPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~ 229 (298)
+++|+|++|..||.+....+...........+ .+...++..+.+++.+||+.+|+
T Consensus 197 ~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 197 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 99999999999998766544333222110000 01134678889999999999999
Q ss_pred CCCCHHHHHH
Q 022347 230 LRPSFSQIIR 239 (298)
Q Consensus 230 ~Rps~~~l~~ 239 (298)
+|||+.++++
T Consensus 277 ~R~s~~~~l~ 286 (290)
T cd07862 277 KRISAYSALS 286 (290)
T ss_pred hcCCHHHHhc
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=264.02 Aligned_cols=213 Identities=23% Similarity=0.381 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
+.+..|+.+++.++||||+++.+++. ++..|+||||++||+|.+++... ....+++..++.++.|++.||.|||+.|
T Consensus 38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 117 (280)
T cd05608 38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117 (280)
T ss_pred HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46778999999999999999999885 55789999999999999887542 2346899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|
T Consensus 118 i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~ 188 (280)
T cd05608 118 IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG--------EEYDFSVDYFALGVTLY 188 (280)
T ss_pred cccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC--------CCCCccccHHHHHHHHH
Confidence 9999999999999854 569999999986543322 2233468899999999865 56788999999999999
Q ss_pred HHHhCCCCCCCCChHHH--HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~~ 246 (298)
+|++|+.||........ ............++..++..+.+++.+||+.+|.+|| +++++++ +.|+.
T Consensus 189 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~--h~~~~ 261 (280)
T cd05608 189 EMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--HPLFR 261 (280)
T ss_pred HHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc--Chhhh
Confidence 99999999976432211 1111122233455677899999999999999999999 7788887 44443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=258.84 Aligned_cols=214 Identities=29% Similarity=0.532 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|+.+++.++||||+++++++ .++..++++||+.+++|.+++... ....++..+..++.|++.||+|||+.|
T Consensus 40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ 118 (262)
T cd05058 40 VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKK 118 (262)
T ss_pred HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34778999999999999999999976 345688999999999999999753 344677888999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||
T Consensus 119 i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 189 (262)
T cd05058 119 FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT--------QKFTTKSDVWSFG 189 (262)
T ss_pred ccccccCcceEEEcCC-CcEEECCccccccccCCcceeecccccCcCCccccChhHhcc--------CccchHHHHHHHH
Confidence 9999999999999955 469999999987432211 1112234668999998754 5678899999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 175 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 175 ~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+++|+|++ |..||..... ............+..+..+++.+.+++.+||..+|++||++.++++.|+.++.
T Consensus 190 ~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 190 VLLWELMTRGAPPYPDVDS-FDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHHcCCCCCCCCCCH-HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 99999999 5666765443 33334444444455566688999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=275.19 Aligned_cols=210 Identities=25% Similarity=0.393 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++||||+++++++. +...|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+.||+
T Consensus 88 ~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~iv 164 (370)
T cd05596 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFI 164 (370)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45778999999999999999999885 4579999999999999999875 4588999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+|||++.+ +.++|+|||++....... ......|++.|+|||++.+.. ....++.++|||||||++|+
T Consensus 165 HrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~DiwSlGvilye 239 (370)
T cd05596 165 HRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG----GDGYYGRECDWWSVGVFLYE 239 (370)
T ss_pred ccCCCHHHEEEcCC-CCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCC----CCCCCCCceeeeehhHHHHH
Confidence 99999999999955 569999999987543322 223456899999999986411 12457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 240 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~--Rps~~~l~~~ 240 (298)
|++|..||.+..................++. .++.++.+++.+||+.+|.+ |+|+++++++
T Consensus 240 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 240 MLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 9999999987654333222222222233343 57999999999999988987 9999999883
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=260.99 Aligned_cols=212 Identities=29% Similarity=0.520 Sum_probs=170.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..+.+.+|+.++++++||||+++++++. +...+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~ 125 (283)
T cd05080 49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHS 125 (283)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999874 2358899999999999999975 459999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||
T Consensus 126 ~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~sl 196 (283)
T cd05080 126 QHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE--------NKFSYASDVWSF 196 (283)
T ss_pred CCeeccccChheEEEcCC-CcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc--------cCCCcccccHHH
Confidence 999999999999999855 5699999999875433221 112234567999998854 567889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHH--------------HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 174 GIVLWELLTNRLPFEGMSNLQ--------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|+++|+|++|..||....... ............+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus 197 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 197 GVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999986533211 011111122233446678899999999999999999999999999
Q ss_pred HHHhh
Q 022347 240 MLNAF 244 (298)
Q Consensus 240 ~l~~~ 244 (298)
.|+.+
T Consensus 277 ~l~~~ 281 (283)
T cd05080 277 ILKEM 281 (283)
T ss_pred HHHHh
Confidence 98865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=258.93 Aligned_cols=212 Identities=35% Similarity=0.627 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~al 92 (298)
..+++.+|+.+++.++|+||+++++++. +...+++|||+++++|.+++.... ...+++..++.++.|++.||
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999985 567999999999999999998742 35689999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
+|||+.|++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.. ..++.++|
T Consensus 119 ~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~D 189 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD--------GIFTSKSD 189 (262)
T ss_pred HHHHcCCcccCccCcceEEECCC-CcEEEcccccccccccccccccccCCCcCccccCHHHhcc--------CCcchhhc
Confidence 99999999999999999999965 569999999998654432 2233456778999998864 46788999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 170 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 170 i~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|||||+++|++++ |..||..... ...............+..++.++.+++.+||+.+|.+|||+.+++++|+
T Consensus 190 i~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 190 VWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999 6999987754 3334444445566677888999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=291.15 Aligned_cols=218 Identities=32% Similarity=0.581 Sum_probs=186.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLR-----PNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+.+|.+|..+++.++||||++++|++ .....+|++|||+||+|..||.+.. +..++....+.++.+|+.|..||
T Consensus 739 ~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL 818 (1025)
T KOG1095|consen 739 VSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL 818 (1025)
T ss_pred HHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH
Confidence 35899999999999999999999998 4556899999999999999998853 34589999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccc--c-ccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--A-ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~--~-~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
+++++|||||..+|+|++.. ..+||+|||+++......... . ..-...|||||.+.. +.++.++||||
T Consensus 819 e~~~fvHRDLAaRNCLL~~~-r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--------~iFtskSDvWs 889 (1025)
T KOG1095|consen 819 ESKHFVHRDLAARNCLLDER-RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--------GIFTSKSDVWS 889 (1025)
T ss_pred HhCCCcCcchhhhheeeccc-CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh--------cccccccchhh
Confidence 99999999999999999966 579999999999433322211 1 123468999999964 88999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 173 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 173 lG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
||+++||+++ |..||.+.++.+.. .....+.+...|..++..+.++|..||+.+|++||++..+++.+........
T Consensus 890 FGVllWEifslG~~PY~~~~n~~v~-~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 890 FGVLLWEIFSLGATPYPSRSNFEVL-LDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred hHHHHHHHHhCCCCCCCCcchHHHH-HHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 9999999999 99999998875554 4345555888889999999999999999999999999999998888765544
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=264.74 Aligned_cols=218 Identities=33% Similarity=0.563 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHH
Q 022347 21 LEGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNF 84 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i 84 (298)
..+.+.+|+.++.++ +||||+++++++. ++..|+||||+++++|.+++.... ...+++..++.+
T Consensus 50 ~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 129 (303)
T cd05088 50 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129 (303)
T ss_pred HHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHH
Confidence 345788999999999 8999999999984 567999999999999999997532 125789999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCC
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
+.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++..............+..|+|||.+.+ ..+
T Consensus 130 ~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~ 200 (303)
T cd05088 130 AADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVY 200 (303)
T ss_pred HHHHHHHHHHHHhCCccccccchheEEecCC-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhc--------cCC
Confidence 9999999999999999999999999999955 4699999999864322222222233567999998754 557
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+.++||||||+++|++++ |..||......+ .............+..+++.+.+++.+||+.+|++||++.+++..|..
T Consensus 201 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 201 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred cccccchhhhhHHHHHHhcCCCCcccCChHH-HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 889999999999999998 999997655432 233333333444556688999999999999999999999999999987
Q ss_pred hhhcc
Q 022347 244 FLFTL 248 (298)
Q Consensus 244 ~~~~~ 248 (298)
.+..-
T Consensus 280 ~~~~~ 284 (303)
T cd05088 280 MLEER 284 (303)
T ss_pred HHHhh
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.75 Aligned_cols=215 Identities=27% Similarity=0.510 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+++.+|+.+++.+.||||+++++++.....++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.|++
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ii 131 (279)
T cd05109 53 NKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45788999999999999999999999777788999999999999999763 34689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 132 H~dlkp~Nil~~~~-~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~ 202 (279)
T cd05109 132 HRDLAARNVLVKSP-NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH--------RRFTHQSDVWSYGVTVW 202 (279)
T ss_pred ccccccceEEEcCC-CcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc--------CCCCchhHHHHHHHHHH
Confidence 99999999999854 4699999999875433221 112234568999998864 56788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 179 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++++ |..||....... .............+..++..+.+++.+||..+|++||++.++++.|......
T Consensus 203 el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 203 ELMTFGAKPYDGIPARE-IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 9998 999997654422 2233333444555677899999999999999999999999999988766443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=262.49 Aligned_cols=211 Identities=32% Similarity=0.583 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAM 92 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~i~~qi~~al 92 (298)
...+.+|+.+++.++||||+++++++. +...++||||+++++|.+++..... ..+++..++.++.|++.||
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 53 RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 346889999999999999999999984 5679999999999999999975322 2368889999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
.|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|
T Consensus 133 ~~lH~~~i~H~di~p~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~D 203 (277)
T cd05032 133 AYLAAKKFVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTKSD 203 (277)
T ss_pred HHHHhCCccccccChheEEEcCC-CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc--------CCCCcccc
Confidence 99999999999999999999965 569999999987543222 1122345678999998754 56788999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 170 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 170 i~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|||||+++|++++ |..||....... .............+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 204 i~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 204 VWSFGVVLWEMATLAEQPYQGLSNEE-VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hHHHHHHHHHhhccCCCCCccCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 9999999999998 999998765433 33333455556677888999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=256.91 Aligned_cols=209 Identities=26% Similarity=0.421 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.++++++||||+++++++. ++..|+||||++|++|.+++.......+++..++.++.|++.||.|||+.|
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~ 121 (256)
T cd08529 42 EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121 (256)
T ss_pred HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999984 567999999999999999998755567999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||++.+ ..++.++|+||||++++
T Consensus 122 i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 192 (256)
T cd08529 122 ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED--------KPYNEKSDVWALGVVLY 192 (256)
T ss_pred cccCCCCcceEEEeCC-CCEEEcccccceeccCccchhhccccCccccCHHHhcC--------CCCCCccchHHHHHHHH
Confidence 9999999999999965 469999999887543322 1223457789999998864 55778999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|++|..||...... ...........+..+..++..+.+++.+||+.+|++||++.++++
T Consensus 193 ~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 193 ECCTGKHPFDANNQG-ALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHhCCCCCCCCCHH-HHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 999999999876543 333334445555666678999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=273.35 Aligned_cols=209 Identities=27% Similarity=0.378 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 21 LEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
..+.+.+|+.++..++ ||||+++++++. ++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~ 124 (332)
T cd05614 47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL 124 (332)
T ss_pred HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3456789999999995 999999999885 55789999999999999998753 4589999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|++||||||+|||++.+ +.++|+|||++....... ......|+..|+|||++.+ ...++.++|||||||+
T Consensus 125 ~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~i 196 (332)
T cd05614 125 GIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGIL 196 (332)
T ss_pred CcEecCCCHHHeEECCC-CCEEEeeCcCCccccccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhh
Confidence 99999999999999955 469999999987533221 2233468999999999864 2346789999999999
Q ss_pred HHHHHhCCCCCCCCC--hHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 177 LWELLTNRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 177 l~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
+|+|++|..||.... ..............+.++..+++.+.+++.+||+.||++|| ++.++++
T Consensus 197 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 197 IFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred hhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 999999999996432 22222333334455667778999999999999999999999 7778887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.61 Aligned_cols=214 Identities=25% Similarity=0.457 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN- 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~- 98 (298)
..+++.+|++++++++||||+++++++. ++..++||||+++++|.+++... +.+++..+..++.|++.||.|||+.
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~ 123 (333)
T cd06650 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 123 (333)
T ss_pred HHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 4457889999999999999999999984 56899999999999999999763 4589999999999999999999975
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+++|+||||+||+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++|+|||||++|
T Consensus 124 ~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~ 193 (333)
T cd06650 124 KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLV 193 (333)
T ss_pred CEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC--------CCCCcHHHHHHHHHHHH
Confidence 79999999999999855 46999999998653221 2233467889999999864 56788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHH-------------------------------------------HHHHhhcCCCCC-CCCcH
Q 022347 179 ELLTNRLPFEGMSNLQAAY-------------------------------------------AAAFKHARPGLP-EDISP 214 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~-~~~~~ 214 (298)
++++|+.||.......... ........+..+ ..++.
T Consensus 194 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (333)
T cd06650 194 EMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGA 273 (333)
T ss_pred HHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCH
Confidence 9999999997543211110 001111112222 23678
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 215 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
++.+|+.+||+.||++|||+.++++ +.++...
T Consensus 274 ~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~ 305 (333)
T cd06650 274 EFQDFVNKCLIKNPAERADLKQLMV--HAFIKRS 305 (333)
T ss_pred HHHHHHHHhccCCcccCcCHHHHhh--CHHHhcC
Confidence 8999999999999999999999987 6666543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=263.38 Aligned_cols=215 Identities=31% Similarity=0.634 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFAL 86 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~ 86 (298)
+++.+|+.+++.+ +||||+++++++. +...+++|||+++++|.+++..... ..+++..+..++.
T Consensus 65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (304)
T cd05101 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY 144 (304)
T ss_pred HHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHH
Confidence 4688999999999 7999999999985 5578999999999999999976322 3477888999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..
T Consensus 145 qi~~al~~LH~~givH~dlkp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~ 215 (304)
T cd05101 145 QVARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------RV 215 (304)
T ss_pred HHHHHHHHHHHCCeeecccccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc--------CC
Confidence 99999999999999999999999999854 5699999999875433221 122344568999998854 56
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++||||||+++|++++ |..||..... ...............+..++..+.+++.+||..+|.+|||+.++++.|+
T Consensus 216 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 216 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 7889999999999999998 7888876543 3333444444455566778999999999999999999999999999998
Q ss_pred hhhhc
Q 022347 243 AFLFT 247 (298)
Q Consensus 243 ~~~~~ 247 (298)
.++.-
T Consensus 295 ~~~~~ 299 (304)
T cd05101 295 RILTL 299 (304)
T ss_pred HHHHh
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=265.40 Aligned_cols=216 Identities=33% Similarity=0.640 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFAL 86 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~ 86 (298)
+++.+|+.+++.+ +||||+++++++. ++..|+||||+++++|.+++..... ..+++..++.++.
T Consensus 68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 147 (307)
T cd05098 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY 147 (307)
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence 4677899999999 7999999999984 5678999999999999999976432 2478899999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|++.||+|||+.|++|+||||+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..
T Consensus 148 qi~~aL~~lH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~ 218 (307)
T cd05098 148 QVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RI 218 (307)
T ss_pred HHHHHHHHHHHCCcccccccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc--------CC
Confidence 99999999999999999999999999965 4699999999875432211 112233468999998864 56
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++|+||||+++|+|++ |..||..... ...............+..++.++.+++.+||..+|.+|||+.++++.|+
T Consensus 219 ~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 219 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred CCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 7889999999999999998 8899876543 3334444444455667788999999999999999999999999999999
Q ss_pred hhhhcc
Q 022347 243 AFLFTL 248 (298)
Q Consensus 243 ~~~~~~ 248 (298)
.++...
T Consensus 298 ~~~~~~ 303 (307)
T cd05098 298 RILALT 303 (307)
T ss_pred HHHHHh
Confidence 887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=273.75 Aligned_cols=211 Identities=24% Similarity=0.403 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||
T Consensus 45 ~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~gi 122 (381)
T cd05626 45 VAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGF 122 (381)
T ss_pred HHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 347889999999999999999999985 55799999999999999999763 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc-----------------------------------------------
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----------------------------------------------- 133 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----------------------------------------------- 133 (298)
+||||||+||+++.+ +.++|+|||++......
T Consensus 123 vHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (381)
T cd05626 123 IHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQ 201 (381)
T ss_pred eecCCcHHHEEECCC-CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccc
Confidence 999999999999955 56999999987422100
Q ss_pred -cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC--C
Q 022347 134 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 210 (298)
Q Consensus 134 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 210 (298)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.....................+ .
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 273 (381)
T cd05626 202 RCLAHSLVGTPNYIAPEVLLR--------KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV 273 (381)
T ss_pred ccccccccCCccccCHHHHcC--------CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCC
Confidence 00112468999999999864 567889999999999999999999998766544333332212222233 3
Q ss_pred CCcHHHHHHHHHhh--hhCCCCCCCHHHHHHHHHhhh
Q 022347 211 DISPDLAFIVQSCW--VEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 211 ~~~~~l~~li~~~l--~~~p~~Rps~~~l~~~l~~~~ 245 (298)
.+++++.+++.+|+ ..++..||++.+++. +.++
T Consensus 274 ~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~--hp~f 308 (381)
T cd05626 274 KLSPEAVDLITKLCCSAEERLGRNGADDIKA--HPFF 308 (381)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhc--Cccc
Confidence 57899999999855 556666999999998 4444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=271.01 Aligned_cols=206 Identities=26% Similarity=0.428 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|+.++.++ +||||+++++++. ++..|+||||+++++|..++... ..+++..+..++.|++.||+|||++|+
T Consensus 40 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i 117 (329)
T cd05618 40 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGI 117 (329)
T ss_pred HHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3567888888877 7999999999985 56799999999999999988653 469999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++..... ........|+..|+|||++.+ ..++.++||||||+++|+
T Consensus 118 vH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 188 (329)
T cd05618 118 IYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFE 188 (329)
T ss_pred eeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccccccCCccccCHHHHcC--------CCCCCccceecccHHHHH
Confidence 999999999999965 4699999999864322 222334568999999999865 567889999999999999
Q ss_pred HHhCCCCCCCCC-------hHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC------HHHHHH
Q 022347 180 LLTNRLPFEGMS-------NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS------FSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~l~~ 239 (298)
|++|..||.... ................+|..++..+.+++.+||+.||.+||+ +.++++
T Consensus 189 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 189 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred HhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 999999995211 111222223334555678889999999999999999999998 467766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=274.50 Aligned_cols=215 Identities=23% Similarity=0.368 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. +...++|+|++ +++|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 128 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~Iv 204 (391)
T PHA03212 128 GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRII 204 (391)
T ss_pred hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 45779999999999999999999885 56789999999 56899988753 4589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc--ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+
T Consensus 205 HrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~e 275 (391)
T PHA03212 205 HRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR--------DPYGPAVDIWSAGIVLFE 275 (391)
T ss_pred cCCCChHhEEEcCC-CCEEEEeCCcccccccccccccccccCccCCCChhhhcC--------CCCCcHHHHHHHHHHHHH
Confidence 99999999999955 4699999999864322 122234468999999999864 567899999999999999
Q ss_pred HHhCCCCCCCCCh------HHHHHHHH----------------------H---hhcCCCCC---------CCCcHHHHHH
Q 022347 180 LLTNRLPFEGMSN------LQAAYAAA----------------------F---KHARPGLP---------EDISPDLAFI 219 (298)
Q Consensus 180 ll~g~~p~~~~~~------~~~~~~~~----------------------~---~~~~~~~~---------~~~~~~l~~l 219 (298)
|++|..||..... ........ . .......+ ..++.++.++
T Consensus 276 lltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L 355 (391)
T PHA03212 276 MATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYL 355 (391)
T ss_pred HHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHH
Confidence 9999987643211 00000000 0 00000000 1246689999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 220 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 220 i~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
+.+||+.||.+|||+.++++ +.++..+..+
T Consensus 356 i~~mL~~dP~~Rpta~elL~--hp~f~~~~~~ 385 (391)
T PHA03212 356 ICKMLAFDAHHRPSAEALLD--FAAFQDIPDP 385 (391)
T ss_pred HHHHhcCChhhCCCHHHHhc--ChhhccCCCC
Confidence 99999999999999999998 7777665443
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.57 Aligned_cols=208 Identities=22% Similarity=0.373 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++|+||+.+.+.+. ++..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.||+
T Consensus 45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ii 124 (285)
T cd05632 45 SMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124 (285)
T ss_pred HHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 45778999999999999999998874 56799999999999999988765555799999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|+||+|+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++|+||||+++|+++
T Consensus 125 H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~ 195 (285)
T cd05632 125 YRDLKPENILLDDY-GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEMI 195 (285)
T ss_pred ecCCCHHHEEECCC-CCEEEecCCcceecCCCCcccCCCCCcCccChHHhcC--------CCCCcccchHHHHHHHHHHH
Confidence 99999999999955 5699999999865433333334568899999999864 56788999999999999999
Q ss_pred hCCCCCCCCChHHHH--HHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 022347 182 TNRLPFEGMSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~ 239 (298)
+|..||......... ............+..++.++.+++..||+.+|.+||+ +.+++.
T Consensus 196 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 196 EGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 999999876543221 1122222334456678899999999999999999999 778877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=257.03 Aligned_cols=209 Identities=29% Similarity=0.548 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ....+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05113 44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFI 122 (256)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46889999999999999999999985 456899999999999999997633 3689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||+|+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 123 H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~~ 193 (256)
T cd05113 123 HRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY--------SKFSSKSDVWAFGVLMWE 193 (256)
T ss_pred ccccCcceEEEcCC-CCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc--------CcccchhHHHHHHHHHHH
Confidence 99999999999954 5699999999875432221 112234567999998864 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|++ |..||....... .........+...+...+..+.+++.+||+.+|.+||++.+++..|+
T Consensus 194 l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 194 VYSLGKMPYERFNNSE-TVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HhcCCCCCcCcCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 998 999998765433 23333444455556678899999999999999999999999998663
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=257.49 Aligned_cols=215 Identities=29% Similarity=0.568 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+.+.+|+.++++++||||+++++++.++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.|+
T Consensus 50 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ 128 (270)
T cd05056 50 VREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRF 128 (270)
T ss_pred HHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4457889999999999999999999998888899999999999999997632 358999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccccc--ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+|+||+|+||+++.+ +.++|+|||++......... ....+...|+|||.+.. ..++.++||||||+++|
T Consensus 129 ~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 199 (270)
T cd05056 129 VHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMW 199 (270)
T ss_pred eccccChheEEEecC-CCeEEccCceeeecccccceecCCCCccccccChhhhcc--------CCCCchhhhHHHHHHHH
Confidence 999999999999954 46999999998754332211 12223457999998754 56788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++++ |..||......... ...........+..++..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus 200 el~~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHcCCCCCCCCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9986 99999876654332 3334444556677889999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=263.80 Aligned_cols=213 Identities=32% Similarity=0.624 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--------------CCCCCCHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFAL 86 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~~i~~ 86 (298)
.++.+|+.+++++ +||||+++++++. ++..+++|||+++++|.+++... ....+++..++.++.
T Consensus 60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 139 (293)
T cd05053 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 4688999999999 7999999999984 56799999999999999999752 234588999999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|++.||.|||+.|++|+||||+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..
T Consensus 140 qi~~al~~LH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~ 210 (293)
T cd05053 140 QVARGMEFLASKKCIHRDLAARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------RV 210 (293)
T ss_pred HHHHHHHHHHHCCccccccceeeEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--------CC
Confidence 99999999999999999999999999955 5699999999875433221 112234567999998754 56
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++||||||+++|++++ |..||.+.... ..............+...+..+.+++.+||..+|++|||+.++++.|+
T Consensus 211 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 211 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred cCcccceeehhhHHHHHhcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 7889999999999999998 99999876543 333444444455566778899999999999999999999999999998
Q ss_pred hhh
Q 022347 243 AFL 245 (298)
Q Consensus 243 ~~~ 245 (298)
.++
T Consensus 290 ~~~ 292 (293)
T cd05053 290 RML 292 (293)
T ss_pred Hhh
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=258.96 Aligned_cols=212 Identities=31% Similarity=0.563 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~L 95 (298)
+..|.+|+.++++++||||+++++++ .....++||||++|++|.+++..... ..+++..++.++.|++.||+||
T Consensus 53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L 132 (277)
T cd05036 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 45688999999999999999999987 45578999999999999999976532 2589999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCC--CceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|+.|++|+||+|+||+++.++ ..++|+|||++........ ......+..|+|||.+.+ ..++.++||
T Consensus 133 H~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di 204 (277)
T cd05036 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--------GIFTSKTDV 204 (277)
T ss_pred HHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc--------CCcCchhHH
Confidence 999999999999999998543 3589999999875432211 112223467999999864 568899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 171 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 171 ~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|||||++|+|++ |..||...... ..............+..++..+.+++.+||+.+|++|||+.+++++|+
T Consensus 205 wslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 205 WSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 999999999997 99999876543 333344444455667778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.25 Aligned_cols=209 Identities=27% Similarity=0.426 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+.+|+.++..++|||+|+++|+- ..+..+|-||||+||+|.+.+.. .+..++.....+..|++.|++|||++|||
T Consensus 1279 ~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIV 1356 (1509)
T KOG4645|consen 1279 KLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIV 1356 (1509)
T ss_pred cchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCce
Confidence 3567999999999999999999986 55678899999999999999986 23467777778889999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
||||||.||+++-+ +.+|++|||.+....... ......||+.|||||++.+.. ...-..+.||||||||
T Consensus 1357 HRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~-----~kG~~~A~DiWslGCV 1430 (1509)
T KOG4645|consen 1357 HRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK-----GKGHGGAADIWSLGCV 1430 (1509)
T ss_pred ecCCCccceeeecC-CcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc-----cCCCCcchhhhcccce
Confidence 99999999999955 589999999998544332 223457999999999998632 1333558999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+.||+||+.||...++.......+--+..|.+|..++++-++||.+||+.||++|.++.|+++
T Consensus 1431 VlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1431 VLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred EEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 999999999999998888888888888899999999999999999999999999999999987
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=278.09 Aligned_cols=218 Identities=26% Similarity=0.425 Sum_probs=181.7
Q ss_pred HHHhcCCCCcHHHHHHHHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHH
Q 022347 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83 (298)
Q Consensus 6 ~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 83 (298)
.|+++++......++ +..+.|..++.... ||.++.++..|+ .+++|+||||+.||++..+.+ ...|++..+.-
T Consensus 398 IK~LKK~~Il~~d~V--e~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarf 472 (694)
T KOG0694|consen 398 IKVLKKGDILQRDEV--ESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARF 472 (694)
T ss_pred EEEeeccceeccccH--HHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHH
Confidence 456666555443332 35567888777775 999999999996 668999999999999544433 37799999999
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCcc
Q 022347 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 84 i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
++..|+.||+|||++||++||||.+|||+|.+| .+||+|||++.... ....+.+.+||+.|+|||++.+ .
T Consensus 473 yaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e--------~ 543 (694)
T KOG0694|consen 473 YAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE--------Q 543 (694)
T ss_pred HHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccCCCCCccccccCChhhcChhhhcc--------C
Confidence 999999999999999999999999999999776 59999999998644 6677888999999999999976 8
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-C----HHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-S----FSQI 237 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s----~~~l 237 (298)
.|+.+.|.|||||+|||||.|+.||++.+.. ..-..+....+..|..+|.+..++++++|..+|++|. + +.+|
T Consensus 544 ~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i 621 (694)
T KOG0694|consen 544 SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDI 621 (694)
T ss_pred cccchhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhh
Confidence 8999999999999999999999999986643 2334445667778889999999999999999999996 3 5666
Q ss_pred HH
Q 022347 238 IR 239 (298)
Q Consensus 238 ~~ 239 (298)
..
T Consensus 622 ~~ 623 (694)
T KOG0694|consen 622 KK 623 (694)
T ss_pred hh
Confidence 55
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=259.03 Aligned_cols=213 Identities=29% Similarity=0.531 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhh----CCCCCCHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSL----RPNKLDLHVALNFALDIAR 90 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~qi~~ 90 (298)
.+.+.+|+.+++.++||||+++++++.. ...++++||+++|+|.+++... ....+++..+..++.|++.
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 123 (272)
T cd05075 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123 (272)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHH
Confidence 3578899999999999999999997621 2468999999999999988532 2244889999999999999
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcc
Q 022347 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 91 al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
||+|||++||+|+||||+||+++.+ +.++|+|||++........ ......+..|++||.+.+ ..++.+
T Consensus 124 ~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~ 194 (272)
T cd05075 124 GMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD--------RVYTTK 194 (272)
T ss_pred HHHHHHHCCeeccccchhheEEcCC-CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC--------CCcChH
Confidence 9999999999999999999999855 4699999999876433221 112235668999998864 567889
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 168 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 168 ~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+||||||+++|++++ |..||...... ..............+..++..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 195 ~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 195 SDVWSFGVTMWEIATRGQTPYPGVENS-EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999 88999775543 33333344444455677889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=264.44 Aligned_cols=216 Identities=31% Similarity=0.631 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFAL 86 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~ 86 (298)
+++.+|+.+++++ +||||+++++++. ++..|++|||+++++|.+++....+ ..+++..+..++.
T Consensus 62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 141 (314)
T cd05099 62 ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141 (314)
T ss_pred HHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHH
Confidence 4678999999999 5999999999885 4578999999999999999976321 3478899999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|++.||.|||++|++|+||||+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..
T Consensus 142 qi~~aL~~lH~~gi~H~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~ 212 (314)
T cd05099 142 QVARGMEYLESRRCIHRDLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------RV 212 (314)
T ss_pred HHHHHHHHHHHCCeeeccccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc--------CC
Confidence 99999999999999999999999999955 4699999999975432211 112233457999998854 56
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++||||||+++|++++ |..||..... ...............+..++..+.+++.+||..+|.+|||+.++++.|.
T Consensus 213 ~~~~~DiwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 213 YTHQSDVWSFGILMWEIFTLGGSPYPGIPV-EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred cCccchhhHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 7889999999999999999 8999976554 3333333344445566778899999999999999999999999999999
Q ss_pred hhhhcc
Q 022347 243 AFLFTL 248 (298)
Q Consensus 243 ~~~~~~ 248 (298)
......
T Consensus 292 ~~~~~~ 297 (314)
T cd05099 292 KVLAAV 297 (314)
T ss_pred HHHHHh
Confidence 876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=267.94 Aligned_cols=204 Identities=27% Similarity=0.410 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|..++..+ +||||+++++++. .+..|+||||++|++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 40 ~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i 117 (318)
T cd05570 40 ECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGI 117 (318)
T ss_pred HHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4567888888888 6999999999885 55799999999999999998763 469999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||||+||+++.+ +.++|+|||++..... ........++..|+|||++.+ ..++.++|||||||++|+
T Consensus 118 vH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslGvil~~ 188 (318)
T cd05570 118 IYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY--------QPYGPAVDWWALGVLLYE 188 (318)
T ss_pred EccCCCHHHeEECCC-CcEEecccCCCeecCcCCCcccceecCccccCHHHhcC--------CCCCcchhhhhHHHHHHH
Confidence 999999999999955 4699999999864222 222233468899999999865 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~ 239 (298)
|++|..||...+..... . .........+..++..+.+++.+||+.||.+||++ .++++
T Consensus 189 l~~G~~pf~~~~~~~~~-~-~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 189 MLAGQSPFEGDDEDELF-Q-SILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HhhCCCCCCCCCHHHHH-H-HHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 99999999876543322 2 22334455677789999999999999999999999 88877
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=284.79 Aligned_cols=211 Identities=24% Similarity=0.413 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHhCC-CCcccceece-e---ec-C---ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGA-C---KD-P---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~-~---~~-~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
+.+++|+.++++|+ |+|||.+++. . .. + ..+|+||||.||+|-|++..+....|++.++++|+.++++|++
T Consensus 79 ~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa 158 (738)
T KOG1989|consen 79 NAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVA 158 (738)
T ss_pred HHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHH
Confidence 36779999999998 9999999993 2 11 1 4789999999999999998766677999999999999999999
Q ss_pred HHHhCC--CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----------ccccccCccceeccccccccccccCCc
Q 022347 94 CLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----------MMTAETGTYRWMAPELYSTVTLRQGEK 161 (298)
Q Consensus 94 ~LH~~g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 161 (298)
+||... |+|||||-+|||++.+ +.+||||||.+....... .......|+.|+|||++.-. .+
T Consensus 159 ~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly-----sg 232 (738)
T KOG1989|consen 159 AMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY-----SG 232 (738)
T ss_pred HHhcCCCccchhhhhhhheEEcCC-CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh-----cC
Confidence 999997 9999999999999955 469999999997432221 11123578999999998642 34
Q ss_pred cCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 162 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 162 ~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
...+.|+|||+|||++|-|+....||+....... ....-.+| ..++..+.+||+.||+.+|++||++.+++.
T Consensus 233 ~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 233 LPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred CCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 6789999999999999999999999987543222 12222233 469999999999999999999999999999
Q ss_pred HHHhhh
Q 022347 240 MLNAFL 245 (298)
Q Consensus 240 ~l~~~~ 245 (298)
.+-.+.
T Consensus 307 ~~~~l~ 312 (738)
T KOG1989|consen 307 EIFELA 312 (738)
T ss_pred HHHHHh
Confidence 887664
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=259.81 Aligned_cols=214 Identities=31% Similarity=0.512 Sum_probs=175.2
Q ss_pred HHHHHHHHHHhCCCCc-ccceeceee-cC------ceeEEEecCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDN-LVKFLGACK-DP------LMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~-Iv~~~~~~~-~~------~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~ 93 (298)
...+|+.+++.++|+| |+.+++++. ++ .+++|+||+ ..+|.+++..... ..++...+..++.||+.||+
T Consensus 56 taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~ 134 (323)
T KOG0594|consen 56 TAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLA 134 (323)
T ss_pred hhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHH
Confidence 4569999999999999 999999973 33 688999999 5599999988553 36888899999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
|||++||+||||||+||+++. .+.+||+|||+++..... .......+|.+|+|||++.+ ...|++..||||
T Consensus 135 ~~H~~~IlHRDLKPQNlLi~~-~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs 206 (323)
T KOG0594|consen 135 FLHSHGILHRDLKPQNLLISS-SGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWS 206 (323)
T ss_pred HHHhCCeecccCCcceEEECC-CCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHh
Confidence 999999999999999999996 457999999999966533 33566688999999999986 357999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC----------------CC------------CCCcHHHHHHHHHhh
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG----------------LP------------EDISPDLAFIVQSCW 224 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----------------~~------------~~~~~~l~~li~~~l 224 (298)
+|||+.||++++..|.+..+.++.......-..|. ++ ....+...+++.+||
T Consensus 207 ~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L 286 (323)
T KOG0594|consen 207 LGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLL 286 (323)
T ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHh
Confidence 99999999999999999887666665543322221 00 112247889999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+.+|.+|.|+...++ +.++...
T Consensus 287 ~y~p~~R~Sa~~al~--h~yf~~~ 308 (323)
T KOG0594|consen 287 QYDPAKRISAKGALT--HPYFSEL 308 (323)
T ss_pred ccCcccCcCHHHHhc--Chhhccc
Confidence 999999999999998 4444444
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=258.06 Aligned_cols=209 Identities=29% Similarity=0.450 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++.+. ++..++||||+++++|.+++.......+++..+..++.+++.+|+|||+.|+
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 122 (256)
T cd08220 43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122 (256)
T ss_pred HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 357889999999999999999999874 5679999999999999999987555568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.++..++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|++
T Consensus 123 ~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l 194 (256)
T cd08220 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG--------KPYNQKSDIWALGCVLYEL 194 (256)
T ss_pred ecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC--------CCCCcccchHHHHHHHHHH
Confidence 99999999999987666789999999986554444444567889999998864 5577899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++|..||...+... ............++..++..+.+++.+||..+|.+|||+.++++
T Consensus 195 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 195 ASLKRAFEAANLPA-LVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HhCCCCcccCchHH-HHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99999998765433 33333344445567778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=258.87 Aligned_cols=207 Identities=24% Similarity=0.402 Sum_probs=166.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
...+|.+|+.+++.++||||+++++++. +...++||||+++++|..++... ...+++..+..++.|++.||+|||+.|
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ 137 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN 137 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 4457889999999999999999999984 56789999999999999998652 346899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCC------CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQ------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
++|+||||+||+++..+ ..++++|||.+...... ....++..|+|||.+.+ ...++.++|||||
T Consensus 138 iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~sl 207 (274)
T cd05076 138 LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSF 207 (274)
T ss_pred ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHH
Confidence 99999999999997432 24799999987543221 22346778999998753 2457889999999
Q ss_pred HHHHHHHH-hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 174 GIVLWELL-TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 174 G~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
|+++|+++ +|..||.......... .. ......+...++.+.+++.+||+.+|.+|||+.++++.|
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKER--FY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHH--HH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99999985 6999997665432211 11 123344555678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=259.07 Aligned_cols=213 Identities=28% Similarity=0.498 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..++|.+|+.++++++||||+++++++. +...++||||+++++|.+++... .+.+++..++.++.|++.||.|||+.|
T Consensus 48 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g 126 (269)
T cd05065 48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN 126 (269)
T ss_pred HHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999984 55789999999999999998763 356899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccccccc------ccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA------ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
++|+||+|+||+++.+ ..++|+|||++........... ...+..|+|||.+.+ ..++.++|||||
T Consensus 127 ~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dvwsl 197 (269)
T cd05065 127 YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--------RKFTSASDVWSY 197 (269)
T ss_pred EeecccChheEEEcCC-CcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc--------Ccccchhhhhhh
Confidence 9999999999999854 5699999998864332211111 112347999998864 567889999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 174 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 174 G~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
|+++|++++ |..||........ ............+..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 198 G~~l~e~l~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 198 GIVMWEVMSYGERPYWDMSNQDV-INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHhcCCCCCCCCCCHHHH-HHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999886 9999987654332 333333344455667899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=257.17 Aligned_cols=211 Identities=34% Similarity=0.546 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.+.+|+.++++++|+||+++++.+.+...+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|
T Consensus 46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H 125 (260)
T cd05073 46 EAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125 (260)
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 57889999999999999999999987778899999999999999998655566889999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||+|+||+++.+ +.++|+|||.+........ .....++..|+|||.+.. ..++.++|+||||+++|++
T Consensus 126 ~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l 196 (260)
T cd05073 126 RDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEI 196 (260)
T ss_pred cccCcceEEEcCC-CcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc--------CCcCccccchHHHHHHHHH
Confidence 9999999999854 5799999998865432211 112234567999998864 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
++ |..||........ ............+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 197 ~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 197 VTYGRIPYPGMSNPEV-IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HhcCCCCCCCCCHHHH-HHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 98 9999987654332 23333333445556788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=255.44 Aligned_cols=211 Identities=33% Similarity=0.600 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+..+.+|+.++++++||||+++++++. .+..++||||+++++|.+++... ...+++..+..++.+++.||.|||+.|
T Consensus 35 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ 113 (250)
T cd05085 35 LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN 113 (250)
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999999985 55789999999999999998753 345889999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc--ccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
++|+||+|+||+++.+ +.++|+|||++......... ....++..|+|||++.. ..++.++||||||+++
T Consensus 114 ~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ll 184 (250)
T cd05085 114 CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY--------GRYSSESDVWSYGILL 184 (250)
T ss_pred eeecccChheEEEcCC-CeEEECCCccceeccccccccCCCCCCcccccCHHHhcc--------CCCCchhHHHHHHHHH
Confidence 9999999999999855 46999999998643322111 11233567999998864 5678899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 178 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|++++ |..||........ ............+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 185 ~~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 185 WETFSLGVCPYPGMTNQQA-REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHhcCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 99998 9999987654332 3333444455666778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=257.42 Aligned_cols=208 Identities=25% Similarity=0.411 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
....|.+|+.+++.++||||+++++++. +...+++|||+++++|..++.. ....+++..++.++.|++.||+|||+.|
T Consensus 47 ~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (262)
T cd05077 47 ISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKD 125 (262)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 4457888999999999999999999985 5578999999999999998865 2345899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCC------ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQK------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
++|+||||+||+++.++. .++++|||++...... ....++..|+|||.+.. ...++.++|||||
T Consensus 126 ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~Diwsl 195 (262)
T cd05077 126 LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVED-------SKNLSIAADKWSF 195 (262)
T ss_pred eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcC-------CCCCCchhHHHHH
Confidence 999999999999985432 2899999988654322 22356778999998752 2567889999999
Q ss_pred HHHHHHHH-hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 174 GIVLWELL-TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 174 G~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|+++|+|+ .|..||......... .. ...........+.++.+++.+||+.+|.+||++.++++.++
T Consensus 196 G~~l~el~~~~~~p~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 196 GTTLWEICYNGEIPLKDKTLAEKE--RF-YEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHHHHHhCCCCCCCCcchhHHH--HH-HhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 99999998 488888765432211 11 11222233345688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=257.05 Aligned_cols=212 Identities=28% Similarity=0.494 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++.+++. .+..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.|+
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i 128 (268)
T cd05063 50 RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNY 128 (268)
T ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 457889999999999999999999984 56789999999999999999763 3568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccccc----ccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|+||||+||+++.+ ..++|+|||++......... .....+..|+|||.+.. ..++.++||||||++
T Consensus 129 ~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~i 199 (268)
T cd05063 129 VHRDLAARNILVNSN-LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIV 199 (268)
T ss_pred eccccchhhEEEcCC-CcEEECCCccceecccccccceeccCCCcCceecCHHHhhc--------CCcChHhHHHHHHHH
Confidence 999999999999954 56999999998754322111 11122457999998864 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|++++ |..||....... ...........+.+..++..+.+++.+||+.+|++||++.++++.|+..
T Consensus 200 l~ell~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 200 MWEVMSFGERPYWDMSNHE-VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHhCCCCCCCcCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999997 999997655433 3333333344455567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=258.10 Aligned_cols=209 Identities=28% Similarity=0.544 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
....+.+.+|+.++++++||||+++++++. +...++++||+++++|.+++... ..+++..+..++.|++.||+|||+
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~ 124 (267)
T cd06628 47 RSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN 124 (267)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh
Confidence 344567889999999999999999999984 56789999999999999999763 458899999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-------ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
.|++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+
T Consensus 125 ~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv 195 (267)
T cd06628 125 RGIIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--------TSYTRKADI 195 (267)
T ss_pred cCcccccCCHHHEEEcCC-CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc--------CCCCchhhh
Confidence 999999999999999854 569999999987543211 1112346788999998864 567889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
||||+++|++++|+.||......... ........+.++..++..+.+++.+||+++|.+||++.++++
T Consensus 196 ~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 196 WSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 99999999999999999876554332 223334456677789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.43 Aligned_cols=216 Identities=25% Similarity=0.381 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.++.+|+.++++++||||+++++++.. ...|+||||+ +++|.+++... ..+++..+..++.|++.||.|||
T Consensus 44 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 44 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred HHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHH
Confidence 367899999999999999999998732 2479999999 56999998753 45899999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
+.||+|+||||+||+++.+ +.++|+|||++....... ......++..|+|||++.+ ....++.++||||
T Consensus 121 ~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~~DvwS 193 (338)
T cd07859 121 TANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS------FFSKYTPAIDIWS 193 (338)
T ss_pred HCCeecCCCCHHHeEECCC-CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc------cccccCchhHHHH
Confidence 9999999999999999955 569999999987532221 1123468899999998753 1246788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHH----------------------HHhhcCC----C---CCCCCcHHHHHHHHHh
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAA----------------------AFKHARP----G---LPEDISPDLAFIVQSC 223 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~----------------------~~~~~~~----~---~~~~~~~~l~~li~~~ 223 (298)
|||++|+|++|+.||.+.+........ ....... . ....+++.+.+++.+|
T Consensus 194 lGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 273 (338)
T cd07859 194 IGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERL 273 (338)
T ss_pred HHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHH
Confidence 999999999999999765432211100 0000000 0 0124678899999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 224 WVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 224 l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
|+.+|++|||++++++ +.|+.....
T Consensus 274 l~~~P~~Rpt~~e~l~--hp~f~~~~~ 298 (338)
T cd07859 274 LAFDPKDRPTAEEALA--DPYFKGLAK 298 (338)
T ss_pred cCcCcccCCCHHHHhc--CchhhhcCc
Confidence 9999999999999998 677765544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=268.32 Aligned_cols=204 Identities=26% Similarity=0.378 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+..|..++..+ +||||+++++++. ++..|+||||+++++|..++... ..+++..+..++.|++.||.|||+.||
T Consensus 40 ~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i 117 (321)
T cd05591 40 DCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGV 117 (321)
T ss_pred HHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3566888888866 7999999999985 55799999999999999988753 468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++..... ........|+..|+|||++.+ ..++.++||||||+++|+
T Consensus 118 vHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~e 188 (321)
T cd05591 118 IYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE--------LEYGPSVDWWALGVLMYE 188 (321)
T ss_pred eccCCCHHHeEECCC-CCEEEeecccceecccCCccccccccCccccCHHHHcC--------CCCCCccceechhHHHHH
Confidence 999999999999965 4699999999864322 222234468899999998864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-------CHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-------SFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-------s~~~l~~ 239 (298)
|++|+.||...+..... ... .......+..++.++.+++.+||+.+|.+|| ++.++++
T Consensus 189 l~tg~~Pf~~~~~~~~~-~~i-~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 189 MMAGQPPFEADNEDDLF-ESI-LHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HhcCCCCCCCCCHHHHH-HHH-HcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 99999999876643332 222 2333445667899999999999999999999 8888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=271.60 Aligned_cols=201 Identities=29% Similarity=0.466 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.++.+|+.++++++||||+++++++. ++..|+||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~ 120 (318)
T cd05582 43 VRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGII 120 (318)
T ss_pred HHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 35678999999999999999999985 56799999999999999998653 4589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++...... .......|+..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 121 H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 191 (318)
T cd05582 121 YRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEM 191 (318)
T ss_pred cCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC--------CCCCCccceeccceEeeee
Confidence 99999999999955 46999999998754333 22334568899999999864 5568899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (298)
++|+.||........... .......++..+++.+.+++.+||+.||.+||++.+
T Consensus 192 ~tg~~p~~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 192 LTGSLPFQGKDRKETMTM--ILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ccCCCCCCCCCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 999999987654333222 223344567788999999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=266.90 Aligned_cols=224 Identities=25% Similarity=0.412 Sum_probs=176.4
Q ss_pred HHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHH
Q 022347 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84 (298)
Q Consensus 6 ~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i 84 (298)
.|++++... ..+.+++ .++.|=.+|....+|.||+++..|++ .++||||||++||++..+|... ..+++..+...
T Consensus 171 mK~LkKS~M-~~~~Qv~-hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfY 246 (550)
T KOG0605|consen 171 MKILKKSEM-LKKNQVE-HVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFY 246 (550)
T ss_pred eecccHHHH-HhhhhHH-HHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHH
Confidence 344544332 2233333 66788899999999999999999975 5899999999999999999863 56999999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcc----------------------cc-c------
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV----------------------TE-M------ 135 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~----------------------~~-~------ 135 (298)
+.+++.|+..||+.|++||||||+|+|+|.+| .+||+|||++..... .. .
T Consensus 247 iaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (550)
T KOG0605|consen 247 IAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPR 325 (550)
T ss_pred HHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcccccccccc
Confidence 99999999999999999999999999999765 599999999852100 00 0
Q ss_pred -------------------cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 022347 136 -------------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196 (298)
Q Consensus 136 -------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 196 (298)
.....|||.|+|||++.+ ..|+..+|.|||||||||||.|.+||.+.+.....
T Consensus 326 ~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--------kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~ 397 (550)
T KOG0605|consen 326 STMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--------KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETY 397 (550)
T ss_pred chhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 012269999999999986 67899999999999999999999999987776555
Q ss_pred HHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCC---CHHHHHHHHHhhh
Q 022347 197 YAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRP---SFSQIIRMLNAFL 245 (298)
Q Consensus 197 ~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~l~~~~ 245 (298)
.+...-.....+| ...+++..+||.+||. ||++|. .+.||-+ +.+.
T Consensus 398 rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~--HPfF 448 (550)
T KOG0605|consen 398 RKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK--HPFF 448 (550)
T ss_pred HHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc--CCcc
Confidence 5444322222233 4578999999999999 999996 5777766 4443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=261.95 Aligned_cols=207 Identities=28% Similarity=0.441 Sum_probs=163.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+.+|+.++++++||||+++++++. ++..++||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 125 (288)
T cd07871 48 CTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125 (288)
T ss_pred hhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 35678999999999999999999985 4578999999965 999988753 34578999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||+|+++|+|
T Consensus 126 H~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l 197 (288)
T cd07871 126 HRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYEM 197 (288)
T ss_pred cCCCCHHHEEECCC-CCEEECcCcceeeccCCCccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHHH
Confidence 99999999999955 469999999987533222 2233467889999998753 24578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcC--------------------C--------CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHAR--------------------P--------GLPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~--------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
++|+.||.+.+..+........... + .....++.++.+|+.+||+.||.+||
T Consensus 198 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~ 277 (288)
T cd07871 198 ATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI 277 (288)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC
Confidence 9999999876543332211110000 0 01124678899999999999999999
Q ss_pred CHHHHHH
Q 022347 233 SFSQIIR 239 (298)
Q Consensus 233 s~~~l~~ 239 (298)
|++++++
T Consensus 278 t~~~~l~ 284 (288)
T cd07871 278 SAEAALR 284 (288)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=254.97 Aligned_cols=208 Identities=33% Similarity=0.617 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. .+..++||||++|++|.+++.... ..+++..++.++.|++.||+|||+.|++
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 122 (256)
T cd05059 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFI 122 (256)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46778999999999999999999884 557899999999999999997633 3689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccccc--ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||+|+||+++.+ +.++|+|||.+......... ....++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 123 H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~il~~ 193 (256)
T cd05059 123 HRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY--------SRFSSKSDVWSFGVLMWE 193 (256)
T ss_pred cccccHhhEEECCC-CcEEECCcccceecccccccccCCCCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHH
Confidence 99999999999955 56999999998754322211 11123357999998864 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
+++ |..||........ ............+..++.++.+++.+||..+|++|||+.++++.|
T Consensus 194 l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 194 VFSEGKMPYERFSNSEV-VESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HhccCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 999 8999976654333 333444445566677899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=257.82 Aligned_cols=212 Identities=31% Similarity=0.586 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec-C------ceeEEEecCCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD-P------LMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARA 91 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~------~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~a 91 (298)
+.+.+|+..++.++||||+++++++.. . ..++++||+++++|..++.... ...+++..++.++.|++.|
T Consensus 46 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~a 125 (273)
T cd05035 46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125 (273)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHH
Confidence 478899999999999999999998632 2 3789999999999999985532 2458999999999999999
Q ss_pred HHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcch
Q 022347 92 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168 (298)
Q Consensus 92 l~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~ 168 (298)
|.|||+.|++|+||||+||+++.+ +.++|+|||++........ ......+..|+|||.+.+ ..++.++
T Consensus 126 L~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~ 196 (273)
T cd05035 126 MEYLSNRNFIHRDLAARNCMLRED-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKS 196 (273)
T ss_pred HHHHHhCCeeccccchheEEECCC-CeEEECCccceeeccccccccccccccCCccccCHhhccc--------CCCCccc
Confidence 999999999999999999999955 4699999999875433221 111234567999998754 5678899
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 169 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 169 Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
||||||+++|++++ |..||.+..+.+ .............+..++..+.+++.+||+.+|.+|||+.+++..|+.+
T Consensus 197 Dv~SlG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 197 DVWAFGVTMWEIATRGQTPYPGVENHE-IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred chHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999 899998765533 3344444556667788999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=245.08 Aligned_cols=217 Identities=24% Similarity=0.394 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHhCCCCcccceecee----ec--CceeEEEecCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGAC----KD--PLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~----~~--~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~ 94 (298)
+..++|++..++++||||++++++. .| ...|++++|+..|||.+.+...+. ..+++.++++|+.++++||.+
T Consensus 63 e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~ 142 (302)
T KOG2345|consen 63 EEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEA 142 (302)
T ss_pred HHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHH
Confidence 4677999999999999999999986 11 258999999999999999987543 358999999999999999999
Q ss_pred HHhCC--CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----------cccccCccceeccccccccccccCCcc
Q 022347 95 LHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----------MTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 95 LH~~g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
||+.. ++|+||||.||++.. .+.+++.|||.+......-. ......|..|+|||.+.- ....
T Consensus 143 lH~~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v-----k~~~ 216 (302)
T KOG2345|consen 143 LHEKEPPYAHRDIKPANILLSD-SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV-----KSHC 216 (302)
T ss_pred HhccCCcccccCCCcceeEecC-CCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec-----ccCc
Confidence 99998 999999999999995 45699999999874322111 112246789999999864 1235
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
..+.++|||||||++|.|+.|..||+...................+| ..+|..+.++++.||+.||.+||++.+++..
T Consensus 217 ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 217 TITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 67889999999999999999999996322111101111111111222 3389999999999999999999999999999
Q ss_pred HHhhh
Q 022347 241 LNAFL 245 (298)
Q Consensus 241 l~~~~ 245 (298)
++.++
T Consensus 297 ~d~Li 301 (302)
T KOG2345|consen 297 LDDLI 301 (302)
T ss_pred HHhhc
Confidence 88654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=270.94 Aligned_cols=214 Identities=32% Similarity=0.549 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC---------------------------
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------------------- 73 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------------------- 73 (298)
+.+.+|+.++.++. ||||+++++++. .+..++||||+++|+|.+++.....
T Consensus 85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (401)
T cd05107 85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR 164 (401)
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence 46889999999998 999999999985 4578999999999999999965321
Q ss_pred ---------------------------------------------------------------------CCCCHHHHHHH
Q 022347 74 ---------------------------------------------------------------------NKLDLHVALNF 84 (298)
Q Consensus 74 ---------------------------------------------------------------------~~~~~~~~~~i 84 (298)
..+++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 244 (401)
T cd05107 165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF 244 (401)
T ss_pred ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence 13567788999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCc
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEK 161 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~ 161 (298)
+.|++.||.|||+.|++|+||||+||+++. ...++|+|||++....... ......++..|+|||.+..
T Consensus 245 ~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------- 315 (401)
T cd05107 245 SYQVANGMEFLASKNCVHRDLAARNVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-------- 315 (401)
T ss_pred HHHHHHHHHHHhcCCcCcccCCcceEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--------
Confidence 999999999999999999999999999995 4579999999987532211 1122345678999998864
Q ss_pred cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 162 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 162 ~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
..++.++||||||+++|+|++ |..||.................++..+..++.++.+++.+||..+|.+||++.+|+..
T Consensus 316 ~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 316 NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 567889999999999999998 8999977655444444444555566677889999999999999999999999999999
Q ss_pred HHhhh
Q 022347 241 LNAFL 245 (298)
Q Consensus 241 l~~~~ 245 (298)
|+..+
T Consensus 396 L~~~~ 400 (401)
T cd05107 396 VGDLL 400 (401)
T ss_pred HHHHh
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=263.76 Aligned_cols=217 Identities=33% Similarity=0.621 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~ 85 (298)
.+++.+|+.+++++ +||||+++++++. ++..++++||+++++|.+++.... ...+++..+..++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (334)
T cd05100 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA 140 (334)
T ss_pred HHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 35788999999999 7999999999984 557899999999999999997532 1347888999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ .
T Consensus 141 ~qi~~al~~LH~~givH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~ 211 (334)
T cd05100 141 YQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------R 211 (334)
T ss_pred HHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--------C
Confidence 999999999999999999999999999955 4699999999875433221 112233467999998864 5
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++||||||+++|+|++ |..||.+.+. ...............+..++.++.+++.+||+.+|.+|||+.++++.|
T Consensus 212 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 67889999999999999998 8899976543 333334444445556677899999999999999999999999999999
Q ss_pred Hhhhhcc
Q 022347 242 NAFLFTL 248 (298)
Q Consensus 242 ~~~~~~~ 248 (298)
+......
T Consensus 291 ~~~~~~~ 297 (334)
T cd05100 291 DRVLTVT 297 (334)
T ss_pred HHHhhhc
Confidence 9887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=274.19 Aligned_cols=206 Identities=22% Similarity=0.375 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. +...|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.||
T Consensus 45 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi 122 (377)
T cd05629 45 LAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGF 122 (377)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 346889999999999999999999985 45799999999999999999753 568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc----------------------------------------------
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---------------------------------------------- 134 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---------------------------------------------- 134 (298)
+||||||+||+++.+ +.++|+|||++.......
T Consensus 123 vHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (377)
T cd05629 123 IHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNR 201 (377)
T ss_pred eccCCCHHHEEECCC-CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence 999999999999955 569999999985221100
Q ss_pred --ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC--
Q 022347 135 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-- 210 (298)
Q Consensus 135 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 210 (298)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....................++.
T Consensus 202 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 273 (377)
T cd05629 202 RLMAYSTVGTPDYIAPEIFLQ--------QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI 273 (377)
T ss_pred cccccccCCCccccCHHHHcc--------CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCC
Confidence 0002358899999999864 5678899999999999999999999987654333222221112223333
Q ss_pred CCcHHHHHHHHHhhhhCCCCC---CCHHHHHH
Q 022347 211 DISPDLAFIVQSCWVEDPNLR---PSFSQIIR 239 (298)
Q Consensus 211 ~~~~~l~~li~~~l~~~p~~R---ps~~~l~~ 239 (298)
.++.++.+++.+||. +|.+| +++.++++
T Consensus 274 ~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 274 HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 478999999999997 67765 59999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=257.86 Aligned_cols=211 Identities=33% Similarity=0.628 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-----PNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
..+.+|+.+++.++||||+++++++. +...++||||+++++|.+++.... ...+++..++.++.|++.||.|||
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 123 (269)
T cd05044 44 KEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123 (269)
T ss_pred HHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999884 557899999999999999997532 234788999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCC----CceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchh
Q 022347 97 ANGIIHRDLKPDNLLLTPDQ----KSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~----~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
+.|++|+||+|+||+++.++ ..++|+|||++........ ......+..|+|||.+.+ ..++.++|
T Consensus 124 ~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~D 195 (269)
T cd05044 124 QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD--------GKFTTQSD 195 (269)
T ss_pred hCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc--------CCcccchh
Confidence 99999999999999998544 2699999999875432211 112244678999998864 56788999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 170 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 170 i~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|||||+++|+|++ |..||....+.. .............+..++..+.+++.+||..+|.+||++.++++.|+
T Consensus 196 v~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 196 VWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHHHHHHHHcCCCCCcccCHHH-HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9999999999998 999998665433 23333334445556778999999999999999999999999999876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.61 Aligned_cols=206 Identities=26% Similarity=0.415 Sum_probs=168.8
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|+.++.++ +||||+.+++++. .+..|+||||++|++|.+++... +.+++..+..++.|++.||+|||++|+
T Consensus 40 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i 117 (327)
T cd05617 40 DWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGI 117 (327)
T ss_pred HHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4677899999888 5999999999885 55789999999999999988753 469999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++.... .........|++.|+|||++.+ ..++.++||||||+++|+
T Consensus 118 vHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~e 188 (327)
T cd05617 118 IYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFE 188 (327)
T ss_pred eccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceecccCCcccCCHHHHCC--------CCCCchheeehhHHHHHH
Confidence 999999999999955 469999999987422 2223344568999999999864 667889999999999999
Q ss_pred HHhCCCCCCCCC-----hHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC------HHHHHH
Q 022347 180 LLTNRLPFEGMS-----NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS------FSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~l~~ 239 (298)
|++|..||.... +...............+|..++..+.+++.+||+.||.+|++ +.++.+
T Consensus 189 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 189 MMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred HHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 999999996321 112222333344455677889999999999999999999997 457765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=268.60 Aligned_cols=203 Identities=28% Similarity=0.385 Sum_probs=164.5
Q ss_pred HHHHHHH-HHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVN-MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~-~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++..|.. +++.++||||+++++.+. ++..|+||||++|++|.+++... ..+++..+..++.||+.||.|||+.||+
T Consensus 41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~giv 118 (323)
T cd05575 41 HIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118 (323)
T ss_pred HHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 4444544 567899999999999885 56799999999999999998753 4689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 119 H~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 189 (323)
T cd05575 119 YRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK--------QPYDRTVDWWCLGAVLYEM 189 (323)
T ss_pred eCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccccccCChhhcChhhhcC--------CCCCccccccccchhhhhh
Confidence 99999999999955 4699999999864322 222334468999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH----HHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS----QIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~----~l~~ 239 (298)
++|..||...+.... .... ......++..+++.+.+++.+||+.+|.+||++. ++++
T Consensus 190 l~g~~pf~~~~~~~~-~~~i-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 190 LYGLPPFYSRDTAEM-YDNI-LNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred hcCCCCCCCCCHHHH-HHHH-HcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 999999987654332 2222 2334456677899999999999999999999874 5554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=262.01 Aligned_cols=213 Identities=26% Similarity=0.420 Sum_probs=170.5
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..+.+|+.+++++ +||||+++++++.+ ...|++|||+++++|.+++.......+++..+..++.|++.||+|
T Consensus 47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~ 126 (272)
T cd06637 47 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126 (272)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 4677899999998 69999999998742 358899999999999999987555678999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
||+.|++|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||++.... .....++.++|+||+
T Consensus 127 LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~Dv~sl 202 (272)
T cd06637 127 LHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSL 202 (272)
T ss_pred HHHCCCccCCCCHHHEEECCC-CCEEEccCCCceecccccccCCcccccccccCHhHhcccc---CcCCCCCchhhHHHH
Confidence 999999999999999999955 46999999998754322 2223346788999999886311 112467889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|+++|+|++|..||........................++..+.+++.+||..+|.+|||+.+++.
T Consensus 203 Gv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 203 GITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 999999999999997655443333322222222334467899999999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=265.23 Aligned_cols=203 Identities=30% Similarity=0.467 Sum_probs=166.0
Q ss_pred HHHHHHHHHHh-CCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSR-VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~-l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+..|..++.. ++||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.|++
T Consensus 41 ~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~iv 118 (316)
T cd05619 41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIV 118 (316)
T ss_pred HHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 45567777776 48999999999985 55789999999999999999753 4589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|+..|+|||++.+ ..++.++|||||||++|+|
T Consensus 119 Hrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 189 (316)
T cd05619 119 YRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG--------QKYNTSVDWWSFGVLLYEM 189 (316)
T ss_pred eCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC--------CCCCchhhhhhHHHHHHHH
Confidence 99999999999965 4699999999864322 122234468899999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~ 239 (298)
++|..||...+..... .. .....+..+..++.++.+++.+||+.+|.+||++. ++.+
T Consensus 190 ~~G~~pf~~~~~~~~~-~~-i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 190 LIGQSPFHGHDEEELF-QS-IRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HhCCCCCCCCCHHHHH-HH-HHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 9999999876543322 22 22334556667899999999999999999999996 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=267.05 Aligned_cols=203 Identities=24% Similarity=0.393 Sum_probs=166.2
Q ss_pred HHHHHHHHHH---HhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMM---SRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l---~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
+.+.+|+.++ +.++||||+++++++. ++..|+||||++|++|..++.. ..+++..++.++.|++.||+|||+.
T Consensus 44 ~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 44 ESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred HHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3555666554 5678999999999985 5679999999999999988864 5699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++||||||+||+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++||||||+++
T Consensus 121 ~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il 191 (324)
T cd05589 121 KIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLI 191 (324)
T ss_pred CeEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC--------CCCCcccchhhHHHHH
Confidence 99999999999999965 4699999999864322 222334568999999999864 5678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
|+|++|..||.+.+....... ........+..+++.+.+++.+||+.+|.+|| ++.++++
T Consensus 192 ~el~~G~~pf~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 192 YEMLVGESPFPGDDEEEVFDS--IVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHhCCCCCCCCCHHHHHHH--HHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 999999999987654333222 23334556778999999999999999999999 5777776
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=265.15 Aligned_cols=213 Identities=30% Similarity=0.441 Sum_probs=182.5
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|+.+|+++. ||||+.+++.|++ ...++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|+
T Consensus 80 ~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gv 156 (382)
T KOG0032|consen 80 EDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGV 156 (382)
T ss_pred HHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 46779999999999 9999999999964 5799999999999999999875 39999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCC---CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQ---KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+|+||||+|+|+.... ..++++|||++............+||+.|+|||++.. ..|+..+||||+|+++
T Consensus 157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~--------~~y~~~~DiWS~Gvi~ 228 (382)
T KOG0032|consen 157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG--------RPYGDEVDVWSIGVIL 228 (382)
T ss_pred eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC--------CCCCcccchhHHHHHH
Confidence 9999999999997442 3699999999998777667778899999999999864 7899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|.|++|..||.+............... .....+.++..+.+++..|+..||..|+|+.++++ +.|+...
T Consensus 229 yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~--HpWi~~~ 299 (382)
T KOG0032|consen 229 YILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ--HPWIKSI 299 (382)
T ss_pred HHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc--CccccCC
Confidence 999999999998775544443322211 22333568999999999999999999999999999 4665543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=257.16 Aligned_cols=215 Identities=28% Similarity=0.547 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+++.+|+.++++++||||+++++++.+...++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.|+
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i 130 (279)
T cd05057 52 ANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRL 130 (279)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4457889999999999999999999997788999999999999999997632 358999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccccc---ccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+|+||+|+||+++.+ +.++|+|||.+......... ....++..|+|||.+.. ..++.++|+||||+++
T Consensus 131 ~H~di~p~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l 201 (279)
T cd05057 131 VHRDLAARNVLVKTP-QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH--------RIYTHKSDVWSYGVTV 201 (279)
T ss_pred EecccCcceEEEcCC-CeEEECCCcccccccCcccceecCCCcccccccCHHHhhc--------CCcCchhhHHHHHHHH
Confidence 999999999999854 46999999998754332211 11223457999998754 5678899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 178 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++++ |..||.+.... ..............+...+..+.+++.+||..+|..||++.++++.|..+..
T Consensus 202 ~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 202 WELMTFGAKPYEGIPAV-EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHhcCCCCCCCCCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99998 99999876543 3333334444455666788999999999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=266.60 Aligned_cols=209 Identities=28% Similarity=0.425 Sum_probs=163.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+++.+|+.++++++||||+++++++.. ...|+||||+++ +|.+++. ..+++..+..++.|++.||.|
T Consensus 64 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~ 138 (359)
T cd07876 64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKH 138 (359)
T ss_pred HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHH
Confidence 3467799999999999999999998732 247999999955 6777664 348889999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+.||+||||||+||+++.+ +.++|+|||++.............++..|+|||++.+ ..++.++||||||
T Consensus 139 LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG 209 (359)
T cd07876 139 LHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVG 209 (359)
T ss_pred HHhCCcccCCCCHHHEEECCC-CCEEEecCCCccccccCccCCCCcccCCCCCchhccC--------CCCCcchhhHHHH
Confidence 999999999999999999955 4699999999976444434445578899999999865 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHH--------------------hhcCCC--------------------CCCCCcH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAF--------------------KHARPG--------------------LPEDISP 214 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~--------------------~~~~~~--------------------~~~~~~~ 214 (298)
+++|+|++|+.||.+.+.......... ....+. .....++
T Consensus 210 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (359)
T cd07876 210 CIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTS 289 (359)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccch
Confidence 999999999999987654322111100 000010 1112457
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 215 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
.+.+|+.+||..||++|||+.++++ +.++.
T Consensus 290 ~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~ 319 (359)
T cd07876 290 QARDLLSKMLVIDPDKRISVDEALR--HPYIT 319 (359)
T ss_pred hHHHHHHHHhccCcccCCCHHHHhc--Cchhh
Confidence 7899999999999999999999998 44543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.58 Aligned_cols=215 Identities=25% Similarity=0.406 Sum_probs=168.4
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++. ++..++||||+++ +|.+++... ...+++..+..++.|++.||+|||+.||+|
T Consensus 50 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH 127 (309)
T cd07872 50 TAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127 (309)
T ss_pred hHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 5668999999999999999999984 5679999999965 898888653 345889999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|+
T Consensus 128 ~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~ 199 (309)
T cd07872 128 RDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFEMA 199 (309)
T ss_pred CCCCHHHEEECCC-CCEEECccccceecCCCccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999955 569999999987533222 2223457889999998753 245788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhh---------------------cCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKH---------------------ARP-------GLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~---------------------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
+|+.||.+.+..+......... ... .....+++++.+++.+||+.||.+|||
T Consensus 200 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 279 (309)
T cd07872 200 SGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS 279 (309)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC
Confidence 9999998755432221111000 000 011246788999999999999999999
Q ss_pred HHHHHHHHHhhhhccCC
Q 022347 234 FSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~~~ 250 (298)
+.++++ +.++..+..
T Consensus 280 ~~e~l~--h~~~~~~~~ 294 (309)
T cd07872 280 AEEAMK--HAYFRSLGT 294 (309)
T ss_pred HHHHhc--Chhhhhccc
Confidence 999998 666665543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=271.33 Aligned_cols=206 Identities=26% Similarity=0.413 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++..++||||+++++++. ++..|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.|+
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 45 IAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred HHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 346889999999999999999999885 56799999999999999999864 569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc------------------------------ccccccCccceecccc
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE------------------------------MMTAETGTYRWMAPEL 150 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~ 150 (298)
+||||||+||+++.+ +.++|+|||++....... ......|++.|+|||+
T Consensus 123 iH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 201 (350)
T cd05573 123 IHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV 201 (350)
T ss_pred eccCCCHHHeEECCC-CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHH
Confidence 999999999999965 469999999987544332 2233468899999999
Q ss_pred ccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH--hhcCCCCCCCCcHHHHHHHHHhhhhCC
Q 022347 151 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF--KHARPGLPEDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p 228 (298)
+.+ ..++.++|||||||++|+|++|+.||.............. .....+....+++++.++|.+||. +|
T Consensus 202 ~~~--------~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 202 LRG--------TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred HcC--------CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Ch
Confidence 865 5788999999999999999999999987764443333222 111122223369999999999998 99
Q ss_pred CCCCC-HHHHHH
Q 022347 229 NLRPS-FSQIIR 239 (298)
Q Consensus 229 ~~Rps-~~~l~~ 239 (298)
.+||+ +.++++
T Consensus 273 ~~R~~s~~~ll~ 284 (350)
T cd05573 273 EDRLGSFEEIKS 284 (350)
T ss_pred hhcCCCHHHHhc
Confidence 99999 999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=256.62 Aligned_cols=219 Identities=29% Similarity=0.468 Sum_probs=167.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH 96 (298)
....+.+|+.+++.++||||+++++.+. ....++||||+++|+|.+++..... ...++..+..++.|++.||+|||
T Consensus 38 ~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 117 (269)
T cd05042 38 EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999885 5579999999999999999976432 23567888999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
+.|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||++...... .....++.++|||||
T Consensus 118 ~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~Diwsl 195 (269)
T cd05042 118 QADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD-LLPKDQTKKSNIWSL 195 (269)
T ss_pred hcCEecccccHhheEecCC-CcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc-ccccccchhhHHHHH
Confidence 9999999999999999955 469999999986432221 11222345679999987531110 012456889999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHhh----cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 174 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKH----ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 174 G~il~~ll~-g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
|+++|+|++ |..||....+........... ..+..+..++..+.+++..|| .+|++|||+++|++.|.
T Consensus 196 G~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 196 GVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 999999999 788988765544333322211 122344568889999999998 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=259.77 Aligned_cols=208 Identities=23% Similarity=0.395 Sum_probs=172.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++|++|+.+++.+. ++..|+||||++|++|.+++.......+++..+..++.|++.||.|||+.|++
T Consensus 45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ii 124 (285)
T cd05630 45 SMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124 (285)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 45678999999999999999999884 56799999999999999998765555699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|+||||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++||||+|+++|+|+
T Consensus 125 H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~ 195 (285)
T cd05630 125 YRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMI 195 (285)
T ss_pred eCCCCHHHEEECCC-CCEEEeeccceeecCCCccccCCCCCccccChHHHcC--------CCCCCccccHHHHHHHHHHH
Confidence 99999999999955 4699999999875443333334468899999999864 56788999999999999999
Q ss_pred hCCCCCCCCChH--HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 022347 182 TNRLPFEGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~ 239 (298)
+|..||...... ...............+..+++++.+++..||+.+|.+||| +.++++
T Consensus 196 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 196 AGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 999999865431 1122222233334456778999999999999999999999 889988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=255.99 Aligned_cols=208 Identities=27% Similarity=0.437 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++.+. ++..|++|||+++++|.+++.......+++..++.++.|++.||.|||+.|+
T Consensus 42 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 121 (255)
T cd08219 42 VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121 (255)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 346778999999999999999999985 5689999999999999999876555668999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++++|||.+........ .....++..|+|||++.+ ..++.++|+||||+++|+
T Consensus 122 ~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~ 192 (255)
T cd08219 122 LHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN--------MPYNNKSDIWSLGCILYE 192 (255)
T ss_pred ccCCCCcceEEECCC-CcEEEcccCcceeecccccccccccCCccccCHHHHcc--------CCcCchhhhhhhchhhee
Confidence 999999999999855 5699999999875433221 223457888999998854 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|..||...+.... ............+..++..+.+++.+||+.+|++|||+.+++.
T Consensus 193 l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 193 LCTLKHPFQANSWKNL-ILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred hhhccCCCCCCCHHHH-HHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 9999999987554332 3333344455567778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=264.21 Aligned_cols=218 Identities=20% Similarity=0.348 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.+++.++||||+++++++. ++..|+||||+++++|.+++..+....+++..++.++.|++.||+|||+.|
T Consensus 42 ~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 121 (327)
T cd08227 42 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121 (327)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456778999999999999999999984 567999999999999999997655556899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
++|+||||+||+++.++ .++++||+......... ......++..|+|||++.+ ....++.++|||
T Consensus 122 iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diw 194 (327)
T cd08227 122 YVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIY 194 (327)
T ss_pred EecCCCChhhEEEecCC-cEEEcccchhhccccccccccccccccccccceecccChHHhhc------ccCCCCchhhHH
Confidence 99999999999999554 69999998654221110 1112245667999999864 113578899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC--------------------------------------------CC
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--------------------------------------------PG 207 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------------------~~ 207 (298)
||||++|+|++|..||.................. ..
T Consensus 195 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (327)
T cd08227 195 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHP 274 (327)
T ss_pred HHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccc
Confidence 9999999999999999765433222111110000 00
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 208 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 208 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
....+++.+.+++.+||+.||++|||++++++ +.++..
T Consensus 275 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~--~p~f~~ 312 (327)
T cd08227 275 YNRTFSPHFHHFVEQCLQRNPDARPSASTLLN--HSFFKQ 312 (327)
T ss_pred cccccCHHHHHHHHHHHhhCchhcCCHHHHhc--Chhhhh
Confidence 11235678999999999999999999999998 444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=271.36 Aligned_cols=215 Identities=26% Similarity=0.410 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++++. +...|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+.||
T Consensus 87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~I 163 (370)
T cd05621 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGL 163 (370)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345778999999999999999999985 5579999999999999999975 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+||||||+||+++.+ +.++|+|||++....... ......|++.|+|||++.+. .....++.++|||||||++|
T Consensus 164 vHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ily 238 (370)
T cd05621 164 IHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLF 238 (370)
T ss_pred EecCCCHHHEEECCC-CCEEEEecccceecccCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHH
Confidence 999999999999955 569999999987543222 12345689999999998641 11234788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCC--CCCCHHHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPN--LRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~--~Rps~~~l~~~l~~~~~ 246 (298)
+|++|..||...+................++. .++..+.+++..||..++. .|+++.++++ +.|+.
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~--hp~~~ 308 (370)
T cd05621 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ--HPFFK 308 (370)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc--CcccC
Confidence 99999999987665443333322222333443 4689999999999975544 3889999998 45543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=268.88 Aligned_cols=207 Identities=25% Similarity=0.381 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++.+++||||+++++.+. +...|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.||
T Consensus 45 ~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~gi 122 (363)
T cd05628 45 VGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGF 122 (363)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 346788999999999999999999986 45789999999999999999753 569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc------------------------------------ccccccCccc
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE------------------------------------MMTAETGTYR 144 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~------------------------------------~~~~~~~~~~ 144 (298)
+||||||+||+++.+ +.++|+|||++....... ......||+.
T Consensus 123 vHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~ 201 (363)
T cd05628 123 IHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPD 201 (363)
T ss_pred EecCCCHHHeEECCC-CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcc
Confidence 999999999999965 469999999986432110 0123468999
Q ss_pred eeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHH
Q 022347 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQS 222 (298)
Q Consensus 145 y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~ 222 (298)
|+|||++.+ ..++.++|||||||++|+|++|..||.+..................++. .+++++.+++.+
T Consensus 202 Y~aPE~~~~--------~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~ 273 (363)
T cd05628 202 YIAPEVFMQ--------TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILR 273 (363)
T ss_pred ccCHHHHcC--------CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHH
Confidence 999999864 5678899999999999999999999987665433322221112222332 478899999998
Q ss_pred hhh--hCCCCCCCHHHHHH
Q 022347 223 CWV--EDPNLRPSFSQIIR 239 (298)
Q Consensus 223 ~l~--~~p~~Rps~~~l~~ 239 (298)
|+. .++..||+++++++
T Consensus 274 l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 274 FCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred HcCChhhcCCCCCHHHHhC
Confidence 664 23345689999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=260.82 Aligned_cols=215 Identities=28% Similarity=0.549 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..++.+|+.++++++||||+++++++.+...++++||+++|+|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iv 131 (303)
T cd05110 53 NVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLV 131 (303)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEcCCCceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence 34688999999999999999999998777788999999999999998763 23589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 132 H~dikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~ 202 (303)
T cd05110 132 HRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTIW 202 (303)
T ss_pred ccccccceeeecCC-CceEEccccccccccCcccccccCCCccccccCCHHHhcc--------CCCChHHHHHHHHHHHH
Confidence 99999999999854 4699999999975433221 112234568999998854 66788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 179 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++++ |..||.+... ...............+..++..+.+++..||..+|++||++.++++.|+.+...
T Consensus 203 el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 203 ELMTFGGKPYDGIPT-REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHhCCCCCCCCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9997 9999976543 222223333334445566888999999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.82 Aligned_cols=206 Identities=23% Similarity=0.416 Sum_probs=166.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++..++||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.||
T Consensus 45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~i 122 (364)
T cd05599 45 VAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGY 122 (364)
T ss_pred HHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 346778999999999999999999985 55799999999999999999763 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc---------------------------------------ccccccC
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---------------------------------------MMTAETG 141 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---------------------------------------~~~~~~~ 141 (298)
+||||||+||+++.+ +.++|+|||++....... ......|
T Consensus 123 vH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 201 (364)
T cd05599 123 IHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG 201 (364)
T ss_pred EeccCCHHHeEECCC-CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence 999999999999955 469999999986422110 0012358
Q ss_pred ccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC--CCcHHHHHH
Q 022347 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFI 219 (298)
Q Consensus 142 ~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l 219 (298)
|+.|+|||++.. ..++.++|||||||++|+|++|..||.+..................++. .+++++.++
T Consensus 202 t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 273 (364)
T cd05599 202 TPDYIAPEVFLQ--------TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDL 273 (364)
T ss_pred CccccCHHHHcC--------CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHH
Confidence 999999998864 5678899999999999999999999987665433322221111222232 478999999
Q ss_pred HHHhhhhCCCCCCC---HHHHHH
Q 022347 220 VQSCWVEDPNLRPS---FSQIIR 239 (298)
Q Consensus 220 i~~~l~~~p~~Rps---~~~l~~ 239 (298)
|.+|+. +|.+|++ +.++++
T Consensus 274 i~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 274 IKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHHHcc-CHhhcCCCCCHHHHhc
Confidence 999997 9999997 999887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.90 Aligned_cols=209 Identities=29% Similarity=0.460 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec--C-------ceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD--P-------LMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIAR 90 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~-------~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~ 90 (298)
..++.+|+..+..++|+||+++...+.. . ..++||||+++|+|.+++.... ...+++..+..++.|++.
T Consensus 75 ~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~ 154 (496)
T PTZ00283 75 KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154 (496)
T ss_pred HHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHH
Confidence 3467899999999999999998876521 1 3689999999999999997532 346899999999999999
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcc
Q 022347 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 91 al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
||+|||+.||+||||||+||+++.+ +.++|+|||++...... .......|++.|+|||++.+ ..++.+
T Consensus 155 aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~k 225 (496)
T PTZ00283 155 AVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--------KPYSKK 225 (496)
T ss_pred HHHHHHhCCEecCCCCHHHEEEeCC-CCEEEEecccCeeccccccccccccccCCcceeCHHHhCC--------CCCCcH
Confidence 9999999999999999999999955 56999999998754321 12234568999999999864 568899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 168 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 168 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
+||||||+++|+|++|+.||...+.. .............++..+++++.+++.+||+.+|.+||++.+++++
T Consensus 226 ~DVwSlGvilyeLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 226 ADMFSLGVLLYELLTLKRPFDGENME-EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 99999999999999999999875543 3334444445556778899999999999999999999999999874
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=271.09 Aligned_cols=211 Identities=27% Similarity=0.526 Sum_probs=186.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
++|..|+.+|+.|+||||+++++++.+ ...-+|+|.+..|+|..|++.+ +.++...+..|+.||+.||.|||++.
T Consensus 86 eR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~ 163 (632)
T KOG0584|consen 86 ERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQD 163 (632)
T ss_pred HHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCC
Confidence 488999999999999999999999843 2477999999999999999975 45888999999999999999999985
Q ss_pred --CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 --IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 --ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|+|||||.+||||+.+-+.|||+|+|++.......... .+|||.|||||++. ..|+...||||||+.|
T Consensus 164 PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks-vIGTPEFMAPEmYE---------E~YnE~VDVYaFGMCm 233 (632)
T KOG0584|consen 164 PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS-VIGTPEFMAPEMYE---------ENYNELVDVYAFGMCM 233 (632)
T ss_pred CCccccccccceEEEcCCcCceeecchhHHHHhhccccce-eccCccccChHHHh---------hhcchhhhhhhhhHHH
Confidence 99999999999999888999999999998755544433 79999999999985 6899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+||+|+..||....+..+.++.+..+..|. +...-.+++++||.+||.. ...|||+.++|. +.++...
T Consensus 234 LEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~d 302 (632)
T KOG0584|consen 234 LEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDED 302 (632)
T ss_pred HHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhccc
Confidence 999999999999988888888888877764 3444578999999999999 999999999998 6666543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.53 Aligned_cols=209 Identities=32% Similarity=0.593 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.+.+|+.++++++||||+++++++.++..+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|
T Consensus 44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H 123 (254)
T cd05083 44 QAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123 (254)
T ss_pred HHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 47889999999999999999999987777899999999999999998655556899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
|||+|+||+++.+ +.++|+|||++...... .........|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 124 ~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~el~~ 192 (254)
T cd05083 124 RDLAARNILVSED-GVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH--------KKFSSKSDVWSYGVLLWEVFS 192 (254)
T ss_pred cccCcceEEEcCC-CcEEECCCccceecccc--CCCCCCCceecCHHHhcc--------CCcCchhhHHHHHHHHHHHHh
Confidence 9999999999855 46999999998653321 112234567999998754 567889999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 183 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 183 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
|..||....... .............+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 193 ~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 193 YGRAPYPKMSLKE-VKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCccCCHHH-HHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 999998765433 233333344445566789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=265.16 Aligned_cols=199 Identities=28% Similarity=0.370 Sum_probs=162.8
Q ss_pred HHHHHHH-HHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVN-MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~-~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++..|.. +++.++||||+++++.+. .+..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+.||+
T Consensus 41 ~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~iv 118 (321)
T cd05603 41 HIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNII 118 (321)
T ss_pred HHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 4555554 678899999999999885 5579999999999999998875 34588999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 119 H~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 189 (321)
T cd05603 119 YRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK--------EPYDRTVDWWCLGAVLYEM 189 (321)
T ss_pred eccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC--------CCCCCcCcccccchhhhhh
Confidence 99999999999965 4699999999875322 222334468899999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (298)
++|..||...+... .... .......++...+..+.+++.+||+.+|.+||++.
T Consensus 190 ~~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 190 LYGLPPFYSRDVSQ-MYDN-ILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hcCCCCCCCCCHHH-HHHH-HhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 99999998765432 2222 23345567778899999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=272.37 Aligned_cols=206 Identities=23% Similarity=0.415 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++.+. ++..|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.||
T Consensus 45 ~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~i 122 (382)
T cd05625 45 VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGF 122 (382)
T ss_pred HHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 447889999999999999999999985 55799999999999999998753 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc-----------------------------------------------
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----------------------------------------------- 133 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----------------------------------------------- 133 (298)
+||||||+|||++.+ +.++|+|||++......
T Consensus 123 vHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (382)
T cd05625 123 IHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQ 201 (382)
T ss_pred ecCCCCHHHEEECCC-CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 999999999999955 46999999987421100
Q ss_pred -cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC--C
Q 022347 134 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 210 (298)
Q Consensus 134 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 210 (298)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.................+ .
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 273 (382)
T cd05625 202 RCLAHSLVGTPNYIAPEVLLR--------TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQA 273 (382)
T ss_pred cccccccccCcccCCHHHhcC--------CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcc
Confidence 00112358899999999864 567889999999999999999999998776544433333212222222 4
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 022347 211 DISPDLAFIVQSCWVEDPNLRPS---FSQIIR 239 (298)
Q Consensus 211 ~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 239 (298)
.+++++.+++.+|+. +|.+|++ +.++++
T Consensus 274 ~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 274 KLSPEASDLIIKLCR-GPEDRLGKNGADEIKA 304 (382)
T ss_pred cCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhc
Confidence 578999999999874 9999987 888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=254.15 Aligned_cols=208 Identities=30% Similarity=0.476 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|+.++++++||||+++++.+. +...|++|||+++++|.+++.......+++.+++.++.+++.||++||+.|
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ 122 (257)
T cd08223 43 RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122 (257)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 446789999999999999999998874 346889999999999999998755566899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+||||++++
T Consensus 123 i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ 193 (257)
T cd08223 123 ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVY 193 (257)
T ss_pred eeccCCCchhEEEecC-CcEEEecccceEEecccCCccccccCCcCccChhHhcC--------CCCCchhhhHHHHHHHH
Confidence 9999999999999954 569999999986543221 2233457889999998864 56778999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++++|..||...+... ..........+..+..+++.+.+++.+||+.+|.+|||+.+++.
T Consensus 194 ~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 194 EMATLKHAFNAKDMNS-LVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHcCCCCCCCCCHHH-HHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 9999999998655433 22333444445566778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=257.04 Aligned_cols=213 Identities=28% Similarity=0.557 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC-------CCCCHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-------NKLDLHVALNFALDIARAM 92 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~i~~qi~~al 92 (298)
..+++.+|+.++++++||||+++++++. .+..|+||||+++++|.+++..... ..+++..+..++.|++.||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 4457889999999999999999999985 4678999999999999999976441 2589999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
+|||+.|++|+||||+||+++.+ +.++++|||++....... ......++..|+|||.+.+ ...+.++||
T Consensus 131 ~~LH~~~i~H~dlkp~Nili~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di 201 (275)
T cd05046 131 DHLSNARFVHRDLAARNCLVSSQ-REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--------DDFSTKSDV 201 (275)
T ss_pred HHhhhcCcccCcCccceEEEeCC-CcEEEcccccccccCcccccccCCceeEEeecChhhhcc--------CCCCchhhH
Confidence 99999999999999999999965 469999999986432211 1122345667999998754 456789999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 171 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 171 ~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
||||+++|++++ |..||.....................+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 202 ~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 202 WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 999999999998 888997655433333322222233445678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=269.49 Aligned_cols=214 Identities=24% Similarity=0.365 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.+++.++||||+++++++. ++..|+||||++|++|.+++... ...+++..+..++.|++.||.|||+.|
T Consensus 44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ 122 (330)
T cd05601 44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG 122 (330)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456889999999999999999999885 55789999999999999999763 346999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|+||||||+||+++.+ +.++|+|||++........ .....+++.|+|||++...... ....++.++||||||+++
T Consensus 123 i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il 199 (330)
T cd05601 123 YVHRDIKPENVLIDRT-GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD--GKGTYGVECDWWSLGVIA 199 (330)
T ss_pred eEcccCchHheEECCC-CCEEeccCCCCeECCCCCceeeecccCCccccCHHHhcccccc--ccCCCCCcceeeccccee
Confidence 9999999999999955 4699999999875433221 2234688999999998642211 135678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|+|++|..||....................++ ..+++.+.+++..||. +|.+|||+.++++
T Consensus 200 ~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 200 YEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred eeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 99999999998765543332222111112222 3578999999999998 9999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=258.25 Aligned_cols=217 Identities=27% Similarity=0.435 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++||||+++++++. ++..++|+||+++++|..++.. ....+++..+..++.|++.||.|||+.|++
T Consensus 47 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~ 125 (282)
T cd06643 47 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKII 125 (282)
T ss_pred HHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46789999999999999999999874 5678999999999999998764 235689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||++.... .....++.++|+||+|+++|+|
T Consensus 126 H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvil~el 201 (282)
T cd06643 126 HRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEM 201 (282)
T ss_pred ecCCCcccEEEccC-CCEEEccccccccccccccccccccccccccCHhhccccC---CCCCCCCccchhhhHHHHHHHH
Confidence 99999999999855 56999999998654322 1223346788999999875311 1235577899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++|..||................ .....+..++.++.+++.+||+.+|.+||++.++++ +.++.
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 266 (282)
T cd06643 202 AQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ--HPFVT 266 (282)
T ss_pred ccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CCCEe
Confidence 99999998765444333322111 122345568899999999999999999999999987 44433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=264.99 Aligned_cols=203 Identities=30% Similarity=0.447 Sum_probs=166.1
Q ss_pred HHHHHHHHHHh-CCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSR-VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~-l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+..|..++.. .+||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+
T Consensus 41 ~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~iv 118 (316)
T cd05592 41 CTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGII 118 (316)
T ss_pred HHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 44556666664 47999999999885 55799999999999999998763 4689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 119 H~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 189 (316)
T cd05592 119 YRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG--------QKYNESVDWWSFGVLLYEM 189 (316)
T ss_pred eCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC--------CCCCCcccchhHHHHHHHH
Confidence 99999999999955 4699999999874322 222334468999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~ 239 (298)
++|..||.+.+..... . ......+.++..++.++.+++.+||+.+|.+||++. ++++
T Consensus 190 l~G~~Pf~~~~~~~~~-~-~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 190 LIGQSPFHGEDEDELF-D-SILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HhCCCCCCCCCHHHHH-H-HHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 9999999876653322 2 233455667778999999999999999999999865 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=254.47 Aligned_cols=217 Identities=29% Similarity=0.462 Sum_probs=165.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
..+.+|+.++++++||||+++++++. ....++||||+++++|.+++..... ...++..+..++.|++.||+|||+.
T Consensus 40 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 119 (269)
T cd05087 40 MKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119 (269)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 46889999999999999999999885 4568999999999999999975332 2456778889999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|++|+||||+||+++.+ +.++|+|||.+........ .....++..|+|||++...... .....++.++|+||||+
T Consensus 120 ~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~ 197 (269)
T cd05087 120 NFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN-LLVVDQTKESNVWSLGV 197 (269)
T ss_pred CEeccccCcceEEEcCC-CcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccc-ccccCCCccchhHHHHH
Confidence 99999999999999954 5699999999865332221 1223456789999988531100 00124678999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhh----cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKH----ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 176 il~~ll~-g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++|+|++ |..||......+......... ..+......++.+.+++..|| .+|++|||+++|+..|.
T Consensus 198 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 198 TIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 9999996 999998765544322221111 112233357788999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=256.09 Aligned_cols=211 Identities=28% Similarity=0.496 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKL--DLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++. ++..++++||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.
T Consensus 49 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~ 127 (268)
T cd06624 49 VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN 127 (268)
T ss_pred HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence 347889999999999999999999985 567899999999999999997632 234 7888999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++|+||+|+||+++.+.+.++|+|||.+....... ......++..|+|||.+.. ....++.++|+||+|+++
T Consensus 128 ~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slGvvl 201 (268)
T cd06624 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK------GPRGYGAPADIWSLGCTI 201 (268)
T ss_pred CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhcc------ccccCCchhhhHHHHHHH
Confidence 999999999999998656689999999986543222 1223357889999998754 123467899999999999
Q ss_pred HHHHhCCCCCCCCChHH-HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 178 WELLTNRLPFEGMSNLQ-AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++++|..||....... ...........+.++..+++++.+++.+||+.+|.+|||+.++++
T Consensus 202 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 202 VEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 99999999997654322 222222233445667788999999999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=254.82 Aligned_cols=208 Identities=33% Similarity=0.569 Sum_probs=172.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++|+||+++.+++. ++..++++||++|++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (265)
T cd06631 45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC 122 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999999985 56789999999999999999753 45889999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcc-------ccccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
++|+||+|+||+++.+ +.++|+|||.+..... ........++..|+|||.+.+ ..++.++|+||
T Consensus 123 i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~s 193 (265)
T cd06631 123 VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE--------SGYGRKSDIWS 193 (265)
T ss_pred cccCCcCHHhEEECCC-CeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC--------CCCcchhhHHH
Confidence 9999999999999954 5699999998864321 111123457889999999864 55778999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
||+++|++++|..||...+........... ...+..+..++.++.+++.+||+.+|.+||++.++++
T Consensus 194 lG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 194 IGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999876554433322222 3345567789999999999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=253.58 Aligned_cols=208 Identities=27% Similarity=0.438 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++|+||+++++++. ++..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++
T Consensus 44 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (256)
T cd08221 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 46789999999999999999999984 56789999999999999999875556789999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||.+....... ......++..|.|||.+.+ ..++.++|+||||+++|+|
T Consensus 124 h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~--------~~~~~~~Dv~slG~i~~~l 194 (256)
T cd08221 124 HRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG--------VKYNFKSDIWALGCVLYEL 194 (256)
T ss_pred ccCCChHhEEEeCC-CCEEECcCcceEEcccccccccccCCCccccCHhhcCC--------CCCCCcchhHHHHHHHHHH
Confidence 99999999999955 569999999987543322 2234467889999998864 4567899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
++|..||....... .............+..++.++.+++.+||..+|.+||++.+++++
T Consensus 195 ~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 195 LTLKRTFDATNPLN-LVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHCCCCCCCCCHHH-HHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 99999998755433 333333444445556789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=258.65 Aligned_cols=213 Identities=29% Similarity=0.544 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC---------CCCCCHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---------PNKLDLHVALNFALDIAR 90 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~i~~qi~~ 90 (298)
..+++.+|+.++.+++||||+++++++. ++..+++|||+++++|.+++.... ...+++..++.++.|++.
T Consensus 62 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05051 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHH
Confidence 3457889999999999999999999985 568999999999999999997643 125899999999999999
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcc
Q 022347 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 91 al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
||+|||+.|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.+
T Consensus 142 al~~LH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~ 212 (296)
T cd05051 142 GMRYLESLNFVHRDLATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------GKFTTK 212 (296)
T ss_pred HHHHHHHcCccccccchhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--------CCCCcc
Confidence 9999999999999999999999955 569999999987532221 1223345678999998754 567889
Q ss_pred hhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHh------hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 168 VDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAAFK------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 168 ~Di~slG~il~~ll~--g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+||||||+++|++++ +..||............... ......+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 999999999999998 67888765543332222111 1112234457789999999999999999999999998
Q ss_pred HHH
Q 022347 240 MLN 242 (298)
Q Consensus 240 ~l~ 242 (298)
.|+
T Consensus 293 ~L~ 295 (296)
T cd05051 293 FLQ 295 (296)
T ss_pred Hhc
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=252.31 Aligned_cols=212 Identities=29% Similarity=0.518 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||+++++|.+++... ...+++..++.++.|++.||+|||+.|+
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i 127 (267)
T cd05066 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGY 127 (267)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 457889999999999999999999984 56789999999999999999763 3468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||++
T Consensus 128 ~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~ 198 (267)
T cd05066 128 VHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIV 198 (267)
T ss_pred eehhhchhcEEECCC-CeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc--------CccCchhhhHHHHHH
Confidence 999999999999855 4699999999875433211 111223467999998864 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|++++ |..||......+. ..........+.+..++..+.+++.+||+.+|.+||++.++++.|...
T Consensus 199 l~ell~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 199 MWEVMSYGERPYWEMSNQDV-IKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHhcCCCCCcccCCHHHH-HHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 999887 9999987654332 333333344455667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=267.26 Aligned_cols=200 Identities=26% Similarity=0.350 Sum_probs=162.8
Q ss_pred HHHHHH-HHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREV-NMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~-~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+..|. .+++.++||||+++++++. ++..|+||||++|++|.+++... ..+++..+..++.|++.||.|||+.||+
T Consensus 41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~gii 118 (325)
T cd05602 41 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118 (325)
T ss_pred HHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 344444 4578899999999999885 56799999999999999999753 4588999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 119 HrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 189 (325)
T cd05602 119 YRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEM 189 (325)
T ss_pred ecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC--------CCCCCccccccccHHHHHH
Confidence 99999999999955 4699999999874322 222334568999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (298)
++|..||.+.+..... ... ......++..+++.+.+++.+||+.+|.+||++.+
T Consensus 190 ~~g~~pf~~~~~~~~~-~~i-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 190 LYGLPPFYSRNTAEMY-DNI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred hcCCCCCCCCCHHHHH-HHH-HhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 9999999876544332 222 22344556678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=254.42 Aligned_cols=209 Identities=27% Similarity=0.525 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. +...++++||+++++|.+++... ..+++..++.++.|++.||+|||+.|
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ 122 (258)
T cd06632 45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN 122 (258)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4457889999999999999999999885 55789999999999999999763 35889999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
++|+||+|+||+++.+ +.++|+|||.+.............++..|++||.+.. ...++.++|+||||+++|+
T Consensus 123 i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~~D~~slG~~l~~ 194 (258)
T cd06632 123 TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ-------QGGYGLAADIWSLGCTVLE 194 (258)
T ss_pred cccCCCCHHHEEECCC-CCEEEccCccceeccccccccccCCCcceeCHHHhcC-------CCCCCchhhhHHHHHHHHH
Confidence 9999999999999955 4699999999876544433344567889999998754 1237889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|..||..................+.++..+++.+.+++.+||..+|.+||++.+++.
T Consensus 195 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 195 MATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 999999998766444444433334455667778999999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=262.59 Aligned_cols=203 Identities=28% Similarity=0.449 Sum_probs=166.5
Q ss_pred HHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+..|..++... +||||+++++++. ++..|+||||++|++|.+++... ..+++..+..++.|++.||+|||+.||+
T Consensus 41 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iv 118 (316)
T cd05620 41 CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGII 118 (316)
T ss_pred HHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 455677777754 8999999999985 56799999999999999998763 4589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|+..|+|||++.+ ..++.++||||||+++|+|
T Consensus 119 HrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~el 189 (316)
T cd05620 119 YRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG--------LKYTFSVDWWSFGVLLYEM 189 (316)
T ss_pred ecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC--------CCCCcccchhhhHHHHHHH
Confidence 99999999999955 4699999999864221 222334568999999999865 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-HHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-SQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~l~~ 239 (298)
++|..||.+.+.... .. ......+.++..++.++.+++.+||+.||.+||++ +++++
T Consensus 190 ~~g~~Pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 190 LIGQSPFHGDDEDEL-FE-SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HhCCCCCCCCCHHHH-HH-HHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 999999987654322 22 22334556677789999999999999999999997 46664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=263.59 Aligned_cols=204 Identities=25% Similarity=0.394 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHhCCCC-cccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHD-NLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp-~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+..|..++..+.|+ +|+.+++++. .+..|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.||
T Consensus 45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i 122 (324)
T cd05587 45 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGI 122 (324)
T ss_pred HHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4677899999999865 5777888874 56799999999999999998753 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++.... .........|++.|+|||++.+ ..++.++||||||+++|+
T Consensus 123 vH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~e 193 (324)
T cd05587 123 IYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYE 193 (324)
T ss_pred EecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCceeeecCCccccChhhhcC--------CCCCcccchhhhHHHHHH
Confidence 999999999999955 469999999986422 1222234468999999999865 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~ 239 (298)
|++|+.||.+.+..... .. .......++..++.++.+++.+||..+|.+|++. .++++
T Consensus 194 lltG~~pf~~~~~~~~~-~~-i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 194 MLAGQPPFDGEDEDELF-QS-IMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHhCCCCCCCCCHHHHH-HH-HHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999876543332 22 2344556778899999999999999999999976 56655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=268.45 Aligned_cols=212 Identities=26% Similarity=0.411 Sum_probs=167.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++.+. ++..|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++||
T Consensus 87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i 163 (371)
T cd05622 87 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGF 163 (371)
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 345778999999999999999999985 5579999999999999999875 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+||||||+||+++.+ +.++|+|||++....... ......|++.|+|||++... .....++.++|||||||++|
T Consensus 164 vHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvily 238 (371)
T cd05622 164 IHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLY 238 (371)
T ss_pred EeCCCCHHHEEECCC-CCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHH
Confidence 999999999999955 569999999987543322 22345689999999998641 11234788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRML 241 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~--Rps~~~l~~~l 241 (298)
+|++|..||...+................++ ..++..+.+++..||..++.+ |+++++++++.
T Consensus 239 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 239 EMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 9999999998765433322222111222233 368999999999999843332 77999998843
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=257.52 Aligned_cols=214 Identities=23% Similarity=0.382 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++.+. ++..|+||||+++++|.+++.......+++..++.++.|++.||.|||+.|+
T Consensus 37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 116 (277)
T cd05577 37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116 (277)
T ss_pred hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 446678999999999999999999885 5679999999999999999987555579999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.+ +.++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus 117 ~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l 187 (277)
T cd05577 117 VYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG--------EVYDFSVDWFALGCTLYEM 187 (277)
T ss_pred ccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccCCCCcCCHHHhcC--------CCCCchhhhHHHHHHHHHH
Confidence 999999999999955 4699999999875443333334457788999998864 4578899999999999999
Q ss_pred HhCCCCCCCCChH--HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhh
Q 022347 181 LTNRLPFEGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 246 (298)
Q Consensus 181 l~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~~ 246 (298)
++|+.||...... ...............+..+++.+.+++.+||+.+|.+|| ++.++++ +.++.
T Consensus 188 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~--h~~~~ 258 (277)
T cd05577 188 IAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE--HPLFK 258 (277)
T ss_pred hhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh--Chhhh
Confidence 9999999765431 111112222334456677899999999999999999999 7777876 44543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=262.91 Aligned_cols=220 Identities=25% Similarity=0.418 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHhCC-CCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 21 LEGRFIREVNMMSRVK-HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~-hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
..+-|.+|+.+|.+|+ |.+||++++|- .++++|+|||+- ..+|..++..... ..+.-.+..+..|++.|+.++|++
T Consensus 402 tl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~ 479 (677)
T KOG0596|consen 402 TLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQH 479 (677)
T ss_pred HHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHh
Confidence 3347889999999997 99999999996 688999999997 5599999987443 334347888899999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccC---CccCCCcchhHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQG---EKKHYNNKVDVYS 172 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~---~~~~~~~~~Di~s 172 (298)
||||.||||.|+++. . +.+||+|||++........ ....+||+.||+||.+........ ..-..++++||||
T Consensus 480 gIVHSDLKPANFLlV-k-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWS 557 (677)
T KOG0596|consen 480 GIVHSDLKPANFLLV-K-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWS 557 (677)
T ss_pred ceeecCCCcccEEEE-e-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhh
Confidence 999999999999998 3 4699999999986544332 345589999999999875433211 1234788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-cCCCCCCCCcH-HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISP-DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
||||+|+|+.|+.||....+.......+... ...++|..-+. ++.++++.||..||++||+..+||+ +.++.
T Consensus 558 LGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq--hpFl~ 631 (677)
T KOG0596|consen 558 LGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ--HPFLQ 631 (677)
T ss_pred hhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc--Ccccc
Confidence 9999999999999998776555555544333 11244433333 3999999999999999999999998 44443
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.52 Aligned_cols=216 Identities=27% Similarity=0.479 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCC------CCCCHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRP------NKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~~~i~~qi~~al~ 93 (298)
.+.+.+|+.++++++||||+++++++. +...+++++|+++++|.+++..... ..+++..++.++.|++.||+
T Consensus 52 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 131 (280)
T cd05043 52 VTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131 (280)
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 457789999999999999999999874 3578999999999999999976432 35899999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|||+.|++|+||+|+||+++.+ ..++|+|||++........ .....++..|+|||.+.+ ..++.++||
T Consensus 132 ~LH~~~i~H~di~p~nil~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di 202 (280)
T cd05043 132 YLHKRGVIHKDIAARNCVIDEE-LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN--------KEYSSASDV 202 (280)
T ss_pred HHHHCCEeecccCHhhEEEcCC-CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc--------CCCCchhhH
Confidence 9999999999999999999855 5699999999875432211 112245667999998864 567889999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 171 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 171 ~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
||||+++|++++ |+.||...+. ...............+..+++++.+++.+||..+|++|||+.++++.|+.+...
T Consensus 203 ~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 203 WSFGVLLWELMTLGQTPYVEIDP-FEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHhHHHHHHHhcCCCCCcCcCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 999999999998 9999986543 233333333444445566789999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=258.97 Aligned_cols=217 Identities=29% Similarity=0.484 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++.+. ++..|+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.|+
T Consensus 63 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~i 139 (292)
T cd06658 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGV 139 (292)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 456889999999999999999999874 5679999999999999998864 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 140 vH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~e 210 (292)
T cd06658 140 IHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIE 210 (292)
T ss_pred eecCCCHHHEEEcCC-CCEEEccCcchhhcccccccCceeecCccccCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 999999999999955 569999999886432221 1223457889999998854 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 253 (298)
+++|..||........... ......... ...++..+.+++.+||..+|.+|||+.++++ +.++....++..
T Consensus 211 l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~~~~ 283 (292)
T cd06658 211 MIDGEPPYFNEPPLQAMRR-IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPPSC 283 (292)
T ss_pred HHhCCCCCCCCCHHHHHHH-HHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCCccc
Confidence 9999999987655433222 222222222 2357889999999999999999999999998 666665555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=271.63 Aligned_cols=206 Identities=22% Similarity=0.368 Sum_probs=165.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++.+++||||+++++.+. ++..|+||||++||+|.+++... +.+++..+..++.||+.||+|||+.||
T Consensus 45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i 122 (376)
T cd05598 45 AAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGF 122 (376)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 346779999999999999999999985 56799999999999999999753 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc--------------------------------------------ccc
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT--------------------------------------------EMM 136 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~--------------------------------------------~~~ 136 (298)
+||||||+||+++.+ +.++|+|||++...... ...
T Consensus 123 vHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (376)
T cd05598 123 IHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLA 201 (376)
T ss_pred EeCCCCHHHEEECCC-CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccc
Confidence 999999999999955 46999999987421100 001
Q ss_pred ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcH
Q 022347 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISP 214 (298)
Q Consensus 137 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 214 (298)
....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.................. ....+++
T Consensus 202 ~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 273 (376)
T cd05598 202 HSLVGTPNYIAPEVLLR--------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSR 273 (376)
T ss_pred cccCCCccccCHHHHcC--------CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCH
Confidence 12368899999999864 5678899999999999999999999987665433222221111112 2235889
Q ss_pred HHHHHHHHhhhhCCCCCC---CHHHHHH
Q 022347 215 DLAFIVQSCWVEDPNLRP---SFSQIIR 239 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rp---s~~~l~~ 239 (298)
++.+++.+|+ .+|.+|+ ++.++++
T Consensus 274 ~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 274 EASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred HHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999977 5999999 8999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=256.22 Aligned_cols=213 Identities=30% Similarity=0.566 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~ 93 (298)
.++.+|+.+++.++||||+++++++. ....|+||||+++|+|.+++..... ...+...+..++.|++.||.
T Consensus 54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 133 (288)
T cd05061 54 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133 (288)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999884 5578999999999999999975321 23567788999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|||++|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+
T Consensus 134 ~lH~~~i~H~dikp~nili~~~-~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv 204 (288)
T cd05061 134 YLNAKKFVHRDLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTSSDM 204 (288)
T ss_pred HHHhCCCcCCCCChheEEEcCC-CcEEECcCCccccccccccccccCCCcccccccCHHHhcc--------CCCChHhHH
Confidence 9999999999999999999954 5699999999875332221 112234567999998864 567889999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 171 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 171 ~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
||||+++|++++ |..||.+....+ .............+...++.+.+++.+||+.+|++|||+.++++.|+..+
T Consensus 205 wslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 205 WSFGVVLWEITSLAEQPYQGLSNEQ-VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 999999999998 788997655433 33333444455566778899999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=256.64 Aligned_cols=205 Identities=28% Similarity=0.457 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++.+. ++..|+|+||+++++|.+++.. ..+++..+..++.|++.|+.|||+.|+
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i 122 (277)
T cd06642 46 IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERK 122 (277)
T ss_pred HHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 457889999999999999999999884 5679999999999999999864 568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 123 vH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e 193 (277)
T cd06642 123 IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDFKADIWSLGITAIE 193 (277)
T ss_pred eccCCChheEEEeCC-CCEEEccccccccccCcchhhhcccCcccccCHHHhCc--------CCCchhhhHHHHHHHHHH
Confidence 999999999999955 5699999999875443221 122356788999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|..||......... ........+.++..++..+.+++.+||+.+|++||++.+++.
T Consensus 194 l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 194 LAKGEPPNSDLHPMRVL-FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHhCCCCCcccchhhHH-hhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999765433222 222333445555678899999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=254.97 Aligned_cols=206 Identities=29% Similarity=0.529 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++.+ ...++++||+++++|.+++... ..+++..++.++.|++.||+|||+.
T Consensus 48 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~ 125 (266)
T cd06651 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN 125 (266)
T ss_pred HHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3478899999999999999999998743 4678999999999999999763 3588999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccc----cccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|++|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|
T Consensus 126 ~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG 196 (266)
T cd06651 126 MIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG--------EGYGRKADVWSLG 196 (266)
T ss_pred CeeeCCCCHHHEEECCC-CCEEEccCCCccccccccccCCccccCCccccccCHHHhCC--------CCCCchhhhHHHH
Confidence 99999999999999855 46999999998643221 11122357788999998864 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|++++|+.||..................+.++..+++.+.+++ +||..+|++||+++++++
T Consensus 197 ~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 197 CTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 9999999999999877655554444444445666777888899998 688889999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=251.37 Aligned_cols=211 Identities=33% Similarity=0.552 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++.+ ...+++|||+++++|.+++.......+++..+..++.+++.||.|||+.|++
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~ 125 (261)
T cd05034 46 EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125 (261)
T ss_pred HHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 468899999999999999999999854 6799999999999999999875556789999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||+|+||+++.+ +.++|+|||.+........ ......+..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 126 h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~ 196 (261)
T cd05034 126 HRDLAARNILVGEN-LVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY--------GRFTIKSDVWSFGILLTE 196 (261)
T ss_pred cCCcchheEEEcCC-CCEEECccccceeccchhhhhhhccCCCccccCHHHhcc--------CCcCchhHHHHHHHHHHH
Confidence 99999999999955 5699999999875432211 111223467999998864 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+++ |+.||.+..... .............+...+.++.+++.+||..+|.+||++.++.+.|+.
T Consensus 197 l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 197 IVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 998 999997765433 333344444555667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=256.66 Aligned_cols=213 Identities=27% Similarity=0.510 Sum_probs=168.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC----------CCCCCHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR----------PNKLDLHVALNFALDIA 89 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~i~~qi~ 89 (298)
..+.|.+|++++++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|++
T Consensus 60 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 139 (295)
T cd05097 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139 (295)
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHH
Confidence 3457889999999999999999999984 567899999999999999986521 12368889999999999
Q ss_pred HHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCc
Q 022347 90 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNN 166 (298)
Q Consensus 90 ~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 166 (298)
.||+|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.
T Consensus 140 ~al~~lH~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~ 210 (295)
T cd05097 140 SGMKYLASLNFVHRDLATRNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------GKFTT 210 (295)
T ss_pred HHHHHHHhcCeeccccChhhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc--------CCcCc
Confidence 99999999999999999999999954 5699999999875332211 112234568999998864 56788
Q ss_pred chhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHH--H----hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 022347 167 KVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAA--F----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238 (298)
Q Consensus 167 ~~Di~slG~il~~ll~--g~~p~~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 238 (298)
++|+||||+++|+|++ +..||............. . .......+..+++.+.+++.+||+.+|++|||+++++
T Consensus 211 ~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 211 ASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred hhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 9999999999999988 667887655433222111 1 1111233456789999999999999999999999999
Q ss_pred HHHH
Q 022347 239 RMLN 242 (298)
Q Consensus 239 ~~l~ 242 (298)
+.|+
T Consensus 291 ~~l~ 294 (295)
T cd05097 291 HFLR 294 (295)
T ss_pred HHHh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=256.00 Aligned_cols=210 Identities=28% Similarity=0.462 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++||||+++.+++. +...|+|+||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~ 120 (274)
T cd06609 44 EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKI 120 (274)
T ss_pred HHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 46779999999999999999999884 5679999999999999999976 3789999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus 121 h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~sDv~slG~il~~l 191 (274)
T cd06609 121 HRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ--------SGYDEKADIWSLGITAIEL 191 (274)
T ss_pred cCCCCHHHEEECCC-CCEEEcccccceeecccccccccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHH
Confidence 99999999999955 56999999998765433 22234467788999999865 4588999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||...+.... .........+..+.. ++..+.+++.+||..+|++|||++++++ +.++..
T Consensus 192 ~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--~~~~~~ 256 (274)
T cd06609 192 AKGEPPLSDLHPMRV-LFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK--HKFIKK 256 (274)
T ss_pred HhCCCCcccCchHHH-HHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh--ChhhcC
Confidence 999999987654332 223333344444544 8899999999999999999999999988 555543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=255.14 Aligned_cols=213 Identities=27% Similarity=0.497 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++.+++.+ ...++||||++|++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~ 128 (284)
T cd05079 50 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR 128 (284)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4578899999999999999999998843 4688999999999999999753 23589999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||
T Consensus 129 gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG 199 (284)
T cd05079 129 QYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ--------SKFYIASDVWSFG 199 (284)
T ss_pred CeeecccchheEEEcCC-CCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc--------CCCCccccchhhh
Confidence 99999999999999955 5699999999875433221 122345667999998754 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCC--------------hHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMS--------------NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
+++|++++++.|+.... ...............+.+..++..+.+++.+||+.+|++|||+.++++.
T Consensus 200 ~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 200 VTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999766542211 1111111122223344566789999999999999999999999999999
Q ss_pred HHhh
Q 022347 241 LNAF 244 (298)
Q Consensus 241 l~~~ 244 (298)
|+.+
T Consensus 280 l~~~ 283 (284)
T cd05079 280 FEAI 283 (284)
T ss_pred HHhh
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=257.56 Aligned_cols=212 Identities=31% Similarity=0.461 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.+.||||+++++.+. +...|+||||++|++|.+++.. ..+++..+..++.|++.||+|||+.|++
T Consensus 62 ~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~ 138 (296)
T cd06654 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVI 138 (296)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46789999999999999999999884 5689999999999999999875 4588999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 139 H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~~l 209 (296)
T cd06654 139 HRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEM 209 (296)
T ss_pred cCCCCHHHEEEcCC-CCEEECccccchhccccccccCcccCCccccCHHHHcC--------CCCCccchHHHHHHHHHHH
Confidence 99999999999855 469999999887533222 1223467889999998864 5567899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
++|+.||................. ....+..++..+.+++.+||..+|.+||++.++++ +.++...
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~--~~~~~~~ 276 (296)
T cd06654 210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIA 276 (296)
T ss_pred HhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh--Chhhhcc
Confidence 999999987655333322221111 12235568889999999999999999999999998 5555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=252.32 Aligned_cols=215 Identities=24% Similarity=0.442 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..+++.+|+.+++.++||||+++++++ .++..+++|||+++++|.+++... ....+++..++.++.|++.||.|||+
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08229 45 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124 (267)
T ss_pred HHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999988 456789999999999999998742 23458999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
.|++|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||++
T Consensus 125 ~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~i 195 (267)
T cd08229 125 RRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCL 195 (267)
T ss_pred CCeecCCCCHHHEEEcCC-CCEEECcchhhhccccCCcccccccCCcCccCHHHhcC--------CCccchhhHHHHHHH
Confidence 999999999999999955 4699999998875433222 223457889999998864 557789999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 177 LWELLTNRLPFEGMSNL-QAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|+|++|..||...... ............+.. +..++..+.+++.+||+.+|.+|||+.++++.+.++
T Consensus 196 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 196 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 99999999999754322 222222222222323 245888999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=256.17 Aligned_cols=219 Identities=29% Similarity=0.472 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++.+. ++..|+||||++|++|..++... ...+++..++.++.|++.||.|||+.|+
T Consensus 53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i 131 (292)
T cd06644 53 LEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKI 131 (292)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 346889999999999999999999874 66799999999999999887653 3568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||.+...... .......++..|+|||.+.+... ....++.++|+||||+++|+
T Consensus 132 ~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~e 207 (292)
T cd06644 132 IHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIE 207 (292)
T ss_pred eecCCCcceEEEcCC-CCEEEccCccceeccccccccceecCCccccCceeeccccc---cCCCCCchhhhHhHHHHHHH
Confidence 999999999999854 56999999987643222 11233457789999998854211 12456789999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|++|..||........... ......+ ..+..++.++.+++.+||..+|++||++.++++ +.++...
T Consensus 208 l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~ 275 (292)
T cd06644 208 MAQIEPPHHELNPMRVLLK-IAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE--HPFVSSV 275 (292)
T ss_pred HhcCCCCCccccHHHHHHH-HhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc--Ccccccc
Confidence 9999999977654332222 2222222 234567889999999999999999999999987 5554443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=256.77 Aligned_cols=213 Identities=28% Similarity=0.511 Sum_probs=168.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC---------CCCCHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---------NKLDLHVALNFALDIAR 90 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~i~~qi~~ 90 (298)
..+++.+|+.++++++||||+++++++. ++..+++|||+++++|.+++..... ..+++..++.++.|++.
T Consensus 62 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 141 (296)
T cd05095 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141 (296)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHH
Confidence 3457889999999999999999999984 5678999999999999999976321 23677889999999999
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcc
Q 022347 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 91 al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
||+|||+.|++|+||||+||+++.+ +.++|+|||++........ ......+..|++||...+ ..++.+
T Consensus 142 al~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~ 212 (296)
T cd05095 142 GMKYLSSLNFVHRDLATRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------GKFTTA 212 (296)
T ss_pred HHHHHHHCCeecccCChheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--------CCccch
Confidence 9999999999999999999999854 5699999999875432221 111233567999997754 567889
Q ss_pred hhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHH--HH----hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 168 VDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAA--AF----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 168 ~Di~slG~il~~ll~--g~~p~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|+||||+++|+|++ |..||......+..... .. .......+..+++.+.+++.+||+.+|.+||++.++.+
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999999998 77888765543322211 11 11112334567899999999999999999999999998
Q ss_pred HHH
Q 022347 240 MLN 242 (298)
Q Consensus 240 ~l~ 242 (298)
.|+
T Consensus 293 ~l~ 295 (296)
T cd05095 293 TLL 295 (296)
T ss_pred HHh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=257.81 Aligned_cols=213 Identities=26% Similarity=0.408 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.++..|+.+++++ +||||+++++++. +...|++|||+++++|.+++.......+++..++.++.|++.||.|
T Consensus 57 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 136 (282)
T cd06636 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136 (282)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHH
Confidence 4677899999999 6999999999873 3468999999999999999987665668899999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
||+.|++|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||.+.... .....++.++|+|||
T Consensus 137 LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~~~~Dvwsl 212 (282)
T cd06636 137 LHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDYRSDIWSL 212 (282)
T ss_pred HHHCCcccCCCCHHHEEECCC-CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCccc---CcCcCCCcccchhHH
Confidence 999999999999999999955 46999999998754321 1223346788999999875311 113567889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|+++|+|++|..||........................++.++.++|.+||..+|.+|||+.++++
T Consensus 213 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 213 GITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 999999999999997655433332222111222223458899999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=262.34 Aligned_cols=204 Identities=25% Similarity=0.413 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+..|..++..+ .||+|+.+++++. ++..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.||
T Consensus 45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i 122 (323)
T cd05616 45 ECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGI 122 (323)
T ss_pred HHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 3566788888777 4899999999885 55789999999999999998753 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+
T Consensus 123 vHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~e 193 (323)
T cd05616 123 IYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYE 193 (323)
T ss_pred EecCCCHHHeEECCC-CcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC--------CCCCCccchhchhHHHHH
Confidence 999999999999955 4699999999874322 222334568999999999864 567899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~ 239 (298)
|++|+.||.+.+.... ... .......++..++.++.+++.+||+.+|.+|++. .++.+
T Consensus 194 lltg~~Pf~~~~~~~~-~~~-i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 194 MLAGQAPFEGEDEDEL-FQS-IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHhCCCCCCCCCHHHH-HHH-HHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 9999999987654333 222 2234456677899999999999999999999974 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=248.82 Aligned_cols=211 Identities=35% Similarity=0.615 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. +...++||||+++++|.+++... ...+++..+..++.+++.||+|||+.|
T Consensus 35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~ 113 (251)
T cd05041 35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN 113 (251)
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999999884 56789999999999999999653 345889999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc---ccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++|+||+|+||+++.+ +.++|+|||.+......... .....+..|+|||.+.+ ..++.++|+||||++
T Consensus 114 i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~i 184 (251)
T cd05041 114 CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY--------GRYTSESDVWSYGIL 184 (251)
T ss_pred EehhhcCcceEEEcCC-CcEEEeeccccccccCCcceeccccCcceeccCChHhhcc--------CCCCcchhHHHHHHH
Confidence 9999999999999955 46999999998754321111 11223457999998764 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
+|++++ |..||........ ............+...+.++.+++.+||..+|.+|||+.++++.|+
T Consensus 185 ~~~l~t~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 185 LWETFSLGDTPYPGMSNQQT-RERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHhccCCCCccCCHHHH-HHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999998 8889877654332 2222233344556778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=254.31 Aligned_cols=214 Identities=32% Similarity=0.498 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++||||+++++.+. +...|+|+||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++
T Consensus 61 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~ 137 (296)
T cd06655 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVI 137 (296)
T ss_pred HHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46779999999999999999999884 5679999999999999999875 4589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|++
T Consensus 138 H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~~l 208 (296)
T cd06655 138 HRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEM 208 (296)
T ss_pred cCCCCHHHEEECCC-CCEEEccCccchhcccccccCCCcCCCccccCcchhcC--------CCCCchhhHHHHHHHHHHH
Confidence 99999999999855 5699999998875433222 223457889999998864 5578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++|..||...+............ .....+..+++.+.+++.+||..+|.+||++.+++. +.++....+
T Consensus 209 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~~~~~ 277 (296)
T cd06655 209 VEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKP 277 (296)
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhhccc
Confidence 99999998766544332222111 112345668899999999999999999999999998 777765554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=245.01 Aligned_cols=218 Identities=26% Similarity=0.497 Sum_probs=183.0
Q ss_pred HHHHHHHHHHhCC-CCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGI 100 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~gi 100 (298)
++...+.+..... +|.||+++|+| .+...+++||.| +..+..++.. ..+++++..+-++...++.||.||.+ +||
T Consensus 136 RILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~v 213 (391)
T KOG0983|consen 136 RILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGV 213 (391)
T ss_pred HHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcce
Confidence 6667887766654 99999999999 466788999999 5577777765 34569999999999999999999987 589
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|||+||+|||+| +.+++||||||++.............|.+.|+|||.+.. .....|+.++||||||++++||
T Consensus 214 iHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp-----~~~~kYDiRaDVWSlGITlveL 287 (391)
T KOG0983|consen 214 IHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDP-----PDKPKYDIRADVWSLGITLVEL 287 (391)
T ss_pred eecccCccceEEc-cCCCEEeecccccceeecccccccccCCccccCccccCC-----CCCCccchhhhhhhhccchhhh
Confidence 9999999999999 456799999999987666666666689999999999975 2247889999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
.||+.||.+.+...+....+....+|.++. .+|+.+++|+..||..|+.+||.+.++++ +.++..-.+.
T Consensus 288 aTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~~ye~a 358 (391)
T KOG0983|consen 288 ATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIKRYETA 358 (391)
T ss_pred hcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc--Ccceeecchh
Confidence 999999999877777777777777776664 48999999999999999999999999998 5655544433
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=250.85 Aligned_cols=214 Identities=27% Similarity=0.479 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+++.+|+.++++++|+||+++++.+. ++..++||||+++++|.+++.... ...+++..++.++.+++.||.|||+.
T Consensus 46 ~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 125 (267)
T cd08224 46 RQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125 (267)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 457889999999999999999999884 567899999999999999986532 34589999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++|+||+|+||+++.+ +.++|+|||++....... ......++..|.|||.+.+ ..++.++|+||||+++
T Consensus 126 ~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il 196 (267)
T cd08224 126 RIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLL 196 (267)
T ss_pred CEecCCcChhhEEECCC-CcEEEeccceeeeccCCCcccceecCCccccCHHHhcc--------CCCCchhcHHHHHHHH
Confidence 99999999999999955 469999999986533221 1223457788999998864 5678899999999999
Q ss_pred HHHHhCCCCCCCCC-hHHHHHHHHHhhcCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 178 WELLTNRLPFEGMS-NLQAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 178 ~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
|++++|+.||.... +.............++.+. .++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 197 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 197 YEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 99999999996543 2222333333333444554 6888999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=264.41 Aligned_cols=209 Identities=27% Similarity=0.403 Sum_probs=165.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+++.+|+.+++.++||||+++++++.. ...|+||||++ ++|.+++. ..+++..+..++.|++.||+|
T Consensus 67 ~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~ 141 (364)
T cd07875 67 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKH 141 (364)
T ss_pred HHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHH
Confidence 3467789999999999999999988632 24799999995 57888775 348889999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||++||+||||||+||+++.+ +.++|+|||++.............++..|+|||++.+ ..++.++||||||
T Consensus 142 LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG 212 (364)
T cd07875 142 LHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVG 212 (364)
T ss_pred HhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC--------CCCCchhhHHhHH
Confidence 999999999999999999955 5699999999986554444445578899999999865 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhh--------------------cCCC--------------------CCCCCcH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKH--------------------ARPG--------------------LPEDISP 214 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------------------~~~~--------------------~~~~~~~ 214 (298)
|++|+|++|+.||.+.+............ ..+. .....+.
T Consensus 213 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (364)
T cd07875 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 292 (364)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccH
Confidence 99999999999998765433322211100 0000 0112346
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 215 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
.+.+++.+||+.||.+|||+.++++ +.++.
T Consensus 293 ~~~dll~~mL~~dP~~R~t~~e~L~--hp~~~ 322 (364)
T cd07875 293 QARDLLSKMLVIDASKRISVDEALQ--HPYIN 322 (364)
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhc--Ccccc
Confidence 7899999999999999999999998 45543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=260.42 Aligned_cols=215 Identities=29% Similarity=0.559 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhC---------------------------
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR--------------------------- 72 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~--------------------------- 72 (298)
+.+.+|+.++.++ +||||+++++++. +...+++|||+++|+|.+++....
T Consensus 55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (343)
T cd05103 55 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134 (343)
T ss_pred HHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhh
Confidence 4677999999999 6899999999873 446889999999999999986521
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC
Q 022347 73 --------------------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114 (298)
Q Consensus 73 --------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~ 114 (298)
...+++..+..++.|++.||+|||+.|++|+||||+||+++.
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 214 (343)
T cd05103 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 214 (343)
T ss_pred hhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC
Confidence 123678888999999999999999999999999999999995
Q ss_pred CCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 022347 115 DQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190 (298)
Q Consensus 115 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~ 190 (298)
+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||...
T Consensus 215 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 215 N-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred C-CcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5 4699999999875322111 112234567999998854 567889999999999999997 99999765
Q ss_pred ChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 191 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
..................+...++++.+++..||+.+|.+|||+.+++++|+.++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 286 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred cccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 44333334444444555566678899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=251.43 Aligned_cols=215 Identities=25% Similarity=0.444 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
...++.+|+.++++++||||+++++++. .+..++++||+++++|.+++.... ...+++..++.++.|++.||.|||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08228 45 ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124 (267)
T ss_pred HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3457889999999999999999999884 567899999999999999886432 2458899999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
.|++|+||+|+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||+|++
T Consensus 125 ~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~ 195 (267)
T cd08228 125 RRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCL 195 (267)
T ss_pred CCeeCCCCCHHHEEEcCC-CCEEECccccceeccchhHHHhcCCCCccccChhhhcc--------CCCCchhhHHHHHHH
Confidence 999999999999999965 4699999998875433221 223457789999998864 557789999999999
Q ss_pred HHHHHhCCCCCCCCCh-HHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 177 LWELLTNRLPFEGMSN-LQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|+|++|..||..... .............++. +..++..+.+++.+||..+|++||++.++++.++.+
T Consensus 196 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 196 LYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 9999999999865432 2222222222233333 345788999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=256.81 Aligned_cols=205 Identities=29% Similarity=0.431 Sum_probs=161.7
Q ss_pred HHHHHHHHHhC---CCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 25 FIREVNMMSRV---KHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 25 ~~~E~~~l~~l---~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+.+|+.+++.+ +||||+++++++.+ ...+++|||++ ++|.+++.......+++..+..++.|++.||.||
T Consensus 46 ~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l 124 (288)
T cd07863 46 TVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124 (288)
T ss_pred HHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 44566666555 79999999998732 34789999996 5999998765555699999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.|++|+||||+||+++.+ +.++|+|||++.............++..|+|||++.+ ..++.++|||||||
T Consensus 125 H~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~ 195 (288)
T cd07863 125 HANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGC 195 (288)
T ss_pred HhCCeecCCCCHHHEEECCC-CCEEECccCccccccCcccCCCccccccccCchHhhC--------CCCCCcchhhhHHH
Confidence 99999999999999999955 5699999999876544333344567889999998864 56788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
++|+|++|..||.................. ..+...++..+.+++.+||+.||.+
T Consensus 196 ~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 275 (288)
T cd07863 196 IFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHK 275 (288)
T ss_pred HHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCccc
Confidence 999999999999776544332222110000 0112356788999999999999999
Q ss_pred CCCHHHHHH
Q 022347 231 RPSFSQIIR 239 (298)
Q Consensus 231 Rps~~~l~~ 239 (298)
|||+.++++
T Consensus 276 R~t~~~~l~ 284 (288)
T cd07863 276 RISAFRALQ 284 (288)
T ss_pred CCCHHHHhc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=265.18 Aligned_cols=199 Identities=29% Similarity=0.386 Sum_probs=162.1
Q ss_pred HHHHHHH-HHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVN-MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~-~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++..|.. +++.++||||+++++.+. ++..|+||||++|++|..++.. ...+++..+..++.||+.||+|||+.|++
T Consensus 41 ~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~giv 118 (325)
T cd05604 41 HIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIV 118 (325)
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4455554 567899999999999885 5679999999999999998875 35689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++..... ........|+..|+|||++.+ ..++.++|||||||++|+|
T Consensus 119 H~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 189 (325)
T cd05604 119 YRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK--------QPYDNTVDWWCLGAVLYEM 189 (325)
T ss_pred ecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC--------CCCCCcCccccccceehhh
Confidence 99999999999955 4699999999864322 222334568999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (298)
++|..||...+.... ..... .....++...+..+.+++.+||+.+|.+||++.
T Consensus 190 ~~G~~pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 190 LYGLPPFYCRDVAEM-YDNIL-HKPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred hcCCCCCCCCCHHHH-HHHHH-cCCccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 999999987654332 22222 233344556889999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=249.81 Aligned_cols=207 Identities=27% Similarity=0.431 Sum_probs=166.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
...+.+|+.++++++||||+++++++.....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 123 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLV 123 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 467889999999999999999999886577899999999999999997633 3689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCC------ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQK------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 102 H~dik~~Nil~~~~~~------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+||||+||+++.++. .++|+|||++..... .....+...|+|||.+.+ ....++.++||||||+
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~ 194 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRN------GQASLTIAADKWSFGT 194 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcC------CCCCcchhhHHHHHHH
Confidence 9999999999986542 599999999876443 122345668999999864 1136788999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 176 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
++|++++ |..||....... ...... .....+......+.+++.+||..+|.+|||+.++++.|
T Consensus 195 ~~~~l~~~~~~p~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSSE-KERFYQ--DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHHHhCCCCCcccCCchh-HHHHHh--cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999999 678887654222 111111 12222333447899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=253.99 Aligned_cols=214 Identities=29% Similarity=0.531 Sum_probs=174.8
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA- 97 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~- 97 (298)
...+++.+|+.++++++||||+++++.+. ++..++++||+++++|.+++.... ..+++..+..++.|++.||+|||+
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (265)
T cd06605 41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119 (265)
T ss_pred HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCC
Confidence 34457889999999999999999999884 567999999999999999998643 568999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
.|++|+||+|+||+++.+ +.++|+|||.+......... ...++..|+|||.+.+ ..++.++|+||||+++
T Consensus 120 ~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l 189 (265)
T cd06605 120 HKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG--------NDYSVKSDIWSLGLSL 189 (265)
T ss_pred CCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHHhh-cccCChhccCHHHHcC--------CCCCchhhHHHHHHHH
Confidence 999999999999999964 56999999998654332222 2567889999998865 5678899999999999
Q ss_pred HHHHhCCCCCCCCC----hHHHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 178 WELLTNRLPFEGMS----NLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 178 ~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++++|..||.... ..............+.++.. ++.++.++|.+||..+|.+|||+.+++. +.++.
T Consensus 190 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~--~~~~~ 261 (265)
T cd06605 190 IELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE--HPFIK 261 (265)
T ss_pred HHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh--Cchhh
Confidence 99999999997652 22233333333444455554 8899999999999999999999999987 44443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=249.91 Aligned_cols=210 Identities=38% Similarity=0.709 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++..++||||+++++++. ++..+++|||+++++|.+++.......+++..+..++.|++.||++||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~ 124 (258)
T smart00219 45 IEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124 (258)
T ss_pred HHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 357889999999999999999999985 4679999999999999999986443338999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccc--cccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+|+||+|+||+++.+ +.++|+|||++.......... ...++..|+|||.+.. ..++.++|+||||++++
T Consensus 125 ~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~i~~ 195 (258)
T smart00219 125 IHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD--------GKFTSKSDVWSFGVLLW 195 (258)
T ss_pred eecccccceEEEccC-CeEEEcccCCceecccccccccccCCCcccccChHHhcc--------CCCCcchhHHHHHHHHH
Confidence 999999999999954 479999999987544332211 1235678999998743 66788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 179 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
+|++ |..||..... ...............+..++.++.+++.+||..+|.+|||+.++++.|
T Consensus 196 ~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 196 EIFTLGESPYPGMSN-EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHhCCCCCCCCCCH-HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 9998 8888876544 333344444555566677899999999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=254.39 Aligned_cols=205 Identities=28% Similarity=0.470 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++++.||||+++++.+. +...|+||||++|++|.+++.. ..+++..+..++.|++.||+|||+.|+
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~i 122 (277)
T cd06640 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKK 122 (277)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 357889999999999999999999985 5679999999999999999875 458899999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 123 vH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Dv~slG~il~e 193 (277)
T cd06640 123 IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ--------SAYDSKADIWSLGITAIE 193 (277)
T ss_pred cCcCCChhhEEEcCC-CCEEEcccccceeccCCccccccccCcccccCHhHhcc--------CCCccHHHHHHHHHHHHH
Confidence 999999999999955 5699999999875433221 222356778999998864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|..||......... ........+.++..++..+.+++.+||+.+|.+||++.+++.
T Consensus 194 l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 194 LAKGEPPNSDMHPMRVL-FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred HHHCCCCCCCcChHhHh-hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 99999999866543322 222333455566678899999999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=252.28 Aligned_cols=210 Identities=28% Similarity=0.503 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
...+.+.+|+.++++++||||+++++++. .+..++|+||++|++|.+++... ..+++..++.++.|++.||.|||+.
T Consensus 45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~ 122 (268)
T cd06630 45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN 122 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34568889999999999999999999985 55789999999999999999763 4589999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-----cccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|++|+||+|+||+++.++..++|+|||.+........ .....++..|+|||.+.+ ..++.++|+|||
T Consensus 123 ~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~sl 194 (268)
T cd06630 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG--------EQYGRSCDVWSV 194 (268)
T ss_pred CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc--------CCCCcccchHHH
Confidence 9999999999999986666799999999875433211 122356789999998854 556789999999
Q ss_pred HHHHHHHHhCCCCCCCCChH---HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 174 GIVLWELLTNRLPFEGMSNL---QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++++++++|..||...... ............+..+..+++++.+++.+||..+|.+||++.+++.
T Consensus 195 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 195 GCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 99999999999999754321 1111122223445666778899999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=263.61 Aligned_cols=204 Identities=27% Similarity=0.404 Sum_probs=162.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+++.+|+.+++.++||||+++++++.. ...|+||||+++ ++.+++. ..+++..+..++.|++.||+|
T Consensus 60 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~ 134 (355)
T cd07874 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKH 134 (355)
T ss_pred HHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHH
Confidence 3467789999999999999999998732 247999999955 7777765 348899999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+.||+||||||+||+++.+ +.++|+|||++.............++..|+|||++.+ ..++.++||||||
T Consensus 135 LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG 205 (355)
T cd07874 135 LHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVG 205 (355)
T ss_pred HHhCCcccCCCChHHEEECCC-CCEEEeeCcccccCCCccccCCccccCCccCHHHHcC--------CCCCchhhHHHHH
Confidence 999999999999999999955 4699999999986554444445578999999999864 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhh--------------------cC--------------------CCCCCCCcH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKH--------------------AR--------------------PGLPEDISP 214 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------------------~~--------------------~~~~~~~~~ 214 (298)
|++|+|++|+.||.+.+............ .. ...+...+.
T Consensus 206 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (355)
T cd07874 206 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 285 (355)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccch
Confidence 99999999999998765433222111000 00 001122456
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 215 DLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
.+.+++.+||+.||.+|||+.++++
T Consensus 286 ~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 286 QARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHHHHHhcCCchhcCCHHHHhc
Confidence 7899999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=260.84 Aligned_cols=212 Identities=28% Similarity=0.433 Sum_probs=166.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+++.+|+.++++++||||+++++++.. ...|++++++ +++|.+++.. ..+++..+..++.|++.||.||
T Consensus 59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~L 134 (343)
T cd07878 59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999988732 2478999998 8899998864 5699999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.||+|+||||+||+++.+ +.++|+|||++...... .....++..|+|||++.+ ...++.++|||||||
T Consensus 135 H~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~ 204 (343)
T cd07878 135 HSAGIIHRDLKPSNVAVNED-CELRILDFGLARQADDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGC 204 (343)
T ss_pred HHCCeecccCChhhEEECCC-CCEEEcCCccceecCCC--cCCccccccccCchHhcC-------CccCCchhhhHhHHH
Confidence 99999999999999999955 46999999998754332 234468899999998853 245788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhh---------------------cCCCC--------CCCCcHHHHHHHHHhhhh
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKH---------------------ARPGL--------PEDISPDLAFIVQSCWVE 226 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~---------------------~~~~~--------~~~~~~~l~~li~~~l~~ 226 (298)
++|+|++|+.||.+.+............ ..+.. ....++.+.+++.+||..
T Consensus 205 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 284 (343)
T cd07878 205 IMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVL 284 (343)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCC
Confidence 9999999999997654332221111000 00111 123566789999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhccCC
Q 022347 227 DPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 227 ~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
||.+|||+.++++ +.++.....
T Consensus 285 dp~~R~s~~ell~--hp~~~~~~~ 306 (343)
T cd07878 285 DSDKRISASEALA--HPYFSQYHD 306 (343)
T ss_pred ChhhCCCHHHHhc--CcchhccCC
Confidence 9999999999998 666665443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=250.37 Aligned_cols=211 Identities=28% Similarity=0.441 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|++|||+++++|.+++... ...+++..+..++.|++.||.|||+.|+
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i 122 (262)
T cd06613 44 FEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGK 122 (262)
T ss_pred HHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 357789999999999999999999884 56799999999999999998763 2468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+... ....++.++|+||||+++|+
T Consensus 123 ~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~~~~Di~slG~~l~~ 196 (262)
T cd06613 123 IHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYDGKCDIWALGITAIE 196 (262)
T ss_pred eecCCChhhEEECCC-CCEEECccccchhhhhhhhccccccCCccccCchhhccc-----ccCCcCchhhhHHHHHHHHH
Confidence 999999999999954 569999999987544322 22334577889999988641 11367889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|..||..................+ ..+..++.++.+++.+||..+|.+|||+.+++.
T Consensus 197 ~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 197 LAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999998766444333322221111 123346788999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=280.57 Aligned_cols=219 Identities=25% Similarity=0.415 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC---------CCCCCHHHHHHHHHHH
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---------PNKLDLHVALNFALDI 88 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~i~~qi 88 (298)
....++|.+|+.++++++||||+++++++. ++..|++|||++|++|.+++.... ....++..++.++.|+
T Consensus 43 e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QI 122 (932)
T PRK13184 43 PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122 (932)
T ss_pred HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHH
Confidence 345668999999999999999999999985 567899999999999999986421 1235667789999999
Q ss_pred HHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-------------------cccccccCccceeccc
Q 022347 89 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-------------------EMMTAETGTYRWMAPE 149 (298)
Q Consensus 89 ~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-------------------~~~~~~~~~~~y~aPE 149 (298)
+.||+|||+.||+||||||+||+++.++ .++|+|||++...... .......|++.|+|||
T Consensus 123 a~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE 201 (932)
T PRK13184 123 CATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE 201 (932)
T ss_pred HHHHHHHHHCCccccCCchheEEEcCCC-CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence 9999999999999999999999999554 6999999998754110 0111235899999999
Q ss_pred cccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhC
Q 022347 150 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVED 227 (298)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~ 227 (298)
.+.+ ..++.++|||||||++|+|++|..||.............. ..... ....+++.+.+++.+||..+
T Consensus 202 ~l~g--------~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~D 272 (932)
T PRK13184 202 RLLG--------VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVD 272 (932)
T ss_pred HhcC--------CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCC
Confidence 8864 5678899999999999999999999976543222221111 11111 12357889999999999999
Q ss_pred CCCCC-CHHHHHHHHHhhhhc
Q 022347 228 PNLRP-SFSQIIRMLNAFLFT 247 (298)
Q Consensus 228 p~~Rp-s~~~l~~~l~~~~~~ 247 (298)
|++|| +++++++.|+.++..
T Consensus 273 P~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 273 PAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhCcCHHHHHHHHHHHHHhc
Confidence 99996 678888888887654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.41 Aligned_cols=213 Identities=30% Similarity=0.512 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++. ....++|+||+++++|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 49 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~ 127 (284)
T cd05081 49 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK 127 (284)
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 357889999999999999999999762 34689999999999999999753 24589999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc----ccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|++|+||||+||+++.+ +.++|+|||++......... ....+...|+|||.+.+ ..++.++||||||
T Consensus 128 ~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 198 (284)
T cd05081 128 RYVHRDLATRNILVESE-NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE--------SKFSVASDVWSFG 198 (284)
T ss_pred CceeccCCHhhEEECCC-CeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc--------CCcChHHHHHHHH
Confidence 99999999999999855 46999999998754322211 11223446999998864 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHH---------------HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNLQ---------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|++++|..++....... ..............+..++.++.+++.+||..+|++|||+.++++
T Consensus 199 ~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 199 VVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999877654322110 001111222233445678899999999999999999999999999
Q ss_pred HHHhh
Q 022347 240 MLNAF 244 (298)
Q Consensus 240 ~l~~~ 244 (298)
.|+.+
T Consensus 279 ~l~~~ 283 (284)
T cd05081 279 QVEAI 283 (284)
T ss_pred HHHhc
Confidence 88753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=260.36 Aligned_cols=212 Identities=34% Similarity=0.517 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec-C-----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD-P-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
+++.+|+.+++.++||||+++++++.. + ..|+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 44 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 44 KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred HHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999999999843 2 5899999995 688888764 356999999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
+.|++||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||
T Consensus 121 ~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG 192 (372)
T cd07853 121 SAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVG 192 (372)
T ss_pred hCCeeCCCCChHHEEECCC-CCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHH
Confidence 9999999999999999955 569999999987533221 2233457889999998864 24578899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHH----------------------h-hcCC-------CCCCCCcHHHHHHHHHhh
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAF----------------------K-HARP-------GLPEDISPDLAFIVQSCW 224 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~----------------------~-~~~~-------~~~~~~~~~l~~li~~~l 224 (298)
|++|+|++|+.||.+.+.......... . ...+ .+....++++.+++.+||
T Consensus 193 ~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 272 (372)
T cd07853 193 CIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272 (372)
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhC
Confidence 999999999999987654332221110 0 0000 123446789999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhc
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+.||.+|||+.++++ +.|+..
T Consensus 273 ~~dP~~R~t~~e~l~--hp~~~~ 293 (372)
T cd07853 273 VFDPDKRISAADALA--HPYLDE 293 (372)
T ss_pred CCChhhCcCHHHHhc--CHhhCC
Confidence 999999999999988 555544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=253.36 Aligned_cols=212 Identities=30% Similarity=0.543 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------------CCCCHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------------NKLDLH 79 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~ 79 (298)
..+++.+|+.++++++||||+++++++. +...++++||+++++|.+++..... ..+++.
T Consensus 51 ~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 130 (288)
T cd05050 51 MQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130 (288)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHH
Confidence 3457889999999999999999999985 4578999999999999999975321 247788
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceecccccccccc
Q 022347 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTL 156 (298)
Q Consensus 80 ~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 156 (298)
.++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+........ ......+..|+|||.+.+
T Consensus 131 ~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--- 206 (288)
T cd05050 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--- 206 (288)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecccccHhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc---
Confidence 899999999999999999999999999999999855 4699999999874332211 112234567999998754
Q ss_pred ccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 022347 157 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235 (298)
Q Consensus 157 ~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (298)
..++.++||||||+++|+|++ |..||.+..... .............+..++.++.+++.+||+.+|.+|||+.
T Consensus 207 -----~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 280 (288)
T cd05050 207 -----NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFA 280 (288)
T ss_pred -----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 567889999999999999997 888987655433 3333333444455677899999999999999999999999
Q ss_pred HHHHHHH
Q 022347 236 QIIRMLN 242 (298)
Q Consensus 236 ~l~~~l~ 242 (298)
++++.|+
T Consensus 281 el~~~l~ 287 (288)
T cd05050 281 SINRILQ 287 (288)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=267.06 Aligned_cols=211 Identities=24% Similarity=0.395 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++.+++||||+++++.+. ++..|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g 121 (360)
T cd05627 44 QVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG 121 (360)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457788999999999999999999985 55789999999999999999753 45899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc------------------------------------ccccccCcc
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE------------------------------------MMTAETGTY 143 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~------------------------------------~~~~~~~~~ 143 (298)
|+||||||+||+++.+ +.++|+|||++....... ......|++
T Consensus 122 ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 200 (360)
T cd05627 122 FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP 200 (360)
T ss_pred eEccCCCHHHEEECCC-CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence 9999999999999955 569999999976332110 011336899
Q ss_pred ceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC--CCcHHHHHHHH
Q 022347 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQ 221 (298)
Q Consensus 144 ~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~ 221 (298)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+..................++. .+++++.+++.
T Consensus 201 ~Y~APE~~~~--------~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~ 272 (360)
T cd05627 201 DYIAPEVFMQ--------TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLIL 272 (360)
T ss_pred cccCHHHHcC--------CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHH
Confidence 9999999865 5678899999999999999999999987665433222221111222332 37889999999
Q ss_pred HhhhhCCCCCCC---HHHHHHHHHhhh
Q 022347 222 SCWVEDPNLRPS---FSQIIRMLNAFL 245 (298)
Q Consensus 222 ~~l~~~p~~Rps---~~~l~~~l~~~~ 245 (298)
+|+. +|.+|++ +.++++ +.|+
T Consensus 273 ~l~~-~p~~R~~~~~~~ei~~--hp~f 296 (360)
T cd05627 273 RFCT-DSENRIGSNGVEEIKS--HPFF 296 (360)
T ss_pred Hhcc-ChhhcCCCCCHHHHhc--CCCC
Confidence 9875 9999985 677776 4443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=266.96 Aligned_cols=210 Identities=25% Similarity=0.402 Sum_probs=159.8
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
....|+.++++++||||+++++++. +...++|+|++ .++|.+++.. ....+++..++.|+.|++.||.|||++||+|
T Consensus 103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (357)
T PHA03209 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIH 180 (357)
T ss_pred ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 3457999999999999999999984 56789999999 5689998865 3356899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
|||||+||+++.+ +.++|+|||++.............++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 181 rDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvvl~ell~ 251 (357)
T PHA03209 181 RDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR--------DKYNSKADIWSAGIVLFEMLA 251 (357)
T ss_pred CCCCHHHEEECCC-CCEEEecCccccccccCcccccccccccccCCeecCC--------CCCCchhhHHHHHHHHHHHHH
Confidence 9999999999955 4699999999875433333344568899999999864 567889999999999999998
Q ss_pred CC-CCCCCCChH-H-------HHHHHHHh---hcCCCCC------------------------------CCCcHHHHHHH
Q 022347 183 NR-LPFEGMSNL-Q-------AAYAAAFK---HARPGLP------------------------------EDISPDLAFIV 220 (298)
Q Consensus 183 g~-~p~~~~~~~-~-------~~~~~~~~---~~~~~~~------------------------------~~~~~~l~~li 220 (298)
+. .+|...... . ........ .....++ ..++..+.++|
T Consensus 252 ~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 331 (357)
T PHA03209 252 YPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLV 331 (357)
T ss_pred cCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHH
Confidence 54 444432211 0 00000000 0000011 13466777899
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 221 QSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 221 ~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
.+||+.||.+|||+.++++ +.|+.
T Consensus 332 ~~mL~~dP~~Rpta~e~l~--hp~f~ 355 (357)
T PHA03209 332 HKMLTFDAAMRPSAEEILN--YPMFA 355 (357)
T ss_pred HHHHcCCcccCcCHHHHhc--Cchhc
Confidence 9999999999999999998 44443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=261.11 Aligned_cols=208 Identities=24% Similarity=0.344 Sum_probs=157.6
Q ss_pred HHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~ 93 (298)
.+.+|+.++++++||||+++++++. +...|++|||+ +++|.+++.... ...+++..+..++.|++.||.
T Consensus 44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~ 122 (317)
T cd07868 44 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122 (317)
T ss_pred HHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999873 34688999999 559988876421 235899999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcC---CCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCc
Q 022347 94 CLHANGIIHRDLKPDNLLLTP---DQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 166 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~---~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 166 (298)
|||+.||+|+||||+||+++. ..+.++|+|||++....... ......+++.|+|||++.+ ...++.
T Consensus 123 ~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~ 195 (317)
T cd07868 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTK 195 (317)
T ss_pred HHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcC-------CCCcCc
Confidence 999999999999999999942 33579999999997543221 2234467899999998864 245788
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHhh------------------------cCC--------
Q 022347 167 KVDVYSFGIVLWELLTNRLPFEGMSNLQ--------AAYAAAFKH------------------------ARP-------- 206 (298)
Q Consensus 167 ~~Di~slG~il~~ll~g~~p~~~~~~~~--------~~~~~~~~~------------------------~~~-------- 206 (298)
++||||+||++|+|++|+.||....... ......... ...
T Consensus 196 ~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (317)
T cd07868 196 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 275 (317)
T ss_pred hhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccc
Confidence 9999999999999999999996432210 000000000 000
Q ss_pred -----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 207 -----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 207 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
......+..+.+++.+||+.||.+|||++++++
T Consensus 276 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 276 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred cchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000123456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=248.40 Aligned_cols=219 Identities=23% Similarity=0.403 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..+.+.+|+.+++.++||||+++++.+. ....|+||||+++|+|.+++..... ...++..++.++.|++.||+|||+
T Consensus 38 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 117 (268)
T cd05086 38 EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117 (268)
T ss_pred HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3468889999999999999999999985 4578999999999999999976432 346777888999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
.|++|+||||+||+++.+ +.++|+|||++...... .......++..|+|||++..... ......++.++||||||
T Consensus 118 ~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG 195 (268)
T cd05086 118 HNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG-GLITAEQTKPSNVWALG 195 (268)
T ss_pred CCeeccCCccceEEEcCC-ccEEecccccccccCcchhhhcccCCcCcccccCchhcccccC-ccccCCCCCcchhHHHH
Confidence 999999999999999855 46999999987532211 11123456788999998753110 00123457899999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhh----cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 175 IVLWELLT-NRLPFEGMSNLQAAYAAAFKH----ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 175 ~il~~ll~-g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
+++|+|++ |..||................ ..+.++..+++.+.+++..|| .+|++||++.++++.|.
T Consensus 196 ~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 196 VTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 99999997 677887655433322222111 224445568899999999999 68999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=251.44 Aligned_cols=205 Identities=29% Similarity=0.525 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
+.+.+|+.++++++||||+++++++.+ ..++++|||++|++|.+++... ..+++..+..++.|++.||.|||+.|
T Consensus 49 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~ 126 (265)
T cd06652 49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM 126 (265)
T ss_pred HHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 478899999999999999999998743 3578999999999999998753 34888999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc----cccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
++|+||+|+||+++.+ +.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||||+
T Consensus 127 i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~ 197 (265)
T cd06652 127 IVHRDIKGANILRDSV-GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADIWSVGC 197 (265)
T ss_pred EecCCCCHHHEEecCC-CCEEECcCccccccccccccccccccCCCCccccChhhhcC--------CCCCcchhHHHHHH
Confidence 9999999999999954 56999999998753321 11223357889999998864 45688999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++|++++|+.||..................+..+..++..+.+++.+|+. +|.+||+++++++
T Consensus 198 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 198 TVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 99999999999987655444433333333455666788889999999995 9999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=248.97 Aligned_cols=213 Identities=27% Similarity=0.412 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.+++.++||||+++++.+. +...++++||+++++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~ 113 (262)
T cd05572 36 QQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG 113 (262)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 3457889999999999999999999875 55799999999999999999763 45899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
++|+||+|+||+++.+ +.++|+|||++.............++..|++||.+.. ..++.++|+||+|+++|+
T Consensus 114 ~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~il~~ 184 (262)
T cd05572 114 IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN--------KGYDFSVDYWSLGILLYE 184 (262)
T ss_pred cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCCcCccChhHhcC--------CCCCChhhhhhhHHHHHH
Confidence 9999999999999965 4699999999886554433334467889999998754 557889999999999999
Q ss_pred HHhCCCCCCCCCh-HHHHHHHHH-hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSN-LQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~~l~~~~~ 246 (298)
+++|..||..... ......... .......+...++++.+++.+||..+|++||+ +.++++ +.|+.
T Consensus 185 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~--~~~~~ 256 (262)
T cd05572 185 LLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK--HKWFN 256 (262)
T ss_pred HHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc--Chhhh
Confidence 9999999987652 222222222 24455666677899999999999999999999 888887 44544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=248.48 Aligned_cols=208 Identities=29% Similarity=0.468 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++.+. +...|+++||+++++|.+++... ...+++..+..++.|++.||.|||+.|+
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i 120 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKK 120 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 468889999999999999999999884 56799999999999999998753 3568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 121 ~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~s~G~il~~ 191 (256)
T cd06612 121 IHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNNKADIWSLGITAIE 191 (256)
T ss_pred ccCCCCcceEEECCC-CcEEEcccccchhcccCccccccccCCccccCHHHHhc--------CCCCchhhHHHHHHHHHH
Confidence 999999999999965 469999999987654333 2233457789999998864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|+.||............... ......+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 192 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 192 MAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 99999999875543332221110 1111233457889999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=253.05 Aligned_cols=210 Identities=27% Similarity=0.388 Sum_probs=165.9
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|
T Consensus 52 ~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 129 (267)
T cd06646 52 LIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMH 129 (267)
T ss_pred HHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 5778999999999999999999884 56789999999999999998753 46899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+. ....++.++|+||+|+++|+|+
T Consensus 130 ~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 130 RDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred cCCCHHHEEECCC-CCEEECcCccceeecccccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999855 469999999987543221 12334578899999987431 1244678999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
+|..||..................+ .....++..+.+++.+||..+|++|||++++++++
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 204 ELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred hCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999986554332221111111111 11235788999999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=263.16 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=162.7
Q ss_pred HHHHHHHHHHhC---CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 24 RFIREVNMMSRV---KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 24 ~~~~E~~~l~~l---~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+..|..++..+ .||||+.+++.+. +...|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.|
T Consensus 39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ 116 (330)
T cd05586 39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD 116 (330)
T ss_pred HHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 344566776665 6999999999885 5579999999999999999875 356899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||||+||+++.+ +.++|+|||++..... ........|+..|+|||.+.+ ...++.++|||||||++|
T Consensus 117 ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~ 188 (330)
T cd05586 117 IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVF 188 (330)
T ss_pred eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcC-------CCCCCCccceeccccEEE
Confidence 9999999999999955 4699999999875322 222334568999999998853 234788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCC----CHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRP----SFSQIIR 239 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp----s~~~l~~ 239 (298)
+|++|..||...+..+. ..... .....++ ..+++++.+++.+||+.+|.+|| ++.++++
T Consensus 189 elltG~~Pf~~~~~~~~-~~~i~-~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 189 EMCCGWSPFYAEDTQQM-YRNIA-FGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred EeccCCCCCCCCCHHHH-HHHHH-cCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 99999999987654332 22222 2222333 34789999999999999999998 5777776
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=248.91 Aligned_cols=213 Identities=29% Similarity=0.501 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-N 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~ 98 (298)
..+.+.+|+..+.+++||||+++++++. ++..++|+||+++++|.+++... ..+++..++.++.|++.||.|||+ .
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ 119 (264)
T cd06623 42 FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR 119 (264)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC
Confidence 4467889999999999999999999884 56799999999999999999864 568999999999999999999999 9
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc-ccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++|+||+|+||+++.+ +.++|+|||.+......... ....++..|+|||.+.. ..++.++|+||||+++
T Consensus 120 ~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il 190 (264)
T cd06623 120 HIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG--------ESYSYAADIWSLGLTL 190 (264)
T ss_pred CCccCCCCHHHEEECCC-CCEEEccCccceecccCCCcccceeecccccCHhhhCC--------CCCCchhhHHHHHHHH
Confidence 99999999999999955 56999999998755433322 23457788999998864 5678899999999999
Q ss_pred HHHHhCCCCCCCCC--hHHHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 178 WELLTNRLPFEGMS--NLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 178 ~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|+|++|..||.... ..............+..+.. ++..+.+++.+||..+|++||++.++++ +.++.
T Consensus 191 ~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~--~~~~~ 260 (264)
T cd06623 191 LECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ--HPFIK 260 (264)
T ss_pred HHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh--CHHHH
Confidence 99999999998765 44444444445555566666 8999999999999999999999999998 45554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=249.55 Aligned_cols=208 Identities=25% Similarity=0.432 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.+++.+|+.++++++||||+++++++. +...+++|||+++++|.+++.... ...+++..++.++.|++.||.|||
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 122 (265)
T cd08217 43 KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122 (265)
T ss_pred HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 357889999999999999999999763 345789999999999999997632 356899999999999999999999
Q ss_pred -----hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhH
Q 022347 97 -----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 97 -----~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
+.+++|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+
T Consensus 123 ~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Dv 193 (265)
T cd08217 123 NRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH--------MSYDEKSDI 193 (265)
T ss_pred cCccccCcceecCCCHHHEEEecC-CCEEEecccccccccCCcccccccccCCCccChhhhcC--------CCCCchhHH
Confidence 8899999999999999954 5799999999886544332 334467889999999864 557889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
||||+++++|++|+.||...+. ............+.++..++..+.+++.+||+.+|.+||++.++++
T Consensus 194 ~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 194 WSLGCLIYELCALSPPFTARNQ-LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHHHHHHCCCcccCcCH-HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9999999999999999987653 3333444444555677788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=247.41 Aligned_cols=207 Identities=29% Similarity=0.452 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++.+++. ++..++|+||+++++|.+++.......+++..++.++.|++.||.|||+.|++
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (256)
T cd08218 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 47889999999999999999999985 56799999999999999999765445689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||++++++
T Consensus 124 h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~i~~~l 194 (256)
T cd08218 124 HRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN--------RPYNNKSDIWALGCVLYEM 194 (256)
T ss_pred cCCCCHHHEEEcCC-CCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC--------CCCCCccchhHHHHHHHHH
Confidence 99999999999855 4699999999875433222 123357788999998864 5677899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++|..||........ .........+..+..++.++.+++.+||+.+|.+||++.++++
T Consensus 195 ~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 195 CTLKHAFEAGNMKNL-VLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HcCCCCccCCCHHHH-HHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 999999986554333 3333445555667788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=245.74 Aligned_cols=208 Identities=31% Similarity=0.568 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ....++++||+++++|.+++... ...+++..++.++.|++.||++||+.|++
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 122 (256)
T cd05112 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVI 122 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46789999999999999999999984 55789999999999999998753 24588999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||+|+||+++. ++.++|+|||.+........ ......+..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 123 h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~--------~~~~~~~Dv~slG~~l~e 193 (256)
T cd05112 123 HRDLAARNCLVGE-NQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMWE 193 (256)
T ss_pred ccccccceEEEcC-CCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc--------CCcChHHHHHHHHHHHHH
Confidence 9999999999984 45699999998875432211 112234568999998864 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
+++ |..||...... ..............+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 194 l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 194 VFSEGKTPYENRSNS-EVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHcCCCCCCCcCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 998 99999765542 22333333334444566789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=255.78 Aligned_cols=209 Identities=26% Similarity=0.396 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++.+. +...|+||||+.|++|.+++.......+++..++.++.|++.||.|||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 124 (316)
T cd05574 45 VKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGI 124 (316)
T ss_pred HHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 357889999999999999999999885 5579999999999999999986545679999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc------------------------------cccccCccceecccc
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM------------------------------MTAETGTYRWMAPEL 150 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~------------------------------~~~~~~~~~y~aPE~ 150 (298)
+|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.
T Consensus 125 ~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 203 (316)
T cd05574 125 VYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203 (316)
T ss_pred eccCCChHHeEEcCC-CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHH
Confidence 999999999999955 4699999998864322110 112356788999999
Q ss_pred ccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 151 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
+.+ ..++.++||||||+++|++++|..||...+.....................++.+.+++.+||..+|++
T Consensus 204 ~~~--------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 275 (316)
T cd05574 204 ISG--------DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSK 275 (316)
T ss_pred HcC--------CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhH
Confidence 864 557889999999999999999999998766544333322222112222236899999999999999999
Q ss_pred CCC----HHHHHH
Q 022347 231 RPS----FSQIIR 239 (298)
Q Consensus 231 Rps----~~~l~~ 239 (298)
||+ +.+++.
T Consensus 276 R~s~~~~~~~ll~ 288 (316)
T cd05574 276 RLGSKRGAAEIKQ 288 (316)
T ss_pred CCCchhhHHHHHc
Confidence 999 888887
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=250.31 Aligned_cols=212 Identities=28% Similarity=0.474 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al 92 (298)
+++.+|+.+++++ .||||+++++++.+ ...++||||+++++|.+++.... ...+++..+..++.|++.||
T Consensus 47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al 126 (275)
T cd06608 47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126 (275)
T ss_pred HHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 5788999999999 69999999999843 24799999999999999987643 46789999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
.|||+.|++|+||+|+||+++.+ +.++|+|||.+...... .......++..|+|||.+..... ....++.++|||
T Consensus 127 ~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~ 202 (275)
T cd06608 127 AYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQ---PDASYDARSDVW 202 (275)
T ss_pred HHHhcCCcccCCCCHHHEEEccC-CeEEECCCccceecccchhhhcCccccccccCHhHhccccc---ccCCccccccHH
Confidence 99999999999999999999955 56999999998653322 22233457889999998754211 134577899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|||+++|++++|+.||............ .....+.. +..++.++.+++.+||..||.+|||+.++++
T Consensus 203 slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 203 SLGITAIELADGKPPLCDMHPMRALFKI-PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HhHHHHHHHHhCCCCccccchHHHHHHh-hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999999999999999865543333322 22222222 2347889999999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=250.46 Aligned_cols=217 Identities=30% Similarity=0.493 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++.+. +...|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~ 125 (280)
T cd06611 47 EDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVI 125 (280)
T ss_pred HHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 47889999999999999999999984 56789999999999999998763 34699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.... .....++.++|+||||+++|+|
T Consensus 126 h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~l 201 (280)
T cd06611 126 HRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIEL 201 (280)
T ss_pred cCCCChhhEEECCC-CCEEEccCccchhhcccccccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHHH
Confidence 99999999999955 469999999876533222 222345788999999875311 1124577899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||........... ......+ ..+..++.++.+++.+||+.+|.+||++.++++ +.|+..
T Consensus 202 ~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~ 267 (280)
T cd06611 202 AQMEPPHHELNPMRVLLK-ILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK--HPFVSD 267 (280)
T ss_pred HhCCCCcccCCHHHHHHH-HhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc--Chhhcc
Confidence 999999987654433222 2222222 234568899999999999999999999999988 555544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=253.33 Aligned_cols=206 Identities=34% Similarity=0.577 Sum_probs=165.6
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
...+|+.++++++||||+++++++. +...++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H 121 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVH 121 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred hhhhhhhcccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccc
Confidence 4456999999999999999999984 66799999999999999999832 56899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccC-ccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+||||+||+++ +.+.++|+|||.+... ..........++..|.|||.+.. ...++.++|+||||+++++|+
T Consensus 122 ~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~ 193 (260)
T PF00069_consen 122 RDIKPENILLD-ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQ-------GKKYTRKSDIWSLGIILYELL 193 (260)
T ss_dssp SSBSGGGEEES-TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTT-------TSSBSTHHHHHHHHHHHHHHH
T ss_pred ccccccccccc-cccccccccccccccccccccccccccccccccccccccc-------ccccccccccccccccccccc
Confidence 99999999999 4456999999998752 23334455678899999999751 267889999999999999999
Q ss_pred hCCCCCCCCChHHH--HHH-HHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 182 TNRLPFEGMSNLQA--AYA-AAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~~~~--~~~-~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|..||........ ... ......... .....+..+.+++.+||+.+|++|||+.++++
T Consensus 194 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 194 TGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999987632111 111 111111111 11223489999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=253.06 Aligned_cols=222 Identities=29% Similarity=0.380 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
......+.+|+.++++++||||+++++++. ++..++||||+ +++|.+++.... ..+++..++.++.|+++||.|||+
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~ 120 (298)
T cd07841 43 DGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS 120 (298)
T ss_pred chhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 334557778999999999999999999985 45799999999 889999997633 369999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||++
T Consensus 121 ~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~i 192 (298)
T cd07841 121 NWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCI 192 (298)
T ss_pred CCeeecCCChhhEEEcCC-CCEEEccceeeeeccCCCccccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHH
Confidence 999999999999999955 569999999987544322 2223356778999998743 2456889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcC---------------------C-----CCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHAR---------------------P-----GLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------------~-----~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
+|++++|..+|.+..+............. + ......+..+.+++.+||+.+|++
T Consensus 193 l~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 272 (298)
T cd07841 193 FAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNK 272 (298)
T ss_pred HHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCccc
Confidence 99999998888765543322221110000 0 011335678999999999999999
Q ss_pred CCCHHHHHHHHHhhhhccCCCC
Q 022347 231 RPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 231 Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
|||+.++++ +.|+.+...+.
T Consensus 273 R~s~~e~l~--~~~~~~~~~~~ 292 (298)
T cd07841 273 RITARQALE--HPYFSNDPAPT 292 (298)
T ss_pred CcCHHHHhh--CccccCCCCCC
Confidence 999999998 77776644433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=254.11 Aligned_cols=215 Identities=27% Similarity=0.428 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++.+. ++..|+++||+++++|.+++.. ..+++..++.++.|++.||.|||+.|+
T Consensus 62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i 138 (297)
T cd06659 62 RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGV 138 (297)
T ss_pred HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 346789999999999999999999884 5679999999999999998765 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 139 vH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e 209 (297)
T cd06659 139 IHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--------TPYGTEVDIWSLGIMVIE 209 (297)
T ss_pred ecCCCCHHHeEEccC-CcEEEeechhHhhcccccccccceecCccccCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 999999999999955 469999999886433221 1223467889999998864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
|++|..||............... .........++..+.+++.+||+.+|.+||++.++++ +.++.....
T Consensus 210 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~--~~~~~~~~~ 279 (297)
T cd06659 210 MVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD--HPFLLQTGL 279 (297)
T ss_pred HHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh--ChhhccCCC
Confidence 99999999866544332221111 1111223457889999999999999999999999998 455554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=251.48 Aligned_cols=207 Identities=27% Similarity=0.492 Sum_probs=165.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++.+. ++..++||||+++++|..+ ..+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i 116 (279)
T cd06619 43 QKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKI 116 (279)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 357889999999999999999999884 5678999999999999764 237888999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||||+||+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus 117 ~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l 186 (279)
T cd06619 117 LHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISG--------EQYGIHSDVWSLGISFMEL 186 (279)
T ss_pred eeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cccCCCCChhhcCceeecC--------CCCCCcchHHHHHHHHHHH
Confidence 999999999999965 46999999998754322 2233467889999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHH------HHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 181 LTNRLPFEGMSNLQ------AAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 181 l~g~~p~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++|+.||....... ...........+.. ...+++++.+++.+||+.+|.+||++.++++ +.++.
T Consensus 187 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~--~~~~~ 257 (279)
T cd06619 187 ALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD--HPFIV 257 (279)
T ss_pred HhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc--Ccccc
Confidence 99999996532211 11111122222222 2347889999999999999999999999988 44443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=250.83 Aligned_cols=203 Identities=29% Similarity=0.460 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. +...|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i 122 (290)
T cd05580 45 VEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDI 122 (290)
T ss_pred HHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 457889999999999999999999985 55789999999999999999763 568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|.||+++.+ +.++|+|||++...... .....+++.|+|||.+.+ ...+.++|+||||+++|+|
T Consensus 123 ~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 191 (290)
T cd05580 123 VYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILS--------KGYGKAVDWWALGILIYEM 191 (290)
T ss_pred ecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--CCCCCCCccccChhhhcC--------CCCCccccHHHHHHHHHHH
Confidence 999999999999955 46999999998765433 234467889999998854 4567899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
++|..||....... ..... ......++..++..+.+++.+||..+|.+|+ +++++++
T Consensus 192 ~~g~~p~~~~~~~~-~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 192 LAGYPPFFDDNPIQ-IYEKI-LEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HhCCCCCCCCCHHH-HHHHH-hcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 99999998765322 22222 2445567778899999999999999999999 7888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=252.24 Aligned_cols=208 Identities=27% Similarity=0.436 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++ ++|.+++..... ..+++..++.++.|++.||.|||+.|+
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 122 (285)
T cd07861 44 STAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122 (285)
T ss_pred HHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 46778999999999999999999985 567999999996 589998865333 568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+
T Consensus 123 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~ 194 (285)
T cd07861 123 LHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAE 194 (285)
T ss_pred eecCCCHHHEEEcCC-CcEEECcccceeecCCCcccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHH
Confidence 999999999999955 569999999986443221 1223356788999998753 2346789999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhc---------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHA---------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
|++|+.||.+............... .......+++++.+++.+||+.||.+||
T Consensus 195 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 274 (285)
T cd07861 195 MATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI 274 (285)
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC
Confidence 9999999986554332222110000 0011234788999999999999999999
Q ss_pred CHHHHHH
Q 022347 233 SFSQIIR 239 (298)
Q Consensus 233 s~~~l~~ 239 (298)
|+.++++
T Consensus 275 t~~~ll~ 281 (285)
T cd07861 275 SAKKALN 281 (285)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=248.90 Aligned_cols=208 Identities=27% Similarity=0.419 Sum_probs=165.9
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.+++.++||||+++++.+. ++..|++|||+++++|.+++... +.+++..++.++.|++.||.|||+.|++|
T Consensus 52 ~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 129 (267)
T cd06645 52 VVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMH 129 (267)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 5678999999999999999999884 56799999999999999998753 46899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+||+|+||+++.+ +.++|+|||++...... .......++..|+|||.+... ....++.++|+||||+++|+|+
T Consensus 130 ~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~l~ 203 (267)
T cd06645 130 RDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred CCCCHHHEEECCC-CCEEECcceeeeEccCcccccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHHHh
Confidence 9999999999955 46999999998643322 122334678899999987421 1245788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCC-C--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPG-L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|..||..................+. . ...++..+.+++.+||..+|++|||++++++
T Consensus 204 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 204 ELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 99999876544333222221211111 1 1247788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=255.18 Aligned_cols=218 Identities=23% Similarity=0.390 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..+++|||+++++|.+++.......+++..+..++.|++.||+|||++||+
T Consensus 44 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~iv 123 (314)
T cd08216 44 KLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI 123 (314)
T ss_pred HHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 47889999999999999999999885 56789999999999999999876556789999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.. ....++.++|+||+
T Consensus 124 H~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws~ 196 (314)
T cd08216 124 HRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ------NLQGYNEKSDIYSV 196 (314)
T ss_pred cCCCCcceEEEecC-CceEEecCccceeeccccccccccccccccccccccccCHHHhcC------CCCCCCcchhHHHH
Confidence 99999999999954 569999999886432211 1122346678999998854 11347789999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC--------------------------------CCCCCCCcHHHHHHHH
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--------------------------------PGLPEDISPDLAFIVQ 221 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~l~~li~ 221 (298)
|+++|+|++|..||.................. ......++.++.+++.
T Consensus 197 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 276 (314)
T cd08216 197 GITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE 276 (314)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHH
Confidence 99999999999999876544333222110000 0011224567889999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+||..+|++|||+.++++ +.++...+
T Consensus 277 ~~l~~~P~~Rpt~~~ll~--~p~~~~~~ 302 (314)
T cd08216 277 LCLQRDPESRPSASQLLN--HSFFKQCK 302 (314)
T ss_pred HHhhcCCCcCcCHHHHhc--CchHhhhc
Confidence 999999999999999998 66665544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=246.73 Aligned_cols=208 Identities=29% Similarity=0.459 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++.+. ++..++++||+++++|.+++.......+++..+..++.|++.||.|||+.|++
T Consensus 44 ~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (257)
T cd08225 44 EASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123 (257)
T ss_pred HHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46779999999999999999999884 56789999999999999999775555689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.++..++|+|||.+........ .....++..|+|||.+.. ..++.++|+||||++++++
T Consensus 124 H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l 195 (257)
T cd08225 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN--------RPYNNKTDIWSLGCVLYEL 195 (257)
T ss_pred cccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcC--------CCCCchhhHHHHHHHHHHH
Confidence 9999999999997766689999998875433221 223357888999998754 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++|..||...+..... ...........+..++..+.+++.+||..+|++|||+.+++.
T Consensus 196 ~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 196 CTLKHPFEGNNLHQLV-LKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HhCCCCCCCccHHHHH-HHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 9999999865543333 233334444556678899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=252.71 Aligned_cols=212 Identities=25% Similarity=0.470 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-N 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~ 98 (298)
..+++.+|++++++++||||+++++++. ++..++||||++|++|.+++... ..+++..+..++.|++.||.|||+ .
T Consensus 42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ 119 (308)
T cd06615 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH 119 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 4457889999999999999999999984 66899999999999999999763 558999999999999999999997 5
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|++|+||+|+||+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 120 ~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~ 189 (308)
T cd06615 120 KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYTVQSDIWSLGLSLV 189 (308)
T ss_pred CEEECCCChHHEEEecC-CcEEEccCCCccccccc-ccccCCCCcCccChhHhcC--------CCCCccchHHHHHHHHH
Confidence 99999999999999955 56999999988654322 1233467889999998754 45778999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHH------------------------------------HHhhcCCCCC-CCCcHHHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAA------------------------------------AFKHARPGLP-EDISPDLAFIVQ 221 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~------------------------------------~~~~~~~~~~-~~~~~~l~~li~ 221 (298)
++++|..||...+... .... ......+..+ ..++.++.+++.
T Consensus 190 ~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (308)
T cd06615 190 EMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVD 268 (308)
T ss_pred HHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHH
Confidence 9999999986543211 1110 0111112222 136788999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+||..+|++|||+.++++ +.|+..
T Consensus 269 ~~l~~~P~~Rpt~~~ll~--~~~~~~ 292 (308)
T cd06615 269 KCLKKNPKERADLKELTK--HPFIKR 292 (308)
T ss_pred HHccCChhhCcCHHHHhc--Chhhhh
Confidence 999999999999999998 555543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=252.35 Aligned_cols=208 Identities=26% Similarity=0.455 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-N 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~ 98 (298)
..+++.+|+++++.++||||+++++.+. .+..++||||+++++|.+++... +.+++..+..++.+++.||.|||+ .
T Consensus 46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ 123 (284)
T cd06620 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH 123 (284)
T ss_pred HHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 4567889999999999999999999985 46789999999999999998753 458999999999999999999997 6
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|++|+||+|+||+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++|+|||||++|
T Consensus 124 ~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~ 193 (284)
T cd06620 124 RIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQG--------GKYTVKSDVWSLGISII 193 (284)
T ss_pred CeeccCCCHHHEEECCC-CcEEEccCCcccchhhh-ccCccccCcccCCHHHHcc--------CCCCccchHHHHHHHHH
Confidence 99999999999999954 56999999988643222 1223467889999998864 56788999999999999
Q ss_pred HHHhCCCCCCCCChH----------HHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 179 ELLTNRLPFEGMSNL----------QAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
++++|..||...... ............+.++.. ++.++.+++.+||+.+|.+|||+.+++++
T Consensus 194 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 194 ELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 999999999864431 112222222333333333 78899999999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=268.36 Aligned_cols=205 Identities=25% Similarity=0.360 Sum_probs=157.9
Q ss_pred HHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++ .++..++|||++ .++|.+++... ...+++..++.|+.|++.||.|||+.||+|
T Consensus 206 ~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 283 (461)
T PHA03211 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283 (461)
T ss_pred CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 566899999999999999999987 466789999999 56999988652 346999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||+|||++.+ +.++|+|||++....... ......|+..|+|||++.+ ..++.++|||||||++||
T Consensus 284 rDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~sDvwSlGviL~E 354 (461)
T PHA03211 284 RDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG--------DPYTPSVDIWSAGLVIFE 354 (461)
T ss_pred CcCCHHHEEECCC-CCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC--------CCCCchHHHHHHHHHHHH
Confidence 9999999999955 469999999987533221 1123468999999999865 567889999999999999
Q ss_pred HHhCCCCCCCCCh-------HHHHHHHHHhhc--------------------------CCCCC-------CCCcHHHHHH
Q 022347 180 LLTNRLPFEGMSN-------LQAAYAAAFKHA--------------------------RPGLP-------EDISPDLAFI 219 (298)
Q Consensus 180 ll~g~~p~~~~~~-------~~~~~~~~~~~~--------------------------~~~~~-------~~~~~~l~~l 219 (298)
|++|..++..... ............ .+... ..++..+.+|
T Consensus 355 l~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 434 (461)
T PHA03211 355 AAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYL 434 (461)
T ss_pred HHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHH
Confidence 9987755422110 111111111000 00000 1345678999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 022347 220 VQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 220 i~~~l~~~p~~Rps~~~l~~ 239 (298)
|.+||+.||.+|||+.|+++
T Consensus 435 i~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 435 VCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHcccChhhCcCHHHHhh
Confidence 99999999999999999998
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=257.31 Aligned_cols=213 Identities=20% Similarity=0.325 Sum_probs=167.1
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++..++||+|+++++.+. ++..|+||||+++|+|.+++... ...+++..+..++.|++.||.|||+.|++
T Consensus 46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ii 124 (332)
T cd05623 46 ACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYV 124 (332)
T ss_pred HHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45788999999999999999999885 55799999999999999999763 24689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+||+++.+ +.++|+|||++....... ......|++.|+|||++.... .....++.++||||||+++|+
T Consensus 125 HrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 125 HRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred ecCCCHHHEEECCC-CCEEEeecchheecccCCcceecccccCccccCHHHHhccc---cCCCCCCCcCCEEeeHHHHHH
Confidence 99999999999955 469999999986432222 122346899999999886321 112467889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCC--CCCCHHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPN--LRPSFSQIIRM 240 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~--~Rps~~~l~~~ 240 (298)
|++|+.||...+................+ ...+++++.+++.+|+..++. .|+++++++++
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 201 MLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99999999876654443333222222222 245799999999999865444 36899999884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=249.01 Aligned_cols=222 Identities=24% Similarity=0.436 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHA-NG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~-~g 99 (298)
+.+.+|+.++++++||||+++++.+. ++..++||||++|++|..++.... ...+++..+..++.|++.||.|||+ .|
T Consensus 44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 123 (286)
T cd06622 44 NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123 (286)
T ss_pred HHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 57889999999999999999999874 668999999999999999987532 2368999999999999999999996 59
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
++|+||+|+||+++. .+.++|+|||.+...... ......++..|+|||.+.+.... ....++.++|+||||+++|+
T Consensus 124 i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~~ 199 (286)
T cd06622 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPN--QNPTYTVQSDVWSLGLSILE 199 (286)
T ss_pred EeeCCCCHHHEEECC-CCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCC--ccCCCCcccchHhHHHHHHH
Confidence 999999999999996 456999999998754322 22334577889999988642211 22456889999999999999
Q ss_pred HHhCCCCCCCCChHH--HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 180 LLTNRLPFEGMSNLQ--AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 180 ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
+++|+.||....... ...........+.++..++.++.+++.+||+.+|.+||++.++++ +.|+...+.
T Consensus 200 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~~ 270 (286)
T cd06622 200 MALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYKN 270 (286)
T ss_pred HHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--ChhhhhccC
Confidence 999999997643322 122223344456677779999999999999999999999999998 566655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=257.61 Aligned_cols=217 Identities=21% Similarity=0.337 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|..++..++||||+++++++. +++.|+||||++|++|.+++... ...+++..+..++.|++.||+|||++|+
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (331)
T cd05597 45 TACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGY 123 (331)
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 346788999999999999999999985 56799999999999999999752 3568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+||||||+||+++.+ +.++|+|||++........ .....|++.|+|||++..... ....++.++|||||||++|
T Consensus 124 vH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED---GKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred EECCCCHHHEEECCC-CCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccc---cccCCCCcceeehhhhHHH
Confidence 999999999999855 4699999999865433222 122458999999999863110 1245778999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCC--CCCCHHHHHHHHHhhh
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPN--LRPSFSQIIRMLNAFL 245 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~--~Rps~~~l~~~l~~~~ 245 (298)
+|++|+.||.+....+.............+ ...++..+.+++.+||..++. .|+++.++++ +.|+
T Consensus 200 el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~--hp~~ 269 (331)
T cd05597 200 EMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD--HPFF 269 (331)
T ss_pred HHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--CCCC
Confidence 999999999876543332222221211222 234789999999998865333 3789999988 4444
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=253.91 Aligned_cols=217 Identities=31% Similarity=0.471 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++||||+++++++. ++..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++
T Consensus 61 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~ 137 (297)
T cd06656 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVI 137 (297)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46779999999999999999999985 5679999999999999999875 4588999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|++
T Consensus 138 H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slGvil~~l 208 (297)
T cd06656 138 HRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEM 208 (297)
T ss_pred cCCCCHHHEEECCC-CCEEECcCccceEccCCccCcCcccCCccccCHHHHcC--------CCCCcHHHHHHHHHHHHHH
Confidence 99999999999855 5699999998865332221 223457889999998864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 253 (298)
++|..||...+............ .....+..++..+.+++.+||..+|++||++.++++ +.++...++...
T Consensus 209 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~~~~~ 280 (297)
T cd06656 209 VEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPLSS 280 (297)
T ss_pred HhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhcccccccc
Confidence 99999997655433222111111 111234567889999999999999999999999998 677766555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=255.80 Aligned_cols=199 Identities=25% Similarity=0.412 Sum_probs=162.9
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+..|..++..+. |++|+++++++. ++..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++|+
T Consensus 45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~i 122 (323)
T cd05615 45 ECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGI 122 (323)
T ss_pred HHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35678888888886 567778888875 45799999999999999998753 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++....... ......|+..|+|||++.+ ..++.++||||||+++|+
T Consensus 123 vHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~e 193 (323)
T cd05615 123 IYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYE 193 (323)
T ss_pred eccCCCHHHeEECCC-CCEEEeccccccccCCCCccccCccCCccccCHHHHcC--------CCCCCccchhhhHHHHHH
Confidence 999999999999955 469999999987532221 2233468899999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (298)
|++|..||.+...... .... .......+..++.++.+++.+||+.+|.+|++.
T Consensus 194 lltG~~pf~~~~~~~~-~~~i-~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 194 MLAGQPPFDGEDEDEL-FQSI-MEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCCCCCCCCHHHH-HHHH-HhCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 9999999987654332 2222 234455677889999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=260.53 Aligned_cols=229 Identities=26% Similarity=0.494 Sum_probs=184.2
Q ss_pred hhhHHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHH
Q 022347 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81 (298)
Q Consensus 3 ~~~~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 81 (298)
+|..|+++.+..... +.+|.+|+++|.+|+||||++++++| .++-+++|+||+++|+|.+|+.++......-...
T Consensus 564 kVAVK~Lr~~a~~~~----r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~ 639 (807)
T KOG1094|consen 564 KVAVKILRPDATKNA----RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPG 639 (807)
T ss_pred EEEEeecCcccchhH----HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchh
Confidence 344555655554443 45899999999999999999999999 5778999999999999999999864444455667
Q ss_pred HHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceecccccccccccc
Q 022347 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQ 158 (298)
Q Consensus 82 ~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 158 (298)
.+|+.||++|++||.+.++|||||.+.|+|++.+ ..+||+|||.++..-.... .....-...|+|+|.+..
T Consensus 640 vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill----- 713 (807)
T KOG1094|consen 640 VSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL----- 713 (807)
T ss_pred HHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh-----
Confidence 7899999999999999999999999999999955 4699999999985433222 222344568999999875
Q ss_pred CCccCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHH--hh-c---CCCCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 159 GEKKHYNNKVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAAF--KH-A---RPGLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 159 ~~~~~~~~~~Di~slG~il~~ll~--g~~p~~~~~~~~~~~~~~~--~~-~---~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
+.++.+||+|++|+++||+++ ...||+...+.+....... .. . -...|..++..+.+++.+||..+-.+
T Consensus 714 ---gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~ 790 (807)
T KOG1094|consen 714 ---GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQ 790 (807)
T ss_pred ---ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhc
Confidence 889999999999999999876 7899988776555444321 11 1 12456779999999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 022347 231 RPSFSQIIRMLNAF 244 (298)
Q Consensus 231 Rps~~~l~~~l~~~ 244 (298)
||+++++...|++.
T Consensus 791 RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 791 RPSFEQLHLFLQED 804 (807)
T ss_pred CCCHHHHHHHHHHh
Confidence 99999999888754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=240.28 Aligned_cols=220 Identities=26% Similarity=0.464 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.++.+|++++.+++ |+||++++++|++ ..+|+|||.+.||+|...|..+ .-|++.++.+++..|+.||.|||.+||
T Consensus 120 ~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgI 197 (463)
T KOG0607|consen 120 SRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGI 197 (463)
T ss_pred HHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCc
Confidence 46779999999997 9999999999964 5799999999999999999874 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCC--ceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 101 IHRDLKPDNLLLTPDQK--SLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
.|||+||+|||-...+. .+|||||.+........ ...+..|+..|||||+..-.. +....|+.++|.
T Consensus 198 AHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv---~qA~~YDKrCDl 274 (463)
T KOG0607|consen 198 AHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV---DQATFYDKRCDL 274 (463)
T ss_pred ccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc---cccccccccccH
Confidence 99999999999864332 58999999876432221 123346888999999875321 134678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC-------------hHHHHHHHHHhhcCCCCCC----CCcHHHHHHHHHhhhhCCCCCCC
Q 022347 171 YSFGIVLWELLTNRLPFEGMS-------------NLQAAYAAAFKHARPGLPE----DISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~-------------~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps 233 (298)
||||+|+|-|++|.+||.+.- ..+......+..+.-++|+ .+|.+..+++..+|..++.+|.+
T Consensus 275 wSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls 354 (463)
T KOG0607|consen 275 WSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS 354 (463)
T ss_pred HHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence 999999999999999997532 1233333445555666664 48899999999999999999999
Q ss_pred HHHHHHHHHhhhhccC
Q 022347 234 FSQIIRMLNAFLFTLR 249 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~~ 249 (298)
+.++++ +.|+....
T Consensus 355 a~~vln--hPw~~~~~ 368 (463)
T KOG0607|consen 355 AAQVLN--HPWVQRCA 368 (463)
T ss_pred hhhccC--Cccccccc
Confidence 999988 45554444
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=259.33 Aligned_cols=208 Identities=23% Similarity=0.350 Sum_probs=156.7
Q ss_pred HHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhh-------CCCCCCHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSL-------RPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~~~i~~qi~~al~ 93 (298)
.+.+|+.++++++||||+++++++. +...++|+||++ ++|.+++... ....+++..++.++.|++.||.
T Consensus 44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 122 (317)
T cd07867 44 SACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122 (317)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999873 346899999995 5888887532 1234889999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcC---CCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCc
Q 022347 94 CLHANGIIHRDLKPDNLLLTP---DQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 166 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~---~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 166 (298)
|||+.|++|+||||+||++.. ..+.++|+|||++....... ......++..|+|||.+.+ ...++.
T Consensus 123 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~ 195 (317)
T cd07867 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTK 195 (317)
T ss_pred HHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcC-------CCccCc
Confidence 999999999999999999942 34579999999997543321 1223467889999998864 245788
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHhh-c------------C--------------------
Q 022347 167 KVDVYSFGIVLWELLTNRLPFEGMSNLQ--------AAYAAAFKH-A------------R-------------------- 205 (298)
Q Consensus 167 ~~Di~slG~il~~ll~g~~p~~~~~~~~--------~~~~~~~~~-~------------~-------------------- 205 (298)
++||||||+++|+|++|..||....... ......... . .
T Consensus 196 ~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (317)
T cd07867 196 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSL 275 (317)
T ss_pred HHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchh
Confidence 9999999999999999999996432210 000000000 0 0
Q ss_pred ----CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 206 ----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 206 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
.......+..+.+++.+||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 276 IKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0001123456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=249.11 Aligned_cols=213 Identities=30% Similarity=0.502 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++++||++|++|.+++.. ..+++..+..++.|++.||+|||+.|++
T Consensus 61 ~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~ 137 (285)
T cd06648 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVI 137 (285)
T ss_pred HHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46789999999999999999999874 5679999999999999999876 4689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus 138 H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~el 208 (285)
T cd06648 138 HRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEM 208 (285)
T ss_pred cCCCChhhEEEcCC-CcEEEcccccchhhccCCcccccccCCccccCHHHhcC--------CCCCCcccHHHHHHHHHHH
Confidence 99999999999955 569999999876433221 1223457889999998854 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++|..||...+....... ......+.. +..++..+.+++.+||..+|++||++.++++ +.++...++
T Consensus 209 l~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~~ 277 (285)
T cd06648 209 VDGEPPYFNEPPLQAMKR-IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGP 277 (285)
T ss_pred HhCCCCCcCCCHHHHHHH-HHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc--CcccccCCC
Confidence 999999977554333222 222222222 2337889999999999999999999999998 677666554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=248.63 Aligned_cols=228 Identities=27% Similarity=0.413 Sum_probs=186.5
Q ss_pred CchhhHHHhcCCCCcH-----HHHHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCC
Q 022347 1 MGKFMKEVLNRGSTSD-----ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPN 74 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~ 74 (298)
||.|+|.|.+..-... ..+..-+++.+|+.++.+++.|+||++|+.| ....+|||||||..|++.+.+.. +.+
T Consensus 46 YGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~-R~K 124 (502)
T KOG0574|consen 46 YGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA-RRK 124 (502)
T ss_pred chHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH-hcC
Confidence 6888888877644331 1122234778999999999999999999976 66789999999999999999976 457
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccc
Q 022347 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYST 153 (298)
Q Consensus 75 ~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 153 (298)
.+++.++..++...+.||+|||...-+|||||..|||++.++ ..||.|||.+......- ...+.+||+.|+|||++..
T Consensus 125 ~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E 203 (502)
T KOG0574|consen 125 PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE 203 (502)
T ss_pred CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhhCccccCcccccHHHHHH
Confidence 899999999999999999999999999999999999999665 69999999997544332 2345689999999999975
Q ss_pred cccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCC
Q 022347 154 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 154 ~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R 231 (298)
-.|..++||||||++..||..|++||.+..+.....-. ....++. -|..+++++-++++.||-.+|++|
T Consensus 204 --------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R 274 (502)
T KOG0574|consen 204 --------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEER 274 (502)
T ss_pred --------hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHH
Confidence 66888999999999999999999999876654332211 1222222 245689999999999999999999
Q ss_pred CCHHHHHH
Q 022347 232 PSFSQIIR 239 (298)
Q Consensus 232 ps~~~l~~ 239 (298)
.|+.++++
T Consensus 275 ~TA~~L~~ 282 (502)
T KOG0574|consen 275 KTALRLCE 282 (502)
T ss_pred HHHHHHhh
Confidence 99999988
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=246.02 Aligned_cols=212 Identities=28% Similarity=0.524 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHHh-CCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSR-VKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 21 ~~~~~~~E~~~l~~-l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
...++.+|+.++.+ ++||||+++++++ .++..+++|||++|++|.+++... ....+++..++.++.|++.||.|||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 33467789988875 7899999999988 466899999999999999988542 2356899999999999999999999
Q ss_pred h-CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 97 A-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 97 ~-~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
+ .|++|+||+|+||+++.+ +.++|+|||.+.............++..|++||.+.+ ..++.++|+||||+
T Consensus 131 ~~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~ 201 (269)
T cd08528 131 KEKRIVHRDLTPNNIMLGED-DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN--------EPYGEKADVWAFGC 201 (269)
T ss_pred cCCceeecCCCHHHEEECCC-CcEEEecccceeecccccccccccCcccCcChhhhcC--------CCCchHHHHHHHHH
Confidence 6 789999999999999955 4699999999976554433344567889999998864 55788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++|++++|..||......... .........+.+ ..+++.+.+++.+||+.||++||++.++..++.
T Consensus 202 ll~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 202 ILYQMCTLQPPFYSTNMLSLA-TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHhCCCcccccCHHHHH-HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 999999999999765543322 222222222222 367899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=251.52 Aligned_cols=213 Identities=28% Similarity=0.459 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee------cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~ 93 (298)
+.+.+|+.+++++ +||||+++++++. ++..++||||++|++|.+++... ....+++..++.++.|++.||.
T Consensus 59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ 138 (286)
T cd06638 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138 (286)
T ss_pred HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence 4677899999999 6999999999862 34689999999999999988642 2345889999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
|||+.+++|+||+|+||+++.++ .++|+|||++....... ......++..|+|||.+.... .....++.++||||
T Consensus 139 ~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~s 214 (286)
T cd06638 139 HLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QLDSTYDARCDVWS 214 (286)
T ss_pred HHHhCCccccCCCHHhEEECCCC-CEEEccCCceeecccCCCccccccCCCcccChhhhchhh---hccccccchhhhhh
Confidence 99999999999999999999654 59999999987543222 223346788999999875311 11245788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
+|+++|+|++|..||............ .....+ ..+..++..+.+++.+||+.+|++|||+.+++++
T Consensus 215 lGvi~~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 215 LGITAIELGDGDPPLADLHPMRALFKI-PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHHHHHHhcCCCCCCCCchhHHHhhc-cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 999999999999999876543332221 111111 2344578899999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=247.10 Aligned_cols=213 Identities=29% Similarity=0.562 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecC-------ceeEEEecCCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIAR 90 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~ 90 (298)
.+++.+|+.++++++||||+++++++... ..+++++|+.+++|.+++.... ...+++..++.++.|++.
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 124 (273)
T cd05074 45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124 (273)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Confidence 35688999999999999999999987321 2478999999999999875422 224788999999999999
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcc
Q 022347 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 91 al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
||+|||+.|++|+||||+||+++.+ ..++|+|||++....... ......++..|++||.+.. ..++.+
T Consensus 125 ~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~ 195 (273)
T cd05074 125 GMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD--------NVYTTH 195 (273)
T ss_pred HHHHHHhCCEeecccchhhEEEcCC-CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc--------Cccchh
Confidence 9999999999999999999999854 569999999987543221 1122234567999998754 567889
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 168 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 168 ~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+||||||+++|++++ |..||.+.+.. ..............+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 196 sDi~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 196 SDVWAFGVTMWEIMTRGQTPYAGVENS-EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred hhhHHHHHHHHHHhhCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999 88999766543 33333333344445567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=248.18 Aligned_cols=205 Identities=29% Similarity=0.471 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. +...|+||||+++++|.+++.. ..+++..+..++.|++.|+.+||+.|+
T Consensus 46 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (277)
T cd06641 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKK 122 (277)
T ss_pred HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCe
Confidence 357889999999999999999999985 5679999999999999999875 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 123 ~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~ 193 (277)
T cd06641 123 IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIE 193 (277)
T ss_pred ecCCCCHHhEEECCC-CCEEEeecccceecccchhhhccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHH
Confidence 999999999999954 569999999886543322 1223356788999998864 456789999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|..||....... ..........+.++..++.++.+++.+||+.+|.+||++.+++.
T Consensus 194 l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 194 LAKGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHcCCCCCCccchHH-HHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999997655332 22223334455566778999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=244.91 Aligned_cols=210 Identities=27% Similarity=0.541 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. .+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|
T Consensus 51 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ 128 (272)
T cd06629 51 MVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG 128 (272)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 3457889999999999999999999985 45789999999999999999764 46899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.. ....++.++|+||||++
T Consensus 129 i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~~Dv~slG~~ 201 (272)
T cd06629 129 ILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS------YSQGYSAKVDIWSLGCV 201 (272)
T ss_pred eeecCCChhhEEEcCC-CeEEEeeccccccccccccccccccccCCccccCHHHhcc------ccCCCCccchhHHHHHH
Confidence 9999999999999954 569999999987533211 1123357789999998764 11347889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|++++|..||....................++ ..++.++.+++.+||..+|.+|||+.++++
T Consensus 202 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 202 VLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 999999999997655544333322222222222 346889999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=245.36 Aligned_cols=211 Identities=28% Similarity=0.461 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++.+. .+..++|+||+++++|.+++... ..+++..+..++.+++.||.|||+.|
T Consensus 42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~ 119 (264)
T cd06626 42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG 119 (264)
T ss_pred HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC
Confidence 4457889999999999999999999874 55789999999999999999763 34889999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc-----ccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
++|+||+|+||+++. ++.++|+|||++......... ....++..|+|||.+.+.. ...++.++||||||
T Consensus 120 i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~~~~Dv~s~G 193 (264)
T cd06626 120 IVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK-----GKGHGRAADIWSLG 193 (264)
T ss_pred cccCCCCHHHEEECC-CCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCC-----CCCCCcccchHHHH
Confidence 999999999999995 457999999998754332221 1235678999999986411 13478899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++++++++|+.||..................+.++.. ++..+.+++.+||+.+|.+||++.+++.
T Consensus 194 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 194 CVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999999999766443333333333334445544 4889999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=260.57 Aligned_cols=210 Identities=24% Similarity=0.400 Sum_probs=164.0
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++. +...|++||++ +++|.+++.. ...+++..++.++.|++.||.|||+.||+|
T Consensus 132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givH 208 (392)
T PHA03207 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIH 208 (392)
T ss_pred cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4468999999999999999999885 56789999999 5689998853 356999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|||||+||+++.+ +.++|+|||++........ .....|+..|+|||++.+ ..++.++|||||||++|+
T Consensus 209 rDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~e 279 (392)
T PHA03207 209 RDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL--------DPYCAKTDIWSAGLVLFE 279 (392)
T ss_pred cCCCHHHEEEcCC-CCEEEccCccccccCcccccccccccccccCccCHhHhcC--------CCCCchhhHHHHHHHHHH
Confidence 9999999999955 4699999999875433221 223468999999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChH--HHHHHHHH--------------------------hhcCCC--CC-----CCCcHHHHHHHHHhh
Q 022347 180 LLTNRLPFEGMSNL--QAAYAAAF--------------------------KHARPG--LP-----EDISPDLAFIVQSCW 224 (298)
Q Consensus 180 ll~g~~p~~~~~~~--~~~~~~~~--------------------------~~~~~~--~~-----~~~~~~l~~li~~~l 224 (298)
|++|+.||.+.... ........ ...++. .+ ..++.++.++|.+||
T Consensus 280 l~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml 359 (392)
T PHA03207 280 MSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKML 359 (392)
T ss_pred HHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHh
Confidence 99999999654321 00011000 000111 11 235678899999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhc
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
..+|++|||+.+++. +.++..
T Consensus 360 ~~dp~~Rpsa~e~l~--~p~f~~ 380 (392)
T PHA03207 360 TFDQEFRPSAQDILS--LPLFTK 380 (392)
T ss_pred ccChhhCCCHHHHhh--Cchhhc
Confidence 999999999999998 555543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.21 Aligned_cols=214 Identities=29% Similarity=0.541 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..+.|.+|+.++++++||||+++++++.+ ...+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~ 127 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS 127 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh
Confidence 45688999999999999999999998743 36899999999999999997632 358999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
.|++|+||+|+||+++.+ +.++|+|||.+........ .....+...|++||.+.+ ..++.++|||||
T Consensus 128 ~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~sl 198 (284)
T cd05038 128 QRYIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT--------SKFSSASDVWSF 198 (284)
T ss_pred CCeecCCCCHHhEEEcCC-CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc--------CCCCcccchHHH
Confidence 999999999999999965 5699999999976542211 111234456999998864 567889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHH--------------HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 174 GIVLWELLTNRLPFEGMSNLQ--------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|+++++|++|..|+....... ..............+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 199 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 199 GVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred hhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999876532211 111122222333445567889999999999999999999999999
Q ss_pred HHHhh
Q 022347 240 MLNAF 244 (298)
Q Consensus 240 ~l~~~ 244 (298)
.|+.+
T Consensus 279 ~l~~i 283 (284)
T cd05038 279 IVDRL 283 (284)
T ss_pred HHhhc
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=249.41 Aligned_cols=216 Identities=26% Similarity=0.434 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. +...|+||||++ ++|.+++.......+++..++.++.|++.||+|||++|++
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~ 124 (294)
T PLN00009 46 STAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124 (294)
T ss_pred HHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46779999999999999999999985 567999999995 5888888765445578889999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.++..++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|
T Consensus 125 H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~l 197 (294)
T PLN00009 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEM 197 (294)
T ss_pred CCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHHH
Confidence 999999999998666679999999987543321 1223356789999998753 24578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcC-----------------------C----CCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHAR-----------------------P----GLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~-----------------------~----~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
++|..||.................. . .....+++++.+++.+||+.+|++||+
T Consensus 198 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 277 (294)
T PLN00009 198 VNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT 277 (294)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC
Confidence 9999999876554433322110000 0 012346788999999999999999999
Q ss_pred HHHHHHHHHhhhhcc
Q 022347 234 FSQIIRMLNAFLFTL 248 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~ 248 (298)
+.++++ +.++...
T Consensus 278 ~~~~l~--~~~~~~~ 290 (294)
T PLN00009 278 ARAALE--HEYFKDL 290 (294)
T ss_pred HHHHhc--CchHhHH
Confidence 999998 5555443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=248.50 Aligned_cols=213 Identities=31% Similarity=0.540 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++|+||+++++.+. ++..|+++||++|++|.+++.... ..+++..++.++.|++.||.|||+.|+
T Consensus 59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi 137 (286)
T cd06614 59 KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNV 137 (286)
T ss_pred HHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 457789999999999999999999884 567999999999999999998743 369999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||.+....... ......++..|++||.+.+ ..++.++|+||||+++|+
T Consensus 138 ~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slGvil~~ 208 (286)
T cd06614 138 IHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR--------KDYGPKVDIWSLGIMCIE 208 (286)
T ss_pred eeCCCChhhEEEcCC-CCEEECccchhhhhccchhhhccccCCcccCCHhHhcC--------CCCCCccccHHHHHHHHH
Confidence 999999999999955 469999999876433221 1123346788999998754 557889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|..||............. ....+.. +..++..+.+++.+||+.+|.+|||+.++++ +.++..
T Consensus 209 l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~ 275 (286)
T cd06614 209 MAEGEPPYLREPPLRALFLIT-TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLKK 275 (286)
T ss_pred HHhCCCCCCCCCHHHHHHHHH-hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhhc
Confidence 999999998765543333322 2222222 2337899999999999999999999999987 555554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=245.46 Aligned_cols=206 Identities=28% Similarity=0.510 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++.+ ...++++||+++++|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 48 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~ 125 (264)
T cd06653 48 VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN 125 (264)
T ss_pred HHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3478899999999999999999998743 3578999999999999998753 3488999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccc----cccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|++|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||||
T Consensus 126 ~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 196 (264)
T cd06653 126 MIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG--------EGYGRKADVWSVA 196 (264)
T ss_pred CEecCCCCHHHEEEcCC-CCEEECccccccccccccccCccccccCCcccccCHhhhcC--------CCCCccccHHHHH
Confidence 99999999999999855 46999999998754321 11123457889999998864 4567899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|++++|+.||..................+.++..+++.+.+++.+||. +|..||++.+++.
T Consensus 197 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 197 CTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 999999999999987765555554444455567788899999999999999 5799999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=246.66 Aligned_cols=207 Identities=28% Similarity=0.407 Sum_probs=172.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.++++++||||+++++.+. +...++|+||+.|++|.+++... ..+++..+..++.|+++||.|||+.|
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~ 120 (258)
T cd05578 43 SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG 120 (258)
T ss_pred HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999999885 55799999999999999999763 46899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
++|+||+|+||+++.+ +.++|+|||.+.............++..|+|||.+.. ..++.++|+||||+++|+
T Consensus 121 i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~ 191 (258)
T cd05578 121 IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--------QGYSVAVDWWSLGVTAYE 191 (258)
T ss_pred eeccCCCHHHeEEcCC-CCEEEeecccccccCCCccccccCCChhhcCHHHHcc--------cCCCCcccchhhHHHHHH
Confidence 9999999999999955 4699999999876544433344567889999998864 447889999999999999
Q ss_pred HHhCCCCCCCCCh--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH--HHHHH
Q 022347 180 LLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF--SQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~~l~~ 239 (298)
+++|..||..... ...... .........+..++..+.+++.+||..+|.+||++ .++++
T Consensus 192 l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 192 CLRGKRPYRGHSRTIRDQIRA-KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHhCCCCCCCCCccHHHHHHH-HhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999987653 222222 22225566777889999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=249.35 Aligned_cols=213 Identities=29% Similarity=0.457 Sum_probs=167.7
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceeec------CceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al 92 (298)
.+.+.+|+.++.++ +||||+++++++.. +..|+||||++|++|.+++... ....+++..++.++.|++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 34677899999999 79999999998732 3589999999999999988642 235689999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
+|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+..... ....++.++|||
T Consensus 142 ~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Di~ 217 (291)
T cd06639 142 QHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ---YDYSYDARCDVW 217 (291)
T ss_pred HHHHhCCeeccCCCHHHEEEcCC-CCEEEeecccchhcccccccccCccCCccccChhhhcCCCC---cccccCCccchH
Confidence 99999999999999999999855 469999999987543322 2223457888999998754110 113467899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|||+++|+|++|+.||............ .....+ ..+..++..+.+++.+||+.+|++||++.++++
T Consensus 218 slGvi~~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 218 SLGITAIELGDGDPPLFDMHPVKTLFKI-PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHHHhhCCCCCCCCcHHHHHHHH-hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999999999999999876554333322 222222 224457788999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=248.24 Aligned_cols=216 Identities=29% Similarity=0.495 Sum_probs=174.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.+++.++||||+++++.+. ++..+++|||+++++|.+++.. ..+++..+..++.|++.||+|||+.|
T Consensus 60 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g 136 (292)
T cd06657 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG 136 (292)
T ss_pred HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456889999999999999999999884 5689999999999999998764 45899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++||||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.. ..++.++|+||+|+++|
T Consensus 137 ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slGvil~ 207 (292)
T cd06657 137 VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVI 207 (292)
T ss_pred eecCCCCHHHEEECCC-CCEEEcccccceecccccccccccccCccccCHHHhcC--------CCCCchhhHHHHHHHHH
Confidence 9999999999999965 469999999876443221 1223457788999998754 45678999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
++++|..||.......... ......+.. ....++..+.+++.+||+.+|.+||++.++++ +.++....++
T Consensus 208 el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~~ 279 (292)
T cd06657 208 EMVDGEPPYFNEPPLKAMK-MIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPP 279 (292)
T ss_pred HHHhCCCCCCCCCHHHHHH-HHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCCC
Confidence 9999999998755433222 222222222 23457889999999999999999999999998 6777665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=248.53 Aligned_cols=211 Identities=24% Similarity=0.377 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++.+. +++.++||||++|++|.+++... ..+++..+..++.|++.||.|||+.|+
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i 122 (305)
T cd05609 45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGI 122 (305)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 347779999999999999999999885 55789999999999999999764 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc----------------ccccccCccceeccccccccccccCCccCC
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----------------MMTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ..+
T Consensus 123 ~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~ 193 (305)
T cd05609 123 VHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------QGY 193 (305)
T ss_pred cccCCchHHEEECCC-CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC--------CCC
Confidence 999999999999954 569999999876311100 0012246778999998754 567
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 165 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+.++|+||||+++|++++|..||.+.............. ..+.....++.++.+++.+||+.+|++||+..++.+.|..
T Consensus 194 ~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 194 GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 889999999999999999999998765433222222211 1222233578999999999999999999986555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=250.65 Aligned_cols=216 Identities=31% Similarity=0.492 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++.+. ++..|+|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.|+
T Consensus 60 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi 136 (293)
T cd06647 60 KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQV 136 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 356789999999999999999999985 5579999999999999999875 458899999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|++||.+.. ..++.++|+||||+++|+
T Consensus 137 ~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~ll~~ 207 (293)
T cd06647 137 IHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIE 207 (293)
T ss_pred eeccCCHHHEEEcCC-CCEEEccCcceecccccccccccccCChhhcCchhhcc--------CCCCchhhHHHHHHHHHH
Confidence 999999999999955 469999999876433222 1223357788999998864 457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+++|..||...+........ .....+. .+..++..+.+++.+||..+|.+||++.+++. +.++...++..
T Consensus 208 ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~~~~~~~ 279 (293)
T cd06647 208 MVEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAKPLS 279 (293)
T ss_pred HHhCCCCCCCCChhhheeeh-hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhcCcccc
Confidence 99999999876543322221 1111222 23456788999999999999999999999998 66766555433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.54 Aligned_cols=208 Identities=29% Similarity=0.447 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. +...++|+||+ +++|.+++.... ..+++..++.++.|++.||+|||+.|+
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i 120 (286)
T cd07832 43 PNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGI 120 (286)
T ss_pred hHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 457889999999999999999999985 55789999999 999999987633 569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ...++.++||||+|++++
T Consensus 121 ~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~ 192 (286)
T cd07832 121 MHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFA 192 (286)
T ss_pred ecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCCccccccCcccccCceeeec-------cccCCchhHHHHHHHHHH
Confidence 999999999999954 569999999987544332 1233467889999998753 245688999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARP----------------------------GLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
++++|..+|.+..+.............+ ......+..+.+++.+||..+|.+
T Consensus 193 ~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 272 (286)
T cd07832 193 ELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSK 272 (286)
T ss_pred HHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhh
Confidence 9999988887655433322211110000 011345788999999999999999
Q ss_pred CCCHHHHHH
Q 022347 231 RPSFSQIIR 239 (298)
Q Consensus 231 Rps~~~l~~ 239 (298)
|||++++++
T Consensus 273 R~~~~~~l~ 281 (286)
T cd07832 273 RLSAAEALR 281 (286)
T ss_pred CCCHHHHhh
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=249.31 Aligned_cols=207 Identities=26% Similarity=0.439 Sum_probs=161.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. +...++++||++ ++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~ 121 (284)
T cd07839 44 SSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121 (284)
T ss_pred cchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 45678999999999999999999985 557899999995 5888887653 35689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|
T Consensus 122 H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l 193 (284)
T cd07839 122 HRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAEL 193 (284)
T ss_pred cCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHHH
Confidence 99999999999955 569999999987543322 2223456789999998754 24568899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhc-------------------CC---------CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHA-------------------RP---------GLPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
++|..|+....+............ .+ .....+++++.+++.+||+.||.+||
T Consensus 194 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 273 (284)
T cd07839 194 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI 273 (284)
T ss_pred HhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC
Confidence 999888644333222222111100 00 11134678999999999999999999
Q ss_pred CHHHHHH
Q 022347 233 SFSQIIR 239 (298)
Q Consensus 233 s~~~l~~ 239 (298)
|++++++
T Consensus 274 t~~~il~ 280 (284)
T cd07839 274 SAEEALQ 280 (284)
T ss_pred CHHHHhc
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=248.56 Aligned_cols=213 Identities=26% Similarity=0.435 Sum_probs=166.7
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++. ++..++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.|++|
T Consensus 50 ~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H 127 (301)
T cd07873 50 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127 (301)
T ss_pred HHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 5668999999999999999999985 567899999996 5999988753 346899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|+
T Consensus 128 ~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~ 199 (301)
T cd07873 128 RDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMS 199 (301)
T ss_pred CCCCHHHEEECCC-CcEEECcCcchhccCCCCCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHHHH
Confidence 9999999999955 469999999987543222 2223456889999998753 245678999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhh--------------------cCC--------CCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKH--------------------ARP--------GLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~--------------------~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
+|+.||...+............ ..+ .....+++.+.++|.+||+.||.+|||
T Consensus 200 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t 279 (301)
T cd07873 200 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS 279 (301)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 9999998765432221110000 000 011346888999999999999999999
Q ss_pred HHHHHHHHHhhhhcc
Q 022347 234 FSQIIRMLNAFLFTL 248 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~ 248 (298)
+.++++ +.|+..+
T Consensus 280 ~~eil~--h~~f~~~ 292 (301)
T cd07873 280 AEEAMK--HPYFHCL 292 (301)
T ss_pred HHHHhc--Ccccccc
Confidence 999998 5555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=246.84 Aligned_cols=208 Identities=28% Similarity=0.417 Sum_probs=165.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. +...++||||+++++|..++.. ...+++..++.++.|++.||.|||+.|+
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i 121 (286)
T cd07847 44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNC 121 (286)
T ss_pred cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 346789999999999999999999985 5578999999999888887654 3458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+
T Consensus 122 ~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~ 193 (286)
T cd07847 122 IHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAE 193 (286)
T ss_pred eecCCChhhEEEcCC-CcEEECccccceecCCCcccccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHH
Confidence 999999999999955 469999999987544332 2223356788999998753 2456789999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhc--------------------CCC---------CCCCCcHHHHHHHHHhhhhCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHA--------------------RPG---------LPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~--------------------~~~---------~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
|++|..||.+..+.+.......... .+. ....++..+.+++.+||+.+|++
T Consensus 194 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 273 (286)
T cd07847 194 LLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTE 273 (286)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccc
Confidence 9999999987665443322111000 000 01346788999999999999999
Q ss_pred CCCHHHHHH
Q 022347 231 RPSFSQIIR 239 (298)
Q Consensus 231 Rps~~~l~~ 239 (298)
||++.+++.
T Consensus 274 Rp~~~eil~ 282 (286)
T cd07847 274 RLSCEELLE 282 (286)
T ss_pred cCCHHHHhc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=263.54 Aligned_cols=210 Identities=20% Similarity=0.295 Sum_probs=158.8
Q ss_pred HHHHHHHHHHhCCC------Ccccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKH------DNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 24 ~~~~E~~~l~~l~h------p~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
.+..|+.++..++| ++|+.+++++. ..+.|+|||++ |++|.+++... ..+++..+..++.||+.||.||
T Consensus 171 ~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yL 247 (467)
T PTZ00284 171 DAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYF 247 (467)
T ss_pred HHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 45567777776654 45888888874 34689999998 88999988753 4699999999999999999999
Q ss_pred Hh-CCCeeecCCCCCEEEcCCCC---------------ceEEeccCCCccCccccccccccCccceeccccccccccccC
Q 022347 96 HA-NGIIHRDLKPDNLLLTPDQK---------------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 159 (298)
Q Consensus 96 H~-~givH~dik~~Nil~~~~~~---------------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 159 (298)
|+ .||+||||||+|||++.++. .+||+|||.+..... ......+++.|+|||++.+
T Consensus 248 H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~------ 319 (467)
T PTZ00284 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG------ 319 (467)
T ss_pred HhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc------
Confidence 98 59999999999999985442 489999998764322 2234578999999999875
Q ss_pred CccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc-------------------------CCCC------
Q 022347 160 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-------------------------RPGL------ 208 (298)
Q Consensus 160 ~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------------~~~~------ 208 (298)
..++.++|||||||++|+|++|+.||.+.++............ .+..
T Consensus 320 --~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (467)
T PTZ00284 320 --LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLA 397 (467)
T ss_pred --CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHH
Confidence 5688999999999999999999999987664332221110000 0000
Q ss_pred --------C-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 209 --------P-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 209 --------~-~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
. ....+.+.+||.+||+.||.+|||++++++ +.|+...
T Consensus 398 ~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~--Hp~~~~~ 444 (467)
T PTZ00284 398 RIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT--HPYVLKY 444 (467)
T ss_pred hhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc--Ccccccc
Confidence 0 011345779999999999999999999998 5666543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=248.18 Aligned_cols=208 Identities=28% Similarity=0.453 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||+. ++|.+++.......+++..++.++.|++.||+|||+.|++
T Consensus 44 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~ 122 (284)
T cd07860 44 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122 (284)
T ss_pred hHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46789999999999999999999984 567999999995 6899998765556789999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|++
T Consensus 123 H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l 194 (284)
T cd07860 123 HRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEM 194 (284)
T ss_pred cCCCCHHHEEECCC-CCEEEeeccchhhcccCccccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHHH
Confidence 99999999999955 469999999987543321 1223346788999998754 23467889999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
++|+.||..................+ .....++.++.++|.+||+.||.+|||
T Consensus 195 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 274 (284)
T cd07860 195 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS 274 (284)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC
Confidence 99999997655433322221111000 012346788999999999999999999
Q ss_pred HHHHHH
Q 022347 234 FSQIIR 239 (298)
Q Consensus 234 ~~~l~~ 239 (298)
+.++++
T Consensus 275 ~~~~l~ 280 (284)
T cd07860 275 AKAALA 280 (284)
T ss_pred HHHHhc
Confidence 999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=255.44 Aligned_cols=214 Identities=21% Similarity=0.330 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|..++..++|+||+++++++. ++..|+||||++||+|.+++... ...+++..+..++.|++.||+|||+.||
T Consensus 45 ~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~i 123 (331)
T cd05624 45 TACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHY 123 (331)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345778999999999999999999985 56799999999999999999763 3468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+|+||||+||+++.+ +.++|+|||++........ .....|++.|+|||++.+... ....++.++||||||+++|
T Consensus 124 iHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwSlGvil~ 199 (331)
T cd05624 124 VHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED---GMGKYGPECDWWSLGVCMY 199 (331)
T ss_pred eeccCchHHEEEcCC-CCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhcccc---CCCCCCCcccEEeeehhhh
Confidence 999999999999955 4699999999865433222 123468999999998864211 1135678999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP---EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 240 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~~l~~~ 240 (298)
+|++|+.||...+................++ ..++.++.+++.+||...+.+ |+++++++++
T Consensus 200 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 200 EMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred hhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999999998765544333322222222233 346899999999999865544 4688888773
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=245.55 Aligned_cols=214 Identities=29% Similarity=0.447 Sum_probs=167.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
..+++.+|++++++++||||+++++++. .+..|+||||++|++|.+++... ....+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l 121 (287)
T cd06621 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121 (287)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999873 23689999999999999987642 235588999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.|++|+||+|+||+++.+ +.++|+|||++........ ....++..|+|||.+.+ ..++.++|+||||+
T Consensus 122 H~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~ 191 (287)
T cd06621 122 HSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQG--------KPYSITSDVWSLGL 191 (287)
T ss_pred HHCCcccCCCCHHHEEEecC-CeEEEeecccccccccccc-ccccCCccccCHHHhcC--------CCCCchhhHHHHHH
Confidence 99999999999999999955 5699999999865432221 23356778999998854 56788999999999
Q ss_pred HHHHHHhCCCCCCCCC----hHHHHHHHHHhhcCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 176 VLWELLTNRLPFEGMS----NLQAAYAAAFKHARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 176 il~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
++|+|++|..||.... ..............+.++ ..+++.+.+++.+||+.+|.+|||+.+++. +.++
T Consensus 192 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~--~~~~ 269 (287)
T cd06621 192 TLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE--HPWI 269 (287)
T ss_pred HHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh--Cccc
Confidence 9999999999997652 112222221111112111 235678999999999999999999999998 5554
Q ss_pred h
Q 022347 246 F 246 (298)
Q Consensus 246 ~ 246 (298)
.
T Consensus 270 ~ 270 (287)
T cd06621 270 K 270 (287)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=246.36 Aligned_cols=204 Identities=26% Similarity=0.391 Sum_probs=161.5
Q ss_pred HHHHHHHHHhCC-CCcccceeceee-c--CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 25 FIREVNMMSRVK-HDNLVKFLGACK-D--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 25 ~~~E~~~l~~l~-hp~Iv~~~~~~~-~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+|+.++.++. ||||+++++++. + +..++||||++ ++|.+++... ...+++..++.++.|++.||+|||+.|+
T Consensus 44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 44 NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 347888999886 999999999884 3 57899999996 5888888753 2468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++. +.++|+|||++.............++..|+|||.+.. ...++.++||||||+++|+|
T Consensus 122 ~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el 192 (282)
T cd07831 122 FHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEI 192 (282)
T ss_pred eecccCHHHEEEcC--CCeEEEecccccccccCCCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHH
Confidence 99999999999996 6799999999976544433334467889999997643 24567899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhh----------------cCCC-----------CCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKH----------------ARPG-----------LPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~----------------~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
++|..||.+.+..+......... .... +...++..+.+++.+||+.+|.+||+
T Consensus 193 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 272 (282)
T cd07831 193 LSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272 (282)
T ss_pred HcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC
Confidence 99999998765433211111000 0000 11246789999999999999999999
Q ss_pred HHHHHH
Q 022347 234 FSQIIR 239 (298)
Q Consensus 234 ~~~l~~ 239 (298)
+.++++
T Consensus 273 ~~~~l~ 278 (282)
T cd07831 273 AKQALR 278 (282)
T ss_pred HHHHhh
Confidence 999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=265.60 Aligned_cols=208 Identities=19% Similarity=0.308 Sum_probs=156.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
...+.+|+.++++++||||+++++++. ++..|++++++ +++|.+++.... ........+..++.|++.||.|||+
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 446889999999999999999999985 55789999999 568888775421 1224466788899999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
+||+||||||+|||++.+ +.++|+|||++....... ......|+..|+|||++.+ ..++.++|||||||
T Consensus 286 ~gIiHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGv 356 (501)
T PHA03210 286 KKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--------DGYCEITDIWSCGL 356 (501)
T ss_pred CCeecCCCCHHHEEECCC-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC--------CCCCcHHHHHHHHH
Confidence 999999999999999955 469999999997544322 2223468999999999865 56888999999999
Q ss_pred HHHHHHhCCC-CCCCCC--hHHHHHHHHHhh--cCC-----------------------CC-----CCCCcHHHHHHHHH
Q 022347 176 VLWELLTNRL-PFEGMS--NLQAAYAAAFKH--ARP-----------------------GL-----PEDISPDLAFIVQS 222 (298)
Q Consensus 176 il~~ll~g~~-p~~~~~--~~~~~~~~~~~~--~~~-----------------------~~-----~~~~~~~l~~li~~ 222 (298)
++|+|++|.. ||.... ............ ... .+ ...++..+.+++.+
T Consensus 357 il~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~k 436 (501)
T PHA03210 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVK 436 (501)
T ss_pred HHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHH
Confidence 9999999765 443221 111111111000 000 00 01245667888999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 022347 223 CWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 223 ~l~~~p~~Rps~~~l~~ 239 (298)
||+.||.+|||+.++++
T Consensus 437 mL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 437 MLTFDWHLRPGAAELLA 453 (501)
T ss_pred HhccCcccCcCHHHHhh
Confidence 99999999999999997
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=245.34 Aligned_cols=211 Identities=28% Similarity=0.483 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhCC---CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRVK---HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~---hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
+++.+|+.++++++ ||||+++++++. +...|+||||++|++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 44 ~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~ 120 (277)
T cd06917 44 SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV 120 (277)
T ss_pred HHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 36778999999997 999999999884 5678999999999999999865 3689999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++|+||+|+||+++. .+.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++
T Consensus 121 ~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l 192 (277)
T cd06917 121 GVIHRDIKAANILVTN-TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITI 192 (277)
T ss_pred CcccCCcCHHHEEEcC-CCCEEEccCCceeecCCCccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHH
Confidence 9999999999999995 4579999999887543322 2233457888999998753 24568899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+|++|..||.......... .......+.++. .++.++.+++.+||+.+|++||++.+++. +.|+..
T Consensus 193 ~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~~ 260 (277)
T cd06917 193 YEMATGNPPYSDVDAFRAMM-LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK--SKWIKA 260 (277)
T ss_pred HHHHhCCCCCCCCChhhhhh-ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhhc
Confidence 99999999998655432221 111222333443 37889999999999999999999999988 566544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=242.35 Aligned_cols=208 Identities=31% Similarity=0.526 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|++++++++|||++++.+.+. +...++++||+++++|.+++.... ...+++..+..++.+++.||.+||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 122 (258)
T cd08215 43 REDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122 (258)
T ss_pred HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 346779999999999999999999874 567899999999999999998743 36699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++|+||+|+||+++.+ +.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+|+++
T Consensus 123 ~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~~ 193 (258)
T cd08215 123 KILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN--------KPYNYKSDIWSLGCVL 193 (258)
T ss_pred CEecccCChHHeEEcCC-CcEEECCccceeecccCcceecceeeeecccChhHhcc--------CCCCccccHHHHHHHH
Confidence 99999999999999954 569999999987544432 2233467888999998754 5578899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++++|..||..... ..............++..++..+.+++.+||..+|++|||+.++++
T Consensus 194 ~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 194 YELCTLKHPFEGENL-LELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHcCCCCCCCCcH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 999999999977653 3333344455566677789999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=245.24 Aligned_cols=209 Identities=31% Similarity=0.478 Sum_probs=167.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++.+. +...|+++||+++++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 36 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~ 113 (265)
T cd05579 36 QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG 113 (265)
T ss_pred HHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 4457889999999999999999999885 55799999999999999999763 36899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---------ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
++|+||+|+||+++.+ +.++|+|||++....... ......++..|++||.... ...+.++|+
T Consensus 114 i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv 184 (265)
T cd05579 114 IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG--------QGHSKTVDW 184 (265)
T ss_pred eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcC--------CCCCcchhh
Confidence 9999999999999965 469999999887433221 1223356778999998764 447889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
||||+++|++++|..||........... ... .....+.. ++..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 185 ~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 185 WSLGCILYEFLVGIPPFHGETPEEIFQN-ILN-GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhc-CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 9999999999999999987654332222 221 22333333 4899999999999999999999944444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=248.05 Aligned_cols=209 Identities=27% Similarity=0.449 Sum_probs=165.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..+++|||++++.+..+... ...+++..++.++.|++.||.|||+.|
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (288)
T cd07833 43 VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHN 120 (288)
T ss_pred chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999985 5679999999988666655543 345899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||++.+ ...++.++|+||||+++
T Consensus 121 i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l 192 (288)
T cd07833 121 IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIM 192 (288)
T ss_pred eecCCCCHHHeEECCC-CCEEEEeeecccccCCCccccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHH
Confidence 9999999999999954 569999999987644433 2233467788999999864 12678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhc------------------------------CCCCCCCCcHHHHHHHHHhhhhC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHA------------------------------RPGLPEDISPDLAFIVQSCWVED 227 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~ 227 (298)
|++++|..||................. ....+..++.++.+++.+||..+
T Consensus 193 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 272 (288)
T cd07833 193 AELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD 272 (288)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccC
Confidence 999999999986654333222111000 00122335888999999999999
Q ss_pred CCCCCCHHHHHH
Q 022347 228 PNLRPSFSQIIR 239 (298)
Q Consensus 228 p~~Rps~~~l~~ 239 (298)
|++|||++++++
T Consensus 273 p~~Rps~~~il~ 284 (288)
T cd07833 273 PKERLTCDELLQ 284 (288)
T ss_pred chhcccHHHHhc
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=252.71 Aligned_cols=218 Identities=25% Similarity=0.392 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++||||+++++++. ++..++|+||+.+++|.+++.......+++..+..++.|++.||+|||+.|++
T Consensus 44 ~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv 123 (328)
T cd08226 44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI 123 (328)
T ss_pred HHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 57889999999999999999999985 56789999999999999999876556699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc--------cccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|+||||+||+++.+ +.++++||+.......... .....++..|+|||++.+ ....++.++|||||
T Consensus 124 HrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diwsl 196 (328)
T cd08226 124 HRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ------DLYGYNVKSDIYSV 196 (328)
T ss_pred cCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcC------CCCCCCchhhHHHH
Confidence 99999999999955 4699999975432111100 011123556999999864 12346889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhh---------------------------------------------cCCCC
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKH---------------------------------------------ARPGL 208 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~ 208 (298)
|+++|++++|..||................ .....
T Consensus 197 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (328)
T cd08226 197 GITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276 (328)
T ss_pred HHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchh
Confidence 999999999999998765433322211100 00111
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 209 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 209 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+..+++.+.+|+.+||+.||++|||++++++ +.|+....
T Consensus 277 ~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~--~~~~~~~~ 315 (328)
T cd08226 277 SKTFSPAFQNLVELCLQQDPEKRPSASSLLS--HAFFKQVK 315 (328)
T ss_pred hhhhhHHHHHHHHHHccCCcccCCCHHHHhh--CHHHHHHH
Confidence 2336678999999999999999999999998 55555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=261.34 Aligned_cols=222 Identities=30% Similarity=0.521 Sum_probs=190.3
Q ss_pred hhHHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHH
Q 022347 4 FMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83 (298)
Q Consensus 4 ~~~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 83 (298)
|..|.++.+..... -++|.+|+.++.+|+|||+|++||...+.-..+|||.+++|||.+.+.......|.......
T Consensus 141 VAVKclr~d~l~~~----mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcd 216 (1039)
T KOG0199|consen 141 VAVKCLRDDSLNAI----MDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCD 216 (1039)
T ss_pred EEEEeccCCccchh----HHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHH
Confidence 34566666665553 35899999999999999999999999888899999999999999999885566799999999
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccc----cccCccceeccccccccccccC
Q 022347 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT----AETGTYRWMAPELYSTVTLRQG 159 (298)
Q Consensus 84 i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~ 159 (298)
++.||+.|+.||..+++|||||-..|+++.. ...|||+|||+.+......... .......|+|||.+..
T Consensus 217 ya~QiA~aM~YLeskrlvHRDLAARNlllas-prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh------ 289 (1039)
T KOG0199|consen 217 YAMQIAKAMQYLESKRLVHRDLAARNLLLAS-PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH------ 289 (1039)
T ss_pred HHHHHHHHHHHHhhhhhhhhhhhhhhheecc-cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc------
Confidence 9999999999999999999999999999985 4569999999998655443322 2234458999999976
Q ss_pred CccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 022347 160 EKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238 (298)
Q Consensus 160 ~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 238 (298)
..++.+||+|++|+++|||++ |..||.+....+.+...- .+.+..-|..++..+.+++..||..+|.+|||+..|.
T Consensus 290 --~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 290 --RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred --ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 889999999999999999999 999999988776655444 6777778899999999999999999999999999997
Q ss_pred H
Q 022347 239 R 239 (298)
Q Consensus 239 ~ 239 (298)
+
T Consensus 367 ~ 367 (1039)
T KOG0199|consen 367 E 367 (1039)
T ss_pred H
Confidence 4
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=240.37 Aligned_cols=208 Identities=32% Similarity=0.573 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++.+.+. +...++++||+++++|.+++.... ..+++..+..++.|++.||.+||+.|
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~ 118 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG 118 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 3457889999999999999999999884 567899999999999999987632 46899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
++||||+|+||+++.+ +.++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++++
T Consensus 119 i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~il~~ 189 (253)
T cd05122 119 IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING--------KPYDYKADIWSLGITAIE 189 (253)
T ss_pred EecCCCCHHHEEEccC-CeEEEeeccccccccccccccceecCCcccCHHHHcC--------CCCCccccHHHHHHHHHH
Confidence 9999999999999954 5699999999876554432334467889999998864 447889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|..||...+.......... ...+..+.. ++..+.+++.+||+.+|.+|||+.++++
T Consensus 190 l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 190 LAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999987644333332222 333333333 3889999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=249.25 Aligned_cols=217 Identities=26% Similarity=0.497 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHh---hhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLV---SLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
..++.+|+.++.++. ||||+++++++. ++..+++|||+. +++.++.. ......+++..+..++.|++.||+|||
T Consensus 46 ~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh 124 (288)
T cd06616 46 QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124 (288)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 457889999999996 999999999874 567899999984 56666442 223456999999999999999999999
Q ss_pred hC-CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 97 AN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 97 ~~-givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
+. |++||||+|+||+++.+ +.++|+|||++.............++..|+|||.+.+.. ...++.++||||+|+
T Consensus 125 ~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~Di~slG~ 198 (288)
T cd06616 125 EELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA-----RDGYDVRSDVWSLGI 198 (288)
T ss_pred hcCCeeccCCCHHHEEEccC-CcEEEeecchhHHhccCCccccccCccCccCHHHhcccc-----ccCCcchhhhhHHHH
Confidence 74 99999999999999955 469999999987544333333446788999999986410 136788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|+|++|+.||..................+.+ +..++.++.+|+.+||+.+|.+|||+.+++. +.++..
T Consensus 199 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~--~~~~~~ 272 (288)
T cd06616 199 TLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE--HPFIKD 272 (288)
T ss_pred HHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhc
Confidence 999999999999765533222222222222222 2347899999999999999999999999998 555443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=243.46 Aligned_cols=209 Identities=30% Similarity=0.497 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|+.+++.++||||+++++.+. +...++++|++++++|.+++..... ..+++..+..++.|++.||.|||+.|
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~ 122 (267)
T cd06610 43 VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122 (267)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346789999999999999999999874 5679999999999999999976443 56899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-----cccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
++|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ...++.++|+||||
T Consensus 123 i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG 194 (267)
T cd06610 123 QIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFG 194 (267)
T ss_pred eecCCCCHHhEEEcCC-CCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHh
Confidence 9999999999999965 5699999999864433221 123357889999998864 13678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|+|++|+.||........... ......+.++ ..+++.+.+++.+||..+|++|||+.++++
T Consensus 195 ~i~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 195 ITAIELATGAAPYSKYPPMKVLML-TLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHhCCCCccccChhhhHHH-HhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 999999999999987655433222 2222222222 257789999999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=242.23 Aligned_cols=207 Identities=27% Similarity=0.457 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
..++.+|+.++++++||||+++.+++ .+...++|+||+++++|.+++.... ...+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~ 122 (256)
T cd08530 43 REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 45677899999999999999999987 4567999999999999999986632 24589999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|++|+||+|.||+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 123 ~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~ 192 (256)
T cd08530 123 KILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG--------RPYSYKSDIWSLGCLLY 192 (256)
T ss_pred CcccCCCCcceEEEecC-CcEEEeeccchhhhccC-CcccccCCccccCHHHHCC--------CCCCchhhHHHHHHHHH
Confidence 99999999999999954 56999999998754443 2233457889999999864 56788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++++|+.||...+.. ...........+..+..++.++.+++.+||..+|++||++.++++
T Consensus 193 ~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 193 EMATFAPPFEARSMQ-DLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHhCCCCCCCCCHH-HHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 999999999876543 333334444555666778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=240.19 Aligned_cols=207 Identities=31% Similarity=0.533 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++.+.+ ...++++||+++++|.+++.... .+++..++.++.|++.||+|||+.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~ 120 (260)
T cd06606 43 LEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN 120 (260)
T ss_pred HHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4578899999999999999999998853 57899999999999999998643 799999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|++|+||+|+||+++.+ +.++|+|||.+........ .....++..|.|||.+.+ ...+.++|+||||+
T Consensus 121 ~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~ 191 (260)
T cd06606 121 GIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG--------EEYGRAADIWSLGC 191 (260)
T ss_pred CccccCCCHHHEEEcCC-CCEEEcccccEEecccccccccccCCCCCccccCHhhhcC--------CCCCchhhHHHHHH
Confidence 99999999999999964 5699999999876554432 344567889999998864 44788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHH-HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++++++|..||....+........ .....+.++...+..+.+++.+||..+|.+||++.+++.
T Consensus 192 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 192 TVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 9999999999998766332222222 223445667788999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=247.01 Aligned_cols=216 Identities=28% Similarity=0.497 Sum_probs=167.7
Q ss_pred HHHHHHHH-HHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 022347 24 RFIREVNM-MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHAN- 98 (298)
Q Consensus 24 ~~~~E~~~-l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~- 98 (298)
++..|+.. ++.++||||+++++++. ++..|++|||++ ++|.+++.... ...+++..++.++.|++.||+|||++
T Consensus 45 ~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (283)
T cd06617 45 RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123 (283)
T ss_pred HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 44556664 66678999999999984 567999999995 68988886532 24689999999999999999999997
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+++|+||||+||+++.+ +.++|+|||.+.............++..|+|||.+.+.. ....++.++|+||||+++|
T Consensus 124 ~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~~l~ 198 (283)
T cd06617 124 SVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL----NQKGYDVKSDVWSLGITMI 198 (283)
T ss_pred CeecCCCCHHHEEECCC-CCEEEeecccccccccccccccccCCccccChhhcCCcc----cccccCccccchhhHHHHH
Confidence 99999999999999955 469999999987654333323346788899999886411 1145678999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|++|+.||..................+.++ ..++.++.+++.+||..+|.+||++.++++ +.++..
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 266 (283)
T cd06617 199 ELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--HPFFEL 266 (283)
T ss_pred HHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhhh
Confidence 9999999997644333333333344444444 357899999999999999999999999988 455444
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=259.61 Aligned_cols=205 Identities=29% Similarity=0.469 Sum_probs=177.3
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+++++.++|||||+++.+.+ ...+|+||||+.+|.+.+|+..+ +...+..+..++.|+.+|++|||+++|||
T Consensus 101 k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivH 178 (596)
T KOG0586|consen 101 KLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVH 178 (596)
T ss_pred HHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceec
Confidence 4779999999999999999999985 66899999999999999999874 44667899999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
||||++||+++.+. +++|+|||++..........+.+|++.|.|||++.+ ....++.+|+||+|+++|.++.
T Consensus 179 rdLk~eNilL~~~m-nikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g-------~~y~gpe~D~Wslgvvly~LV~ 250 (596)
T KOG0586|consen 179 RDLKAENILLDENM-NIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNG-------KKYDGPEVDIWSLGVVLYALVE 250 (596)
T ss_pred cccchhhccccccc-ceeeeccccceeecccccccccCCCCCccChHhhcC-------cccCCcceehhhhhhhheeeee
Confidence 99999999999665 499999999998888888888899999999999986 2456789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 183 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
|..||++.+-... .. ........++--++.++.++|+++|.++|.+|++.+++...
T Consensus 251 GsLPFDG~~lk~L-r~-rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 251 GSLPFDGQNLKEL-RP-RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccccCCcccccc-cc-hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 9999987543221 11 12223345566688999999999999999999999999883
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=246.43 Aligned_cols=207 Identities=28% Similarity=0.375 Sum_probs=164.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-c--CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-D--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+|+.++.+++||||+++++++. + ...|+|+||++ ++|.+++.... ..+++..++.++.|++.||+|||+.|
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ 126 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW 126 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678999999999999999999874 3 67999999996 59999887633 46899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ...++.++|+||||+++|
T Consensus 127 i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~ 198 (293)
T cd07843 127 ILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFA 198 (293)
T ss_pred eeeccCCHHHEEECCC-CcEEEeecCceeeccCCccccccccccccccCchhhcC-------CccccchhhHHHHHHHHH
Confidence 9999999999999955 56999999998765443 22233456788999998754 234678999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHh-----------------------------hcCCCCCCC-CcHHHHHHHHHhhhhCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFK-----------------------------HARPGLPED-ISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~-~~~~l~~li~~~l~~~p 228 (298)
+|++|..||............... .....++.. +++.+.+++.+||+.+|
T Consensus 199 ~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 278 (293)
T cd07843 199 ELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDP 278 (293)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCc
Confidence 999999999876543332221100 001112222 58889999999999999
Q ss_pred CCCCCHHHHHH
Q 022347 229 NLRPSFSQIIR 239 (298)
Q Consensus 229 ~~Rps~~~l~~ 239 (298)
++|||+.+++.
T Consensus 279 ~~R~t~~ell~ 289 (293)
T cd07843 279 AKRISAEDALK 289 (293)
T ss_pred cccCCHHHHhc
Confidence 99999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=250.31 Aligned_cols=207 Identities=28% Similarity=0.421 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+++.+|+.++++++||||+++++++.. ...|+||||+. ++|.+++.. .++...+..++.|++.||+||
T Consensus 60 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~L 134 (353)
T cd07850 60 KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHL 134 (353)
T ss_pred HHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999998732 24799999995 589888764 288999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.|++|+||||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++||||||+
T Consensus 135 H~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~ 205 (353)
T cd07850 135 HSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGC 205 (353)
T ss_pred HhCCeeeCCCCHHHEEECCC-CCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC--------CCCCCchhhHhHHH
Confidence 99999999999999999965 4699999999976544433344567889999999864 56788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhc--------------------CCC---------------------CCCCCcH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHA--------------------RPG---------------------LPEDISP 214 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------------------~~~---------------------~~~~~~~ 214 (298)
++|+|++|+.||...+............. .+. .+...++
T Consensus 206 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
T cd07850 206 IMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKAS 285 (353)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchh
Confidence 99999999999987654322211110000 000 0113466
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 215 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
.+.+++.+||+.||.+|||+.++++ +.|+
T Consensus 286 ~~~~li~~~L~~dP~~R~t~~eiL~--~~~~ 314 (353)
T cd07850 286 QARDLLSKMLVIDPEKRISVDDALQ--HPYI 314 (353)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc--ChhH
Confidence 7899999999999999999999998 4444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.84 Aligned_cols=198 Identities=23% Similarity=0.346 Sum_probs=159.7
Q ss_pred HHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 022347 31 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 109 (298)
Q Consensus 31 ~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~N 109 (298)
++....||||+.+++.+. ++..++||||++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus 50 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~N 127 (279)
T cd05633 50 LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPAN 127 (279)
T ss_pred HHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHH
Confidence 333457999999999884 56789999999999999998753 459999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 022347 110 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189 (298)
Q Consensus 110 il~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 189 (298)
|+++.+ +.++|+|||++....... .....++..|+|||.+.. ...++.++|+||+|+++|++++|..||..
T Consensus 128 il~~~~-~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 128 ILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred EEECCC-CCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 999955 569999999986543222 223468899999998742 24578899999999999999999999975
Q ss_pred CCh-HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 190 MSN-LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 190 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
... ...............++..++.++.+++.+||..||.+|| |+.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 199 HKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 432 1122222223344566778999999999999999999999 6999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=244.61 Aligned_cols=205 Identities=30% Similarity=0.451 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.+++.++||||+++.+++. ++..|+|+||+. |++.+++... ...+++..+..++.|++.||.|||+.|++
T Consensus 60 ~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~ 137 (307)
T cd06607 60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERI 137 (307)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 46889999999999999999999985 567899999995 5888877642 34689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|+||+|+||+++.+ +.++|+|||++...... ....++..|+|||.+... ....++.++||||||+++|+++
T Consensus 138 H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el~ 208 (307)
T cd06607 138 HRDIKAGNILLTEP-GTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELA 208 (307)
T ss_pred ecCCCcccEEECCC-CCEEEeecCcceecCCC---CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHHH
Confidence 99999999999955 46999999988654322 234567889999987431 1255788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|..||...+........ .....+.. +..++..+.+++.+||..+|.+||++.+++.
T Consensus 209 tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 209 ERKPPLFNMNAMSALYHI-AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred cCCCCCCCccHHHHHHHH-hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 999999876544433322 22222222 3457889999999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=242.38 Aligned_cols=208 Identities=28% Similarity=0.459 Sum_probs=165.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|++|||+ +++|.+++.......+++..++.++.|++.||+|||+.|++
T Consensus 43 ~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~ 121 (283)
T cd07835 43 STAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121 (283)
T ss_pred hHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46778999999999999999999984 56799999999 56999999775445689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++. .+.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|
T Consensus 122 H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l 193 (283)
T cd07835 122 HRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAEM 193 (283)
T ss_pred CCCCCHHHEEEcC-CCcEEEeecccccccCCCccccCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHHH
Confidence 9999999999996 4579999999987543221 1122345788999998753 23567899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhc---------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHA---------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
++|+.||................. .......++..+.+++.+||+.+|.+|||
T Consensus 194 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 273 (283)
T cd07835 194 VNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273 (283)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC
Confidence 999999987654433222111000 00112457789999999999999999999
Q ss_pred HHHHHH
Q 022347 234 FSQIIR 239 (298)
Q Consensus 234 ~~~l~~ 239 (298)
+.++++
T Consensus 274 ~~~il~ 279 (283)
T cd07835 274 AKAALQ 279 (283)
T ss_pred HHHHhc
Confidence 999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=240.10 Aligned_cols=203 Identities=25% Similarity=0.323 Sum_probs=159.2
Q ss_pred HHHHHH-HHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 25 FIREVN-MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 25 ~~~E~~-~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+..|.. +....+||||+++++++. ++..|+|+||++|++|.+++... ..+++..+..++.|++.||.|||+.|++|
T Consensus 43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H 120 (260)
T cd05611 43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120 (260)
T ss_pred HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 334444 345568999999999985 56799999999999999999763 45899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
+||+|+||+++.+ +.++|+|||++..... .....++..|+|||.+.+ ..++.++||||||+++|++++
T Consensus 121 ~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~ 188 (260)
T cd05611 121 RDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILG--------VGDDKMSDWWSLGCVIFEFLF 188 (260)
T ss_pred CCCCHHHeEECCC-CcEEEeecccceeccc---cccCCCCcCccChhhhcC--------CCCcchhhhHHHHHHHHHHHH
Confidence 9999999999965 4699999998875333 223357788999998864 447889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhh--cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 183 NRLPFEGMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 183 g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
|..||...+............ ........+++.+.+++.+||..+|++||++.++.+.+
T Consensus 189 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 189 GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 999998765433222211111 12233446789999999999999999999765444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=236.89 Aligned_cols=207 Identities=30% Similarity=0.569 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|++++++++|||++++++++. ++..+++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~ 119 (254)
T cd06627 42 ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG 119 (254)
T ss_pred HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 3457889999999999999999999874 56789999999999999999764 56899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++.+ +.++|+|||.+........ .....++..|+|||...+ ..++.++|+|++|++++
T Consensus 120 i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~~lG~~l~ 190 (254)
T cd06627 120 VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM--------SGASTASDIWSLGCTVI 190 (254)
T ss_pred cccCCCCHHHEEECCC-CCEEEeccccceecCCCcccccccccchhhcCHhhhcC--------CCCCcchhHHHHHHHHH
Confidence 9999999999999954 5699999999875443322 223457889999998764 34788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++++|..||............ .....+..+..++..+.+++.+||..+|++|||+.+++.
T Consensus 191 ~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 191 ELLTGNPPYYDLNPMAALFRI-VQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHhCCCCCCCccHHHHHHHH-hccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 999999999876644333332 334555677788999999999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=246.40 Aligned_cols=209 Identities=27% Similarity=0.393 Sum_probs=163.2
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceeec-Cc-----eeEEEecCCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACKD-PL-----MVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~~-~~-----~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~al 92 (298)
+.+.+|+.+++++. ||||+++++++.. .. .|+||||+++ +|.+++.... ...+++..++.++.|++.||
T Consensus 45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L 123 (295)
T cd07837 45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123 (295)
T ss_pred hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHH
Confidence 46778999999995 6999999998742 22 7999999975 8999886532 23589999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
.|||+.|++|+||+|+||+++.+++.++|+|||++...... .......+++.|+|||.+.+ ...++.++|+|
T Consensus 124 ~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~ 196 (295)
T cd07837 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIW 196 (295)
T ss_pred HHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHH
Confidence 99999999999999999999974678999999998753322 11222356778999998753 24568899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC------------------C--------CCCCCCcHHHHHHHHHhhh
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------------------P--------GLPEDISPDLAFIVQSCWV 225 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~~~l~~li~~~l~ 225 (298)
|||+++|+|++|..||.+................ + .....++.++.++|.+||.
T Consensus 197 slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 276 (295)
T cd07837 197 SVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLR 276 (295)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHcc
Confidence 9999999999999999876554433322110000 0 0113478889999999999
Q ss_pred hCCCCCCCHHHHHH
Q 022347 226 EDPNLRPSFSQIIR 239 (298)
Q Consensus 226 ~~p~~Rps~~~l~~ 239 (298)
.+|.+||++.+++.
T Consensus 277 ~~P~~R~~~~eil~ 290 (295)
T cd07837 277 YDPAKRISAKAALT 290 (295)
T ss_pred CChhhcCCHHHHhc
Confidence 99999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=245.64 Aligned_cols=191 Identities=22% Similarity=0.354 Sum_probs=156.5
Q ss_pred CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC
Q 022347 36 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114 (298)
Q Consensus 36 ~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~ 114 (298)
+||||+++++.+. ++..|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC
Confidence 6999999999984 56799999999999999999764 36899999999999999999999999999999999999997
Q ss_pred CCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 022347 115 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194 (298)
Q Consensus 115 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 194 (298)
++..++|+|||++...... ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......
T Consensus 145 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKG--------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred CCCeEEEecCccceecCCC---ccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 6647999999988654322 23357889999999864 567889999999999999999999997543321
Q ss_pred HHHHHH--HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 022347 195 AAYAAA--FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-FSQIIR 239 (298)
Q Consensus 195 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~l~~ 239 (298)
...... ........+..+++.+.+++.+||+.+|.+||+ ++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111111 112333455678999999999999999999995 699986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=240.84 Aligned_cols=205 Identities=31% Similarity=0.496 Sum_probs=169.1
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
++.+|+.++++++||||+++++++. ....++|+||+++++|.+++... ....+++..++.++.|++.||.|||+.|+
T Consensus 48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i 127 (260)
T cd08222 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127 (260)
T ss_pred HHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 5668999999999999999999884 55789999999999999988652 23568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++. +.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++|+
T Consensus 128 ~h~~l~~~nili~~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~ 197 (260)
T cd08222 128 LHRDLKAKNIFLKN--NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH--------QGYDSKSDIWSLGCILYE 197 (260)
T ss_pred cccCCChhheEeec--CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 99999999999973 34999999988654322 22223457788999998754 556778999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|..||....... ..........+..+..++.++.+++.+||..+|++||++.++++
T Consensus 198 l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 198 MCCLAHAFEGQNFLS-VVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHhCCCCCCCccHHH-HHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 999999997654433 23333344556667788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=242.35 Aligned_cols=210 Identities=29% Similarity=0.420 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++|||++++++++. +...++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.|+
T Consensus 69 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i 146 (317)
T cd06635 69 WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNM 146 (317)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 357889999999999999999999985 557899999996 4888877543 3458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.+ +.++|+|||++..... .....++..|+|||.+... ....++.++|+||||+++|+|
T Consensus 147 ~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Dv~slGvil~el 217 (317)
T cd06635 147 IHRDIKAGNILLTEP-GQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 217 (317)
T ss_pred ccCCCCcccEEECCC-CCEEEecCCCccccCC---cccccCCccccChhhhhcC-----CCCCCCccccHHHHHHHHHHH
Confidence 999999999999855 5699999998864332 2234578889999987421 124578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++|..||........................+++.+.+++.+||+.+|.+||++.++++++-
T Consensus 218 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 218 AERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 99999997765444333333222233334568889999999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=240.65 Aligned_cols=205 Identities=23% Similarity=0.347 Sum_probs=164.6
Q ss_pred HHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 022347 29 VNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 107 (298)
Q Consensus 29 ~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~ 107 (298)
+..++...||+|+.+.+++. ++..++||||++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|
T Consensus 48 ~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p 125 (278)
T cd05606 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKP 125 (278)
T ss_pred HHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCH
Confidence 34555568999999999885 56789999999999999988753 4699999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCC
Q 022347 108 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 187 (298)
Q Consensus 108 ~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 187 (298)
+||+++.+ +.++|+|||++....... .....++..|+|||.+.. ...++.++||||+|+++|+|++|..||
T Consensus 126 ~nili~~~-~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l~~g~~p~ 196 (278)
T cd05606 126 ANILLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPF 196 (278)
T ss_pred HHEEECCC-CCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHHHhCCCCC
Confidence 99999955 569999999987543222 233468899999999853 235788999999999999999999999
Q ss_pred CCCChH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhh
Q 022347 188 EGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 246 (298)
Q Consensus 188 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~~ 246 (298)
...... ..............++..++..+.+++.+||..+|.+|| ++.++++ +.++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~--~~~~~ 259 (278)
T cd05606 197 RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--HPFFR 259 (278)
T ss_pred CCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh--Ccccc
Confidence 765321 111222233345567777899999999999999999999 9999987 44443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=243.17 Aligned_cols=209 Identities=29% Similarity=0.467 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.+++.++||||+++++++. ++..|+|+||+++++|.++... ...+++..++.++.|++.||+|||+.|
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHN 120 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456789999999999999999999985 5579999999999999887654 245899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|
T Consensus 121 i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~ 192 (286)
T cd07846 121 IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVT 192 (286)
T ss_pred ccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHH
Confidence 9999999999999855 569999999987543322 2223457889999998753 244678899999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhc--------------------CC---------CCCCCCcHHHHHHHHHhhhhCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHA--------------------RP---------GLPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~--------------------~~---------~~~~~~~~~l~~li~~~l~~~p~ 229 (298)
+|++|..||................. .+ .....++..+.+++.+||+.+|+
T Consensus 193 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 272 (286)
T cd07846 193 EMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPD 272 (286)
T ss_pred HHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcc
Confidence 99999999976554322111110000 00 01235678899999999999999
Q ss_pred CCCCHHHHHH
Q 022347 230 LRPSFSQIIR 239 (298)
Q Consensus 230 ~Rps~~~l~~ 239 (298)
+||++.++++
T Consensus 273 ~Rp~~~~il~ 282 (286)
T cd07846 273 DRPSSSQLLH 282 (286)
T ss_pred cchhHHHHhc
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=254.83 Aligned_cols=203 Identities=29% Similarity=0.409 Sum_probs=166.3
Q ss_pred HHHHHHHHHhC-CCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 25 FIREVNMMSRV-KHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 25 ~~~E~~~l~~l-~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
-.+|+.++... +||||+++.+.+.+ .+.|+|||.+.|+-+.+-+.. .+....++..|+.+|+.|+.|||++|+||
T Consensus 362 ~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~---~~~~~~e~~~w~~~lv~Av~~LH~~gvvh 438 (612)
T KOG0603|consen 362 NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS---KPEFCSEASQWAAELVSAVDYLHEQGVVH 438 (612)
T ss_pred cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHh---cchhHHHHHHHHHHHHHHHHHHHhcCeee
Confidence 44677555555 69999999999965 479999999999988887764 23333778889999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
|||||+|||++.+.+.++|+|||.+...... .....-|..|.|||++.. ..|+.++|+||||+++|+||+
T Consensus 439 RDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~--------~~yt~acD~WSLGvlLy~ML~ 508 (612)
T KOG0603|consen 439 RDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAI--------QEYTEACDWWSLGVLLYEMLT 508 (612)
T ss_pred cCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhcc--------CCCCcchhhHHHHHHHHHHHh
Confidence 9999999999535567999999999765444 333456889999999864 789999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 183 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
|+.||.......+... .-..+.+...+|.+.++|+..||+.+|.+|+++.++.. +.|+
T Consensus 509 G~tp~~~~P~~~ei~~---~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~ 566 (612)
T KOG0603|consen 509 GRTLFAAHPAGIEIHT---RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA--HPWF 566 (612)
T ss_pred CCCccccCCchHHHHH---hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence 9999987765433322 22344555789999999999999999999999999988 6666
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.21 Aligned_cols=211 Identities=28% Similarity=0.438 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++|||++++++++. +...|+||||+. +++.+++... ...+++..+..++.|++.||.|||+.|++
T Consensus 66 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~ 143 (313)
T cd06633 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMI 143 (313)
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46788999999999999999999985 457899999995 5888887652 34689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|+||+|+||+++.+ +.++|+|||++..... .....++..|+|||.+... ....++.++||||||+++|+|+
T Consensus 144 H~dl~p~nili~~~-~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~slGvil~el~ 214 (313)
T cd06633 144 HRDIKAGNILLTEP-GQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELA 214 (313)
T ss_pred cCCCChhhEEECCC-CCEEEeecCCCcccCC---CCCccccccccChhhcccc-----CCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999855 4699999998864322 2234678889999987421 1245778999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|..||...+....................++..+.+++.+||+.+|.+||++.+++. +.++.
T Consensus 215 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~--~~~~~ 277 (313)
T cd06633 215 ERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR--HDFVR 277 (313)
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CcccC
Confidence 9999998766544443333222222233457888999999999999999999999987 44444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=234.06 Aligned_cols=210 Identities=27% Similarity=0.451 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHHhC-CCCcccceecee-ecCceeEEEecCCCCCHHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS---LRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
++++..|.....+- +.||||+++|.+ .++..|++||.| ..||..+.+. .+...+++..+-.|..-.+.||.||.
T Consensus 106 q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK 184 (361)
T KOG1006|consen 106 QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK 184 (361)
T ss_pred HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH
Confidence 45788888866555 599999999985 778899999999 6688877653 33466999999999999999999998
Q ss_pred h-CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 97 A-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 97 ~-~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
+ ..|+|||+||+|||++..+ .+||||||++......-......|...|+|||.+.. ....|+-+||+||||+
T Consensus 185 ~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 185 EELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGI 257 (361)
T ss_pred HHhhhhhccCChhheEEecCC-CEeeecccchHhHHHHHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcc
Confidence 7 4899999999999999665 599999999986655555566688999999999975 2346899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++||+.||+.||..++...+....+..+.++-+.. .++..+..+|..||-+|...||++.++..
T Consensus 258 TL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 258 TLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 99999999999999888777666666665554332 37899999999999999999999999987
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=236.08 Aligned_cols=202 Identities=26% Similarity=0.423 Sum_probs=173.7
Q ss_pred HHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 103 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~ 103 (298)
-..|-++|..++||.+..+...|+ .+.+|+||||..||.|.-.+.. .+.|++.........|++||.|||+++||+|
T Consensus 215 TlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYR 292 (516)
T KOG0690|consen 215 TLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYR 292 (516)
T ss_pred hhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeee
Confidence 346889999999999999988885 6689999999999999887765 3669999999999999999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEeccCCCccC-ccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 104 DLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 104 dik~~Nil~~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
|||.+|+++|+++. +||.|||++... .......+.+||+.|+|||++.. ..|+.+.|.|.+|++||||++
T Consensus 293 DlKLENLlLDkDGH-IKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD--------nDYgraVDWWG~GVVMYEMmC 363 (516)
T KOG0690|consen 293 DLKLENLLLDKDGH-IKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED--------NDYGRAVDWWGVGVVMYEMMC 363 (516)
T ss_pred echhhhheeccCCc-eEeeecccchhcccccceeccccCChhhcCchhhcc--------ccccceeehhhhhHHHHHHHh
Confidence 99999999998864 999999999853 44556678899999999999965 889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 183 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
|+.||.+.+... ....+-.....+|..++++...|+..+|..||.+|. ++.++.+
T Consensus 364 GRLPFyn~dh~k--LFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 364 GRLPFYNKDHEK--LFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ccCcccccchhH--HHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 999999766422 223333445678889999999999999999999993 5667665
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=241.43 Aligned_cols=206 Identities=26% Similarity=0.459 Sum_probs=159.7
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++. +...++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.|++|
T Consensus 49 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H 126 (291)
T cd07844 49 TAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126 (291)
T ss_pred hHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4568999999999999999999985 5579999999964 9999887633 46899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||+|+++|+|+
T Consensus 127 ~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~ 198 (291)
T cd07844 127 RDLKPQNLLISER-GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYEMA 198 (291)
T ss_pred ccCCHHHEEEcCC-CCEEECccccccccCCCCccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHHHH
Confidence 9999999999955 469999999986533211 1122345778999998753 245678999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcC--------------------------C---CCCCCCc--HHHHHHHHHhhhhCCCC
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHAR--------------------------P---GLPEDIS--PDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~--------------------------~---~~~~~~~--~~l~~li~~~l~~~p~~ 230 (298)
+|..||.+................ . .....++ ..+.+++.+||+.+|++
T Consensus 199 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 278 (291)
T cd07844 199 TGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKK 278 (291)
T ss_pred hCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccc
Confidence 999999765532222211111000 0 0001233 78889999999999999
Q ss_pred CCCHHHHHH
Q 022347 231 RPSFSQIIR 239 (298)
Q Consensus 231 Rps~~~l~~ 239 (298)
|||+.++++
T Consensus 279 Rps~~e~l~ 287 (291)
T cd07844 279 RISAAEAMK 287 (291)
T ss_pred ccCHHHHhc
Confidence 999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=247.56 Aligned_cols=215 Identities=29% Similarity=0.470 Sum_probs=164.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..+++.+|+.++++++||||+++++++.. ...|+++||++ ++|.+++.. ..+++..+..++.|++.||+|
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~ 121 (336)
T cd07849 46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKY 121 (336)
T ss_pred hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999987632 24799999995 588888764 569999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ...++.++||
T Consensus 122 LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv 193 (336)
T cd07849 122 IHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDI 193 (336)
T ss_pred HHhCCeeccCCCHHHEEECCC-CCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHH
Confidence 999999999999999999955 5699999999875432211 122457889999998643 2457889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHH----------------------Hhhc--CCC-----CCCCCcHHHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAA----------------------FKHA--RPG-----LPEDISPDLAFIVQ 221 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~----------------------~~~~--~~~-----~~~~~~~~l~~li~ 221 (298)
||||+++|+|++|+.||.+.+......... .... ... .....++++.+++.
T Consensus 194 wslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (336)
T cd07849 194 WSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLD 273 (336)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHH
Confidence 999999999999999997654321111000 0000 000 11245788999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+||+.+|.+|||+.++++ +.++....
T Consensus 274 ~~l~~dP~~Rpt~~e~l~--hp~~~~~~ 299 (336)
T cd07849 274 KMLTFNPHKRITVEEALA--HPYLEQYH 299 (336)
T ss_pred HHcCCChhhCcCHHHHhc--CccccccC
Confidence 999999999999999998 55555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=241.71 Aligned_cols=210 Identities=26% Similarity=0.376 Sum_probs=167.5
Q ss_pred HHHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 21 LEGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
..+++.+|+.++.++ +||||+++++.+. +...|+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~ 124 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL 124 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 445778999999999 5999999999885 45688999999999999999763 4588999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ....++.++||||||++
T Consensus 125 ~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~~ 197 (290)
T cd05613 125 GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG------GDGGHDKAVDWWSMGVL 197 (290)
T ss_pred CeeccCCCHHHeEECCC-CCEEEeeCccceecccccccccccccCCcccCChhhccC------CCCCCCccccHHHHHHH
Confidence 99999999999999965 569999999987543322 1223457889999998854 12346778999999999
Q ss_pred HHHHHhCCCCCCCCCh--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 177 LWELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
+|++++|..||..... .............+..+..+++.+.+++.+||+.+|.+|| ++.+++.
T Consensus 198 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 198 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 9999999999964321 1111222222334556777899999999999999999997 7777776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=240.82 Aligned_cols=213 Identities=27% Similarity=0.402 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.+++.++|||++++.+++. +...++||||+. +++.+++... ...+++..+..++.|++.||.|||+.|+
T Consensus 59 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i 136 (308)
T cd06634 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNM 136 (308)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 346779999999999999999999884 557899999995 5888877542 3458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.+ +.++|+|||++...... ....++..|+|||.+.+. ....++.++||||||+++|+|
T Consensus 137 ~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 137 IHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred ccCCCCHHhEEECCC-CcEEECCcccceeecCc---ccccCCccccCHHHHhhc-----ccCCCCcccchHHHHHHHHHH
Confidence 999999999999855 56999999988654322 234577899999987531 124567899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||........................++..+.+++.+||..+|.+||++.+++. +.++..
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~--~~~~~~ 272 (308)
T cd06634 208 AERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (308)
T ss_pred HcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhh--Cccccc
Confidence 99999987655433333222222222234468889999999999999999999999998 344443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=241.99 Aligned_cols=206 Identities=28% Similarity=0.437 Sum_probs=164.1
Q ss_pred HHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 25 FIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 25 ~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
..+|+..+.+++ ||||+++++++. ++..++||||+ +++|.+++.......+++..+..++.|++.+|.|||+.|++|
T Consensus 44 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H 122 (283)
T cd07830 44 NLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122 (283)
T ss_pred HHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 457999999999 999999999884 56799999999 889999988754456899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
+||+|+||+++.+ +.++|+|||.+.............++..|+|||.+.. ...++.++|+||||++++++++
T Consensus 123 ~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el~~ 194 (283)
T cd07830 123 RDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAELYT 194 (283)
T ss_pred CCCChhhEEEcCC-CCEEEeecccceeccCCCCcCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHHHh
Confidence 9999999999954 5699999999876544333344567889999998753 2457889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhhcC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 022347 183 NRLPFEGMSNLQAAYAAAFKHAR----------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSF 234 (298)
Q Consensus 183 g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (298)
|+.||.................. .......+..+.+++.+||+.+|.+|||+
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 274 (283)
T cd07830 195 LRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274 (283)
T ss_pred CCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence 99999765543322211110000 00011236789999999999999999999
Q ss_pred HHHHH
Q 022347 235 SQIIR 239 (298)
Q Consensus 235 ~~l~~ 239 (298)
.+++.
T Consensus 275 ~ei~~ 279 (283)
T cd07830 275 SQALQ 279 (283)
T ss_pred HHHhh
Confidence 99986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=243.55 Aligned_cols=207 Identities=23% Similarity=0.363 Sum_probs=179.4
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
-..+|-++|.+++.+.||.+-.+|+ .+.+|+|+..|.||+|.-.|-+..+..|+++.+..++.+|+.||++||+.+||+
T Consensus 231 maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVY 310 (591)
T KOG0986|consen 231 MALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVY 310 (591)
T ss_pred HhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceee
Confidence 3568999999999999999988775 568999999999999999998877778999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
||+||+|||+| +.+.++|+|+|++.............||.+|||||++.. ..|+...|.|||||++|+|+.
T Consensus 311 RDLKPeNILLD-d~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n--------e~Y~~s~Dwf~lGCllYemi~ 381 (591)
T KOG0986|consen 311 RDLKPENILLD-DHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN--------EVYDFSPDWFSLGCLLYEMIA 381 (591)
T ss_pred ccCChhheeec-cCCCeEeeccceEEecCCCCccccccCcccccCHHHHcC--------CcccCCccHHHHHhHHHHHHc
Confidence 99999999999 555799999999998888887777799999999999975 569999999999999999999
Q ss_pred CCCCCCCCChHHH--HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 183 NRLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 183 g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
|+.||........ ............+++.+|++++++++.+|..||.+|. .+.++.+
T Consensus 382 G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 382 GHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred ccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 9999976543221 2223344455667889999999999999999999995 4667766
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=246.51 Aligned_cols=215 Identities=23% Similarity=0.388 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---------------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~q 87 (298)
+.+.+|+.++++++||||+++++.+.. ...|+||||++ ++|.+++.. ..+++..++.++.|
T Consensus 47 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~q 122 (342)
T cd07854 47 KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQ 122 (342)
T ss_pred HHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHH
Confidence 457789999999999999999987632 24789999996 599988864 46899999999999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccC
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
++.||.|||+.|++|+||||+||+++.++..++|+|||.+....... ......++..|+|||.+.. ...
T Consensus 123 i~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~ 195 (342)
T cd07854 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-------PNN 195 (342)
T ss_pred HHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhC-------ccc
Confidence 99999999999999999999999998666779999999986532211 1122356788999997643 245
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-----------------------hcCC-----CCCCCCcHH
Q 022347 164 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-----------------------HARP-----GLPEDISPD 215 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----------------------~~~~-----~~~~~~~~~ 215 (298)
++.++|||||||++|+|++|..||............... .... .+...++.+
T Consensus 196 ~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (342)
T cd07854 196 YTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275 (342)
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHH
Confidence 778999999999999999999999866543322211100 0000 012357788
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 216 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 216 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
+.+++.+||+.+|.+|||+.+++. +.++.....
T Consensus 276 ~~~li~~~L~~dP~~R~t~~ell~--h~~~~~~~~ 308 (342)
T cd07854 276 ALDFLEQILTFNPMDRLTAEEALM--HPYMSCYSC 308 (342)
T ss_pred HHHHHHHHhCCCchhccCHHHHhC--CCccccccC
Confidence 999999999999999999999988 677765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=240.47 Aligned_cols=206 Identities=26% Similarity=0.431 Sum_probs=159.0
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.+++.++|+||+++.+++. +...|+|+||+. +++.+++... ...+++..+..++.|++.||.|||+.|++|
T Consensus 49 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H 126 (291)
T cd07870 49 TAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126 (291)
T ss_pred HHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5668999999999999999999985 457899999995 6888777542 345788889999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+++
T Consensus 127 ~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~ 198 (291)
T cd07870 127 RDLKPQNLLISYL-GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIEML 198 (291)
T ss_pred CCCChHHEEEcCC-CcEEEeccccccccCCCCCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999955 469999999887533221 1223346789999998753 134677899999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcC-----------------CC-----CC---------CCCcHHHHHHHHHhhhhCCCC
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHAR-----------------PG-----LP---------EDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~-----~~---------~~~~~~l~~li~~~l~~~p~~ 230 (298)
+|..||....+............. +. .+ ...+..+.+++.+|+..+|.+
T Consensus 199 ~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~ 278 (291)
T cd07870 199 QGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKD 278 (291)
T ss_pred hCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCccc
Confidence 999999866543222222111000 00 00 113568899999999999999
Q ss_pred CCCHHHHHH
Q 022347 231 RPSFSQIIR 239 (298)
Q Consensus 231 Rps~~~l~~ 239 (298)
|||+.+++.
T Consensus 279 R~t~~~~l~ 287 (291)
T cd07870 279 RISAQDALL 287 (291)
T ss_pred CcCHHHHhc
Confidence 999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=234.15 Aligned_cols=206 Identities=32% Similarity=0.480 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++.+. +...+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~ 113 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG 113 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999885 56789999999999999999763 35899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++.+ +.++|+|||.+...... .......++..|+|||...+ ...+.++|+||||+++|
T Consensus 114 ~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~ 184 (250)
T cd05123 114 IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG--------KGYGKAVDWWSLGVLLY 184 (250)
T ss_pred ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcCCccccChHHhCC--------CCCCchhhHHHHHHHHH
Confidence 9999999999999955 56999999998764433 22334467889999998864 45678999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH---HHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF---SQIIR 239 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~---~~l~~ 239 (298)
++++|..||...+... ...... .....++...+..+.+++.+||..+|++||++ +++++
T Consensus 185 ~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 185 EMLTGKPPFYAEDRKE-IYEKIL-KDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHCCCCCCCCCHHH-HHHHHh-cCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 9999999997765422 222222 24566777889999999999999999999999 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=241.03 Aligned_cols=213 Identities=27% Similarity=0.362 Sum_probs=166.0
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+|+.++++++||||+++++++.+ +..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+.|+
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i 129 (309)
T cd07845 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFI 129 (309)
T ss_pred hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45579999999999999999998843 35899999995 5899988753 3568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ...++.++||||||+++|+
T Consensus 130 ~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 130 IHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred ecCCCCHHHEEECCC-CCEEECccceeeecCCccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHH
Confidence 999999999999954 569999999987644321 2222345778999998753 2457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcC-----------------CCC-----------CCCCcHHHHHHHHHhhhhCCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHAR-----------------PGL-----------PEDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~-----------~~~~~~~l~~li~~~l~~~p~~R 231 (298)
|++|..||.+.+.............. ... ....++.+.++|.+||+.||.+|
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhC
Confidence 99999999876654433222110000 000 01257889999999999999999
Q ss_pred CCHHHHHHHHHhhhhcc
Q 022347 232 PSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 232 ps~~~l~~~l~~~~~~~ 248 (298)
||+.+++. +.|+...
T Consensus 282 ~t~~~il~--h~~f~~~ 296 (309)
T cd07845 282 ATAEEALE--SSYFKEK 296 (309)
T ss_pred cCHHHHhc--ChhhccC
Confidence 99999998 6666543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=245.03 Aligned_cols=219 Identities=30% Similarity=0.468 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecC------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..+.+.+|+.++++++||||+++.+++... ..|++|||++ ++|.+++... ..+++..++.++.|++.||++
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~ 118 (330)
T cd07834 42 DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKY 118 (330)
T ss_pred hhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999987432 6899999996 5899988753 369999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
||+.|++|+||||.||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+
T Consensus 119 LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi 190 (330)
T cd07834 119 LHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDI 190 (330)
T ss_pred HHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccccccccccccccccCcCCceeeec-------ccCCCcchhH
Confidence 999999999999999999965 579999999998654432 2233467888999999865 1267889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC-----------------------------CCCCCCCcHHHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-----------------------------PGLPEDISPDLAFIVQ 221 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~ 221 (298)
||||+++|+|++|..||.+................ ......++..+.+++.
T Consensus 191 ~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 270 (330)
T cd07834 191 WSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLE 270 (330)
T ss_pred HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHH
Confidence 99999999999999999876543222111110000 0012346788999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+||+.+|.+||++.++++ +.|+.....+.
T Consensus 271 ~~l~~~P~~Rpt~~~ll~--~~~~~~~~~~~ 299 (330)
T cd07834 271 KMLVFDPKKRITADEALA--HPYLAQLHDPE 299 (330)
T ss_pred HHccCChhhCCCHHHHHh--CccHHhhcccc
Confidence 999999999999999998 66666655543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=240.37 Aligned_cols=209 Identities=29% Similarity=0.440 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. +...++|+||+++ +|.+++.... ..+++..+..++.|++.||.|||+.|
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ 118 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG 118 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457779999999999999999999884 5678999999965 8888887632 57899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ...++.++|+||||+++|
T Consensus 119 i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~ 190 (283)
T cd05118 119 ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFA 190 (283)
T ss_pred eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHH
Confidence 9999999999999954 569999999987544432 2223457788999998754 236788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARP----------------------------GLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
++++|+.||...+..............+ .....++.++.+++.+||+++|.+
T Consensus 191 ~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 270 (283)
T cd05118 191 ELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270 (283)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCccc
Confidence 9999999998766544322221110000 012246788999999999999999
Q ss_pred CCCHHHHHH
Q 022347 231 RPSFSQIIR 239 (298)
Q Consensus 231 Rps~~~l~~ 239 (298)
||++.+++.
T Consensus 271 Rp~~~~ll~ 279 (283)
T cd05118 271 RITAEQALA 279 (283)
T ss_pred CcCHHHHhh
Confidence 999999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=229.57 Aligned_cols=238 Identities=24% Similarity=0.350 Sum_probs=179.8
Q ss_pred CchhhHHHhcCCCCcH----HHHHHHH---------HHHHHHHHHHhCCCCcccceecee-e-cCceeEEEecCCCCCHH
Q 022347 1 MGKFMKEVLNRGSTSD----ERALLEG---------RFIREVNMMSRVKHDNLVKFLGAC-K-DPLMVIVTELLPGMSLR 65 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~----~~~~~~~---------~~~~E~~~l~~l~hp~Iv~~~~~~-~-~~~~~lv~e~~~~~sL~ 65 (298)
||+|||.+-++..... ..++++. ...+|+.+++.++||||+.+..++ . +...++++||.+. +|+
T Consensus 37 YG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~ 115 (438)
T KOG0666|consen 37 YGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLW 115 (438)
T ss_pred cceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHH
Confidence 6899999887776643 2222222 366899999999999999999987 3 6689999999977 999
Q ss_pred HHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC---CCceEEeccCCCccCcccc----c
Q 022347 66 KYLVSLRP---NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFGLAREETVTE----M 135 (298)
Q Consensus 66 ~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~---~~~~~l~dfg~~~~~~~~~----~ 135 (298)
..|+-+.. +.++...+..|++||+.|++|||+.=|+||||||.|||+..+ .+.|||+|+|+++.....- .
T Consensus 116 ~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s 195 (438)
T KOG0666|consen 116 HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLAS 195 (438)
T ss_pred HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccccccc
Confidence 99876432 458999999999999999999999999999999999999855 2579999999998654322 2
Q ss_pred cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHhhcCC
Q 022347 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL---------QAAYAAAFKHARP 206 (298)
Q Consensus 136 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---------~~~~~~~~~~~~~ 206 (298)
......|.+|+|||++.| ...|+.+.|+|++|||+.||++-.+.|.+.... ++.......-+.|
T Consensus 196 ~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~P 268 (438)
T KOG0666|consen 196 LDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTP 268 (438)
T ss_pred CCceEEEEEecChHHhcc-------cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCC
Confidence 233467899999999987 478999999999999999999988777542210 1111111000000
Q ss_pred ------C---CC--------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 207 ------G---LP--------------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 207 ------~---~~--------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
. +| ..-++...+|+.+||..||.+|.|+++.++ +.+...-
T Consensus 269 t~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle--h~yF~~d 343 (438)
T KOG0666|consen 269 TDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE--HPYFTED 343 (438)
T ss_pred ccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc--ccccccC
Confidence 0 00 113344779999999999999999999988 4554443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=244.28 Aligned_cols=217 Identities=25% Similarity=0.388 Sum_probs=166.1
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
.+.+.+|+.+++++ +||||+++++.+. ....|++++++ +++|.+++.. ...+++..++.++.|++.||.||
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~L 121 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYI 121 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHH
Confidence 45677899999999 4999999998642 13578999998 5699999865 35689999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|+.|++|+||||+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ...++.++||
T Consensus 122 H~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di 193 (332)
T cd07857 122 HSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDV 193 (332)
T ss_pred HhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC-------CCCCCcHHHH
Confidence 99999999999999999955 569999999987433211 1123467889999998753 2457889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHH----------------------h---hc-CC---CCCCCCcHHHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAF----------------------K---HA-RP---GLPEDISPDLAFIVQ 221 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------------~---~~-~~---~~~~~~~~~l~~li~ 221 (298)
||+|+++|++++|..||...+.......... . .. .. ......+..+.+++.
T Consensus 194 ~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (332)
T cd07857 194 WSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273 (332)
T ss_pred HHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHH
Confidence 9999999999999999976543221111000 0 00 00 112335788999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
+||+.+|.+|||+.+++. +.++...+.+
T Consensus 274 ~~l~~~P~~R~t~~~ll~--~~~~~~~~~~ 301 (332)
T cd07857 274 KLLAFDPTKRISVEEALE--HPYLAIWHDP 301 (332)
T ss_pred HHccCCcccCCCHHHHhc--ChhhhhhcCc
Confidence 999999999999999988 7777766543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=240.08 Aligned_cols=216 Identities=27% Similarity=0.507 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~g 99 (298)
.++.+|+.++.+.. ||||+++++++. +...|++|||+ ++++.+++... ...+++..+..++.|++.||+|||+ .|
T Consensus 58 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 58 KRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred HHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 35556777666665 999999999985 56799999998 55888877653 3478999999999999999999997 59
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
++|+||+|+||+++.+ +.++|+|||++.............++..|+|||.+.+.. ....++.++||||||+++|+
T Consensus 136 i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~e 210 (296)
T cd06618 136 VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD----PNPKYDIRADVWSLGISLVE 210 (296)
T ss_pred EecCCCcHHHEEEcCC-CCEEECccccchhccCCCcccCCCCCccccCHhhcCCCC----CccccccchhHHHHHHHHHH
Confidence 9999999999999854 579999999987544333333345678899999986411 12457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|+.||..................+..+ ..++.++.+++.+||..+|.+||++.++++ +.++..
T Consensus 211 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 278 (296)
T cd06618 211 LATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--HPFIRR 278 (296)
T ss_pred HHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhhc
Confidence 999999997654333333333333333333 247899999999999999999999999988 455443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=245.37 Aligned_cols=215 Identities=27% Similarity=0.439 Sum_probs=166.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.++.+|+.+++.++||||+++++++.. ...|+++||+ +++|.+++... ..+++..+..++.|++.||.|||
T Consensus 49 ~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH 125 (337)
T cd07858 49 KRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH 125 (337)
T ss_pred HHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999998742 2479999999 56999988753 46999999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
+.|++|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||.+.. ...++.++||||||+
T Consensus 126 ~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~ 197 (337)
T cd07858 126 SANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGC 197 (337)
T ss_pred hCCEecCCCCHHHEEEcCC-CCEEECcCccccccCCCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHH
Confidence 9999999999999999955 56999999998754332 22233457889999998753 134788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHH----------------------Hhhc----C---CCCCCCCcHHHHHHHHHhhhh
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAA----------------------FKHA----R---PGLPEDISPDLAFIVQSCWVE 226 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~----------------------~~~~----~---~~~~~~~~~~l~~li~~~l~~ 226 (298)
++|+|++|+.||.+.+......... .... . ......+++++.+++.+||+.
T Consensus 198 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 277 (337)
T cd07858 198 IFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVF 277 (337)
T ss_pred HHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcC
Confidence 9999999999997654221111000 0000 0 011245788999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhccCC
Q 022347 227 DPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 227 ~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
+|.+|||+.++++ +.++.....
T Consensus 278 ~P~~Rps~~ell~--h~~~~~~~~ 299 (337)
T cd07858 278 DPSKRITVEEALA--HPYLASLHD 299 (337)
T ss_pred ChhhccCHHHHHc--CcchhhhcC
Confidence 9999999999998 555554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=247.18 Aligned_cols=223 Identities=26% Similarity=0.404 Sum_probs=192.2
Q ss_pred hhHHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHH
Q 022347 4 FMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82 (298)
Q Consensus 4 ~~~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 82 (298)
+..|++++.-..+.+. ++.+..|-.++..++.|.||++|..|. +.+.|++||-|-||.|+..+... +.|++..+.
T Consensus 448 fAlKilkK~hIVdtkQ--qeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tar 523 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQ--QEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR--GSFDDYTAR 523 (732)
T ss_pred HHHHHHhHhhccchhH--HHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc--CCcccchhh
Confidence 4456666654444442 356779999999999999999999995 45899999999999999999864 569999999
Q ss_pred HHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCcc
Q 022347 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 83 ~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.++..+++|++|||++||++|||||+|++++.+ +.+||.|||++.........-+.+||+.|.|||++.. .
T Consensus 524 F~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn--------K 594 (732)
T KOG0614|consen 524 FYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN--------K 594 (732)
T ss_pred hhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhccCCceeeecCCcccccchhhhc--------c
Confidence 999999999999999999999999999999965 4699999999999888888888999999999999986 6
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQI 237 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l 237 (298)
..+.+.|.||||+++|||++|.+||.+.++..........-....+|..++....+++++++..+|.+|.- +.++
T Consensus 595 GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DI 674 (732)
T KOG0614|consen 595 GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDI 674 (732)
T ss_pred CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHH
Confidence 66889999999999999999999999988876655555555556788899999999999999999999964 6666
Q ss_pred HH
Q 022347 238 IR 239 (298)
Q Consensus 238 ~~ 239 (298)
-.
T Consensus 675 kk 676 (732)
T KOG0614|consen 675 KK 676 (732)
T ss_pred Hh
Confidence 65
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=237.71 Aligned_cols=208 Identities=28% Similarity=0.462 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|+.++++++||||+++++++. ++..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|+
T Consensus 43 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (284)
T cd07836 43 STAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121 (284)
T ss_pred HHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35668999999999999999999985 5678999999975 8999887643 2458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|+||+++.+ +.++|+|||++....... ......++..|++||.+.+ ...++.++|+||||+++|+
T Consensus 122 ~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~ 193 (284)
T cd07836 122 LHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAE 193 (284)
T ss_pred eeCCCCHHHEEECCC-CcEEEeecchhhhhcCCccccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHH
Confidence 999999999999954 569999999986433221 1223356788999998754 2456789999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhc----------------CCC-----------CCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHA----------------RPG-----------LPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~----------------~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
+++|+.||.+.+............. ... +....++.+.+++.+||+.+|.+||
T Consensus 194 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 273 (284)
T cd07836 194 MITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI 273 (284)
T ss_pred HHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC
Confidence 9999999987654332222111000 000 1124577899999999999999999
Q ss_pred CHHHHHH
Q 022347 233 SFSQIIR 239 (298)
Q Consensus 233 s~~~l~~ 239 (298)
++.++++
T Consensus 274 ~~~~~l~ 280 (284)
T cd07836 274 SAHDALQ 280 (284)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=241.74 Aligned_cols=207 Identities=25% Similarity=0.322 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec-----------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD-----------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 91 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~a 91 (298)
..+.+|+.++++++||||+++++++.+ +..++|+||+++ ++.+++... ...+++..++.++.|++.|
T Consensus 51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~a 128 (302)
T cd07864 51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEG 128 (302)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHH
Confidence 466789999999999999999998742 268999999965 787777653 3468999999999999999
Q ss_pred HHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 92 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 92 l~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
|+|||+.|++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ...++.++|
T Consensus 129 L~~LH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~D 200 (302)
T cd07864 129 LNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG-------EERYGPAID 200 (302)
T ss_pred HHHHHhCCeecCCCCHHHEEECCC-CcEEeCcccccccccCCcccccccceeccCccChHHhcC-------CCCCCchhH
Confidence 999999999999999999999954 569999999987543322 1122245678999998753 234678999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC----------------------------CCCCCCcHHHHHHHH
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP----------------------------GLPEDISPDLAFIVQ 221 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~ 221 (298)
|||||+++++|++|+.||..................+ .....++..+.+++.
T Consensus 201 i~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 280 (302)
T cd07864 201 VWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLD 280 (302)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHH
Confidence 9999999999999999998655433222211100000 011246889999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 022347 222 SCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~ 239 (298)
+||+.+|.+||++.++++
T Consensus 281 ~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 281 HMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHccCChhhCCCHHHHhc
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=241.75 Aligned_cols=211 Identities=26% Similarity=0.384 Sum_probs=165.8
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++. ++..++||||++ ++|.+++... ..+++..+..++.|++.||+|||+.|++|
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H 142 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMH 142 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4678999999999999999999984 568999999995 5999998753 45899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcc---------------ccccccccCccceeccccccccccccCCccCCCcc
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETV---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
+||+|+||+++.+ +.++|+|||.+..... ........++..|+|||.+.+ ...++.+
T Consensus 143 ~dl~~~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~ 214 (335)
T PTZ00024 143 RDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYHFA 214 (335)
T ss_pred ccccHHHeEECCC-CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc-------CCCCCcH
Confidence 9999999999955 5699999999875431 111122345778999998854 2346889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC--------------------------CCCCCCcHHHHHHHH
Q 022347 168 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--------------------------GLPEDISPDLAFIVQ 221 (298)
Q Consensus 168 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~ 221 (298)
+|+||||+++|+|++|..||.+.++.............+ ......+..+.+++.
T Consensus 215 ~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 294 (335)
T PTZ00024 215 VDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQ 294 (335)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHH
Confidence 999999999999999999998776544332221100000 011245788999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+||+.+|.+|||+++++. +.|+..
T Consensus 295 ~~l~~~P~~R~s~~~~l~--~~~~~~ 318 (335)
T PTZ00024 295 SLLKLNPLERISAKEALK--HEYFKS 318 (335)
T ss_pred HHcCCCchhccCHHHHhc--CcccCC
Confidence 999999999999999998 555543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=237.08 Aligned_cols=191 Identities=23% Similarity=0.279 Sum_probs=153.4
Q ss_pred HHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 103 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~ 103 (298)
+.+|...+....||||+++++++. +...+++|||++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~ 109 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCR 109 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 335556666678999999999885 56789999999999999998764 358999999999999999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhC
Q 022347 104 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183 (298)
Q Consensus 104 dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g 183 (298)
||||+||+++.++ .++++|||.+....... ....++..|+|||.+.+ ..++.++|+||+|+++|++++|
T Consensus 110 dlkp~Nil~~~~~-~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g 178 (237)
T cd05576 110 DLNPNNILLDDRG-HIQLTYFSRWSEVEDSC--DGEAVENMYCAPEVGGI--------SEETEACDWWSLGAILFELLTG 178 (237)
T ss_pred CCCHHHEEEcCCC-CEEEecccchhcccccc--ccCCcCccccCCcccCC--------CCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999654 59999999876543321 22345677999998754 5577899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 022347 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234 (298)
Q Consensus 184 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (298)
..|+...... ........++..+++.+.+++.+||+.||.+||++
T Consensus 179 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 179 KTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 9887543211 01112234566788999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=240.17 Aligned_cols=203 Identities=15% Similarity=0.248 Sum_probs=154.1
Q ss_pred HHHHHHHhCCCCcccceeceeecC-----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 27 REVNMMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 27 ~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+...+..++|+||+++++++... ..+++++++ ..++.+.+... ...++..+..++.|++.||+|||+.|++
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ii 148 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGIS 148 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 444556677899999999876322 357888887 55888777653 3367888999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc--------cccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
||||||+||+++.+ +.++|+|||++...... .......|++.|+|||.+.+ ..++.++|||||
T Consensus 149 HrDiKp~Nill~~~-~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------~~~~~~~DiwSl 219 (294)
T PHA02882 149 HGDIKPENIMVDGN-NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------ACVTRRGDLESL 219 (294)
T ss_pred cCCCCHHHEEEcCC-CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--------CCCCcHHHHHHH
Confidence 99999999999855 46999999998754221 11122368999999998865 668899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHH----HHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYA----AAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
||++|+|++|+.||........... ....... .......++++.+++..|+..+|++||++.++.+.+
T Consensus 220 G~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 220 GYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999999999999987632221111 1111111 111345688999999999999999999999998865
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=244.15 Aligned_cols=216 Identities=26% Similarity=0.415 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.+.+.+|+.++++++||||+++++++. ....++||||+ +++|.+++... ..+++..++.++.|++.||+|||
T Consensus 48 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH 124 (334)
T cd07855 48 AKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH 124 (334)
T ss_pred hHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH
Confidence 346778999999999999999999873 23689999999 46999998653 45899999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-----cccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
+.|++|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ...++.++|||
T Consensus 125 ~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~ 196 (334)
T cd07855 125 SANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMW 196 (334)
T ss_pred HCCeecCCCCHHHEEEcCC-CcEEecccccceeecccCcCCCcccccccccccccChHHhcC-------CcccccccchH
Confidence 9999999999999999955 5699999999875432211 123467889999998753 23578899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHH----------------------Hhhc--CCC-----CCCCCcHHHHHHHHH
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAA----------------------FKHA--RPG-----LPEDISPDLAFIVQS 222 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~----------------------~~~~--~~~-----~~~~~~~~l~~li~~ 222 (298)
|||+++|+|++|+.||.+.+......... .... ... +....+.++.+++.+
T Consensus 197 slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 276 (334)
T cd07855 197 SVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ 276 (334)
T ss_pred HHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHH
Confidence 99999999999999997755332211100 0000 001 113468899999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 223 CWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 223 ~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
||+.+|.+|||+++++. +.|+.....
T Consensus 277 ~l~~~P~~Rpt~~~~l~--~~~~~~~~~ 302 (334)
T cd07855 277 MLQFDPEERITVEQALQ--HPFLAQYHD 302 (334)
T ss_pred HccCChhhCcCHHHHHh--ChhhhhccC
Confidence 99999999999999988 666655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=238.66 Aligned_cols=215 Identities=26% Similarity=0.341 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 21 LEGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
..+++.+|+.++.++ +||||+++++.+. +...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~ 124 (288)
T cd05583 47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL 124 (288)
T ss_pred HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 445788999999999 5999999999885 55788999999999999998753 4589999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|++|+||+|.||+++.+ +.++|+|||++........ .....++..|++||.+.+ .....+.++|+||||++
T Consensus 125 ~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~i 197 (288)
T cd05583 125 GIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG------GSGGHDKAVDWWSLGVL 197 (288)
T ss_pred CeeccCCCHHHeEECCC-CCEEEEECccccccccccccccccccCCccccCHHHhcC------CCCCCcchhhhHHHHHH
Confidence 99999999999999955 4699999999875433221 122357889999998754 11236789999999999
Q ss_pred HHHHHhCCCCCCCCCh--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 177 LWELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
+|+|++|..||..... ................+..++..+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 198 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 198 TFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 9999999999964321 1111122222344556777899999999999999999999988777766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=241.05 Aligned_cols=214 Identities=29% Similarity=0.420 Sum_probs=166.1
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
..+.+|+.+++++ +||||+++++++.. ...|+||||++ ++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~ 126 (337)
T cd07852 51 QRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG 126 (337)
T ss_pred hhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3566899999999 99999999998742 35899999996 599998875 3688999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc------ccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||
T Consensus 127 ~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~s 198 (337)
T cd07852 127 NVIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWS 198 (337)
T ss_pred CeecCCCCHHHEEEcCC-CcEEEeeccchhccccccccccCcchhcccccccccCceeeec-------cccccccchHHH
Confidence 99999999999999955 469999999987443221 1223457889999998753 245678999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc--------------------------C---CCCCCCCcHHHHHHHHHh
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--------------------------R---PGLPEDISPDLAFIVQSC 223 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------------------------~---~~~~~~~~~~l~~li~~~ 223 (298)
||+++|+|++|+.||.+............... . ......++.++.+++.+|
T Consensus 199 lG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (337)
T cd07852 199 VGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKL 278 (337)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHh
Confidence 99999999999999976544332111110000 0 011123688999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 224 WVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 224 l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
|+.+|.+|||+.++++ +.++.....
T Consensus 279 l~~~P~~Rps~~~il~--~~~~~~~~~ 303 (337)
T cd07852 279 LVFNPNKRLTAEEALE--HPYVAQFHN 303 (337)
T ss_pred ccCCcccccCHHHHhh--Chhhhhhcc
Confidence 9999999999999998 556655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=244.52 Aligned_cols=214 Identities=29% Similarity=0.448 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cC------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+++.+|+.++++++||||+++.+++. ++ ..++|+||+ +++|.+++.. ..+++..++.++.|++.||+||
T Consensus 59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~L 134 (343)
T cd07851 59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Confidence 46778999999999999999998763 22 389999999 7799999875 5699999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.|++|+||+|+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++||||||+
T Consensus 135 H~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv 204 (343)
T cd07851 135 HSAGIIHRDLKPSNIAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGC 204 (343)
T ss_pred HHCCeecCCCCHHHeEECCC-CCEEEcccccccccccc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHH
Confidence 99999999999999999954 56999999998764332 233456788999998753 135678999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcC--------------------------C---CCCCCCcHHHHHHHHHhhhh
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHAR--------------------------P---GLPEDISPDLAFIVQSCWVE 226 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------------~---~~~~~~~~~l~~li~~~l~~ 226 (298)
++|++++|+.||.+................ . .....+++.+.+++.+||..
T Consensus 205 ~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~ 284 (343)
T cd07851 205 IMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVL 284 (343)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCC
Confidence 999999999999876543322211110000 0 01124688999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 227 DPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 227 ~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+|.+|||+.++++ +.++.....+.
T Consensus 285 ~P~~Rpt~~ell~--h~~~~~~~~~~ 308 (343)
T cd07851 285 DPDKRITAAEALA--HPYLAEYHDPE 308 (343)
T ss_pred ChhhCCCHHHHhc--CCCccccCCCc
Confidence 9999999999988 66666554443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=242.13 Aligned_cols=214 Identities=27% Similarity=0.429 Sum_probs=168.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecC-------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+.+.+|+.++++++||||+++++++..+ ..++||||+ |++|.+++.. ..+++..++.++.|++.||+
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~ 132 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLK 132 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHH
Confidence 445788999999999999999999987422 358999999 7899998864 56899999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||+.|++|+||+|+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++|+|||
T Consensus 133 ~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~sl 202 (343)
T cd07880 133 YIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSV 202 (343)
T ss_pred HHHhCCeecCCCCHHHEEEcCC-CCEEEeecccccccccC--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHH
Confidence 9999999999999999999954 56999999998754322 123356788999998753 1346789999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhh----------------------cC-------CCCCCCCcHHHHHHHHHhh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKH----------------------AR-------PGLPEDISPDLAFIVQSCW 224 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~----------------------~~-------~~~~~~~~~~l~~li~~~l 224 (298)
|+++|++++|..||.+.+............ .. ......+++.+.+++.+||
T Consensus 203 G~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 282 (343)
T cd07880 203 GCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKML 282 (343)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHc
Confidence 999999999999998665432221111000 00 0112357788999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
..+|.+|||+.+++. +.++.....
T Consensus 283 ~~dP~~R~t~~~~l~--~~~~~~~~~ 306 (343)
T cd07880 283 VLDAESRITAAEALA--HPYFEEFHD 306 (343)
T ss_pred CCChhhCCCHHHHhc--CccHhhhcC
Confidence 999999999999997 666665544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=239.93 Aligned_cols=209 Identities=22% Similarity=0.346 Sum_probs=159.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH 96 (298)
+.+.+|+.++++++||||+++++++.+ ...++||||++ ++|.+++..... ..+++..++.++.|++.||+|||
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 125 (316)
T cd07842 47 QSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125 (316)
T ss_pred HHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH
Confidence 466789999999999999999999843 46899999995 478777754322 36899999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcC---CCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchh
Q 022347 97 ANGIIHRDLKPDNLLLTP---DQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~---~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
+.|++|+||+|+||+++. ..+.++|+|||++........ .....++..|+|||.+.+ ...++.++|
T Consensus 126 ~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~D 198 (316)
T cd07842 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAID 198 (316)
T ss_pred hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHH
Confidence 999999999999999986 135699999999875433221 122356788999998753 245688999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHH-------------------------hhcCCCCC-------
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQ--------AAYAAAF-------------------------KHARPGLP------- 209 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~--------~~~~~~~-------------------------~~~~~~~~------- 209 (298)
|||||+++++|++|..||....... ....... .......+
T Consensus 199 v~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (316)
T cd07842 199 IWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKW 278 (316)
T ss_pred HHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHH
Confidence 9999999999999999997544321 0000000 00001111
Q ss_pred ----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 210 ----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 210 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
...+..+.+++.+||+.+|.+|||+.++++
T Consensus 279 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 279 MEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 146678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=236.37 Aligned_cols=207 Identities=27% Similarity=0.409 Sum_probs=161.6
Q ss_pred HHHHHHHHHHHhC---CCCcccceeceeec-Cc-----eeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV---KHDNLVKFLGACKD-PL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 23 ~~~~~E~~~l~~l---~hp~Iv~~~~~~~~-~~-----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+.+|+.+++++ +||||+++++++.+ .. .+++|||+. ++|.+++.......+++..++.++.|++.||.
T Consensus 43 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~ 121 (287)
T cd07838 43 LSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121 (287)
T ss_pred hhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence 3555777777666 59999999999843 33 899999995 58999987654456899999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||+.|++|+||+|+||+++.+ +.++|+|||.+.............++..|+|||.+.+ ..++.++|+|||
T Consensus 122 ~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~s~ 192 (287)
T cd07838 122 FLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ--------SSYATPVDMWSV 192 (287)
T ss_pred HHHHCCeeeccCChhhEEEccC-CCEEEeccCcceeccCCcccccccccccccChHHhcc--------CCCCCcchhhhH
Confidence 9999999999999999999966 5799999999876544433334456788999999864 567889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC-------------------------CCCCCCCcHHHHHHHHHhhhhCC
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p 228 (298)
|+++|+|++|..||......+........... ......++..+.+++.+||+.+|
T Consensus 193 G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 272 (287)
T cd07838 193 GCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNP 272 (287)
T ss_pred HHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCC
Confidence 99999999999999876543322221110000 00012356778899999999999
Q ss_pred CCCCCHHHHHH
Q 022347 229 NLRPSFSQIIR 239 (298)
Q Consensus 229 ~~Rps~~~l~~ 239 (298)
.+||++.+++.
T Consensus 273 ~~Rp~~~~il~ 283 (287)
T cd07838 273 HKRISAFEALQ 283 (287)
T ss_pred ccCCCHHHHhc
Confidence 99999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=234.91 Aligned_cols=205 Identities=26% Similarity=0.467 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|..+++++. ||||+++++.+. ++..++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|
T Consensus 45 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~ 122 (280)
T cd05581 45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG 122 (280)
T ss_pred HHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356789999999999 999999999884 55799999999999999999763 36999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---------------------cccccCccceecccccccccccc
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---------------------MTAETGTYRWMAPELYSTVTLRQ 158 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~ 158 (298)
++|+||+|+||+++.++ .++|+|||.+........ .....++..|+|||....
T Consensus 123 ~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~----- 196 (280)
T cd05581 123 IIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE----- 196 (280)
T ss_pred eeecCCCHHHeEECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-----
Confidence 99999999999999554 699999999875433221 122346788999998764
Q ss_pred CCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH----
Q 022347 159 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF---- 234 (298)
Q Consensus 159 ~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~---- 234 (298)
..++.++|+||||++++++++|..||......... ... ......++..+++.+.+++.+||+.+|.+||++
T Consensus 197 ---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 271 (280)
T cd05581 197 ---KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF-QKI-LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGY 271 (280)
T ss_pred ---CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH-HHH-HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCH
Confidence 45788999999999999999999999876643322 222 234455677889999999999999999999999
Q ss_pred HHHHH
Q 022347 235 SQIIR 239 (298)
Q Consensus 235 ~~l~~ 239 (298)
.++++
T Consensus 272 ~~ll~ 276 (280)
T cd05581 272 DELKA 276 (280)
T ss_pred HHHhc
Confidence 88876
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=235.30 Aligned_cols=209 Identities=29% Similarity=0.466 Sum_probs=164.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. .+..++|+||++ ++|.+++.... ..+++..++.++.|++.||++||+.|
T Consensus 41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~ 118 (282)
T cd07829 41 IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR 118 (282)
T ss_pred ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456778999999999999999999884 568999999996 59999998742 46999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++||||+|+||+++.+ +.++|+|||.+....... .......+..|+|||.+.+ ...++.++|+||||+++|
T Consensus 119 i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~ 190 (282)
T cd07829 119 ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFA 190 (282)
T ss_pred cccCCCChheEEEcCC-CCEEEecCCcccccCCCccccCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHH
Confidence 9999999999999954 569999999987544322 2223345678999998854 236788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhh-------------------cCC--------CCCCCCcHHHHHHHHHhhhhCCCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKH-------------------ARP--------GLPEDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~-------------------~~~--------~~~~~~~~~l~~li~~~l~~~p~~R 231 (298)
++++|..||................ ..+ ......+..+.+++.+||+.+|++|
T Consensus 191 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 270 (282)
T cd07829 191 EMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKR 270 (282)
T ss_pred HHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccC
Confidence 9999999997765433322211100 000 0012347789999999999999999
Q ss_pred CCHHHHHH
Q 022347 232 PSFSQIIR 239 (298)
Q Consensus 232 ps~~~l~~ 239 (298)
|++.+++.
T Consensus 271 p~~~~~l~ 278 (282)
T cd07829 271 ISAKEALK 278 (282)
T ss_pred CCHHHHhh
Confidence 99999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=234.58 Aligned_cols=208 Identities=28% Similarity=0.387 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-c--CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-D--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++. + +..++|+||+++ +|.+++... ...+++..++.++.|++.||+|||+.
T Consensus 42 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~ 119 (287)
T cd07840 42 PITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN 119 (287)
T ss_pred hHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346779999999999999999999985 3 579999999964 899988753 24689999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||++
T Consensus 120 ~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~ 191 (287)
T cd07840 120 GILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCI 191 (287)
T ss_pred CceeccCcHHHeEEcCC-CCEEEccccceeeccCCCcccccccccccccCCceeeEc-------cccCChHHHHHHHHHH
Confidence 99999999999999954 569999999987554432 1223356778999998753 2356789999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcC------C-----------------------CCCCCCcHHHHHHHHHhhhhC
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHAR------P-----------------------GLPEDISPDLAFIVQSCWVED 227 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~------~-----------------------~~~~~~~~~l~~li~~~l~~~ 227 (298)
+|+|++|+.||...+.............. + .+...++..+.+++.+||..+
T Consensus 192 l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 271 (287)
T cd07840 192 LAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLD 271 (287)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCC
Confidence 99999999999876543222211110000 0 001113788999999999999
Q ss_pred CCCCCCHHHHHH
Q 022347 228 PNLRPSFSQIIR 239 (298)
Q Consensus 228 p~~Rps~~~l~~ 239 (298)
|.+||++.++++
T Consensus 272 P~~Rp~~~~~l~ 283 (287)
T cd07840 272 PKKRISADQALQ 283 (287)
T ss_pred hhhCcCHHHHhh
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=239.17 Aligned_cols=215 Identities=29% Similarity=0.427 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+.+|+.++++++||||+++++++.. ...|++++++ |++|.+++.. ..+++..++.++.|++.||+|
T Consensus 60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~ 135 (345)
T cd07877 60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKY 135 (345)
T ss_pred HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHH
Confidence 3467789999999999999999998732 2467888887 8899998865 458999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+.|++|+||+|+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++||||||
T Consensus 136 LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG 205 (345)
T cd07877 136 IHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVG 205 (345)
T ss_pred HHHCCeeecCCChHHEEEcCC-CCEEEeccccccccccc--ccccccCCCccCHHHHhC-------ccCCCchhhHHHHH
Confidence 999999999999999999965 46999999998754322 233467888999998753 24567899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhc---------------------CCC--------CCCCCcHHHHHHHHHhhh
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHA---------------------RPG--------LPEDISPDLAFIVQSCWV 225 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---------------------~~~--------~~~~~~~~l~~li~~~l~ 225 (298)
+++|+|++|+.||...+............. .+. .....++++.+++.+||+
T Consensus 206 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 285 (345)
T cd07877 206 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 285 (345)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcC
Confidence 999999999999976554322211100000 000 112357889999999999
Q ss_pred hCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 226 EDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 226 ~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
.+|.+||++.++++ +.++.....+.
T Consensus 286 ~dp~~R~t~~e~l~--h~~f~~~~~~~ 310 (345)
T cd07877 286 LDSDKRITAAQALA--HAYFAQYHDPD 310 (345)
T ss_pred CChhhcCCHHHHhc--ChhhhhcCCCC
Confidence 99999999999998 66766554433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=228.52 Aligned_cols=207 Identities=36% Similarity=0.587 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+..+++++|+||+++++.+. +...++++||+++++|.+++.... .+++..++.++.+++.++.+||+.|+
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i 108 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGI 108 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence 468889999999999999999999984 567899999999999999997633 28999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|.||+++.+ +.++|+|||.+.............++..|++||...+ ..++.++|+|+||++++++
T Consensus 109 ~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Di~slG~~l~~l 179 (244)
T smart00220 109 IHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG--------KGYGKAVDVWSLGVILYEL 179 (244)
T ss_pred ecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHHHHcc--------CCCCchhhHHHHHHHHHHH
Confidence 999999999999955 5699999999986655444445567889999998863 5677899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++|..||........................ ++.++.+++.+||..+|++||++.++++
T Consensus 180 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 180 LTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 9999999874444443333332222222222 8899999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=258.53 Aligned_cols=209 Identities=26% Similarity=0.412 Sum_probs=176.4
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
-|..|=.+|.--+.+=|++++..|+| .++|+||||++||+|-.++.... ++++..+..++..|+.||.-||+.|+||
T Consensus 121 ~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVH 198 (1317)
T KOG0612|consen 121 CFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVH 198 (1317)
T ss_pred HHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcccee
Confidence 57788889999999999999999975 58999999999999999998743 6999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+|||+|..| .++|.|||.+........ ....+|||.|.|||++..... ..+.|++.+|.||+|+++|||
T Consensus 199 RDiKPDNvLld~~G-HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~---~~g~yG~ecDwWSlGV~~YEM 274 (1317)
T KOG0612|consen 199 RDIKPDNVLLDKSG-HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGD---GKGEYGRECDWWSLGVFMYEM 274 (1317)
T ss_pred ccCCcceeEecccC-cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcC---CccccCCccchhhhHHHHHHH
Confidence 99999999999765 599999999986554332 345689999999999976332 237899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPS---FSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 239 (298)
+.|..||+...-.....+...+.....+| ..+|.++.+||.+.+. +|+.|.. ++++..
T Consensus 275 lyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 275 LYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 99999999866555555554554555666 5699999999998876 7888877 888877
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=235.73 Aligned_cols=206 Identities=26% Similarity=0.399 Sum_probs=157.3
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec---------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+|+.++++++||||+++++++.. ...++||||+. ++|.+++.. ....+++..++.++.|++.||.|
T Consensus 57 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~ 134 (310)
T cd07865 57 TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYY 134 (310)
T ss_pred HHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHH
Confidence 45689999999999999999998732 24599999995 588888765 23468999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-----cccccCccceeccccccccccccCCccCCCcchh
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
||+.|++|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ...++.++|
T Consensus 135 lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~D 206 (310)
T cd07865 135 IHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPID 206 (310)
T ss_pred HHHCCeeccCCCHHHEEECCC-CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC-------CcccCchhh
Confidence 999999999999999999955 5699999999875432211 123356778999998753 234678999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH--hhcCC---------------CCC-------------CCCcHHHHHH
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF--KHARP---------------GLP-------------EDISPDLAFI 219 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~---------------~~~-------------~~~~~~l~~l 219 (298)
|||||+++|+|++|..||...+.......... ...++ ..+ ...+..+.++
T Consensus 207 i~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dl 286 (310)
T cd07865 207 MWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDL 286 (310)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHH
Confidence 99999999999999999976554322111110 00000 000 1134677899
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 022347 220 VQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 220 i~~~l~~~p~~Rps~~~l~~ 239 (298)
|.+||..+|.+|||++++++
T Consensus 287 i~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 287 IDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhcCChhhccCHHHHhc
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=235.80 Aligned_cols=214 Identities=28% Similarity=0.462 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|+.++++++||||+++.+++. +...|+++||+ +++|.+++.. ..+++..+..++.|+++||.|||+.|
T Consensus 53 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~ 128 (328)
T cd07856 53 AKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG 128 (328)
T ss_pred hHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346778999999999999999999874 45689999999 6799988864 45888899999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
++|+||+|+||+++.+ +.++|+|||.+...... .....++..|+|||.+.+ ...++.++|+||||+++|+
T Consensus 129 iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e 198 (328)
T cd07856 129 VVHRDLKPSNILINEN-CDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAE 198 (328)
T ss_pred cccCCCCHHHEeECCC-CCEEeCccccccccCCC--cCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHH
Confidence 9999999999999954 56999999998753321 123356778999998743 2457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHH----------------------HhhcC--CC-----CCCCCcHHHHHHHHHhhhhCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAA----------------------FKHAR--PG-----LPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~----------------------~~~~~--~~-----~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
+++|..||............. ..... .. ....++..+.+++.+||+.+|++
T Consensus 199 l~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 278 (328)
T cd07856 199 MLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQK 278 (328)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhh
Confidence 999999997654321110000 00000 00 11346789999999999999999
Q ss_pred CCCHHHHHHHHHhhhhccCCC
Q 022347 231 RPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 231 Rps~~~l~~~l~~~~~~~~~~ 251 (298)
||++++++. +.++.....+
T Consensus 279 R~t~~ell~--~~~~~~~~~~ 297 (328)
T cd07856 279 RISAAEALA--HPYLAPYHDP 297 (328)
T ss_pred CCCHHHHhc--CCccccccCC
Confidence 999999988 6666555444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=241.50 Aligned_cols=214 Identities=26% Similarity=0.412 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
...+.+|+.++++++||||+++++++.. ...|+|+||+. .+|..++. ..+++..+..++.|++.||+|
T Consensus 58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~ 132 (342)
T cd07879 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKY 132 (342)
T ss_pred hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHH
Confidence 3467799999999999999999998742 24689999995 47877653 458999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+.|++||||+|+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++|+||||
T Consensus 133 LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG 202 (342)
T cd07879 133 IHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVG 202 (342)
T ss_pred HHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcC-------ccccCchHHHHHHH
Confidence 999999999999999999965 56999999998754321 123356788999998753 23578899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhh---------------------cCCCC--------CCCCcHHHHHHHHHhhh
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKH---------------------ARPGL--------PEDISPDLAFIVQSCWV 225 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~---------------------~~~~~--------~~~~~~~l~~li~~~l~ 225 (298)
+++|+|++|+.||.+.+............ ..+.. ....+..+.+++.+||+
T Consensus 203 vil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 282 (342)
T cd07879 203 CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLE 282 (342)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcC
Confidence 99999999999998765433222111100 00000 12467789999999999
Q ss_pred hCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 226 EDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 226 ~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
.+|.+||++++++. +.++...++..
T Consensus 283 ~dP~~R~~~~e~l~--h~~f~~~~~~~ 307 (342)
T cd07879 283 LDVDKRLTATEALE--HPYFDSFRDAD 307 (342)
T ss_pred CChhhCcCHHHHhc--Ccchhhccccc
Confidence 99999999999997 56666655433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=234.28 Aligned_cols=236 Identities=21% Similarity=0.296 Sum_probs=179.6
Q ss_pred CchhhHHHhcCCCC------cHHHHHHHHHHHHHHHHHHhCCC--C----cccceeceee-cCceeEEEecCCCCCHHHH
Q 022347 1 MGKFMKEVLNRGST------SDERALLEGRFIREVNMMSRVKH--D----NLVKFLGACK-DPLMVIVTELLPGMSLRKY 67 (298)
Q Consensus 1 ~g~~~~~v~~~~~~------~~~~~~~~~~~~~E~~~l~~l~h--p----~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~ 67 (298)
||+|++.+...... .....+..+..+-|+++|.++.+ | -++++.++|+ .++.|||+|.+ |-|+.++
T Consensus 102 FGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dF 180 (415)
T KOG0671|consen 102 FGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDF 180 (415)
T ss_pred ccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHH
Confidence 56666555555421 12344555667789999999942 2 3677778885 67899999999 8899999
Q ss_pred HhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC-------------------CCCceEEeccCCCc
Q 022347 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP-------------------DQKSLKLADFGLAR 128 (298)
Q Consensus 68 l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~-------------------~~~~~~l~dfg~~~ 128 (298)
+.++...+++...+..+++|++++++|||+.+++|-||||+||++.. .+..|+|+|||.+.
T Consensus 181 lk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAt 260 (415)
T KOG0671|consen 181 LKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSAT 260 (415)
T ss_pred hccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcc
Confidence 99988888999999999999999999999999999999999999841 12358999999998
Q ss_pred cCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHh----
Q 022347 129 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFK---- 202 (298)
Q Consensus 129 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~---- 202 (298)
...... .....|..|.|||++.+ -.++.++||||+|||++|+++|...|...++.+.+.- .+..
T Consensus 261 f~~e~h--s~iVsTRHYRAPEViLg--------LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~ 330 (415)
T KOG0671|consen 261 FDHEHH--STIVSTRHYRAPEVILG--------LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPS 330 (415)
T ss_pred eeccCc--ceeeeccccCCchheec--------cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcH
Confidence 755444 44577999999999987 5678899999999999999999999987765443211 1110
Q ss_pred -------------hcCCCCCC-------------------------CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 203 -------------HARPGLPE-------------------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 203 -------------~~~~~~~~-------------------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
..+...+. .-..++.+|+++||..||.+|+|+.|.++ +.+
T Consensus 331 ~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~--HpF 408 (415)
T KOG0671|consen 331 RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS--HPF 408 (415)
T ss_pred HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc--CHH
Confidence 00111110 11235889999999999999999999998 666
Q ss_pred hhccC
Q 022347 245 LFTLR 249 (298)
Q Consensus 245 ~~~~~ 249 (298)
...+.
T Consensus 409 F~~~~ 413 (415)
T KOG0671|consen 409 FARLT 413 (415)
T ss_pred hhcCC
Confidence 65543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=253.75 Aligned_cols=212 Identities=28% Similarity=0.470 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHhCC-CCcccceecee------ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+++.-|..+|+.+. |||++.+++++ .++.+|+|||||.|||..|+++...+..+.|..+..|++.++.||.+|
T Consensus 60 eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL 139 (953)
T KOG0587|consen 60 EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL 139 (953)
T ss_pred HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 45567888998885 99999999987 345899999999999999999998888899999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|+..++|+|||-.|||++.++ .|||+|||.+..... .....+.+||+.|||||++... +.....|+.++|+||||
T Consensus 140 H~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~---e~~d~tyd~R~D~WsLG 215 (953)
T KOG0587|consen 140 HNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACD---ESPDATYDYRSDLWSLG 215 (953)
T ss_pred hhcceeeecccCceEEEeccC-cEEEeeeeeeeeeecccccccCcCCCcccccceeeecc---cCCCCCcccccchhhcc
Confidence 999999999999999999665 599999999875443 3345677899999999999752 33457788999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++..||..|.+|+-++.+...+.... .+.++.+ |..+++++-++|..||..|..+||+..++++
T Consensus 216 ITaIEladG~PPl~DmHPmraLF~Ip-RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 216 ITAIEMAEGAPPLCDMHPMRALFLIP-RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ceeehhcCCCCCccCcchhhhhccCC-CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 99999999999998877765544432 2222222 4678999999999999999999999999987
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.98 Aligned_cols=216 Identities=32% Similarity=0.595 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC------------C--CCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------P--NKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~------------~--~~~~~~~~~~i~ 85 (298)
.+.+..|+.+++.+. ||||+.++++|. ++..++|+||+..|+|.+|+...+ . ..++....+.++
T Consensus 345 ~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa 424 (609)
T KOG0200|consen 345 KKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFA 424 (609)
T ss_pred HHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHH
Confidence 347889999999995 999999999995 568999999999999999998855 0 128889999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccc--ccc--CccceeccccccccccccCCc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--AET--GTYRWMAPELYSTVTLRQGEK 161 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~~~ 161 (298)
+||+.|++||++.+++||||-..|||+..+ ..+||+|||+++......... ... -...|+|||.+..
T Consensus 425 ~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-------- 495 (609)
T KOG0200|consen 425 YQIANGMEYLASVPCVHRDLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-------- 495 (609)
T ss_pred HHHHHHHHHHhhCCccchhhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--------
Confidence 999999999999999999999999999955 579999999998544333222 111 2346999999964
Q ss_pred cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 162 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 162 ~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
..|+.+|||||+|+++||+++ |..||.+.............+.+...|..+++++.+++..||+.+|++||++.++.+.
T Consensus 496 ~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 496 RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 789999999999999999999 9999998664555566677788889999999999999999999999999999999999
Q ss_pred HHhhhh
Q 022347 241 LNAFLF 246 (298)
Q Consensus 241 l~~~~~ 246 (298)
+...+.
T Consensus 576 ~~~~l~ 581 (609)
T KOG0200|consen 576 FEKHLQ 581 (609)
T ss_pred HHHHHH
Confidence 998654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=230.19 Aligned_cols=215 Identities=25% Similarity=0.380 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
+-..+...+|..+.+.|+||.||++|+++. .+.+|-|.|||+|.+|.-|++.+ +.+++.++..|+.||+.||.||.
T Consensus 508 eNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLN 585 (775)
T KOG1151|consen 508 ENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLN 585 (775)
T ss_pred hhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHh
Confidence 334446778999999999999999999983 45699999999999999999874 45899999999999999999999
Q ss_pred hC--CCeeecCCCCCEEEcCC--CCceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCC
Q 022347 97 AN--GIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 97 ~~--givH~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
+. .|+|-||||.|||+... .+.+||.|||++......+ ..+...||.+|++||++.-. ......
T Consensus 586 EikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg----kePPKI 661 (775)
T KOG1151|consen 586 EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG----KEPPKI 661 (775)
T ss_pred ccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecC----CCCCcc
Confidence 87 59999999999999622 2479999999998544322 23456799999999998642 123567
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 165 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA--AFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+.+.||||+|+|+|+|+.|+.||......+..... +.......+| +.++++...||++||++..++|.+..++..
T Consensus 662 snKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 662 SNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 88999999999999999999999865443333322 1111122233 458999999999999999999999988876
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=232.20 Aligned_cols=206 Identities=26% Similarity=0.378 Sum_probs=157.2
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec---------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+|+.++++++||||+++++.+.+ ...++|+||+. ++|...+... ...+++..+..++.|+++||.|
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~ 130 (311)
T cd07866 53 TALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINY 130 (311)
T ss_pred hHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHH
Confidence 45689999999999999999987621 24799999995 4787777642 3469999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc------------cccccCccceeccccccccccccCCcc
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM------------MTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
||+.|++|+||+|+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+ ..
T Consensus 131 lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~ 202 (311)
T cd07866 131 LHENHILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ER 202 (311)
T ss_pred HHhCCeecCCCCHHHEEECCC-CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-------CC
Confidence 999999999999999999955 5699999999874332211 112245778999998753 24
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC------------C---------CC-------CCCCcH
Q 022347 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------------P---------GL-------PEDISP 214 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------~---------~~-------~~~~~~ 214 (298)
.++.++||||||+++|+|++|+.||.+................ + .. ...+++
T Consensus 203 ~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (311)
T cd07866 203 RYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGP 282 (311)
T ss_pred ccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCCh
Confidence 5788999999999999999999999876543322221110000 0 00 023446
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 215 DLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
.+.+++.+||+.+|.+|||+.+++.
T Consensus 283 ~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 283 EGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hHHHHHHHHcccCcccCcCHHHHhc
Confidence 7889999999999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.15 Aligned_cols=162 Identities=38% Similarity=0.612 Sum_probs=142.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~ 93 (298)
.+++.+|++++++++|||||+++++-++ ....++||||.||||...+....+ .++++.+.+.++..+..||.
T Consensus 55 ~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~ 134 (732)
T KOG4250|consen 55 RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALR 134 (732)
T ss_pred HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHH
Confidence 3578899999999999999999998532 346799999999999999986433 56999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCC---CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|||+.||+||||||.||++.... ...||+|||.++............||..|.+||++.. .+.|+...|.
T Consensus 135 ~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDL 207 (732)
T KOG4250|consen 135 HLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDL 207 (732)
T ss_pred HHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeeh
Confidence 99999999999999999986432 2689999999998888888888899999999999852 3788999999
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 022347 171 YSFGIVLWELLTNRLPFEGM 190 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~ 190 (298)
|||||++|++.||..||...
T Consensus 208 WS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 208 WSFGVTLYECATGELPFIPF 227 (732)
T ss_pred hhhhhHHHHHhccCCCCCcC
Confidence 99999999999999999643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=246.96 Aligned_cols=236 Identities=26% Similarity=0.488 Sum_probs=194.3
Q ss_pred CchhhHHHhcCCCCc------------HHHHHHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHH
Q 022347 1 MGKFMKEVLNRGSTS------------DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYL 68 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l 68 (298)
||+|||++..+.-.. ....+.-+++.+|+-.+.+++|||++++++++..+...||++|+++|+|.+|+
T Consensus 709 fGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP~G~LlDyv 788 (1177)
T KOG1025|consen 709 FGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMPLGCLLDYV 788 (1177)
T ss_pred ceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcccchHHHHH
Confidence 677777776554222 11122234788999999999999999999999888899999999999999999
Q ss_pred hhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccce
Q 022347 69 VSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRW 145 (298)
Q Consensus 69 ~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y 145 (298)
+.++ ..+-....+.|+.||+.|+.|||.+++|||||-..|||+..- ..+|+.|||++........ .......+.|
T Consensus 789 r~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d~~ey~~~~gK~pikw 866 (1177)
T KOG1025|consen 789 REHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPDEKEYSAPGGKVPIKW 866 (1177)
T ss_pred HHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCcccccccccccccCcHH
Confidence 9855 457788899999999999999999999999999999999844 5699999999986544332 2233445688
Q ss_pred eccccccccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhh
Q 022347 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 224 (298)
Q Consensus 146 ~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 224 (298)
+|-|.+.. +.|+.++||||+|+++||++| |..||.+... .+.-.....+.+.+.|..++.++..++.+||
T Consensus 867 male~i~~--------~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle~geRLsqPpiCtiDVy~~mvkCw 937 (1177)
T KOG1025|consen 867 MALESIRI--------RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLEKGERLSQPPICTIDVYMVMVKCW 937 (1177)
T ss_pred HHHHHhhc--------cCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHhccccCCCCCCccHHHHHHHHHHh
Confidence 99898864 889999999999999999999 9999987654 4444555566778888999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhc
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
-.|++.||+++++...+......
T Consensus 938 mid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 938 MIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccCcccCccHHHHHHHHHHHhcC
Confidence 99999999999999988776543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=242.72 Aligned_cols=208 Identities=24% Similarity=0.382 Sum_probs=174.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+++|+.+|.++.||+||.+.-.|+ .+..++|||.+ +|+..+.|-....+++++.....++.||+.||.|||-+||+
T Consensus 608 sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIv 686 (888)
T KOG4236|consen 608 SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIV 686 (888)
T ss_pred HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhccee
Confidence 46779999999999999999988886 45789999999 56777777655567899999999999999999999999999
Q ss_pred eecCCCCCEEEcCCC--CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+|||+.... ..+||||||+++.++.........||+.|+|||++.. ..|...-|+||+|+|+|.
T Consensus 687 HCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrn--------kGyNrSLDMWSVGVIiYV 758 (888)
T KOG4236|consen 687 HCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRN--------KGYNRSLDMWSVGVIIYV 758 (888)
T ss_pred eccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhh--------ccccccccceeeeEEEEE
Confidence 999999999997432 3699999999999888888788899999999999975 678888999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
-++|..||....+.-+..+...=..++.-...++.+..+||..+|+.+-.+|.|.+.-++
T Consensus 759 sLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 759 SLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred EecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 999999997665443333322222233333568899999999999999999999988776
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=269.09 Aligned_cols=203 Identities=23% Similarity=0.415 Sum_probs=153.8
Q ss_pred HHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCe
Q 022347 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH---ANGII 101 (298)
Q Consensus 26 ~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~giv 101 (298)
..|+..+++++||||+++++++. ++..|+||||+++|+|.+++.. +++..+..++.|++.|++||| +.+++
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 805 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVV 805 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 35688999999999999999985 5578999999999999999963 789999999999999999999 66999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+||+++.+. ..++. ++....... .....++..|+|||++.+ ..++.++||||||+++|||+
T Consensus 806 H~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~el~ 872 (968)
T PLN00113 806 VGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT---DTKCFISSAYVAPETRET--------KDITEKSDIYGFGLILIELL 872 (968)
T ss_pred cCCCCHHhEEECCCC-ceEEE-ecccccccc---CCCccccccccCcccccC--------CCCCcccchhhHHHHHHHHH
Confidence 999999999998554 34443 554432211 122357889999998864 66889999999999999999
Q ss_pred hCCCCCCCCC----hHHHHHHHHHhh------cCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 182 TNRLPFEGMS----NLQAAYAAAFKH------ARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 182 ~g~~p~~~~~----~~~~~~~~~~~~------~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
+|+.||.... ............ ..+.+. .....++.+++.+||+.+|++|||+.++++.|+...
T Consensus 873 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 873 TGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred hCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 9999985321 111111111100 011111 112235778999999999999999999999998765
Q ss_pred h
Q 022347 246 F 246 (298)
Q Consensus 246 ~ 246 (298)
.
T Consensus 953 ~ 953 (968)
T PLN00113 953 R 953 (968)
T ss_pred c
Confidence 5
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=210.77 Aligned_cols=212 Identities=25% Similarity=0.409 Sum_probs=166.7
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec---------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
...+|+.+|..++|+|++.++..|.. ..+|+|+++|+. +|.-++.+. ..+++..++.++..++++||.|
T Consensus 62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~ 139 (376)
T KOG0669|consen 62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYY 139 (376)
T ss_pred HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHH
Confidence 45689999999999999999988721 248999999966 898888763 3569999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
+|+..|+|||+|+.|+|++.++ .++|.|||+++...... .......|.+|++||.+.| .+.|+++.|
T Consensus 140 iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iD 211 (376)
T KOG0669|consen 140 IHRNKILHRDMKAANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPID 211 (376)
T ss_pred HHHhhHHhhcccHhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc-------ccccCCcch
Confidence 9999999999999999999665 69999999997443322 2334456899999999986 588999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH------hhcCC--------------CCCC-------------CCcHHH
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF------KHARP--------------GLPE-------------DISPDL 216 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~------~~~~~--------------~~~~-------------~~~~~l 216 (298)
||.-|||+.+|+++.+.+.+..+.+....... ...+| +++. .-.++.
T Consensus 212 iWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a 291 (376)
T KOG0669|consen 212 IWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEA 291 (376)
T ss_pred hHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhH
Confidence 99999999999999998887655443332211 00111 1111 123578
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 217 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 217 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
.+|+..+|..||.+|++++++++ +.+...
T Consensus 292 ~dLle~ll~~DP~kR~~ad~aln--h~~F~k 320 (376)
T KOG0669|consen 292 LDLLEKLLKLDPTKRIDADQALN--HDFFWK 320 (376)
T ss_pred HHHHHHHhccCcccCcchHhhhc--hhhhhc
Confidence 89999999999999999999998 455443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=200.75 Aligned_cols=206 Identities=29% Similarity=0.437 Sum_probs=169.7
Q ss_pred HHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
...+|+.+|+.++|.||+++++.. .+..+.+|+||| ..+|.+|... .++.++.+.+..++.|++.||.|+|++++.|
T Consensus 47 salreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlh 124 (292)
T KOG0662|consen 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLH 124 (292)
T ss_pred HHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 567999999999999999999987 567789999999 5599999876 4567999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
+|+||+|.+++.++ .+|+.|||+++..+..- ..+....|.+|.+|.++.+ ...|++..|+||-|||+.|+.
T Consensus 125 rdlkpqnllin~ng-elkladfglarafgipvrcysaevvtlwyrppdvlfg-------akly~tsidmwsagcifaela 196 (292)
T KOG0662|consen 125 RDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_pred ccCCcceEEeccCC-cEEecccchhhhcCCceEeeeceeeeeeccCcceeee-------eehhccchHhhhcchHHHHHh
Confidence 99999999999665 59999999999766544 3455678999999999987 367899999999999999998
Q ss_pred h-CCCCCCCCChHHHHHHHHHhhcCC------C---CC------------------CCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 182 T-NRLPFEGMSNLQAAYAAAFKHARP------G---LP------------------EDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 182 ~-g~~p~~~~~~~~~~~~~~~~~~~~------~---~~------------------~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
. |.+.|++.+-.++.......-+.+ . +| +.++..-++++..+|.-+|.+|.+
T Consensus 197 nagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris 276 (292)
T KOG0662|consen 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS 276 (292)
T ss_pred hcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC
Confidence 8 777788766555554443322221 1 11 123345689999999999999999
Q ss_pred HHHHHH
Q 022347 234 FSQIIR 239 (298)
Q Consensus 234 ~~~l~~ 239 (298)
+++.++
T Consensus 277 aeaalq 282 (292)
T KOG0662|consen 277 AEAALQ 282 (292)
T ss_pred HHHHhc
Confidence 999887
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=218.26 Aligned_cols=208 Identities=29% Similarity=0.444 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
++..+|+.++..++|+||+.++.++.- ...|+|||++ ..+|...+. ..++-..+..|+.|++.|+.+|
T Consensus 60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~l 134 (369)
T KOG0665|consen 60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHL 134 (369)
T ss_pred hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHH
Confidence 467799999999999999999998831 2589999999 559999887 3477888999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.||+||||||+||++..+ ..+||+|||+++.....-..+.+..+..|.|||++.+ ..+....||||+||
T Consensus 135 hs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~--------~~~ke~vdiwSvGc 205 (369)
T KOG0665|consen 135 HSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGC 205 (369)
T ss_pred HhcceeecccCcccceecch-hheeeccchhhcccCcccccCchhheeeccCchheec--------cCCcccchhhhhhh
Confidence 99999999999999999955 5699999999998776666677889999999999987 34888999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC-----------------------------CCC-----------CCcHH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPG-----------------------------LPE-----------DISPD 215 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~-----------~~~~~ 215 (298)
++.||++|...|.+.+..++..+.....+.+. +|+ .-+..
T Consensus 206 i~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ 285 (369)
T KOG0665|consen 206 IMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSL 285 (369)
T ss_pred HHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHH
Confidence 99999999999988766555544332222111 111 12345
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 216 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 216 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+++++.+||..+|++|.|+.++++ +.++.
T Consensus 286 ardll~~MLvi~pe~Risv~daL~--HPY~~ 314 (369)
T KOG0665|consen 286 ARDLLSKMLVIDPEKRISVDDALR--HPYIK 314 (369)
T ss_pred HHHHHHHhhccChhhcccHHHHhc--CCeee
Confidence 889999999999999999999998 55553
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=248.99 Aligned_cols=105 Identities=31% Similarity=0.514 Sum_probs=94.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++..++||||+++++.+. ....|+||||+.|++|.+++... ..+++..++.++.||+.||.|||+.|
T Consensus 47 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g 124 (669)
T cd05610 47 MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG 124 (669)
T ss_pred HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999998874 56899999999999999999753 45889999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
|+|+||||+|||++.+ +.++|+|||++.
T Consensus 125 IiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 125 IIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 9999999999999955 469999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=214.04 Aligned_cols=215 Identities=28% Similarity=0.466 Sum_probs=179.7
Q ss_pred HHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhC------CCCCCHHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR------PNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~L 95 (298)
.+..|.-++..+.|||++++.+++. ....++++.+..-|+|..|+...+ ...++..+...++.|++.|++||
T Consensus 333 ~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl 412 (563)
T KOG1024|consen 333 LLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL 412 (563)
T ss_pred HHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence 5667888888889999999999873 346889999998899999998322 23467778888999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc---ccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
|++|++|.||-..|++++ +.-.+||+|=.+++.....+.. ........|++||.+.. ..|+.++|+||
T Consensus 413 h~~~ViHkDiAaRNCvId-d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n--------~~yssasDvWs 483 (563)
T KOG1024|consen 413 HNHGVIHKDIAARNCVID-DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN--------SHYSSASDVWS 483 (563)
T ss_pred HhcCcccchhhhhcceeh-hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh--------hhhcchhhhHH
Confidence 999999999999999999 6678999999999854433221 12234558999999975 78999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 173 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 173 lG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
||+++|||++ |+.||-..++ .+......++.+...|-++|+++..++.-||...|++||+++|+...|.++-..+
T Consensus 484 fGVllWELmtlg~~PyaeIDP-fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 484 FGVLLWELMTLGKLPYAEIDP-FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred HHHHHHHHHhcCCCCccccCH-HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 9999999999 9999987665 3444556678888889999999999999999999999999999999998876554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=221.57 Aligned_cols=243 Identities=30% Similarity=0.455 Sum_probs=182.6
Q ss_pred CchhhHHHhcCCCCcHH--HHHHHHHHHHHHHHHHh--CCCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhh
Q 022347 1 MGKFMKEVLNRGSTSDE--RALLEGRFIREVNMMSR--VKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSL 71 (298)
Q Consensus 1 ~g~~~~~v~~~~~~~~~--~~~~~~~~~~E~~~l~~--l~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~ 71 (298)
||.|+|..+.....-.. ...-++.|..|-.+.+. ++|+||++++++-+ ...++||++|.+.|+|.+|++.
T Consensus 223 fg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~- 301 (534)
T KOG3653|consen 223 FGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA- 301 (534)
T ss_pred cceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh-
Confidence 78999998888544321 13344578888888875 47999999999853 2268999999999999999997
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccc
Q 022347 72 RPNKLDLHVALNFALDIARAMDCLHAN---------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAE 139 (298)
Q Consensus 72 ~~~~~~~~~~~~i~~qi~~al~~LH~~---------givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 139 (298)
...+|....+|+..++.||+|||+. .|+|||||..|||+..|. ...|+|||++....... .....
T Consensus 302 --ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~~p~~~~~d~~~q 378 (534)
T KOG3653|consen 302 --NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALRLEPGKPQGDTHGQ 378 (534)
T ss_pred --ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEEecCCCCCcchhhh
Confidence 6799999999999999999999965 599999999999999554 69999999998654432 22335
Q ss_pred cCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCC------------CCCC---CC-hHHHHH-HHHHh
Q 022347 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL------------PFEG---MS-NLQAAY-AAAFK 202 (298)
Q Consensus 140 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~------------p~~~---~~-~~~~~~-~~~~~ 202 (298)
.||.+|||||++.+.-.-+. ...-.+.||||+|.|+||+++... ||+. .. ..++.. ....+
T Consensus 379 VGT~RYMAPEvLEgainl~d--~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~k 456 (534)
T KOG3653|consen 379 VGTRRYMAPEVLEGAINLQD--RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRK 456 (534)
T ss_pred hhhhhhcCHHHHhhhccccc--HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhh
Confidence 79999999999976322111 222247899999999999988532 3431 11 122222 22345
Q ss_pred hcCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 203 HARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 203 ~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
..+|.+++. ...-+++.++.||+.|++.|.|+.-+.+.+..+...-+
T Consensus 457 K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 457 KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 566666643 34568899999999999999999999998887765443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=202.20 Aligned_cols=184 Identities=28% Similarity=0.467 Sum_probs=154.3
Q ss_pred HHHHHHHHHHHHHhC-CCCcccceecee-ecCceeEEEecCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRV-KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
..++..+|+.+..+. .+|.+|.+++.+ ..+..||.||.| ..||..+.+. .++...++..+-+|+..++.||.|||
T Consensus 87 ~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~ 165 (282)
T KOG0984|consen 87 EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH 165 (282)
T ss_pred HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH
Confidence 345677899877766 599999999976 567899999999 6699998876 24567999999999999999999999
Q ss_pred hC-CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 97 AN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 97 ~~-givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
++ .++|||+||+|||++.++ .+|+||||++......-..+...|...|+|||.+.... ....|+-+|||||||+
T Consensus 166 ~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~----n~~gY~vksDvWSLGI 240 (282)
T KOG0984|consen 166 SKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPEL----NQKGYSVKSDVWSLGI 240 (282)
T ss_pred HHhhhhhccCCcceEEEccCC-cEEEcccccceeehhhhHHHHhcCCCccCChhhcCccc----Ccccceeehhhhhhhh
Confidence 86 899999999999999765 69999999998655554444467889999999997632 2247899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCC
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 210 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 210 (298)
++.||.+++.||+......+....+.....|.+|.
T Consensus 241 tmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 241 TMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 99999999999999888888888888777777664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=204.34 Aligned_cols=210 Identities=21% Similarity=0.383 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceeecC---ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
+.+.+|+.+|..|. ||||+.+++...+. ...+|+||+.+.+...+.. .++...+...+.+++.||.|+|+.
T Consensus 77 kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~ 151 (338)
T KOG0668|consen 77 KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM 151 (338)
T ss_pred HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc
Confidence 45669999999998 99999999998543 5679999998888777654 378888999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
||.|||+||.|++++.....++|+|+|++..............+..|.-||++.. ...|+.+-|+|||||++.
T Consensus 152 GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd-------y~~YDYSLD~WS~GcmlA 224 (338)
T KOG0668|consen 152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLA 224 (338)
T ss_pred CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheee-------chhccccHHHHHHHHHHH
Confidence 9999999999999998888899999999987776666566677888999999975 367888999999999999
Q ss_pred HHHhCCCCC-CCCChHHHHHHHHHhh---------------cCCC--------------------CCCCCcHHHHHHHHH
Q 022347 179 ELLTNRLPF-EGMSNLQAAYAAAFKH---------------ARPG--------------------LPEDISPDLAFIVQS 222 (298)
Q Consensus 179 ~ll~g~~p~-~~~~~~~~~~~~~~~~---------------~~~~--------------------~~~~~~~~l~~li~~ 222 (298)
.|+..+.|| .+.++.+++.+....- ..+. -...++++..+|+..
T Consensus 225 ~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldk 304 (338)
T KOG0668|consen 225 SMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDK 304 (338)
T ss_pred HHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHH
Confidence 999988886 4555555544332110 0111 112356899999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 223 CWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 223 ~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|..|-.+|+|+.|.+. +.+..
T Consensus 305 lLrYDHqeRlTakEam~--HpyF~ 326 (338)
T KOG0668|consen 305 LLRYDHQERLTAKEAMA--HPYFA 326 (338)
T ss_pred HHhhccccccchHHHhc--CchHH
Confidence 99999999999999987 44443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=219.71 Aligned_cols=193 Identities=28% Similarity=0.444 Sum_probs=163.5
Q ss_pred HHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 022347 27 REVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104 (298)
Q Consensus 27 ~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~d 104 (298)
.|-++|..- +-|.++++..+|+ -+.+|+||||+.||+|-..|+.. +++.+..+..++..|+-||=|||++||++||
T Consensus 398 ~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRD 475 (683)
T KOG0696|consen 398 VEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRD 475 (683)
T ss_pred hhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeee
Confidence 466666655 4678888888885 46899999999999999888763 6699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCCccC-ccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhC
Q 022347 105 LKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183 (298)
Q Consensus 105 ik~~Nil~~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g 183 (298)
||.+|||++.++ .+||.|||++... .......+.+||+.|+|||++.. .+|+.+.|.||+|+++|||+.|
T Consensus 476 LKLDNvmLd~eG-HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y--------qPYgksvDWWa~GVLLyEmlaG 546 (683)
T KOG0696|consen 476 LKLDNVMLDSEG-HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAG 546 (683)
T ss_pred ccccceEeccCC-ceEeeecccccccccCCcceeeecCCCcccccceEEe--------cccccchhHHHHHHHHHHHHcC
Confidence 999999999665 5999999999753 33445567799999999999976 7899999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 184 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
+.||++.+.. ++.+. +......+|..+|.+..+++...|...|.+|.
T Consensus 547 QpPFdGeDE~-elF~a-I~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 547 QPPFDGEDED-ELFQA-IMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CCCCCCCCHH-HHHHH-HHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 9999987653 33333 34455678899999999999999999999994
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=240.36 Aligned_cols=211 Identities=26% Similarity=0.410 Sum_probs=158.6
Q ss_pred HHHHHHHH---HHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCC---HHHHHHHHHH
Q 022347 16 DERALLEG---RFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLD---LHVALNFALD 87 (298)
Q Consensus 16 ~~~~~~~~---~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~---~~~~~~i~~q 87 (298)
..++.+.+ ...+|+..|..-+ |||||++++.-. +.+.||+.|.| ..+|++++... ...+. .-..+.++.|
T Consensus 537 AVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~-~~d~~~~~~i~~~~~l~q 614 (903)
T KOG1027|consen 537 AVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESS-GLDVEMQSDIDPISVLSQ 614 (903)
T ss_pred hHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhcc-ccchhhcccccHHHHHHH
Confidence 44444444 3469999999886 999999999875 55899999999 55999999874 11111 1345778999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCC---C-CceEEeccCCCccCcccc----ccccccCccceeccccccccccccC
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPD---Q-KSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQG 159 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~---~-~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~ 159 (298)
+++||++||+.+||||||||+||||+.. + .+++|+|||++....... ......||-+|.|||++..
T Consensus 615 ~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~------ 688 (903)
T KOG1027|consen 615 IASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE------ 688 (903)
T ss_pred HHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc------
Confidence 9999999999999999999999999862 2 478999999998654332 2445679999999999975
Q ss_pred CccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 022347 160 EKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236 (298)
Q Consensus 160 ~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 236 (298)
..-+.+.|||||||++|++++ |..||.+.-..+. .+..+... .+...-..+..+||.+|+.++|..||+|.+
T Consensus 689 --~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 689 --DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred --cccCcccchhhcCceEEEEecCCccCCCchHHhhh---hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHH
Confidence 334558999999999999999 5999986432211 11111111 111111128999999999999999999999
Q ss_pred HHH
Q 022347 237 IIR 239 (298)
Q Consensus 237 l~~ 239 (298)
|+.
T Consensus 764 VL~ 766 (903)
T KOG1027|consen 764 VLN 766 (903)
T ss_pred HhC
Confidence 987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=239.86 Aligned_cols=198 Identities=19% Similarity=0.207 Sum_probs=135.5
Q ss_pred cCceeEEEecCCCCCHHHHHhhhCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCE
Q 022347 49 DPLMVIVTELLPGMSLRKYLVSLRPN------------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 110 (298)
Q Consensus 49 ~~~~~lv~e~~~~~sL~~~l~~~~~~------------------~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Ni 110 (298)
+...++|+||+++++|.+++...... ......+..++.|++.||.|||+.||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 45789999999999999998753210 012334667999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCCccCcc--ccccccccCccceeccccccccccccCC--------------ccCCCcchhHHHHH
Q 022347 111 LLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGE--------------KKHYNNKVDVYSFG 174 (298)
Q Consensus 111 l~~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~--------------~~~~~~~~Di~slG 174 (298)
|++.+.+.++|+|||++..... ........+++.|+|||.+......... ...++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9996566799999999974322 2223445788999999976432111100 11345577999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHh----------hcCCC----------CCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFK----------HARPG----------LPEDISPDLAFIVQSCWVEDPNLRPSF 234 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~----------~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (298)
|++|+|+++..++... .......... ..... ..+.......+|+.+||+.||.+|||+
T Consensus 367 viL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 367 LIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 9999999977664421 1111111000 00000 011123345689999999999999999
Q ss_pred HHHHHHHHhhhhccCC
Q 022347 235 SQIIRMLNAFLFTLRP 250 (298)
Q Consensus 235 ~~l~~~l~~~~~~~~~ 250 (298)
.++++ +.++.....
T Consensus 445 ~e~L~--Hpff~~~~~ 458 (566)
T PLN03225 445 KAALA--HPYFDREGL 458 (566)
T ss_pred HHHhC--CcCcCCCCc
Confidence 99999 677655433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=212.75 Aligned_cols=218 Identities=28% Similarity=0.476 Sum_probs=166.6
Q ss_pred HHHHHHHHHHHhC--CCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV--KHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l--~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+.+.+|.++.... +|+||+.+++.-. ...+|+|++|.+.|||.||+.. ..++....++++..+++||++|
T Consensus 248 ~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHL 324 (513)
T KOG2052|consen 248 RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHL 324 (513)
T ss_pred hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHH
Confidence 3566888888765 8999999998852 2369999999999999999987 6799999999999999999999
Q ss_pred HhC--------CCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-----cccccccCccceeccccccccccccCCcc
Q 022347 96 HAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 96 H~~--------givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
|.. .|.|||||..|||+..+ +.+.|+|+|++...... .......||.+|||||++...-..+ .-
T Consensus 325 H~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~--~F 401 (513)
T KOG2052|consen 325 HMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMK--HF 401 (513)
T ss_pred HHHHhcCCCCchhhccccccccEEEccC-CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChh--hh
Confidence 954 49999999999999965 56999999999754332 2234558999999999997521111 01
Q ss_pred CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCh---HHHHHHH--HHhhcCCCCCCCCc-----HHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLTN----------RLPFEGMSN---LQAAYAA--AFKHARPGLPEDIS-----PDLAFIVQS 222 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g----------~~p~~~~~~---~~~~~~~--~~~~~~~~~~~~~~-----~~l~~li~~ 222 (298)
..-..+||||||.|+||++.. +.||.+..+ ..+.... ..+..+|.+|..+. ..+..+++.
T Consensus 402 esyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMke 481 (513)
T KOG2052|consen 402 ESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKE 481 (513)
T ss_pred hhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHH
Confidence 112378999999999999752 468865432 2233332 24556676665543 347789999
Q ss_pred hhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 223 CWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 223 ~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
||..||..|-|+--+-..|.+...
T Consensus 482 CW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 482 CWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred hhcCCchhhhHHHHHHHHHHHHhc
Confidence 999999999999998888877653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=243.55 Aligned_cols=196 Identities=21% Similarity=0.291 Sum_probs=142.3
Q ss_pred HHHhCCC-Ccccceeceee--------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 31 MMSRVKH-DNLVKFLGACK--------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 31 ~l~~l~h-p~Iv~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
-.+.++| +||+.+++++. +..+++++|++ +++|.+++.. ....+++.+++.++.||+.||+|||++||+
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 25 GSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred ccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3456667 68888888761 23567888988 6699999975 235699999999999999999999999999
Q ss_pred eecCCCCCEEEcCC------------------CCceEEeccCCCccCcccc-----------------ccccccCcccee
Q 022347 102 HRDLKPDNLLLTPD------------------QKSLKLADFGLAREETVTE-----------------MMTAETGTYRWM 146 (298)
Q Consensus 102 H~dik~~Nil~~~~------------------~~~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~y~ 146 (298)
||||||+|||++.. ...++++|||+++...... ......+|+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999632 2346677777665321100 001135788899
Q ss_pred ccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhh
Q 022347 147 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 226 (298)
Q Consensus 147 aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 226 (298)
|||++.+ ..++.++|||||||++|||++|..|+....... ........+.......+....++.+||++
T Consensus 183 APE~~~~--------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ 251 (793)
T PLN00181 183 SPEEDNG--------SSSNCASDVYRLGVLLFELFCPVSSREEKSRTM---SSLRHRVLPPQILLNWPKEASFCLWLLHP 251 (793)
T ss_pred Chhhhcc--------CCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH---HHHHHhhcChhhhhcCHHHHHHHHHhCCC
Confidence 9999865 567899999999999999999988876432211 11111111211112245567899999999
Q ss_pred CCCCCCCHHHHHH
Q 022347 227 DPNLRPSFSQIIR 239 (298)
Q Consensus 227 ~p~~Rps~~~l~~ 239 (298)
+|.+||++.++++
T Consensus 252 ~P~~Rps~~eil~ 264 (793)
T PLN00181 252 EPSCRPSMSELLQ 264 (793)
T ss_pred ChhhCcChHHHhh
Confidence 9999999999988
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=203.68 Aligned_cols=198 Identities=25% Similarity=0.407 Sum_probs=166.3
Q ss_pred HHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+.|-.+..+. +||.+|-+..+|+ +..+++|.||++||+|--.++. .++++++.+..+...|+.||.|||++||+
T Consensus 296 wvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgii 373 (593)
T KOG0695|consen 296 WVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGII 373 (593)
T ss_pred hHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCee
Confidence 344566666666 5999999999995 6789999999999999776664 46799999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCcc-CccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
++|||.+|++++..+ .+||.|+|.+.. .......++.+||+.|.|||++.+ ..|+...|.|+||++|+||
T Consensus 374 yrdlkldnvlldaeg-hikltdygmcke~l~~gd~tstfcgtpnyiapeilrg--------eeygfsvdwwalgvlmfem 444 (593)
T KOG0695|consen 374 YRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEM 444 (593)
T ss_pred eeeccccceEEccCC-ceeecccchhhcCCCCCcccccccCCCcccchhhhcc--------cccCceehHHHHHHHHHHH
Confidence 999999999999665 699999999974 344556778899999999999976 8899999999999999999
Q ss_pred HhCCCCCCC------CChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 181 LTNRLPFEG------MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 181 l~g~~p~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
+.|+.||.- ..+.+.....++-.....+|..++-....+++.-|..||.+|.
T Consensus 445 magrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 445 MAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 999999952 1233444444555555677888888899999999999999994
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=216.63 Aligned_cols=197 Identities=23% Similarity=0.417 Sum_probs=155.9
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
....|-.||...+++-||++|..|+| +.+|+||||++||++-.++-. -+.|++..+..++..+..|+++.|..|++|
T Consensus 675 HVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIH 752 (1034)
T KOG0608|consen 675 HVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIH 752 (1034)
T ss_pred hhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhcccee
Confidence 45578889999999999999999964 589999999999999998865 366999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccc-----------c--------------------------------ccccc
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVT-----------E--------------------------------MMTAE 139 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-----------~--------------------------------~~~~~ 139 (298)
|||||+|||||.++. |||.|||++...--. . .....
T Consensus 753 RDiKPDNILIDrdGH-IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahsl 831 (1034)
T KOG0608|consen 753 RDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSL 831 (1034)
T ss_pred cccCccceEEccCCc-eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhh
Confidence 999999999998865 999999998621000 0 00112
Q ss_pred cCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHhhcCCCCCCCCcHHHH
Q 022347 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA--AFKHARPGLPEDISPDLA 217 (298)
Q Consensus 140 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~ 217 (298)
.||+.|+|||++.. ..++..+|.||.|+|+|+|+.|+.||-.........+. ...........+++.++.
T Consensus 832 vgt~nyiapevl~r--------~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~ 903 (1034)
T KOG0608|consen 832 VGTPNYIAPEVLAR--------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEAL 903 (1034)
T ss_pred cCCCcccChHHhcc--------cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHH
Confidence 58999999999974 67788999999999999999999999776544333222 222233344467999999
Q ss_pred HHHHHhhhhCCCCCC
Q 022347 218 FIVQSCWVEDPNLRP 232 (298)
Q Consensus 218 ~li~~~l~~~p~~Rp 232 (298)
++|.+++. .++.|.
T Consensus 904 ~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 904 DLIQKLCC-SADSRL 917 (1034)
T ss_pred HHHHHHhc-Chhhhh
Confidence 99977654 555664
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=194.01 Aligned_cols=163 Identities=28% Similarity=0.342 Sum_probs=126.6
Q ss_pred CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccC
Q 022347 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 141 (298)
Q Consensus 62 ~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 141 (298)
|||.+++... ...+++..++.++.|++.||.|||+.+ ||+||+++.+ +.+++ ||++...... ...+
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCC
Confidence 6899999763 356999999999999999999999998 9999999855 45777 9988654332 2257
Q ss_pred ccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC------CCCCCcH-
Q 022347 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG------LPEDISP- 214 (298)
Q Consensus 142 ~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~- 214 (298)
++.|+|||++.+ ..++.++||||||+++|+|++|..||.................... .+..++.
T Consensus 67 ~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 67 DPYFMAPEVIQG--------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred cccccChHHhcC--------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence 899999999865 5678899999999999999999999976544333333333222222 1122333
Q ss_pred -HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 215 -DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 215 -~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++.+++.+||..+|.+||++.++++++.....
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 69999999999999999999999998765543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=203.89 Aligned_cols=213 Identities=30% Similarity=0.453 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCCcccceeceeecC------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHH
Q 022347 18 RALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 91 (298)
Q Consensus 18 ~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~a 91 (298)
.-..-+++.+|+++|..++|.|++..++..+-. .+|+++|.+ ..+|.+.|-. +..++...+.-+++||+.|
T Consensus 92 ~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRG 168 (449)
T KOG0664|consen 92 NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRG 168 (449)
T ss_pred HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhh
Confidence 334445788999999999999999999887432 478999999 5589888875 4668999999999999999
Q ss_pred HHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchh
Q 022347 92 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 92 l~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
|.|||+.||.||||||.|++++ .+..+||||||+++....... +.....|..|.|||++.| .+.|+.+.|
T Consensus 169 LKYLHsA~ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvD 240 (449)
T KOG0664|consen 169 LKYLHTANILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVD 240 (449)
T ss_pred hHHHhhcchhhccCCCccEEec-cCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhc-------chhhcCccc
Confidence 9999999999999999999999 556799999999986554433 344567889999999986 478999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC------------------------CCC--------CCCcHHHH
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------------------------GLP--------EDISPDLA 217 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~~~--------~~~~~~l~ 217 (298)
|||+|||+.|++..+..|....+.+++.....--+.+ .++ ..-..+..
T Consensus 241 iWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav 320 (449)
T KOG0664|consen 241 IWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAV 320 (449)
T ss_pred eehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHH
Confidence 9999999999999888888766655544322111111 111 12334566
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 218 FIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 218 ~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++..++.++|+.|.+.++.+.++
T Consensus 321 ~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 321 DLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHHhCCCCcccccHhhhcccc
Confidence 788899999999999988887744
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=229.79 Aligned_cols=178 Identities=31% Similarity=0.491 Sum_probs=132.8
Q ss_pred eeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCc
Q 022347 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131 (298)
Q Consensus 52 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~ 131 (298)
+||-||||+..++.+++..+.... .....|+++.+|++||.|+|+.|++||||||.|||++.+ +.|||+|||++....
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~ 748 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLK 748 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCC-CCeeecccccchhhh
Confidence 689999999988888887643211 467889999999999999999999999999999999955 469999999997511
Q ss_pred -------------------cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 022347 132 -------------------VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192 (298)
Q Consensus 132 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 192 (298)
.....+..+||..|+|||++.+. ....|+.++|+||||+|++||+. ||...-.
T Consensus 749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~-----~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME 820 (1351)
T KOG1035|consen 749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT-----SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME 820 (1351)
T ss_pred hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc-----ccccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence 01123445799999999998752 12479999999999999999974 5654322
Q ss_pred HHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 193 LQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 193 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
-.........+..|.- ...--+.-..+|.+|++.||.+||||.+++.
T Consensus 821 Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 821 RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 2222222222211111 2223355678999999999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=216.10 Aligned_cols=211 Identities=25% Similarity=0.400 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHHHHhCC------CCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHH
Q 022347 19 ALLEGRFIREVNMMSRVK------HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIAR 90 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~------hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~ 90 (298)
+.+.+.=.+|+++|++|. --|+++++..| ..+++|+|+|.+ ..+|.+.++..+. -.+....+..++.|++.
T Consensus 469 E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLfl 547 (752)
T KOG0670|consen 469 EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFL 547 (752)
T ss_pred hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHH
Confidence 444555568999999995 35899998887 467899999999 6699999987543 35888999999999999
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 91 al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
||..|-..||+|.||||+|||++.....+||||||.+...+.... ..+..+..|.|||++.| ..|+...|+
T Consensus 548 ALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG--------~~yd~~iD~ 618 (752)
T KOG0670|consen 548 ALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILG--------LPYDYPIDT 618 (752)
T ss_pred HHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccc-cHHHHHHhccCcceeec--------CcccCCccc
Confidence 999999999999999999999998888999999999987554433 34456789999999987 788999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-hcCC-------------------------------------------
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARP------------------------------------------- 206 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~------------------------------------------- 206 (298)
||+||++||+.||+..|++..+.+.+...... +..|
T Consensus 619 WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt 698 (752)
T KOG0670|consen 619 WSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT 698 (752)
T ss_pred eeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcc
Confidence 99999999999999999987664433321110 0000
Q ss_pred -----------CCCCC---CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 207 -----------GLPED---ISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 207 -----------~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
.++.. .-..+++|+..||..||.+|.|..+.|.
T Consensus 699 kdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 699 KDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01111 1135889999999999999999999887
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=194.74 Aligned_cols=210 Identities=24% Similarity=0.365 Sum_probs=161.6
Q ss_pred HHHHHHHHHHHHhCC-CCcccceece-ee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVK-HDNLVKFLGA-CK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~Iv~~~~~-~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.++|.+|.-.--.|. |.||+.-|+. |+ .+..++++||++.|+|..-+.. ..+-+.....++.|+++|+.|+|++
T Consensus 64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk 140 (378)
T KOG1345|consen 64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK 140 (378)
T ss_pred HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc
Confidence 347888888776775 9999998876 43 5578899999999999987765 6688899999999999999999999
Q ss_pred CCeeecCCCCCEEEc-CCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
++||||||.+|||+- .+..++||||||.+...+..-. ....+..|.+||..... .+......+.+|+|.||+++
T Consensus 141 nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~--~~~~~~~y~~pe~~~~~---~ne~~~~~ps~D~WqfGIi~ 215 (378)
T KOG1345|consen 141 NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK--YLEYVNNYHAPELCDTV---VNEKLVVNPSTDIWQFGIIF 215 (378)
T ss_pred chhhcccccceEEEecCCccEEEeeecccccccCceeh--hhhhhcccCCcHHHhhc---cccceEecccccchheeeee
Confidence 999999999999985 4445899999999976543322 22345678999987653 22345667899999999999
Q ss_pred HHHHhCCCCCCCC---ChHHHHHHHHHhhcCCCCCC---CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 178 WELLTNRLPFEGM---SNLQAAYAAAFKHARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 178 ~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+.|++|+.||... +..-..+........+..|. .+++.+..+.++-|.+++++|-...+...
T Consensus 216 f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 216 FYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred eeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 9999999999743 22223333444445555554 47888999999999999999955544444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=190.42 Aligned_cols=178 Identities=37% Similarity=0.642 Sum_probs=151.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+..++.++|++|+++++++. ....++++|+++|++|.+++.... ..++...++.++.+++.++.+||+.|+
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~ 113 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGI 113 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 457889999999999999999999985 467899999999899999998632 358999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+|+||+|.||+++...+.++|+|||.+....... ......+...|.+||.... ...++.++|+|++|+++++
T Consensus 114 ~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~ 186 (215)
T cd00180 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYE 186 (215)
T ss_pred eccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcc-------cCCCCchhhhHHHHHHHHH
Confidence 9999999999999624579999999987544332 1233456778999998864 1367789999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
+ ..+.+++..|++.+|.+||++.++++.
T Consensus 187 l---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 187 L---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred H---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 8 578899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=210.90 Aligned_cols=218 Identities=21% Similarity=0.249 Sum_probs=149.0
Q ss_pred HHHHHHHHHhCCCCcc-----cceeceee---------cCceeEEEecCCCCCHHHHHhhhCC-----------------
Q 022347 25 FIREVNMMSRVKHDNL-----VKFLGACK---------DPLMVIVTELLPGMSLRKYLVSLRP----------------- 73 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~I-----v~~~~~~~---------~~~~~lv~e~~~~~sL~~~l~~~~~----------------- 73 (298)
+..|+.++.+++|.++ ++++++|. ++..|+|+||+++++|.+++.....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3457777777776554 56666652 2468999999999999999874210
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc--ccccCcccee
Q 022347 74 -----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWM 146 (298)
Q Consensus 74 -----~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~ 146 (298)
..+++..+..++.|++.+|.|||+.|++|+||||+||+++.+ ..++|+|||++......... .....++.|+
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCccee
Confidence 124567788999999999999999999999999999999965 46999999998654332211 2234478999
Q ss_pred ccccccccccccCC--------------ccCCCcchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHH---------HHHh
Q 022347 147 APELYSTVTLRQGE--------------KKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYA---------AAFK 202 (298)
Q Consensus 147 aPE~~~~~~~~~~~--------------~~~~~~~~Di~slG~il~~ll~g~~-p~~~~~~~~~~~~---------~~~~ 202 (298)
|||.+......... ......+.|+||+||++|+|++|.. ||.+......... ....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 99988532110000 0111235799999999999999875 6653211100000 0011
Q ss_pred hcC--CCCCCCCcHHHHHHHHHhhhhCC---CCCCCHHHHHHHHHhhh
Q 022347 203 HAR--PGLPEDISPDLAFIVQSCWVEDP---NLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 203 ~~~--~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~l~~~l~~~~ 245 (298)
... ....+..++...+++.+||..+| .+|+|++++++ +.|+
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~--Hp~f 503 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS--HRFF 503 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC--CCCc
Confidence 111 22235578899999999999765 68999999998 5444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=214.40 Aligned_cols=208 Identities=27% Similarity=0.414 Sum_probs=171.3
Q ss_pred HHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
-+++|+-+++.++||||+.+++.+ .+..+|++||||.||+|++..+- .+.+++.++...++..+.||+|||+.|=+|
T Consensus 58 ~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~h 135 (829)
T KOG0576|consen 58 GIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIH 135 (829)
T ss_pred ccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCccc
Confidence 355899999999999999999988 56689999999999999998764 467999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||..||+++ +.+.+++.|||.+..+...- .....+||+.|+|||+..- +..+.|...+|||++|+...|+-
T Consensus 136 RdiKGanillt-d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaav-----erkggynqlcdiwa~gitAiel~ 209 (829)
T KOG0576|consen 136 RDIKGANILLT-DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV-----ERKGGYNQLCDIWALGITAIELG 209 (829)
T ss_pred ccccccceeec-ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHH-----Hhcccccccccccccccchhhhh
Confidence 99999999999 55569999999987655433 2345689999999998642 23467888999999999999998
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
.-+.|.-+..+.+...-.......+ .-+..+++.+.+|++.+|-.+|++||+++.++.
T Consensus 210 eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 210 ELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 8788866555555444433333222 223458899999999999999999999998876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=197.82 Aligned_cols=92 Identities=29% Similarity=0.468 Sum_probs=81.6
Q ss_pred HHHHHHHHHHHHHHhCC-----C---Ccccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVK-----H---DNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~-----h---p~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~ 86 (298)
...+....|+.+|++++ | .+||++++.|. +.+.|+|+|++ |.+|..+|.....+.++...+..|+.
T Consensus 116 hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~ 194 (590)
T KOG1290|consen 116 HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICR 194 (590)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHH
Confidence 35566779999999984 2 48999999983 34799999999 88999999987778899999999999
Q ss_pred HHHHHHHHHHhC-CCeeecCCCCCEEE
Q 022347 87 DIARAMDCLHAN-GIIHRDLKPDNLLL 112 (298)
Q Consensus 87 qi~~al~~LH~~-givH~dik~~Nil~ 112 (298)
||+.||.|||++ ||+|-||||+|||+
T Consensus 195 qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 195 QVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHHHHhcCccccCCCcceeee
Confidence 999999999985 99999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=179.97 Aligned_cols=169 Identities=36% Similarity=0.550 Sum_probs=138.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+..+.+++|+|++++++++. +...++++|++++++|.+++..... .+++..+..++.+++.++.+||+.|+
T Consensus 41 ~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i 119 (225)
T smart00221 41 REEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGI 119 (225)
T ss_pred HHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 457889999999999999999999885 5679999999999999999986322 28899999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+|+||+|.||+++.+ ..++|+|||.+....... ......+...|++||.+. ....++.++|+|+||++++
T Consensus 120 ~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~~Dv~~lG~~~~ 191 (225)
T smart00221 120 VHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL-------GGKGYGEAVDIWSLGVILY 191 (225)
T ss_pred ecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc-------CCCCCCchhhHHHHHHHHH
Confidence 999999999999955 579999999987654432 223345677899999873 1256677999999999999
Q ss_pred HHHhCCCCCCC-CChHHHHHHH
Q 022347 179 ELLTNRLPFEG-MSNLQAAYAA 199 (298)
Q Consensus 179 ~ll~g~~p~~~-~~~~~~~~~~ 199 (298)
++++|+.||.. .++.......
T Consensus 192 ~l~~g~~pf~~~~~~~~~~~~~ 213 (225)
T smart00221 192 ELLWGPEPFSGEGEFTSLLSDV 213 (225)
T ss_pred HHHHCCCCccccchhHHHHHHH
Confidence 99999999977 3443333333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=200.03 Aligned_cols=153 Identities=25% Similarity=0.463 Sum_probs=130.5
Q ss_pred HHHHHHHHhCC---CCcccceeceeec-CceeEEEecC-CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 26 IREVNMMSRVK---HDNLVKFLGACKD-PLMVIVTELL-PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 26 ~~E~~~l~~l~---hp~Iv~~~~~~~~-~~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
-.|+++|..++ |+||++++++|++ +++||+||-. +|.+|.++|.-+ ..+++.++..|+.|++.|+++||+.||
T Consensus 614 p~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~i 691 (772)
T KOG1152|consen 614 PSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGI 691 (772)
T ss_pred chhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCc
Confidence 35999999998 9999999999974 5788999964 556999999863 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||-+|+.++.+ +-++|+|||.+.... ..+.....||..|.|||++.| ....+...|||+||+++|.+
T Consensus 692 vhrdikdenvivd~~-g~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillyti 762 (772)
T KOG1152|consen 692 VHRDIKDENVIVDSN-GFVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTI 762 (772)
T ss_pred eecccccccEEEecC-CeEEEeeccchhhhc-CCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEE
Confidence 999999999999955 469999999986533 334456689999999999976 34456788999999999999
Q ss_pred HhCCCCCCC
Q 022347 181 LTNRLPFEG 189 (298)
Q Consensus 181 l~g~~p~~~ 189 (298)
+....||.+
T Consensus 763 vykenpyyn 771 (772)
T KOG1152|consen 763 VYKENPYYN 771 (772)
T ss_pred EeccCCCcC
Confidence 988888864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=186.33 Aligned_cols=209 Identities=27% Similarity=0.423 Sum_probs=161.2
Q ss_pred HHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++.+|+++|..+. +.||+.+.+++. ++..++|+||+++....+++.. ++..++...++.++.||.++|..||+
T Consensus 80 ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIv 154 (418)
T KOG1167|consen 80 RILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIV 154 (418)
T ss_pred HHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCcc
Confidence 6779999999997 999999999984 6689999999999999998865 77899999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCc-----------------c--c---------c-----------------cc
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREET-----------------V--T---------E-----------------MM 136 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~-----------------~--~---------~-----------------~~ 136 (298)
||||||+|++.+...+...|+|||++.... . . . ..
T Consensus 155 HRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~ 234 (418)
T KOG1167|consen 155 HRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSER 234 (418)
T ss_pred ccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcccee
Confidence 999999999999888889999999986100 0 0 0 00
Q ss_pred ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH---------------
Q 022347 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM-SNLQAAYAAA--------------- 200 (298)
Q Consensus 137 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~-~~~~~~~~~~--------------- 200 (298)
....||++|.|||++... ..-++++||||.|+|++.++++..||-.. ++........
T Consensus 235 anrAGT~GfRaPEvL~k~-------~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~ 307 (418)
T KOG1167|consen 235 ANRAGTPGFRAPEVLFRC-------PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALP 307 (418)
T ss_pred cccCCCCCCCchHHHhhc-------cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcC
Confidence 012589999999999753 45577999999999999999999998432 1111111000
Q ss_pred --------------------Hhhc--------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 201 --------------------FKHA--------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 201 --------------------~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+... .....+.++..+.+++.+|++.||.+|.|+++.|+ +.+..
T Consensus 308 g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk--HpFF~ 385 (418)
T KOG1167|consen 308 GRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK--HPFFD 385 (418)
T ss_pred CceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc--CcCCc
Confidence 0000 00011234568899999999999999999999988 44443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-23 Score=176.86 Aligned_cols=216 Identities=23% Similarity=0.330 Sum_probs=169.3
Q ss_pred HHHHHHHHHHhCCC----Ccccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 24 RFIREVNMMSRVKH----DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 24 ~~~~E~~~l~~l~h----p~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
.+..|..++..+.. +++..+++.. .+.+.|+||+.+ |.+|.++......+.++..+++.|+.|++.+|.+||+
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 35578888888873 6889999888 355789999999 9999999877666789999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCC----CceEEeccCCCc--cCcccc--------c-cccccCccceeccccccccccccCCcc
Q 022347 98 NGIIHRDLKPDNLLLTPDQ----KSLKLADFGLAR--EETVTE--------M-MTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~----~~~~l~dfg~~~--~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++||||||+|+++.... ..+.|.|||+++ ...... . .....||..|.++..+.+ .
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------~ 212 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------I 212 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--------C
Confidence 9999999999999998653 469999999998 321111 1 123458999999998875 7
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHhhcCCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY--AAAFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
..+.+.|+||+++++.+++.|..||.......... .......... .....+.++..+...+-..+...+|++..+..
T Consensus 213 e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 213 EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 78899999999999999999999997655322211 1111111111 33446677888888888899999999999999
Q ss_pred HHHhhhhcc
Q 022347 240 MLNAFLFTL 248 (298)
Q Consensus 240 ~l~~~~~~~ 248 (298)
.+.......
T Consensus 293 ~l~~~~~~~ 301 (322)
T KOG1164|consen 293 LLKDVFDSE 301 (322)
T ss_pred HHHHHHHhc
Confidence 988877664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=174.77 Aligned_cols=205 Identities=27% Similarity=0.382 Sum_probs=154.1
Q ss_pred CCCcccceeceeec----------------------------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHH
Q 022347 36 KHDNLVKFLGACKD----------------------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87 (298)
Q Consensus 36 ~hp~Iv~~~~~~~~----------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~q 87 (298)
+|||||.++++|.+ ..+|+||..++. +|.+|+.. ...+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHH
Confidence 59999999876522 147899999855 99999976 44666677888999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCCC---CceEEeccCCCccCcc-------ccccccccCccceeccccccccccc
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLAREETV-------TEMMTAETGTYRWMAPELYSTVTLR 157 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~~---~~~~l~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~ 157 (298)
+++|+.|||++|+.|||+|.+||++.-+. ..++|.|||++-.... .+......|+...+|||+....+-
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG- 428 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG- 428 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC-
Confidence 99999999999999999999999985332 2578999999864332 112223357778999998865221
Q ss_pred cCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 022347 158 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237 (298)
Q Consensus 158 ~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (298)
....-.| .++|.|+.|.+.||++....||.+....--......+...|.+|+.+++.+++++...|+.||.+|+|..=.
T Consensus 429 p~avvny-~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 429 PNAVVNY-EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred Cceeecc-chhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 1111122 488999999999999999999987544332233345566788999999999999999999999999987766
Q ss_pred HHHHHhhhh
Q 022347 238 IRMLNAFLF 246 (298)
Q Consensus 238 ~~~l~~~~~ 246 (298)
.+.|+-.+.
T Consensus 508 ANvl~LsLw 516 (598)
T KOG4158|consen 508 ANVLNLSLW 516 (598)
T ss_pred HhHHHHHHh
Confidence 665554443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=168.70 Aligned_cols=226 Identities=29% Similarity=0.477 Sum_probs=180.5
Q ss_pred hhHHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHH
Q 022347 4 FMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82 (298)
Q Consensus 4 ~~~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 82 (298)
++.||++.... -..+.++|..|.-.|+-+.||||+++++.|.. .++.+++.|++.|||+..+++...-..+..++.
T Consensus 216 ivakil~vr~~---t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav 292 (448)
T KOG0195|consen 216 IVAKILNVREV---TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAV 292 (448)
T ss_pred hhhhhhhhhhc---chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHH
Confidence 34555554332 23344588899999999999999999999964 589999999999999999998555567888999
Q ss_pred HHHHHHHHHHHHHHhCC--CeeecCCCCCEEEcCCCCceEE--eccCCCccCccccccccccCccceecccccccccccc
Q 022347 83 NFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKL--ADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 158 (298)
Q Consensus 83 ~i~~qi~~al~~LH~~g--ivH~dik~~Nil~~~~~~~~~l--~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 158 (298)
+++.+++.|++|||+.. |.---|+...+++|.+-. .+| .|--++. ........+.|++||.+...+
T Consensus 293 ~faldiargmaflhslep~ipr~~lns~hvmidedlt-arismad~kfsf------qe~gr~y~pawmspealqrkp--- 362 (448)
T KOG0195|consen 293 RFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT-ARISMADTKFSF------QEVGRAYSPAWMSPEALQRKP--- 362 (448)
T ss_pred HHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh-hheecccceeee------eccccccCcccCCHHHHhcCc---
Confidence 99999999999999874 455568888999985532 333 2221111 112335678999999886421
Q ss_pred CCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 022347 159 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238 (298)
Q Consensus 159 ~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 238 (298)
....-.++|+|||++++||+.|...||.+..+.+.-.+....+.+..+|++++..+..++.-|+..||.+||.++.++
T Consensus 363 --ed~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 363 --EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred --hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 233446899999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHHHhh
Q 022347 239 RMLNAF 244 (298)
Q Consensus 239 ~~l~~~ 244 (298)
-.|+..
T Consensus 441 pilekm 446 (448)
T KOG0195|consen 441 PILEKM 446 (448)
T ss_pred hhHHHh
Confidence 877654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-24 Score=195.39 Aligned_cols=242 Identities=21% Similarity=0.245 Sum_probs=165.7
Q ss_pred chhhHHHhcCCCCcHHHHHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHH
Q 022347 2 GKFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80 (298)
Q Consensus 2 g~~~~~v~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 80 (298)
|-|+.||..+....-.-+..++++ .|++ ...++|||++++.-+. .+...|+|-+|+.+ +|+|.+..+. -+...+
T Consensus 47 G~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRP--FL~~iE 121 (1431)
T KOG1240|consen 47 GLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRP--FLVLIE 121 (1431)
T ss_pred ceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccch--HHHHHH
Confidence 445555555544443344444454 4455 7778999999998876 45678899999955 9999887632 267778
Q ss_pred HHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCc----ccccc----ccccCccceecccccc
Q 022347 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET----VTEMM----TAETGTYRWMAPELYS 152 (298)
Q Consensus 81 ~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~----~~~~~----~~~~~~~~y~aPE~~~ 152 (298)
...|+.|++.||..+|+.||+|||||.+|||+. .-+.+.|+||..-...- +.... .+....-+|.|||.+.
T Consensus 122 KkWiaFQLL~al~qcH~~gVcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv 200 (1431)
T KOG1240|consen 122 KKWIAFQLLKALSQCHKLGVCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFV 200 (1431)
T ss_pred HHHHHHHHHHHHHHHHHcCccccccccceEEEe-eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhh
Confidence 889999999999999999999999999999998 44469999999875321 11111 1112334899999987
Q ss_pred ccc--cccCCccC-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCC----CCCCCCcHHHHHHHHHhh
Q 022347 153 TVT--LRQGEKKH-YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCW 224 (298)
Q Consensus 153 ~~~--~~~~~~~~-~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l 224 (298)
... ........ .+++-||||+||++.|+++ |+++|+-. ++.... .+... -+..--+..++.++..|+
T Consensus 201 ~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr-~~~~~~~e~~Le~Ied~~~Rnlil~Mi 275 (1431)
T KOG1240|consen 201 SALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYR-SGNADDPEQLLEKIEDVSLRNLILSMI 275 (1431)
T ss_pred ccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHh-ccCccCHHHHHHhCcCccHHHHHHHHH
Confidence 632 22222233 6789999999999999999 88888621 111111 00000 000112236999999999
Q ss_pred hhCCCCCCCHHHHHHH-------------HHhhhhccCCCCCC
Q 022347 225 VEDPNLRPSFSQIIRM-------------LNAFLFTLRPPSPS 254 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~-------------l~~~~~~~~~~~~~ 254 (298)
+.||.+|.+++++++. |..++....+.+..
T Consensus 276 ~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~~~~~~~~ 318 (1431)
T KOG1240|consen 276 QRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDRFVPLTTS 318 (1431)
T ss_pred ccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHhcCCcccc
Confidence 9999999999999985 55556666665533
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=191.57 Aligned_cols=211 Identities=25% Similarity=0.380 Sum_probs=163.3
Q ss_pred HHHHHHHHHhCCCCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 103 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~ 103 (298)
+..|+.+-.++.|||++..+..+.+ ...+-.||||++ +|..++... ..++..++..++.|++.|+.|+|..|+.|+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~Giahr 444 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHR 444 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceec
Confidence 6678888899999999988877632 223333999999 999999863 368889999999999999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEeccCCCccCccc-----cccccccCccceeccccccccccccCCccCCC-cchhHHHHHHHH
Q 022347 104 DLKPDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVL 177 (298)
Q Consensus 104 dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~~~Di~slG~il 177 (298)
|+|++|+++..++ .++|+|||.+...... .......|+..|+|||.+.+ ..|. ...||||.|+++
T Consensus 445 dlK~enll~~~~g-~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~--------~~ydpr~vDiwS~~ii~ 515 (601)
T KOG0590|consen 445 DLKLENLLVTENG-ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTG--------KEYDPRAVDVWSCGIIY 515 (601)
T ss_pred cCccccEEEecCC-ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccc--------cccCcchhhhhhccceE
Confidence 9999999999654 7999999998643221 23345678999999999976 4444 467999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHH-H------HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAA-A------FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+.|.+|+.||......+..... . .......+...++...+.+|.+||+.+|.+|.|++++++ ..|+..+.
T Consensus 516 ~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--d~W~~~i~ 592 (601)
T KOG0590|consen 516 ICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN--DEWIRSIE 592 (601)
T ss_pred EEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh--ChHhhhcc
Confidence 9999999999754433322111 0 011111233457788999999999999999999999998 67766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-20 Score=150.97 Aligned_cols=217 Identities=20% Similarity=0.319 Sum_probs=172.2
Q ss_pred HHHHHHHHHHhCC-CCcccceeceeec-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++..|....+.|. .++|.+.+.+.+. -+-.+|+|.+ |.||.|++.- .++.|+..++..++.|++.-++++|++.+|
T Consensus 69 QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LI 146 (449)
T KOG1165|consen 69 QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLI 146 (449)
T ss_pred hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhccee
Confidence 4567888888885 7999998888754 4677999999 9999998764 668899999999999999999999999999
Q ss_pred eecCCCCCEEEcC----CCCceEEeccCCCccCccccc--------cccccCccceeccccccccccccCCccCCCcchh
Q 022347 102 HRDLKPDNLLLTP----DQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 102 H~dik~~Nil~~~----~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
.|||||+|+||.. +.+.|.++|||++...-.... ...-.||..||+--.+.+ +.-+.+.|
T Consensus 147 YRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--------rEQSRRDD 218 (449)
T KOG1165|consen 147 YRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--------REQSRRDD 218 (449)
T ss_pred ecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc--------chhhhhhh
Confidence 9999999999963 344799999999985433221 123368999999887776 77788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhhcCC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 170 VYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+-|||-++++.|.|..||.+.. +..+.+..+-...+. .+..++|.++..-+.-.-..+-.+-|+++-+...+..
T Consensus 219 LEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 219 LEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred HHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 9999999999999999998753 223333333222111 2335688899999988889999999999999999988
Q ss_pred hhhccCC
Q 022347 244 FLFTLRP 250 (298)
Q Consensus 244 ~~~~~~~ 250 (298)
++..+..
T Consensus 299 vldr~g~ 305 (449)
T KOG1165|consen 299 VLDRLGE 305 (449)
T ss_pred HHHhcCC
Confidence 8776653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-20 Score=156.42 Aligned_cols=215 Identities=32% Similarity=0.481 Sum_probs=167.2
Q ss_pred HHHHHHHHHHHHHhCCCC-cccceeceeecC-ceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVKHD-NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp-~Iv~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
....+.+|+.++..+.|+ +|+++.+.+... ..+++++++.++++.+++..... ..++......++.|++.++.|+|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 455788999999999988 799999998544 46999999999999977765321 268999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-------ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
.|++|+|+||+||+++..+..++++|||.+....... ......++..|.+||.+.+.. ...+....|+
T Consensus 120 ~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~ 194 (384)
T COG0515 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDI 194 (384)
T ss_pred CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC-----CCCCCchHhH
Confidence 9999999999999999665469999999987433322 235567899999999886410 1467789999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhcCC----CCCCCC----cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARP----GLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|++++++++|..||..... .............+ ...... ...+.+++..++..+|..|.+..+...
T Consensus 195 ~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 195 WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 9999999999999999877653 23333333332222 111112 257899999999999999998887776
Q ss_pred H
Q 022347 240 M 240 (298)
Q Consensus 240 ~ 240 (298)
.
T Consensus 275 ~ 275 (384)
T COG0515 275 H 275 (384)
T ss_pred c
Confidence 4
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=145.94 Aligned_cols=215 Identities=21% Similarity=0.315 Sum_probs=167.7
Q ss_pred HHHHHHHHHHhCCC-Ccccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVKH-DNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~h-p~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+..|..+...|++ ..|..+..+. +..+-.+||+.+ |.||.+++.- ..+.|+..+++-++-|++.-++|+|.++++
T Consensus 56 qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fi 133 (341)
T KOG1163|consen 56 QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFI 133 (341)
T ss_pred chhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccc
Confidence 46679999999985 6777777776 455788999999 9999998764 557799999999999999999999999999
Q ss_pred eecCCCCCEEEcCC--CCceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 102 HRDLKPDNLLLTPD--QKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 102 H~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
||||||+|+|+.-+ .+.+.++|||++...-... ....-.||..|.+--.+.+ ..-+.+.|+-
T Consensus 134 HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--------~eqSRRDDme 205 (341)
T KOG1163|consen 134 HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--------IEQSRRDDME 205 (341)
T ss_pred cccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh--------hhhhhhhhhh
Confidence 99999999998633 3468999999997432211 1122368889988776665 4557789999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhhcCC-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 172 SFGIVLWELLTNRLPFEGMSNL--QAAYAAAFKHARP-----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
|+|.++.++..|..||.+.... .+....+. .... .+-.++|.++.-.+.-|-..--++-|++.-+.+.++.+
T Consensus 206 SvgYvLmYfnrG~LPWQglka~tk~QKyEkI~-EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 206 SVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS-EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred hhcceeeeeecCCCcccccchhhHHHHHHHHH-HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999986432 22222222 2222 23367899999999999999999999999999988887
Q ss_pred hhccC
Q 022347 245 LFTLR 249 (298)
Q Consensus 245 ~~~~~ 249 (298)
...+.
T Consensus 285 fr~ln 289 (341)
T KOG1163|consen 285 FRTLN 289 (341)
T ss_pred Hhhcc
Confidence 76654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=166.24 Aligned_cols=212 Identities=33% Similarity=0.511 Sum_probs=159.4
Q ss_pred HHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-eeecCCCCC
Q 022347 32 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI-IHRDLKPDN 109 (298)
Q Consensus 32 l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi-vH~dik~~N 109 (298)
|+.+.|.|+.++++.+ .++..++|.+||+.|+|.|.+.. ....+++.....++.+++.||.|||...| +||.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 4678999999999998 45678999999999999999986 44568888889999999999999999866 999999999
Q ss_pred EEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCC
Q 022347 110 LLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186 (298)
Q Consensus 110 il~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p 186 (298)
++++ ....+||.|||+....... ..........-|.|||.+....... .....+.+.||||+|++++|+++.+.|
T Consensus 80 Clvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~-~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 80 CLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS-LESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc-ccccccccCCeehHHHHHHHHHhccCc
Confidence 9999 6678999999998764321 1111112345799999997632111 112357789999999999999999999
Q ss_pred CCCCChH---HHHHHHHHhhc----CCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 187 FEGMSNL---QAAYAAAFKHA----RPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 187 ~~~~~~~---~~~~~~~~~~~----~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|...... .+......... +|.+. ...++++..++..||..+|.+||+++++...+.....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9763321 22222222212 22222 1355679999999999999999999999887765544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=159.97 Aligned_cols=121 Identities=26% Similarity=0.258 Sum_probs=93.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+.|.+|+.+|++++|+||++.+.. .+..|+||||++|++|.. +.. .. ...++.+++.+|.|||+.||
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~--~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gI 132 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLA--TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGI 132 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEE--cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCC
Confidence 45578999999999999999863332 245799999999999973 211 11 14678899999999999999
Q ss_pred eeecC-CCCCEEEcCCCCceEEeccCCCccCccccc---------cccccCccceeccccccc
Q 022347 101 IHRDL-KPDNLLLTPDQKSLKLADFGLAREETVTEM---------MTAETGTYRWMAPELYST 153 (298)
Q Consensus 101 vH~di-k~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~ 153 (298)
+|||| ||+||+++.+ +.++|+|||++........ .....+++.|.+||.+..
T Consensus 133 iHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 133 THNDLAKPQNWLMGPD-GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eeCCCCCcceEEEcCC-CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999 9999999855 4699999999985433221 123356778999999865
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-20 Score=155.56 Aligned_cols=170 Identities=22% Similarity=0.333 Sum_probs=110.8
Q ss_pred ceeEEEecCCCCCHHHHHhh---hCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccC
Q 022347 51 LMVIVTELLPGMSLRKYLVS---LRPN--KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125 (298)
Q Consensus 51 ~~~lv~e~~~~~sL~~~l~~---~~~~--~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg 125 (298)
+.+++|+-+ .++|.+++.. .... .+.....+.+..|++..+++||..|++|+||+|+|++++.++ .++|+||+
T Consensus 113 n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v~Lg~F~ 190 (288)
T PF14531_consen 113 NRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG-GVFLGDFS 190 (288)
T ss_dssp SEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS--EEE--GG
T ss_pred hhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC-CEEEcChH
Confidence 357899988 5699988654 2221 123344466778999999999999999999999999999765 59999998
Q ss_pred CCccCccccccccccCccceeccccccccc-cccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc
Q 022347 126 LAREETVTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204 (298)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 204 (298)
.....+..... ...+..|.+||...... ... ....++.+.|.|+||+++|.|++|..||........... .
T Consensus 191 ~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~-~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~ 262 (288)
T PF14531_consen 191 SLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQ-NNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----D 262 (288)
T ss_dssp GEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHH-SEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----G
T ss_pred HHeecCceeec--cCCCcccCChhhhhhhcccCc-ccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----c
Confidence 87765544332 33457789999764311 011 234678899999999999999999999986533211100 1
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 022347 205 RPGLPEDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 205 ~~~~~~~~~~~l~~li~~~l~~~p~~R 231 (298)
...+. ++|+.++.||..+|+.+|.+|
T Consensus 263 f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 263 FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 22334 789999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.7e-20 Score=160.22 Aligned_cols=196 Identities=28% Similarity=0.418 Sum_probs=158.9
Q ss_pred HHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
....|-.++..++ ||.++.+...++ +...+++.+|..||.|...+.. ...+++.........++-+++++|+.|++
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~ii 119 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIA 119 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHH
Confidence 4556778888887 999999998885 6689999999999999876654 34578888888999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|+|+|++||+++.+| .+++.|||.+...-..... +|+..|+|||++++ ...++|.||+|+++++++
T Consensus 120 yrd~k~enilld~~G-hi~~tdfglske~v~~~~~---cgt~eymApEI~~g----------h~~a~D~ws~gvl~fell 185 (612)
T KOG0603|consen 120 YRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIING----------HLSAADWWSFGVLAFELL 185 (612)
T ss_pred HhcccccceeecccC-ccccCCchhhhHhHhhhhc---ccchhhhhhHhhhc----------cCCcccchhhhhhHHHHh
Confidence 999999999999665 5999999999864443332 78999999999852 466899999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH--HHHHHHH
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF--SQIIRML 241 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~~l~~~l 241 (298)
+|..||.. +.... +-.....+|...+..+++++..++..+|.+|.-. ..+.+..
T Consensus 186 tg~~pf~~-----~~~~~-Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 186 TGTLPFGG-----DTMKR-ILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hCCCCCch-----HHHHH-HhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 99999987 22222 2233456778899999999999999999999633 3444433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-20 Score=146.30 Aligned_cols=126 Identities=16% Similarity=0.298 Sum_probs=96.4
Q ss_pred HHHHHHHHHhCCCCcccceeceee---------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACK---------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~---------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+.+|+..+.++.||+|..+.+++. ++..+++|||++|.+|.++.. +++ ....+++.++..+
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~l 151 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESL 151 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHH
Confidence 689999999999999999988753 135789999999999988732 233 2456999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.|++|||++|+||+++.++ ++|+|||............. ... ...+..++|+|+||+
T Consensus 152 H~~gi~H~Dikp~Nili~~~g--i~liDfg~~~~~~e~~a~d~-----------~vl--------er~y~~~~di~~lg~ 210 (232)
T PRK10359 152 HQHGMVSGDPHKGNFIVSKNG--LRIIDLSGKRCTAQRKAKDR-----------IDL--------ERHYGIKNEIKDLGY 210 (232)
T ss_pred HHcCCccCCCChHHEEEeCCC--EEEEECCCcccccchhhHHH-----------HHH--------HhHhcccccccceeE
Confidence 999999999999999998654 99999998764322111110 111 144557899999999
Q ss_pred HHHHHH
Q 022347 176 VLWELL 181 (298)
Q Consensus 176 il~~ll 181 (298)
++....
T Consensus 211 ~~~~~~ 216 (232)
T PRK10359 211 YLLIYK 216 (232)
T ss_pred eehHHH
Confidence 987653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-20 Score=158.19 Aligned_cols=170 Identities=31% Similarity=0.507 Sum_probs=129.7
Q ss_pred ceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 51 LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 51 ~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
++||.|++|.-.+|.+|+..... ...++...+.++.|++.|+.| +|.+|+|+||.||+...+. .++|.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhheee
Confidence 58899999999999999975433 457888999999999999999 9999999999999998554 699999999875
Q ss_pred Ccccc-------ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 022347 130 ETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 201 (298)
Q Consensus 130 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 201 (298)
..... ......||.+|++||.+.+ ..|+.++|||+||++++|++. -...++. ........
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--------~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r 473 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG--------QQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIR 473 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh--------hhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhh
Confidence 43333 3455679999999999986 789999999999999999987 2333321 11122222
Q ss_pred hhcCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 022347 202 KHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237 (298)
Q Consensus 202 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 237 (298)
.+..+ .+..+++.+ ..|+.+++.+.|.+||++.+.
T Consensus 474 ~g~ip~~~~~d~p~e-~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIPPEFLQDYPEE-YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCChHHhhcCcHH-HHHHHHhcCCCcccCchHHHH
Confidence 22222 233344443 489999999999999955443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=136.50 Aligned_cols=146 Identities=18% Similarity=0.154 Sum_probs=107.4
Q ss_pred HHHHHHHHHHhCC-CCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+++|++|. |++|++++++ +..+++|||+.|.+|.+.+.. ....++.|++.+|.++|+.||+|
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvH 114 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAH 114 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCcc
Confidence 5789999999996 5889999886 346899999999999754321 11357789999999999999999
Q ss_pred ecC-CCCCEEEcCCCCceEEeccCCCccCcccccc--------------ccccCccceeccccccccccccCCccCCCcc
Q 022347 103 RDL-KPDNLLLTPDQKSLKLADFGLAREETVTEMM--------------TAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 103 ~di-k~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
+|| ||+||+++.++ .++|+|||++......... .....++.|++|+...-. ....-.+
T Consensus 115 rDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l------~~~~~~~ 187 (218)
T PRK12274 115 NDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL------KRTSWIR 187 (218)
T ss_pred CCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh------ccchhHH
Confidence 999 79999998554 6999999999844332210 011245566666644321 1122256
Q ss_pred hhHHHHHHHHHHHHhCCCCCC
Q 022347 168 VDVYSFGIVLWELLTNRLPFE 188 (298)
Q Consensus 168 ~Di~slG~il~~ll~g~~p~~ 188 (298)
.+.++.|+-+|.++|+..+.-
T Consensus 188 ~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 188 ELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHhcchHHHHHhccCCcc
Confidence 788899999999999887754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=129.88 Aligned_cols=100 Identities=14% Similarity=0.267 Sum_probs=80.2
Q ss_pred HHHHHHHHHHHhC-----CCCcccceeceeecC----c-eeEEEec--CCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-----KHDNLVKFLGACKDP----L-MVIVTEL--LPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 90 (298)
Q Consensus 23 ~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~----~-~~lv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~ 90 (298)
+.+.+|+.+++++ .||||++++++++.+ . +.+|+|| +.+++|.+++.. ..+++. ..++.+++.
T Consensus 41 ~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~ 115 (210)
T PRK10345 41 KEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLK 115 (210)
T ss_pred HHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHH
Confidence 4678999999999 579999999998644 3 3378999 557999999975 346655 356788887
Q ss_pred HH-HHHHhCCCeeecCCCCCEEEcCC---CCceEEeccCCC
Q 022347 91 AM-DCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFGLA 127 (298)
Q Consensus 91 al-~~LH~~givH~dik~~Nil~~~~---~~~~~l~dfg~~ 127 (298)
++ +|||+.+|+|+||||+||+++.. +..++|+|++.+
T Consensus 116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 77 99999999999999999999743 236999995433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-17 Score=128.59 Aligned_cols=101 Identities=20% Similarity=0.174 Sum_probs=80.8
Q ss_pred HHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L-H~~givH 102 (298)
...+|+..+.++.++++......... ..++||||++|+++...... ...+++..+..++.|++.+|.++ |+.||+|
T Consensus 65 ~~~~E~~~l~~l~~~~v~~p~~~~~~-~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiH 141 (190)
T cd05147 65 WAEKEMRNLKRLVTAGIPCPEPILLK-SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVH 141 (190)
T ss_pred HHHHHHHHHHHHHHCCCCCCcEEEec-CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 44569999999998887544333222 24899999988777654322 25689999999999999999999 7999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
|||||+||+++ + +.++|+|||++..
T Consensus 142 rDlkP~NIli~-~-~~v~LiDFG~a~~ 166 (190)
T cd05147 142 ADLSEYNLLYH-D-GKLYIIDVSQSVE 166 (190)
T ss_pred CCCCHHHEEEE-C-CcEEEEEcccccc
Confidence 99999999998 3 4599999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.7e-16 Score=123.06 Aligned_cols=104 Identities=19% Similarity=0.123 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHH-HhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY-LVSLRPNKLDLHVALNFALDIARAMDCLHA-NG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~g 99 (298)
...+.+|...+.++.|++|.....+... ..++||||++|+++... +.. ..++......++.|++.++.++|. .|
T Consensus 63 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g 138 (190)
T cd05145 63 FAWAEKEFRNLKRLYEAGVPVPEPILLK-KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG 138 (190)
T ss_pred HHHHHHHHHHHHHHHhCCCCCceEEEec-CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3456789999999999988554444322 24899999988755443 332 457888999999999999999999 99
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCc
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~ 131 (298)
|+|+||||+||+++ + +.++|+|||++....
T Consensus 139 ivHrDlkP~NIll~-~-~~~~liDFG~a~~~~ 168 (190)
T cd05145 139 LVHGDLSEYNILYH-D-GKPYIIDVSQAVELD 168 (190)
T ss_pred EecCCCChhhEEEE-C-CCEEEEEcccceecC
Confidence 99999999999998 4 469999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=147.13 Aligned_cols=202 Identities=21% Similarity=0.276 Sum_probs=143.0
Q ss_pred HHHHHHhCC---CCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 022347 28 EVNMMSRVK---HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 103 (298)
Q Consensus 28 E~~~l~~l~---hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~ 103 (298)
-.+++.+|+ -+.|..+..++ -.+.-++|+||.+.|||.+++.. .+..++..+..+..|++..+..||..+||||
T Consensus 741 ~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHg 818 (974)
T KOG1166|consen 741 CLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHG 818 (974)
T ss_pred hHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecc
Confidence 334445555 24455555544 23456799999999999999984 4669999999999999999999999999999
Q ss_pred cCCCCCEEEcC------CCCceEEeccCCCccCcc---ccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 104 DLKPDNLLLTP------DQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 104 dik~~Nil~~~------~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||||+|+++.. +...++|+|||.+..... ........+|..+-.+|+..| +..+...|.|.|+
T Consensus 819 DiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g--------rpWtYq~DyfGlA 890 (974)
T KOG1166|consen 819 DIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG--------RPWTYQIDYFGLA 890 (974)
T ss_pred cCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC--------CCCchhhhhHHHH
Confidence 99999999952 334699999999975433 223455678889999999876 8889999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcH-HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP-DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
.+++.||.|+.-- ............++..+-. -...++..+|..+-..=|...++...|+.++..
T Consensus 891 a~~h~mLFG~y~q--------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 891 ATVHVMLFGKYME--------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred HHHHHHHHHHHHH--------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 9999999987531 0000000000111111112 245677888885555557888888887776643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=121.05 Aligned_cols=101 Identities=31% Similarity=0.430 Sum_probs=85.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
...++.+|+.++..+.|++|.....++ ..+..+++|||++|++|.+++.... . ....++.+++.+|.++|+.|
T Consensus 42 ~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~ 115 (211)
T PRK14879 42 RRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG 115 (211)
T ss_pred HHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC
Confidence 345788999999999999988776665 4556889999999999999986521 2 78899999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
++|+|++|.||+++ + +.++|+|||.+..
T Consensus 116 i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 116 IIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred cccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 99999999999998 4 4599999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.6e-16 Score=141.87 Aligned_cols=135 Identities=32% Similarity=0.573 Sum_probs=106.2
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc----------------cccccccCccceeccccc
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----------------EMMTAETGTYRWMAPELY 151 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~ 151 (298)
++.+++|||+.||+|+|+||+|.++. ..+.+|+.|||++...... -.....++|+.|.|||++
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceee-ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 38899999999999999999999999 5567999999998632111 011234799999999999
Q ss_pred cccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh--hcCCCCCCCCcHHHHHHHHHhhhhCCC
Q 022347 152 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK--HARPGLPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 152 ~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (298)
.- ..|+...|.|++|+|+|+.+-|+.||.+... ++++...+. ..+++--..+++++++++.++|+.+|.
T Consensus 231 lr--------qgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~ 301 (1205)
T KOG0606|consen 231 LR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPL 301 (1205)
T ss_pred hh--------hccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChH
Confidence 74 6789999999999999999999999988654 333333322 223333455889999999999999999
Q ss_pred CCC
Q 022347 230 LRP 232 (298)
Q Consensus 230 ~Rp 232 (298)
.|-
T Consensus 302 ~Rl 304 (1205)
T KOG0606|consen 302 CRL 304 (1205)
T ss_pred hhc
Confidence 995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=118.84 Aligned_cols=99 Identities=25% Similarity=0.338 Sum_probs=79.1
Q ss_pred HHHHHHHHHHHhCCCCcc--cceeceee--cCc---eeEEEecCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNL--VKFLGACK--DPL---MVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~I--v~~~~~~~--~~~---~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.++.+|+.++.++.|++| +..+++.. ... .++|||+++| .+|.+++.. ..+++. .+.+++.+|.+
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~ 157 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIAR 157 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHH
Confidence 467899999999998885 56666542 222 3599999997 699998865 345554 35689999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
||+.||+|+||||.|||++.++ .++|+|||.+..
T Consensus 158 lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~~~~ 191 (239)
T PRK01723 158 FHDAGVYHADLNAHNILLDPDG-KFWLIDFDRGEL 191 (239)
T ss_pred HHHCCCCCCCCCchhEEEcCCC-CEEEEECCCccc
Confidence 9999999999999999998654 699999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.1e-15 Score=133.93 Aligned_cols=97 Identities=25% Similarity=0.340 Sum_probs=83.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.+++.++|++|+....++ .....++||||++|++|.+++. ....++.+++.+|.+||+.|
T Consensus 379 ~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g 448 (535)
T PRK09605 379 RTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG 448 (535)
T ss_pred HHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC
Confidence 345788999999999999998876665 3456789999999999999875 34678999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
++||||||+||+++ + +.++|+|||++..
T Consensus 449 iiHrDlkp~NILl~-~-~~~~liDFGla~~ 476 (535)
T PRK09605 449 IVHGDLTTSNFIVR-D-DRLYLIDFGLGKY 476 (535)
T ss_pred CccCCCChHHEEEE-C-CcEEEEeCccccc
Confidence 99999999999995 3 4699999998855
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.9e-15 Score=119.10 Aligned_cols=102 Identities=21% Similarity=0.225 Sum_probs=79.9
Q ss_pred HHHHHHHHHHHHHhCCCCc--ccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 21 LEGRFIREVNMMSRVKHDN--LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~--Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
++..+.+|+..+.++.+.+ ++++++. ...++||||++|++|..+... ...+....+..++.|++.++.+||+.
T Consensus 93 ~~~~~~~E~~~L~~L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~ 167 (237)
T smart00090 93 VRLWAEKEFRNLQRLYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE 167 (237)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeEe---cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc
Confidence 4456779999999997633 3344432 345899999999888766532 23456667789999999999999999
Q ss_pred C-CeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 G-IIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 g-ivH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
| ++|+||||+||+++ + +.++|+|||.+..
T Consensus 168 g~iiH~Dikp~NIli~-~-~~i~LiDFg~a~~ 197 (237)
T smart00090 168 GELVHGDLSEYNILVH-D-GKVVIIDVSQSVE 197 (237)
T ss_pred CCEEeCCCChhhEEEE-C-CCEEEEEChhhhc
Confidence 9 99999999999998 4 4699999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=115.14 Aligned_cols=97 Identities=27% Similarity=0.385 Sum_probs=80.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++..+.|+++.....++ .++..+++|||++|++|.+++.... . .++.+++.+|.+||+.|+
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi 111 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGI 111 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCe
Confidence 45788999999999988765544443 4456789999999999999876421 1 789999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
+|+|++|.||+++ + +.++++|||.+..
T Consensus 112 ~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 112 VHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred ecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 9999999999998 4 4699999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-13 Score=122.40 Aligned_cols=142 Identities=18% Similarity=0.253 Sum_probs=111.0
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCe
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~giv 101 (298)
...+.++-|+.++||||+++++.++ ++.+|+|+|.+ ..|..++++ +....+...++||+.||.||| ..+++
T Consensus 55 ~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lv 127 (690)
T KOG1243|consen 55 LAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLV 127 (690)
T ss_pred HHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCee
Confidence 4557888999999999999999984 67899999998 478888876 336777888999999999998 57899
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|++|..+.|+++..+ .++|++|.++........ .........|..|+.+.. -+-..|.|.||++++++
T Consensus 128 HgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~----------s~~s~D~~~Lg~li~el 196 (690)
T KOG1243|consen 128 HGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP----------SEWSIDSWGLGCLIEEL 196 (690)
T ss_pred eccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc----------cccchhhhhHHHHHHHH
Confidence 999999999999665 599999998765433322 111223345777775532 12356999999999999
Q ss_pred HhC
Q 022347 181 LTN 183 (298)
Q Consensus 181 l~g 183 (298)
+.|
T Consensus 197 ~ng 199 (690)
T KOG1243|consen 197 FNG 199 (690)
T ss_pred hCc
Confidence 998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.3e-16 Score=141.17 Aligned_cols=215 Identities=26% Similarity=0.340 Sum_probs=164.2
Q ss_pred HHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCC
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGI 100 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~gi 100 (298)
....|..+-+.+. |+|++.+++... ....++..++..|+++.+.+........+....-..+.|+..++.|+| ..++
T Consensus 66 ~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~ 145 (601)
T KOG0590|consen 66 HIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGV 145 (601)
T ss_pred hcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccccc
Confidence 4446777777777 999999999885 456889999999999999883211114666777889999999999999 9999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc----ccccccccC-ccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
.|+||+|+|.+++.++..+++.|||++..... ........| ++.|.|||...+ .....+..|+||.|+
T Consensus 146 ~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~ 218 (601)
T KOG0590|consen 146 THRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGI 218 (601)
T ss_pred ccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccc
Confidence 99999999999996653799999999985444 223344567 999999999864 135567889999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHA---RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++.-+++|..||................. .......++....+++.+++..+|..|.+.+++-. ..++..
T Consensus 219 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~--d~~~~~ 291 (601)
T KOG0590|consen 219 VLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL--DNWLSS 291 (601)
T ss_pred cccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc--cccccc
Confidence 99999999999976554333222222221 13334568888999999999999999999998865 444433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.8e-13 Score=107.98 Aligned_cols=96 Identities=19% Similarity=0.191 Sum_probs=76.5
Q ss_pred HHHHHHHHHHHhCCCCc--ccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHDN--LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~--Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+.+|..++.++.|++ ++..++ ....++||||++|++|.+.... .....++.+++.++.++|+.|+
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi 146 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGI 146 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCC
Confidence 35778999999998874 333433 3456899999999999765331 3456788999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccC
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREE 130 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~ 130 (298)
+|+||+|+||+++.+ +.++|+|||.+...
T Consensus 147 ~H~Dl~p~Nill~~~-~~~~liDfg~~~~~ 175 (198)
T cd05144 147 IHGDLSEFNILVDDD-EKIYIIDWPQMVST 175 (198)
T ss_pred CcCCCCcccEEEcCC-CcEEEEECCccccC
Confidence 999999999999954 56999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-13 Score=113.34 Aligned_cols=195 Identities=22% Similarity=0.320 Sum_probs=132.2
Q ss_pred HHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 022347 30 NMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANG-- 99 (298)
Q Consensus 30 ~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~g-- 99 (298)
.-|-++.|.||+++..++.+ ....+++||++.|++..++++.+. ..+....-.+|+.||++||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 34556679999999998743 257899999999999999987443 34677777899999999999999974
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccC-----ccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREE-----TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|+|+++..+.|++..++ -+++.--...... ..........+.++|.+||.=. ....+.++|||++|
T Consensus 199 iihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--------~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--------TTNTTGASDIYKFG 269 (458)
T ss_pred cccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--------ccccccchhhhhhh
Confidence 99999999999999554 3554321111100 0011122335677899998532 24456789999999
Q ss_pred HHHHHHHhCCCCCCC-CCh--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 175 IVLWELLTNRLPFEG-MSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 175 ~il~~ll~g~~p~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
+..++|..+..--.. ... .++....... .+ -...-+.++..|++.+|..||++..++-+
T Consensus 270 mcAlemailEiq~tnseS~~~~ee~ia~~i~----~l---en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 270 MCALEMAILEIQSTNSESKVEVEENIANVII----GL---ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHHHHHheeccCCCcceeehhhhhhhhee----ec---cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 999999876543211 111 1111111111 11 11224578999999999999999998763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=120.38 Aligned_cols=200 Identities=28% Similarity=0.303 Sum_probs=152.3
Q ss_pred HHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHH----HHHHHHhCC
Q 022347 26 IREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR----AMDCLHANG 99 (298)
Q Consensus 26 ~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~----al~~LH~~g 99 (298)
.+|+...++++ |+|.++.+..++ ++.+++-+|++ +.+|.++.... ..-++...++..+.+... ||..+|..+
T Consensus 165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~ 242 (524)
T KOG0601|consen 165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN 242 (524)
T ss_pred cchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc
Confidence 36777777775 999999777775 56788888888 78999998763 234788889999999999 999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc------ccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
++|-|++|.||+...+...++++|||+.......... ....+...|++||... ..++..+|||++
T Consensus 243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl 313 (524)
T KOG0601|consen 243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSL 313 (524)
T ss_pred ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcch
Confidence 9999999999999977567999999998765544321 1225677899999986 567889999999
Q ss_pred HHHHHHHHhCCCCCCCC--ChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 174 GIVLWELLTNRLPFEGM--SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|.++.+..++..+.... ......... ....++-...+.++...+..|++.+|..|++...+..
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 99999988876554332 111111111 1222333456777888999999999999999887766
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.9e-12 Score=97.18 Aligned_cols=97 Identities=24% Similarity=0.292 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHhCCC--Ccccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 022347 23 GRFIREVNMMSRVKH--DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN- 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~h--p~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~- 98 (298)
..+.+|+.++..++| +++++++.+.. .+..+++|||++|+++..+ +......++.+++.+++++|..
T Consensus 36 ~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~ 106 (155)
T cd05120 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLP 106 (155)
T ss_pred hHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCC
Confidence 467899999999986 58888888774 4578999999988777643 4566677899999999999985
Q ss_pred --CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 --GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 --givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
+++|+|++|.||+++. .+.++++|||.+..
T Consensus 107 ~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 107 LLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred ceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 7999999999999995 45799999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.1e-11 Score=94.73 Aligned_cols=108 Identities=19% Similarity=0.197 Sum_probs=79.9
Q ss_pred HHHHHHHHHHHHHHHHHHhCCC--CcccceeceeecCceeEEEecCCCCCHHH-HHhhhCCCCCCHHHHHHHHHHHHHHH
Q 022347 16 DERALLEGRFIREVNMMSRVKH--DNLVKFLGACKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 16 ~~~~~~~~~~~~E~~~l~~l~h--p~Iv~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~i~~qi~~al 92 (298)
..+..++....+|...|+++.. -+++.++++ ...++||||+.++.+.. .+.. ..++......+..+++.++
T Consensus 64 ~~~~~~~~wa~kE~r~L~rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l 137 (197)
T cd05146 64 NPRKIIRMWAEKEMHNLKRMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMM 137 (197)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHH
Confidence 3455566667799999999963 456666654 34579999996643321 2222 2355566778889999999
Q ss_pred HHH-HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCc
Q 022347 93 DCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131 (298)
Q Consensus 93 ~~L-H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~ 131 (298)
..| |+.|++||||++.||++. + +.+.|+|||.+....
T Consensus 138 ~~l~H~~glVHGDLs~~NIL~~-~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 138 KQLYKECNLVHADLSEYNMLWH-D-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHhCCeecCCCCHHHEEEE-C-CcEEEEECCCceeCC
Confidence 998 899999999999999997 3 359999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.9e-11 Score=91.25 Aligned_cols=100 Identities=24% Similarity=0.351 Sum_probs=77.9
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
+...++-.+|..++.++.--.|....-+. ......|+|||++|..|.+++... ...++..+-.-+.-||.
T Consensus 40 klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~ 110 (204)
T COG3642 40 KLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHK 110 (204)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh
Confidence 34455778999999999755554433332 334567999999999999888763 25567788888899999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.||+||||.++||++..+ .+.++|||++..
T Consensus 111 ~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 111 AGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred cCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 999999999999999843 399999999854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-10 Score=98.94 Aligned_cols=194 Identities=19% Similarity=0.299 Sum_probs=135.2
Q ss_pred ceeEEEecCCCC-CHHHHHhhh---C-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccC
Q 022347 51 LMVIVTELLPGM-SLRKYLVSL---R-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125 (298)
Q Consensus 51 ~~~lv~e~~~~~-sL~~~l~~~---~-~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg 125 (298)
..-++|+.++|. .+.+++... + ...+.|...++.+..++.+.+.||++|.+-||++++|+|++.+ ..++|+|-+
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsD 162 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSD 162 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEccc
Confidence 366888988774 555555431 1 1237889999999999999999999999999999999999955 458899876
Q ss_pred CCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhC-CCCCCCCC-------hHHHHH
Q 022347 126 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMS-------NLQAAY 197 (298)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g-~~p~~~~~-------~~~~~~ 197 (298)
.-....+........+...|++||.-.-. .......+...|.|.||+++++++.| ..||.+.. ..+...
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~---sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLP---SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccc---cccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 65544444444556788999999976411 11234556789999999999999985 89997532 111000
Q ss_pred H-----HHHhh--cCC----CCC-CCCcHHHHHHHHHhhhh--CCCCCCCHHHHHHHHHhhhhcc
Q 022347 198 A-----AAFKH--ARP----GLP-EDISPDLAFIVQSCWVE--DPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 198 ~-----~~~~~--~~~----~~~-~~~~~~l~~li~~~l~~--~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
. ...+. ... ..| .-+++.+..++.+|+.. ++.-|||++.++..|..+..++
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0 00001 111 111 23678899999999864 3678999999999887765444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.8e-11 Score=89.62 Aligned_cols=111 Identities=23% Similarity=0.313 Sum_probs=85.7
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
+..+++-.+|.++|.++.--+|.-..-++ ....-+|+|||++| .++.+++...............++..+-+.+.-||
T Consensus 51 kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH 130 (229)
T KOG3087|consen 51 KLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH 130 (229)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh
Confidence 34456788999999999755665443333 23345799999977 58889887755444444555788999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCCCce--EEeccCCCcc
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSL--KLADFGLARE 129 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~--~l~dfg~~~~ 129 (298)
..+++||||..+||++..++..+ .++|||++..
T Consensus 131 ~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 131 DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999999999999998776654 8999999854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.9e-11 Score=92.94 Aligned_cols=95 Identities=23% Similarity=0.269 Sum_probs=67.6
Q ss_pred HHHHHHHHhCCCCc--ccceeceeecCceeEEEecCCCCCHHH-HHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCe
Q 022347 26 IREVNMMSRVKHDN--LVKFLGACKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGII 101 (298)
Q Consensus 26 ~~E~~~l~~l~hp~--Iv~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~giv 101 (298)
..|...+.++.+.+ +.++++. ...++||||++|+++.. .+... ... ..+..++.+++.++.++|. .|++
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~iv 137 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL---NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGLV 137 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec---CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCcC
Confidence 35666666665433 3334332 24689999998854321 11110 011 5678899999999999999 9999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
|+||+|+||+++ + +.++|+|||.+..
T Consensus 138 H~Dl~p~Nili~-~-~~~~liDfg~a~~ 163 (187)
T cd05119 138 HGDLSEYNILVD-D-GKVYIIDVPQAVE 163 (187)
T ss_pred cCCCChhhEEEE-C-CcEEEEECccccc
Confidence 999999999999 4 4699999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.5e-10 Score=96.67 Aligned_cols=183 Identities=17% Similarity=0.238 Sum_probs=131.7
Q ss_pred HHHHHHHhCCCCcccceecee-----ecCceeEEEecCCC-CCHHHHHhhhC-------------CCCCCHHHHHHHHHH
Q 022347 27 REVNMMSRVKHDNLVKFLGAC-----KDPLMVIVTELLPG-MSLRKYLVSLR-------------PNKLDLHVALNFALD 87 (298)
Q Consensus 27 ~E~~~l~~l~hp~Iv~~~~~~-----~~~~~~lv~e~~~~-~sL~~~l~~~~-------------~~~~~~~~~~~i~~q 87 (298)
.-+++++++.|+|||++.+++ .+..+++|++|.++ ++|.++..... +...++..+|.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 457899999999999998876 34568999999887 68888765432 233678999999999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcc
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
+..||.++|+.|+.-+-|.+.+|+++.+. +++|+..|+........ . +-+.. -.+
T Consensus 402 LtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~-----------~--~~le~-----------~Qq 456 (655)
T KOG3741|consen 402 LTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDP-----------T--EPLES-----------QQQ 456 (655)
T ss_pred HHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecCCC-----------C--cchhH-----------Hhh
Confidence 99999999999999999999999999554 68888777653322111 0 11111 226
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 168 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 168 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
.|.=.||.+++.|.+|..--...+..+..... .+...++.++++++.-....++++ -++.+++.++-
T Consensus 457 ~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~-------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 457 NDLRDLGLLLLALATGTENSNRTDSTQSSHLT-------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred hhHHHHHHHHHHHhhcccccccccchHHHHHH-------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 79999999999999985432111222222111 123568888999999888888887 67777776553
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-10 Score=94.09 Aligned_cols=105 Identities=24% Similarity=0.208 Sum_probs=81.0
Q ss_pred HHHHHHHHHHhCCCCccc--ceeceee------cCceeEEEecCCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLV--KFLGACK------DPLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv--~~~~~~~------~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+|...+.+|..-+|. ++.++.. ....++|||++++. +|.+++........+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 366899988888644443 3344432 12478999999885 89999865333456677788999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCC------CCceEEeccCCCc
Q 022347 95 LHANGIIHRDLKPDNLLLTPD------QKSLKLADFGLAR 128 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~------~~~~~l~dfg~~~ 128 (298)
||..||+|+|+++.|||++.+ ...+.|+||+.+.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999999999999999999842 3478999999774
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-10 Score=90.46 Aligned_cols=92 Identities=24% Similarity=0.247 Sum_probs=68.6
Q ss_pred HHHHHHHHHHhCCCCcccc-eeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--
Q 022347 24 RFIREVNMMSRVKHDNLVK-FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI-- 100 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~-~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi-- 100 (298)
.+.+|+.+++.+.+.++++ ++... ....++||||++|.++.+. .. ....++.+++.+|+.||+.++
T Consensus 38 ~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~~l~~~-------~~---~~~~~~~~l~~~l~~LH~~~~~~ 106 (170)
T cd05151 38 NRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGSELLTE-------DF---SDPENLEKIAKLLKKLHSSPLPD 106 (170)
T ss_pred CHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCCccccc-------cc---cCHHHHHHHHHHHHHHhCCCCCC
Confidence 3458888888887655543 44433 3345799999999887643 01 113456799999999999985
Q ss_pred ---eeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 101 ---IHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 101 ---vH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
+|||++|.||+++ ++ .++++||+.+.
T Consensus 107 ~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~ 135 (170)
T cd05151 107 LVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG 135 (170)
T ss_pred ceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence 9999999999998 43 58999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.7e-11 Score=109.69 Aligned_cols=146 Identities=15% Similarity=0.327 Sum_probs=105.3
Q ss_pred HHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccc----------cccCccceeccccccc
Q 022347 85 ALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT----------AETGTYRWMAPELYST 153 (298)
Q Consensus 85 ~~qi~~al~~LH~~-givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~y~aPE~~~~ 153 (298)
+.+++.|+.|+|+. ++||++|.|++|.++.+ +.+||+.|+++.......... .......|.|||++.+
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45667999999986 89999999999999955 469999999987543311111 1134558999999975
Q ss_pred cccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH--HhhcCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 154 VTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA--FKHARPGLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 154 ~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
...+.++|+||+|+++|.+.. |+..+............. ........+..+++++++=+.+++..+...
T Consensus 184 --------~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 184 --------TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred --------ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCccc
Confidence 567889999999999999984 666554433222111111 111222344678999999999999999999
Q ss_pred CCCHHHHHH
Q 022347 231 RPSFSQIIR 239 (298)
Q Consensus 231 Rps~~~l~~ 239 (298)
||++..+..
T Consensus 256 rp~~~~l~~ 264 (700)
T KOG2137|consen 256 RPTLDLLLS 264 (700)
T ss_pred Ccchhhhhc
Confidence 998777755
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-11 Score=107.06 Aligned_cols=200 Identities=23% Similarity=0.213 Sum_probs=144.3
Q ss_pred HHHHHHHhCC-CCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 022347 27 REVNMMSRVK-HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104 (298)
Q Consensus 27 ~E~~~l~~l~-hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~d 104 (298)
.|+.+...+. |.+++.++..+ +....|+--|||+++++...+.. ...+.+...+++..|++.++.++|+..++|+|
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d 391 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLD 391 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhccc
Confidence 6777777775 88888877665 56678899999999998877633 24478888999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceec-cccccccccccCCccCCCcchhHHHHHHHHHHHHhC
Q 022347 105 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA-PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183 (298)
Q Consensus 105 ik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g 183 (298)
++|.||++..++...+++|||......... .......++.| .|.+. ....+..+.|+|+||..+.+..++
T Consensus 392 ~~psni~i~~~~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~-------e~~~~~~~~~~~sl~~~~~e~~~~ 462 (524)
T KOG0601|consen 392 VKPSNILISNDGFFSKLGDFGCWTRLAFSS--GVFHHIDRLYPIAEILL-------EDYPHLSKADIFSLGLSVDEAITG 462 (524)
T ss_pred ccccceeeccchhhhhccccccccccceec--ccccccccccccchhhc-------cccccccccccccccccccccccC
Confidence 999999999665678899999886422211 11122334442 44443 236777899999999999999887
Q ss_pred CCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 184 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
...-+..... ..+..+..+..+. ....+..+.+.+..+++..||.+.++..+.+
T Consensus 463 ~~ls~~~~~~----~~i~~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 463 SPLSESGVQS----LTIRSGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccCcccccc----eeeecccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 6543332221 1222233333333 3378889999999999999999988766443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.4e-10 Score=86.61 Aligned_cols=105 Identities=25% Similarity=0.292 Sum_probs=70.3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCC--cccceeceeecCceeEEEecCC--CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHH
Q 022347 16 DERALLEGRFIREVNMMSRVKHD--NLVKFLGACKDPLMVIVTELLP--GMSLRKYLVSLRPNKLDLHVALNFALDIARA 91 (298)
Q Consensus 16 ~~~~~~~~~~~~E~~~l~~l~hp--~Iv~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~a 91 (298)
.+....+....+|...|.++..- ++++++++. ..++||||++ |..+..+... .++......++.+++..
T Consensus 46 ~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~ 118 (188)
T PF01163_consen 46 SWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEE 118 (188)
T ss_dssp -CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHH
Confidence 34566667888999999999865 456666543 3469999998 6555554332 12234456677788885
Q ss_pred HHH-HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 92 MDC-LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 92 l~~-LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
+.. +|+.|++|||+++.||+++.+ .+.++|||.+..
T Consensus 119 ~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~qav~ 155 (188)
T PF01163_consen 119 IIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFGQAVD 155 (188)
T ss_dssp HHHHHHCTTEEESS-STTSEEEETT--CEEE--GTTEEE
T ss_pred HHHHHHhcCceecCCChhhEEeecc--eEEEEecCccee
Confidence 554 689999999999999999954 599999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-09 Score=96.79 Aligned_cols=102 Identities=24% Similarity=0.337 Sum_probs=69.5
Q ss_pred HHHHHHHHHhCC----CCcccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 022347 25 FIREVNMMSRVK----HDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR-AMDCLHA 97 (298)
Q Consensus 25 ~~~E~~~l~~l~----hp~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~-al~~LH~ 97 (298)
|.+|...+.++. |.+-+.+-..+ ..+..++||||++|++|.++..... ...+ ...++..++. .+..+|.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHh
Confidence 556666666652 32222322222 1334689999999999998765421 1222 2345555655 4788999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~ 131 (298)
.|++|+|++|.||+++.+ +.++++|||++....
T Consensus 276 ~g~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 999999999999999855 469999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.4e-10 Score=104.32 Aligned_cols=189 Identities=25% Similarity=0.312 Sum_probs=137.1
Q ss_pred CCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC
Q 022347 36 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114 (298)
Q Consensus 36 ~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~ 114 (298)
.+|-++.....+ .....+++++|..|++|...++... ..+..-....+..+..++++||...+.|+|++|.|++...
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY 939 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcc
Confidence 344444444333 3456889999999999999887633 3555556667778899999999999999999999999986
Q ss_pred CCCceEEeccCCCccCc-------c-------------------------ccccccccCccceeccccccccccccCCcc
Q 022347 115 DQKSLKLADFGLAREET-------V-------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 115 ~~~~~~l~dfg~~~~~~-------~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
++ ...+.||+...... . ........+++.|.+||...+ .
T Consensus 940 ~g-h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--------~ 1010 (1205)
T KOG0606|consen 940 DG-HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--------R 1010 (1205)
T ss_pred cC-CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--------c
Confidence 65 58888887322100 0 011223357899999999976 5
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 022347 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (298)
.....+|.|++|+++++.++|..||......+...... ....++..+...+.+.++++.+.+..++.+|-.+.
T Consensus 1011 ~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1011 RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 66778999999999999999999998766543322221 11223344556889999999999999999997655
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.3e-09 Score=84.28 Aligned_cols=104 Identities=30% Similarity=0.413 Sum_probs=80.5
Q ss_pred HHHHHHHHHHhCCCCcc--cceeceeec-----CceeEEEecCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNL--VKFLGACKD-----PLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~I--v~~~~~~~~-----~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+..+|...+..|..-+| ++.+++... ...++|+|+++| .+|.+++..... .+......++.+++..+.-|
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHH
Confidence 56688888888864444 445555432 135899999988 489999876322 66677888999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCC--CceEEeccCCCcc
Q 022347 96 HANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLARE 129 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~--~~~~l~dfg~~~~ 129 (298)
|..||+|+|+++.|||++.++ ..+.++||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999664 2689999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-08 Score=91.63 Aligned_cols=75 Identities=20% Similarity=0.304 Sum_probs=51.8
Q ss_pred CceeEEEecCCCCCHHHHHhhhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCC---CceEEe
Q 022347 50 PLMVIVTELLPGMSLRKYLVSLRPN----KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLA 122 (298)
Q Consensus 50 ~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~---~~~~l~ 122 (298)
+..++||||++|+++.++-.-...+ .+.+..+..++.|+ ...|++|+|+||.||+++.++ +.++++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~ll 306 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIAL 306 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence 3467999999999998753211111 13333333344444 469999999999999998664 279999
Q ss_pred ccCCCccCc
Q 022347 123 DFGLAREET 131 (298)
Q Consensus 123 dfg~~~~~~ 131 (298)
|||+.....
T Consensus 307 DFGivg~l~ 315 (537)
T PRK04750 307 DFGIVGSLN 315 (537)
T ss_pred ecceEEECC
Confidence 999986543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.9e-08 Score=76.12 Aligned_cols=107 Identities=17% Similarity=0.202 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHhCCCCc--ccceecee--ecC---ceeEEEecCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDN--LVKFLGAC--KDP---LMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~--Iv~~~~~~--~~~---~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.-|.+|...|.+|..-+ ++++.... ..+ ..+||+|-++| .+|.+++.+..-.+.+......++.+++.++.-
T Consensus 64 ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~ 143 (216)
T PRK09902 64 PTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKK 143 (216)
T ss_pred hHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHH
Confidence 35778999999886433 44444221 111 36799998854 599999876443456788888999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCC-ceEEeccCCCcc
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARE 129 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~-~~~l~dfg~~~~ 129 (298)
||..|+.|+|+.+.||+++.++. .+.++||.-++.
T Consensus 144 LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 144 MHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999999999999999984432 499999986653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-07 Score=76.88 Aligned_cols=104 Identities=21% Similarity=0.232 Sum_probs=77.9
Q ss_pred cHHHHHHHHHHHHHHHHHHhCCCC--cccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHH
Q 022347 15 SDERALLEGRFIREVNMMSRVKHD--NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 15 ~~~~~~~~~~~~~E~~~l~~l~hp--~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al 92 (298)
..+....+....+|..+|.+|... .|+..+++ +...+|||+++|-.|... +++....-.++..|+.-+
T Consensus 146 ~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~---nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~ 215 (304)
T COG0478 146 GSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW---NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEV 215 (304)
T ss_pred cchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc---ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHH
Confidence 345555566778999999999755 67777664 456799999999776542 123445556677777777
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.-+-..|+||||+++-||+++.+++ +.++||-.+..
T Consensus 216 ~~~~~~GiVHGDlSefNIlV~~dg~-~~vIDwPQ~v~ 251 (304)
T COG0478 216 RKAYRRGIVHGDLSEFNILVTEDGD-IVVIDWPQAVP 251 (304)
T ss_pred HHHHHcCccccCCchheEEEecCCC-EEEEeCccccc
Confidence 7777999999999999999997654 99999976644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.68 E-value=7.8e-08 Score=77.83 Aligned_cols=104 Identities=26% Similarity=0.409 Sum_probs=75.9
Q ss_pred HHHHHHHHHHHhCCCC--cccceeceeec----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHD--NLVKFLGACKD----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp--~Iv~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
..+.+|..++..+.+. .+.+++.+..+ +..++||||++|.++.+.+.. ..++......++.+++.+|..||
T Consensus 40 ~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 40 HDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALH 116 (223)
T ss_pred ccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHh
Confidence 3677899999999764 45667776643 356899999999988765431 23566666667777777777776
Q ss_pred h--------------------------------------------------------CCCeeecCCCCCEEEcCC-CCce
Q 022347 97 A--------------------------------------------------------NGIIHRDLKPDNLLLTPD-QKSL 119 (298)
Q Consensus 97 ~--------------------------------------------------------~givH~dik~~Nil~~~~-~~~~ 119 (298)
+ ..++|||+++.||+++.+ .+.+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~ 196 (223)
T cd05154 117 SVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVV 196 (223)
T ss_pred CCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEE
Confidence 3 236899999999999863 3457
Q ss_pred EEeccCCCcc
Q 022347 120 KLADFGLARE 129 (298)
Q Consensus 120 ~l~dfg~~~~ 129 (298)
.|+||+.+..
T Consensus 197 ~iID~e~~~~ 206 (223)
T cd05154 197 AVLDWELATL 206 (223)
T ss_pred EEEecccccc
Confidence 8999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-07 Score=74.71 Aligned_cols=66 Identities=27% Similarity=0.455 Sum_probs=52.1
Q ss_pred ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 51 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 51 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
..+++|||++|..|.++.. +++ .+...+.+++.-||+.|++|||.+|.|++++.+ + ++++|++...
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~-i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-G-IRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-c-EEEEECcccc
Confidence 3568999999988876532 222 244567788999999999999999999999843 3 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.1e-06 Score=68.97 Aligned_cols=99 Identities=21% Similarity=0.227 Sum_probs=77.7
Q ss_pred HHHHHHHhCCC-CcccceeceeecCceeEEEecCCCCCHHHHHhh-hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCe
Q 022347 27 REVNMMSRVKH-DNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHA---NGII 101 (298)
Q Consensus 27 ~E~~~l~~l~h-p~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~LH~---~giv 101 (298)
.|..++..+++ +++++++|+|.+ +++.||...+++...... ......+|..+.+|+.++++.+.+|+. ..+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 68889999986 699999999943 589999976655421000 011236899999999999999999998 4588
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
-.|++++|+-++.+ +.++++|.+....
T Consensus 85 lcDv~~~nfgv~~~-~~lk~iDld~v~~ 111 (188)
T PF12260_consen 85 LCDVSPDNFGVNDD-GRLKLIDLDDVFV 111 (188)
T ss_pred EeecchHHeEEeCC-CcEEEEechhcch
Confidence 89999999999944 5699999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-05 Score=77.07 Aligned_cols=196 Identities=17% Similarity=0.183 Sum_probs=133.4
Q ss_pred HHHHHHHHHhCCCCcccceeceeec----C-ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKD----P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~----~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
-.-|+..+.+..|+|+..++.+.-. + ...+..+++...++...+... ...+....+.+..++.+||.++|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3357788889999999999988621 2 345677888888888888764 44788899999999999999999996
Q ss_pred CeeecCCCC---CEEEcCCCCceEEe--ccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPD---NLLLTPDQKSLKLA--DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~---Nil~~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
..|.-+..+ +.-.+.+ +.+..+ ||+.+.................+.++|.... .........|+|.+|
T Consensus 307 l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~------~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE------NTAKKSRLTDLWCLG 379 (1351)
T ss_pred cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc------ccchhhhhhHHHHHH
Confidence 655555444 2222222 234444 7777766555444444455566777776643 223444557999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
.....+..|..+-....... . . ++.....+..+...+|+.-+.++|+++.+++.+
T Consensus 380 ll~~~~~~~~~i~~~~~~~~----~----~---l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVPV----S----L---LDVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHhhhhhcCcccccccchh----h----h---hccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999888765422111100 0 0 111122268889999999999999999999883
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.5e-05 Score=62.06 Aligned_cols=107 Identities=22% Similarity=0.227 Sum_probs=73.3
Q ss_pred HHHHHHHHHHHHHHHHHhCC--CCcccceeceeecCceeEEEecCCCCCH-HHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 17 ERALLEGRFIREVNMMSRVK--HDNLVKFLGACKDPLMVIVTELLPGMSL-RKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
.+..+.....+|..-|+++. +-.+.+.+++.. -.+||||+....+ .-.+ ++-++...+...+..+++..+.
T Consensus 107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~---nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~ 180 (268)
T COG1718 107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN---NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMR 180 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC---CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHH
Confidence 34444455668888888885 445556666553 3599999944310 0011 1122333467788889999988
Q ss_pred HHHh-CCCeeecCCCCCEEEcCCCCceEEeccCCCccCc
Q 022347 94 CLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131 (298)
Q Consensus 94 ~LH~-~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~ 131 (298)
-|-. .|+|||||+.-|||+. ++ .+.++|++.+....
T Consensus 181 ~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~QaV~~~ 217 (268)
T COG1718 181 RLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVSQAVTID 217 (268)
T ss_pred HHHHhcCcccccchhhheEEE-CC-eEEEEECccccccC
Confidence 8877 8999999999999999 43 48999999886533
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=4.6e-06 Score=75.06 Aligned_cols=148 Identities=20% Similarity=0.204 Sum_probs=106.5
Q ss_pred HHHHHHHHHhCCCCc-ccceeceee-cCceeEEEecCCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 25 FIREVNMMSRVKHDN-LVKFLGACK-DPLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~-Iv~~~~~~~-~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..-++++|.+++||| .+..++-++ +.+.++.++++.++ +....+.. ....+...+...++..-..+++++|+.-=+
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~ 358 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKV 358 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccccccc
Confidence 446889999999999 666666553 66899999999887 33222211 112234445566677778899999998778
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|+| ||+... +..+..||+...............+++.++|||.... ..+..+-|.|++|.-..++.
T Consensus 359 ~~d----~~l~s~--~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~--------~~~~~~p~~~~~~~~~~~~a 424 (829)
T KOG0576|consen 359 HRD----NILGSE--EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE--------NTIDGCPDSGSLAVSAIQMA 424 (829)
T ss_pred Ccc----cccccc--cccccccccCCcccCcccccccCCCCCCCCCchhhcc--------cccccCCCccCCCcchhhcC
Confidence 887 777763 3589999999877666555566688999999998754 66777889999998666665
Q ss_pred hCCCCC
Q 022347 182 TNRLPF 187 (298)
Q Consensus 182 ~g~~p~ 187 (298)
-|-.|-
T Consensus 425 p~~pPr 430 (829)
T KOG0576|consen 425 PGLPPR 430 (829)
T ss_pred CCCCCC
Confidence 565543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=9.7e-05 Score=66.63 Aligned_cols=88 Identities=20% Similarity=0.320 Sum_probs=57.8
Q ss_pred ccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHH-HHHHHhCCCeeecCCCCCEEEcC---C
Q 022347 40 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA-MDCLHANGIIHRDLKPDNLLLTP---D 115 (298)
Q Consensus 40 Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~a-l~~LH~~givH~dik~~Nil~~~---~ 115 (298)
|++++..+. ....++|||++|..+.|.-.- ....++...+. ..+.++ +..+=..|++|+|-+|.||++.+ .
T Consensus 266 VP~Vy~~~s-t~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~---~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~ 340 (538)
T KOG1235|consen 266 VPKVYWDLS-TKRVLTMEYVDGIKINDLDAI-DKRGISPHDIL---NKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEG 340 (538)
T ss_pred CCeehhhcC-cceEEEEEecCCccCCCHHHH-HHcCCCHHHHH---HHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCC
Confidence 444444332 357799999999877765322 22445655443 333333 23334568999999999999994 3
Q ss_pred CCceEEeccCCCccCcc
Q 022347 116 QKSLKLADFGLAREETV 132 (298)
Q Consensus 116 ~~~~~l~dfg~~~~~~~ 132 (298)
+..+.+.|||+......
T Consensus 341 ~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 341 DEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccEEEEcccccccccH
Confidence 56899999999875443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00021 Score=57.97 Aligned_cols=28 Identities=21% Similarity=0.252 Sum_probs=23.8
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
.++|||++|.||+++.+ + +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCC-C-cEEEechhcC
Confidence 47899999999999854 4 8899998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0002 Score=64.71 Aligned_cols=103 Identities=19% Similarity=0.312 Sum_probs=65.2
Q ss_pred HHHHHHHHHHhCC-----CCccc--ceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVK-----HDNLV--KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 24 ~~~~E~~~l~~l~-----hp~Iv--~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
++.+|..-+.++. .|+|. +++.-+ .+...++|||++|..+.+...-.. ..++...+...+.++ -+..+=
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~ 282 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLL 282 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHH
Confidence 3455665555552 34332 222212 245679999999999998853322 445544333322221 134444
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCc
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~ 131 (298)
..|++|+|.+|.||+++.+ +.+.+.|||+.....
T Consensus 283 ~dgffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 RDGFFHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred hcCccccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 5899999999999999966 569999999987544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00014 Score=70.25 Aligned_cols=106 Identities=23% Similarity=0.374 Sum_probs=65.1
Q ss_pred HHHHHHHHHHhCC-CCcc--cceeceeec----CceeEEEecCCCCCHHH--------------------HH---hhhCC
Q 022347 24 RFIREVNMMSRVK-HDNL--VKFLGACKD----PLMVIVTELLPGMSLRK--------------------YL---VSLRP 73 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~I--v~~~~~~~~----~~~~lv~e~~~~~sL~~--------------------~l---~~~~~ 73 (298)
.+.+|..+++.+. |++| ++++.++.+ +..|+||||++|..+.+ .+ +....
T Consensus 84 ~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~ 163 (822)
T PLN02876 84 AVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADV 163 (822)
T ss_pred HHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCc
Confidence 5679999999996 6765 677777754 35789999998865321 11 11000
Q ss_pred C---------C--CCHHHHHHHHHH---------------HHHHHHHHHh-----------CCCeeecCCCCCEEEcCCC
Q 022347 74 N---------K--LDLHVALNFALD---------------IARAMDCLHA-----------NGIIHRDLKPDNLLLTPDQ 116 (298)
Q Consensus 74 ~---------~--~~~~~~~~i~~q---------------i~~al~~LH~-----------~givH~dik~~Nil~~~~~ 116 (298)
. + +...++..|..+ +...+.+|.. ..+||||+++.|++++.++
T Consensus 164 ~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~ 243 (822)
T PLN02876 164 DAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTE 243 (822)
T ss_pred hhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCC
Confidence 0 0 111222222221 2233556632 2499999999999998543
Q ss_pred C-ceEEeccCCCcc
Q 022347 117 K-SLKLADFGLARE 129 (298)
Q Consensus 117 ~-~~~l~dfg~~~~ 129 (298)
. ..-|+||..+..
T Consensus 244 ~~v~aVLDWE~a~~ 257 (822)
T PLN02876 244 DRVIGILDWELSTL 257 (822)
T ss_pred CeEEEEEeeecccc
Confidence 3 457999998864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00025 Score=58.31 Aligned_cols=44 Identities=14% Similarity=0.191 Sum_probs=30.1
Q ss_pred HHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHH
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKY 67 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~ 67 (298)
++.+|+.+++.+. +--+.+++++.. ++..++|||+++|.++...
T Consensus 37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 4457888887774 333455666654 3457899999999887753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0004 Score=56.79 Aligned_cols=29 Identities=38% Similarity=0.551 Sum_probs=23.6
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
+++|||+++.||+++ ++...-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~-~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQ-DGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEE-CCCEEEEEeCcccC
Confidence 589999999999998 44445699999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0015 Score=51.70 Aligned_cols=97 Identities=23% Similarity=0.354 Sum_probs=66.1
Q ss_pred HHHHHHHHHHhCC------CCcccceeceeecC-ceeEEEecCCC------CCHHHHHhhhCCCCCCHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVK------HDNLVKFLGACKDP-LMVIVTELLPG------MSLRKYLVSLRPNKLDLHVALNFALDIAR 90 (298)
Q Consensus 24 ~~~~E~~~l~~l~------hp~Iv~~~~~~~~~-~~~lv~e~~~~------~sL~~~l~~~~~~~~~~~~~~~i~~qi~~ 90 (298)
+..+|+....++. +.+|.+++|+.+.+ ..-+|+|.+.+ .||.+++.+ ..++. . +...+-+
T Consensus 57 ~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~ 129 (199)
T PF10707_consen 57 QNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDE 129 (199)
T ss_pred HHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHH
Confidence 4456666666555 88999999998543 45677775432 378888865 44655 3 3334455
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCC--C-ceEEec-cCCC
Q 022347 91 AMDCLHANGIIHRDLKPDNLLLTPDQ--K-SLKLAD-FGLA 127 (298)
Q Consensus 91 al~~LH~~givH~dik~~Nil~~~~~--~-~~~l~d-fg~~ 127 (298)
-..+|-+.+|+.+|++|+||++.... . .++|+| ||..
T Consensus 130 f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 130 FKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred HHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 56688899999999999999997433 2 477777 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00032 Score=62.29 Aligned_cols=46 Identities=24% Similarity=0.465 Sum_probs=38.7
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec--CceeEEEecCCCCCHHHHHhh
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVS 70 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~ 70 (298)
++.....+++.++|+|..+++++... ....+|+|++ +.||.+++..
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 45577889999999999999998743 3588999999 8899999876
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.39 E-value=2.6e-05 Score=76.85 Aligned_cols=202 Identities=12% Similarity=0.003 Sum_probs=131.0
Q ss_pred HHHHHHHhCCCCcccceecee---ecCceeEEEecCCCCCHHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--
Q 022347 27 REVNMMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPN--KLDLHVALNFALDIARAMDCLHANG-- 99 (298)
Q Consensus 27 ~E~~~l~~l~hp~Iv~~~~~~---~~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~g-- 99 (298)
.|..-++...|+++...+.-. ++...|.+++++.+|.+.+.+.....+ .....-+...-.+.+....-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 455566778899998887765 344678999999999999988653221 2333333333333366666766542
Q ss_pred ---CeeecCCCCCEEEcCCCCceEEeccCCCc-cCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 ---IIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ---ivH~dik~~Nil~~~~~~~~~l~dfg~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
-+|.++++-|.++..+ .++++.++|+.+ ............+++.|+.|++.+. -.++.++|+|..|+
T Consensus 1358 g~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~--------ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE--------IKFTKRSDILRRSL 1428 (2724)
T ss_pred CccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH--------HhhhhHHHHHHHHH
Confidence 7899999999999944 569999999998 4334444455567788888888764 56677799999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
.+|....|..+|.... +...+...+ ..-.+++.-.|.+.-.....+|-..-..||.-...++
T Consensus 1429 ~ly~rs~~n~~fi~fl--q~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls 1491 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFIFFL--QPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLS 1491 (2724)
T ss_pred HHHHHhcccHHHHHHH--HHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcc
Confidence 9999988887764211 111111111 1112233334445555555566666667776555544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0013 Score=53.36 Aligned_cols=30 Identities=37% Similarity=0.641 Sum_probs=20.1
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCC
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~ 127 (298)
..++|||+++.||+++.+++.+.|+||+.+
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred cEEEEeccccccceeeeccceeEEEecccc
Confidence 359999999999999944455679999866
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0048 Score=52.36 Aligned_cols=41 Identities=20% Similarity=0.161 Sum_probs=30.4
Q ss_pred HHHHHHHHHHhCCC---Ccccceeceee----cCceeEEEecCCCCCH
Q 022347 24 RFIREVNMMSRVKH---DNLVKFLGACK----DPLMVIVTELLPGMSL 64 (298)
Q Consensus 24 ~~~~E~~~l~~l~h---p~Iv~~~~~~~----~~~~~lv~e~~~~~sL 64 (298)
.+..|...|+.+.- -.+.++++.+. .+..+||||+++|+++
T Consensus 53 ~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 53 VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred HHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 56688888888853 35777787663 2458999999998765
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0028 Score=53.39 Aligned_cols=94 Identities=20% Similarity=0.271 Sum_probs=65.9
Q ss_pred HHHHHHHHHHhCCCC--cccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVKHD--NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp--~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
...+|...++.|.-. -|+..++ .+..++|||++.|-+|...-+ ...+-.+...++.-+--|.++|++
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD---~~RH~Vvmelv~g~Pl~~v~~--------v~d~~~ly~~lm~~Iv~la~~GlI 224 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPID---HNRHCVVMELVDGYPLRQVRH--------VEDPPTLYDDLMGLIVRLANHGLI 224 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCccc---ccceeeHHHhhcccceeeeee--------cCChHHHHHHHHHHHHHHHHcCce
Confidence 456788888887532 2333444 345689999999988765321 112234455666667788899999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
|||.+--||+++.+ ..++++||-....
T Consensus 225 HgDFNEFNimv~dd-~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDD-DKIVVIDFPQMVS 251 (465)
T ss_pred ecccchheeEEecC-CCEEEeechHhhc
Confidence 99999999999954 4599999986653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0075 Score=50.57 Aligned_cols=31 Identities=29% Similarity=0.533 Sum_probs=24.8
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.++|||+++.||+++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999995444456999997744
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.024 Score=46.92 Aligned_cols=29 Identities=38% Similarity=0.619 Sum_probs=24.6
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.++|+|+.|.||+++.++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence 489999999999998554 78999997754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.029 Score=48.37 Aligned_cols=110 Identities=22% Similarity=0.197 Sum_probs=75.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.++.++-....|++-|+++..-.|.-.--..-. ...|||+|+ |.+=+..-. .++..++...+..+-.+++.-+.-|-
T Consensus 205 PRKMVk~WAEKE~RNLkRl~~aGIP~PePIlLk-~hVLVM~Fl-Grdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY 281 (520)
T KOG2270|consen 205 PRKMVKTWAEKEMRNLKRLNNAGIPCPEPILLK-NHVLVMEFL-GRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLY 281 (520)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCCCCCCceeee-cceEeeeec-cCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHH
Confidence 455566667789999999987774332222222 346999999 433222110 12345777788888888888877775
Q ss_pred h-CCCeeecCCCCCEEEcCCCCceEEeccCCCccCc
Q 022347 97 A-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131 (298)
Q Consensus 97 ~-~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~ 131 (298)
+ .++||.||.--|+|+. ++ .+.++|.+.+....
T Consensus 282 ~~c~LVHADLSEfN~Lyh-dG-~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 282 QKCRLVHADLSEFNLLYH-DG-KLYIIDVSQSVEHD 315 (520)
T ss_pred HHhceeccchhhhhheEE-CC-EEEEEEccccccCC
Confidence 4 6999999999999998 43 59999999886543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.044 Score=42.22 Aligned_cols=93 Identities=22% Similarity=0.242 Sum_probs=64.5
Q ss_pred HHHHHHHHHHhCCCCcccc-eeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVK-FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~-~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
-+..|.++|..+...++-+ ++.+..+ ++.|||+.|.+|.++-.. .+... +..+++.---|...||-|
T Consensus 61 ~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H 128 (201)
T COG2112 61 NLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEH 128 (201)
T ss_pred hHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccch
Confidence 5668999999998877755 3443333 355999999899886542 12223 345666666788899999
Q ss_pred ecCC-CCCEEEcCCCCceEEeccCCCcc
Q 022347 103 RDLK-PDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 103 ~dik-~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
+.|+ |...++..++ .+.|+||..+..
T Consensus 129 ~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 129 GELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred hhhcCCceeEEecCC-cEEEEEccchhh
Confidence 9998 5444444343 599999998863
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.071 Score=45.41 Aligned_cols=31 Identities=29% Similarity=0.571 Sum_probs=26.5
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccC
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~ 130 (298)
.++|||+++.|++++.++. +-|+||+.+...
T Consensus 199 ~lvHGD~~~gNlii~~~~~-~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRP-TGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCe-eEEEeccccccC
Confidence 3899999999999996665 889999988653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.042 Score=47.27 Aligned_cols=70 Identities=23% Similarity=0.336 Sum_probs=56.6
Q ss_pred ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 51 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 51 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
+.|++|++. |++|.- + .--..+++..++++.+..++-+... .+=|+|+.-.||+++ + +.|.|+||-+++.
T Consensus 300 y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-GNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-CceEEEEeeeeec
Confidence 577888887 767643 1 2245788899999999998888875 688999999999999 4 4599999999984
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.03 Score=45.65 Aligned_cols=30 Identities=27% Similarity=0.481 Sum_probs=25.2
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
+++|+|+++.||+++.+.+.+.|+||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 599999999999999633469999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.12 Score=45.40 Aligned_cols=29 Identities=28% Similarity=0.267 Sum_probs=23.7
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
..++|.|+.+.||+.+.+ .+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence 468999999999998633 49999998764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.14 Score=44.34 Aligned_cols=29 Identities=21% Similarity=0.403 Sum_probs=23.6
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
..++|||+.+.||+++.++ ++++|+..+.
T Consensus 192 ~~llHGDl~~gNi~~~~~~--~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE--TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC--CEEEcCcccc
Confidence 3589999999999998543 7899987663
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.29 Score=43.24 Aligned_cols=29 Identities=24% Similarity=0.439 Sum_probs=24.0
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
..++|||+++.||++..+ .++++||.++.
T Consensus 223 ~~l~HgDl~~gni~~~~~--~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE--ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC--CcEEEeccccc
Confidence 359999999999999854 38999997664
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.047 Score=46.54 Aligned_cols=30 Identities=43% Similarity=0.651 Sum_probs=25.2
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
.+++|||+++.|++++.+ +...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 589999999999999855 346799998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.056 Score=45.90 Aligned_cols=30 Identities=40% Similarity=0.515 Sum_probs=25.3
Q ss_pred CCeeecCCCCCEEEcCC---CCceEEeccCCCc
Q 022347 99 GIIHRDLKPDNLLLTPD---QKSLKLADFGLAR 128 (298)
Q Consensus 99 givH~dik~~Nil~~~~---~~~~~l~dfg~~~ 128 (298)
+++|+|+.+.||+++.+ .+.+.++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999854 2469999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.072 Score=45.42 Aligned_cols=29 Identities=28% Similarity=0.503 Sum_probs=24.4
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
.+++|||+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 47999999999999985 348899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.055 Score=45.82 Aligned_cols=30 Identities=40% Similarity=0.557 Sum_probs=24.7
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
.+++|||++|.|++++.+ +.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 479999999999999954 446799998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.029 Score=48.11 Aligned_cols=31 Identities=35% Similarity=0.525 Sum_probs=25.0
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.|++|||+++.||+++. +...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEEC-CceEEEEecccccC
Confidence 38999999999999984 34457999997743
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.92 E-value=0.081 Score=45.92 Aligned_cols=31 Identities=23% Similarity=0.555 Sum_probs=26.2
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.++|+|+++.||+++.+.+.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999985445699999987753
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.75 E-value=0.06 Score=42.06 Aligned_cols=29 Identities=28% Similarity=0.494 Sum_probs=24.3
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
-.+|+|+.|.|+++..+ + ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~-~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSAS-G-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECC-C-EEEEeCCcccC
Confidence 36999999999999844 4 88999998854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.73 E-value=0.22 Score=42.98 Aligned_cols=30 Identities=33% Similarity=0.503 Sum_probs=25.8
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
++|+|+.+.||+++.+++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999985556799999998753
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.46 Score=41.82 Aligned_cols=63 Identities=21% Similarity=0.296 Sum_probs=46.7
Q ss_pred eeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCeeecCCCCCEEEcCCCC
Q 022347 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD-CLHANGIIHRDLKPDNLLLTPDQK 117 (298)
Q Consensus 52 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~-~LH~~givH~dik~~Nil~~~~~~ 117 (298)
..++-+|..|.++..+++. ...++....+++.-...|+- .|--.+++|.|++|.||++..+.+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence 4577789999999999986 44556666666666666644 444569999999999999975443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.52 E-value=0.13 Score=44.27 Aligned_cols=44 Identities=41% Similarity=0.552 Sum_probs=31.4
Q ss_pred HHHHHHHHHHHhC--------C--CeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 86 LDIARAMDCLHAN--------G--IIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 86 ~qi~~al~~LH~~--------g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.++...+..+.+. + +||+|+.|.||+++.++..+-++||+-+..
T Consensus 175 a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 175 AALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 4445555555533 3 999999999999996543478999997743
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.18 Score=39.90 Aligned_cols=31 Identities=32% Similarity=0.537 Sum_probs=25.0
Q ss_pred CCCeeecCCCCCEEEcCCCC----ceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQK----SLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~----~~~l~dfg~~~ 128 (298)
..++|||+.+.|+++..++. .+.++||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 36999999999999985432 58899998763
|
subfamily of choline kinases |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.48 E-value=0.042 Score=44.04 Aligned_cols=31 Identities=35% Similarity=0.553 Sum_probs=20.0
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.++|+|+.+.||+++...+.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 4899999999999943455799999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.16 Score=42.47 Aligned_cols=47 Identities=32% Similarity=0.377 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHHHHHhC--CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 82 LNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 82 ~~i~~qi~~al~~LH~~--givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
...+..+-.++.-++.. -++|+|+.|+|++.+..+ .++|+||..+..
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence 33445555555555544 599999999999999534 599999998864
|
|
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.81 E-value=0.26 Score=41.24 Aligned_cols=99 Identities=20% Similarity=0.272 Sum_probs=61.7
Q ss_pred HHHHHHHhCC-CCcccceeceeecCceeEEEecCCCCCHHHH----------H-------hh---h--CCCCCCHHHHHH
Q 022347 27 REVNMMSRVK-HDNLVKFLGACKDPLMVIVTELLPGMSLRKY----------L-------VS---L--RPNKLDLHVALN 83 (298)
Q Consensus 27 ~E~~~l~~l~-hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~----------l-------~~---~--~~~~~~~~~~~~ 83 (298)
+|+..++.|. |-.=.++++.|.++ +|+||++|.+|.-- + +. . .+++.-|..+..
T Consensus 127 ~Ev~afk~L~a~G~ap~Ly~tF~NG---Lvyefi~g~tL~p~~mr~pki~~lIAr~mak~H~~~~~g~~pkp~lw~km~~ 203 (391)
T KOG4720|consen 127 NEVIAFKLLAAYGFAPKLYGTFNNG---LVYEFIQGKTLEPEHMREPKIFRLIARRMAKIHSIVATGGNPKPPLWEKMRK 203 (391)
T ss_pred HHHHHHHHHHHcCcChhhhheecCc---eEEeeecCcccChhhccChHHHHHHHHHHHHhheeccCCCCCCCcHHHHHHH
Confidence 6777777775 77778888888776 89999999887531 0 00 0 011111111111
Q ss_pred HH--------------------------HHHHHHHHHHHhCC----CeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 84 FA--------------------------LDIARAMDCLHANG----IIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 84 i~--------------------------~qi~~al~~LH~~g----ivH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
++ ..+..--++|-..+ ++|.||=..||+.+...+.+.++||..+.
T Consensus 204 f~~lv~~~f~de~~kq~~~~~~~~~~L~~Ei~~l~E~l~~L~sPVVFcHNDLL~~Niiy~~~~~~v~fIDYEYa~ 278 (391)
T KOG4720|consen 204 FLQLVPTSFEDEINKQNLFDEPSPEDLGEEISKLKEMLSMLKSPVVFCHNDLLCGNIIYDSEKGSVEFIDYEYAG 278 (391)
T ss_pred HHHhcCchhhcccchhhcccCCCHHHHHHHHHHHHHHHHhhCCCeEEeecchhhcceeeccccCcEEEEeecccc
Confidence 11 11222222222222 78999999999999888899999998875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.12 Score=41.43 Aligned_cols=83 Identities=16% Similarity=0.205 Sum_probs=51.9
Q ss_pred HHHHHHHHHhCCCCcccceeceeecC-ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCe
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GII 101 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--giv 101 (298)
|..+..++.++ -+|+++..- ++ ..-++.|+|-.. +..+.. ++.-=+.+|.-.|+. +.+
T Consensus 105 y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~-----------~i~~~N----~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 105 YFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKI-----------KINFSN----FITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCc-----------ccchhH----HHHHhHHHHHHhhccCCCee
Confidence 45666777665 245555521 22 345888888321 111111 112225678888954 799
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCC
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLA 127 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~ 127 (298)
|||..|+||+-|..+ .+||.|-+.-
T Consensus 166 HGD~np~NiM~D~~G-~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFG-YLKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCC-CEEecChhhh
Confidence 999999999999664 6999997754
|
The function of this family is unknown. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.02 E-value=0.16 Score=43.39 Aligned_cols=50 Identities=28% Similarity=0.375 Sum_probs=32.3
Q ss_pred HHHHHHHHHHHHHHHH----hCCCeeecCCCCCEEEcCCCC-----------------ceEEeccCCCccC
Q 022347 81 ALNFALDIARAMDCLH----ANGIIHRDLKPDNLLLTPDQK-----------------SLKLADFGLAREE 130 (298)
Q Consensus 81 ~~~i~~qi~~al~~LH----~~givH~dik~~Nil~~~~~~-----------------~~~l~dfg~~~~~ 130 (298)
+..++.|++.-.--+- ..+++|.||||+|||+-.+.. .++|.||++++..
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 4556667655432232 347999999999999963321 3567788877643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.81 E-value=0.28 Score=41.88 Aligned_cols=30 Identities=17% Similarity=0.205 Sum_probs=25.3
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
+++|||+.++|++++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 799999999999998554 488999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.48 E-value=1.7 Score=43.64 Aligned_cols=32 Identities=34% Similarity=0.493 Sum_probs=25.7
Q ss_pred CCCeeecCCCCCEEEcCCC--CceEEeccCCCcc
Q 022347 98 NGIIHRDLKPDNLLLTPDQ--KSLKLADFGLARE 129 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~--~~~~l~dfg~~~~ 129 (298)
.+++|+|+++.||+++.++ ...-|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999654 2334999998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=91.39 E-value=0.52 Score=37.38 Aligned_cols=84 Identities=32% Similarity=0.481 Sum_probs=60.0
Q ss_pred HHHHHHHHHHHhCC---CCcc--cceecee--e-cC----------------ceeEEEecCCCCCHHHHHhhhCCCCCCH
Q 022347 23 GRFIREVNMMSRVK---HDNL--VKFLGAC--K-DP----------------LMVIVTELLPGMSLRKYLVSLRPNKLDL 78 (298)
Q Consensus 23 ~~~~~E~~~l~~l~---hp~I--v~~~~~~--~-~~----------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 78 (298)
+-|..|.+...+|+ +.++ ++++|+. . +. ...||.||.+... .+..
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~ 167 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI 167 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch
Confidence 36888999888886 4456 8888886 1 10 2347888775533 1222
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCC
Q 022347 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127 (298)
Q Consensus 79 ~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~ 127 (298)
. =+.++.+-+..+|..||+-+|+++.|.. + -+|+|||.+
T Consensus 168 ~----~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 168 R----DIPQMLRDLKILHKLGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred h----HHHHHHHHHHHHHHCCeeeccCcccccc---C---CEEEecccC
Confidence 2 2557788889999999999999999986 2 479999865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 298 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-32 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-28 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-27 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-24 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-23 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-23 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-23 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-23 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-23 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-23 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-22 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-22 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-22 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-22 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-22 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-22 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-22 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-22 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-22 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-22 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-21 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-21 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-21 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-21 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-21 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-21 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-21 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-21 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-21 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-21 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-21 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-21 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-21 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-21 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-21 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-21 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-20 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-20 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-20 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-20 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-20 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-20 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-19 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-19 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-19 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-16 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-13 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-109
Identities = 89/242 (36%), Positives = 134/242 (55%), Gaps = 14/242 (5%)
Query: 15 SDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-VSLR 72
D A F+REV +M R++H N+V F+GA + P + IVTE L SL + L S
Sbjct: 71 QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 73 PNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
+LD L+ A D+A+ M+ LH I+HR+LK NLL+ + ++K+ DFGL+R +
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLK 189
Query: 131 TVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
T + GT WMAPE+ + N K DVYSFG++LWEL T + P+
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVL--------RDEPSNEKSDVYSFGVILWELATLQQPWGN 241
Query: 190 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249
++ Q A FK R +P +++P +A I++ CW +P RPSF+ I+ +L + +
Sbjct: 242 LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
Query: 250 PP 251
PP
Sbjct: 302 PP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-108
Identities = 76/250 (30%), Positives = 121/250 (48%), Gaps = 20/250 (8%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGM 62
K + + G T E F REV +MS + H N+VK G +P +V E +P
Sbjct: 50 KSLILGDSEGETEMIEKFQE--FQREVFIMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCG 106
Query: 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKS-- 118
L L+ + + + V L LDIA ++ + I+HRDL+ N+ L ++
Sbjct: 107 DLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165
Query: 119 --LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
K+ADFGL+++ ++ G ++WMAPE E++ Y K D YSF ++
Sbjct: 166 VCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIG------AEEESYTEKADTYSFAMI 217
Query: 177 LWELLTNRLPFEGMSNLQAAYAAA--FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
L+ +LT PF+ S + + + RP +PED P L +++ CW DP RP F
Sbjct: 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF 277
Query: 235 SQIIRMLNAF 244
S I++ L+
Sbjct: 278 SYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-106
Identities = 80/244 (32%), Positives = 120/244 (49%), Gaps = 23/244 (9%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLV 69
R ++ + +E + + +KH N++ G C K+P + +V E G L + L
Sbjct: 39 RHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL- 97
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANG---IIHRDLKPDNLLLT-------PDQKSL 119
++ + +N+A+ IAR M+ LH IIHRDLK N+L+ K L
Sbjct: 98 --SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155
Query: 120 KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
K+ DFGLARE T M+A G Y WMAPE+ ++ DV+S+G++LWE
Sbjct: 156 KITDFGLAREWHRTTKMSA-AGAYAWMAPEVI--------RASMFSKGSDVWSYGVLLWE 206
Query: 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
LLT +PF G+ L AY A +P A +++ CW DP+ RPSF+ I+
Sbjct: 207 LLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266
Query: 240 MLNA 243
L
Sbjct: 267 QLTT 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-106
Identities = 78/256 (30%), Positives = 126/256 (49%), Gaps = 16/256 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALN 83
FI E+ +SRV H N+VK GAC +P+ +V E G SL L P A++
Sbjct: 48 FIVELRQLSRVNHPNIVKLYGACLNPVC-LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 84 FALDIARAMDCLHA---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 140
+ L ++ + LH+ +IHRDLKP NLLL LK+ DFG A + + MT
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNK 164
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAA 199
G+ WMAPE++ E +Y+ K DV+S+GI+LWE++T R PF+ + A
Sbjct: 165 GSAAWMAPEVF--------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 259
RP L +++ + ++ CW +DP+ RPS +I++++ + +
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276
Query: 260 TNEAAATSNGAMTEFS 275
+ +G + +
Sbjct: 277 QHSLPPGEDGRVEPYV 292
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-105
Identities = 62/254 (24%), Positives = 117/254 (46%), Gaps = 16/254 (6%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
+++ ++++ F REV + +H+N+V F+GAC P + I+T L G +L
Sbjct: 62 LIDIERDNEDQ---LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ LD++ A +I + M LHA GI+H+DLK N+ D + + DFGL
Sbjct: 119 VVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY--DNGKVVITDFGL 175
Query: 127 AREETVT------EMMTAETGTYRWMAPELYSTVTL-RQGEKKHYNNKVDVYSFGIVLWE 179
V + + + G +APE+ ++ + +K ++ DV++ G + +E
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235
Query: 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQII 238
L PF+ + +P L + + +++ I+ CW + RP+F++++
Sbjct: 236 LHAREWPFKTQPAEAIIWQMG-TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294
Query: 239 RMLNAFLFTLRPPS 252
ML R S
Sbjct: 295 DMLEKLPKRNRRLS 308
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-105
Identities = 63/242 (26%), Positives = 105/242 (43%), Gaps = 18/242 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSL 64
VL S F E + H N++ LGAC+ P ++T +P SL
Sbjct: 40 VLKVRDWSTR---KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--NGIIHRDLKPDNLLLTPDQKSLKLA 122
L +D A+ FALD+AR M LH I L ++++ + + +++
Sbjct: 97 YNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARIS 155
Query: 123 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
+ W+APE L++ + D++SF ++LWEL+T
Sbjct: 156 MADVKFSFQ----SPGRMYAPAWVAPEA-----LQKKPEDTNRRSADMWSFAVLLWELVT 206
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
+PF +SN++ A + RP +P ISP ++ +++ C EDP RP F I+ +L
Sbjct: 207 REVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
Query: 243 AF 244
Sbjct: 267 KM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-102
Identities = 72/245 (29%), Positives = 122/245 (49%), Gaps = 17/245 (6%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY 67
+LN + + + F EV ++ + +H N++ F+G P + IVT+ G SL +
Sbjct: 53 MLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHH 109
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
L + K ++ ++ A AR MD LHA IIHRDLK +N+ L + ++K+ DFGLA
Sbjct: 110 LHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLA 167
Query: 128 REETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
E++ +G+ WMAPE+ +R + Y+ + DVY+FGIVL+EL+T +
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEV-----IRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
Query: 185 LPFEGMSNLQAAYAA-AFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
LP+ ++N P L + + ++ C + + RPSF +I+
Sbjct: 223 LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
Query: 241 LNAFL 245
+
Sbjct: 283 IEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 2e-85
Identities = 74/257 (28%), Positives = 112/257 (43%), Gaps = 30/257 (11%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F++EV +M ++H N++KF+G KD + +TE + G +LR + S ++ ++
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVS 112
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-------- 135
FA DIA M LH+ IIHRDL N L+ + K++ +ADFGLAR +
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 136 -------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
G WMAPE+ + + Y+ KVDV+SFGIVL E++
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEM-----ING---RSYDEKVDVFSFGIVLCEIIGRVNADP 223
Query: 189 GMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247
+ + P + P I C DP RPSF ++ L
Sbjct: 224 DYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
Query: 248 L---RPPSPSVPESDTN 261
L P P + + D
Sbjct: 284 LAGHLPLGPQLEQLDRG 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-77
Identities = 57/258 (22%), Positives = 97/258 (37%), Gaps = 46/258 (17%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
E+ ++H+N++ F+ A + ++T+ SL YL + LD
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSM 136
Query: 82 LNFALDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE--- 130
L A + LH I HRDLK N+L+ + + +AD GLA +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISD 195
Query: 131 --TVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----- 182
V GT R+M PE L ++ + D+YSFG++LWE+
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ---SYIMADMYSFGLILWEVARRCVSG 252
Query: 183 -----NRLPFEGMSNLQAAY-----AAAFKHARPGLPE-----DISPDLAFIVQSCWVED 227
+LP+ + +Y K RP P + + ++ CW +
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 228 PNLRPSFSQIIRMLNAFL 245
P R + ++ + L
Sbjct: 313 PASRLTALRVKKTLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-77
Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 44/254 (17%)
Query: 27 REVNMMSRVKHDNLVKFLGAC-----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
E+ ++H+N++ F+ + + ++T SL YL + LD
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSC 107
Query: 82 LNFALDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 133
L L IA + LH I HRDLK N+L+ + +AD GLA + +
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQS 166
Query: 134 EMM-----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT------ 182
GT R+MAPE+ Q + +VD+++FG+VLWE+
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
Query: 183 ----NRLPFEGMSNLQAAY-----AAAFKHARPGLPEDISPD-----LAFIVQSCWVEDP 228
+ PF + ++ RP +P D LA +++ CW ++P
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284
Query: 229 NLRPSFSQIIRMLN 242
+ R + +I + L
Sbjct: 285 SARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 6e-73
Identities = 56/255 (21%), Positives = 102/255 (40%), Gaps = 46/255 (18%)
Query: 27 REVNMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
E+ ++H+N++ F+ A + +V++ SL YL + +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGM 141
Query: 82 LNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE--- 130
+ AL A + LH I HRDLK N+L+ + + +AD GLA
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSA 200
Query: 131 --TVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----- 182
T+ GT R+MAPE L ++ ++ E + D+Y+ G+V WE+
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE---SFKRADIYAMGLVFWEIARRCSIG 257
Query: 183 -----NRLPFEGMSNLQAAY-----AAAFKHARPGLPE-----DISPDLAFIVQSCWVED 227
+LP+ + + + RP +P + +A I++ CW +
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317
Query: 228 PNLRPSFSQIIRMLN 242
R + +I + L+
Sbjct: 318 GAARLTALRIKKTLS 332
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 5e-67
Identities = 65/259 (25%), Positives = 103/259 (39%), Gaps = 46/259 (17%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDL 78
+ EV + +KH+N+++F+GA K V ++T SL +L + N +
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSW 120
Query: 79 HVALNFALDIARAMDCLHAN----------GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
+ + A +AR + LH + I HRD+K N+LL + + +ADFGLA
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLAL 179
Query: 129 ---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--- 182
+ GT R+MAPE+ Q + ++D+Y+ G+VLWEL +
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD---AFLRIDMYAMGLVLWELASRCT 236
Query: 183 --------NRLPFEGM-----SNLQAAYAAAFKHARPGLPEDISPD-----LAFIVQSCW 224
LPFE S K RP L + L ++ CW
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 225 VEDPNLRPSFSQIIRMLNA 243
D R S + +
Sbjct: 297 DHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-66
Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 25 FIREVNM--MSRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKL 76
FI E N+ + ++HDN+ +F+ + ++V E P SL KYL +
Sbjct: 52 FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTS 108
Query: 77 DLHVALNFALDIARAMDCLHA---------NGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
D + A + R + LH I HRDL N+L+ D + ++DFGL+
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLS 167
Query: 128 REETVTEM---------MTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
T + +E GT R+MAPE L V LR E +VD+Y+ G++
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE--SALKQVDMYALGLIY 225
Query: 178 WELL---TNRLPFEGMSNLQAAYAA---------------AFKHARPGLPEDISPD---- 215
WE+ T+ P E + Q A+ + + RP PE +
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285
Query: 216 --LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN 261
L ++ CW +D R + + + P + +
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-58
Identities = 73/252 (28%), Positives = 116/252 (46%), Gaps = 30/252 (11%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
D +A +F++E ++ + H N+V+ +G C K P+ IV EL+ G
Sbjct: 146 SCRETLPPDLKA----KFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFL 200
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+L + +L + L D A M+ L + IHRDL N L+T ++ LK++DFG
Sbjct: 201 TFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFG 258
Query: 126 LAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
++REE + +W APE L G Y+++ DV+SFGI+LWE +
Sbjct: 259 MSREEADGVYAASGGLRQVPVKWTAPE-----ALNYG---RYSSESDVWSFGILLWETFS 310
Query: 183 N-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
P+ +SN Q + G PE + +++ CW +P RPSFS I
Sbjct: 311 LGASPYPNLSNQQ-----TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365
Query: 238 IRMLNAFLFTLR 249
+ L + R
Sbjct: 366 YQELQSIRKRHR 377
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 7e-56
Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-----MVIVTELL 59
E+ +R T ER RF E M+ ++H N+V+F + + + +V+VTEL+
Sbjct: 56 WCELQDRKLTKSERQ----RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111
Query: 60 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK 117
+L+ YL R + + V ++ I + + LH IIHRDLK DN+ +T
Sbjct: 112 TSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 169
Query: 118 SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
S+K+ D GLA + + GT +MAPE+Y ++ Y+ VDVY+FG+ +
Sbjct: 170 SVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMY---------EEKYDESVDVYAFGMCM 219
Query: 178 WELLTNRLPFEGMSNLQAAY-AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
E+ T+ P+ N Y + P++ I++ C ++ + R S
Sbjct: 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 7e-56
Identities = 78/247 (31%), Positives = 125/247 (50%), Gaps = 31/247 (12%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
L +GS S + F+ E N+M +++H LV+ ++P+ I+TE + SL
Sbjct: 44 SLKQGSMSPDA------FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVD 96
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L + KL ++ L+ A IA M + IHRDL+ N+L++ D S K+ADFGL
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGL 155
Query: 127 AREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
AR E TA G +W APE + G + K DV+SFGI+L E++T+
Sbjct: 156 ARLIEDNE-YTAREGAKFPIKWTAPE-----AINYG---TFTIKSDVWSFGILLTEIVTH 206
Query: 184 -RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
R+P+ GM+N + ++ G P++ +L +++ CW E P RP+F +
Sbjct: 207 GRIPYPGMTNPE-----VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261
Query: 239 RMLNAFL 245
+L F
Sbjct: 262 SVLEDFF 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-55
Identities = 70/247 (28%), Positives = 118/247 (47%), Gaps = 36/247 (14%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
+ +T+ F+ E ++M++++H NLV+ LG + + IVTE + SL
Sbjct: 52 IKNDATAQA-------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 104
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL S + L L F+LD+ AM+ L N +HRDL N+L++ + K++DFGL
Sbjct: 105 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGL 163
Query: 127 AREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
+E + + + +W APE LR+ ++ K DV+SFGI+LWE+ +
Sbjct: 164 TKEAS-----STQDTGKLPVKWTAPE-----ALREK---KFSTKSDVWSFGILLWEIYSF 210
Query: 184 -RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
R+P+ + G P+ P + ++++CW D +RPSF Q+
Sbjct: 211 GRVPYPRIPLKD-----VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 265
Query: 239 RMLNAFL 245
L
Sbjct: 266 EQLEHIK 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-55
Identities = 69/248 (27%), Positives = 117/248 (47%), Gaps = 36/248 (14%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
+ +T+ F+ E ++M++++H NLV+ LG + + IVTE + SL
Sbjct: 223 CIKNDATAQA-------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
YL S + L L F+LD+ AM+ L N +HRDL N+L++ + K++DFG
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFG 334
Query: 126 LAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
L +E + + + +W APE LR+ ++ K DV+SFGI+LWE+ +
Sbjct: 335 LTKEAS-----STQDTGKLPVKWTAPE-----ALREK---KFSTKSDVWSFGILLWEIYS 381
Query: 183 N-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
R+P+ + G P+ P + ++++CW D RP+F Q+
Sbjct: 382 FGRVPYPRIPLKD-----VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQL 436
Query: 238 IRMLNAFL 245
L
Sbjct: 437 REQLEHIR 444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-54
Identities = 72/247 (29%), Positives = 115/247 (46%), Gaps = 32/247 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L + E F++E +M +KH NLV+ LG C + P I+TE + +L
Sbjct: 46 LKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLD 98
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL ++ V L A I+ AM+ L IHRDL N L+ + +K+ADFGL
Sbjct: 99 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGL 157
Query: 127 AREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
+R T + TA G +W APE +L ++ K DV++FG++LWE+ T
Sbjct: 158 SRLMT-GDTYTAHAGAKFPIKWTAPE-----SLAYN---KFSIKSDVWAFGVLLWEIATY 208
Query: 184 -RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
P+ G+ Q ++ PE + ++++CW +P+ RPSF++I
Sbjct: 209 GMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 263
Query: 239 RMLNAFL 245
+
Sbjct: 264 QAFETMF 270
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-54
Identities = 66/270 (24%), Positives = 109/270 (40%), Gaps = 35/270 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L + + F+ E ++S+ H N+V+ +G P I+ EL+ G L+
Sbjct: 68 LPEVCSEQDEL----DFLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKS 122
Query: 67 YLVSLRPN-----KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-- 119
+L RP L + L+ A DIA L N IHRD+ N LLT
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182
Query: 120 KLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
K+ DFG+AR+ +WM PE +G + +K D +SFG++
Sbjct: 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE-----AFMEG---IFTSKTDTWSFGVL 234
Query: 177 LWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLR 231
LWE+ + +P+ SN + + G P++ + I+ CW P R
Sbjct: 235 LWEIFSLGYMPYPSKSNQEV-----LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 232 PSFSQIIRMLNAFLFTLRPPSPSVPESDTN 261
P+F+ I+ + + ++P
Sbjct: 290 PNFAIILERIEYCTQDPDVINTALPIEYGP 319
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-54
Identities = 60/245 (24%), Positives = 112/245 (45%), Gaps = 25/245 (10%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
L ++ + E +M+ V + ++ + LG C + ++T+L+P L
Sbjct: 51 ELREATSPKANK----EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
Y+ + + LN+ + IA+ M+ L ++HRDL N+L+ + +K+ DFGL
Sbjct: 106 YVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGL 163
Query: 127 AREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
A+ E G +WMA E L+ Y ++ DV+S+G+ +WEL+
Sbjct: 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI----------YTHQSDVWSYGVTVWELM 213
Query: 182 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
T P++G+ + + K R P + D+ I++ CW+ D + RP F ++I
Sbjct: 214 TFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272
Query: 241 LNAFL 245
+
Sbjct: 273 FSKMA 277
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-53
Identities = 66/270 (24%), Positives = 109/270 (40%), Gaps = 35/270 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L + + F+ E ++S+ H N+V+ +G P I+ EL+ G L+
Sbjct: 109 LPEVCSEQDEL----DFLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKS 163
Query: 67 YLVSLRPN-----KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-- 119
+L RP L + L+ A DIA L N IHRD+ N LLT
Sbjct: 164 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223
Query: 120 KLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
K+ DFG+AR+ +WM PE +G + +K D +SFG++
Sbjct: 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE-----AFMEGI---FTSKTDTWSFGVL 275
Query: 177 LWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLR 231
LWE+ + +P+ SN + + G P++ + I+ CW P R
Sbjct: 276 LWEIFSLGYMPYPSKSNQEV-----LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330
Query: 232 PSFSQIIRMLNAFLFTLRPPSPSVPESDTN 261
P+F+ I+ + + ++P
Sbjct: 331 PNFAIILERIEYCTQDPDVINTALPIEYGP 360
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-53
Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 32/260 (12%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
L G+ S E F++E +M +++H+ LV+ ++P+ IVTE + SL
Sbjct: 215 TLKPGTMSPEA------FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD 267
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L L L ++ A IA M + +HRDL+ N+L+ + K+ADFGL
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGL 326
Query: 127 AREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN- 183
AR E + +W APE + K DV+SFGI+L EL T
Sbjct: 327 ARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKG 378
Query: 184 RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
R+P+ GM N + G P + L ++ CW ++P RP+F +
Sbjct: 379 RVPYPGMVNRE-----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433
Query: 240 MLNAFLFTLRPPSPSVPESD 259
L + P +
Sbjct: 434 FLEDY---FTSTEPQYQPGE 450
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-53
Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 32/248 (12%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
L + E F++E +M +KH NLV+ LG C + P I+TE + +L
Sbjct: 252 TLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLL 304
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
YL ++ V L A I+ AM+ L IHR+L N L+ + +K+ADFG
Sbjct: 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFG 363
Query: 126 LAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
L+R T + TA G +W APE + ++ K DV++FG++LWE+ T
Sbjct: 364 LSRLMT-GDTYTAHAGAKFPIKWTAPESLA--------YNKFSIKSDVWAFGVLLWEIAT 414
Query: 183 N-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
P+ G+ Q ++ PE + ++++CW +P+ RPSF++I
Sbjct: 415 YGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469
Query: 238 IRMLNAFL 245
+
Sbjct: 470 HQAFETMF 477
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-53
Identities = 77/230 (33%), Positives = 113/230 (49%), Gaps = 25/230 (10%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F+ E N+M ++HD LVK K+P+ I+TE + SL +L S +K L ++
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT- 142
F+ IA M + IHRDL+ N+L++ K+ADFGLAR E TA G
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNE-YTAREGAK 346
Query: 143 --YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAA 199
+W APE + + K DV+SFGI+L E++T R+P+ GMSN +
Sbjct: 347 FPIKWTAPEAIN--------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----- 393
Query: 200 AFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ G PE+ +L I+ CW P RP+F I +L+ F
Sbjct: 394 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-52
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 31/252 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L+R + + F+RE +M + H N++ +G + L ++ + L +
Sbjct: 57 LSRITEMQQVE----AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ 112
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
++ S + N + ++F L +AR M+ L +HRDL N +L + ++K+ADFGL
Sbjct: 113 FIRSPQRN-PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGL 170
Query: 127 AREETVTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
AR+ E + + + +W A E +L+ + K DV+SFG++LWELL
Sbjct: 171 ARDILDREYYSVQQHRHARLPVKWTALE-----SLQTYR---FTTKSDVWSFGVLLWELL 222
Query: 182 T-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
T P+ + G PE L ++Q CW DP +RP+F
Sbjct: 223 TRGAPPYRHIDPFDL-----THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRV 277
Query: 237 IIRMLNAFLFTL 248
++ + + L
Sbjct: 278 LVGEVEQIVSAL 289
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-52
Identities = 70/260 (26%), Positives = 110/260 (42%), Gaps = 32/260 (12%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
L G+ S E F++E +M +++H+ LV+ ++P+ IVTE + SL
Sbjct: 298 TLKPGTMSPEA------FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD 350
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L L L ++ A IA M + +HRDL+ N+L+ + K+ADFGL
Sbjct: 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGL 409
Query: 127 AREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN- 183
AR E + +W APE + K DV+SFGI+L EL T
Sbjct: 410 ARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKG 461
Query: 184 RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
R+P+ GM N + G P + L ++ CW ++P RP+F +
Sbjct: 462 RVPYPGMVNRE-----VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516
Query: 240 MLNAFLFTLRPPSPSVPESD 259
L + P +
Sbjct: 517 FLEDY---FTSTEPQYQPGE 533
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-52
Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 37/249 (14%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
+ GS S++ F +E M ++ H LVKF G C + P+ IVTE + L
Sbjct: 40 IKEGSMSEDE------FFQEAQTMMKLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLN 92
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL S L+ L D+ M L ++ IHRDL N L+ +K++DFG+
Sbjct: 93 YLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGM 150
Query: 127 AREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
R + + GT +W APE Y Y++K DV++FGI++WE+
Sbjct: 151 TRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFK----------YSSKSDVWAFGILMWEVF 199
Query: 182 TN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
+ ++P++ +N + G P S + I+ SCW E P RP+F Q
Sbjct: 200 SLGKMPYDLYTNSEV-----VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQ 254
Query: 237 IIRMLNAFL 245
++ +
Sbjct: 255 LLSSIEPLR 263
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-52
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 27 REVNMMSRVKHDNLVKFLGA-----------------CKDPLMVIVTELLPGMSLRKYLV 69
REV ++++ H N+V + G K + I E +L +++
Sbjct: 53 REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129
R KLD +AL I + +D +H+ +I+RDLKP N+ L ++ +K+ DFGL
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ-VKIGDFGLVTS 171
Query: 130 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
T GT R+M+PE + Y +VD+Y+ G++L ELL
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQI--------SSQDYGKEVDLYALGLILAELLHVCDTAFE 223
Query: 190 MSNLQAAYAAAFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
S F R G + + ++Q + P RP+ S+I+R L
Sbjct: 224 TSKF-------FTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-52
Identities = 67/252 (26%), Positives = 116/252 (46%), Gaps = 31/252 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
LNR + E + +F+ E +M H N++ LG C + ++V + LR
Sbjct: 61 LNRITDIGEVS----QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 116
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
++ + N + + F L +A+ M L + +HRDL N +L ++ ++K+ADFGL
Sbjct: 117 FIRNETHN-PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGL 174
Query: 127 AREETVTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
AR+ E + T +WMA E +L+ + + K DV+SFG++LWEL+
Sbjct: 175 ARDMYDKEYYSVHNKTGAKLPVKWMALE-----SLQTQK---FTTKSDVWSFGVLLWELM 226
Query: 182 T-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
T P+ ++ + G PE L ++ CW +RPSFS+
Sbjct: 227 TRGAPPYPDVNTFDI-----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281
Query: 237 IIRMLNAFLFTL 248
++ ++A T
Sbjct: 282 LVSRISAIFSTF 293
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-52
Identities = 71/249 (28%), Positives = 117/249 (46%), Gaps = 37/249 (14%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
+ G+ S+E FI E +M ++ H LV+ G C + P+ +VTE + L
Sbjct: 40 IREGAMSEED------FIEEAEVMMKLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSD 92
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL + + L LD+ M L +IHRDL N L+ + + +K++DFG+
Sbjct: 93 YLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGM 150
Query: 127 AREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
R + T+ TGT +W +PE +S Y++K DV+SFG+++WE+
Sbjct: 151 TRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR----------YSSKSDVWSFGVLMWEVF 199
Query: 182 TN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
+ ++P+E SN + + G P S + I+ CW E P RP+FS+
Sbjct: 200 SEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSR 254
Query: 237 IIRMLNAFL 245
++R L
Sbjct: 255 LLRQLAEIA 263
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-52
Identities = 70/249 (28%), Positives = 120/249 (48%), Gaps = 37/249 (14%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
+ GS S++ FI E +M + H+ LV+ G C + P+ I+TE + L
Sbjct: 56 IKEGSMSEDE------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIF-IITEYMANGCLLN 108
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL +R + L D+ AM+ L + +HRDL N L+ DQ +K++DFGL
Sbjct: 109 YLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGL 166
Query: 127 AREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
+R E T+ G+ RW PE +YS +++K D+++FG+++WE+
Sbjct: 167 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK----------FSSKSDIWAFGVLMWEIY 215
Query: 182 TN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
+ ++P+E +N + +H GL P S + I+ SCW E + RP+F
Sbjct: 216 SLGKMPYERFTNSET-----AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKI 270
Query: 237 IIRMLNAFL 245
++ + +
Sbjct: 271 LLSNILDVM 279
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-52
Identities = 64/247 (25%), Positives = 114/247 (46%), Gaps = 32/247 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKY 67
++ R +F++E M + H ++VK +G ++P+ I+ EL LR +
Sbjct: 51 CKNCTSDSVRE----KFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF 105
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
L + LDL + +A ++ A+ L + +HRD+ N+L++ +KL DFGL+
Sbjct: 106 LQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 163
Query: 128 REETVTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
R + A G +WMAPE + + + + DV+ FG+ +WE+L +
Sbjct: 164 RYMEDSTYYKASKGKLPIKWMAPESINF----------RRFTSASDVWMFGVCMWEILMH 213
Query: 184 -RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
PF+G+ N G +P + P L ++ CW DP+ RP F+++
Sbjct: 214 GVKPFQGVKNND-----VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 268
Query: 239 RMLNAFL 245
L+ L
Sbjct: 269 AQLSTIL 275
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 9e-52
Identities = 67/263 (25%), Positives = 117/263 (44%), Gaps = 48/263 (18%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L + + + F RE +++ ++H+++VKF G C DPL+ +V E + L K
Sbjct: 53 LKDPTLAARKD-----FQREAELLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNK 106
Query: 67 YLVSLRPN--------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+L + P+ +L L L+ A IA M L + +HRDL N L+
Sbjct: 107 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 166
Query: 113 TPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNK 167
+K+ DFG++R+ T+ T RWM PE +Y + +
Sbjct: 167 G-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK----------FTTE 215
Query: 168 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQS 222
DV+SFG++LWE+ T + P+ +SN + + G P ++ ++
Sbjct: 216 SDVWSFGVILWEIFTYGKQPWFQLSNTEV-----IECITQGRVLERPRVCPKEVYDVMLG 270
Query: 223 CWVEDPNLRPSFSQIIRMLNAFL 245
CW +P R + +I ++L+A
Sbjct: 271 CWQREPQQRLNIKEIYKILHALG 293
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-52
Identities = 62/256 (24%), Positives = 104/256 (40%), Gaps = 46/256 (17%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
VL++ + + F +MMS++ H +LV G C D + +V E + SL
Sbjct: 47 VLDKAHRNYSES-----FFEAASMMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLD 100
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL------ 119
YL + +++ L A +A AM L N +IH ++ N+LL ++
Sbjct: 101 TYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 120 -KLADFGLAREETVTEMMTAETGTY----RWMAPE--LYSTVTLRQGEKKHYNNKVDVYS 172
KL+D G++ W+ PE K+ N D +S
Sbjct: 160 IKLSDPGISIT-------VLPKDILQERIPWVPPECIENP---------KNLNLATDKWS 203
Query: 173 FGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPN 229
FG LWE+ + P + + + + LP + +LA ++ +C +P+
Sbjct: 204 FGTTLWEICSGGDKPLSALDSQRK-----LQFYEDRHQLPAPKAAELANLINNCMDYEPD 258
Query: 230 LRPSFSQIIRMLNAFL 245
RPSF IIR LN+
Sbjct: 259 HRPSFRAIIRDLNSLF 274
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-51
Identities = 75/262 (28%), Positives = 123/262 (46%), Gaps = 44/262 (16%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
L +T + + + E+ MM + KH N++ LGAC PL VI E +LR
Sbjct: 75 LKDDATEKDLS----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLR 129
Query: 66 KYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+YL + RP ++ ++ +AR M+ L + IHRDL N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 112 LTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKV 168
+T + +K+ADFGLAR+ + T +WMAPE L Y ++
Sbjct: 190 VTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQS 240
Query: 169 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSC 223
DV+SFG+++WE+ T P+ G+ + FK + G P + + +L +++ C
Sbjct: 241 DVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDC 295
Query: 224 WVEDPNLRPSFSQIIRMLNAFL 245
W P+ RP+F Q++ L+ L
Sbjct: 296 WHAVPSQRPTFKQLVEDLDRIL 317
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-51
Identities = 64/265 (24%), Positives = 112/265 (42%), Gaps = 36/265 (13%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-------KDPLMVIVTELLPG 61
L + F+RE M H ++ K +G + P+ +++ +
Sbjct: 59 LKADIIASSDIE---EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH 115
Query: 62 MSLRKYLVSLRP----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 117
L +L++ R L L + F +DIA M+ L + IHRDL N +L D
Sbjct: 116 GDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-M 174
Query: 118 SLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174
++ +ADFGL+R+ + + +W+A E +L Y DV++FG
Sbjct: 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE-----SLADNL---YTVHSDVWAFG 226
Query: 175 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPN 229
+ +WE++T + P+ G+ N + + + G P + ++ ++ CW DP
Sbjct: 227 VTMWEIMTRGQTPYAGIENAEI-----YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPK 281
Query: 230 LRPSFSQIIRMLNAFLFTLRPPSPS 254
RPSF+ + L L L S S
Sbjct: 282 QRPSFTCLRMELENILGHLSVLSTS 306
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-51
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 53/276 (19%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMS 63
L + R+ + +E++++ + H++++K+ G C L +V E +P S
Sbjct: 67 ALKADAGPQHRS----GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGS 121
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
LR YL + + L L FA I M LHA IHRDL N+LL + + +K+ D
Sbjct: 122 LRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD-NDRLVKIGD 177
Query: 124 FGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
FGLA+ E W APE + DV+SFG+ L
Sbjct: 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK----------FYYASDVWSFGVTL 227
Query: 178 WELLT---------------NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAF 218
+ELLT + M+ L+ + G P+ ++
Sbjct: 228 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL-----TELLERGERLPRPDKCPAEVYH 282
Query: 219 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 254
++++CW + + RP+F +I +L + +PS
Sbjct: 283 LMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-51
Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 37/255 (14%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
+N ++ ER F+ E ++M ++V+ LG P +VI EL+ L+
Sbjct: 63 VNEAASMRERI----EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI-MELMTRGDLKS 117
Query: 67 YLVSLRPN--------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 118
YL SLRP L + A +IA M L+AN +HRDL N ++ D +
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FT 176
Query: 119 LKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFG+ R+ T+ RWM+PE +L+ G + DV+SFG+
Sbjct: 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGV---FTTYSDVWSFGV 228
Query: 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNL 230
VLWE+ T P++G+SN Q + G P++ L +++ CW +P +
Sbjct: 229 VLWEIATLAEQPYQGLSNEQV-----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKM 283
Query: 231 RPSFSQIIRMLNAFL 245
RPSF +II + +
Sbjct: 284 RPSFLEIISSIKEEM 298
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 70/242 (28%), Positives = 104/242 (42%), Gaps = 23/242 (9%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
L S A+ + FIREVN M + H NL++ G P+ +VTEL P SL
Sbjct: 53 CLKPDVLSQPEAMDD--FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLD 109
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
L L +A+ +A M L + IHRDL NLLL + +K+ DFGL
Sbjct: 110 RLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGL 167
Query: 127 AREETVTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
R + + + W APE T +++ D + FG+ LWE+
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT----------FSHASDTWMFGVTLWEM 217
Query: 181 LTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
T + P+ G++ Q + + R PED D+ ++ CW P RP+F +
Sbjct: 218 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277
Query: 240 ML 241
L
Sbjct: 278 FL 279
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 75/262 (28%), Positives = 123/262 (46%), Gaps = 44/262 (16%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
L +T + + + E+ MM + KH N++ LGAC PL VI E +LR
Sbjct: 121 LKDDATEKDLS----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLR 175
Query: 66 KYLVSLRPN--------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+YL + RP ++ ++ +AR M+ L + IHRDL N+L
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235
Query: 112 LTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKV 168
+T + +K+ADFGLAR+ + T +WMAPE L Y ++
Sbjct: 236 VTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQS 286
Query: 169 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSC 223
DV+SFG+++WE+ T P+ G+ + FK + G P + + +L +++ C
Sbjct: 287 DVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDC 341
Query: 224 WVEDPNLRPSFSQIIRMLNAFL 245
W P+ RP+F Q++ L+ L
Sbjct: 342 WHAVPSQRPTFKQLVEDLDRIL 363
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-51
Identities = 68/260 (26%), Positives = 111/260 (42%), Gaps = 43/260 (16%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L S S + F RE +++ ++H ++V+F G C PL+++ E + L +
Sbjct: 79 LKEASESARQD-----FQREAELLTMLQHQHIVRFFGVCTEGRPLLMV-FEYMRHGDLNR 132
Query: 67 YLVSLRPN-------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 113
+L S P+ L L L A +A M L +HRDL N L+
Sbjct: 133 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192
Query: 114 PDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDV 170
+K+ DFG++R+ T+ T RWM PE ++ + + + DV
Sbjct: 193 QG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE-----SILYRK---FTTESDV 243
Query: 171 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWV 225
+SFG+VLWE+ T + P+ +SN +A G P P++ I++ CW
Sbjct: 244 WSFGVVLWEIFTYGKQPWYQLSNTEA-----IDCITQGRELERPRACPPEVYAIMRGCWQ 298
Query: 226 EDPNLRPSFSQIIRMLNAFL 245
+P R S + L A
Sbjct: 299 REPQQRHSIKDVHARLQALA 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-51
Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 44/262 (16%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
L +T + + I E+ MM + KH N++ LGAC PL VI E +LR
Sbjct: 109 LKSDATEKDLS----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLR 163
Query: 66 KYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+YL + RP +L ++ A +AR M+ L + IHRDL N+L
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223
Query: 112 LTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKV 168
+T D +K+ADFGLAR+ + T +WMAPE L Y ++
Sbjct: 224 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE-----ALFDRI---YTHQS 274
Query: 169 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSC 223
DV+SFG++LWE+ T P+ G+ + FK + G P + + +L +++ C
Sbjct: 275 DVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKEGHRMDKPSNCTNELYMMMRDC 329
Query: 224 WVEDPNLRPSFSQIIRMLNAFL 245
W P+ RP+F Q++ L+ +
Sbjct: 330 WHAVPSQRPTFKQLVEDLDRIV 351
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-51
Identities = 60/243 (24%), Positives = 107/243 (44%), Gaps = 21/243 (8%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
V+ S + + + H ++V+ LG C L +VT+ LP SL
Sbjct: 49 VIEDKSGRQSFQ----AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD 103
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
++ R L + LN+ + IA+ M L +G++HR+L N+LL +++ADFG+
Sbjct: 104 HVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK-SPSQVQVADFGV 161
Query: 127 AREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
A + + +WMA E Y ++ DV+S+G+ +WEL+T
Sbjct: 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTVWELMTF 213
Query: 184 -RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
P+ G+ + K R P+ + D+ ++ CW+ D N+RP+F ++
Sbjct: 214 GAEPYAGLRLAE-VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272
Query: 243 AFL 245
Sbjct: 273 RMA 275
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 6e-51
Identities = 67/252 (26%), Positives = 116/252 (46%), Gaps = 31/252 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
LNR + E + +F+ E +M H N++ LG C + ++V + LR
Sbjct: 125 LNRITDIGEVS----QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
++ + N + + F L +A+ M L + +HRDL N +L ++ ++K+ADFGL
Sbjct: 181 FIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGL 238
Query: 127 AREETVTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
AR+ E + T +WMA E +L+ + + K DV+SFG++LWEL+
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALE-----SLQTQK---FTTKSDVWSFGVLLWELM 290
Query: 182 T-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
T P+ ++ + G PE L ++ CW +RPSFS+
Sbjct: 291 TRGAPPYPDVNTFDI-----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 345
Query: 237 IIRMLNAFLFTL 248
++ ++A T
Sbjct: 346 LVSRISAIFSTF 357
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-51
Identities = 63/273 (23%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
L ++ + E +M+ V + ++ + LG C + ++T+L+P L
Sbjct: 51 ELREATSPKANK----EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
Y+ + + LN+ + IA+ M+ L ++HRDL N+L+ + +K+ DFGL
Sbjct: 106 YVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGL 163
Query: 127 AREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
A+ E G +WMA E L+ Y ++ DV+S+G+ +WEL+
Sbjct: 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI----------YTHQSDVWSYGVTVWELM 213
Query: 182 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
T P++G+ + + K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 214 TFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272
Query: 241 LNAFL------------FTLRPPSPSVPESDTN 261
+ + PSP+
Sbjct: 273 FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-51
Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 32/248 (12%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
+ T D + +F+ E +M + H ++VK +G ++P I+ EL P L
Sbjct: 47 TCKKDCTLDNKE----KFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGH 101
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL + L + + ++L I +AM L + +HRD+ N+L+ + +KL DFGL
Sbjct: 102 YLERNKN-SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGL 159
Query: 127 AREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
+R + A +WM+PE + + DV+ F + +WE+L+
Sbjct: 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRR----------FTTASDVWMFAVCMWEILS 209
Query: 183 N-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ PF + N G P+ P L ++ CW DP+ RP F+++
Sbjct: 210 FGKQPFFWLENKD-----VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264
Query: 238 IRMLNAFL 245
+ L+
Sbjct: 265 VCSLSDVY 272
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 9e-51
Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 51/269 (18%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L ++ E + E N++ +V H +++K GAC PL++IV E SLR
Sbjct: 61 LKENASPSELR----DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRG 115
Query: 67 YLVSLRP----------------------NKLDLHVALNFALDIARAMDCLHANGIIHRD 104
+L R L + ++FA I++ M L ++HRD
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175
Query: 105 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEK 161
L N+L+ + +K++DFGL+R+ + + +WMA E +L
Sbjct: 176 LAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE-----SLFDHI- 228
Query: 162 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDL 216
Y + DV+SFG++LWE++T P+ G+ + F + G P++ S ++
Sbjct: 229 --YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-----FNLLKTGHRMERPDNCSEEM 281
Query: 217 AFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ CW ++P+ RP F+ I + L +
Sbjct: 282 YRLMLQCWKQEPDKRPVFADISKDLEKMM 310
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 9e-51
Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 35/258 (13%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGM 62
+ ++S R + E F+ E M H N+++ LG C + P +++ +
Sbjct: 70 MKLDNSSQ-REIEE--FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG 126
Query: 63 SLRKYLVSLRP----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 118
L YL+ R + L L F +DIA M+ L +HRDL N +L D +
Sbjct: 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMT 185
Query: 119 LKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175
+ +ADFGL+++ + +W+A E +L Y +K DV++FG+
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE-----SLADRV---YTSKSDVWAFGV 237
Query: 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNL 230
+WE+ T P+ G+ N + + + G PED +L I+ SCW DP
Sbjct: 238 TMWEIATRGMTPYPGVQNHEM-----YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLD 292
Query: 231 RPSFSQIIRMLNAFLFTL 248
RP+FS + L L +L
Sbjct: 293 RPTFSVLRLQLEKLLESL 310
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-50
Identities = 64/260 (24%), Positives = 110/260 (42%), Gaps = 43/260 (16%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L + R F E + +R++H N+V LG PL ++ L +
Sbjct: 47 LKDKAEGPLRE----EFRHEAMLRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHE 101
Query: 67 YLVSLRPN--------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+LV P+ L+ ++ IA M+ L ++ ++H+DL N+L+
Sbjct: 102 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 161
Query: 113 TPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVD 169
D+ ++K++D GL RE + + RWMAPE + G ++ D
Sbjct: 162 Y-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE-----AIMYG---KFSIDSD 212
Query: 170 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCW 224
++S+G+VLWE+ + P+ G SN + R P+D + ++ CW
Sbjct: 213 IWSYGVVLWEVFSYGLQPYCGYSNQDV-----VEMIRNRQVLPCPDDCPAWVYALMIECW 267
Query: 225 VEDPNLRPSFSQIIRMLNAF 244
E P+ RP F I L A+
Sbjct: 268 NEFPSRRPRFKDIHSRLRAW 287
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-50
Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L G T +R F+ E ++M + H N+++ G M IVTE + SL
Sbjct: 85 LKAGYTERQRR----DFLSEASIMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDT 139
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L + + + + + M L G +HRDL N+L+ K++DFGL
Sbjct: 140 FLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGL 197
Query: 127 ARE-ETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
+R E + TG RW APE + +++ DV+SFG+V+WE+L
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPE-----AIAFR---TFSSASDVWSFGVVMWEVLA 249
Query: 183 N-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
P+ M+N G P L ++ CW +D RP FSQI
Sbjct: 250 YGERPYWNMTNRDV-----ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQI 304
Query: 238 IRMLNAFL 245
+ +L+A +
Sbjct: 305 VSVLDALI 312
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-50
Identities = 65/275 (23%), Positives = 106/275 (38%), Gaps = 46/275 (16%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-------------PL 51
+K + ++ REV +++++H +V++ A +
Sbjct: 35 IKRIRLPNRELAREKVM-----REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89
Query: 52 MVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 110
+ I +L +L+ ++ + + V L+ L IA A++ LH+ G++HRDLKP N+
Sbjct: 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNI 149
Query: 111 LLTPDQKSLKLADFGLAR-------------EETVTEMMTAETGTYRWMAPELYSTVTLR 157
T D +K+ DFGL T + GT +M+PE
Sbjct: 150 FFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI------ 202
Query: 158 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 217
Y++KVD++S G++L+ELL PF P L P
Sbjct: 203 --HGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEY 257
Query: 218 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252
+VQ P RP II NA L P
Sbjct: 258 VMVQDMLSPSPMERPEAINIIE--NAVFEDLDFPG 290
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 16/238 (6%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMS 63
+KE+ +S ER REV +++ +KH N+V++ + ++ + IV + G
Sbjct: 54 IKEINISRMSSKEREES----RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L K + + + L++ + I A+ +H I+HRD+K N+ LT D +++L D
Sbjct: 110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGD 168
Query: 124 FGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
FG+AR + E+ A GT +++PE+ E K YNNK D+++ G VL+EL T
Sbjct: 169 FGIARVLNSTVELARACIGTPYYLSPEIC--------ENKPYNNKSDIWALGCVLYELCT 220
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
+ FE +++ + P + S DL +V + +P RPS + I+
Sbjct: 221 LKHAFEA-GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-50
Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 38/272 (13%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L G T +R F+ E +M + H N+++ G P+M I+TE + +L K
Sbjct: 81 LKAGYTEKQRV----DFLGEAGIMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDK 135
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L + + + + IA M L +HRDL N+L+ K++DFGL
Sbjct: 136 FLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGL 193
Query: 127 ARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+R E E +G RW APE Y + + + DV+SFGIV+WE+
Sbjct: 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY----------RKFTSASDVWSFGIVMWEV 243
Query: 181 LTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+T P+ +SN + K G P D + ++ CW ++ RP F+
Sbjct: 244 MTYGERPYWELSNHEV-----MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFA 298
Query: 236 QIIRMLNAFLFTLRPPSPSVPESDTNEAAATS 267
I+ +L+ +R P +D + +
Sbjct: 299 DIVSILDKL---IRAPDSLKTLADFDPRVSIR 327
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 3e-50
Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 28/246 (11%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
++ R +F++E M + H ++VK +G ++P+ I+ EL LR
Sbjct: 425 TCKNCTSDSVRE----KFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 479
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L + LDL + +A ++ A+ L + +HRD+ N+L++ +KL DFGL
Sbjct: 480 FLQVRKF-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGL 537
Query: 127 AREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN- 183
+R + A G +WMAPE ++ + + DV+ FG+ +WE+L +
Sbjct: 538 SRYMEDSTYYKASKGKLPIKWMAPE-----SINFR---RFTSASDVWMFGVCMWEILMHG 589
Query: 184 RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
PF+G+ N G +P + P L ++ CW DP+ RP F+++
Sbjct: 590 VKPFQGVKNND-----VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644
Query: 240 MLNAFL 245
L+ L
Sbjct: 645 QLSTIL 650
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-50
Identities = 73/260 (28%), Positives = 115/260 (44%), Gaps = 37/260 (14%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
L + ER + E+ ++S + H N+V LGAC P +VI TE L
Sbjct: 61 LKPSAHLTERE----ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI-TEYCCYGDLL 115
Query: 66 KYLVSLRPNKLDLHVA----------------LNFALDIARAMDCLHANGIIHRDLKPDN 109
+L R + + + L+F+ +A+ M L + IHRDL N
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175
Query: 110 LLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNN 166
+LLT + K+ DFGLAR+ + +WMAPE ++ Y
Sbjct: 176 ILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE-----SIFNCV---YTF 226
Query: 167 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 225
+ DV+S+GI LWEL + P+ GM Y + R PE ++ I+++CW
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
Query: 226 EDPNLRPSFSQIIRMLNAFL 245
DP RP+F QI++++ +
Sbjct: 287 ADPLKRPTFKQIVQLIEKQI 306
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-50
Identities = 59/258 (22%), Positives = 116/258 (44%), Gaps = 26/258 (10%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
VL +G+ + +RE +M ++ + +V+ +G C + LM +V E+ G L K
Sbjct: 44 VLKQGTEKADTE----EMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHK 98
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+LV + ++ + ++ M L +HRDL N+LL ++ K++DFGL
Sbjct: 99 FLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGL 156
Query: 127 AREETVTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
++ + TA + +W APE + ++++ DV+S+G+ +WE
Sbjct: 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRK----------FSSRSDVWSYGVTMWEA 206
Query: 181 LTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
L+ + P++ M + A + R P + P+L ++ CW+ RP F + +
Sbjct: 207 LSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265
Query: 240 MLNAFLFTLRPPSPSVPE 257
+ A ++L
Sbjct: 266 RMRACYYSLASKVEGHHH 283
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-50
Identities = 79/270 (29%), Positives = 124/270 (45%), Gaps = 55/270 (20%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELL 59
K MKE ++ D+ F E+ ++ ++ H N++ LGAC + L + E
Sbjct: 58 KRMKE----YASKDDHR----DFAGELEVLCKLGHHPNIINLLGACEHRGYLY-LAIEYA 108
Query: 60 PGMSLRKYLVSLRPNKLDLHVA--------------LNFALDIARAMDCLHANGIIHRDL 105
P +L +L R + D A L+FA D+AR MD L IHRDL
Sbjct: 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 168
Query: 106 KPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGE 160
N+L+ + K+ADFGL+R + E+ +T RWMA E YS
Sbjct: 169 AARNILVGEN-YVAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSV------- 217
Query: 161 KKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPD 215
Y DV+S+G++LWE+++ P+ GM+ + ++ G P + +
Sbjct: 218 ---YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YEKLPQGYRLEKPLNCDDE 269
Query: 216 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ +++ CW E P RPSF+QI+ LN L
Sbjct: 270 VYDLMRQCWREKPYERPSFAQILVSLNRML 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 7e-50
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 48/251 (19%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
F RE+ ++ ++HDN+VK+ G C + L ++ E LP SLR YL + ++D
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDHIK 115
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAE 139
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL + E +
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVK 174
Query: 140 TGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT------------ 182
W APE S ++ DV+SFG+VL+EL T
Sbjct: 175 EPGESPIFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224
Query: 183 ----NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSF 234
M + + P+ ++ I+ CW + N RPSF
Sbjct: 225 MRMIGNDKQGQMIVFH-----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 235 SQIIRMLNAFL 245
+ ++
Sbjct: 280 RDLALRVDQIR 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 9e-50
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 48/251 (19%)
Query: 25 FIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
F RE+ ++ ++HDN+VK+ G C + L ++ E LP SLR YL + ++D
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDHIK 146
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAE 139
L + I + M+ L IHRDL N+L+ ++ +K+ DFGL + E +
Sbjct: 147 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVK 205
Query: 140 TGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT------------ 182
W APE S ++ DV+SFG+VL+EL T
Sbjct: 206 EPGESPIFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 255
Query: 183 ----NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSF 234
M + + P+ ++ I+ CW + N RPSF
Sbjct: 256 MRMIGNDKQGQMIVFH-----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 310
Query: 235 SQIIRMLNAFL 245
+ ++
Sbjct: 311 RDLALRVDQIR 321
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-50
Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 36/259 (13%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD---PLMVIVTELLPGMSL 64
L G+T E + E+ ++ + H N+V LGAC PLMVI E +L
Sbjct: 65 LKEGATHSEHR----ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI-VEFCKFGNL 119
Query: 65 RKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 110
YL S R + L L + ++ +A+ M+ L + IHRDL N+
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 111 LLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNK 167
LL+ +K+ DFGLAR+ + +WMAPE T+ Y +
Sbjct: 180 LLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-----TIFDRV---YTIQ 230
Query: 168 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 226
DV+SFG++LWE+ + P+ G+ + + R P+ +P++ + CW
Sbjct: 231 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 290
Query: 227 DPNLRPSFSQIIRMLNAFL 245
+P+ RP+FS+++ L L
Sbjct: 291 EPSQRPTFSELVEHLGNLL 309
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 70/269 (26%), Positives = 115/269 (42%), Gaps = 51/269 (18%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L +++D +A F RE +M+ + N+VK LG C P+ ++ E + L +
Sbjct: 85 LKEEASADMQA----DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL-FEYMAYGDLNE 139
Query: 67 YLVSLRP----------------------NKLDLHVALNFALDIARAMDCLHANGIIHRD 104
+L S+ P L L A +A M L +HRD
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199
Query: 105 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEK 161
L N L+ + +K+ADFGL+R + A+ RWM PE ++
Sbjct: 200 LATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE-----SIFYNR- 252
Query: 162 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDL 216
Y + DV+++G+VLWE+ + P+ GM++ + + R G PE+ +L
Sbjct: 253 --YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-----IYYVRDGNILACPENCPLEL 305
Query: 217 AFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+++ CW + P RPSF I R+L
Sbjct: 306 YNLMRLCWSKLPADRPSFCSIHRILQRMC 334
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-49
Identities = 57/253 (22%), Positives = 105/253 (41%), Gaps = 34/253 (13%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
+L + + + E N+M ++ + +V+ +G C + M +V E+ L K
Sbjct: 51 ILKNEANDPAL---KDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNK 106
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL + + + ++ M L + +HRDL N+LL Q K++DFGL
Sbjct: 107 YL--QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGL 163
Query: 127 AREETVTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
++ E A+T +W APE Y +++K DV+SFG+++WE
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYK----------FSSKSDVWSFGVLMWEA 213
Query: 181 LTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+ + P+ GM + G P ++ ++ CW D RP F+
Sbjct: 214 FSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFA 268
Query: 236 QIIRMLNAFLFTL 248
+ L + + +
Sbjct: 269 AVELRLRNYYYDV 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-49
Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 21/238 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELLPGM 62
+K ++ +RA R + EV +V +H V+ A ++ ++ + TEL G
Sbjct: 87 VKRSMSPFRGPKDRA----RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141
Query: 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
SL+++ L + D A+ LH+ G++H D+KP N+ L P + KL
Sbjct: 142 SLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLG 199
Query: 123 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
DFGL E + G R+MAPEL L+ Y DV+S G+ + E+
Sbjct: 200 DFGLLVELGTAGAGEVQEGDPRYMAPEL-----LQGS----YGTAADVFSLGLTILEVAC 250
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
N G Q + P +S +L ++ DP LR + ++ +
Sbjct: 251 NMELPHGGEGWQQLRQ---GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-49
Identities = 76/265 (28%), Positives = 113/265 (42%), Gaps = 42/265 (15%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
L + S ER + E+ MM+++ H+N+V LGAC P+ +I E L
Sbjct: 83 LKEKADSSERE----ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI-FEYCCYGDLL 137
Query: 66 KYLVSLRPNKLDLHVA---------------------LNFALDIARAMDCLHANGIIHRD 104
YL S R + + L FA +A+ M+ L +HRD
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197
Query: 105 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEK 161
L N+L+T K +K+ DFGLAR+ +WMAPE +L +G
Sbjct: 198 LAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE-----SLFEGI- 250
Query: 162 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 220
Y K DV+S+GI+LWE+ + P+ G+ Y + P + ++ I+
Sbjct: 251 --YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM 308
Query: 221 QSCWVEDPNLRPSFSQIIRMLNAFL 245
QSCW D RPSF + L L
Sbjct: 309 QSCWAFDSRKRPSFPNLTSFLGCQL 333
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-49
Identities = 71/261 (27%), Positives = 115/261 (44%), Gaps = 43/261 (16%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
L + +DE+ + E+ +MS + +H+N+V LGAC P++VI TE L
Sbjct: 84 LKSTAHADEKE----ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI-TEYCCYGDLL 138
Query: 66 KYLVSLRP------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 113
+L + L+F+ +A+ M L + IHRD+ N+LLT
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 114 PDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDV 170
K+ DFGLAR+ + +WMAPE ++ Y + DV
Sbjct: 199 NG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE-----SIFDCV---YTVQSDV 249
Query: 171 YSFGIVLWELLT-NRLPFEG-MSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCW 224
+S+GI+LWE+ + P+ G + N + +K + G P ++ I+Q+CW
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKF-----YKLVKDGYQMAQPAFAPKNIYSIMQACW 304
Query: 225 VEDPNLRPSFSQIIRMLNAFL 245
+P RP+F QI L
Sbjct: 305 ALEPTHRPTFQQICSFLQEQA 325
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-49
Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 51/266 (19%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSL 64
L S + A +E+ ++ + H+N+VK+ G C + + ++ E LP SL
Sbjct: 58 LKPESGGNHIA----DLKKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSL 112
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
++YL NK++L L +A+ I + MD L + +HRDL N+L+ + +K+ DF
Sbjct: 113 KEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDF 170
Query: 125 GLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
GL + ET E T + W APE + S + DV+SFG+ L
Sbjct: 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK----------FYIASDVWSFGVTLH 220
Query: 179 ELLT---------------NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFI 219
ELLT M+ + + G P + ++ +
Sbjct: 221 ELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL-----VNTLKEGKRLPCPPNCPDEVYQL 275
Query: 220 VQSCWVEDPNLRPSFSQIIRMLNAFL 245
++ CW P+ R SF +I A L
Sbjct: 276 MRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 54/249 (21%), Positives = 110/249 (44%), Gaps = 17/249 (6%)
Query: 24 RFIREVNMMSRVKH--DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV 80
+ E+ +++++ D +++ + +V E + L +L + +D
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWE 128
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMT 137
++ ++ A+ +H +GI+H DLKP N L+ LKL DFG+A +T + +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 138 AETGTYRWMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-L 193
++ GT +M PE S+ K + K DV+S G +L+ + + PF+ + N +
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+A + P+ DL +++ C DP R S +++ + ++ P
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVN 304
Query: 254 SVPESDTNE 262
+ + T E
Sbjct: 305 QMAKGTTEE 313
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 66/286 (23%), Positives = 107/286 (37%), Gaps = 54/286 (18%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMS 63
L +R F RE+ ++ + D +VK+ G + L +V E LP
Sbjct: 59 QLQHSGPDQQRD-----FQREIQILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGC 112
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
LR +L R +LD L ++ I + M+ L + +HRDL N+L+ + +K+AD
Sbjct: 113 LRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIAD 170
Query: 124 FGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
FGLA+ + W APE + ++ + DV+SFG+VL
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI----------FSRQSDVWSFGVVL 220
Query: 178 WELLTN-RLPFEGMSNLQAAYAAAFKHARPGL-----------------PEDISPDLAFI 219
+EL T A + R P ++ +
Sbjct: 221 YELFTYCDKSCSPS----AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHEL 276
Query: 220 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLR----PPSPSVPESDTN 261
++ CW P RPSFS + L+ R + PE +
Sbjct: 277 MKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHH 322
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-48
Identities = 53/249 (21%), Positives = 109/249 (43%), Gaps = 17/249 (6%)
Query: 24 RFIREVNMMSRVKH--DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV 80
+ E+ +++++ D +++ + +V E + L +L + +D
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWE 156
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMT 137
++ ++ A+ +H +GI+H DLKP N L+ LKL DFG+A +T + +
Sbjct: 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 138 AETGTYRWMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-L 193
++ G +M PE S+ K + K DV+S G +L+ + + PF+ + N +
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+A + P+ DL +++ C DP R S +++ + ++ P
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVN 332
Query: 254 SVPESDTNE 262
+ + T E
Sbjct: 333 QMAKGTTEE 341
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-48
Identities = 54/249 (21%), Positives = 110/249 (44%), Gaps = 17/249 (6%)
Query: 24 RFIREVNMMSRVKH--DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV 80
+ E+ +++++ D +++ + +V E + L +L + +D
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWE 109
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMT 137
++ ++ A+ +H +GI+H DLKP N L+ LKL DFG+A +T + +
Sbjct: 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 138 AETGTYRWMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-L 193
++ GT +M PE S+ K + K DV+S G +L+ + + PF+ + N +
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 194 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+A + P+ DL +++ C DP R S +++ + ++ P
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVN 285
Query: 254 SVPESDTNE 262
+ + T E
Sbjct: 286 QMAKGTTEE 294
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-48
Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 46/286 (16%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRK 66
L G T +R F+ E ++M + H N+++ G P+M IVTE + SL
Sbjct: 81 LKVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVTKSKPVM-IVTEYMENGSLDS 135
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L + + + IA M L G +HRDL N+L+ K++DFGL
Sbjct: 136 FLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGL 193
Query: 127 ARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
R E E G RW +PE Y + + + DV+S+GIVLWE+
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY----------RKFTSASDVWSYGIVLWEV 243
Query: 181 LTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFS 235
++ P+ MSN K G P D L ++ CW +D N RP F
Sbjct: 244 MSYGERPYWEMSNQDV-----IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 236 QIIRMLNAFL-----------FTLRPPSPSVPESDTNEAAATSNGA 270
QI+ +L+ + RP + + +S+ + + G
Sbjct: 299 QIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-48
Identities = 64/247 (25%), Positives = 100/247 (40%), Gaps = 25/247 (10%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPG 61
KE+ T E+ +L + EVN++ +KH N+V++ D + IV E G
Sbjct: 36 WKELDYGSMTEAEKQML----VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91
Query: 62 MSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLH-----ANGIIHRDLKPDNLLLTP 114
L + + L L + A+ H + ++HRDLKP N+ L
Sbjct: 92 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151
Query: 115 DQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173
Q ++KL DFGLAR T GT +M+PE + YN K D++S
Sbjct: 152 KQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM--------NRMSYNEKSDIWSL 202
Query: 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
G +L+EL PF + + + +P S +L I+ RPS
Sbjct: 203 GCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 261
Query: 234 FSQIIRM 240
+I+
Sbjct: 262 VEEILEN 268
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-47
Identities = 58/248 (23%), Positives = 94/248 (37%), Gaps = 34/248 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSL-RPNKLDLH 79
+RE ++ ++ H N+VK ++ V++ E P SL L L
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---DQKSLKLADFGLAREETVTEMM 136
L D+ M+ L NGI+HR++KP N++ Q KL DFG ARE E
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ-- 194
+ GT ++ P++Y LR+ +K Y VD++S G+ + T LPF +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 195 ------------AAYAAAFKHARPG-------------LPEDISPDLAFIVQSCWVEDPN 229
+ + + A G L + L ++ + D
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 230 LRPSFSQI 237
F Q
Sbjct: 293 KCWGFDQF 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-47
Identities = 58/256 (22%), Positives = 94/256 (36%), Gaps = 34/256 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSL-RPNKLDLH 79
+RE ++ ++ H N+VK ++ V++ E P SL L L
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFGLAREETVTEMM 136
L D+ M+ L NGI+HR++KP N++ Q KL DFG ARE E
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---- 192
+ GT ++ P++Y LR+ +K Y VD++S G+ + T LPF
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 193 -------LQAAYAAAFKHARPG----------------LPEDISPDLAFIVQSCWVEDPN 229
+ + A + L + L ++ + D
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 230 LRPSFSQIIRMLNAFL 245
F Q + L
Sbjct: 293 KCWGFDQFFAETSDIL 308
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-47
Identities = 61/243 (25%), Positives = 113/243 (46%), Gaps = 20/243 (8%)
Query: 5 MKEV-LNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 62
+K+V + + RA I+E++++ ++ H N++K+ + + + IV EL
Sbjct: 62 LKKVQIFDLMDAKARADC----IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 63 SLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
L + + + K + + + + A++ +H+ ++HRD+KP N+ +T +K
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-VK 176
Query: 121 LADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
L D GL R + T + GT +M+PE + YN K D++S G +L+E
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--------HENGYNFKSDIWSLGCLLYE 228
Query: 180 LLTNRLPFEG-MSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQI 237
+ + PF G NL + + P LP D S +L +V C DP RP + +
Sbjct: 229 MAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
Query: 238 IRM 240
+
Sbjct: 289 YDV 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-47
Identities = 71/269 (26%), Positives = 122/269 (45%), Gaps = 30/269 (11%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRK 66
+ E L RF REV+ S++ H N+V + ++ +V E + G +L +
Sbjct: 43 AIFIPPREKEETLK--RFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE 100
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
Y+ S P L + A+NF I + H I+HRD+KP N+L+ + K+LK+ DFG+
Sbjct: 101 YIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGI 157
Query: 127 AR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
A+ E ++T+ GT ++ +PE Q + + + D+YS GIVL+E+L
Sbjct: 158 AKALSETSLTQTNHV-LGTVQYFSPE--------QAKGEATDECTDIYSIGIVLYEMLVG 208
Query: 184 RLPFEGMSNLQAAYAAAFKHAR---PGLP----EDISPDLAFIVQSCWVEDPNLRP-SFS 235
PF G + + A KH + P + +DI L+ ++ +D R +
Sbjct: 209 EPPFNGETAVSIAI----KHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264
Query: 236 QIIRMLNAFLFTLRPPSPSVPESDTNEAA 264
++ L++ L R A
Sbjct: 265 EMKDDLSSVLHENRANEDVYELDKMKTIA 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-46
Identities = 53/248 (21%), Positives = 93/248 (37%), Gaps = 44/248 (17%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGA--------------CKDPLMVIVTELLPGMSLRKYLV 69
+ EV +++ + H +V++ A K + I E +L +
Sbjct: 48 TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR- 128
S I A+ +H+ GIIHRDLKP N+ + + +K+ DFGLA+
Sbjct: 108 S-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKN 165
Query: 129 --------------EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174
++ +T+ GT ++A E+ HYN K+D+YS G
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD-------GTGHYNEKIDMYSLG 218
Query: 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---PGLPEDISPDLAFIVQSCWVEDPNLR 231
I+ +E++ PF + P ++ I++ DPN R
Sbjct: 219 IIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 232 PSFSQIIR 239
P ++
Sbjct: 276 PGARTLLN 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 59/264 (22%), Positives = 117/264 (44%), Gaps = 27/264 (10%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY 67
VL +G+ + +RE +M ++ + +V+ +G C+ +++V E+ G L K+
Sbjct: 370 VLKQGTEKADTE----EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKF 425
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
LV R ++ + ++ M L +HR+L N+LL ++ K++DFGL+
Sbjct: 426 LVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLS 483
Query: 128 REETVTEMM-TAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
+ + TA + +W APE + ++++ DV+S+G+ +WE L
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRK----------FSSRSDVWSYGVTMWEAL 533
Query: 182 TN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
+ + P++ M + A + R P + P+L ++ CW+ RP F + +
Sbjct: 534 SYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 592
Query: 241 LNAFLFTLRPPSPSVPESDTNEAA 264
+ A + V E A
Sbjct: 593 MRAC---YYSLASKVEGGSALEVA 613
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-46
Identities = 61/272 (22%), Positives = 105/272 (38%), Gaps = 34/272 (12%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-----MVIVTELL 59
+K +L E A RE +M H N+++ + C ++
Sbjct: 59 LKRILCHEQQDREEA------QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 60 PGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 117
+L + L+ L L L I R ++ +HA G HRDLKP N+LL D+
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-DEG 171
Query: 118 SLKLADFGLAREETVT----------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167
L D G + + + A+ T + APEL +++ + +
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL---FSVQSHCV--IDER 226
Query: 168 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVE 226
DV+S G VL+ ++ P++ + + A A + S L ++ S
Sbjct: 227 TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTV 286
Query: 227 DPNLRPSFSQIIRMLNAFLFTLRPPSPSVPES 258
DP+ RP ++ L A L+PP+P +
Sbjct: 287 DPHQRPHIPLLLSQLEA----LQPPAPGQHTT 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-45
Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 2 GKFM--KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTEL 58
+ KE+ + + L E+ + +KH N+V++LG+ + + I E
Sbjct: 47 QVRIAIKEI-PERDSRYSQPL-----HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100
Query: 59 LPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 117
+PG SL L S P K + + I + LH N I+HRD+K DN+L+
Sbjct: 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG 160
Query: 118 SLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
LK++DFG ++ + TGT ++MAPE+ + Y D++S G
Sbjct: 161 VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------DKGPRGYGKAADIWSLGCT 214
Query: 177 LWELLTNRLPFEGMSNLQAAYAAAFK----HARPGLPEDISPDL-AFIVQSCWVEDPNLR 231
+ E+ T + PF L AA FK P +PE +S + AFI++ C+ DP+ R
Sbjct: 215 IIEMATGKPPF---YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK-CFEPDPDKR 270
Query: 232 PSFSQIIRMLNAFLFTLRPPSPSVPE 257
+ ++ + FL + P+
Sbjct: 271 ACANDLLV--DEFLKVSSKKKKTQPK 294
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-45
Identities = 43/257 (16%), Positives = 91/257 (35%), Gaps = 40/257 (15%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGA-CKDPLMVIVTELLPGM 62
+K + S + +REV + + +H ++V++ A +D M+I E G
Sbjct: 41 IKRSKKPLAGSVDEQ----NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 96
Query: 63 SLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-- 118
SL + + + L + R + +H+ ++H D+KP N+ ++
Sbjct: 97 SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 156
Query: 119 ----------------LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 162
K+ D G T E G R++A E+ E
Sbjct: 157 ASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEGDSRFLANEVLQ-------ENY 206
Query: 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQS 222
+ K D+++ + + + + P +P+ +S + +++
Sbjct: 207 THLPKADIFALALTVVCAAGAEPLPRNGD----QWHEIRQGRLPRIPQVLSQEFTELLKV 262
Query: 223 CWVEDPNLRPSFSQIIR 239
DP RPS +++
Sbjct: 263 MIHPDPERRPSAMALVK 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-44
Identities = 70/266 (26%), Positives = 121/266 (45%), Gaps = 32/266 (12%)
Query: 24 RFIREVNMMSRVKHDNLVKFL-----GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 78
RF RE + + H +V PL IV E + G++LR + + P +
Sbjct: 58 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTP 115
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
A+ D +A++ H NGIIHRD+KP N++++ +K+ DFG+AR +
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVT 174
Query: 139 ET----GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
+T GT ++++PE Q + + DVYS G VL+E+LT PF G S +
Sbjct: 175 QTAAVIGTAQYLSPE--------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226
Query: 195 AAYAAAFKHAR------PGLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFT 247
AY +H R E +S DL +V ++P R + +++ L
Sbjct: 227 VAY----QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282
Query: 248 LRPPSPS-VPESDTNEAAATSNGAMT 272
P +P + +++ +++ G ++
Sbjct: 283 EPPEAPKVLTDAERTSLLSSAAGNLS 308
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLH 79
LE + E+ + + +V GA ++ V I ELL G SL + + + L
Sbjct: 93 LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPED 150
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEM 135
AL + ++ LH I+H D+K DN+LL+ D L DFG L + +
Sbjct: 151 RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 136 MTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
+T + GT MAPE V + + + KVD++S ++ +L P+
Sbjct: 211 LTGDYIPGTETHMAPE----VVMGKP----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262
Query: 194 QAAYA-AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
A+ +P +P A +Q ++P R S
Sbjct: 263 PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-42
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 27/228 (11%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVS-LRPNKLDLHVALNFA 85
++ M N V L + + I +L +L+ ++ + V L+
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-------------EETV 132
+ IA A++ LH+ G++HRDLKP N+ T D +K+ DFGL
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 133 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
T + GT +M+PE Q +Y++KVD++S G++L+ELL F
Sbjct: 230 YATHTGQVGTKLYMSPE--------QIHGNNYSHKVDIFSLGLILFELLY---SFSTQME 278
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
P L P +VQ P RP + II
Sbjct: 279 RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 23/229 (10%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFL-------GACKDPLMVIVTELLPGMSLRKYLVSL-R 72
R+ E+ +M ++ H N+V + L ++ E G LRKYL
Sbjct: 55 NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLAREE 130
L DI+ A+ LH N IIHRDLKP+N++L P + K+ D G A+E
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174
Query: 131 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
E+ T GT +++APEL E+K Y VD +SFG + +E +T PF
Sbjct: 175 DQGELCTEFVGTLQYLAPELL--------EQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
Query: 191 SN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ + +D++ + F S + PN
Sbjct: 227 WQPVQWHGKVREKSNEHIVVYDDLTGAVKF---SSVLPTPNHLSGILAG 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLH 79
+E + REV + S ++H N+++ G D V ++ E P ++ + L + +K D
Sbjct: 52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQ 109
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
+ ++A A+ H+ +IHRD+KP+NLLL + LK+ADFG +
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWS---VHAPSSRRT 165
Query: 140 T--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
GT ++ PE+ E + ++ KVD++S G++ +E L + PFE + Q Y
Sbjct: 166 DLCGTLDYLPPEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETY 216
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P+ ++ ++ +P+ RP +++
Sbjct: 217 KRISR-VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 3e-40
Identities = 40/245 (16%), Positives = 91/245 (37%), Gaps = 20/245 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGM-- 62
++ L RG + ++A + RFI +++ + +++ +D ++ L P M
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 63 ---SLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 117
+ + L+S L H L L + R + LH G++H L+P +++L
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 118 SLKLADFGLAREETVTEMMTAETGTYRWMAPEL---YSTVTLRQGEKKHYNNKVDVYSFG 174
+ L F + + + + PEL +T++ + + D ++ G
Sbjct: 245 -VFLTGFEHLVRDG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
+V++ + LP F+ ++I + +++ R
Sbjct: 301 LVIYWIWCADLPITK-DAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 235 SQIIR 239
Q +
Sbjct: 355 LQAME 359
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 17/234 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRK 66
++ + + E+++ + H ++V F G +D V +V EL SL +
Sbjct: 47 IVPKSLLLKPH--QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 104
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ L A + I LH N +IHRDLK NL L + +K+ DFGL
Sbjct: 105 LHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGL 161
Query: 127 A-REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
A + E E GT ++APE+ S KK ++ +VDV+S G +++ LL +
Sbjct: 162 ATKVEYDGERKKVLCGTPNYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
PFE S L+ Y K +P+ I+P A ++Q DP RP+ ++++
Sbjct: 214 PFET-SCLKETYLRI-KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-40
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLH 79
+ R EV + ++KH ++++ +D V +V E+ + +YL + R +
Sbjct: 54 MVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSEN 112
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTA 138
A +F I M LH++GI+HRDL NLLLT ++K+ADFGLA + + E
Sbjct: 113 EARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYT 171
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY- 197
GT +++PE+ + + + + DV+S G + + LL R PF+ ++
Sbjct: 172 LCGTPNYISPEIAT--------RSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLN 222
Query: 198 ---AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A ++ +P +S + ++ +P R S S ++
Sbjct: 223 KVVLADYE-----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 17/234 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRK 66
++ + + E+++ + H ++V F G +D V +V EL SL +
Sbjct: 73 IVPKSLLLKPH--QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 130
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ L A + I LH N +IHRDLK NL L + +K+ DFGL
Sbjct: 131 LHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGL 187
Query: 127 A-REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
A + E E GT ++APE+ S KK ++ +VDV+S G +++ LL +
Sbjct: 188 ATKVEYDGERKKVLCGTPNYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKP 239
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
PFE S L+ Y K +P+ I+P A ++Q DP RP+ ++++
Sbjct: 240 PFET-SCLKETYLRI-KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 34/240 (14%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYL--VSLRPNKLDLHVA 81
F E+ +S +H +LV +G C + M+++ + + +L+++L L +
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAR---EETVTEMMT 137
L + AR + LH IIHRD+K N+LL D+ K+ DFG+++ E T + T
Sbjct: 142 LEICIGAARGLHYLHTRAIIHRDVKSINILL--DENFVPKITDFGISKKGTELDQTHLST 199
Query: 138 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF-----EGMSN 192
GT ++ PE + K DVYSFG+VL+E+L R M N
Sbjct: 200 VVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
Query: 193 LQAAYAAAFKHAR-------PGLPEDISPDLAF----IVQSCWVEDPNLRPSFSQIIRML 241
L A +A + P L + I P+ C RPS ++ L
Sbjct: 252 L-AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 15/220 (6%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLH 79
+E + RE+ + S ++H N+++ D + ++ E P L K L + + D
Sbjct: 57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQ 114
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
+ F ++A A+ H +IHRD+KP+NLL+ + LK+ADFG + T
Sbjct: 115 RSATFMEELADALHYCHERKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM- 172
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
GT ++ PE+ E K ++ KVD++ G++ +E L PF+ + +
Sbjct: 173 CGTLDYLPPEMI--------EGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRR 223
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P +S ++ P R ++
Sbjct: 224 IVN-VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-39
Identities = 65/237 (27%), Positives = 101/237 (42%), Gaps = 30/237 (12%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNK-LDLHVAL 82
F +E+ +M++ +H+NLV+ LG D + +V +P SL L L L H+
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAE 139
A A ++ LH N IHRD+K N+LL + K++DFGLAR + T M +
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTA-KISDFGLARASEKFAQTVMTSRI 195
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAA 196
GT +MAPE G K D+YSFG+VL E++T + L
Sbjct: 196 VGTTAYMAPE-ALR-----G---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LD 245
Query: 197 YAAAFKHARPGLPEDISPDL-----------AFIVQSCWVEDPNLRPSFSQIIRMLN 242
+ + + I + + C E N RP ++ ++L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-39
Identities = 59/296 (19%), Positives = 108/296 (36%), Gaps = 47/296 (15%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP---------LMVI 54
+K +L+ + I+EV M ++ H N+V+F A ++
Sbjct: 58 LKRLLSNEEEKNRAI------IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111
Query: 55 VTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLL 111
+TEL G L ++L + L L RA+ +H IIHRDLK +NLL
Sbjct: 112 LTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170
Query: 112 LTPDQKSLKLADFGLAREETVT-------------EMMTAETGTYRWMAPELYSTVTLRQ 158
L+ +Q ++KL DFG A + E T + PE+ +
Sbjct: 171 LS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS--- 226
Query: 159 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDL 216
K D+++ G +L+ L + PFE + L + + +P
Sbjct: 227 --NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------RIVNGKYSIPPHDTQYTVF 278
Query: 217 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMT 272
++++ +P R S ++++ L S + + ++
Sbjct: 279 HSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLS 334
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-39
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 38/246 (15%)
Query: 24 RFIREVNMMSRVKHDNLVKF--LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
R RE R++ ++V G D + + L+ G+ L L P L A
Sbjct: 80 RMQREARTAGRLQEPHVVPIHDFGE-IDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRA 136
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTA 138
+ I A+D HA G HRD+KP+N+L++ D L DFG+A +E +T++
Sbjct: 137 VAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNT 195
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
GT +MAPE + + H + D+Y+ VL+E LT P++G +
Sbjct: 196 -VGTLYYMAPE--------RFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-----LS 241
Query: 199 AAFKH----------ARPGLPEDISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFT 247
H RPG+P ++ ++P R + + +A L T
Sbjct: 242 VMGAHINQAIPRPSTVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297
Query: 248 LRPPSP 253
Sbjct: 298 ADQDRA 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 54/241 (22%), Positives = 90/241 (37%), Gaps = 35/241 (14%)
Query: 24 RFIREVNMMSRVKHDNLVK------FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD 77
+ E ++ V H ++V+ DP+ IV E + G SL+ + KL
Sbjct: 125 MAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLP 180
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 137
+ A+ + L+I A+ LH+ G+++ DLKP+N++LT +Q LKL D G +
Sbjct: 181 VAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ--LKLIDLGAVSRINSFGYL- 237
Query: 138 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
GT + APE+ T D+Y+ G L L + G
Sbjct: 238 --YGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAALTLDLPTRNG-------- 278
Query: 198 AAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPSV 255
P +++ DP R + ++ L L + V
Sbjct: 279 -RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGV 337
Query: 256 P 256
P
Sbjct: 338 P 338
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-38
Identities = 46/261 (17%), Positives = 96/261 (36%), Gaps = 34/261 (13%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMS 63
++ + F E+ +++ +K++ + G + V I+ E + S
Sbjct: 70 KRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS 129
Query: 64 LRKYLVS------LRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQ 116
+ K+ + + V + + +H I HRD+KP N+L+ +
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN- 188
Query: 117 KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176
+KL+DFG + ++ + GTY +M PE +S E + KVD++S GI
Sbjct: 189 GRVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFS------NESSYNGAKVDIWSLGIC 241
Query: 177 LWELLTNRLPFEGMSNLQAAY------------------AAAFKHARPGLPEDISPDLAF 218
L+ + N +PF +L + +S +
Sbjct: 242 LYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID 301
Query: 219 IVQSCWVEDPNLRPSFSQIIR 239
++ ++P R + ++
Sbjct: 302 FLKLFLRKNPAERITSEDALK 322
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 50/223 (22%), Positives = 89/223 (39%), Gaps = 19/223 (8%)
Query: 27 REVNMMSRV-KHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
REV ++ +H N++++ KD I EL +L++Y+ + +
Sbjct: 66 REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQ-KDFAHLGLEPITL 123
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAR----EETVTEMM 136
+ LH+ I+HRDLKP N+L++ ++DFGL +
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 195
+ GT W+APE+ L + K++ VD++S G V + +++ PF QA
Sbjct: 184 SGVPGTEGWIAPEM-----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238
Query: 196 AYA-AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
A + +++ DP RPS +
Sbjct: 239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 5e-37
Identities = 38/259 (14%), Positives = 85/259 (32%), Gaps = 20/259 (7%)
Query: 11 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP-----GMSLR 65
RG + ++A + RFI +++ + +++ +D ++ L P +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 66 KYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
+ L+S L H L L + R + LH G++H L+P +++L + L
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTG 254
Query: 124 FGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
F + + + A + Q D ++ G+ ++ +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPF---GQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
LP F+ ++I + +++ R Q +
Sbjct: 312 CADLPNTD-DAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET- 364
Query: 242 NAFLFTLRPPSPSVPESDT 260
+ S ++P T
Sbjct: 365 PEYEQLRTELSAALPLYQT 383
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-37
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 20/236 (8%)
Query: 13 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR 72
S A E+ ++ ++ H ++K IV EL+ G L +V
Sbjct: 175 IGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN- 233
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREE 130
+L + + A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++
Sbjct: 234 -KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 131 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
T +M GT ++APE+ L YN VD +S G++L+ L+ PF
Sbjct: 293 GETSLMRTLCGTPTYLAPEV-----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE- 346
Query: 191 SNLQAAYAAAFKHARPGLPE----DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 239
Q + + ++S DL V+ V DP R + + +R
Sbjct: 347 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL---VKKLLVVDPKARFTTEEALR 399
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-36
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL--HV 80
+ E+ ++ + H N++K +D + IV E G L + +VS + L
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTA 138
+ A+ H+ ++H+DLKP+N+L S +K+ DFGLA E T
Sbjct: 126 VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQA 195
GT +MAPE++ K+ K D++S G+V++ LLT LPF G S Q
Sbjct: 186 AAGTALYMAPEVF---------KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 196 AYAAAFKHARPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQI 237
A +A ++P DL ++ +DP RPS +Q+
Sbjct: 237 ATYKEPNYAVE--CRPLTPQAVDL---LKQMLTKDPERRPSAAQV 276
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ + EV ++ + H N++K +D +V E G L ++ K + A
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAA 139
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAET 140
+ + LH + I+HRDLKP+NLLL + ++ + +K+ DFGL+ + M
Sbjct: 140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAY 197
GT ++APE+ +K Y+ K DV+S G++L+ LL PF G ++ L+
Sbjct: 200 GTAYYIAPEVL---------RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ P ++S +++ D R S Q
Sbjct: 251 KGKYTFDSPEWK-NVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 45/242 (18%), Positives = 95/242 (39%), Gaps = 30/242 (12%)
Query: 24 RFIREVNMMSRVK-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLV-----SLRPNKL 76
+ E+ +++ H N++++ + + I EL +L+ +
Sbjct: 54 IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQ 112
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS------------LKLADF 124
+ ++ IA + LH+ IIHRDLKP N+L++ + + ++DF
Sbjct: 113 KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 125 GLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
GL + + + + +GT W APEL Q K+ +D++S G V +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQT-KRRLTRSIDIFSMGCVFYY 231
Query: 180 LLTN-RLPFEGMSNLQAAYAAA---FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235
+L+ + PF + ++ + + + ++ DP RP+
Sbjct: 232 ILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291
Query: 236 QI 237
++
Sbjct: 292 KV 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 18/220 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+REV ++ ++ H N++K +D +V E+ G L ++S + A
Sbjct: 72 SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAA 129
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAET 140
+ + +H N I+HRDLKP+NLLL + + + +++ DFGL+ ++ M +
Sbjct: 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAY 197
GT ++APE+ Y+ K DV+S G++L+ LL+ PF G + L+
Sbjct: 190 GTAYYIAPEVL---------HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ P +S +++ P++R S
Sbjct: 241 KGKYTFELPQWK-KVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+REV ++ ++ H N++K +D IV EL G L ++ + H A
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAA 124
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAET 140
+ + +H + I+HRDLKP+N+LL + ++ +K+ DFGL+ M
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAY 197
GT ++APE+ + Y+ K DV+S G++L+ LL+ PF G + L+
Sbjct: 185 GTAYYIAPEVL---------RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ P IS D +++ P+LR + +Q
Sbjct: 236 TGKYAFDLPQWR-TISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 14/221 (6%)
Query: 25 FIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVAL 82
+I E+ +++ H +VK LGA D + I+ E PG ++ ++ L + +
Sbjct: 63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV 121
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ A++ LH+ IIHRDLK N+L+T + ++LADFG++ + T + ++
Sbjct: 122 -VCRQMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKT-LQKRDSFI 178
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT WMAPE+ V + Y+ K D++S GI L E+ P ++ ++ A
Sbjct: 179 GTPYWMAPEV---VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 235
Query: 201 FKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
K P L P S + ++ ++P RPS +Q++
Sbjct: 236 -KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-35
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 20/236 (8%)
Query: 13 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR 72
S A E+ ++ ++ H ++K IV EL+ G L +V
Sbjct: 50 IGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG-- 107
Query: 73 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREE 130
+L + + A+ LH NGIIHRDLKP+N+LL + ++ +K+ DFG ++
Sbjct: 108 NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 131 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
T +M GT ++APE+ L YN VD +S G++L+ L+ PF
Sbjct: 168 GETSLMRTLCGTPTYLAPEV-----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE- 221
Query: 191 SNLQAAYAAAFKHARPGLPE----DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 239
Q + + ++S DL V+ V DP R + + +R
Sbjct: 222 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL---VKKLLVVDPKARFTTEEALR 274
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-35
Identities = 55/227 (24%), Positives = 106/227 (46%), Gaps = 21/227 (9%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFL----GACKDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+ +E+ ++ ++ H N+VK + +D L +V EL+ + + L
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-MVFELVNQGPVMEVP---TLKPL 134
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
A + D+ + ++ LH IIHRD+KP NLL+ + +K+ADFG++ E ++ +
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDAL 193
Query: 137 TAET-GTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
+ T GT +MAPE S +K ++ +DV++ G+ L+ + + PF +
Sbjct: 194 LSNTVGTPAFMAPESLS------ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIM 246
Query: 195 AAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
++ K P+ DI+ DL ++ ++P R +I
Sbjct: 247 CLHSKI-KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 18/222 (8%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV 80
E++++ + H N++K +D +VTE G L + +++ +K D
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECD 147
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTA 138
A N I + LH + I+HRD+KP+N+LL + +K+ DFGL+ + +
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQA 195
GT ++APE+ KK YN K DV+S G++++ LL PF G ++ ++
Sbjct: 208 RLGTAYYIAPEVL---------KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258
Query: 196 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
+ +IS + +++ D N R + +
Sbjct: 259 VEKGKYYFDFNDWK-NISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 26/224 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
RF +E+ +M + H N+++ +D + +V EL G L + +V A
Sbjct: 52 RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAA 109
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAET 140
D+ A+ H + HRDLKP+N L T S LKL DFGLA +MM +
Sbjct: 110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT +++P++ + Y + D +S G++++ LL PF
Sbjct: 170 GTPYYVSPQVL---------EGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKI 219
Query: 201 FKHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQI 237
+ PE +SP L ++ + P R + Q
Sbjct: 220 -REGTFTFPEKDWLNVSPQAESL---IRRLLTKSPKQRITSLQA 259
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 3e-34
Identities = 30/237 (12%), Positives = 66/237 (27%), Gaps = 23/237 (9%)
Query: 17 ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM---VIVTELLPG--MSLRKYL--V 69
E A R + + ++ + D + +++ L L V
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184
Query: 70 SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129
+ + + R L + G++H PDNL + PD L L D +
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWK 243
Query: 130 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
A + + E + + ++ + G+ ++ + LPF
Sbjct: 244 V--GTRGPASSVPVTYAPRE------FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 190 MSNLQAAYAAAFKHARPGLPE-------DISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
++ PG + + ++ D R + +
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-34
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALN 83
+E+ ++S+ + K+ G+ KD + I+ E L G S L P LD +A
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIAT- 123
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+I + +D LH+ IHRD+K N+LL+ + +KLADFG+A + T T + T G
Sbjct: 124 ILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT-QIKRNTFVG 181
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T WMAPE V + Y++K D++S GI EL P + ++ +
Sbjct: 182 TPFWMAPE----VIKQSA----YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP- 232
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
K+ P L + S L V++C ++P+ RP+
Sbjct: 233 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+REV ++ ++ H N++K +D IV EL G L ++ + H A
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAA 124
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAET 140
+ + +H + I+HRDLKP+N+LL + ++ +K+ DFGL+ M
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT ++APE+ + Y+ K DV+S G++L+ LL+ PF G + +
Sbjct: 185 GTAYYIAPEVL---------RGTYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKR 233
Query: 201 FKHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQI 237
+ + IS DL ++ P+LR + +Q
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDL---IRKMLTFHPSLRITATQC 274
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 124
+ L + L L + ++ +A+ M+ L + IHRDL N+LL+ +K+ DF
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDF 237
Query: 125 GLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
GLAR+ + +WMAPE + Y + DV+SFG++LWE+
Sbjct: 238 GLARDIYKDPDYVRKGDARLPLKWMAPE--------TIFDRVYTIQSDVWSFGVLLWEIF 289
Query: 182 TN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
+ P+ G+ + + R P+ +P++ + CW +P+ RP+FS+++
Sbjct: 290 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
Query: 241 LNAFL 245
L L
Sbjct: 350 LGNLL 354
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 34/114 (29%), Positives = 44/114 (38%), Gaps = 15/114 (13%)
Query: 9 LNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC---KDPLMVIVTELLPGMSL 64
L G+T E + E+ ++ + H N+V LGAC PLMVIV E +L
Sbjct: 60 LKEGATHSEHR----ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNL 114
Query: 65 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 118
YL S R + AR G I DLK +T Q S
Sbjct: 115 STYLRSKRNEFVPYKT------KGARFRQGKDYVGAIPVDLKRRLDSITSSQSS 162
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 12/219 (5%)
Query: 24 RFIREVNM-MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL--VSLRPNKLDLH 79
R + ++++ M V V F GA ++ + I EL+ SL K+ V + +
Sbjct: 51 RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPED 109
Query: 80 VALNFALDIARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
+ A+ I +A++ LH+ +IHRD+KP N+L+ +K+ DFG++
Sbjct: 110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDI 168
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
+ G +MAPE + +K Y+ K D++S GI + EL R P++
Sbjct: 169 DAGCKPYMAPE----RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 224
Query: 199 AAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQ 236
+ P LP D S + C ++ RP++ +
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALN 83
I+E+++M + ++VK+ G+ K+ + IV E S+ ++ LR L +A
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT- 129
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+ ++ LH IHRD+K N+LL + KLADFG+A + T T M T G
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDT-MAKRNTVIG 187
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T WMAPE+ + YN D++S GI E+ + P+ + ++A +
Sbjct: 188 TPFWMAPEVIQ--------EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP- 238
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPS 233
+ P PE S + V+ C V+ P R +
Sbjct: 239 TNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 15/215 (6%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85
REV +M + H N+VK + + ++ E G + YLV+ ++ A +
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKF 120
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 145
I A+ H I+HRDLK +NLLL ++K+ADFG + E TV + A G +
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 146 MAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
APEL+ K Y+ +VDV+S G++L+ L++ LPF+G NL+
Sbjct: 180 AAPELFQ--------GKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR-ERVLRG 229
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ +P +S D +++ V +P R + QI++
Sbjct: 230 KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+E+ +M ++H LV + +D M +V +LL G LR +L + F
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLF 120
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTY 143
++ A+D L IIHRD+KPDN+LL D+ + + DF +A +T GT
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRETQITTMAGTK 178
Query: 144 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAF 201
+MAPE+ + Y+ VD +S G+ +ELL R P+ S + + F
Sbjct: 179 PYMAPEM-----FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-HTF 232
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ P S ++ +++ +P+ R
Sbjct: 233 ETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 67/242 (27%), Positives = 102/242 (42%), Gaps = 34/242 (14%)
Query: 25 FIREVNMMSRVKHDNLVKFLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNK--LDLHVA 81
F EV M+S H NL++ G C P ++V + S+ L ++ LD
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 82 LNFALDIARAMDCLH--AN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMM 136
AL AR + LH + IIHRD+K N+LL + ++ + DFGLA+ + T +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA-VVGDFGLAKLMDYKDTHVT 192
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
TA GT +APE ST G + K DV+ +G++L EL+T + F+
Sbjct: 193 TAVRGTIGHIAPEYLST-----G---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 197 YAAAFKHARP-----GLPEDISPDL------------AFIVQSCWVEDPNLRPSFSQIIR 239
+ L + DL + C P RP S+++R
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 240 ML 241
ML
Sbjct: 305 ML 306
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-33
Identities = 58/252 (23%), Positives = 105/252 (41%), Gaps = 22/252 (8%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKF---LGACKDPLMVIVTELLPG--MSLRKYLVSLRPNK 75
E +E+ ++ R++H N+++ L + M +V E + + +
Sbjct: 49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KR 105
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETV 132
+ A + + ++ LH+ GI+H+D+KP NLLLT +LK++ G+A
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAA 164
Query: 133 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+ G+ + PE+ + G KVD++S G+ L+ + T PFEG N
Sbjct: 165 DDTCRTSQGSPAFQPPEIAN------GLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DN 217
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM--LNAFLFTLRP 250
+ + K +P D P L+ +++ +P R S QI +
Sbjct: 218 IYKLFENIGK-GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEA 276
Query: 251 PSPSVPESDTNE 262
P P P DT +
Sbjct: 277 PVPIPPSPDTKD 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-33
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 11/218 (5%)
Query: 24 RFIREVN-MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
R + +++ ++ +V+ G + + I EL+ + + + +
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERIL 126
Query: 82 LNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 140
+ I +A+ L +G+IHRD+KP N+LL ++ +KL DFG++ +
Sbjct: 127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
G +MAPE + Y+ + DV+S GI L EL T + P++
Sbjct: 186 GCAAYMAPERIDPPDPTKP---DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 201 FKHARPGLPEDI--SPDLAFIVQSCWVEDPNLRPSFSQ 236
+ P LP + S D V+ C +D RP +++
Sbjct: 243 LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 8e-33
Identities = 33/193 (17%), Positives = 68/193 (35%), Gaps = 25/193 (12%)
Query: 27 REVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNK---LDLHVAL 82
+ + + +KF A V+V EL +L + + + + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTP----------DQKSLKLADFGLAREETV 132
+FA+ + ++ +H IIH D+KPDN +L L L D G + + +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 133 ---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ TA+ T + E+ K +N ++D + ++ +L
Sbjct: 236 FPKGTIFTAKCETSGFQCVEML--------SNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 190 MSNLQAAYAAAFK 202
+ F+
Sbjct: 288 NEGGECKPEGLFR 300
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-33
Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 24/223 (10%)
Query: 22 EGRFIREVNMMSRVKHD--NLVKFLGACKDPLM-VIVTEL-LPGMSLRKYLVSLRPNKLD 77
R EV ++ +V +++ L + P V++ E P L ++ L
Sbjct: 90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQ 147
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 137
+A +F + A+ H G++HRD+K +N+L+ ++ LKL DFG T
Sbjct: 148 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD 207
Query: 138 AETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
+ GT + PE Y+ V+S GI+L++++ +PFE +
Sbjct: 208 FD-GTRVYSPPEWIR--------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--- 255
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ + +S + +++ C P+ RP+F +I
Sbjct: 256 -----IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 58/241 (24%), Positives = 107/241 (44%), Gaps = 25/241 (10%)
Query: 3 KFM-KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTEL-L 59
KF+ KE + ++ L G+ E+ ++SRV+H N++K L ++ +V E
Sbjct: 55 KFIKKEKVLEDCWIEDPKL--GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHG 112
Query: 60 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 119
G+ L ++ R +LD +A + A+ L IIHRD+K +N+++ + ++
Sbjct: 113 SGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA-EDFTI 169
Query: 120 KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLW 178
KL DFG A ++ GT + APE+ Y +++++S G+ L+
Sbjct: 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM--------GNPYRGPELEMWSLGVTLY 221
Query: 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
L+ PF L+ AA P +S +L +V P R + +++
Sbjct: 222 TLVFEENPFC---ELEETVEAAIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLV 273
Query: 239 R 239
Sbjct: 274 T 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 57/282 (20%), Positives = 101/282 (35%), Gaps = 60/282 (21%)
Query: 6 KEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSL 64
K + + + D + EV +M ++ H N+ + +D + +V EL G L
Sbjct: 61 KNKIRQINPKDVERI-----KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL 115
Query: 65 RKYLVSLRPNKLDLHV--------------------------------------ALNFAL 86
L + N
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAR-----EETVTEMMTAET 140
I A+ LH GI HRD+KP+N L + ++ +KL DFGL++ MT +
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAY 197
GT ++APE+ L + Y K D +S G++L LL +PF G+++ +
Sbjct: 236 GTPYFVAPEV-----LN-TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289
Query: 198 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P +SP ++ + + + R + ++
Sbjct: 290 NKKLCFENPNYN-VLSPLARDLLSNLLNRNVDERFDAMRALQ 330
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 19/227 (8%)
Query: 25 FIREVNMMSRV-KHDNLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+E+NM+ + H N+ + GA D + +V E S+ + + + N L
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 77 D-LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
+A +I R + LH + +IHRD+K N+LLT + +KL DFG++ + T +
Sbjct: 127 KEEWIAY-ICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRT-V 183
Query: 136 MTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 193
T GT WMAPE+ + + Y+ K D++S GI E+ P M +
Sbjct: 184 GRRNTFIGTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
Query: 194 QAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+A + ++ P L + S ++SC V++ + RP+ Q+++
Sbjct: 241 RALFLIP-RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 18/239 (7%)
Query: 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLH 79
+ G+ RE+ + +H +++K P +V E + G L Y+ +++
Sbjct: 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEM 111
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
A I A+D H + ++HRDLKP+N+LL + K+ADFGL+ + E +
Sbjct: 112 EARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTS 170
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
G+ + APE+ S + Y +VD++S G++L+ LL LPF+ ++ +
Sbjct: 171 CGSPNYAAPEVIS--------GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFK 221
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 257
+PE ++ +A ++ DP R + I F PS PE
Sbjct: 222 KIRG-GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHE---WFKQDLPSYLFPE 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 71/237 (29%), Positives = 112/237 (47%), Gaps = 23/237 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALN 83
I E+ +M K+ N+V +L + + +V E L G SL + +D +A
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAA- 120
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+ +A++ LH+N +IHRD+K DN+LL S+KL DFG + T T G
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE-QSKRSTMVG 178
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T WMAPE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 179 TPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA- 229
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
+ P L PE +S + C D R S ++++ + FL +P S P
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 71/285 (24%), Positives = 122/285 (42%), Gaps = 34/285 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ RE + +++H N+V+ + ++ +V +L+ G L + +V+ A
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADAS 131
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAET 140
+ I ++ H+NGI+HR+LKP+NLLL + + + +KLADFGLA E +E
Sbjct: 132 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 191
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT +++PE+ L+ K Y+ VD+++ G++L+ LL PF Q A
Sbjct: 192 GTPGYLSPEV-----LK---KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQ 241
Query: 201 FKHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
K P ++P L + S +P R + Q L R
Sbjct: 242 IKAGAYDYPSPEWDTVTPEAKSL---IDSMLTVNPKKRITADQA---LKVPWICNRERVA 295
Query: 254 SVPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 298
S + +F+AR + K A L + + NL
Sbjct: 296 SAIHRQDTVD------CLKKFNARRKLKGAILTTMIATRNLSNLG 334
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 31/230 (13%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN- 83
++E+ MS+ H N+V + + + +V +LL G S+ + + L+
Sbjct: 61 LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 84 -----FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTE 134
++ ++ LH NG IHRD+K N+LL + S+++ADFG LA +T
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITR 179
Query: 135 MMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
+T GT WMAPE+ + + Y+ K D++SFGI EL T P+
Sbjct: 180 NKVRKTFVGTPCWMAPEVME-------QVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
Query: 193 LQAAYAAAFKHARPGLPEDI---------SPDLAFIVQSCWVEDPNLRPS 233
++ ++ P L + ++ C +DP RP+
Sbjct: 233 MKVLMLTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 22 EGRFIREVNMMSRV----KHDNLVKFLGACKDPLM-VIVTEL-LPGMSLRKYLVSLRPNK 75
EV ++ +V H +++ L + ++V E LP L Y+
Sbjct: 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--P 135
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
L + F + A+ H+ G++HRD+K +N+L+ + KL DFG
Sbjct: 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195
Query: 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
+ GT + PE S + Y+ V+S GI+L++++ +PFE +
Sbjct: 196 TDFD-GTRVYSPPEWIS--------RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI- 245
Query: 195 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
A P +SPD +++ C P+ RPS +I+
Sbjct: 246 -------LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ RE + +++H N+V+ + ++ +V +L+ G L + +V+ A
Sbjct: 51 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADAS 108
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAET 140
+ I ++ H+NGI+HR+LKP+NLLL + + + +KLADFGLA E +E
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 168
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT +++PE+ L+ K Y+ VD+++ G++L+ LL PF Q A
Sbjct: 169 GTPGYLSPEV-----LK---KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQ 218
Query: 201 FKHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQI 237
K P ++P L + S +P R + Q
Sbjct: 219 IKAGAYDYPSPEWDTVTPEAKSL---IDSMLTVNPKKRITADQA 259
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 64/237 (27%), Positives = 110/237 (46%), Gaps = 23/237 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALN 83
EV +M +H N+V+ + + ++ E L G +L + +L+ +A
Sbjct: 90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIAT- 145
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+ +A+ LHA G+IHRD+K D++LLT +KL+DFG + + + ++ G
Sbjct: 146 VCEAVLQALAYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD-VPKRKSLVG 203
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T WMAPE+ S + Y +VD++S GI++ E++ P+ S +QA
Sbjct: 204 TPYWMAPEVIS--------RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR- 254
Query: 202 KHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
P L +SP L ++ V DP R + +++ + FL P VP
Sbjct: 255 DSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQTGLPECLVP 309
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV 80
+ E+ ++ R+ H N++K + P + +V EL+ G L +V
Sbjct: 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK--GYYSERD 149
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTA 138
A + I A+ LH NGI+HRDLKP+NLL TP + LK+ADFGL++ +M
Sbjct: 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
GT + APE+ LR Y +VD++S GI+ + LL PF Q +
Sbjct: 210 VCGTPGYCAPEI-----LR---GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF- 260
Query: 199 AAFKHARPGLPE----DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 239
+ ++S DL V+ V DP R + Q ++
Sbjct: 261 RRILNCEYYFISPWWDEVSLNAKDL---VRKLIVLDPKKRLTTFQALQ 305
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-31
Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 26/236 (11%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPG 61
K M + ++++ + I+EV + +++H N +++ G ++ +V E G
Sbjct: 85 KKMS--YSGKQSNEKWQDI----IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 138
Query: 62 MSLRKYLVSLRPNKLD-LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
+ L+ + L + +A + + LH++ +IHRD+K N+LL+ + +K
Sbjct: 139 SASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVK 194
Query: 121 LADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
L DFG A + M A + GT WMAPE+ + ++ Y+ KVDV+S GI
Sbjct: 195 LGDFGSA-----SIMAPANSFVGTPYWMAPEV-----ILAMDEGQYDGKVDVWSLGITCI 244
Query: 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPS 233
EL + P M+ + A Y A ++ P L S V SC + P RP+
Sbjct: 245 ELAERKPPLFNMNAMSALYHIA-QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 299
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 14/222 (6%)
Query: 24 RFIREVN-MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLR--KYLVSLRPNKLDLH 79
+ + +++ +M +V+F GA ++ I EL+ + KY+ S+ + +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 80 VALNFALDIARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 138
+ L +A++ L N IIHRD+KP N+LL ++KL DFG++ + + T
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTR 184
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
+ G +MAPE ++ Y+ + DV+S GI L+EL T R P+ +++
Sbjct: 185 DAGCRPYMAPE----RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240
Query: 199 AAFKHARPGLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQ 236
K P L SP V C +D + RP + +
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 67/257 (26%), Positives = 115/257 (44%), Gaps = 21/257 (8%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRK 66
++R + R RE++ + ++H +++K P + +V E G L
Sbjct: 41 FISRQLLKKSD--MHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGG-ELFD 97
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
Y+V + ++ F I A++ H + I+HRDLKP+NLLL D ++K+ADFGL
Sbjct: 98 YIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGL 154
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRL 185
+ T + G+ + APE+ + K Y +VDV+S GIVL+ +L RL
Sbjct: 155 SNIMTDGNFLKTSCGSPNYAAPEVIN--------GKLYAGPEVDVWSCGIVLYVMLVGRL 206
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
PF+ + + +P+ +SP +++ V DP R + +I R
Sbjct: 207 PFDD-EFIPNLFKKV-NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP---W 261
Query: 246 FTLRPPSPSVPESDTNE 262
F + P P +
Sbjct: 262 FNVNLPDYLRPMEEVQG 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 21/238 (8%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRK 66
+++ D +E+ + + H+N+VKF G ++ + + E G L
Sbjct: 39 IVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ + A F + + LH GI HRD+KP+NLLL ++ +LK++DFGL
Sbjct: 95 RIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGL 151
Query: 127 A---REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLT 182
A R ++ GT ++APEL ++ ++ VDV+S GIVL +L
Sbjct: 152 ATVFRYNNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVDVWSCGIVLTAMLA 203
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
LP++ S+ Y+ + P + I ++ VE+P+ R + I +
Sbjct: 204 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-31
Identities = 56/244 (22%), Positives = 95/244 (38%), Gaps = 19/244 (7%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDPLMV-IVTELLP 60
K + +++E L ++EV+++ +V H N+++ + +V +L+
Sbjct: 48 KIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK 107
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
L YL L + + LH I+HRDLKP+N+LL D ++K
Sbjct: 108 KGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIK 164
Query: 121 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
L DFG + + E + GT ++APE+ Y +VD++S G++++ L
Sbjct: 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM--NDNHPGYGKEVDMWSTGVIMYTL 222
Query: 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISP---DLAFIVQSCWVEDPNLRPS 233
L PF Q D S DL V V P R +
Sbjct: 223 LAGSPPFWHRK--QMLMLRMIMSGNYQFGSPEWDDYSDTVKDL---VSRFLVVQPQKRYT 277
Query: 234 FSQI 237
+
Sbjct: 278 AEEA 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 55/305 (18%), Positives = 103/305 (33%), Gaps = 71/305 (23%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALN 83
E+++ H N+V + D + +VT + S + + + + ++ L +A
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY- 132
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA--------REETVTEM 135
+ +A+D +H G +HR +K ++L++ + L+ R+ V +
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
W++PE+ L+Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 192 PKYSVKVLPWLSPEV-----LQQ-NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
Query: 196 --------------------------------------------AYAAAFKHARPGLPED 211
+
Sbjct: 246 LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
Query: 212 ISPDLAFIVQSCWVEDPNLRPS---------FSQIIRMLNAFLFTLRPPSPSVPESDTNE 262
SP V+ C +P+ RPS F QI R + L L P + + ++
Sbjct: 306 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQ 365
Query: 263 AAATS 267
+ S
Sbjct: 366 SQDHS 370
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 39/296 (13%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMS 63
+K V TS E RE ++ +KH ++V+ L M+ +V E + G
Sbjct: 54 VKIVDVAKFTSSPGLSTE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD 112
Query: 64 LRKYLVSLRPNKLDL--HVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-L 119
L +V VA ++ I A+ H N IIHRD+KP +LL + + + +
Sbjct: 113 LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172
Query: 120 KLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178
KL FG+A + + GT +MAPE+ ++ ++ Y VDV+ G++L+
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-----VK---REPYGKPVDVWGCGVILF 224
Query: 179 ELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISP---DLAFIVQSCWVEDPNLRPS 233
LL+ LPF G + +K IS DL V+ + DP R +
Sbjct: 225 ILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS-HISESAKDL---VRRMLMLDPAERIT 280
Query: 234 FSQIIR---MLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAFLR 286
+ + + + + P E + +F+AR + K A L
Sbjct: 281 VYEALNHPWLKERDRYAYKIHLPETVEQ------------LRKFNARRKLKGAVLA 324
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 24/188 (12%)
Query: 20 LLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLRKYLVSL 71
L + RF RE+ +M VKH N+V G KD + + +V E +P ++ +
Sbjct: 73 LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHY 131
Query: 72 RPNKLDL---HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
K + + L + + R++ +H+ GI HRD+KP NLLL P LKL DFG A+
Sbjct: 132 AKLKQTMPMLLIKL-YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 129 EETVTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
E + + YR APEL T +Y +D++S G V+ EL+ +
Sbjct: 191 ILIAGEPNVSYICSRYYR--APELIFGAT-------NYTTNIDIWSTGCVMAELMQGQPL 241
Query: 187 FEGMSNLQ 194
F G S +
Sbjct: 242 FPGESGID 249
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 25/269 (9%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMS 63
+K +++ D +E+ + + H+N+VKF G ++ + + E G
Sbjct: 37 VK-IVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L + + A F + + LH GI HRD+KP+NLLL ++ +LK++D
Sbjct: 92 LFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISD 148
Query: 124 FGLA---REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWE 179
FGLA R ++ GT ++APEL ++ ++ VDV+S GIVL
Sbjct: 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVDVWSCGIVLTA 200
Query: 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQII 238
+L LP++ S+ Y+ + P + I ++ VE+P+ R + I
Sbjct: 201 MLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 239 R---MLNAFLFTLRPPSPSVPESDTNEAA 264
+ + P + + +
Sbjct: 261 KDRWYNKPLKKGAKRPRVTSGGVSESPSG 289
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-30
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+E+ MS ++H LV A +D MV++ E + G L + + NK+ A+
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAV 258
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG 141
+ + + + +H N +H DLKP+N++ T LKL DFGL + + TG
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 318
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T + APE+ E K D++S G++ + LL+ PF G +
Sbjct: 319 TAEFAAPEVA--------EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNV 368
Query: 202 KHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQ 236
K + + IS D ++ + DPN R + Q
Sbjct: 369 KSCDWNMDDSAFSGISEDGKDF---IRKLLLADPNTRMTIHQ 407
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-30
Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 46/270 (17%)
Query: 3 KFMKEVLNRGS-----------TSDERAL----LEGRFIREVNMMSRV-KHDNLVKFLGA 46
+ K+VL G T + AL + +EV+ + ++V L
Sbjct: 31 QLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 47 CKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101
++ I+ E + G L + A DI A+ LH++ I
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIA 150
Query: 102 HRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 159
HRD+KP+NLL + ++ + LKL DFG A+E T + T T ++APE+
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-------- 201
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-------DI 212
+ Y+ D++S G++++ LL PF + QA + R G ++
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 213 SP---DLAFIVQSCWVEDPNLRPSFSQIIR 239
S L ++ DP R + +Q +
Sbjct: 261 SEDAKQL---IRLLLKTDPTERLTITQFMN 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 37/294 (12%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMS 63
K + R S + R + REV+++ +V H N++ ++ +V++ EL+ G
Sbjct: 42 AKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGE 101
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLK 120
L +L L A +F I ++ LH I H DLKP+N++L +K
Sbjct: 102 LFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 121 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
L DFGLA E GT ++APE+ + + + D++S G++ + L
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-----VNY---EPLGLEADMWSIGVITYIL 211
Query: 181 LTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---DLAFIVQSCWVEDPNLRPSF 234
L+ PF G + L A ++ S D ++ V++ R +
Sbjct: 212 LSGASPFLGDTKQETLANITAVSYDFDEEFFS-QTSELAKDF---IRKLLVKETRKRLTI 267
Query: 235 SQIIRMLNAFLFTLRPP---SPSVPESDTNEAAATSNGAMTEFSARARGKFAFL 285
+ LR P ++ + + + R R K +F
Sbjct: 268 QEA----------LRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFS 311
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-30
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 14/189 (7%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMS 63
K + R S + R + REV+++ +V H N++ ++ +V++ EL+ G
Sbjct: 42 AKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE 101
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLK 120
L +L L A +F I ++ LH I H DLKP+N++L +K
Sbjct: 102 LFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 121 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
L DFGLA E GT ++APE+ + + + D++S G++ + L
Sbjct: 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-----VNY---EPLGLEADMWSIGVITYIL 211
Query: 181 LTNRLPFEG 189
L+ PF G
Sbjct: 212 LSGASPFLG 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 14/189 (7%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMS 63
K + R +S R + REVN++ ++H N++ ++ +V++ EL+ G
Sbjct: 35 AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGE 94
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLK 120
L +L L A F I + LH+ I H DLKP+N++L +K
Sbjct: 95 LFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIK 152
Query: 121 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
L DFG+A + GT ++APE+ + + + D++S G++ + L
Sbjct: 153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-----VNY---EPLGLEADMWSIGVITYIL 204
Query: 181 LTNRLPFEG 189
L+ PF G
Sbjct: 205 LSGASPFLG 213
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 55/242 (22%), Positives = 102/242 (42%), Gaps = 24/242 (9%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMS 63
K + R + S R + REV+++ ++H N++ ++ ++++ EL+ G
Sbjct: 41 AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE 100
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLK 120
L +L L A F I + LH+ I H DLKP+N++L + +K
Sbjct: 101 LFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 121 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+ DFGLA + GT ++APE+ + + + D++S G++ + L
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-----VNY---EPLGLEADMWSIGVITYIL 210
Query: 181 LTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---DLAFIVQSCWVEDPNLRPSF 234
L+ PF G + L A ++ + S D ++ V+DP R +
Sbjct: 211 LSGASPFLGDTKQETLANVSAVNYEFEDEYFS-NTSALAKDF---IRRLLVKDPKKRMTI 266
Query: 235 SQ 236
Sbjct: 267 QD 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 21/235 (8%)
Query: 13 STSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVS 70
+ ++ + RE +++ +V H +++ + + + + +V +L+ L YL
Sbjct: 134 LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE 193
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
L + + A+ LHAN I+HRDLKP+N+LL + ++L+DFG +
Sbjct: 194 --KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHL 250
Query: 131 TVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
E + GT ++APE L ++ Y +VD+++ G++L+ LL PF
Sbjct: 251 EPGEKLRELCGTPGYLAPEILKCSMDETH---PGYGKEVDLWACGVILFTLLAGSPPFWH 307
Query: 190 MSNLQAAYAAAFKHARPGLPE----DISP---DLAFIVQSCWVEDPNLRPSFSQI 237
Q + D S DL + DP R + Q
Sbjct: 308 RR--QILMLRMIMEGQYQFSSPEWDDRSSTVKDL---ISRLLQVDPEARLTAEQA 357
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 69/302 (22%), Positives = 123/302 (40%), Gaps = 39/302 (12%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMS 63
+ + ++ + LE RE + +KH N+V+ + + ++ +L+ G
Sbjct: 41 AMIINTKKLSARDHQKLE----REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKL 121
L + +V+ A + I A+ H G++HR+LKP+NLLL + + + +KL
Sbjct: 97 LFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKL 154
Query: 122 ADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
ADFGLA E E + GT +++PE+ LR K Y VD+++ G++L+ L
Sbjct: 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEV-----LR---KDPYGKPVDLWACGVILYIL 206
Query: 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPS 233
L PF Q K P ++P DL + +P+ R +
Sbjct: 207 LVGYPPFWDED--QHRLYQQIKAGAYDFPSPEWDTVTPEAKDL---INKMLTINPSKRIT 261
Query: 234 FSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKR 293
++ L + R S + +F+AR + K A L + +
Sbjct: 262 AAEA---LKHPWISHRSTVASCMHRQETVD------CLKKFNARRKLKGAILTVMLATRN 312
Query: 294 TK 295
Sbjct: 313 FS 314
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 22/263 (8%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPN 74
+ A ++ RE+ ++H N+V+F P + I+ E G L + + +
Sbjct: 54 ERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-- 111
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVT 133
+ A F + + H+ I HRDLK +N LL LK+ DFG ++ +
Sbjct: 112 RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 134 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSN 192
+ GT ++APE+ ++ Y+ DV+S G+ L+ +L PFE
Sbjct: 172 SQPKSTVGTPAYIAPEVLL--------RQEYDGKIADVWSCGVTLYVMLVGAYPFED-PE 222
Query: 193 LQAAYAAAFKHARPG---LPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR---MLNAF 244
Y + +P+D ISP+ ++ +V DP R S +I L
Sbjct: 223 EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282
Query: 245 LFTLRPPSPSVPESDTNEAAATS 267
L S + + E S
Sbjct: 283 PADLMNESNTGSQFQEPEQPMQS 305
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 61/260 (23%), Positives = 112/260 (43%), Gaps = 20/260 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRK 66
+LNR + G+ RE+ + +H +++K P + +V E + G L
Sbjct: 48 ILNRQKIRSLD--VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD 105
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
Y+ +LD + I +D H + ++HRDLKP+N+LL + K+ADFGL
Sbjct: 106 YICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGL 162
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRL 185
+ + E + G+ + APE+ S + Y +VD++S G++L+ LL L
Sbjct: 163 SNMMSDGEFLRTSCGSPNYAAPEVIS--------GRLYAGPEVDIWSSGVILYALLCGTL 214
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR---MLN 242
PF+ ++ + P+ ++P + +++ DP R + I
Sbjct: 215 PFDD-DHVPTLFKKI-CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272
Query: 243 AFLFTLRPPSPSVPESDTNE 262
L P PS + ++
Sbjct: 273 DLPKYLFPEDPSYSSTMIDD 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 21/221 (9%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
E+++M+++ H NL++ A + +V+V E + G L ++ L +
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTI 190
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG 141
F I + +H I+H DLKP+N+L D K +K+ DFGLAR E + G
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYA 198
T ++APE+ + + D++S G++ + LL+ PF G ++ L A
Sbjct: 251 TPEFLAPEV-----VNY---DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
Query: 199 AAFKHARPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQ 236
+ DIS + + +++ + R S S+
Sbjct: 303 CRWDLEDEEFQ-DISEEAKEF---ISKLLIKEKSWRISASE 339
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 49/221 (22%), Positives = 99/221 (44%), Gaps = 21/221 (9%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
E+++M+++ H L+ A +D MV++ E L G L + + K+ +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVI 152
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG 141
N+ + +H + I+H D+KP+N++ T S+K+ DFGLA + E++ T
Sbjct: 153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYA 198
T + APE+ +++ D+++ G++ + LL+ PF G + LQ
Sbjct: 213 TAEFAAPEIV--------DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264
Query: 199 AAFKHARPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQ 236
++ +SP D +++ ++P R +
Sbjct: 265 CDWEFDEDAFS-SVSPEAKDF---IKNLLQKEPRKRLTVHD 301
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 40/228 (17%), Positives = 99/228 (43%), Gaps = 23/228 (10%)
Query: 18 RALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKL 76
+ + +E+++++ +H N++ + + +V++ E + G+ + + + + +L
Sbjct: 41 KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFEL 99
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEM 135
+ +++ + A+ LH++ I H D++P+N++ T ++K+ +FG AR+ +
Sbjct: 100 NEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
+ APE+ + + D++S G +++ LL+ PF +
Sbjct: 160 FRLLFTAPEYYAPEV-----HQH---DVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ 209
Query: 196 AYAAAFKHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQ 236
+A E+ IS D V V++ R + S+
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISIEAMDF---VDRLLVKERKSRMTASE 254
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 61/188 (32%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 20 LLEGRFI-REVNMMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLRKYLVSL 71
L + RF RE+ +M ++ H N+V+ G KD + + +V + +P ++ +
Sbjct: 88 LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHY 146
Query: 72 RPNKLDL---HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128
K L +V L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG A+
Sbjct: 147 SRAKQTLPVIYVKL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
Query: 129 EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
+ E + + YR APEL T Y + +DV+S G VL ELL +
Sbjct: 206 QLVRGEPNVSYICSRYYR--APELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPI 256
Query: 187 FEGMSNLQ 194
F G S +
Sbjct: 257 FPGDSGVD 264
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 38/265 (14%), Positives = 79/265 (29%), Gaps = 50/265 (18%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRK 66
++ + L + +SR+ + + L ++V E + G SL++
Sbjct: 63 FVDPQGVLPDDVL--QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE 120
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+ A+ +A A D H G+ P + ++ D + LA
Sbjct: 121 VADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPAT 175
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
+ + D+ G L+ LL NR P
Sbjct: 176 MPDANP----------------------------------QDDIRGIGASLYALLVNRWP 201
Query: 187 FEGMSNLQAAYAAAFKHARPGLPE------DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
+ +++ A A + E DI ++ + D +R + S ++ +
Sbjct: 202 LPE-AGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA-STLLNL 259
Query: 241 LNAFLFTLRPPSPSVPESDTNEAAA 265
+ P + +AA
Sbjct: 260 MQQATAVADRTEVLGPIDEAPVSAA 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-29
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV 80
+ E+ ++ ++KH+N+V + +V +L+ G L ++
Sbjct: 50 DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKD 107
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTA 138
A + A+ LH NGI+HRDLKP+NLL TP++ S + + DFGL++ E M TA
Sbjct: 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
GT ++APE+ +K Y+ VD +S G++ + LL PF + ++
Sbjct: 168 -CGTPGYVAPEVL--------AQKPYSKAVDCWSIGVITYILLCGYPPFYEET--ESKLF 216
Query: 199 AAFKHARPGLPE----DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 239
K DIS D + +DPN R + + +
Sbjct: 217 EKIKEGYYEFESPFWDDISESAKDF---ICHLLEKDPNERYTCEKALS 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 56/292 (19%), Positives = 106/292 (36%), Gaps = 38/292 (13%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDPL-MVIVTELLPGM 62
K + R D RA + E+ ++ K ++ ++ ++++ E G
Sbjct: 59 AKFLKKRRRGQDCRAEIL----HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LK 120
+ + + + + I + LH N I+H DLKP N+LL + +K
Sbjct: 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 121 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+ DFG++R+ + GT ++APE+ L D+++ GI+ + L
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEI-----LNY---DPITTATDMWNIGIIAYML 226
Query: 181 LTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP---DLAFIVQSCWVEDPNLRPSF 234
LT+ PF G N ++ +S D +QS V++P RP+
Sbjct: 227 LTHTSPFVGEDNQETYLNISQVNVDYSEETFS-SVSQLATDF---IQSLLVKNPEKRPTA 282
Query: 235 SQIIRMLNAFLFTLRPP--SPSVPESDTNEAAATSNGAMTEFSARARGKFAF 284
L E+ + +S+ + S R+
Sbjct: 283 EIC----------LSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTS 324
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 54/286 (18%)
Query: 3 KFMKEVLNRGS-----------TSDERAL-------LEGR--FIREVNMMSRVK-HDNLV 41
+ ++VL G+ TS E A+ R REV M+ + + H N++
Sbjct: 15 QLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 42 KFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100
+ + ++ +V E + G S+ ++ R + A D+A A+D LH GI
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGI 132
Query: 101 IHRDLKPDNLLL-TPDQKS-LKLADFGLAR--------EETVTEMMTAETGTYRWMAPEL 150
HRDLKP+N+L P+Q S +K+ DF L T + G+ +MAPE+
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 151 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGL 208
V E Y+ + D++S G++L+ LL+ PF S+ A + L
Sbjct: 193 ---VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 209 PEDI--------SPDLAFI-------VQSCWVEDPNLRPSFSQIIR 239
E I D A I + V D R S +Q+++
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 16/173 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ M+ ++KH NLV L + + +V E ++ L + H+ +
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDR-YQRGVPEHLVKSI 107
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT- 142
+A++ H + IHRD+KP+N+L+T +KL DFG AR T ++ E T
Sbjct: 108 TWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATR 166
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
YR +PEL + Y VDV++ G V ELL+ + G S++
Sbjct: 167 WYR--SPELL----VGD---TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 17/210 (8%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
RE ++MSR+ H VK +D + L KY+ + D +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFY 135
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET--G 141
+I A++ LH GIIHRDLKP+N+LL + +++ DFG A+ ++ A + G
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T ++++PEL +K D+++ G ++++L+ PF N +
Sbjct: 195 TAQYVSPELL--------TEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIF-QKI 244
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
PE P +V+ V D R
Sbjct: 245 IKLEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 55/256 (21%), Positives = 97/256 (37%), Gaps = 58/256 (22%)
Query: 26 IREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE+ ++ +V F GA D + I E + G SL + L + ++ +
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKV 136
Query: 85 ALDIARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 143
++ + + + L I+HRD+KP N+L+ + +KL DFG++ + + M + GT
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTR 194
Query: 144 RWMAPELYSTVTLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 202
+M+PE R QG HY+ + D++S G+ L E+ R P + +
Sbjct: 195 SYMSPE-------RLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
Query: 203 HAR-----------------------------------------PGLPEDI-SPDLAFIV 220
P LP + S + V
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
Query: 221 QSCWVEDPNLRPSFSQ 236
C +++P R Q
Sbjct: 306 NKCLIKNPAERADLKQ 321
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 41/177 (23%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 24 RFIREVNMMSRVK-HDNLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLH 79
+ RE+ ++ ++ N++ KDP+ +V E + ++ +L D
Sbjct: 76 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DYD 131
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
+ + +I +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA +
Sbjct: 132 IRF-YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 140 TGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 194
+ R+ PEL + Y+ +D++S G +L ++ + P F G N
Sbjct: 191 VAS-RYFKGPELLVDY-------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 70/314 (22%), Positives = 121/314 (38%), Gaps = 50/314 (15%)
Query: 5 MKEVLNRGS-----------TSDERAL-------LEGRFIREVNMMSR-VKHDNLVKFLG 45
+KE + GS T+ E A+ + E+ ++ R +H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT--EEIEILLRYGQHPNIITLKD 83
Query: 46 ACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104
D V +VTEL+ G L ++ + A I + ++ LHA G++HRD
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 105 LKPDNLLLT---PDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGE 160
LKP N+L + +S+++ DFG A++ ++ T ++APE V RQG
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE----VLERQG- 196
Query: 161 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPED----ISP- 214
Y+ D++S G++L+ +LT PF + A + L +S
Sbjct: 197 ---YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 215 --DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMT 272
DL V DP+ R + + + L P + +
Sbjct: 254 AKDL---VSKMLHVDPHQRLTAALV---LRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAA 307
Query: 273 EFSARARGKFAFLR 286
+SA R + L
Sbjct: 308 TYSALNRNQSPVLE 321
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 61/269 (22%), Positives = 105/269 (39%), Gaps = 43/269 (15%)
Query: 3 KFMKEVLNRGS-----------TSDERAL--LE--GRFIREVNMMSRV-KHDNLVKFLGA 46
K +VL G T ++ AL L+ + REV + R + ++V+ +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 47 CKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101
++ IV E L G L + A I A+ LH+ I
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 183
Query: 102 HRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 159
HRD+KP+NLL + + LKL DFG A+E T +T T ++APE V +
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE----VLGPEK 239
Query: 160 EKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPED----IS 213
Y+ D++S G++++ LL PF + + + P +S
Sbjct: 240 ----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295
Query: 214 P---DLAFIVQSCWVEDPNLRPSFSQIIR 239
L +++ +P R + ++ +
Sbjct: 296 EEVKML---IRNLLKTEPTQRMTITEFMN 321
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 45/185 (24%), Positives = 84/185 (45%), Gaps = 26/185 (14%)
Query: 24 RFIREVNMMSRVKHDNLVKFL--------GACKDPLMVIVTELLPGMSLRKYLVSLRPNK 75
R ++ + ++ + H N+V+ +D + +V E +P +L + + +
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQ 123
Query: 76 LDL---HVALNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 130
+ + + F + R++ CLH + HRD+KP N+L+ +LKL DFG A++
Sbjct: 124 VAPPPILIKV-FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 131 TVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188
+ +E A + YR APEL HY VD++S G + E++ F
Sbjct: 183 SPSEPNVAYICSRYYR--APELIFGNQ-------HYTTAVDIWSVGCIFAEMMLGEPIFR 233
Query: 189 GMSNL 193
G ++
Sbjct: 234 GDNSA 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 16/173 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ ++ +++H+NLV L CK +V E + ++ L L PN LD V +
Sbjct: 72 MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDL-ELFPNGLDYQVVQKY 129
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT- 142
I + H++ IIHRD+KP+N+L++ +KL DFG AR E+ E T
Sbjct: 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATR 188
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
YR APEL G+ Y VDV++ G ++ E+ F G S++
Sbjct: 189 WYR--APELLV------GD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 145
I A++ LH GII+RD+K +N+LL + + L DFGL++E E A GT +
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK--- 202
MAP++ +G ++ VD +S G++++ELLT PF + + A +
Sbjct: 227 MAPDIV------RGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRIL 279
Query: 203 HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ P P+++S ++Q ++DP R
Sbjct: 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKLD 77
R +RE+ +++ H N++ +VTEL+ L + + R
Sbjct: 75 RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISP 133
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 137
H+ F I + LH G++HRDL P N+LL + + + DF LARE+T T
Sbjct: 134 QHIQY-FMYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKT 191
Query: 138 AETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
YR APEL + K + VD++S G V+ E+ + F G +
Sbjct: 192 HYVTHRWYR--APELV-------MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 17/174 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ ++ +KH N+V+ D + +V E L+KY S LD + +F
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS-CNGDLDPEIVKSF 106
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT- 142
+ + + H+ ++HRDLKP NLL+ LKLA+FGLAR + +AE T
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 194
YR P++ L K Y+ +D++S G + EL P F G
Sbjct: 166 WYR--PPDV-----LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 62/269 (23%), Positives = 105/269 (39%), Gaps = 47/269 (17%)
Query: 5 MKEVLNRGS-----------TSDERAL------LEGRFIREVNMMSRVK-HDNLVKFLGA 46
+ L GS ++ A+ +E +E+ + + H N+VK
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 47 CKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 105
D L +V ELL G L + + + A + A+ +H G++HRDL
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 106 KPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 162
KP+NLL + +K+ DFG AR + + T + APEL L +
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL-----LN---QN 184
Query: 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-----AFKHARPGLPED----IS 213
Y+ D++S G++L+ +L+ ++PF+ +A K + +S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 214 P---DLAFIVQSCWVEDPNLRPSFSQIIR 239
DL +Q DPN R S +
Sbjct: 245 QEAKDL---IQGLLTVDPNKRLKMSGLRY 270
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 5e-26
Identities = 55/173 (31%), Positives = 84/173 (48%), Gaps = 16/173 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ +KH N+VK +V+V E L L+K L L+ A +F
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV-CEGGLESVTAKSF 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT- 142
L + + H ++HRDLKP NLL+ + LK+ADFGLAR + T E T
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
YR AP++ L K Y+ +D++S G + E++ F G+S
Sbjct: 165 WYR--APDV-----LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F E +++ + A +D + +V + G L L+S ++L +A
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMAR 178
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET- 140
+ ++ A+D +H +HRD+KPDN+L+ D ++LADFG + + +
Sbjct: 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 141 -GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
GT +++PE+ + +G K Y + D +S G+ ++E+L PF +L Y
Sbjct: 237 VGTPDYISPEI---LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGK 292
Query: 200 AFKH----ARPGLPEDISPD 215
H P D+S +
Sbjct: 293 IMNHKERFQFPTQVTDVSEN 312
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 16/173 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IRE++++ + H N+V + + + +V E + L+K L L +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE-NKTGLQDSQIKIY 124
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT- 142
+ R + H + I+HRDLKP NLL+ +LKLADFGLAR + T E T
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
YR AP++ L G K Y+ VD++S G + E++T + F G+++
Sbjct: 184 WYR--APDV-----L-MGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 33/185 (17%)
Query: 26 IREVN---MMSRVKHDNLVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
IREV + +H N+V+ ++ + +V E + L YL + +
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGV 117
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
+ + R +D LH++ ++HRDLKP N+L+T +KLADFGLAR + +
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 137 TAETGT--YRWMAPEL-----YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
T+ T YR APE+ Y+T VD++S G + E+ + F G
Sbjct: 177 TSVVVTLWYR--APEVLLQSSYAT-------------PVDLWSVGCIFAEMFRRKPLFRG 221
Query: 190 MSNLQ 194
S++
Sbjct: 222 SSDVD 226
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E M+S V H +++ G +D + ++ + + G L L + + VA +A
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAA 113
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYR 144
++ A++ LH+ II+RDLKP+N+LL + +K+ DFG A+ T GT
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD----VTYTLCGTPD 168
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 204
++APE V + YN +D +SFGI+++E+L PF SN Y +A
Sbjct: 169 YIAPE----VVSTKP----YNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTY-EKILNA 218
Query: 205 RPGLPEDISPDLAFIVQSCWVEDPNLR 231
P + D+ ++ D + R
Sbjct: 219 ELRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPG---MSLRKYLVSLRPNKLDLH 79
F E ++M+ +V+ A +D + +V E +PG ++L + +
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL------MSNYDVPEK 168
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTA 138
A + ++ A+D +H+ G IHRD+KPDN+LL D+ LKLADFG + M+
Sbjct: 169 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRC 226
Query: 139 ET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
+T GT +++PE V QG +Y + D +S G+ L+E+L PF +L
Sbjct: 227 DTAVGTPDYISPE----VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGT 281
Query: 197 Y 197
Y
Sbjct: 282 Y 282
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 51/146 (34%), Positives = 85/146 (58%), Gaps = 14/146 (9%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 145
+A A+D LH+ GII+RDLKP+N+LL + +KL DFGL++E + A + GT +
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKES-IDHEKKAYSFCGTVEY 192
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
MAPE V R+G + D +SFG++++E+LT LPF+G + + A+
Sbjct: 193 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETM-TMILKAK 242
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
G+P+ +SP+ +++ + +P R
Sbjct: 243 LGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 56/180 (31%), Positives = 83/180 (46%), Gaps = 23/180 (12%)
Query: 26 IREVN---MMSRVKHDNLVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKL 76
+REV + +H N+V+ + ++ + +V E + LR YL P L
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGL 117
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
+ R +D LHAN I+HRDLKP+N+L+T ++KLADFGLAR + +
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 176
Query: 137 TAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
T T YR APE+ L Y VD++S G + E+ + F G S
Sbjct: 177 TPVVVTLWYR--APEVL----L--QST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86
E ++ V LVK + KD + +V E + G + +L R + A +A
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAA 148
Query: 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRW 145
I + LH+ +I+RDLKP+NLL+ DQ+ +++ DFG A+ V GT
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKR--VKGRTWTLCGTPEA 204
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
+APE + L +G YN VD ++ G++++E+ PF Y +
Sbjct: 205 LAPE----IILSKG----YNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIY-EKIVSGK 254
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
P S DL ++++ D R
Sbjct: 255 VRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 55/177 (31%), Positives = 95/177 (53%), Gaps = 19/177 (10%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL----VSLRPNKLDLHV 80
IRE+++M +KH+N+V+ + + +V E + L+KY+ V P L+L++
Sbjct: 51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNL 109
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE 139
F + + + H N I+HRDLKP NLL+ + LKL DFGLAR + ++E
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 140 TGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
T YR AP++ + G + Y+ +D++S G +L E++T + F G ++ +
Sbjct: 169 VVTLWYR--APDVL----M--GS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 16/146 (10%)
Query: 54 IVTELLPGMSLRKYLVSLRPNKLDL---HVALNFALDIARAMDCLHANGIIHRDLKPDNL 110
++ E +P +L K L S + + +++ + + RA+ +H+ GI HRD+KP NL
Sbjct: 115 VIMEYVP-DTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 111 LLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKV 168
L+ +LKL DFG A++ +E A + YR APEL T Y +
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGAT-------EYTPSI 223
Query: 169 DVYSFGIVLWELLTNRLPFEGMSNLQ 194
D++S G V EL+ + F G +++
Sbjct: 224 DLWSIGCVFGELILGKPLFSGETSID 249
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F E +++ + + A +D + +V E G L L+S ++ +A
Sbjct: 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMAR 165
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ +I A+D +H G +HRD+KPDN+LL ++LADFG + + +
Sbjct: 166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAV 224
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT +++PE+ V G Y + D ++ G+ +E+ + PF + Y
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGS-YGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKI 282
Query: 201 FKHAR----PGLPEDISPD 215
+ P + E + +
Sbjct: 283 VHYKEHLSLPLVDEGVPEE 301
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 14/146 (9%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 145
I+ A+ LH GII+RDLKP+N++L +KL DFGL +E + + T GT +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKES-IHDGTVTHTFCGTIEY 187
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
MAPE + +R G +N VD +S G +++++LT PF G N + +
Sbjct: 188 MAPE----ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTI-DKILKCK 237
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
LP ++ + +++ + R
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-24
Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 16/173 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
IREV+++ +KH N+V + + +V E L L++YL N +++H F
Sbjct: 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD-CGNIINMHNVKLF 105
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT- 142
+ R + H ++HRDLKP NLL+ ++ LKLADFGLAR +++ T+ E T
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTL 164
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
YR P++ L Y+ ++D++ G + +E+ T R F G + +
Sbjct: 165 WYR--PPDI-----LLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 14/146 (9%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 145
IA A+ LH+ I++RDLKP+N+LL + L DFGL +E + T T GT +
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEY 205
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
+APE V +Q Y+ VD + G VL+E+L PF N Y +
Sbjct: 206 LAPE----VLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMY-DNILNKP 255
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
L +I+ +++ +D R
Sbjct: 256 LQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 28/189 (14%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK-YLVS----------LR 72
+RE+ ++ R+ HDN+VK + ++ L Y+V L
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 73 PNKL-DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--- 128
L + H L F + R + +H+ ++HRDLKP NL + + LK+ DFGLAR
Sbjct: 114 QGPLLEEHARL-FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 129 -EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
+ ++ T YR +P L +Y +D+++ G + E+LT +
Sbjct: 173 PHYSHKGHLSEGLVTKWYR--SPRLL-------LSPNNYTKAIDMWAAGCIFAEMLTGKT 223
Query: 186 PFEGMSNLQ 194
F G L+
Sbjct: 224 LFAGAHELE 232
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 145
I+ A++ LH GII+RDLK DN+LL + +KL D+G+ +E + T T GT +
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNY 176
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------- 198
+APE + + Y VD ++ G++++E++ R PF+ + +
Sbjct: 177 IAPE----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ +P +S A +++S +DP R
Sbjct: 229 QVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
IREV+++ ++H N+++ L ++ E L+KY+ + + V +
Sbjct: 81 IREVSLLKELQHRNIIELKSVIHHNHRLH-LIFEYAE-NDLKKYMDKNPD--VSMRVIKS 136
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAREETV-TEMMTA 138
F + ++ H+ +HRDLKP NLLL+ S LK+ DFGLAR + T
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 139 ETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
E T YR PE+ L G +HY+ VD++S + E+L F G S +
Sbjct: 197 EIITLWYR--PPEIL----L--GS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 14/146 (9%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 145
I A+ LH GII+RDLK DN+LL + KLADFG+ +E + +T T GT +
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEG-ICNGVTTATFCGTPDY 190
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 205
+APE + Y VD ++ G++L+E+L PFE N + A +
Sbjct: 191 IAPE----ILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLF-EAILNDE 240
Query: 206 PGLPEDISPDLAFIVQSCWVEDPNLR 231
P + D I++S ++P +R
Sbjct: 241 VVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 145
I+ A++ LH GII+RDLK DN+LL + +KL D+G+ +E + T T GT +
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNY 219
Query: 146 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------- 198
+APE + + Y VD ++ G++++E++ R PF+ + +
Sbjct: 220 IAPE----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ +P +S A +++S +DP R
Sbjct: 272 QVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-24
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +E +++ T +T G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCG 167
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T ++APE V Y VD + G+V++E++ RLPF + + +
Sbjct: 168 TPEYLAPE----VLEDND----YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLF-ELI 217
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
P +SP+ ++ +DP R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-24
Identities = 61/180 (33%), Positives = 86/180 (47%), Gaps = 25/180 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL 76
R RE+ ++ +KH+N++ L + +VT L+ G L + KL
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKL 129
Query: 77 -DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
D HV I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR +
Sbjct: 130 TDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADE 185
Query: 136 MTAETGTYRW-MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
MT T RW APE+ HYN VD++S G ++ ELLT R F G ++
Sbjct: 186 MTGYVAT-RWYRAPEIMLNW-------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-24
Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 16/179 (8%)
Query: 55 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114
V E L G L ++ +K DL A +A +I + LH+ GI++RDLK DN+LL
Sbjct: 96 VMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 153
Query: 115 DQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172
D +K+ADFG+ +E + T GT ++APE+ + YN+ VD +S
Sbjct: 154 D-GHIKIADFGMCKEN-MLGDAKTNTFCGTPDYIAPEIL--------LGQKYNHSVDWWS 203
Query: 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
FG++L+E+L + PF G + + + + + P P + + ++ +V +P R
Sbjct: 204 FGVLLYEMLIGQSPFHG-QDEEELF-HSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 26 IREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
+RE+ ++ + H N++ L A + +V + + L + L +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKD-NSLVLTPSHIKAY 117
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT- 142
L + ++ LH + I+HRDLKP+NLLL + LKLADFGLA+ T + T
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTR 176
Query: 143 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
YR APEL L + Y VD+++ G +L ELL G S+L
Sbjct: 177 WYR--APEL-----LFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 45/150 (30%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 141
+A +IA + L + GII+RDLK DN++L + +K+ADFG+ +E + + +T +T G
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCG 183
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T ++APE + Q Y VD ++FG++L+E+L + PFEG + + +
Sbjct: 184 TPDYIAPE----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELF-QSI 233
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
P+ +S + I + + P R
Sbjct: 234 MEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 14/162 (8%)
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 131
+ + A+ +A +IA + L + GII+RDLK DN++L + +K+ADFG+ +E
Sbjct: 435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN- 492
Query: 132 VTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 189
+ + +T +T GT ++APE + Q Y VD ++FG++L+E+L + PFEG
Sbjct: 493 IWDGVTTKTFCGTPDYIAPE----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG 544
Query: 190 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ + + P+ +S + I + + P R
Sbjct: 545 -EDEDELF-QSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL 76
R RE+ ++ ++H+N++ L + +V + L+K +
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM---GLKFS 124
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
+ + + + + +H+ G++HRDLKP NL + D + LK+ DFGLAR M
Sbjct: 125 EEKIQY-LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEM 180
Query: 137 TAETGTYRW-MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
T T RW APE+ HYN VD++S G ++ E+LT + F+G L
Sbjct: 181 TGYVVT-RWYRAPEVI-------LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 28 EVNMMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 84
E ++ +V +V L KD L +V L+ G L+ ++ + A+ +
Sbjct: 234 EKQILEKVNSRFVVS-LAYAYETKDAL-CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 144
A +I ++ LH I++RDLKP+N+LL D ++++D GLA + + GT
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILL-DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-- 202
+MAPE+ + + Y D ++ G +L+E++ + PF+ + +
Sbjct: 351 YMAPEVV--------KNERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLV 401
Query: 203 -HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
E SP + +DP R
Sbjct: 402 KEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 52/186 (27%), Positives = 77/186 (41%), Gaps = 43/186 (23%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL 76
R RE+ +M V H N++ L + IV EL+
Sbjct: 70 RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA--------------- 114
Query: 77 DLHVALNFALD----------IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L + LD + + LH+ GIIHRDLKP N+++ D LK+ DFGL
Sbjct: 115 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGL 173
Query: 127 AREETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
AR + MMT T R+ APE+ Y VD++S G ++ E++ +
Sbjct: 174 ARTAGTSFMMTPYVVT-RYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGV 224
Query: 186 PFEGMS 191
F G
Sbjct: 225 LFPGTD 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL 76
R RE+ ++ ++H+N++ L + +V + G L K + + KL
Sbjct: 70 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKL 125
Query: 77 -DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
+ + + + + +HA GIIHRDLKP NL + D + LK+ DFGLAR
Sbjct: 126 GEDRIQF-LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--QADSE 181
Query: 136 MTAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
MT T RW APE+ Y VD++S G ++ E++T + F+G +L
Sbjct: 182 MTGYVVT-RWYRAPEVI-------LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-23
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 25/177 (14%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL 76
R RE+ +M V H N++ L + +V EL+ +L + + +
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI---QMELD 162
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
++ + + LH+ GIIHRDLKP N+++ D LK+ DFGLAR + MM
Sbjct: 163 HERMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMM 220
Query: 137 TAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
T T YR APE+ Y VD++S G ++ E++ +++ F G
Sbjct: 221 TPYVVTRYYR--APEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-23
Identities = 58/184 (31%), Positives = 88/184 (47%), Gaps = 28/184 (15%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL- 76
R +RE+ ++ R +H+N++ + P + IV +L+ L K L + L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT---QHLS 126
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETV 132
+ H+ F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR +
Sbjct: 127 NDHICY-FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDH 184
Query: 133 TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
T +T T YR APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 185 TGFLTEYVATRWYR--APEIM-------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235
Query: 191 SNLQ 194
L
Sbjct: 236 HYLD 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-23
Identities = 46/230 (20%), Positives = 81/230 (35%), Gaps = 49/230 (21%)
Query: 27 REVNMMSRV-KHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHV 80
REV + R + ++V+ + ++ IV E L G L +
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTA 138
A I A+ LH+ I HRD+KP+NLL + + LKL DFG A
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------- 167
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAA 196
E + Y+ D++S G++++ LL PF +
Sbjct: 168 ---------KET---------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 209
Query: 197 YAAAFKHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIR 239
+ + P +S L +++ +P R + ++ +
Sbjct: 210 MKTRIRMGQYEFPNPEWSEVSEEVKML---IRNLLKTEPTQRMTITEFMN 256
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 54/188 (28%), Positives = 78/188 (41%), Gaps = 35/188 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL- 76
R +RE+ ++ KH+N++ + I+ EL+ L + + L
Sbjct: 55 RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLS 110
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-------- 128
D H+ F RA+ LH + +IHRDLKP NLL+ + LK+ DFGLAR
Sbjct: 111 DDHIQY-FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAAD 168
Query: 129 ---EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
M T YR APE+ Y+ +DV+S G +L EL
Sbjct: 169 NSEPTGQQSGMVEFVATRWYR--APEVM-------LTSAKYSRAMDVWSCGCILAELFLR 219
Query: 184 RLPFEGMS 191
R F G
Sbjct: 220 RPIFPGRD 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 28 EVNMMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVAL 82
E ++++V +V L K L +V ++ G +R ++ ++ A+
Sbjct: 235 EKKILAKVHSRFIVS-LAYAFETKTDL-CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ I ++ LH II+RDLKP+N+LL D +++++D GLA E +
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLD-DDGNVRISDLGLAVEL-KAGQTKTKGYA 350
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT +MAPEL + Y+ VD ++ G+ L+E++ R PF +
Sbjct: 351 GTPGFMAPELL--------LGEEYDFSVDYFALGVTLYEMIAARGPFRA-RGEKVENKEL 401
Query: 201 FK---HARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+ P+ SP ++ +DP R
Sbjct: 402 KQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 84 FALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 140
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +E + + T +T
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEG-IKDGATMKTFC 310
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
GT ++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 311 GTPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLF-EL 360
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
P + P+ ++ +DP R
Sbjct: 361 ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 38/190 (20%)
Query: 26 IREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK--YLV------------SL 71
+RE+ ++ +KH+N+V + + T+ P + YLV S
Sbjct: 64 LREIKILQLLKHENVVNLIE-------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116
Query: 72 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-- 129
K L + + +H N I+HRD+K N+L+T LKLADFGLAR
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFS 175
Query: 130 ---ETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184
+ T T YR PEL L GE + Y +D++ G ++ E+ T
Sbjct: 176 LAKNSQPNRYTNRVVTLWYR--PPELL----L--GE-RDYGPPIDLWGAGCIMAEMWTRS 226
Query: 185 LPFEGMSNLQ 194
+G +
Sbjct: 227 PIMQGNTEQH 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 7e-21
Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 14/179 (7%)
Query: 55 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114
+ +L+ G L +L +A +I ++ +H +++RDLKP N+LL
Sbjct: 270 ILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD- 326
Query: 115 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174
+ ++++D GLA + + + + GT+ +MAPE+ + Y++ D +S G
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ-------KGVAYDSSADWFSLG 378
Query: 175 IVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 231
+L++LL PF + LP+ SP+L +++ D N R
Sbjct: 379 CMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 31/186 (16%)
Query: 26 IREVNMMSRVKHDNLVK----FLGACKDPLMVIVTELLPGMSLRKYLVSLR-------PN 74
RE+ ++ +KH N++ FL + ++ + L + R P
Sbjct: 66 CREIALLRELKHPNVISLQKVFLSHADRKVW-LLFDYAE-HDLWHIIKFHRASKANKKPV 123
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS---LKLADFGLAREET 131
+L + + I + LHAN ++HRDLKP N+L+ + +K+AD G AR
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 132 V-TEMMTAETGT-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
+ + YR APEL L G +HY +D+++ G + ELLT+
Sbjct: 184 SPLKPLADLDPVVVTFWYR--APELL----L--GA-RHYTKAIDIWAIGCIFAELLTSEP 234
Query: 186 PFEGMS 191
F
Sbjct: 235 IFHCRQ 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-20
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 46/195 (23%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL- 76
R +RE+ +++R+K D +++ ++ IV E+ L+K + P L
Sbjct: 71 RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKT--PIFLT 127
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-------- 128
+ H+ ++ + +H +GIIHRDLKP N LL D +K+ DFGLAR
Sbjct: 128 EEHIKT-ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDT 185
Query: 129 ---------------EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVY 171
+ + + +T+ T YR APEL +++Y +D++
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILL-------QENYTKSIDIW 236
Query: 172 SFGIVLWELLTNRLP 186
S G + ELL
Sbjct: 237 STGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 9e-20
Identities = 66/278 (23%), Positives = 107/278 (38%), Gaps = 65/278 (23%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL- 76
R +RE+ +++R+ HD++VK L + +V E+ +K + P L
Sbjct: 98 RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLT 154
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-------- 128
+LH+ ++ + +H+ GI+HRDLKP N L+ D S+K+ DFGLAR
Sbjct: 155 ELHIKT-LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENG 212
Query: 129 --------------------EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNN 166
+ + +T T YR APEL L Q ++Y
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APEL----ILLQ---ENYTE 263
Query: 167 KVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 226
+DV+S G + ELL + P P L+ ++
Sbjct: 264 AIDVWSIGCIFAELLNMIKENVAYHADR----------GPLFPGSSCFPLSPDQKAGNDF 313
Query: 227 DPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA 264
+ R + Q+ + N L PS E+ E A
Sbjct: 314 KFHTRGNRDQLNVIFN----ILGTPSEEDIEALEKEDA 347
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 29/190 (15%)
Query: 17 ERALLEGRFIREVNMMSRVKHD-----NLVKFL------GACKDPLMVIVTELLPGMSLR 65
E A E + ++ VN K D +++K L G + V+V E+L G +L
Sbjct: 60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV-VMVFEVL-GENLL 117
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKS-----L 119
+ + L + + +D +H GIIH D+KP+N+L+ +
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 120 KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
K+AD G A + +T YR +PE V L + D++S +++E
Sbjct: 178 KIADLGNACWYDEHYTNSIQTREYR--SPE----VLLGAP----WGCGADIWSTACLIFE 227
Query: 180 LLTNRLPFEG 189
L+T FE
Sbjct: 228 LITGDFLFEP 237
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-19
Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 12/144 (8%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+ + ELL M+L + + + L + FA I + +D LH N IIH DLKP+N+L
Sbjct: 174 ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL 232
Query: 112 LT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170
L + +K+ DFG + E ++ YR APE V L Y +D+
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APE----VILGAR----YGMPIDM 282
Query: 171 YSFGIVLWELLTNRLPFEGMSNLQ 194
+S G +L ELLT G
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGD 306
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 44/197 (22%)
Query: 24 RFIREVNMMSRVK-HDNLVKFLGACKDPLMV---IVTELLPGMSLRKYLVSLRPNKL-DL 78
R RE+ +++ + H+N+V L + +V + + L + + N L +
Sbjct: 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA---NILEPV 109
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------- 128
H + + + LH+ G++HRD+KP N+LL + +K+ADFGL+R
Sbjct: 110 HKQY-VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTN 167
Query: 129 ------------EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174
+ ++T T YR APE+ Y +D++S G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGS-------TKYTKGIDMWSLG 218
Query: 175 IVLWELLTNRLPFEGMS 191
+L E+L + F G S
Sbjct: 219 CILGEILCGKPIFPGSS 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GIIHRDLKPDN 109
+ +V E+L +L L + + L++ FA + A+ L IIH DLKP+N
Sbjct: 131 LCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN 189
Query: 110 LLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168
+LL P + ++K+ DFG + + ++ YR +PE V L Y+ +
Sbjct: 190 ILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE----VLLGMP----YDLAI 239
Query: 169 DVYSFGIVLWELLTNRLPFEGMSNLQ 194
D++S G +L E+ T F G + +
Sbjct: 240 DMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 43/194 (22%), Positives = 70/194 (36%), Gaps = 64/194 (32%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNL 110
+ +V E+L G L K+++ L L + + +D LH IIH D+KP+N+
Sbjct: 120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178
Query: 111 LLTPDQKSL------------------------------------------------KLA 122
LL+ +++ + K+A
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 123 DFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
D G A + TE + T YR + E V + G YN D++S + +EL
Sbjct: 239 DLGNACWVHKHFTEDIQ--TRQYR--SLE----VLIGSG----YNTPADIWSTACMAFEL 286
Query: 181 LTNRLPFEGMSNLQ 194
T FE S +
Sbjct: 287 ATGDYLFEPHSGEE 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 33/163 (20%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
M I ELL G + ++L L + A + A+ LH N + H DLKP+N+L
Sbjct: 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155
Query: 112 LT------------------PDQKSLKLADFGLA--REETVTEMMTAETGTYRWMAPELY 151
S+++ADFG A E T ++ T YR PE
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIV--ATRHYR--PPE-- 209
Query: 152 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
V L G + DV+S G +L+E F+ N +
Sbjct: 210 --VILELG----WAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 35/164 (21%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
+ IV ELL G+S ++ + N L A I ++++ LH+N + H DLKP+
Sbjct: 92 ICIVFELL-GLSTYDFI---KENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPE 147
Query: 109 NLLL------------------TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 150
N+L T +K+ DFG A + T YR APE
Sbjct: 148 NILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APE- 204
Query: 151 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
V L G ++ DV+S G +L E F + +
Sbjct: 205 ---VILALG----WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 44/172 (25%), Positives = 70/172 (40%), Gaps = 45/172 (26%)
Query: 52 MVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
M ++ E L G SL + + N + + ++I +A++ L + H DLKP+
Sbjct: 111 MCLIFEPL-GPSLYEII---TRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE 166
Query: 109 NLLL------------------------TPDQKSLKLADFGLA--REETVTEMMTAETGT 142
N+LL +KL DFG A + + ++ T
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSII--NTRQ 224
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
YR APE V L G ++ D++SFG VL EL T L F +++
Sbjct: 225 YR--APE----VILNLG----WDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 21/78 (26%), Positives = 35/78 (44%), Gaps = 4/78 (5%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+V E L G+ L+K L + + ++ +H N +H D+K NLLL
Sbjct: 128 FMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184
Query: 113 -TPDQKSLKLADFGLARE 129
+ + LAD+GL+
Sbjct: 185 GYKNPDQVYLADYGLSYR 202
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-12
Identities = 21/103 (20%), Positives = 37/103 (35%), Gaps = 11/103 (10%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
++ + G L+K + L +L I ++ +H + +H D+K NLLL
Sbjct: 128 FMIMDRF-GSDLQKIY-EANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185
Query: 113 -TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWM 146
+ + L D+GLA GT +
Sbjct: 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 2/90 (2%)
Query: 41 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100
G +D +V L G SL+ L + L L A + A++ LH N
Sbjct: 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180
Query: 101 IHRDLKPDNLLL-TPDQKSLKLADFGLARE 129
+H ++ +N+ + DQ + LA +G A
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 45/154 (29%), Positives = 66/154 (42%), Gaps = 28/154 (18%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
V+V ELL G SL + L + K L L A + ++ +H+ IHRD+KPDN L+
Sbjct: 81 VMVMELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138
Query: 113 --TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPELYSTVTLRQGEKK 162
+ + DFGLA++ T + E TGT R+ S T
Sbjct: 139 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA-----SINT------- 186
Query: 163 HYNN----KVDVYSFGIVLWELLTNRLPFEGMSN 192
H + D+ S G VL LP++G+
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 30/154 (19%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
+V ELL G SL + L L L L A+ + M+ +H+ +I+RD+KP+N L+
Sbjct: 81 AMVLELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138
Query: 113 ----TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPELYSTVTLRQGE 160
Q+ + + DF LA+E ET + E TGT R+M S T
Sbjct: 139 GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM-----SINT----- 188
Query: 161 KKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 190
H + D+ + G + L LP++G+
Sbjct: 189 --HLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 30/154 (19%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
V+V +LL G SL + L+ L K + A + + +H +++RD+KPDN L+
Sbjct: 82 VLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139
Query: 113 ----TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPELYSTVTLRQGE 160
+ + + + DFG+ + T + E +GT R+M S T
Sbjct: 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM-----SINT----- 189
Query: 161 KKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 190
H + D+ + G V L LP++G+
Sbjct: 190 --HLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 28/152 (18%)
Query: 53 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 112
V+V +LL G SL + L + KL L L A + ++ +H+ +HRD+KPDN L+
Sbjct: 79 VLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
Query: 113 --TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPELYSTVTLRQGEKK 162
+ + DFGLA++ T + E TGT R+ S T
Sbjct: 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA-----SVNT------- 184
Query: 163 HYNN----KVDVYSFGIVLWELLTNRLPFEGM 190
H + D+ S G VL L LP++G+
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 8e-05
Identities = 57/322 (17%), Positives = 97/322 (30%), Gaps = 106/322 (32%)
Query: 3 KFMKEVLNRG---------STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 53
KF++EVL + + +++ +I + + R+ +DN F K
Sbjct: 81 KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD---RLYNDN-QVFA---KYN--- 130
Query: 54 IVTELLPGMSLRKYLVSLRPNK-LDLHVALNF-----ALDIARAMD--CLHANGI----I 101
V+ L P + LR+ L+ LRP K + + L ALD+ + C I +
Sbjct: 131 -VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL 189
Query: 102 HRDLKPD-------NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY--S 152
P+ LL D +D + + + R + + Y
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS---IQAELRRLLKSKPYENC 246
Query: 153 TVTLRQGEKKHYNNKVDVYSFGIVLWE--------LLTNR-------------------- 184
+ L +V + W LLT R
Sbjct: 247 LLVLL-----------NVQNAKA--WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 185 -----LPFEGMSNLQAAYAAAFKHARPGLPE---DISP-DLAFIVQSC------WVEDPN 229
P E S L Y LP +P L+ I +S W D
Sbjct: 294 HSMTLTPDEVKS-LLLKYL---DCRPQDLPREVLTTNPRRLSIIAESIRDGLATW--DNW 347
Query: 230 LRPSFSQIIRMLNAFLFTLRPP 251
+ ++ ++ + L L P
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPA 369
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 1e-04
Identities = 39/302 (12%), Positives = 79/302 (26%), Gaps = 85/302 (28%)
Query: 40 LVKFLG---------ACK-DPLMV-IVTELLPGMSLR-KYLVSLRPNKLD--LHVALNFA 85
L+K+L +P + I+ E + + +KL + +LN
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN-V 365
Query: 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-- 143
L+ A + P + + L L ++ ++ + Y
Sbjct: 366 LEPAEYRKMFDRLSVF-----PPSAHIPT--ILLSL--IWFDVIKSDVMVVVNKLHKYSL 416
Query: 144 --RWMAPELYS--------TVTLRQGEKKH------YN------------NKVDVYSFGI 175
+ S V L H YN +D Y +
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY-- 474
Query: 176 VLWEL---LTNRLPFEGMSNLQAAY------AAAFKHARPGL--PEDISPDLA------- 217
+ L N E M+ + + +H I L
Sbjct: 475 --SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP 532
Query: 218 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA-ATSNGAMTEFSA 276
+I + P + +++ + FL + +D A + A+ E +
Sbjct: 533 YICDND--------PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAH 584
Query: 277 RA 278
+
Sbjct: 585 KQ 586
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 3e-04
Identities = 21/107 (19%), Positives = 33/107 (30%), Gaps = 5/107 (4%)
Query: 28 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87
+ + KD + IV E G L +R L A +
Sbjct: 113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQ 169
Query: 88 IARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 133
+ ++ A+ HRDL N+LL KL + T+
Sbjct: 170 LTASLAVAEASLRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIP 215
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 298 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.74 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.7 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.17 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.89 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.91 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.26 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.71 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.37 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.24 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.9 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.97 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 89.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 88.86 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.68 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.98 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.6 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=361.64 Aligned_cols=220 Identities=30% Similarity=0.497 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.++|.+|+.++++++|||||++++++.++.+||||||++||+|.+++... ...+++..++.|+.|++.||+|||++||+
T Consensus 76 ~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~Ii 154 (307)
T 3omv_A 76 FQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNII 154 (307)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45899999999999999999999999878899999999999999999753 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
||||||+|||++.+ +.+||+|||++...... .......||+.|+|||++.+. ....|+.++|||||||++|
T Consensus 155 HRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl~ 228 (307)
T 3omv_A 155 HRDMKSNNIFLHEG-LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVLY 228 (307)
T ss_dssp CSCCCSSSEEEETT-EEEEECCCSSCBC------------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHHH
T ss_pred CCccCHHHEEECCC-CcEEEeeccCceecccCCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHHH
Confidence 99999999999954 57999999999754322 233455799999999998641 1246899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcC----CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
||++|+.||.+.++............. +..+..+++++.+|+.+||+.||.+|||+.++++.|+.+...+
T Consensus 229 Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 229 ELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 999999999987766555555444332 2355678999999999999999999999999999988765443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=364.49 Aligned_cols=208 Identities=30% Similarity=0.450 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++|||||++++++. ++.+|||||||+||+|.+++...+...+++..++.|+.||+.||+|||++||
T Consensus 67 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~I 146 (350)
T 4b9d_A 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146 (350)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 457889999999999999999999985 5679999999999999999987666678999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.++ .+||+|||++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+
T Consensus 147 iHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~--------~~y~~~~DiwSlGvilye 217 (350)
T 4b9d_A 147 LHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN--------KPYNNKSDIWALGCVLYE 217 (350)
T ss_dssp EETTCCGGGEEECTTC-CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred eeccCCHHHEEECCCC-CEEEcccccceeecCCcccccccCCCccccCHHHHCC--------CCCCcHHHHHHHHHHHHH
Confidence 9999999999999654 69999999998765433 2344579999999999865 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|+.||.+.+..+ ..........+..+..+|+++.+||.+||+.||.+|||++++++
T Consensus 218 mltG~~PF~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 218 LCTLKHAFEAGSMKN-LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHSSCSCCCSSHHH-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHCCCCCCCcCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999998866544 44445555666778889999999999999999999999999987
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=359.67 Aligned_cols=217 Identities=27% Similarity=0.511 Sum_probs=187.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-----------CCCCCHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-----------PNKLDLHVALNFALDI 88 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~~i~~qi 88 (298)
..++|.+|+.++++++|||||+++++|. ++..|+||||++||+|.+++.... ...+++..++.|+.|+
T Consensus 58 ~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 137 (299)
T 4asz_A 58 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137 (299)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHH
Confidence 3468999999999999999999999995 567999999999999999997632 3569999999999999
Q ss_pred HHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCC
Q 022347 89 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN 165 (298)
Q Consensus 89 ~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 165 (298)
+.||+|||+++|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..++
T Consensus 138 a~gl~yLH~~~iiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~ 208 (299)
T 4asz_A 138 AAGMVYLASQHFVHRDLATRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFT 208 (299)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------CCCC
T ss_pred HHHHHHHHhCCcccCccCHhhEEECCC-CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--------CCCC
Confidence 999999999999999999999999955 569999999997543322 2223458899999999975 6789
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 166 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 166 ~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
.++|||||||++|||+| |+.||.+.+..+ .......+..+..|..+|+++.+|+.+||+.||++|||+.++.+.|+.+
T Consensus 209 ~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 209 TESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999998 999999876544 4455556667788899999999999999999999999999999999887
Q ss_pred hhc
Q 022347 245 LFT 247 (298)
Q Consensus 245 ~~~ 247 (298)
...
T Consensus 288 ~~~ 290 (299)
T 4asz_A 288 AKA 290 (299)
T ss_dssp HHH
T ss_pred Hhc
Confidence 654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=360.15 Aligned_cols=217 Identities=29% Similarity=0.528 Sum_probs=181.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-------------CCCCCHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-------------PNKLDLHVALNFAL 86 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~i~~ 86 (298)
..++|.+|+.++++++|||||+++++|. ++..|+||||++||+|.+++.... ...+++..++.|+.
T Consensus 86 ~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 165 (329)
T 4aoj_A 86 ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165 (329)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHH
Confidence 3468999999999999999999999995 457999999999999999997632 24589999999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|++.||+|||+.+|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+ ..
T Consensus 166 qia~gl~yLH~~~iiHRDLKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~ 236 (329)
T 4aoj_A 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RK 236 (329)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC----------------CCCCGGGCCHHHHTT--------CC
T ss_pred HHHHHHHHHhcCCeecccccHhhEEECCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcC--------CC
Confidence 99999999999999999999999999954 579999999998543322 2234578999999999865 67
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++|||||||++|||++ |+.||.+..+.+. ......+.++..|..+++++.+|+.+||+.||++|||+.+|+++|+
T Consensus 237 ~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~-~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred CCccccccchHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 8999999999999999999 9999998766443 4445566677888999999999999999999999999999999999
Q ss_pred hhhhc
Q 022347 243 AFLFT 247 (298)
Q Consensus 243 ~~~~~ 247 (298)
.+...
T Consensus 316 ~l~~~ 320 (329)
T 4aoj_A 316 ALAQA 320 (329)
T ss_dssp HHHHS
T ss_pred HHhhC
Confidence 87653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=358.41 Aligned_cols=214 Identities=27% Similarity=0.485 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFA 85 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~ 85 (298)
..++|.+|+.++++++|||||+++++|. ++..++||||+++|+|.+++.... ...+++..++.|+
T Consensus 72 ~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 151 (308)
T 4gt4_A 72 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151 (308)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHH
Confidence 3457999999999999999999999995 567899999999999999996532 1358999999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+ .
T Consensus 152 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~ 222 (308)
T 4gt4_A 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--------G 222 (308)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--------C
T ss_pred HHHHHHHHHHHhCCCCCCCccccceEECCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--------C
Confidence 999999999999999999999999999954 569999999998543322 2334578999999999875 6
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++|||||||++|||++ |..||.+....+ ....+..+..++.|..+|+++.+|+.+||+.||.+|||+.+|++.|
T Consensus 223 ~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 223 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 78999999999999999998 899999876543 4455556677788899999999999999999999999999999999
Q ss_pred Hhh
Q 022347 242 NAF 244 (298)
Q Consensus 242 ~~~ 244 (298)
+.+
T Consensus 302 ~a~ 304 (308)
T 4gt4_A 302 RAW 304 (308)
T ss_dssp HTS
T ss_pred Hhc
Confidence 875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-53 Score=352.56 Aligned_cols=211 Identities=30% Similarity=0.574 Sum_probs=179.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.++|.+|+.++++++|||||++++++.+ +.+|+||||++||+|.+++... ..+++..+..|+.||+.||+|||
T Consensus 69 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH 146 (290)
T 3fpq_A 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH 146 (290)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Confidence 4689999999999999999999999843 3589999999999999999864 45999999999999999999999
Q ss_pred hCC--CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 97 ANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 97 ~~g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
++| |+||||||+|||++...+.+||+|||++..... .......||+.|+|||++. ..|+.++||||||
T Consensus 147 ~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~---------~~y~~~~DiwSlG 216 (290)
T 3fpq_A 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFG 216 (290)
T ss_dssp TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHH
T ss_pred HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcC---------CCCCcHHHHHHHH
Confidence 999 999999999999985456799999999975333 2334568999999999874 3589999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++|+|++|+.||.+..+.............+ .++...++++.+||.+||+.||.+|||+.++++ +.|+.
T Consensus 217 vilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~~ 287 (290)
T 3fpq_A 217 MCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp HHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred HHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--Ccccc
Confidence 99999999999998777666655555444333 345668899999999999999999999999998 55554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=361.40 Aligned_cols=213 Identities=29% Similarity=0.496 Sum_probs=182.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+|++++|||||++++++. ++.+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+
T Consensus 116 ~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~Ii 192 (346)
T 4fih_A 116 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVI 192 (346)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45779999999999999999999985 5689999999999999999976 5699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 193 HRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyem 263 (346)
T 4fih_A 193 HRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEM 263 (346)
T ss_dssp CCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHH
T ss_pred cccCCHHHEEECCCC-CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHH
Confidence 999999999999654 6999999999865433 33456789999999999864 6789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++|..||.+.+.... ...+.....+. .+..+++++.+||.+||+.||.+|||++|+++ +.|+....+
T Consensus 264 l~G~~PF~~~~~~~~-~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~~~ 332 (346)
T 4fih_A 264 VDGEPPYFNEPPLKA-MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 332 (346)
T ss_dssp HHSSCTTTTSCHHHH-HHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCC
T ss_pred HHCCCCCCCcCHHHH-HHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCCCC
Confidence 999999988665443 33333333333 33468999999999999999999999999998 778776544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=363.00 Aligned_cols=217 Identities=25% Similarity=0.310 Sum_probs=181.7
Q ss_pred HHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 022347 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104 (298)
Q Consensus 26 ~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~d 104 (298)
.+|+.++++++|||||++++++. ++.+||||||++||+|.+++... +.+++..+..++.||+.||+|||++||+|||
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD 175 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGD 175 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 47999999999999999999985 56799999999999999999874 4599999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCCccCcccc------ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 105 LKPDNLLLTPDQKSLKLADFGLAREETVTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 105 ik~~Nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|||+|||++.++..+||+|||++....... ......||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvily 247 (336)
T 4g3f_A 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG--------KPCDAKVDIWSSCCMML 247 (336)
T ss_dssp CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC--------CCCCcHHHHHHHHHHHH
Confidence 999999999776579999999997543321 1223469999999999975 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 253 (298)
+|++|+.||.+........... .... ..++..+++++.++|.+||+.||.+|||+.|++++|...+........
T Consensus 248 emltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~h 323 (336)
T 4g3f_A 248 HMLNGCHPWTQYFRGPLCLKIA-SEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323 (336)
T ss_dssp HHHHSSCSSTTTCCSCCHHHHH-HSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred HHHHCcCCCCCCCHHHHHHHHH-cCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence 9999999998765433322222 2222 246778999999999999999999999999999999998877665443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=342.63 Aligned_cols=211 Identities=30% Similarity=0.510 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.++++++||||+++++++. ++..|+||||+ +|+|.+++... +.+++..+..++.||+.||+|||++|
T Consensus 56 ~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~ 132 (275)
T 3hyh_A 56 MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK 132 (275)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999995 55799999999 77999999763 56999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||||+|||++.+ +.+||+|||++.............||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 133 IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~y~~~~~DiwSlGvily~ 204 (275)
T 3hyh_A 133 IVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYV 204 (275)
T ss_dssp CCCCCCCTTTEEECTT-CCEEECCSSCC---------------CTTSCHHHHSS-------SSCCCTHHHHHHHHHHHHH
T ss_pred cccccCChHHeEECCC-CCEEEeecCCCeecCCCCccCCeeECcccCChhhhcC-------CCCCCChhhhHHHHHHHHH
Confidence 9999999999999955 4699999999987665555566789999999999865 1234679999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++|+.||.+.+.. ..... .......+|..+|+++.+||.+||+.||.+|||++|+++ +.|+.
T Consensus 205 lltg~~PF~~~~~~-~~~~~-i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k 267 (275)
T 3hyh_A 205 MLCRRLPFDDESIP-VLFKN-ISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFK 267 (275)
T ss_dssp HHHSSCSSCCSSHH-HHHHH-HHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHH
T ss_pred HHHCCCCCCCCCHH-HHHHH-HHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc--Ccccc
Confidence 99999999876543 33333 344566778889999999999999999999999999998 56664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=349.88 Aligned_cols=203 Identities=26% Similarity=0.419 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++|||||+++++++ ++.+|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+
T Consensus 77 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~Ii 154 (311)
T 4aw0_A 77 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGII 154 (311)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 47889999999999999999999996 45799999999999999999874 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc---ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
||||||+|||++.+ +.+||+|||++..... .......+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 155 HRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvily 225 (311)
T 4aw0_A 155 HRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIY 225 (311)
T ss_dssp CSCCSGGGEEECTT-SCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH--------SCBCHHHHHHHHHHHHH
T ss_pred cCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC--------CCCCcHHHHHHHHHHHH
Confidence 99999999999965 4699999999985432 223455689999999999975 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 238 (298)
+|++|..||.+.+.... ...+ ......+|..+++++.+||.+||+.||.+|||++|++
T Consensus 226 eml~G~~PF~~~~~~~~-~~~i-~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 226 QLVAGLPPFRAGNEGLI-FAKI-IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHSSCSSCCSSHHHH-HHHH-HHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHhCCCCCCCCCHHHH-HHHH-HcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 99999999987664433 3332 3345677889999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=362.23 Aligned_cols=213 Identities=29% Similarity=0.496 Sum_probs=182.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+|++++|||||++++++. ++.+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+
T Consensus 193 ~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~Ii 269 (423)
T 4fie_A 193 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVI 269 (423)
T ss_dssp GGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 35779999999999999999999985 5689999999999999999976 5699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+|||++.++ .+||+|||++...... ......+||+.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 270 HRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyem 340 (423)
T 4fie_A 270 HRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEM 340 (423)
T ss_dssp CCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT--------CCBCTHHHHHHHHHHHHHH
T ss_pred cccCCHHHEEEcCCC-CEEEecCccceECCCCCccccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHH
Confidence 999999999999654 6999999999865433 33456689999999999865 6789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++|..||.+.+..... ..+.....+ ..+..+++++.+||.+||+.||.+|||+.|+++ +.|+....+
T Consensus 341 l~G~~PF~~~~~~~~~-~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~~~ 409 (423)
T 4fie_A 341 VDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 409 (423)
T ss_dssp HHSSCTTTTSCHHHHH-HHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCC
T ss_pred HHCCCCCCCcCHHHHH-HHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCCCC
Confidence 9999999887654443 333333333 334578999999999999999999999999998 777776443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=356.47 Aligned_cols=217 Identities=29% Similarity=0.552 Sum_probs=188.1
Q ss_pred HHHHHHHHHHHHhCCC-Ccccceeceee--cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKH-DNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNF 84 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~h-p~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i 84 (298)
.+.|.+|+.+|++++| ||||+++++|. ++.+|+|||||++|+|.+++.... ...+++..++.+
T Consensus 111 ~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 190 (353)
T 4ase_A 111 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190 (353)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHH
Confidence 3578899999999976 99999999984 346899999999999999997532 234899999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCc
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEK 161 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~ 161 (298)
+.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+
T Consensus 191 ~~qia~gl~yLH~~~iiHRDLK~~NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------- 261 (353)
T 4ase_A 191 SFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------- 261 (353)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------
T ss_pred HHHHHHHHHhHhhCCeecCccCccceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--------
Confidence 9999999999999999999999999999955 569999999998543322 2234568899999999975
Q ss_pred cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 162 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 162 ~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
..|+.++|||||||++|||++ |..||.+.............+.++..|..+++++.+++.+||+.||.+|||+.+++++
T Consensus 262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 678999999999999999998 9999998766566666667777888899999999999999999999999999999999
Q ss_pred HHhhhhc
Q 022347 241 LNAFLFT 247 (298)
Q Consensus 241 l~~~~~~ 247 (298)
|+.++..
T Consensus 342 L~~llq~ 348 (353)
T 4ase_A 342 LGNLLQA 348 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9988764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=337.78 Aligned_cols=208 Identities=29% Similarity=0.477 Sum_probs=172.0
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
++.+|+.++++++|||||++++++. ++.+|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+|
T Consensus 72 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiH 149 (304)
T 3ubd_A 72 RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIY 149 (304)
T ss_dssp ------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence 5778999999999999999999985 56799999999999999999874 46999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|||||+|||++.++ .+||+|||++..... ........||+.|+|||++.+ ..|+.++|||||||++|+|+
T Consensus 150 RDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyeml 220 (304)
T 3ubd_A 150 RDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEML 220 (304)
T ss_dssp SSCCGGGEEECTTS-CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCHHHeEEcCCC-CEEecccccceeccCCCccccccccCcccCCHHHhcc--------CCCCCCCcccchHHHHHHHH
Confidence 99999999999654 699999999975433 333455689999999999865 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHHhhhh
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIRMLNAFLF 246 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~~l~~~~~ 246 (298)
+|+.||.+.+..+.. ..+ ......+|..+|+++.+||.+||+.||.+|||+ +++++ +.|+.
T Consensus 221 tG~~PF~~~~~~~~~-~~i-~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~--Hp~f~ 286 (304)
T 3ubd_A 221 TGTLPFQGKDRKETM-TMI-LKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR--HSFFS 286 (304)
T ss_dssp HSSCSSCCSSHHHHH-HHH-HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT--SGGGT
T ss_pred hCCCCCCCcCHHHHH-HHH-HcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc--Ccccc
Confidence 999999887654433 322 344567788899999999999999999999984 67776 55554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=335.64 Aligned_cols=215 Identities=30% Similarity=0.484 Sum_probs=163.4
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec-C------------ceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-P------------LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFAL 86 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~------------~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~ 86 (298)
..+++.+|+.++++++|||||++++++.+ + ++|+||||++||+|.+++..... ...++..++.++.
T Consensus 46 ~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~ 125 (299)
T 4g31_A 46 AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125 (299)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHH
Confidence 44578899999999999999999998742 1 37999999999999999986432 2356677899999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-------------ccccccCccceeccccccc
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-------------MMTAETGTYRWMAPELYST 153 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~ 153 (298)
||+.||+|||++||+||||||+|||++.++ .+||+|||++....... .....+||+.|+|||++.+
T Consensus 126 qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 204 (299)
T 4g31_A 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204 (299)
T ss_dssp HHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCCCC--------------------------CCCTTSCHHHHTT
T ss_pred HHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC
Confidence 999999999999999999999999999654 69999999997543321 1223469999999999875
Q ss_pred cccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 154 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 154 ~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
..|+.++|||||||++|||++ ||.+..+.............++.....++.+.+||.+||+.||.+|||
T Consensus 205 --------~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps 273 (299)
T 4g31_A 205 --------NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273 (299)
T ss_dssp --------CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC
T ss_pred --------CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcC
Confidence 678999999999999999996 776533222222222222222223345567889999999999999999
Q ss_pred HHHHHHHHHhhhhccC
Q 022347 234 FSQIIRMLNAFLFTLR 249 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~~ 249 (298)
+.++++ +.|+..+.
T Consensus 274 ~~eil~--h~~~~~~~ 287 (299)
T 4g31_A 274 AINIIE--NAVFEDLD 287 (299)
T ss_dssp HHHHHT--SGGGCCC-
T ss_pred HHHHhc--CHhhCCCC
Confidence 999998 66766543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=331.52 Aligned_cols=216 Identities=26% Similarity=0.420 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+++.+|+.+|++++|||||++++++. .+.+|+||||++ |+|.+++.. .+.+++..+..++.||+.||+|
T Consensus 97 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~y 173 (398)
T 4b99_A 97 AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKY 173 (398)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Confidence 357889999999999999999999863 246899999995 689999975 3569999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-----cccccccCccceeccccccccccccCCccCCCcchh
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+|||++.+ ...++.++|
T Consensus 174 lH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~D 245 (398)
T 4b99_A 174 MHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAID 245 (398)
T ss_dssp HHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHH
T ss_pred HHHCcCcCCCcCccccccCCC-CCEEEeecceeeecccCccccccccccceeChHhcCHHHhcC-------CCCCCChhh
Confidence 999999999999999999955 46999999999754322 23345689999999999864 246789999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC-----------------------------CCCCCcHHHHHHH
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG-----------------------------LPEDISPDLAFIV 220 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li 220 (298)
|||+||++|+|++|+.||.+.+..............+. +...+++++.+||
T Consensus 246 iWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 325 (398)
T 4b99_A 246 LWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLL 325 (398)
T ss_dssp HHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHH
T ss_pred eehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHH
Confidence 99999999999999999998776555444332222111 1134688999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 221 QSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 221 ~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
.+||..||.+|||+.++++ +.|+.....
T Consensus 326 ~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~ 353 (398)
T 4b99_A 326 GRMLRFEPSARISAAAALR--HPFLAKYHD 353 (398)
T ss_dssp HHHSCSSTTTSCCHHHHTT--SGGGTTTCC
T ss_pred HHHCcCChhHCcCHHHHhc--CHhhCcCCC
Confidence 9999999999999999998 788876554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=326.19 Aligned_cols=217 Identities=24% Similarity=0.382 Sum_probs=165.4
Q ss_pred HHHHHHHHHhCCCCcccceeceeecC-----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN- 98 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~- 98 (298)
+..|+..+.+++|||||++++++.++ .+||||||++||+|.+++.. ..+++..+.+++.|++.||+|||++
T Consensus 44 ~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~ 120 (303)
T 3hmm_A 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred HHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhh
Confidence 34677777899999999999998432 47999999999999999986 5699999999999999999999987
Q ss_pred -------CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCc
Q 022347 99 -------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 166 (298)
Q Consensus 99 -------givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 166 (298)
||+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||++.+... .....++.
T Consensus 121 ~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~--~~~~~~~~ 197 (303)
T 3hmm_A 121 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFK 197 (303)
T ss_dssp CSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC--TTCHHHHH
T ss_pred hhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccccc--ccCCccCh
Confidence 99999999999999955 569999999997543322 1223479999999999864110 01134678
Q ss_pred chhHHHHHHHHHHHHhCCCCCC----------CCC----hHHHHHHHHH-hhcCCCCCCC-----CcHHHHHHHHHhhhh
Q 022347 167 KVDVYSFGIVLWELLTNRLPFE----------GMS----NLQAAYAAAF-KHARPGLPED-----ISPDLAFIVQSCWVE 226 (298)
Q Consensus 167 ~~Di~slG~il~~ll~g~~p~~----------~~~----~~~~~~~~~~-~~~~~~~~~~-----~~~~l~~li~~~l~~ 226 (298)
++|||||||++|||++|..||. +.. .......... ...++.+|.. .++.+.+|+.+||+.
T Consensus 198 k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 198 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCS
T ss_pred hHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHccc
Confidence 9999999999999999976553 211 1222222222 2334555543 335788999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhc
Q 022347 227 DPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 227 ~p~~Rps~~~l~~~l~~~~~~ 247 (298)
||.+|||+.++++.|+.+...
T Consensus 278 dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 278 NGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SGGGSCCHHHHHHHHHHHHHC
T ss_pred CHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999887643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=318.53 Aligned_cols=212 Identities=23% Similarity=0.350 Sum_probs=168.6
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.++.+|+.+|+.+ .||||+++++++. +++.|+||||++||+|.+++. .+++.++..++.|++.||+|||++||
T Consensus 64 ~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gI 138 (361)
T 4f9c_A 64 IRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGI 138 (361)
T ss_dssp HHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3577999999998 5999999999985 568999999999999999984 38999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc-----------------------------cccccccCccceeccccc
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-----------------------------EMMTAETGTYRWMAPELY 151 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~ 151 (298)
+||||||+|||++.+.+.+||+|||++...... .......||+.|+|||++
T Consensus 139 iHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 218 (361)
T 4f9c_A 139 VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL 218 (361)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred EeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 999999999999977678999999999643221 112334799999999998
Q ss_pred cccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-----------------------------
Q 022347 152 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK----------------------------- 202 (298)
Q Consensus 152 ~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~----------------------------- 202 (298)
.+ ...++.++||||+||++|+|++|+.||....+.......+..
T Consensus 219 ~~-------~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~ 291 (361)
T 4f9c_A 219 TK-------CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDL 291 (361)
T ss_dssp TT-------CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCH
T ss_pred cC-------CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhh
Confidence 64 245889999999999999999999999654432222111100
Q ss_pred --------hc----------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 203 --------HA----------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 203 --------~~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
.. .......+++++.+||.+||+.||.+|||++|+++ +.|+.++
T Consensus 292 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~--Hp~f~~i 359 (361)
T 4f9c_A 292 RKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM 359 (361)
T ss_dssp HHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGTTC
T ss_pred hHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccCCC
Confidence 00 00112457899999999999999999999999998 7777654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=341.01 Aligned_cols=216 Identities=26% Similarity=0.394 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+|+.++||||+++++++. ++.+|+||||++||+|.+++.. ....+++..+..++.||+.||.|||++||
T Consensus 198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~i 276 (573)
T 3uto_A 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNY 276 (573)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 357889999999999999999999996 5579999999999999999965 23569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCC-CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.+ .+.+||+|||++.............||+.|+|||++.+ ..|+.++|||||||++|+
T Consensus 277 iHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~--------~~y~~~~DiWSlGvilye 348 (573)
T 3uto_A 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYI 348 (573)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHH
T ss_pred eeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC--------CCCCcHHHHHHHHHHHHH
Confidence 999999999999854 35799999999987666655566789999999999975 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|++|..||.+.+..+........... ......+++++.+||.+||+.||.+|||+.++++ +.|+...
T Consensus 349 ml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~~~ 417 (573)
T 3uto_A 349 LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPG 417 (573)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTSCC
T ss_pred HHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcCCC
Confidence 99999999987665443333222221 2233568999999999999999999999999998 6666543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=332.76 Aligned_cols=208 Identities=23% Similarity=0.329 Sum_probs=174.1
Q ss_pred HHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 022347 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104 (298)
Q Consensus 26 ~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~d 104 (298)
..++.+++.++|||||+++++++ ++.+|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+|||
T Consensus 240 ~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRD 317 (689)
T 3v5w_A 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRD 317 (689)
T ss_dssp HHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred HHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 34577788889999999999996 45799999999999999999874 4699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCC
Q 022347 105 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184 (298)
Q Consensus 105 ik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~ 184 (298)
|||+|||++.++ .+||+|||++....... ....+||+.|+|||++.. ...|+.++|+|||||++|+|++|.
T Consensus 318 LKPeNILld~~G-~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEmLtG~ 388 (689)
T 3v5w_A 318 LKPANILLDEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGH 388 (689)
T ss_dssp CSGGGEEECTTS-CEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CchHHeEEeCCC-CEEecccceeeecCCCC-CCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999654 69999999998654332 345689999999999853 256899999999999999999999
Q ss_pred CCCCCCChH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhhh
Q 022347 185 LPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 246 (298)
Q Consensus 185 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~~l~~~~~ 246 (298)
.||.+.... ..............+|..+|+++.+||.+||+.||.+|++ ++++++ +.|+.
T Consensus 389 ~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--HpfF~ 454 (689)
T 3v5w_A 389 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 454 (689)
T ss_dssp CTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--SGGGT
T ss_pred CCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--Ccccc
Confidence 999754321 1122233345566788899999999999999999999997 788887 55554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=302.75 Aligned_cols=222 Identities=39% Similarity=0.694 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.|
T Consensus 78 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 157 (309)
T 3p86_A 78 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157 (309)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence 357889999999999999999999985 4578999999999999999976321 23899999999999999999999999
Q ss_pred --CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 --IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 --ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|+||||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ ..++.++||||||++
T Consensus 158 ~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~i 228 (309)
T 3p86_A 158 PPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDVYSFGVI 228 (309)
T ss_dssp SCCCCTTCCGGGEEECTT-CCEEECCCC-----------------CCTTSCHHHHTT--------CCCCTTHHHHHHHHH
T ss_pred CCEECCCCChhhEEEeCC-CcEEECCCCCCccccccccccccCCCCccccChhhhcC--------CCCCchhhHHHHHHH
Confidence 9999999999999955 469999999997543322 2334578999999999865 567889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+|+|++|..||....................++..+++++.+++.+||+.+|.+|||+.++++.|+.++....+++
T Consensus 229 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 229 LWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp HHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 9999999999998776665555555666777888999999999999999999999999999999999988765543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=301.97 Aligned_cols=214 Identities=29% Similarity=0.477 Sum_probs=181.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.+++.++||||+++++++. ++..|+||||++|++|.+++... +.+++..++.++.|++.||+|||+.||
T Consensus 58 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i 135 (328)
T 3fe3_A 58 LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRI 135 (328)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 457889999999999999999999985 55799999999999999999764 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+||+++.+ +.++|+|||++.............|++.|+|||++.+ ....+.++||||||+++|+|
T Consensus 136 vHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 136 VHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-------KKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp CCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHT-------CCCCSHHHHHHHHHHHHHHH
T ss_pred eccCCCHHHEEEcCC-CCEEEeeccCceecCCCCccccccCCcceeCcccccC-------CCcCCchhhhhhhHHHHHHH
Confidence 999999999999955 4699999999986655555566789999999999865 12335799999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
++|..||.+.+..... . .........|..+++++.+++.+||..||.+|||++++++ +.|+....
T Consensus 208 l~g~~pf~~~~~~~~~-~-~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~~~ 272 (328)
T 3fe3_A 208 VSGSLPFDGQNLKELR-E-RVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK--DRWINAGH 272 (328)
T ss_dssp HHSSCSSCCSSHHHHH-H-HHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT--CTTTTTTC
T ss_pred HhCCCCCCCCCHHHHH-H-HHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CHhhcCCC
Confidence 9999999876643332 2 2334455677789999999999999999999999999998 66665433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=307.76 Aligned_cols=217 Identities=31% Similarity=0.614 Sum_probs=184.1
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~ 85 (298)
.+++.+|+.+++++ +||||+++++++. ++..|+||||++||+|.+++..... ..+++..++.++
T Consensus 130 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 209 (370)
T 2psq_A 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209 (370)
T ss_dssp HHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHH
Confidence 35788999999999 8999999999985 5679999999999999999987432 348999999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ .
T Consensus 210 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~ 280 (370)
T 2psq_A 210 YQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------R 280 (370)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------C
T ss_pred HHHHHHHHHHHhCCeeccccchhhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--------C
Confidence 999999999999999999999999999955 469999999997543322 2233456789999999864 6
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++||||||+++|+|++ |..||.+.... ...........+..+..++.++.+++.+||+.+|.+|||+.++++.|
T Consensus 281 ~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 78999999999999999999 99999876543 33444555566777888999999999999999999999999999999
Q ss_pred Hhhhhcc
Q 022347 242 NAFLFTL 248 (298)
Q Consensus 242 ~~~~~~~ 248 (298)
+.++...
T Consensus 360 ~~il~~~ 366 (370)
T 2psq_A 360 DRILTLT 366 (370)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9987644
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=301.17 Aligned_cols=220 Identities=28% Similarity=0.497 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ...+++..++.++.|++.||.|||+.|
T Consensus 93 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ 171 (325)
T 3kul_A 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG 171 (325)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999995 45789999999999999999753 356999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+||||||+||+++.+ +.++|+|||++....... ......++..|+|||++.+ ..++.++||||||+
T Consensus 172 ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~ 242 (325)
T 3kul_A 172 YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGV 242 (325)
T ss_dssp EECSCCSGGGEEECTT-CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH--------CEECHHHHHHHHHH
T ss_pred eeCCCCCcceEEECCC-CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC--------CCCCcHHHHHHHHH
Confidence 9999999999999955 569999999997543321 1222345678999999865 56788999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 176 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
++|+|++ |..||.+..... .............+..+++.+.+++.+||..+|.+|||+.++++.|+.++......
T Consensus 243 il~ell~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 243 VMWEVLAYGERPYWNMTNRD-VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp HHHHHHTTSCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred HHHHHHcCCCCCcccCCHHH-HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 9999999 999998766543 34444555666777889999999999999999999999999999999998765443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=295.85 Aligned_cols=217 Identities=28% Similarity=0.540 Sum_probs=175.3
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
...+++.+|+.++++++||||+++++++.++..|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.|
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ 136 (281)
T 1mp8_A 58 SVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR 136 (281)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3456888999999999999999999999888899999999999999999763 346999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
++|+||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 137 i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l 207 (281)
T 1mp8_A 137 FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCM 207 (281)
T ss_dssp CCCSCCSGGGEEEEET-TEEEECC-------------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHH
T ss_pred eecccccHHHEEECCC-CCEEECccccccccCcccccccccCCCcccccChhhccc--------CCCCCccCchHHHHHH
Confidence 9999999999999955 5799999999976443221 223356778999999864 5678899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 178 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+|++ |..||.+...... ............+..+++.+.+++.+||+.+|.+|||+.++++.|+.++..
T Consensus 208 ~ell~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 208 WEILMHGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCcCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99997 9999987655433 333444555667788999999999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=303.73 Aligned_cols=221 Identities=32% Similarity=0.609 Sum_probs=188.6
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~ 85 (298)
.+++.+|+.+++++ +||||+++++++. ++..++||||+++|+|.+++..... ..+++..++.++
T Consensus 118 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 197 (382)
T 3tt0_A 118 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197 (382)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHH
Confidence 35788999999999 8999999999985 5578999999999999999987542 358999999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++....... ......++..|+|||++.+ .
T Consensus 198 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~ 268 (382)
T 3tt0_A 198 YQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------R 268 (382)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------C
T ss_pred HHHHHHHHHHHhCCEecCCCCcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--------C
Confidence 999999999999999999999999999955 469999999998554322 2233456789999999865 6
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++||||||+++|+|++ |..||.+... ...............+..+++++.+++.+||+.+|.+|||+.++++.|
T Consensus 269 ~~~~~~DiwslG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 269 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 78899999999999999999 9999987654 344455556667777888999999999999999999999999999999
Q ss_pred HhhhhccCCCC
Q 022347 242 NAFLFTLRPPS 252 (298)
Q Consensus 242 ~~~~~~~~~~~ 252 (298)
+.++.......
T Consensus 348 ~~~~~~~~~~~ 358 (382)
T 3tt0_A 348 DRIVALTSNQE 358 (382)
T ss_dssp HHHHHHSCSCC
T ss_pred HHHHHHHhcCC
Confidence 99987665544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=291.50 Aligned_cols=213 Identities=31% Similarity=0.465 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++|++|.+++.. ..+++..++.++.|++.||+|||+.||+
T Consensus 62 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 138 (297)
T 3fxz_A 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVI 138 (297)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 46779999999999999999999984 5679999999999999999986 4699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.++ .++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 139 H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 209 (297)
T 3fxz_A 139 HRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEM 209 (297)
T ss_dssp CCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC--------SCBCTHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCC-CEEEeeCCCceecCCcccccCCccCCcCccChhhhcC--------CCCCcHHHHHHHHHHHHHH
Confidence 999999999999654 69999999987544332 2344578999999999865 6688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
++|..||.+.+............. ....+..+++.+.+++.+||+.||.+|||+.++++ +.++....
T Consensus 210 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~ 277 (297)
T 3fxz_A 210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAK 277 (297)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCC
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhcccC
Confidence 999999988766554443332222 23345678999999999999999999999999998 66666543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=301.67 Aligned_cols=220 Identities=32% Similarity=0.479 Sum_probs=177.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ...+++..++.++.|++.||+|||+.|
T Consensus 50 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ 128 (310)
T 3s95_A 50 TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN 128 (310)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4457889999999999999999999985 56799999999999999999863 456999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc---------------ccccCccceeccccccccccccCCccCC
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---------------TAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
++|+||||+||+++.+ +.++|+|||++......... ....|++.|+|||.+.+ ..+
T Consensus 129 ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~ 199 (310)
T 3s95_A 129 IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--------RSY 199 (310)
T ss_dssp EECSCCSTTSEEECTT-SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT--------CCC
T ss_pred ccCCCCCcCeEEECCC-CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC--------CCC
Confidence 9999999999999955 46999999999754332211 14468999999999865 678
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 165 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+.++||||||+++|+|++|..||......... ............+..+++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus 200 ~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~ 279 (310)
T 3s95_A 200 DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279 (310)
T ss_dssp CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 89999999999999999999988653211000 00000011122456788899999999999999999999999999998
Q ss_pred hhhccCC
Q 022347 244 FLFTLRP 250 (298)
Q Consensus 244 ~~~~~~~ 250 (298)
+...+..
T Consensus 280 l~~~~~~ 286 (310)
T 3s95_A 280 LRMHLAG 286 (310)
T ss_dssp HHHHHHH
T ss_pred HHHhccC
Confidence 8766543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=303.66 Aligned_cols=217 Identities=29% Similarity=0.499 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..++|.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|
T Consensus 89 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ 167 (373)
T 2qol_A 89 QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG 167 (373)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457899999999999999999999985 45789999999999999999763 346999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+||||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+
T Consensus 168 ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~SlG~ 238 (373)
T 2qol_A 168 YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------RKFTSASDVWSYGI 238 (373)
T ss_dssp CCCSCCCGGGEEECTT-CCEEECCC----------------------CTTSCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred eeCCCCCcceEEEcCC-CCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc--------CCcCchhcHHHHHH
Confidence 9999999999999955 4699999999975433211 112234678999999865 67889999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 176 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
++|++++ |..||....... .............+..++..+.+++.+||+.+|.+||++.++++.|+.++...
T Consensus 239 il~ellt~g~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 239 VLWEVMSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHTTC-CTTTTCCHHH-HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 9999998 999998766543 33444444555667789999999999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=304.69 Aligned_cols=218 Identities=29% Similarity=0.502 Sum_probs=183.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~L 95 (298)
..++.+|+.++++++||||+++++++. +...++||||++||+|.+++..... ..+++..++.++.|++.||+||
T Consensus 118 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 197 (367)
T 3l9p_A 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197 (367)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH
Confidence 346889999999999999999999985 5578999999999999999987542 4589999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCC--CceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|+.||+||||||+||+++.++ ..++|+|||++...... .......+++.|+|||++.+ ..++.++||
T Consensus 198 H~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Dv 269 (367)
T 3l9p_A 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDT 269 (367)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--------CCCCHHHHH
T ss_pred HhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC--------CCCCcHHHH
Confidence 999999999999999998433 35999999998743221 22233457889999999865 678899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 171 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 171 ~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|||||++|+|++ |..||...... ..............+..++..+.+++.+||+.+|.+|||+.+++++|+.+....
T Consensus 270 wslG~il~ellt~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 270 WSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 999999999998 99999876653 344455555666777889999999999999999999999999999998876544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=298.92 Aligned_cols=216 Identities=26% Similarity=0.515 Sum_probs=182.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+++.+|+.++++++||||+++++++.++..++|+||+.+|+|.+++... ...+++..++.++.|++.||.|||+.||
T Consensus 60 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i 138 (327)
T 3poz_A 60 ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRL 138 (327)
T ss_dssp CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence 345788999999999999999999999888899999999999999999863 3569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 139 vH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il 209 (327)
T 3poz_A 139 VHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTV 209 (327)
T ss_dssp CCSCCCGGGEEEEET-TEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred eCCCCChheEEECCC-CCEEEccCcceeEccCCcccccccCCCccccccChHHhcc--------CCCCchhhhhhhHHHH
Confidence 999999999999955 569999999987533222 2223356779999999875 6788999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 178 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+|++ |..||.+..... .............+..++..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 210 ~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 210 WELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHTTSCCTTTTCCGGG-HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHhcCCCCccCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 99999 999998765433 3344444555667788999999999999999999999999999999887653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=299.16 Aligned_cols=212 Identities=18% Similarity=0.331 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++||||+++++++. .+..++||||++|++|.+++... ...+++..++.++.|++.||.|||+.||+
T Consensus 46 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~giv 124 (321)
T 1tki_A 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIG 124 (321)
T ss_dssp HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46789999999999999999999985 56799999999999999999752 34699999999999999999999999999
Q ss_pred eecCCCCCEEEcCC-CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ .+.++|+|||++.............+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 125 H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l 196 (321)
T 1tki_A 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC--------CCCCchhhHHHHHHHHHHH
Confidence 99999999999853 45799999999986655444455678999999999864 5578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||.+.......... ... ...++ ..+++++.+++.+||..||.+|||+.++++ +.|+..
T Consensus 197 l~g~~pf~~~~~~~~~~~i-~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 263 (321)
T 1tki_A 197 LSGINPFLAETNQQIIENI-MNA-EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ 263 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHH-HHT-CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred HhCCCCCcCCCHHHHHHHH-HcC-CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc--Chhhcc
Confidence 9999999886654433322 222 22222 468999999999999999999999999998 666654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=302.42 Aligned_cols=217 Identities=29% Similarity=0.555 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceeec--CceeEEEecCCCCCHHHHHhhhCC-------------------------
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP------------------------- 73 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~------------------------- 73 (298)
.+++.+|+.++.++ +||||+++++++.+ ...++||||++||+|.+++.....
T Consensus 69 ~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (359)
T 3vhe_A 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148 (359)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------
T ss_pred HHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchh
Confidence 35788999999999 79999999999853 358999999999999999986432
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcC
Q 022347 74 ---------------------------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 114 (298)
Q Consensus 74 ---------------------------------------~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~ 114 (298)
..+++..++.++.|++.||+|||+.||+||||||+||+++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~ 228 (359)
T 3vhe_A 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 228 (359)
T ss_dssp -----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred hhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC
Confidence 11889999999999999999999999999999999999985
Q ss_pred CCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 022347 115 DQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 190 (298)
Q Consensus 115 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~ 190 (298)
+ +.++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.
T Consensus 229 ~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 229 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp G-GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred C-CcEEEEeccceeeecccccchhccccCCCceeEChhhhcC--------CCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 5 469999999997543221 2233457889999999865 668899999999999999998 99999887
Q ss_pred ChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 191 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
..................+..+++++.+++.+||+.+|.+|||+.+++++|+.++..
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 300 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 765666666666677778888999999999999999999999999999999988764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=286.92 Aligned_cols=213 Identities=30% Similarity=0.555 Sum_probs=181.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++
T Consensus 50 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 128 (269)
T 4hcu_A 50 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVI 128 (269)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46789999999999999999999985 4578999999999999999976 335699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 129 H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ 199 (269)
T 4hcu_A 129 HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWE 199 (269)
T ss_dssp CSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred cCCcchheEEEcCC-CCEEeccccccccccccccccccCcccccccCCHHHhcC--------CCCCchhhhHHHHHHHHH
Confidence 99999999999855 469999999997543322 2233456778999999865 568899999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++ |..||...... ..............+..+++.+.+++.+||+.+|.+|||+.+++++|+.+..
T Consensus 200 ll~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 200 VFSEGKIPYENRSNS-EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHTTSCCTTTTCCHH-HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCCCCCCHH-HHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 999 99999876654 3344445555666777899999999999999999999999999999998765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=289.83 Aligned_cols=210 Identities=36% Similarity=0.710 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG- 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g- 99 (298)
.+.+.+|+.+++.++||||+++++++. ++..++||||++|++|.+++.. ..+++..++.++.|++.||.|||+.|
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~ 126 (271)
T 3dtc_A 50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAI 126 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357889999999999999999999985 5578999999999999999864 56999999999999999999999999
Q ss_pred --CeeecCCCCCEEEcCC-------CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 100 --IIHRDLKPDNLLLTPD-------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 100 --ivH~dik~~Nil~~~~-------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
++||||||+||+++.+ .+.++|+|||++........ ....+++.|+|||.+.+ ..++.++||
T Consensus 127 ~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~--------~~~~~~~Di 197 (271)
T 3dtc_A 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRA--------SMFSKGSDV 197 (271)
T ss_dssp SCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHH--------CCCSHHHHH
T ss_pred CceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhcc--------CCCCchhhH
Confidence 8999999999999852 45699999999975443322 24468999999999865 567889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
||||+++|+|++|..||.+...................+..+++.+.+++.+||+.+|.+|||+.+++++|+.
T Consensus 198 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 198 WSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 9999999999999999998877666555555556667788899999999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=299.28 Aligned_cols=219 Identities=29% Similarity=0.517 Sum_probs=182.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC----------------------CCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP----------------------NKLD 77 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~~~ 77 (298)
..+.+.+|+.++++++||||+++++++. ++..|+||||+++++|.+++..... ..++
T Consensus 93 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 172 (343)
T 1luf_A 93 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172 (343)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCC
Confidence 4457889999999999999999999985 5678999999999999999987431 5689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceecccccccc
Q 022347 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTV 154 (298)
Q Consensus 78 ~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 154 (298)
+..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+
T Consensus 173 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~- 250 (343)
T 1luf_A 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY- 250 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-
Confidence 99999999999999999999999999999999999955 469999999987533221 2233457889999998865
Q ss_pred ccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 155 TLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 155 ~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
..++.++||||||+++|+|++ |..||.+..... .............+..+++.+.+++.+||+.+|.+|||
T Consensus 251 -------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 322 (343)
T 1luf_A 251 -------NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322 (343)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 568899999999999999999 999998766533 34444555566778889999999999999999999999
Q ss_pred HHHHHHHHHhhhhccC
Q 022347 234 FSQIIRMLNAFLFTLR 249 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~~ 249 (298)
+.++++.|+.+.....
T Consensus 323 ~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 323 FCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHHHHHHHHTTC---
T ss_pred HHHHHHHHHHHHhhhh
Confidence 9999999998776543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=305.40 Aligned_cols=213 Identities=23% Similarity=0.349 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||
T Consensus 54 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~gi 131 (444)
T 3soa_A 54 HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGV 131 (444)
T ss_dssp HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 457889999999999999999999985 55789999999999999999864 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcC--CCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTP--DQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~--~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+||||||+||+++. +++.++|+|||++....... ......|++.|+|||++.+ ..++.++||||||+++
T Consensus 132 vHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvil 203 (444)
T 3soa_A 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK--------DPYGKPVDLWACGVIL 203 (444)
T ss_dssp BCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHH
T ss_pred cccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC--------CCCCCccccHHHHHHH
Confidence 99999999999984 23569999999997654432 2345579999999999864 5688999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|+|++|..||.+.+............... .....+++++.+++.+||+.||.+|||+.++++ +.|+.
T Consensus 204 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~--hp~~~ 272 (444)
T 3soa_A 204 YILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK--HPWIS 272 (444)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SCTTH
T ss_pred HHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Ccccc
Confidence 99999999998766544333322222211 222468999999999999999999999999998 55554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=290.37 Aligned_cols=214 Identities=28% Similarity=0.514 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+++.+|+.++++++||||+++++++.++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 57 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 135 (281)
T 3cc6_A 57 KEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCV 135 (281)
T ss_dssp HHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45788999999999999999999999888889999999999999999764 34589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 136 H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 206 (281)
T 3cc6_A 136 HRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMWE 206 (281)
T ss_dssp CCCCSGGGEEEEET-TEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred cCCCccceEEECCC-CcEEeCccCCCcccccccccccccCCCCcceeCchhhcc--------CCCCchhccHHHHHHHHH
Confidence 99999999999955 5799999999876443321 233456788999998864 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++ |..||........ ............+..+++.+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 207 llt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 207 ILSFGKQPFFWLENKDV-IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHTTTCCTTTTSCGGGH-HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCcccCChHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 998 9999976554333 33334445566677899999999999999999999999999999988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=289.03 Aligned_cols=214 Identities=28% Similarity=0.492 Sum_probs=183.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+++.+|+.++++++||||+++++++.+ +..++||||+++++|.+++.......+++..++.++.|++.||.|||+.
T Consensus 51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (271)
T 3kmu_A 51 SRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130 (271)
T ss_dssp HHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 3578899999999999999999999853 5689999999999999999875545699999999999999999999999
Q ss_pred C--CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 99 G--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 99 g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
| ++|+||||+||+++.+ +.++|+|||++..... ....+++.|+|||.+.+.. ...++.++||||||++
T Consensus 131 ~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~-----~~~~~~~~Di~slG~i 200 (271)
T 3kmu_A 131 EPLIPRHALNSRSVMIDED-MTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKP-----EDTNRRSADMWSFAVL 200 (271)
T ss_dssp SSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCG-----GGSCHHHHHHHHHHHH
T ss_pred CCceecCCCccceEEEcCC-cceeEEeccceeeecc----cCccCCccccChhhhccCC-----CCCCCchhhHHHHHHH
Confidence 9 9999999999999955 4589998887754222 2346789999999986511 1234458999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
+|+|++|..||.+................+..+..+++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 201 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 201 LWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999999999999887766666666667778888899999999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=309.26 Aligned_cols=217 Identities=34% Similarity=0.537 Sum_probs=185.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.|.+|+.++++++||||+++++++.++..|+||||+++|+|.+++.......+++..++.++.|++.||+|||++||+|
T Consensus 228 ~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 307 (454)
T 1qcf_A 228 EAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307 (454)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 57889999999999999999999998888999999999999999998644346899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+|||++.+ +.+||+|||++....... ......++..|+|||++.. ..++.++||||||+++|+|
T Consensus 308 rDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el 378 (454)
T 1qcf_A 308 RDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEI 378 (454)
T ss_dssp SSCSGGGEEECTT-CCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEECCC-CcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc--------CCCCcHHHHHhHHHHHHHH
Confidence 9999999999955 569999999998644322 1223345778999999864 5688999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
++ |..||.+....+. ........+...+..+++++.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 379 ~t~g~~P~~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 379 VTYGRIPYPGMSNPEV-IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp HTTSCCSSTTCCHHHH-HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred HhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 99 9999988765443 34444556667788899999999999999999999999999999998876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=287.11 Aligned_cols=221 Identities=34% Similarity=0.643 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHA--- 97 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~--- 97 (298)
.+.|.+|+.++++++||||+++++++.+ ..++||||++|++|.+++..... ..++...++.++.|++.||+|||+
T Consensus 45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~ 123 (307)
T 2eva_A 45 RKAFIVELRQLSRVNHPNIVKLYGACLN-PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123 (307)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEBCTT-TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcC-CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3578899999999999999999998874 47899999999999999986432 247899999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+||+||||||+||+++.++..++|+|||++...... .....++..|+|||++.+ ..++.++||||||+++
T Consensus 124 ~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il 193 (307)
T 2eva_A 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG--------SNYSEKCDVFSWGIIL 193 (307)
T ss_dssp SCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC--------CCCCTHHHHHHHHHHH
T ss_pred CCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC--------CCCCcHHHHHHHHHHH
Confidence 899999999999999966656899999998754322 223468999999999864 5688999999999999
Q ss_pred HHHHhCCCCCCCCCh-HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 022347 178 WELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 253 (298)
|+|++|..||..... .............+..+..+++.+.+++.+||+.+|.+|||+.++++.|+.+.........
T Consensus 194 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 194 WEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp HHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred HHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 999999999986533 2233334445556677788999999999999999999999999999999998877665443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=307.90 Aligned_cols=219 Identities=30% Similarity=0.497 Sum_probs=183.1
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.|.+|+.++++++||||+++++++.++..++||||+++|+|.+++.......+++..++.++.|++.||+|||++||+|
T Consensus 224 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 303 (452)
T 1fmk_A 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303 (452)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 46889999999999999999999998788999999999999999997644456999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 304 rDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el 374 (452)
T 1fmk_A 304 RDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTEL 374 (452)
T ss_dssp SCCSGGGEEECGG-GCEEECCCCTTC--------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred CCCChhhEEECCC-CCEEECCCccceecCCCceecccCCcccccccCHhHHhc--------CCCCccccHHhHHHHHHHH
Confidence 9999999999854 469999999997643322 1122345678999998865 5688999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
++ |..||.+....+ .........+...+..+++.+.+++.+||+.+|.+|||++++++.|+.+.....+.
T Consensus 375 ~t~g~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 375 TTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp HTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred HhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 99 999998876544 33444556667778889999999999999999999999999999999988765543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=299.64 Aligned_cols=207 Identities=26% Similarity=0.409 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 73 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iv 150 (362)
T 2bdw_A 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIV 150 (362)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 47889999999999999999999985 45789999999999999999753 4589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCC--CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.++ ..++|+|||++.............|++.|+|||++.+ ..++.++||||||+++|+
T Consensus 151 H~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ 222 (362)
T 2bdw_A 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYI 222 (362)
T ss_dssp CCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHH
T ss_pred eccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 999999999998543 3699999999987655544455679999999999864 568899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|..||.+.+................ ....+++++.++|.+||+.||.+|||+.++++
T Consensus 223 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 223 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999999987665433322222211111 11357899999999999999999999999988
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=304.90 Aligned_cols=216 Identities=31% Similarity=0.560 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..++|.+|+.++++++||||+++++++. ++..|+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.|
T Consensus 155 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ 233 (377)
T 3cbl_A 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC 233 (377)
T ss_dssp HHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999985 45789999999999999999763 245899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccccc---ccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++||||||+||+++.+ +.++|+|||++......... ....++..|+|||.+.+ ..++.++||||||++
T Consensus 234 ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~i 304 (377)
T 3cbl_A 234 CIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGIL 304 (377)
T ss_dssp EECSCCSGGGEEECTT-CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred cCCcccCHHHEEEcCC-CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc--------CCCCchhhHHHHHHH
Confidence 9999999999999955 46999999998754332211 11234668999999865 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|+|++ |..||.+..... .............+..+++++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 305 l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 305 LWETFSLGASPYPNLSNQQ-TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHTTSCCSSTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 999998 999998876543 3344455566777888999999999999999999999999999999887653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=294.89 Aligned_cols=217 Identities=27% Similarity=0.489 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. .+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|+
T Consensus 90 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (333)
T 1mqb_A 90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNY 168 (333)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 457889999999999999999999985 46799999999999999999763 3569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||++
T Consensus 169 vH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 239 (333)
T 1mqb_A 169 VHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIV 239 (333)
T ss_dssp CCSCCCGGGEEECTT-CCEEECCCCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHH
T ss_pred eCCCCChheEEECCC-CcEEECCCCcchhhccccccccccCCCCccccccCchhccc--------CCCCchhhhHHHHHH
Confidence 999999999999955 469999999997543321 1122345778999999864 568889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+|+|++ |..||....... .............+..+++.+.+++.+||+.+|.+||++.++++.|+.++....
T Consensus 240 l~ellt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 240 MWEVMTYGERPYWELSNHE-VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp HHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHHHHcCCCCCcccCCHHH-HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 999999 999998766533 344444555666677899999999999999999999999999999998876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=290.37 Aligned_cols=216 Identities=26% Similarity=0.515 Sum_probs=183.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+++.+|+.++++++||||+++++++.++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|+
T Consensus 61 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i 138 (291)
T 1xbb_A 61 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 138 (291)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 356788999999999999999999999888899999999999999999863 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||++
T Consensus 139 ~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 209 (291)
T 1xbb_A 139 VHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVL 209 (291)
T ss_dssp ECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred EcCCCCcceEEEeCC-CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc--------CCCChhhhHHHHHHH
Confidence 999999999999955 5799999999875433221 222345688999999865 557889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+|+|++ |..||.+..... ..........+..+..+++.+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus 210 l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 210 MWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 999999 999998766533 34444555567778889999999999999999999999999999999988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=296.80 Aligned_cols=210 Identities=25% Similarity=0.382 Sum_probs=177.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+
T Consensus 60 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giv 137 (361)
T 2yab_A 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIA 137 (361)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46789999999999999999999996 4578999999999999999975 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCC---ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||+||+++.++. .++|+|||++.............|++.|+|||++.+ ..++.++||||||+++|
T Consensus 138 HrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~ 209 (361)
T 2yab_A 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITY 209 (361)
T ss_dssp CCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC--------CCCCccccHHHHHHHHH
Confidence 9999999999985553 699999999986655544556679999999999864 56889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|++|..||.+.+..... ..... ....+ ...+++.+.+||.+||..||.+|||+.++++ +.|+.
T Consensus 210 ~ll~g~~Pf~~~~~~~~~-~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~ 277 (361)
T 2yab_A 210 ILLSGASPFLGDTKQETL-ANITA-VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR--HPWIT 277 (361)
T ss_dssp HHHHSCCSSCCSSHHHHH-HHHHT-TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTS
T ss_pred HHHhCCCCCCCCCHHHHH-HHHHh-cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CcCcC
Confidence 999999999876654333 22222 22222 2568899999999999999999999999997 45543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=288.26 Aligned_cols=222 Identities=24% Similarity=0.518 Sum_probs=188.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+++.+|+.++++++||||+++++++.++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|+
T Consensus 53 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 131 (287)
T 1u59_A 53 DTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNF 131 (287)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34578899999999999999999999988889999999999999999975 34569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||++
T Consensus 132 ~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 202 (287)
T 1u59_A 132 VHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVT 202 (287)
T ss_dssp ECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHH
T ss_pred eeCCCchheEEEcCC-CCEEECcccceeeeccCcceeeccccccccccccCHHHhcc--------CCCCchhhHHHHHHH
Confidence 999999999999954 5799999999975433221 223346789999999864 567889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 253 (298)
+|+|++ |..||....... ..........+..+..+++++.+++.+||+.+|.+|||+.+++++|+.++.+...+..
T Consensus 203 l~ellt~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 203 MWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp HHHHHTTSCCTTTTCCTHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHcCCCCCcccCCHHH-HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 999998 999998766543 3344455556777888999999999999999999999999999999999887665443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=291.48 Aligned_cols=219 Identities=32% Similarity=0.527 Sum_probs=185.7
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC----------------CCCCHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP----------------NKLDLHVALN 83 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~~~ 83 (298)
.+.+.+|+.+++++ +||||+++++++. ++..++||||+++++|.+++..... ..+++..++.
T Consensus 70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (313)
T 1t46_A 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149 (313)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred HHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHH
Confidence 35788999999999 8999999999985 5678999999999999999987432 2489999999
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCC
Q 022347 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGE 160 (298)
Q Consensus 84 i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 160 (298)
++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+
T Consensus 150 ~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------- 221 (313)
T 1t46_A 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN------- 221 (313)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------
T ss_pred HHHHHHHHHHHHHHCCeecCCCccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC-------
Confidence 99999999999999999999999999999955 5799999999976543322 223346778999998865
Q ss_pred ccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 161 KKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 161 ~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
..++.++||||||+++|+|++ |..||.+...................+..++..+.+++.+||+.||.+|||+.++++
T Consensus 222 -~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 222 -CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 568899999999999999998 999998876555555555555566667789999999999999999999999999999
Q ss_pred HHHhhhhccC
Q 022347 240 MLNAFLFTLR 249 (298)
Q Consensus 240 ~l~~~~~~~~ 249 (298)
.|+..+.+..
T Consensus 301 ~L~~~~~~~~ 310 (313)
T 1t46_A 301 LIEKQISEST 310 (313)
T ss_dssp HHHHHHHHTC
T ss_pred HHHHHHHHhh
Confidence 9999887643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=292.01 Aligned_cols=216 Identities=28% Similarity=0.556 Sum_probs=182.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC----------------------CCCCH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP----------------------NKLDL 78 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~~~~ 78 (298)
.+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++..... ..+++
T Consensus 70 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (314)
T 2ivs_A 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149 (314)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECH
T ss_pred HHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCH
Confidence 357889999999999999999999985 5679999999999999999987432 23899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccc
Q 022347 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVT 155 (298)
Q Consensus 79 ~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 155 (298)
..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+
T Consensus 150 ~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 226 (314)
T 2ivs_A 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-- 226 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--
T ss_pred HHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC--
Confidence 9999999999999999999999999999999999954 569999999997543322 2233456788999999865
Q ss_pred cccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 022347 156 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234 (298)
Q Consensus 156 ~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (298)
..++.++||||||+++|+|++ |..||.+..... .............+..+++++.+++.+||+.||.+|||+
T Consensus 227 ------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 299 (314)
T 2ivs_A 227 ------HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVF 299 (314)
T ss_dssp ------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ------CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 567889999999999999999 999998765433 334444555667778899999999999999999999999
Q ss_pred HHHHHHHHhhhhc
Q 022347 235 SQIIRMLNAFLFT 247 (298)
Q Consensus 235 ~~l~~~l~~~~~~ 247 (298)
.++++.|+.++..
T Consensus 300 ~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 300 ADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhh
Confidence 9999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.66 Aligned_cols=220 Identities=29% Similarity=0.472 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.|
T Consensus 54 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ 131 (294)
T 4eqm_A 54 TLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR 131 (294)
T ss_dssp HHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4467889999999999999999999985 45789999999999999999875 45999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
++||||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 132 i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l 202 (294)
T 4eqm_A 132 IVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG--------EATDECTDIYSIGIVL 202 (294)
T ss_dssp CCCCCCCGGGEEECTT-SCEEECCCSSSTTC-------------CCSSCCHHHHHT--------CCCCTTHHHHHHHHHH
T ss_pred cccCCCCHHHEEECCC-CCEEEEeCCCccccccccccccCccccCccccCHhHhcC--------CCCCchHhHHHHHHHH
Confidence 9999999999999955 469999999997654332 2233468999999999865 5678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCC----CCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHhhhhccCCCC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~l~~~l~~~~~~~~~~~ 252 (298)
|+|++|..||.+............ ...+ ..+..+++.+.+++.+||+.||.+|| ++.++.+.|..++...+...
T Consensus 203 ~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 203 YEMLVGEPPFNGETAVSIAIKHIQ-DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HHHHHSSCSSCSSCHHHHHHHHHS-SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred HHHHhCCCCCCCCChHHHHHHHhh-ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 999999999988765544333332 2222 23467899999999999999999998 89999999988776655433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=288.42 Aligned_cols=218 Identities=31% Similarity=0.562 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+.+.+|+.++++++||||+++++++.++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 64 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~ 142 (289)
T 3og7_A 64 LQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSII 142 (289)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 35788999999999999999999988888899999999999999999653 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc---ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||+||+++.+ +.++|+|||++..... ........+++.|+|||.+... ....++.++||||||+++|
T Consensus 143 H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~ 216 (289)
T 3og7_A 143 HRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVLY 216 (289)
T ss_dssp CSCCCGGGEEEETT-TEEEECCCC------------------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHHH
T ss_pred cccCccceEEECCC-CCEEEccceeccccccccccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHHH
Confidence 99999999999955 5799999999875432 2222344689999999988521 1256788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|++|..||.+................. .....+++.+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 217 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 9999999998876655555444433322 2345788999999999999999999999999999988654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=299.99 Aligned_cols=214 Identities=21% Similarity=0.375 Sum_probs=178.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
..+.+|+.++++++||||+++++++. +...++||||++|++|.+++... ...+++..++.++.|++.||.|||+.||+
T Consensus 93 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giv 171 (387)
T 1kob_A 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIV 171 (387)
T ss_dssp HHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46889999999999999999999985 45799999999999999998752 34699999999999999999999999999
Q ss_pred eecCCCCCEEEcCC-CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ .+.++|+|||++.............+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 172 HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 243 (387)
T 1kob_A 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVL 243 (387)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHH
T ss_pred ecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC--------CCCCCcccEeeHhHHHHHH
Confidence 99999999999743 35699999999986655444445578999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||.+.+............. .......+++++.++|.+||+.||.+|||+.++++ +.|+..
T Consensus 244 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 310 (387)
T 1kob_A 244 LSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLKG 310 (387)
T ss_dssp HHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTSS
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh--CccccC
Confidence 999999988765444333222211 22333568999999999999999999999999998 566554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=286.31 Aligned_cols=220 Identities=31% Similarity=0.518 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.+.+|+.++++++||||+++++++.++..++||||+++++|.+++.......+++..++.++.|++.||+|||+.|++|
T Consensus 53 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 132 (279)
T 1qpc_A 53 DAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132 (279)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 46889999999999999999999998888999999999999999997643346999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 133 ~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 203 (279)
T 1qpc_A 133 RDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEI 203 (279)
T ss_dssp SCCSGGGEEECTT-SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHH
T ss_pred cCCCHhhEEEcCC-CCEEECCCcccccccCcccccccCCCCccCccChhhhcc--------CCCCchhhhHHHHHHHHHH
Confidence 9999999999955 5699999999975443221 223346778999999864 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
++ |..||.+..... .............+..+++++.+++.+||..+|.+|||+.++++.|+.++.......
T Consensus 204 ~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 204 VTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp HTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred HhCCCCCCcccCHHH-HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 99 999998766543 334444555566778899999999999999999999999999999999987755433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=296.52 Aligned_cols=219 Identities=32% Similarity=0.530 Sum_probs=182.9
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC---------------------CCCCH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---------------------NKLDL 78 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~ 78 (298)
.+.+.+|+.+++++ +||||+++++++. ++..++||||+++|+|.+++..... ..+++
T Consensus 92 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 171 (344)
T 1rjb_A 92 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171 (344)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCH
Confidence 35788999999999 8999999999985 5679999999999999999986432 23789
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccc
Q 022347 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVT 155 (298)
Q Consensus 79 ~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 155 (298)
..++.++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+
T Consensus 172 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-- 248 (344)
T 1rjb_A 172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-- 248 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--
Confidence 9999999999999999999999999999999999955 5799999999975433221 223346778999998864
Q ss_pred cccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 022347 156 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234 (298)
Q Consensus 156 ~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 234 (298)
..++.++||||||+++|+|++ |..||.+...................+..+++++.+++.+||+.||.+|||+
T Consensus 249 ------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 249 ------GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp ------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ------CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 568899999999999999998 9999988765555555555566667778899999999999999999999999
Q ss_pred HHHHHHHHhhhhccC
Q 022347 235 SQIIRMLNAFLFTLR 249 (298)
Q Consensus 235 ~~l~~~l~~~~~~~~ 249 (298)
.+++++|+..+....
T Consensus 323 ~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 323 PNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHHHHHC----
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999998876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.64 Aligned_cols=219 Identities=24% Similarity=0.528 Sum_probs=185.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
++|.+|+.++++++||||+++++++.++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+|
T Consensus 381 ~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 459 (613)
T 2ozo_A 381 EEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459 (613)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEc
Confidence 478899999999999999999999988889999999999999999975 3456999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|||||+|||++.+ +.+||+|||++........ .....++..|+|||++.+ ..++.++||||||+++|
T Consensus 460 rDlkp~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 460 RNLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp SCCSGGGEEEEET-TEEEECCCSTTTTCC--------------CCTTSCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred CcCCHHHEEEcCC-CcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC--------CCCCcHHHHHHHHHHHH
Confidence 9999999999954 5799999999986533221 122245578999999865 67889999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 179 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 179 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+|++ |..||.+....+ .......+.+...+..+++++.+++.+||+.+|.+|||+.++++.|+.++.......
T Consensus 531 ellt~G~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp HHHTTSCCTTTTCCSHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred HHHHCCCCCCCCCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 9998 999998876544 344455566777888899999999999999999999999999999999987765544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=288.23 Aligned_cols=218 Identities=28% Similarity=0.520 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+++.+|+.++++++||||+++++++ .++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|
T Consensus 70 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~ 148 (298)
T 3f66_A 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK 148 (298)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35788999999999999999999986 34578999999999999999975 3356899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
++||||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||
T Consensus 149 i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 219 (298)
T 3f66_A 149 FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFG 219 (298)
T ss_dssp CCCSCCSGGGEEECTT-CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH--------CCCCHHHHHHHHH
T ss_pred ccCCCCchheEEECCC-CCEEECcccccccccccchhccccccCCCCCccccChHHhcC--------CCCChHHHHHHHH
Confidence 9999999999999955 469999999997543322 1223356778999999865 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 175 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 175 ~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
+++|+|++ |..||....... .............+..+++.+.+++.+||+.+|.+|||+.++++.|+.++.....
T Consensus 220 ~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 220 VLLWELMTRGAPPYPDVNTFD-ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHHHHTTSCCSSTTSCTTT-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHHHHHhCCCCCCccCCHHH-HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 99999999 566676554433 3334445555666778999999999999999999999999999999998876544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=285.56 Aligned_cols=211 Identities=34% Similarity=0.630 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--I 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g--i 100 (298)
+++.+|+.++++++||||+++++++.+.. ++||||+++++|.+++... ...+++..++.++.|++.||+|||+.| +
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 145 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT-EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC-eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence 57889999999999999999999986554 7999999999999988753 356999999999999999999999999 9
Q ss_pred eeecCCCCCEEEcCCCC----ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQK----SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|+||||+||+++.++. .++|+|||++..... ......+++.|+|||.+.+ ....++.++||||||++
T Consensus 146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~ 217 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMI 217 (287)
T ss_dssp BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHH
T ss_pred ecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhcc------CCCCcCchhhHHHHHHH
Confidence 99999999999985442 389999999975433 2334578999999998843 23567889999999999
Q ss_pred HHHHHhCCCCCCCCChHHH--HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 177 LWELLTNRLPFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+|+|++|..||........ ..........+.++..+++++.+++.+||+.||.+|||+.++++.|+.
T Consensus 218 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 9999999999987653332 233334455667788899999999999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=318.89 Aligned_cols=216 Identities=26% Similarity=0.518 Sum_probs=183.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+++.+|+.++++++||||+++++++.++..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++||
T Consensus 413 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~i 490 (635)
T 4fl3_A 413 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 490 (635)
T ss_dssp GHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 346788999999999999999999999888899999999999999999763 469999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+||||||+|||++.+ +.++|+|||++....... ......++..|+|||++.+ ..++.++||||||++
T Consensus 491 iHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~sDvwSlGv~ 561 (635)
T 4fl3_A 491 VHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVL 561 (635)
T ss_dssp CCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-------------CGGGSCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred eCCCCChHhEEEeCC-CCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC--------CCCCcHHHHHHHHHH
Confidence 999999999999955 579999999987543322 1223346778999999865 678899999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+|+|++ |..||.+..... .............+..+++++.++|..||+.||.+|||+.++++.|+.+..++
T Consensus 562 l~ellt~G~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 562 MWEAFSYGQKPYRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999998 999998876543 44455566677788899999999999999999999999999999999887654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=286.41 Aligned_cols=221 Identities=28% Similarity=0.431 Sum_probs=183.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec--CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|+.++++++||||+++++++.+ ...++||||+.+++|.+++.. ....+++..++.++.|++.||+|||+.|
T Consensus 66 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (298)
T 3pls_A 66 VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK 144 (298)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578899999999999999999999843 345899999999999999976 3456899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
++||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||
T Consensus 145 i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 215 (298)
T 3pls_A 145 FVHRDLAARNCMLDES-FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT--------YRFTTKSDVWSFG 215 (298)
T ss_dssp CCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT--------CCCCHHHHHHHHH
T ss_pred cccCCCCcceEEEcCC-CcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc--------CCCChhhchhhHH
Confidence 9999999999999955 469999999997543322 2233457889999999864 6688999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+++|+|++|..|+....+................+..+++.+.+++.+||+.+|.+|||+.++++.|+.++..+....
T Consensus 216 ~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 216 VLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp HHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 999999996555444333344445555555666778899999999999999999999999999999999988765433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=295.19 Aligned_cols=214 Identities=27% Similarity=0.525 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+++.+|+.++++++||||+++++++.++..++|++|+.+|+|.+++... ...+++..++.++.|++.||.|||+.||+|
T Consensus 62 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 140 (327)
T 3lzb_A 62 KEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140 (327)
T ss_dssp HHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCeeEEEEEEecCCceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcC
Confidence 4678999999999999999999999877899999999999999999863 356999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 141 ~Dikp~NIl~~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~e 211 (327)
T 3lzb_A 141 RDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWE 211 (327)
T ss_dssp SCCCGGGEEEEET-TEEEECCTTC----------------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCC-CCEEEccCcceeEccCccccccccCCCccccccCHHHHcC--------CCCChHHHHHHHHHHHHH
Confidence 9999999999855 5699999999975433222 223346778999999875 678899999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++ |..||.+..... .............+..++.++.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 212 ll~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 212 LMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHTTSCCTTTTCCGGG-HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHCCCCCCCCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 999 999998765533 3344445556667788999999999999999999999999999999988754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=292.64 Aligned_cols=219 Identities=28% Similarity=0.511 Sum_probs=175.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecC-c------eeEEEecCCCCCHHHHHhhhCC----CCCCHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-L------MVIVTELLPGMSLRKYLVSLRP----NKLDLHVALNFALDIAR 90 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~------~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~i~~qi~~ 90 (298)
.+++.+|+.++++++||||+++++++.+. . .++||||+++++|.+++..... ..+++..++.++.|++.
T Consensus 69 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~ 148 (323)
T 3qup_A 69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148 (323)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHH
Confidence 45788999999999999999999998433 2 3899999999999999975321 25899999999999999
Q ss_pred HHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCCCcc
Q 022347 91 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167 (298)
Q Consensus 91 al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 167 (298)
||.|||+.|++||||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+ ..++.+
T Consensus 149 al~~LH~~~ivH~Dikp~NIli~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~ 219 (323)
T 3qup_A 149 GMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--------NLYTVH 219 (323)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC-----------------CCGGGCCHHHHHH--------CCCCHH
T ss_pred HHHHHHcCCcccCCCCcceEEEcCC-CCEEEeeccccccccccccccccccccCcccccCchhhcC--------CCCCCc
Confidence 9999999999999999999999955 5699999999975433222 223346778999999865 568899
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 168 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 168 ~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+||||||+++|+|++ |..||.+...... ............+..+++++.+++.+||+.||.+|||+.++++.|+.++.
T Consensus 220 ~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 220 SDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhhHHHHHHHHHhCCCCCccccChHHH-HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999 9999987665443 34444555667778899999999999999999999999999999999887
Q ss_pred ccCC
Q 022347 247 TLRP 250 (298)
Q Consensus 247 ~~~~ 250 (298)
....
T Consensus 299 ~~~~ 302 (323)
T 3qup_A 299 HLSV 302 (323)
T ss_dssp C---
T ss_pred Hhhh
Confidence 6543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=300.19 Aligned_cols=214 Identities=25% Similarity=0.377 Sum_probs=177.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ...+++..++.++.|++.||+|||+.||
T Consensus 130 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i 208 (373)
T 2x4f_A 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYI 208 (373)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 357889999999999999999999985 45789999999999999988752 3458999999999999999999999999
Q ss_pred eeecCCCCCEEEc-CCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||++. .+.+.++|+|||++.............+++.|+|||++.+ ..++.++||||||+++|+
T Consensus 209 vH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 280 (373)
T 2x4f_A 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY--------DFVSFPTDMWSVGVIAYM 280 (373)
T ss_dssp ECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT--------CBCCHHHHHHHHHHHHHH
T ss_pred ccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC--------CCCCcHHhHHHHHHHHHH
Confidence 9999999999984 2445799999999987655555555679999999998864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++|..||.+.+............... .....+++++.+||.+||+.||.+|||+.++++ +.|+.
T Consensus 281 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~--hp~~~ 347 (373)
T 2x4f_A 281 LLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK--HPWLS 347 (373)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcCcC
Confidence 999999998876554433333222111 122468999999999999999999999999998 45543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=287.56 Aligned_cols=208 Identities=24% Similarity=0.424 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+
T Consensus 50 ~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iv 127 (337)
T 1o6l_A 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVV 127 (337)
T ss_dssp HHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46779999999999999999999985 55799999999999999999764 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.++ .++|+|||++.... .........||+.|+|||++.+ ..++.++|+||||+++|+|
T Consensus 128 HrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 198 (337)
T 1o6l_A 128 YRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEM 198 (337)
T ss_dssp CCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCC-CEEEeeccchhhcccCCCcccccccChhhCChhhhcC--------CCCCchhhcccchhHHHHH
Confidence 999999999999654 69999999997532 2333445678999999999864 5688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhh
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 245 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~ 245 (298)
++|..||.+.+.... ... .......+|..+++++.++|.+||+.||.+|| ++.++++ +.++
T Consensus 199 l~g~~Pf~~~~~~~~-~~~-i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~--h~~f 264 (337)
T 1o6l_A 199 MCGRLPFYNQDHERL-FEL-ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--HRFF 264 (337)
T ss_dssp HHSSCSSCCSSHHHH-HHH-HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGG
T ss_pred hcCCCCCCCCCHHHH-HHH-HHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc--CCCc
Confidence 999999987654332 222 23345567788999999999999999999999 8999988 4443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=295.00 Aligned_cols=214 Identities=27% Similarity=0.392 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+++.++||||+++++++. ++..|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.||+
T Consensus 50 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~giv 127 (323)
T 3tki_A 50 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGIT 127 (323)
T ss_dssp -CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 56789999999999999999999986 45789999999999999998753 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
||||||+||+++.+ +.++|+|||++...... .......|++.|+|||++.+ ...++.++||||||+++|
T Consensus 128 H~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ 199 (323)
T 3tki_A 128 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLT 199 (323)
T ss_dssp CSCCSGGGEEECTT-CCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC-------SSBCHHHHHHHHHHHHHH
T ss_pred ccccchHHEEEeCC-CCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc-------CCCCCCcccHHHHHHHHH
Confidence 99999999999955 46999999999754322 22335578999999999864 123477899999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+|++|..||................. .......+++.+.+|+.+||+.||.+|||+.++++ +.|+...
T Consensus 200 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~~ 268 (323)
T 3tki_A 200 AMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNKP 268 (323)
T ss_dssp HHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTCC
T ss_pred HHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh--Chhhccc
Confidence 99999999987654333333322222 12223568899999999999999999999999998 6666543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=296.90 Aligned_cols=217 Identities=29% Similarity=0.494 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC------------CCCCCHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------PNKLDLHVALNFALD 87 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~i~~q 87 (298)
.+.+.+|+.+++++ +||||+++++++. ++..++||||+++|+|.+++.... ...+++..++.++.|
T Consensus 93 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 172 (333)
T 2i1m_A 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172 (333)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHH
Confidence 35788999999999 8999999999985 567999999999999999997632 245899999999999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccCCccCC
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
++.||.|||+.||+|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..+
T Consensus 173 i~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~ 243 (333)
T 2i1m_A 173 VAQGMAFLASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------CVY 243 (333)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------CCC
T ss_pred HHHHHHHHhcCCcccCCcccceEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhcc--------CCC
Confidence 9999999999999999999999999954 5799999999975433221 223345778999998865 568
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 165 NNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+.++||||||+++|+|++ |..||.+...................+...++.+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 244 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 899999999999999998 9999987765555555555555666677889999999999999999999999999999988
Q ss_pred hhhc
Q 022347 244 FLFT 247 (298)
Q Consensus 244 ~~~~ 247 (298)
....
T Consensus 324 ~~~~ 327 (333)
T 2i1m_A 324 QAQE 327 (333)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 7654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.73 Aligned_cols=209 Identities=27% Similarity=0.427 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. .+..|+||||++||+|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 60 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~giv 137 (384)
T 4fr4_A 60 RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRII 137 (384)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 46789999999999999999999985 45799999999999999999863 4699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+||+++.++ .++|+|||++.............||+.|+|||++... ....++.++|||||||++|+|+
T Consensus 138 HrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~ell 211 (384)
T 4fr4_A 138 HRDMKPDNILLDEHG-HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYELL 211 (384)
T ss_dssp CCCCSGGGEEECTTS-CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHHH
T ss_pred eccCcHHHeEECCCC-CEEEeccceeeeccCCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHHH
Confidence 999999999999654 6999999999876555555667899999999998631 1245788999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 022347 182 TNRLPFEGMSN-LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-FSQIIR 239 (298)
Q Consensus 182 ~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~l~~ 239 (298)
+|..||..... ...............++..+++.+.++|.+||+.||.+||+ ++++++
T Consensus 212 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 212 RGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 99999975432 12222233445566778889999999999999999999998 777776
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=293.24 Aligned_cols=219 Identities=32% Similarity=0.571 Sum_probs=182.9
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~ 85 (298)
.+++.+|+.+++++ +||||+++++++. ++..|+||||+++++|.+++.... ...+++..++.++
T Consensus 69 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 148 (327)
T 1fvr_A 69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148 (327)
T ss_dssp -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHH
Confidence 34688999999999 8999999999985 567999999999999999997642 2469999999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCC
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 165 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 165 (298)
.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++
T Consensus 149 ~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~ 219 (327)
T 1fvr_A 149 ADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYT 219 (327)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEEC
T ss_pred HHHHHHHHHHHhCCccCCCCccceEEEcCC-CeEEEcccCcCccccccccccCCCCCccccChhhhcc--------ccCC
Confidence 999999999999999999999999999855 4699999999875444433344466788999999864 5678
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 166 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 166 ~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
.++||||||+++|+|++ |..||.+..... .............+..+++.+.+++.+||..+|.+|||+.++++.|+.+
T Consensus 220 ~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 220 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhcchHHHHHHHHHHcCCCCCCCCCcHHH-HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 89999999999999998 999998765433 3344444455667778999999999999999999999999999999998
Q ss_pred hhccCC
Q 022347 245 LFTLRP 250 (298)
Q Consensus 245 ~~~~~~ 250 (298)
+.....
T Consensus 299 ~~~~~~ 304 (327)
T 1fvr_A 299 LEERKT 304 (327)
T ss_dssp HHSSSC
T ss_pred HHhhcC
Confidence 876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.98 Aligned_cols=209 Identities=28% Similarity=0.397 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|..++..+ +||||+++++++. ++..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||
T Consensus 68 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gi 145 (353)
T 3txo_A 68 ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGI 145 (353)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4677899999998 6999999999996 45799999999999999999864 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.+ +.++|+|||++.... .........||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 146 vHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 216 (353)
T 3txo_A 146 IYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE--------MLYGPAVDWWAMGVLLYE 216 (353)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCSCC---------CCGGGCCHHHHHH--------HHCTTHHHHHHHHHHHHH
T ss_pred cccCCCHHHEEECCC-CCEEEccccceeecccCCccccccCCCcCeEChhhcCC--------CCcCCccCCCcchHHHHH
Confidence 999999999999965 469999999997533 2233445579999999999865 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~l~~~l~~~~~ 246 (298)
|++|..||.+.+..... .. .......++..+++.+.+++.+||+.||.+||++ .++++ +.++.
T Consensus 217 ll~G~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--hp~f~ 285 (353)
T 3txo_A 217 MLCGHAPFEAENEDDLF-EA-ILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--HPFFK 285 (353)
T ss_dssp HHHSSCSSCCSSHHHHH-HH-HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--SGGGT
T ss_pred HHhCCCCCCCCCHHHHH-HH-HHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--CCccc
Confidence 99999999886654332 22 2344556778899999999999999999999998 78877 45543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=286.25 Aligned_cols=217 Identities=27% Similarity=0.485 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+++.+|+.++++++||||+++++++. ....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 55 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (295)
T 3ugc_A 55 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK 133 (295)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 357889999999999999999999873 34689999999999999999763 34599999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||
T Consensus 134 ~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 204 (295)
T 3ugc_A 134 RYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFG 204 (295)
T ss_dssp TCCCSCCSGGGEEEEET-TEEEECCCCSCC-------------CTTCGGGGCCHHHHHH--------CCCCHHHHHHHHH
T ss_pred CcccCCCCHhhEEEcCC-CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC--------CCCChHHHHHHHH
Confidence 99999999999999955 579999999997643322 1223356778999999865 5688999999999
Q ss_pred HHHHHHHhCCCCCCCCChH---------------HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNL---------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|+|++|..||...... ...............+..+++++.+++.+||+.+|.+|||+.++++
T Consensus 205 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 205 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999988643211 1122233344566677889999999999999999999999999999
Q ss_pred HHHhhhhcc
Q 022347 240 MLNAFLFTL 248 (298)
Q Consensus 240 ~l~~~~~~~ 248 (298)
.|+.+..++
T Consensus 285 ~L~~l~~~l 293 (295)
T 3ugc_A 285 RVDQIRDNM 293 (295)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHHHhc
Confidence 999887654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=295.38 Aligned_cols=213 Identities=27% Similarity=0.410 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ....+++..++.++.|++.||+|||++
T Consensus 70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 149 (351)
T 3c0i_A 70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149 (351)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 357889999999999999999999985 56789999999999999888653 234589999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCC--CceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 99 givH~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
||+||||||+||+++.++ ..++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+
T Consensus 150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~ 221 (351)
T 3c0i_A 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR--------EPYGKPVDVWGCGV 221 (351)
T ss_dssp TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHH
T ss_pred CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC--------CCCCchHhhHHHHH
Confidence 999999999999998543 3499999999976544322 344578999999999864 56789999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++|+|++|..||.+.. ............... ...+++++.++|.+||+.||.+|||+.++++ +.|+.
T Consensus 222 il~~ll~g~~pf~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~ 291 (351)
T 3c0i_A 222 ILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN--HPWLK 291 (351)
T ss_dssp HHHHHHHSSCSSCSSH--HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred HHHHHHHCCCCCCCcH--HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Chhhc
Confidence 9999999999998743 222333322222111 1468899999999999999999999999998 44544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.43 Aligned_cols=221 Identities=20% Similarity=0.358 Sum_probs=174.4
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
...+.+.+|+.++++++||||+++++++. ++..|+||||+++++|.+++.......+++..++.++.||+.||+|||+.
T Consensus 68 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 147 (389)
T 3gni_B 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 147 (389)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34567889999999999999999999985 56799999999999999999876556799999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccc--------cccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
||+||||||+||+++.+ +.++|+|||.+...... .......++..|+|||++.+ ....++.++||
T Consensus 148 ~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~Di 220 (389)
T 3gni_B 148 GYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDI 220 (389)
T ss_dssp TEECCCCSGGGEEECTT-CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST------TSSCBCTHHHH
T ss_pred CeecCCCCHHHEEEcCC-CCEEEcccccceeeccccccccccccccccccccccccCHHHHhc------cCCCCCcHhHH
Confidence 99999999999999955 46999999987643221 11223368889999999864 12468889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh--------------------------------------------cCC
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH--------------------------------------------ARP 206 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------------------------------------------~~~ 206 (298)
|||||++|+|++|..||.+.............. ...
T Consensus 221 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (389)
T 3gni_B 221 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSH 300 (389)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------------------------------
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCC
Confidence 999999999999999998754433222111000 011
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 207 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 207 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
..+..+++.+.+||.+||+.||.+|||+.++++ +.|+....
T Consensus 301 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~--hp~f~~~~ 341 (389)
T 3gni_B 301 PYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN--HSFFKQIK 341 (389)
T ss_dssp -----CCHHHHHHHHHHTCSCTTTSCCHHHHTT--SGGGGGC-
T ss_pred ccccccCHHHHHHHHHHhhcCcccCCCHHHHhc--CHHHHHHh
Confidence 234567899999999999999999999999998 66666554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.03 Aligned_cols=219 Identities=31% Similarity=0.613 Sum_probs=184.0
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~ 85 (298)
.+++.+|+.+++++ +||||+++++++. ++..++||||+++++|.+++..... ..+++..++.++
T Consensus 84 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 163 (334)
T 2pvf_A 84 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163 (334)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHH
Confidence 35788999999999 8999999999985 5578999999999999999986432 248999999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ .
T Consensus 164 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~ 234 (334)
T 2pvf_A 164 YQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------R 234 (334)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--------C
T ss_pred HHHHHHHHHHHhCCeeCCCCccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC--------C
Confidence 999999999999999999999999999955 469999999997544322 2233456788999998865 5
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++||||||+++|+|++ |..||.+... ...............+..++.++.+++.+||+.+|.+|||+.++++.|
T Consensus 235 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 67889999999999999999 9999987654 333444455556677788999999999999999999999999999999
Q ss_pred HhhhhccCC
Q 022347 242 NAFLFTLRP 250 (298)
Q Consensus 242 ~~~~~~~~~ 250 (298)
+.++.....
T Consensus 314 ~~l~~~~~~ 322 (334)
T 2pvf_A 314 DRILTLTTN 322 (334)
T ss_dssp HHHHHHHC-
T ss_pred HHHHhcccc
Confidence 998876554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=290.06 Aligned_cols=210 Identities=23% Similarity=0.375 Sum_probs=176.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 59 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iv 136 (326)
T 2y0a_A 59 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIA 136 (326)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 46789999999999999999999985 45789999999999999999753 5699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCC---ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||+||+++.++. .++|+|||++.............+++.|+|||++.+ ..++.++||||||+++|
T Consensus 137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 208 (326)
T 2y0a_A 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITY 208 (326)
T ss_dssp CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC--------CCCCcHHHHHHHHHHHH
Confidence 9999999999985542 699999999986654444455678999999999864 56889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|++|..||.+............ ....+ ...++..+.+++.+||+.||.+|||+.++++ +.++.
T Consensus 209 ~ll~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~ 276 (326)
T 2y0a_A 209 ILLSGASPFLGDTKQETLANVSA--VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIK 276 (326)
T ss_dssp HHHHSCCSSCCSSHHHHHHHHHH--TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTS
T ss_pred HHHHCcCCCCCCCHHHHHHHHHh--cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--CCCcc
Confidence 99999999987665443332221 22222 2468899999999999999999999999998 55553
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=287.67 Aligned_cols=218 Identities=27% Similarity=0.425 Sum_probs=174.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..++||||+++ +|.+++... ...+++..++.++.|++.||.|||+.|
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ 139 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR 139 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999985 5579999999964 888888763 356999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ...++.++||||||+++|
T Consensus 140 ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ 211 (311)
T 3niz_A 140 ILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFA 211 (311)
T ss_dssp EECCCCCGGGEEECTT-CCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHH
T ss_pred cccCCCchHhEEECCC-CCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHH
Confidence 9999999999999965 46999999999764432 22344578999999998864 256788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCC----------------------------CCCCCcHHHHHHHHHhhhhCCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPG----------------------------LPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
+|++|..||.+................+. ....+++++.+|+.+||+.||.+
T Consensus 212 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 291 (311)
T 3niz_A 212 EMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291 (311)
T ss_dssp HHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTT
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhH
Confidence 99999999987655443333221111110 12347789999999999999999
Q ss_pred CCCHHHHHHHHHhhhhccCC
Q 022347 231 RPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 231 Rps~~~l~~~l~~~~~~~~~ 250 (298)
|||+.++++ +.|+..+.+
T Consensus 292 Rpt~~ell~--hp~f~~~~~ 309 (311)
T 3niz_A 292 RISARDAMN--HPYFKDLDP 309 (311)
T ss_dssp SCCHHHHHT--SGGGTTSCT
T ss_pred CCCHHHHhc--CcccccCCc
Confidence 999999998 677766543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=297.23 Aligned_cols=211 Identities=25% Similarity=0.415 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|..++.++ +||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||
T Consensus 97 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~gi 174 (396)
T 4dc2_A 97 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGI 174 (396)
T ss_dssp CHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 3577899999887 7999999999985 45799999999999999999864 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccC-ccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.+ +.++|+|||++... ..........||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 175 vHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~~DiwslGvllye 245 (396)
T 4dc2_A 175 IYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFE 245 (396)
T ss_dssp BCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred EeccCCHHHEEECCC-CCEEEeecceeeecccCCCccccccCCcccCCchhhcC--------CCCChHHHHHHHHHHHHH
Confidence 999999999999965 46999999999752 33344456689999999999865 678899999999999999
Q ss_pred HHhCCCCCCCCCh-------HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSN-------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~l~~~l~~~~~ 246 (298)
|++|..||..... ...............+|..+++++.+||.+||+.||.+||++ +++++ +.|+.
T Consensus 246 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~--Hpff~ 323 (396)
T 4dc2_A 246 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFFR 323 (396)
T ss_dssp HHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH--STTTT
T ss_pred HHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc--Ccccc
Confidence 9999999964321 122233344456677888999999999999999999999985 67766 44443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=281.21 Aligned_cols=214 Identities=30% Similarity=0.540 Sum_probs=179.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 126 (268)
T 3sxs_A 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFI 126 (268)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45789999999999999999999985 45789999999999999999764 34599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 127 H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 197 (268)
T 3sxs_A 127 HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY--------FKYSSKSDVWAFGILMWE 197 (268)
T ss_dssp ESSCSGGGEEECTT-CCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH--------SEEETTHHHHHHHHHHHH
T ss_pred cCCcCcceEEECCC-CCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc--------cCCchhhhhHHHHHHHHH
Confidence 99999999999955 4699999999875433222 223345678999999865 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++ |..||........ ............+..+++.+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 198 l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 198 VFSLGKMPYDLYTNSEV-VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHcCCCCCccccChHHH-HHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 999 9999987665443 333444555666777899999999999999999999999999999887543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=293.77 Aligned_cols=213 Identities=26% Similarity=0.509 Sum_probs=178.9
Q ss_pred HHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 103 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~ 103 (298)
++.+|+.++++++||||+++++++.++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.||+||
T Consensus 61 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 139 (325)
T 3kex_A 61 AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHR 139 (325)
T ss_dssp SCCHHHHHHHTCCCTTBCCEEEEECBSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhcCCCCCcCeEEEEEcCCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 566899999999999999999999888899999999999999999763 3468999999999999999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 104 DLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 104 dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 140 Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el 210 (325)
T 3kex_A 140 NLAARNVLLKSP-SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTVWEL 210 (325)
T ss_dssp CCSSTTEEESSS-SCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred ccchheEEECCC-CeEEECCCCcccccCcccccccccCCCCcccccChHHhcc--------CCCChhhHhHHhHHHHHHH
Confidence 999999999855 469999999998643322 2233456779999999865 5688999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++ |..||.+..... .............+..++.++.+++.+||..+|.+|||+.++++.|+.+...
T Consensus 211 ~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 211 MTFGAEPYAGLRLAE-VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HTTSCCTTTTSCTTH-HHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HhCCCCCccccCHHH-HHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99 999998765433 3333444455666777889999999999999999999999999999987654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=281.49 Aligned_cols=215 Identities=25% Similarity=0.397 Sum_probs=179.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ..+++..++.++.|++.||.|||+.|++
T Consensus 50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 127 (284)
T 3kk8_A 50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIV 127 (284)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcC
Confidence 57889999999999999999999985 45689999999999999998764 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCC--CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.++ ..++|+|||++.............+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus 128 H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ 199 (284)
T 3kk8_A 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYI 199 (284)
T ss_dssp CSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC--------CCCCcccchHHHHHHHHH
Confidence 999999999997443 3499999999976655555555678999999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
|++|..||.+................. .....+++++.+++.+||+.+|.+|||+.++++ +.|+....
T Consensus 200 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~~ 269 (284)
T 3kk8_A 200 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICNRE 269 (284)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHHSCC
T ss_pred HHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc--CccccCCh
Confidence 999999998776544433333222222 222468999999999999999999999999998 66665433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=300.53 Aligned_cols=212 Identities=33% Similarity=0.581 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-c-CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.|.+|+.++++++||||+++++++. + +..|+||||+++|+|.+++.......+++..++.++.|++.||+|||++|+
T Consensus 231 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 310 (450)
T 1k9a_A 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310 (450)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 46889999999999999999999974 3 368999999999999999987655568999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+||+++.+ +.++|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 311 vHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el 379 (450)
T 1k9a_A 311 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 379 (450)
T ss_dssp ECSCCCGGGEEECTT-SCEEECCCTTCEECC--------CCCTTTSCHHHHHS--------SCCCHHHHHHHHHHHHHHH
T ss_pred eCCCCCHhhEEECCC-CCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHH
Confidence 999999999999955 469999999997543322 22356788999999864 6788999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++ |..||......+. ......+.+...+..+++.+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 380 ~t~g~~P~~~~~~~~~-~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 380 YSFGRVPYPRIPLKDV-VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HTTTCCSSTTSCTTTH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHH-HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 98 9999987654333 34445566777888999999999999999999999999999999988754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=282.49 Aligned_cols=213 Identities=24% Similarity=0.471 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ 129 (279)
T 3fdn_A 52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR 129 (279)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999999985 45789999999999999999864 45999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
++|+||||+||+++.+ +.++|+|||++....... .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 130 i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 199 (279)
T 3fdn_A 130 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYE 199 (279)
T ss_dssp CEECCCCGGGEEECTT-SCEEECSCCEESCC---------CCCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHH
T ss_pred EecccCChHhEEEcCC-CCEEEEeccccccCCccc-ccccCCCCCccCHhHhcc--------CCCCccchhHhHHHHHHH
Confidence 9999999999999855 469999999886543322 234578999999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
|++|..||......... .........++..+++.+.+++.+||+.+|.+|||+.++++ +.|+....
T Consensus 200 l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~~ 265 (279)
T 3fdn_A 200 FLVGKPPFEANTYQETY--KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITANS 265 (279)
T ss_dssp HHHSSCTTCCSSHHHHH--HHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHHC
T ss_pred HHHCCCCCCCCcHHHHH--HHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh--CccccCCc
Confidence 99999999876543332 22344556677889999999999999999999999999999 67766544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=288.10 Aligned_cols=218 Identities=30% Similarity=0.545 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecC------ceeEEEecCCCCCHHHHHhhh----CCCCCCHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSL----RPNKLDLHVALNFALDIARA 91 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~qi~~a 91 (298)
.+++.+|+.++++++||||+++++++.+. ..++||||+++++|.+++... ....+++..++.++.|++.|
T Consensus 80 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a 159 (313)
T 3brb_A 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159 (313)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHH
Confidence 35788999999999999999999998432 359999999999999998542 23569999999999999999
Q ss_pred HHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcch
Q 022347 92 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168 (298)
Q Consensus 92 l~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~ 168 (298)
|.|||+.|++||||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++
T Consensus 160 L~~LH~~~ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~ 230 (313)
T 3brb_A 160 MEYLSNRNFLHRDLAARNCMLRDD-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKS 230 (313)
T ss_dssp HHHHHTTTCCCCCCSGGGEEECTT-SCEEECSCSCC----------------CCGGGSCHHHHHS--------SCCCHHH
T ss_pred HHHHHhCCcccCCCCcceEEEcCC-CcEEEeecCcceecccccccCcccccCCCccccCchhhcC--------CCccchh
Confidence 999999999999999999999955 469999999997543322 1223356778999999864 6688999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 169 DVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 169 Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
||||||+++|+|++ |..||........ ............+..+++.+.+++.+||..+|.+|||+.++++.|+.++..
T Consensus 231 Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 231 DVWAFGVTMWEIATRGMTPYPGVQNHEM-YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999 8999987655433 334445556677788999999999999999999999999999999998876
Q ss_pred cC
Q 022347 248 LR 249 (298)
Q Consensus 248 ~~ 249 (298)
++
T Consensus 310 lp 311 (313)
T 3brb_A 310 LP 311 (313)
T ss_dssp C-
T ss_pred cC
Confidence 54
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.36 Aligned_cols=218 Identities=30% Similarity=0.500 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
++|.+|+.++++++||||+++++++.++..|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+|
T Consensus 307 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 386 (535)
T 2h8h_A 307 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386 (535)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 46889999999999999999999998788999999999999999997644456999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+|||++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 387 rDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~el 457 (535)
T 2h8h_A 387 RDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTEL 457 (535)
T ss_dssp SCCSGGGEEECGG-GCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred CCCCHhhEEEcCC-CcEEEcccccceecCCCceecccCCcCcccccCHHHhcc--------CCCCchhhHHHHHHHHHHH
Confidence 9999999999854 469999999998654322 1223345678999998865 5688999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++ |..||.+....+ .........+...+..++..+.+||.+||+.||++|||+.+|++.|+.++....+
T Consensus 458 ~t~g~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 458 TTKGRVPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp TTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred HhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 99 999998876543 3344455566677888999999999999999999999999999999988766544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.57 Aligned_cols=220 Identities=26% Similarity=0.369 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. .+..++||||+++ +|.+++... ...+++..++.++.|++.||+|||+.|
T Consensus 55 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ 132 (346)
T 1ua2_A 55 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW 132 (346)
T ss_dssp -CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3447889999999999999999999985 5679999999965 899988763 346899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ...++.++||||||+++|
T Consensus 133 ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ 204 (346)
T 1ua2_A 133 ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILA 204 (346)
T ss_dssp CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHH
T ss_pred EECCCCCHHHEEEcCC-CCEEEEecccceeccCCcccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHH
Confidence 9999999999999965 46999999999765432 23344578999999998854 245788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCC--------------------------CCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPG--------------------------LPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
+|++|..||.+................+. ....+++++.++|.+||+.||.+||
T Consensus 205 ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 284 (346)
T 1ua2_A 205 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284 (346)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC
Confidence 99999999988776554444332211110 0145678999999999999999999
Q ss_pred CHHHHHHHHHhhhhccCCCC
Q 022347 233 SFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 233 s~~~l~~~l~~~~~~~~~~~ 252 (298)
|+.++++ +.++.....+.
T Consensus 285 t~~ell~--h~~f~~~~~~~ 302 (346)
T 1ua2_A 285 TATQALK--MKYFSNRPGPT 302 (346)
T ss_dssp CHHHHHT--SGGGTSSSCCC
T ss_pred CHHHHhc--ChhhhcCCCCC
Confidence 9999998 77776654443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=289.33 Aligned_cols=215 Identities=30% Similarity=0.526 Sum_probs=180.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------CCCCCHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------PNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al 92 (298)
.+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|++.||
T Consensus 72 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 151 (322)
T 1p4o_A 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151 (322)
T ss_dssp HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHH
Confidence 346889999999999999999999985 457899999999999999997632 14579999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
.|||++||+||||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++|
T Consensus 152 ~~lH~~~i~H~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~D 222 (322)
T 1p4o_A 152 AYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSD 222 (322)
T ss_dssp HHHHHTTCBCSCCSGGGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHH
T ss_pred HHHHHCCCccCCCccceEEEcCC-CeEEECcCccccccccccccccccCCCCCCCccChhhhcc--------CCCCchhh
Confidence 99999999999999999999955 469999999997543322 2223356788999999864 56888999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 170 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 170 i~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|||||+++|+|++ |..||...... ..............+..+++.+.+++.+||+.+|.+|||+.++++.|+..+.
T Consensus 223 i~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 223 VWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHHHHHHHTSCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHHHHHHhcCCCccccCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 9999999999999 89999876543 3344444555566778899999999999999999999999999999987644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=281.81 Aligned_cols=214 Identities=27% Similarity=0.532 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 64 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 142 (283)
T 3gen_A 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFL 142 (283)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46789999999999999999999985 45789999999999999999763 34599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus 143 H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~ 213 (283)
T 3gen_A 143 HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWE 213 (283)
T ss_dssp CSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHH
T ss_pred CCCCccceEEEcCC-CCEEEccccccccccccccccccCCccCcccCCHHHhcc--------CCCCchhhHHHHHHHHHH
Confidence 99999999999955 469999999997543322 2223346778999999865 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++ |..||....... .............+..+++.+.+++.+||+.+|.+|||+.+++++|..++.+
T Consensus 214 l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 214 IYSLGKMPYERFTNSE-TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHTTTCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCccccChhH-HHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 998 999998776543 3344455556666778899999999999999999999999999999987754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=290.25 Aligned_cols=212 Identities=25% Similarity=0.407 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|..++.++ +||||+++++++. ++..|+||||++||+|.+++... ..+++..++.++.|++.||.|||++|
T Consensus 53 ~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ 130 (345)
T 3a8x_A 53 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG 130 (345)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34677999999988 8999999999985 46799999999999999999864 45999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||||+||+++.+ +.++|+|||++.... .........|++.|+|||++.+ ..++.++|||||||++|
T Consensus 131 ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 201 (345)
T 3a8x_A 131 IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMF 201 (345)
T ss_dssp CBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHH
T ss_pred ceecCCCHHHEEECCC-CCEEEEeccccccccCCCCcccccCCCccccCccccCC--------CCCChHHhHHHHHHHHH
Confidence 9999999999999965 469999999997532 2333455679999999999865 56789999999999999
Q ss_pred HHHhCCCCCCCCCh-------HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHHHHHhhh
Q 022347 179 ELLTNRLPFEGMSN-------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFL 245 (298)
Q Consensus 179 ~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~l~~~l~~~~ 245 (298)
+|++|..||..... ...............+|..++.++.++|.+||+.||.+||++ .++++ +.++
T Consensus 202 ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~--hp~f 279 (345)
T 3a8x_A 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFF 279 (345)
T ss_dssp HHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT--SGGG
T ss_pred HHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc--CCcc
Confidence 99999999965211 112222333445667788899999999999999999999985 67766 4554
Q ss_pred h
Q 022347 246 F 246 (298)
Q Consensus 246 ~ 246 (298)
.
T Consensus 280 ~ 280 (345)
T 3a8x_A 280 R 280 (345)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=294.34 Aligned_cols=213 Identities=28% Similarity=0.381 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. .+..++||||++|++|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 93 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iv 170 (349)
T 2w4o_A 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIV 170 (349)
T ss_dssp ------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 46779999999999999999999985 45789999999999999999763 4589999999999999999999999999
Q ss_pred eecCCCCCEEEcC--CCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+||+++. +.+.++|+|||++.............+++.|+|||++.+ ..++.++||||||+++|+
T Consensus 171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 242 (349)
T 2w4o_A 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG--------CAYGPEVDMWSVGIITYI 242 (349)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTT--------CCCCTHHHHHHHHHHHHH
T ss_pred ecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC--------CCCCcccchHHHHHHHHH
Confidence 9999999999974 245799999999986555444455678999999999864 568899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|..||................... .....++.++.+++.+||+.||.+|||+.++++ +.|+..
T Consensus 243 ll~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~ 311 (349)
T 2w4o_A 243 LLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVTG 311 (349)
T ss_dssp HHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTTS
T ss_pred HHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccCC
Confidence 999999998766555444444333222 233568999999999999999999999999998 666543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=301.53 Aligned_cols=214 Identities=24% Similarity=0.400 Sum_probs=164.0
Q ss_pred HHHHHHHHHH-hCCCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 24 RFIREVNMMS-RVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 24 ~~~~E~~~l~-~l~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
.+.+|+.++. ..+||||+++++++. +...|+||||++||+|.+++.......+++..++.++.|++.||.|||+
T Consensus 100 ~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 179 (400)
T 1nxk_A 100 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179 (400)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567888874 457999999999874 3468999999999999999987555569999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCC--CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
.||+||||||+||+++.+ .+.++|+|||++.............+|+.|+|||++.+ ..++.++|||||||
T Consensus 180 ~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~ 251 (400)
T 1nxk_A 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGV 251 (400)
T ss_dssp TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC--------CCSSSHHHHHHHHH
T ss_pred CCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC--------CCCCCcccHHHHHH
Confidence 999999999999999853 45799999999986555444456678999999999864 67889999999999
Q ss_pred HHHHHHhCCCCCCCCChHH----HHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 176 VLWELLTNRLPFEGMSNLQ----AAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|+|++|..||.+..... ........... ......+++++.+||.+||+.||.+|||+.++++ +.|+..
T Consensus 252 il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 327 (400)
T 1nxk_A 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 327 (400)
T ss_dssp HHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred HHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CccccC
Confidence 9999999999997654211 11111111111 1122468999999999999999999999999998 555543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=288.97 Aligned_cols=212 Identities=29% Similarity=0.436 Sum_probs=171.2
Q ss_pred HHHHHHHHHHhC---CCCcccceeceeecC------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRV---KHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 24 ~~~~E~~~l~~l---~hp~Iv~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+|+.+++++ +||||+++++++... ..++||||+. ++|.+++.......+++..++.++.|++.||+|
T Consensus 57 ~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 135 (308)
T 3g33_A 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135 (308)
T ss_dssp HHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 444666666665 599999999998432 4789999995 599999987655669999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+.||+|+||||+||+++.+ +.++|+|||++.............+++.|+|||++.+ ..++.++||||||
T Consensus 136 lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG 206 (308)
T 3g33_A 136 LHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVG 206 (308)
T ss_dssp HHHTTCCCSCCCTTTEEECTT-SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT--------SCCCSTHHHHHHH
T ss_pred HHHCCcccCCCCHHHEEEcCC-CCEEEeeCccccccCCCcccCCccccccccCchHHcC--------CCCCchHHHHHHH
Confidence 999999999999999999855 4699999999987655555556678999999999865 5688899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC-------------------------CCCCCcHHHHHHHHHhhhhCCC
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG-------------------------LPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~ 229 (298)
+++|+|++|..||.+................+. ....+++.+.+++.+||+.||.
T Consensus 207 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (308)
T 3g33_A 207 CIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPH 286 (308)
T ss_dssp HHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCc
Confidence 999999999999988766554443322211110 1135788999999999999999
Q ss_pred CCCCHHHHHHHHHhhhhc
Q 022347 230 LRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 230 ~Rps~~~l~~~l~~~~~~ 247 (298)
+|||+.++++ +.|+..
T Consensus 287 ~R~t~~e~l~--h~~~~~ 302 (308)
T 3g33_A 287 KRISAFRALQ--HSYLHK 302 (308)
T ss_dssp TSCCHHHHHT--STTC--
T ss_pred cCCCHHHHhc--CccccC
Confidence 9999999998 666554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=279.61 Aligned_cols=213 Identities=30% Similarity=0.560 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 48 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 126 (267)
T 3t9t_A 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVI 126 (267)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 46789999999999999999999985 55789999999999999999763 35689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 127 H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 197 (267)
T 3t9t_A 127 HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWE 197 (267)
T ss_dssp CSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred cCCCchheEEECCC-CCEEEcccccccccccccccccccccccccccChhhhcC--------CCccchhchhhhHHHHHH
Confidence 99999999999855 469999999987543322 2233456778999999864 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++ |..||....... .............+..+++.+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 198 l~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 198 VFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCHHH-HHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999 899998765433 334444555566677889999999999999999999999999999998765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=305.01 Aligned_cols=214 Identities=32% Similarity=0.567 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++|.+|+.++++++||||+++++++. ++..|+||||+++|+|.+++.......+++..++.++.|++.||+|||++||+
T Consensus 261 ~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 340 (495)
T 1opk_A 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340 (495)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 47889999999999999999999985 55789999999999999999875556799999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+|||++.+ +.+||+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+
T Consensus 341 HrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlG~~l~e 411 (495)
T 1opk_A 341 HRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWE 411 (495)
T ss_dssp CSCCSGGGEEECGG-GCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHH
T ss_pred cCCCChhhEEECCC-CcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc--------CCCCcHHhHHhHHHHHHH
Confidence 99999999999855 569999999997643322 1223345678999999865 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++ |..||.+.+... .........+...+..+++.+.++|.+||+.+|.+|||+.++++.|+.++.
T Consensus 412 l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 412 IATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHTTSCCSSTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 999 999998766543 334445556667788899999999999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=289.85 Aligned_cols=220 Identities=28% Similarity=0.518 Sum_probs=180.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++.+ ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~ 153 (318)
T 3lxp_A 77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ 153 (318)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4578899999999999999999999853 468999999999999999976 4599999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||
T Consensus 154 ~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 224 (318)
T 3lxp_A 154 HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFG 224 (318)
T ss_dssp TEECSCCSGGGEEECTT-CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH--------CEEEHHHHHHHHH
T ss_pred CccCCCCchheEEEcCC-CCEEECCccccccccccccccccccCCCCCceeeChHHhcC--------CCCCcHHHHHHHH
Confidence 99999999999999955 569999999997544322 2233457788999999865 5677899999999
Q ss_pred HHHHHHHhCCCCCCCCChH--------------HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNL--------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
+++|+|++|..||...... ...............+..+++++.+++.+||+.||.+|||+.++++.
T Consensus 225 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 304 (318)
T 3lxp_A 225 VTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304 (318)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999998753221 11222233445566778899999999999999999999999999999
Q ss_pred HHhhhhccCCCCC
Q 022347 241 LNAFLFTLRPPSP 253 (298)
Q Consensus 241 l~~~~~~~~~~~~ 253 (298)
|+.+........|
T Consensus 305 L~~l~~~~~~~~p 317 (318)
T 3lxp_A 305 LKTVHEKYQGQAP 317 (318)
T ss_dssp HHHHHHHHHC---
T ss_pred HHHHHHhhccCCC
Confidence 9999887765444
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=287.80 Aligned_cols=212 Identities=29% Similarity=0.482 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ...+++..++.++.|++.||.|||+.|+
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~i 134 (289)
T 4fvq_A 56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTL 134 (289)
T ss_dssp HHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence 357889999999999999999999985 55789999999999999999863 3349999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCc-------eEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKS-------LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
+||||||+||+++.++.. ++|+|||++....... ...++..|+|||.+.+ ...++.++|||||
T Consensus 135 vH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~-------~~~~~~~~Diwsl 204 (289)
T 4fvq_A 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQERIPWVPPECIEN-------PKNLNLATDKWSF 204 (289)
T ss_dssp CCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHC-------GGGCCHHHHHHHH
T ss_pred ECCCcCcceEEEecCCcccccccceeeeccCcccccccCcc---ccCCcCcccCHHHhCC-------CCCCCchhHHHHH
Confidence 999999999999855432 9999999987543322 2246778999998863 2457889999999
Q ss_pred HHHHHHHHhC-CCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 174 GIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 174 G~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+++|+|++| ..||..... ...... .......+...++++.+++.+||+.||.+|||+.++++.|+.++..
T Consensus 205 G~il~el~~g~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 205 GTTLWEICSGGDKPLSALDS-QRKLQF--YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHHHHHHTTTCCTTTTSCH-HHHHHH--HHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHHHHHHHcCCCCCccccch-HHHHHH--hhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 9999999995 455554433 222222 2335556677888999999999999999999999999999987764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=306.98 Aligned_cols=214 Identities=22% Similarity=0.374 Sum_probs=181.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+
T Consensus 229 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIv 308 (576)
T 2acx_A 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308 (576)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 46789999999999999999999985 45799999999999999999875555699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+||+++.+ +.++|+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 309 HrDLKPeNILld~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--------~~~~~~~DiwSLGvilyeLl 379 (576)
T 2acx_A 309 YRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMI 379 (576)
T ss_dssp CCCCCGGGEEECTT-SCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT--------CEESSHHHHHHHHHHHHHHH
T ss_pred ccCCchheEEEeCC-CCeEEEecccceecccCccccccCCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHH
Confidence 99999999999955 4699999999986655444455689999999999865 56789999999999999999
Q ss_pred hCCCCCCCCCh--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhhc
Q 022347 182 TNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLFT 247 (298)
Q Consensus 182 ~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~~~ 247 (298)
+|..||..... ...............++..+++++.+||.+||+.||.+|| +++++++ +.|+..
T Consensus 380 tG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--HpfF~~ 450 (576)
T 2acx_A 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--HPLFKK 450 (576)
T ss_dssp HSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--SGGGTT
T ss_pred hCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--Chhhcc
Confidence 99999987532 1222233344556677888999999999999999999999 7899987 555543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=295.46 Aligned_cols=210 Identities=29% Similarity=0.455 Sum_probs=174.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.+++.++||||+++++++. .+..++||||+ +|+|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 54 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giv 130 (336)
T 3h4j_B 54 MRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIV 130 (336)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 46889999999999999999999985 45789999999 78999998764 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+||+++.+ +.++|+|||++.............|++.|+|||++.+ ....+.++||||||+++|+|+
T Consensus 131 H~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll 202 (336)
T 3h4j_B 131 HRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-------KLYAGPEVDVWSCGIVLYVML 202 (336)
T ss_dssp CCCCSTTTEEECTT-CCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCC-------SGGGCHHHHHHHHHHHHHHHH
T ss_pred ecCCchhhEEEcCC-CCEEEEEeccceeccCCcccccccCCcCcCCHHHHcC-------CCCCCCccchhHHHHHHHHHH
Confidence 99999999999955 4699999999987666555566689999999999864 123367999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|..||.+...... ...........+..+++++.+++.+||+.||.+|||+.++++ +.|+..
T Consensus 203 ~g~~Pf~~~~~~~~--~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 264 (336)
T 3h4j_B 203 VGRLPFDDEFIPNL--FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFNV 264 (336)
T ss_dssp HSSCSSBCSSSTTC--BCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHHT
T ss_pred hCCCCCCCccHHHH--HHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh--Chhhcc
Confidence 99999976432111 011122334566779999999999999999999999999998 556543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=288.88 Aligned_cols=208 Identities=30% Similarity=0.480 Sum_probs=164.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecC-----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
..+++.+|+.++++++||||+++++++... ..|+||||++|++|.+++... ..+++..++.++.|++.||+||
T Consensus 55 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~l 132 (311)
T 3ork_A 55 FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFS 132 (311)
T ss_dssp HHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 445788999999999999999999987422 349999999999999999864 4599999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
|+.||+|+||||+||+++.+ +.++|+|||++....... ......|++.|+|||.+.+ ..++.++|||
T Consensus 133 H~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~ 203 (311)
T 3ork_A 133 HQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVY 203 (311)
T ss_dssp HHTTCCCCCCCGGGEEEETT-SCEEECCCSCC------------------CCTTCCHHHHHT--------CCCCHHHHHH
T ss_pred HHCCCCcCCCCHHHEEEcCC-CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC--------CCCCchHhHH
Confidence 99999999999999999955 469999999997543321 2223468999999999865 5688899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|||+++|+|++|..||.+................+. ....+++++.+++.+||+.||.+||++.+++.
T Consensus 204 slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 204 SLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 999999999999999988766554444333222221 23568999999999999999999997666655
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=293.86 Aligned_cols=219 Identities=28% Similarity=0.514 Sum_probs=174.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.++|.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|
T Consensus 134 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 212 (373)
T 3c1x_A 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK 212 (373)
T ss_dssp HHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 357889999999999999999999863 4578999999999999999975 3346899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|+||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||
T Consensus 213 ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG 283 (373)
T 3c1x_A 213 FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFG 283 (373)
T ss_dssp CCCSCCCGGGEEECTT-CCEEECCC---------------------CCGGGSCHHHHHH--------CCCCHHHHHHHHH
T ss_pred EecCccchheEEECCC-CCEEEeeccccccccccccccccccCCCCCcccccChHHhcC--------CCCCcHHHHHHHH
Confidence 9999999999999955 469999999997543221 1123356778999999865 6788999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 175 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 175 ~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
+++|+|++ |..||......+. ............+..+++.+.+++.+||+.+|.+|||+.++++.|+.++......
T Consensus 284 ~il~ellt~~~~p~~~~~~~~~-~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 284 VLLWELMTRGAPPYPDVNTFDI-TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp HHHHHHHTTSCCSCTTSCSSCH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHHHhCcCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 99999999 7788876554332 2333445556667789999999999999999999999999999999998776543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=299.82 Aligned_cols=212 Identities=25% Similarity=0.422 Sum_probs=179.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.+++.++||||+++++++. .+..|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+.||
T Consensus 60 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~gi 137 (476)
T 2y94_A 60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMV 137 (476)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 347889999999999999999999985 4579999999999999999975 3569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+||+++.+ +.++|+|||++.............|++.|+|||++.+ ....+.++||||||+++|+|
T Consensus 138 vHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el 209 (476)
T 2y94_A 138 VHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYAL 209 (476)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTT-------CCBCSHHHHHHHHHHHHHHH
T ss_pred CcccccHHHEEEecC-CCeEEEeccchhhccccccccccCCCcCeEChhhccC-------CCCCCCcceehhhHHHHHHH
Confidence 999999999999955 4699999999987655555556689999999999864 12346899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||.+...... .... .......+..+++++.+++.+||+.||.+|||+.++++ +.|+..
T Consensus 210 ltG~~Pf~~~~~~~~-~~~i-~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~--hp~~~~ 272 (476)
T 2y94_A 210 LCGTLPFDDDHVPTL-FKKI-CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE--HEWFKQ 272 (476)
T ss_dssp HHSSCSSCCSSSHHH-HHHH-HTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHHT
T ss_pred hhCCCCCCCCCHHHH-HHHH-hcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh--CHHhhh
Confidence 999999987654332 2332 23345567779999999999999999999999999998 555543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=288.69 Aligned_cols=217 Identities=29% Similarity=0.549 Sum_probs=183.5
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceeec--CceeEEEecCCCCCHHHHHhhhCC--------------CCCCHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFA 85 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~ 85 (298)
+.+.+|+.++.++ +||||+++++++.+ ...++||||+++++|.+++..... ..+++..++.++
T Consensus 75 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (316)
T 2xir_A 75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154 (316)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHH
T ss_pred HHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHH
Confidence 4788999999999 69999999999843 458999999999999999986432 127899999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCcc
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ .
T Consensus 155 ~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~ 225 (316)
T 2xir_A 155 FQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------R 225 (316)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------C
T ss_pred HHHHHHHHHHHhCCcccccCccceEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc--------c
Confidence 999999999999999999999999999855 469999999997543322 1223456788999999865 6
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
.++.++||||||+++|+|++ |..||.+...................+..+++.+.+++.+||+.+|.+|||+.+++++|
T Consensus 226 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 68899999999999999998 99999877655555555566666777788999999999999999999999999999999
Q ss_pred Hhhhhcc
Q 022347 242 NAFLFTL 248 (298)
Q Consensus 242 ~~~~~~~ 248 (298)
+.++...
T Consensus 306 ~~~~~~~ 312 (316)
T 2xir_A 306 GNLLQAN 312 (316)
T ss_dssp HHHHHHH
T ss_pred HHHHhhh
Confidence 9887653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=283.95 Aligned_cols=208 Identities=25% Similarity=0.377 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
+++.+|+.++++++||||+++++++. ++..|+||||+++++|.+++.. ..+++..++.++.|++.||+|||+.|
T Consensus 81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46889999999999999999999985 3468999999999999886543 56999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+|+||||+||+++.++ .++|+|||++....... ......+++.|+|||.+.+.. ...++.++||||||+++|
T Consensus 158 ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~~l~ 231 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-----KIFSGKALDVWAMGVTLY 231 (298)
T ss_dssp EECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC-----CCEESHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCC-----CCCCCchhhhHhHHHHHH
Confidence 99999999999999654 69999999997544322 234457899999999986411 112477899999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|++|..||...................+....+++++.+++.+||+.||.+|||+.++++
T Consensus 232 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 232 CFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9999999998765433322222222222333578999999999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.34 Aligned_cols=217 Identities=24% Similarity=0.416 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..++||||+++ ++.+++.. ....+++..++.++.|++.||+|||+.||
T Consensus 45 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 122 (292)
T 3o0g_A 45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122 (292)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 346779999999999999999999985 5679999999965 66666654 23569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ...++.++||||||+++|+
T Consensus 123 vH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ 194 (292)
T 3o0g_A 123 LHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAE 194 (292)
T ss_dssp ECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCC-CCEEEeecccceecCCccccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHH
Confidence 999999999999965 46999999999754432 23344578999999999864 2347899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHAR----------------------------PGLPEDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~R 231 (298)
|++|..||....+............. ......+++++.+|+.+||+.||.+|
T Consensus 195 l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 274 (292)
T 3o0g_A 195 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274 (292)
T ss_dssp HTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhC
Confidence 99988875444443333333322111 01223578999999999999999999
Q ss_pred CCHHHHHHHHHhhhhccCC
Q 022347 232 PSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 232 ps~~~l~~~l~~~~~~~~~ 250 (298)
||++++++ +.|+....+
T Consensus 275 ~t~~e~l~--hp~f~~~~p 291 (292)
T 3o0g_A 275 ISAEEALQ--HPYFSDFCP 291 (292)
T ss_dssp CCHHHHHT--SGGGTTC--
T ss_pred CCHHHHhc--CcccccCCC
Confidence 99999998 777765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=282.13 Aligned_cols=215 Identities=32% Similarity=0.568 Sum_probs=183.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||++|++|.+++.......+++..++.++.|++.||.|||+.|++
T Consensus 54 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 133 (288)
T 3kfa_A 54 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133 (288)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCcc
Confidence 46789999999999999999999985 55789999999999999999876666799999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 134 H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 204 (288)
T 3kfa_A 134 HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWE 204 (288)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCCcceEEEcCC-CCEEEccCccceeccCCccccccCCccccCcCChhhhcc--------CCCCchhhHHHHHHHHHH
Confidence 99999999999855 469999999997544322 2223345678999999865 567899999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++ |..||...+... .............+..+++.+.+++.+||..+|.+|||+.++++.|+.++..
T Consensus 205 ll~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 205 IATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHTTSCCSSTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHH-HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 999 999998765433 3344445556677788999999999999999999999999999999987764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=291.95 Aligned_cols=219 Identities=17% Similarity=0.247 Sum_probs=174.2
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec-----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+..|+..++.++||||+++++++.. ...|+||||+ |++|.+++.. ....+++..++.++.|++.||+|||+.
T Consensus 94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~ 171 (364)
T 3op5_A 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH 171 (364)
T ss_dssp HHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567778888999999999999742 3589999999 9999999986 345699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcC-CCCceEEeccCCCccCccccc--------cccccCccceeccccccccccccCCccCCCcchh
Q 022347 99 GIIHRDLKPDNLLLTP-DQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 99 givH~dik~~Nil~~~-~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
||+||||||+|||++. +.+.++|+|||++........ .....||+.|+|||++.+ ..++.++|
T Consensus 172 ~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D 243 (364)
T 3op5_A 172 EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------VAPSRRGD 243 (364)
T ss_dssp TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------CCCCHHHH
T ss_pred CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--------CCCCchhh
Confidence 9999999999999982 234699999999975433221 123348999999999865 56899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC--------C-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--------G-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
|||||+++|+|++|..||.+................. . ....+++++.+++..||..+|.+||++.++++.
T Consensus 244 i~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 244 LEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 9999999999999999998533222211111111000 0 125688999999999999999999999999999
Q ss_pred HHhhhhccCCCC
Q 022347 241 LNAFLFTLRPPS 252 (298)
Q Consensus 241 l~~~~~~~~~~~ 252 (298)
|+..+.......
T Consensus 324 l~~~~~~~~~~~ 335 (364)
T 3op5_A 324 LLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHTTCCC
T ss_pred HHHHHHHcCCCc
Confidence 999998776554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=282.69 Aligned_cols=212 Identities=30% Similarity=0.569 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec-----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
..+.+.+|+.++++++||||+++++++.+ ...++||||+++++|.+++... ..+++..++.++.|++.||.||
T Consensus 68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~l 145 (290)
T 1t4h_A 68 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFL 145 (290)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999998742 3589999999999999999864 4589999999999999999999
Q ss_pred HhCC--CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 96 HANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 96 H~~g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|+.| ++|+||||+||+++.+.+.++|+|||++...... ......+++.|+|||++. ..++.++|||||
T Consensus 146 H~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~sl 215 (290)
T 1t4h_A 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAF 215 (290)
T ss_dssp HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHH
T ss_pred HcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHH
Confidence 9999 9999999999999855567999999998653332 223446899999999875 347889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|+++|+|++|..||..................+ .++...++++.+++.+||+.+|.+|||+.++++ +.|+.
T Consensus 216 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~f~ 287 (290)
T 1t4h_A 216 GMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp HHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred HHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh--Ccccc
Confidence 999999999999998876666555554443332 345567899999999999999999999999998 55543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=278.76 Aligned_cols=213 Identities=28% Similarity=0.453 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
+.+.+|+.++++++||||+++++++. .+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|
T Consensus 65 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 144 (285)
T 3is5_A 65 EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144 (285)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46779999999999999999999985 45789999999999999998653 2356999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCC--CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 ivH~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|+|+||||+||+++.+ .+.++|+|||++.............+++.|+|||.+. ..++.++||||||+++
T Consensus 145 ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il 215 (285)
T 3is5_A 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVM 215 (285)
T ss_dssp CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHH
T ss_pred EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHH
Confidence 9999999999999532 3469999999998655555555667899999999874 4578899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|+|++|..||.+................. .....+++++.+++.+||+.||.+|||+.++++ +.|+.
T Consensus 216 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~f~ 283 (285)
T 3is5_A 216 YFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH--HEWFK 283 (285)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGG
T ss_pred HHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHhh
Confidence 99999999998876544333332222221 122347899999999999999999999999997 55544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=288.49 Aligned_cols=214 Identities=27% Similarity=0.400 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.++++++||||+++++++. ++..++||||+. |+|.+++... ...+++..++.++.|++.||.|||+.|
T Consensus 97 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ 174 (348)
T 1u5q_A 97 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN 174 (348)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999999985 567899999996 6888888653 356999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||||+||+++.+ +.++|+|||++...... ....+++.|+|||++.+. ....++.++||||||+++|+
T Consensus 175 ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~e 245 (348)
T 1u5q_A 175 MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIE 245 (348)
T ss_dssp CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTT-----SSCCBCTHHHHHHHHHHHHH
T ss_pred eeeCCCCHHHEEECCC-CCEEEeeccCceecCCC---CcccCCcceeCHhhhccc-----cCCCCCcHHHHHHHHHHHHH
Confidence 9999999999999954 57999999999764432 345789999999988531 12567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|..||.+...................+..+++.+.+++.+||+.+|.+|||++++++ +.++..
T Consensus 246 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--h~~~~~ 311 (348)
T 1u5q_A 246 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 311 (348)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh--Chhhhc
Confidence 999999998876655544443333333345678999999999999999999999999998 555543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=290.19 Aligned_cols=204 Identities=29% Similarity=0.466 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+..|..++..+ +||||+++++++. .+..|+||||++||+|.+++... ..+++..++.++.|++.||+|||+.||
T Consensus 62 ~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i 139 (345)
T 1xjd_A 62 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGI 139 (345)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3567899999877 8999999999986 45799999999999999999864 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.++ .++|+|||++..... ........||+.|+|||++.+ ..++.++|+||||+++|+
T Consensus 140 vHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 210 (345)
T 1xjd_A 140 VYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYE 210 (345)
T ss_dssp BCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHH
T ss_pred EeCCCChhhEEECCCC-CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC--------CCCCChhhhHHHHHHHHH
Confidence 9999999999999654 699999999975332 233445679999999999865 568899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~ 239 (298)
|++|..||.+.+..... .. .....+.++..+++++.++|.+||..||.+||++. ++++
T Consensus 211 ll~g~~Pf~~~~~~~~~-~~-i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 211 MLIGQSPFHGQDEEELF-HS-IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHSSCSSCCSSHHHHH-HH-HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HhcCCCCCCCCCHHHHH-HH-HHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 99999999876653332 22 23445667788999999999999999999999997 7766
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=288.90 Aligned_cols=218 Identities=29% Similarity=0.503 Sum_probs=181.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~L 95 (298)
..++.+|+.++++++||||+++++++. +...|+||||++|++|.+++..... ..+++..++.++.|++.||.||
T Consensus 77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L 156 (327)
T 2yfx_A 77 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156 (327)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH
Confidence 347889999999999999999999985 4578999999999999999987432 3489999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCC--CCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 96 HANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|+.|++||||||+||+++.+ +..++|+|||++...... .......+++.|+|||.+.+ ..++.++||
T Consensus 157 H~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di 228 (327)
T 2yfx_A 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDT 228 (327)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--------CCCCHHHHH
T ss_pred hhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--------CCCCchhhH
Confidence 99999999999999999843 336999999998643221 12233457889999999864 567899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 171 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 171 ~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
||||+++|+|++ |..||...... ..............+..+++.+.+++.+||+.+|.+|||+.+++++|+.+....
T Consensus 229 ~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 229 WSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHHHHHHHcCCCCCCCCcCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 999999999998 99999876543 334444555566677889999999999999999999999999999998876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=285.40 Aligned_cols=210 Identities=26% Similarity=0.394 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ..+++..++.++.|++.||.|||+.||
T Consensus 65 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i 142 (327)
T 3a62_A 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGI 142 (327)
T ss_dssp ------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 346779999999999999999999985 56799999999999999999864 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.+ +.++|+|||++...... .......|++.|+|||++.+ ..++.++||||||+++|+
T Consensus 143 vH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 213 (327)
T 3a62_A 143 IYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR--------SGHNRAVDWWSLGALMYD 213 (327)
T ss_dssp CCCCCCTTTEEECTT-SCEEECCCSCC----------CTTSSCCTTSCHHHHTT--------SCCCTHHHHHHHHHHHHH
T ss_pred EcccCCHHHeEECCC-CcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC--------CCCCCcccchhHHHHHHH
Confidence 999999999999955 46999999998753322 22344578999999999864 567889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~~ 246 (298)
|++|..||.+.+....... .......++..+++++.+++.+||+.||.+|| ++.++++ +.++.
T Consensus 214 l~~g~~pf~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--hp~f~ 281 (327)
T 3a62_A 214 MLTGAPPFTGENRKKTIDK--ILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--HPFFR 281 (327)
T ss_dssp HHHSSCSCCCSSHHHHHHH--HHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--SGGGS
T ss_pred HHHCCCCCCCCCHHHHHHH--HHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--CCccc
Confidence 9999999987665433322 22345567788999999999999999999999 7888887 55554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=283.00 Aligned_cols=211 Identities=29% Similarity=0.467 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||++|++|.+++.. ..+++..++.++.|++.||.|||+.|++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iv 163 (321)
T 2c30_A 87 ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVI 163 (321)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46779999999999999999999984 5679999999999999999875 5699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 164 H~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el 234 (321)
T 2c30_A 164 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--------SLYATEVDIWSLGIMVIEM 234 (321)
T ss_dssp CCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEECCC-CcEEEeeeeeeeecccCccccccccCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHH
Confidence 99999999999955 469999999987544322 2344578999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
++|..||......... ........+.+ +..+++.+.+++.+||+.||.+|||+.++++ +.++...
T Consensus 235 ~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~~ 301 (321)
T 2c30_A 235 VDGEPPYFSDSPVQAM-KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQT 301 (321)
T ss_dssp HHSSCTTTTSCHHHHH-HHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGGGC
T ss_pred HhCCCCCCCCCHHHHH-HHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc--ChhhccC
Confidence 9999999876654433 22333332222 3357899999999999999999999999998 5666543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=288.02 Aligned_cols=212 Identities=25% Similarity=0.417 Sum_probs=161.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. .+..|+||||++||+|.+++... +.+++..++.++.|++.||.|||++||+
T Consensus 61 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~iv 138 (361)
T 3uc3_A 61 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQIC 138 (361)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35679999999999999999999985 56799999999999999999764 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCC-ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCC-CcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~~Di~slG~il~~ 179 (298)
||||||+||+++.++. .++|+|||++.............|++.|+|||++.+ ..+ +.++||||||+++|+
T Consensus 139 H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~e 210 (361)
T 3uc3_A 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--------QEYDGKIADVWSCGVTLYV 210 (361)
T ss_dssp SCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHC--------SSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcC--------CCCCCCeeeeehhHHHHHH
Confidence 9999999999985432 599999999975444444455679999999999864 344 345899999999999
Q ss_pred HHhCCCCCCCCChH---HHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNL---QAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|..||.+.... ....... ......++ ..+++++.+||.+||+.+|.+|||+.++++ +.|+..
T Consensus 211 ll~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~ 280 (361)
T 3uc3_A 211 MLVGAYPFEDPEEPRDYRKTIQRI-LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT--HSWFLK 280 (361)
T ss_dssp HHHSSCSCC----CCCHHHHHHHH-HTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHT
T ss_pred HHhCCCCCCCCccHHHHHHHHHHH-hcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh--Ccchhc
Confidence 99999999865432 1222222 12222233 358999999999999999999999999998 566644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=288.84 Aligned_cols=214 Identities=26% Similarity=0.430 Sum_probs=157.0
Q ss_pred HHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
...+.+|+.+++.+. ||||+++++++. +...|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.|
T Consensus 49 ~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ 126 (325)
T 3kn6_A 49 EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG 126 (325)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346779999999997 999999999996 45789999999999999999863 56999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCC--ceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~--~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|+||||||+||+++.++. .++|+|||++...... .......+++.|+|||++.+ ..++.++||||||++
T Consensus 127 ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~i 198 (325)
T 3kn6_A 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ--------NGYDESCDLWSLGVI 198 (325)
T ss_dssp EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------------CCCCHHHHHHHHHHH
T ss_pred CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC--------CCCCCccchHHHHHH
Confidence 999999999999985442 6999999999754332 22344567999999999864 668899999999999
Q ss_pred HHHHHhCCCCCCCCCh------HHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 177 LWELLTNRLPFEGMSN------LQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|+|++|..||..... ........ ......++ ..+++++.+++.+||+.||.+|||+.++++ +.|+.
T Consensus 199 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~ 275 (325)
T 3kn6_A 199 LYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQ 275 (325)
T ss_dssp HHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGC
T ss_pred HHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--Chhhc
Confidence 9999999999976432 12222222 22222222 357899999999999999999999999987 67766
Q ss_pred cc
Q 022347 247 TL 248 (298)
Q Consensus 247 ~~ 248 (298)
..
T Consensus 276 ~~ 277 (325)
T 3kn6_A 276 DG 277 (325)
T ss_dssp TT
T ss_pred cC
Confidence 53
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=292.65 Aligned_cols=215 Identities=24% Similarity=0.400 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHhCC-CCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 22 EGRFIREVNMMSRVK-HDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
.+++.+|+.+++++. ||||+++++++.. ...|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+
T Consensus 52 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~ 127 (388)
T 3oz6_A 52 AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS 127 (388)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356779999999998 9999999999842 36899999996 599999986 569999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcc----------------------ccccccccCccceeccccccccc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV----------------------TEMMTAETGTYRWMAPELYSTVT 155 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~ 155 (298)
.||+||||||+||+++.+ +.++|+|||++..... ........+|+.|+|||++.+
T Consensus 128 ~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 204 (388)
T 3oz6_A 128 GGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-- 204 (388)
T ss_dssp TTEECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT--
T ss_pred CCEEeCCCCHHHeEEcCC-CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC--
Confidence 999999999999999965 4699999999974322 112234578999999999864
Q ss_pred cccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC----------------------------
Q 022347 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---------------------------- 207 (298)
Q Consensus 156 ~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------- 207 (298)
...++.++|||||||++|+|++|+.||.+.+..............+.
T Consensus 205 -----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (388)
T 3oz6_A 205 -----STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQS 279 (388)
T ss_dssp -----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC----
T ss_pred -----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCC
Confidence 25688999999999999999999999988766544433321111110
Q ss_pred -----------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 208 -----------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 208 -----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
.+..+++++.+|+.+||+.||.+|||++++++ +.++.....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~--Hp~~~~~~~ 337 (388)
T 3oz6_A 280 NKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK--HPFVSIFHN 337 (388)
T ss_dssp -CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT--STTTTTTCC
T ss_pred CHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC--CHHHHHhcC
Confidence 11267889999999999999999999999998 677665543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=281.26 Aligned_cols=216 Identities=32% Similarity=0.531 Sum_probs=179.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..+++.+|+.++++++||||+++++++.++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|+
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i 142 (291)
T 1u46_A 64 AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRF 142 (291)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCcccEEEEEccCCceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 345788999999999999999999999777799999999999999999764 2458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||++
T Consensus 143 ~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 213 (291)
T 1u46_A 143 IHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVT 213 (291)
T ss_dssp ECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred ccCCCchheEEEcCC-CCEEEccccccccccccccchhhhccCCCCceeeCchhhcC--------CCCCchhhHHHHHHH
Confidence 999999999999855 579999999987543322 1223356778999999865 557889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|+|++ |..||.....................+..+++++.+++.+||..+|.+|||+.++++.|+....
T Consensus 214 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 214 LWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 999999 9999988766554444433444556667899999999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=278.90 Aligned_cols=209 Identities=24% Similarity=0.421 Sum_probs=175.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++
T Consensus 51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 128 (277)
T 3f3z_A 51 DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVA 128 (277)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46889999999999999999999985 45789999999999999998764 4599999999999999999999999999
Q ss_pred eecCCCCCEEE---cCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||+||++ + ..+.++|+|||++.............+++.|+|||.+.+ .++.++||||||+++|
T Consensus 129 H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~Di~slG~~l~ 198 (277)
T 3f3z_A 129 HRDLKPENFLFLTDS-PDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG---------LYGPECDEWSAGVMMY 198 (277)
T ss_dssp CCCCSGGGEEESSSS-TTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT---------CBCTTHHHHHHHHHHH
T ss_pred CCCCCHHHEEEecCC-CCCcEEEEecccceeccCccchhccCCCCCccChHHhcc---------cCCchhhehhHHHHHH
Confidence 99999999999 4 345699999999986655555556678999999998753 4788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|++|..||............. ......+ ..+++.+.+++.+||+.+|.+|||+.++++ +.|+..
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~~ 267 (277)
T 3f3z_A 199 VLLCGYPPFSAPTDSEVMLKIR--EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE--HEWFEK 267 (277)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHH
T ss_pred HHHHCCCCCCCCCHHHHHHHHH--hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence 9999999998876544333322 2222233 268899999999999999999999999998 555544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=286.31 Aligned_cols=219 Identities=29% Similarity=0.470 Sum_probs=178.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++. +...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.
T Consensus 68 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~ 146 (327)
T 3lxl_A 68 QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR 146 (327)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 357889999999999999999999873 346899999999999999997632 3599999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||
T Consensus 147 ~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 217 (327)
T 3lxl_A 147 RCVHRDLAARNILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--------NIFSRQSDVWSFG 217 (327)
T ss_dssp TEECSCCSGGGEEEEET-TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--------CEEEHHHHHHHHH
T ss_pred CccCCCCChhhEEECCC-CCEEEcccccceecccCCccceeeccCCccccccCHHHhcc--------CCCChHHhHHHHH
Confidence 99999999999999855 569999999997543322 2233457788999999865 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCCh--------------HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSN--------------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
+++|+|++|..||..... ................+..+++.+.+++.+||+.||.+|||+.+++++
T Consensus 218 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 218 VVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999864322 122333344455566778899999999999999999999999999999
Q ss_pred HHhhhhccCC
Q 022347 241 LNAFLFTLRP 250 (298)
Q Consensus 241 l~~~~~~~~~ 250 (298)
|+.++.....
T Consensus 298 L~~~~~~~~~ 307 (327)
T 3lxl_A 298 LDMLWSGSRG 307 (327)
T ss_dssp HHHC------
T ss_pred HHHHHhhhcC
Confidence 9988765543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=302.15 Aligned_cols=214 Identities=27% Similarity=0.397 Sum_probs=168.2
Q ss_pred HHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 103 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~ 103 (298)
.+.+|+.++++++||||+++++++.++..|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.||+||
T Consensus 186 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr 263 (419)
T 3i6u_A 186 NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263 (419)
T ss_dssp CHHHHHHHHHHCCCTTBCCCCEEEESSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEecCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 57899999999999999999999988889999999999999998875 3569999999999999999999999999999
Q ss_pred cCCCCCEEEcCCC--CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 104 DLKPDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 104 dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||+||+++.++ ..++|+|||++.............|++.|+|||++.+. ....++.++||||||+++|+|+
T Consensus 264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecC-----CCCCCCchhhhHhHHHHHHHHH
Confidence 9999999997433 35999999999876655555566799999999998531 1256788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|..||.................... ....+++.+.+++.+||+.||.+|||+.++++ +.|+.
T Consensus 339 tg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~ 404 (419)
T 3i6u_A 339 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR--HPWLQ 404 (419)
T ss_dssp HSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGC
T ss_pred HCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC--CcccC
Confidence 99999986543322222322222221 12468899999999999999999999999998 55543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.25 Aligned_cols=222 Identities=26% Similarity=0.403 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
+.+.+|+.++++++||||+++++++.+ ...++||||++|++|.+++..... ..+++..++.++.|++.||+|||+.
T Consensus 52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 131 (319)
T 4euu_A 52 DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131 (319)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 467799999999999999999998843 268999999999999999986432 3499999999999999999999999
Q ss_pred CCeeecCCCCCEEE----cCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLL----TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~----~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+|+||||+||++ + ....++|+|||++.............++..|+|||++............++.++||||||
T Consensus 132 ~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG 210 (319)
T 4euu_A 132 GIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG 210 (319)
T ss_dssp TEECSCCSGGGEEEEECTT-SCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHH
T ss_pred CEecCCCCHHHEEEeccCC-CCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHH
Confidence 99999999999998 4 334699999999987655555556678999999998864322222346788999999999
Q ss_pred HHHHHHHhCCCCCCCCCh---HHHHHHHHHhhcCC------------------------CCCCCCcHHHHHHHHHhhhhC
Q 022347 175 IVLWELLTNRLPFEGMSN---LQAAYAAAFKHARP------------------------GLPEDISPDLAFIVQSCWVED 227 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~~ 227 (298)
+++|+|++|..||..... ............+. .++..++..+.+++.+||+.|
T Consensus 211 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d 290 (319)
T 4euu_A 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290 (319)
T ss_dssp HHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCC
Confidence 999999999999964322 22333333332221 122235567899999999999
Q ss_pred CCCCCCHHHHHHHHHhhh
Q 022347 228 PNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 228 p~~Rps~~~l~~~l~~~~ 245 (298)
|.+|||+++++++.....
T Consensus 291 P~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 291 QEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTTSCCHHHHHHHHHHHT
T ss_pred hhhhccHHHhhhccHHHh
Confidence 999999999999887644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=292.85 Aligned_cols=216 Identities=25% Similarity=0.416 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.|
T Consensus 80 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 159 (321)
T 2qkw_B 80 EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159 (321)
T ss_dssp HHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC
Confidence 47889999999999999999999985 5678999999999999999875332 35899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++||||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ..++.++||||||++
T Consensus 160 ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~i 230 (321)
T 2qkw_B 160 IIHRDVKSINILLDEN-FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVV 230 (321)
T ss_dssp EECSCCCSTTEEECTT-CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH--------CBCCTHHHHHHHHHH
T ss_pred eecCCCCHHHEEECCC-CCEEEeecccccccccccccccccccCCCccccCHHHhcC--------CCCCcccchHhHHHH
Confidence 9999999999999955 56999999998753321 12233457899999999865 567899999999999
Q ss_pred HHHHHhCCCCCCCCChH-----HHHHHHHHhhc------CC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 177 LWELLTNRLPFEGMSNL-----QAAYAAAFKHA------RP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~-----~~~~~~~~~~~------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
+|+|++|+.||...... ........... .+ ..+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 231 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 231 LFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99999999999754321 11111111110 11 12233456789999999999999999999999999
Q ss_pred Hhhhhc
Q 022347 242 NAFLFT 247 (298)
Q Consensus 242 ~~~~~~ 247 (298)
+..+..
T Consensus 311 ~~~l~~ 316 (321)
T 2qkw_B 311 EYALRL 316 (321)
T ss_dssp HHHHHS
T ss_pred HHHhhc
Confidence 988764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.30 Aligned_cols=218 Identities=28% Similarity=0.535 Sum_probs=183.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
....+++.+|+.++++++||||+++++++.++..|+||||+++|+|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 432 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~ 510 (656)
T 2j0j_A 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK 510 (656)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34456889999999999999999999999888899999999999999999863 34689999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
||+||||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+ ..++.++||||||++
T Consensus 511 givHrDikp~NILl~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~i 581 (656)
T 2j0j_A 511 RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVC 581 (656)
T ss_dssp TCCCSCCSGGGEEEEET-TEEEECCCCCCCSCCC----------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred CccccccchHhEEEeCC-CCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC--------CCCCchhhHHHHHHH
Confidence 99999999999999955 5799999999986543322 223356789999999865 578899999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|+|++ |..||.+....+. ............+..+++.+.+++.+||..||.+|||+.++++.|+.++..
T Consensus 582 l~ellt~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 582 MWEILMHGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHTTSCCTTTTCCHHHH-HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCHHHH-HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999997 9999987765443 344445566677888999999999999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=283.07 Aligned_cols=220 Identities=25% Similarity=0.372 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
....+++.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ..+++..++.++.|++.||.|||+
T Consensus 75 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~ 152 (309)
T 2h34_A 75 PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA 152 (309)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 334568889999999999999999999985 56789999999999999999864 459999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
.||+|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+
T Consensus 153 ~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 223 (309)
T 2h34_A 153 AGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE--------SHATYRADIYALTC 223 (309)
T ss_dssp TTCCCSCCCGGGEEECTT-SCEEECSCCC----------------CCGGGCCGGGTCC------------CCCHHHHHHH
T ss_pred CcCCcCCCChHHEEEcCC-CCEEEecCccCccccccccccccccCCCcCccCHHHHcC--------CCCCchHhHHHHHH
Confidence 999999999999999955 469999999987544322 2234468899999999864 56788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHhhhhccCC
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~l~~~l~~~~~~~~~ 250 (298)
++|+|++|..||...... ........... ...+..+++++.+++.+||+.||.+|| +++++++.|+..+.....
T Consensus 224 il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 224 VLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp HHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred HHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 999999999999876543 22222222111 134567899999999999999999999 999999999988766544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=284.86 Aligned_cols=207 Identities=25% Similarity=0.376 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 86 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iv 163 (350)
T 1rdq_E 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLI 163 (350)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46789999999999999999999986 45799999999999999999874 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+||+++.++ .++|+|||++...... .....|++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 164 HrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell 232 (350)
T 1rdq_E 164 YRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp CCCCSGGGEEECTTS-CEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHH
T ss_pred cccCccceEEECCCC-CEEEcccccceeccCC--cccccCCccccCHHHhcC--------CCCCCcCCEecccHhHhHHh
Confidence 999999999999654 6999999999764332 234578999999999865 56789999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhhh
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 246 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~~l~~~~~ 246 (298)
+|..||.+.+.... ... .......++..+++++.++|.+||+.||.+||+ ++++++ +.++.
T Consensus 233 ~g~~Pf~~~~~~~~-~~~-i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~--h~~f~ 298 (350)
T 1rdq_E 233 AGYPPFFADQPIQI-YEK-IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFA 298 (350)
T ss_dssp HSSCSSCCSSHHHH-HHH-HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGT
T ss_pred hCCCCCCCCCHHHH-HHH-HHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh--CcCcC
Confidence 99999987655433 222 233456678889999999999999999999998 899887 45543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=281.03 Aligned_cols=207 Identities=26% Similarity=0.419 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|..+++.++||||+++++++. +...|+||||++||+|.+++... ..+++..++.++.|++.||.|||++||+
T Consensus 51 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iv 128 (318)
T 1fot_A 51 EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDII 128 (318)
T ss_dssp HHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46778999999999999999999996 45799999999999999999863 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+||+++.+ +.++|+|||++..... ......||+.|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 129 HrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell 197 (318)
T 1fot_A 129 YRDLKPENILLDKN-GHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEML 197 (318)
T ss_dssp CCCCCGGGEEECTT-SCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHH
T ss_pred ccCCChheEEEcCC-CCEEEeecCcceecCC--ccccccCCccccCHhHhcC--------CCCCcccchhhhHHHHHHHH
Confidence 99999999999955 4699999999975433 2234578999999999864 56888999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhh
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 246 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~~ 246 (298)
+|..||.+.+...... .. ......++..+++++.+++.+||..||.+|| +++++++ +.++.
T Consensus 198 ~g~~pf~~~~~~~~~~-~i-~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--hp~f~ 263 (318)
T 1fot_A 198 AGYTPFYDSNTMKTYE-KI-LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFK 263 (318)
T ss_dssp HSSCTTCCSSHHHHHH-HH-HHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGS
T ss_pred hCCCCCCCCCHHHHHH-HH-HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--Ccccc
Confidence 9999998766543332 22 2344567788999999999999999999999 8999987 55543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=285.57 Aligned_cols=213 Identities=29% Similarity=0.440 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.|
T Consensus 84 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ 161 (335)
T 2owb_A 84 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR 161 (335)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4457889999999999999999999985 45789999999999999998764 45999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+|+||||+||+++.+ +.++|+|||++...... .......++..|+|||++.+ ..++.++||||||+++|
T Consensus 162 ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 232 (335)
T 2owb_A 162 VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMY 232 (335)
T ss_dssp EECSCCCGGGEEECTT-CCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT--------SCBCTHHHHHHHHHHHH
T ss_pred CEecCCCchhEEEcCC-CCEEEeeccCceecccCcccccccCCCccccCHHHhcc--------CCCCchhhHHHHHHHHH
Confidence 9999999999999955 46999999999754322 22344568999999999864 56788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+|++|..||........... .......++..+++.+.+++.+||+.||.+|||+.++++ +.++...
T Consensus 233 ~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~~ 298 (335)
T 2owb_A 233 TLLVGKPPFETSCLKETYLR--IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSG 298 (335)
T ss_dssp HHHHSSCTTCCSSHHHHHHH--HHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTS
T ss_pred HHHHCcCCCCCCCHHHHHHH--HhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccCC
Confidence 99999999987654433222 233445667789999999999999999999999999998 5565543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=287.42 Aligned_cols=217 Identities=27% Similarity=0.439 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeecC-------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al 92 (298)
...+++.+|+.++++++||||+++++++... ..|+||||+ +++|.+++.. ..+++..+..++.|++.||
T Consensus 66 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L 141 (367)
T 1cm8_A 66 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGL 141 (367)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999998432 469999999 8899999986 5699999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
.|||+.||+||||||+||+++.+ +.++|+|||++...... .....+++.|+|||++.+ ...++.++||||
T Consensus 142 ~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diws 211 (367)
T 1cm8_A 142 RYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWS 211 (367)
T ss_dssp HHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHH
T ss_pred HHHHHCCccccCcCHHHEEEcCC-CCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhC-------CCCCChhhhHHH
Confidence 99999999999999999999965 46999999999764332 344578999999998864 246889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-----------------------------CCCCCCcHHHHHHHHHh
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQSC 223 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~ 223 (298)
|||++|+|++|+.||.+.+..............+ .+....++.+.+|+.+|
T Consensus 212 lG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~m 291 (367)
T 1cm8_A 212 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 291 (367)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence 9999999999999998876554433322111111 12346789999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 224 WVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 224 l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
|..||.+|||+.++++ +.++.....+.
T Consensus 292 L~~dP~~R~t~~e~l~--hp~f~~~~~~~ 318 (367)
T 1cm8_A 292 LVLDAEQRVTAGEALA--HPYFESLHDTE 318 (367)
T ss_dssp SCSSTTTSCCHHHHHH--SGGGTTTC---
T ss_pred ccCChhHCCCHHHHhc--ChHHHhhcCCc
Confidence 9999999999999998 77777665443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=280.57 Aligned_cols=213 Identities=28% Similarity=0.520 Sum_probs=178.1
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
+++.+|+.++++++||||+++++++.+ ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ 146 (302)
T 4e5w_A 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ 146 (302)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 468899999999999999999999843 46899999999999999996643 46999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+
T Consensus 147 i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 217 (302)
T 4e5w_A 147 YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--------SKFYIASDVWSFGV 217 (302)
T ss_dssp EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--------CEEEHHHHHHHHHH
T ss_pred cccCCCchheEEEcCC-CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC--------CCCCcchhHHHHHH
Confidence 9999999999999855 579999999997544332 2234467788999999865 56778999999999
Q ss_pred HHHHHHhCCCCCCCC--------------ChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 176 VLWELLTNRLPFEGM--------------SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 176 il~~ll~g~~p~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
++|+|++|..|+... ..................+..+++.+.+++.+||+.||.+|||+.++++.|
T Consensus 218 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 218 TLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 999999998875421 222333344445556677888999999999999999999999999999999
Q ss_pred Hhhh
Q 022347 242 NAFL 245 (298)
Q Consensus 242 ~~~~ 245 (298)
+.++
T Consensus 298 ~~ll 301 (302)
T 4e5w_A 298 EALL 301 (302)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=295.43 Aligned_cols=215 Identities=26% Similarity=0.435 Sum_probs=177.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. .+..|+||||++|++|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 66 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iv 143 (486)
T 3mwu_A 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIV 143 (486)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 46789999999999999999999996 45789999999999999998764 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCC--CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+||+++.+ ...++|+|||++.............|++.|+|||++. ..++.++||||||+++|+
T Consensus 144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ 214 (486)
T 3mwu_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYI 214 (486)
T ss_dssp CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGG---------SCCCHHHHHHHHHHHHHH
T ss_pred eccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhC---------CCCCchhhHHHHHHHHHH
Confidence 99999999999632 3469999999998665555555668999999999985 348889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
|++|..||.+................... ...+++++.++|.+||+.+|.+|||+.++++ +.|+.....
T Consensus 215 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~~~ 285 (486)
T 3mwu_A 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYSS 285 (486)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHTCC
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccCcc
Confidence 99999999887665443333322222222 2458899999999999999999999999998 677765543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.37 Aligned_cols=220 Identities=26% Similarity=0.398 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC----------------------------
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---------------------------- 72 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~---------------------------- 72 (298)
.+++.+|+.++++++||||+++++++. ++..++||||++||+|.+++....
T Consensus 72 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (345)
T 3hko_A 72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151 (345)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccc
Confidence 357889999999999999999999995 457899999999999999985211
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCC-ceEEeccCCCccCcccc-----cc
Q 022347 73 ----------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTE-----MM 136 (298)
Q Consensus 73 ----------~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~-~~~l~dfg~~~~~~~~~-----~~ 136 (298)
...+++..++.++.|++.||+|||+.||+|+||||+||+++.++. .++|+|||++....... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 231 (345)
T 3hko_A 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231 (345)
T ss_dssp SCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----
T ss_pred cccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccc
Confidence 112467788999999999999999999999999999999985542 69999999997532211 23
Q ss_pred ccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcH
Q 022347 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISP 214 (298)
Q Consensus 137 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 214 (298)
....+++.|+|||++.+ ....++.++||||||+++|+|++|..||.+...................+ ..+++
T Consensus 232 ~~~~gt~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (345)
T 3hko_A 232 TTKAGTPYFVAPEVLNT------TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP 305 (345)
T ss_dssp ---CCCGGGCCHHHHTC------SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCH
T ss_pred cccCCCccccCchhhcc------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCH
Confidence 34578999999999854 23567889999999999999999999998877655544443332222222 24789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 215 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
.+.+++.+||+.+|.+|||+.++++ +.|+....
T Consensus 306 ~~~~li~~~l~~~p~~Rps~~~~l~--hp~~~~~~ 338 (345)
T 3hko_A 306 LARDLLSNLLNRNVDERFDAMRALQ--HPWISQFS 338 (345)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHH--SHHHHTTS
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhc--ChhhccCh
Confidence 9999999999999999999999998 66665543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=297.70 Aligned_cols=210 Identities=24% Similarity=0.401 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~gi 100 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++|++|.+++... ..+++..+..++.|++.||+|||+ .||
T Consensus 193 ~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~gi 270 (446)
T 4ejn_A 193 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNV 270 (446)
T ss_dssp --------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence 46778999999999999999999985 56799999999999999999764 459999999999999999999998 999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.+ +.++|+|||++.... .........||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 271 iHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 341 (446)
T 4ejn_A 271 VYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYE 341 (446)
T ss_dssp CCCCCCGGGEEECSS-SCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHH
T ss_pred EECCCCHHHEEECCC-CCEEEccCCCceeccCCCcccccccCCccccCHhhcCC--------CCCCCccchhhhHHHHHH
Confidence 999999999999965 469999999997533 2333445679999999999865 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~~~ 247 (298)
|++|..||.+.+....... .......++..+++++.+||.+||+.||.+|| ++.++++ +.++..
T Consensus 342 ll~g~~Pf~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--hp~f~~ 410 (446)
T 4ejn_A 342 MMCGRLPFYNQDHEKLFEL--ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--HRFFAG 410 (446)
T ss_dssp HHHSSCSSCCSSHHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGTT
T ss_pred HhhCCCCCCCCCHHHHHHH--HHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--CccccC
Confidence 9999999987665433222 23345567788999999999999999999999 9999998 555543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=299.21 Aligned_cols=216 Identities=26% Similarity=0.354 Sum_probs=173.4
Q ss_pred HHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+.+|+.++++++||||+++++++.. .++++||||+++ +|.+++.. .....+++..++.++.||+.||.||
T Consensus 94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3479999999999999999998721 137799999965 77776653 2346699999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.||+||||||+|||++.+++.+||+|||++.............+++.|+|||++.+ ...++.++|||||||
T Consensus 173 H~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~ 245 (420)
T 1j1b_A 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGC 245 (420)
T ss_dssp HTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHH
Confidence 9999999999999999997767789999999986554444455678999999999864 246889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCC---------------C------------CCCCCcHHHHHHHHHhhhhCC
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARP---------------G------------LPEDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------------~------------~~~~~~~~l~~li~~~l~~~p 228 (298)
++|+|++|+.||.+....+...........+ . ++..+++++.+||.+||+.||
T Consensus 246 il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP 325 (420)
T 1j1b_A 246 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325 (420)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSG
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCCh
Confidence 9999999999999876655444332211100 0 234568999999999999999
Q ss_pred CCCCCHHHHHHHHHhhhhccCC
Q 022347 229 NLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 229 ~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
.+|||+.++++ +.|+..+..
T Consensus 326 ~~R~t~~e~l~--hp~f~~~~~ 345 (420)
T 1j1b_A 326 TARLTPLEACA--HSFFDELRD 345 (420)
T ss_dssp GGSCCHHHHHT--SGGGGGGGC
T ss_pred hHCCCHHHHhC--CHhhccccc
Confidence 99999999998 667665543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=281.02 Aligned_cols=218 Identities=27% Similarity=0.467 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
+.+.+|+.++++++||||+++++++. ++..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~ 126 (317)
T 2pmi_A 48 STAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126 (317)
T ss_dssp HHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999985 557999999996 59999987632 2458999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
.||+||||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ...++.++||||||++
T Consensus 127 ~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~i 198 (317)
T 2pmi_A 127 NKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCI 198 (317)
T ss_dssp TTEECCCCCGGGEEECTT-CCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHH
T ss_pred CCeeeCCCChHHeEEcCC-CCEEECcCccceecCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHH
Confidence 999999999999999965 46999999999754432 22344578999999999864 2467889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcC--------------------------------CCCCCCCcHHHHHHHHHhh
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHAR--------------------------------PGLPEDISPDLAFIVQSCW 224 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l 224 (298)
+|+|++|..||.+................ +..+..++.++.+|+.+||
T Consensus 199 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 278 (317)
T 2pmi_A 199 LAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLL 278 (317)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHC
Confidence 99999999999887654443332211110 0112357889999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
+.||.+|||+.++++ +.|+......
T Consensus 279 ~~dP~~Rpt~~e~l~--hp~f~~~~~~ 303 (317)
T 2pmi_A 279 QLNPDMRLSAKQALH--HPWFAEYYHH 303 (317)
T ss_dssp CSSGGGSCCHHHHTT--SGGGGGGCC-
T ss_pred CCCcccCCCHHHHhC--Chhhhcccch
Confidence 999999999999998 7777765543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=282.87 Aligned_cols=211 Identities=24% Similarity=0.374 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..++||||++|++|.+++.. ...+++..++.++.|++.||.|||+.|+
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i 136 (321)
T 2a2a_A 59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKI 136 (321)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 346889999999999999999999985 4578999999999999999975 3468999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCC---ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+|+||||+||+++.++. .++|+|||++.............+++.|+|||.+.+ ..++.++||||||+++
T Consensus 137 vH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVIT 208 (321)
T ss_dssp ECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHH
T ss_pred ecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC--------CCCCCccccHHHHHHH
Confidence 99999999999986653 699999999986555444455678999999999864 5678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|+|++|..||.+......... ... ..... +..++..+.+++.+||+.||.+|||+.++++ +.++.
T Consensus 209 ~~l~~g~~pf~~~~~~~~~~~-i~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~--hp~~~ 277 (321)
T 2a2a_A 209 YILLSGASPFLGDTKQETLAN-ITS-VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR--HPWIT 277 (321)
T ss_dssp HHHHHSCCSSCCSSHHHHHHH-HHT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH--STTTS
T ss_pred HHHHHCCCCCCCCCHHHHHHH-HHh-cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc--Ccccc
Confidence 999999999987665433322 222 22222 2568899999999999999999999999998 55543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=286.43 Aligned_cols=223 Identities=23% Similarity=0.380 Sum_probs=180.1
Q ss_pred HHHHHHHHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 16 DERALLEGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 16 ~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
.......+.+.+|+.+++++ +||||+++++++. .+..|+||||++|++|.+++... ..+++..++.++.|++.||.
T Consensus 137 ~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~ 214 (365)
T 2y7j_A 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVS 214 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Confidence 33455567889999999999 7999999999985 56799999999999999999864 45999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||+.|++|+||||+||+++.+ +.++|+|||++.............|++.|+|||++.+... .....++.++|||||
T Consensus 215 ~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~Di~sl 291 (365)
T 2y7j_A 215 FLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD--ETHPGYGKEVDLWAC 291 (365)
T ss_dssp HHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTC--TTSCCBCTTHHHHHH
T ss_pred HHHhCCeecCCCCHHHEEECCC-CCEEEEecCcccccCCCcccccCCCCCCccChhhcccccc--ccCcCCCchhhHHhH
Confidence 9999999999999999999955 4699999999986655555556689999999998864211 112457889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
|+++|+|++|..||..................... ...++..+.+++.+||+.||.+|||+.++++ +.|+
T Consensus 292 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~f 363 (365)
T 2y7j_A 292 GVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ--HPFF 363 (365)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGG
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--Cccc
Confidence 99999999999999876554333222221111111 1467889999999999999999999999998 4444
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=282.28 Aligned_cols=216 Identities=21% Similarity=0.310 Sum_probs=174.9
Q ss_pred HHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+.+|+.+++++ +||||+++++++. ++..++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.||+
T Consensus 50 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ii 127 (330)
T 2izr_A 50 QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLI 127 (330)
T ss_dssp CHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 577999999999 8999999999985 55789999999 99999999863 45799999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCC----ceEEeccCCCccCccccc--------cccccCccceeccccccccccccCCccCCCcchh
Q 022347 102 HRDLKPDNLLLTPDQK----SLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 102 H~dik~~Nil~~~~~~----~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
||||||+||+++.++. .++|+|||++........ .....||+.|+|||++.+ ..++.++|
T Consensus 128 HrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D 199 (330)
T 2izr_A 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--------KEQSRRDD 199 (330)
T ss_dssp CCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHH
T ss_pred ccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC--------CCCCchhH
Confidence 9999999999985432 299999999975433221 234578999999999865 66889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhc---CC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHA---RP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~---~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
|||||+++|+|++|..||.+... ............ .. .....++ ++.+++..||+.+|.+||+++++.+.|+.
T Consensus 200 i~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 200 LEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 99999999999999999987432 222222221111 11 1123355 99999999999999999999999999998
Q ss_pred hhhccCC
Q 022347 244 FLFTLRP 250 (298)
Q Consensus 244 ~~~~~~~ 250 (298)
...+...
T Consensus 279 ~~~~~~~ 285 (330)
T 2izr_A 279 LFDRKGY 285 (330)
T ss_dssp HHHHTTC
T ss_pred HHHHcCC
Confidence 8876644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=287.92 Aligned_cols=212 Identities=19% Similarity=0.268 Sum_probs=171.1
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+|+..++.++||||+++++++. +...|+||||+ |++|.+++.... .+++..++.++.|++.||+|||+.
T Consensus 94 ~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~ 170 (345)
T 2v62_A 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN 170 (345)
T ss_dssp HHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4778999999999999999999874 34789999999 999999998643 699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCC-CceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 99 GIIHRDLKPDNLLLTPDQ-KSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 99 givH~dik~~Nil~~~~~-~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
||+||||||+||+++.++ +.++|+|||++....... ......++..|+|||++.+ ..++.++|
T Consensus 171 ~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D 242 (345)
T 2v62_A 171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------VALSRRSD 242 (345)
T ss_dssp TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------CCCCHHHH
T ss_pred CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--------CCCCchhh
Confidence 999999999999998554 279999999997543221 1134478999999999865 56899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP---------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
|||||+++|+|++|..||....................++ ..+++++.+++.+||..+|.+|||+.++++.
T Consensus 243 i~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 243 VEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 9999999999999999996532212111111111111122 2688999999999999999999999999999
Q ss_pred HHhhhh
Q 022347 241 LNAFLF 246 (298)
Q Consensus 241 l~~~~~ 246 (298)
|+....
T Consensus 323 L~~~~~ 328 (345)
T 2v62_A 323 LNPHGI 328 (345)
T ss_dssp HCTTCC
T ss_pred HhccCC
Confidence 987544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=298.00 Aligned_cols=217 Identities=21% Similarity=0.341 Sum_probs=175.9
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|..++..++||||+++++++. ++..|+||||++||+|.+++... ...+++..++.++.|++.||.|||+.||+|
T Consensus 120 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiH 198 (437)
T 4aw2_A 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198 (437)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence 3789999999999999999999985 55799999999999999999762 356999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+|||++.++ .+||+|||++....... ......||+.|+|||++.... .....++.++|||||||++|+|
T Consensus 199 rDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~~~~~~DvwSlGvil~el 274 (437)
T 4aw2_A 199 RDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---GGKGRYGPECDWWSLGVCMYEM 274 (437)
T ss_dssp CCCSGGGEEECTTS-CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHH---TSCCEECTHHHHHHHHHHHHHH
T ss_pred cccCHHHeeEcCCC-CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcc---cCCCCCCCcCeeHHHHHHHHHH
Confidence 99999999999554 69999999997543322 223457999999999986311 0125678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhh---cCCCCCCCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKH---ARPGLPEDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~l~~~l~~~~~~ 247 (298)
++|+.||.+.+..+......... ..+.....+++++.+||.+||..+|++ ||+++++++ +.|+..
T Consensus 275 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--Hpff~~ 344 (437)
T 4aw2_A 275 LYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK--HPFFSG 344 (437)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--SGGGTT
T ss_pred HhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC--CCccCC
Confidence 99999998876554443333222 223333458999999999999887777 999999998 666543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=274.86 Aligned_cols=212 Identities=23% Similarity=0.395 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|+
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i 135 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKV 135 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 457889999999999999999999985 45789999999999999999874 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.++ .++|+|||++....... .....++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 136 ~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 205 (284)
T 2vgo_A 136 IHRDIKPENLLMGYKG-ELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEG--------KTHDEKVDLWCAGVLCYEF 205 (284)
T ss_dssp ECCCCSGGGEEECTTC-CEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTT--------CCBCTTHHHHHHHHHHHHH
T ss_pred eecCCCHHHEEEcCCC-CEEEecccccccCcccc-cccccCCCCcCCHHHhcc--------CCCCcccchhhHHHHHHHH
Confidence 9999999999999554 69999999986543322 234568999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
++|..||.......... ........++..++..+.+++.+||+.+|.+|||+.++++ +.++....
T Consensus 206 ~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~~~ 270 (284)
T 2vgo_A 206 LVGMPPFDSPSHTETHR--RIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKANS 270 (284)
T ss_dssp HHSSCTTCCSSHHHHHH--HHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHHHC
T ss_pred HHCCCCCCCCCHhHHHH--HHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHhhc
Confidence 99999998766543322 2233455677889999999999999999999999999998 56665443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=277.74 Aligned_cols=212 Identities=28% Similarity=0.431 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||+++ +|.+++... ...+++..++.++.|++.||+|||+.||+
T Consensus 45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 122 (288)
T 1ob3_A 45 STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVL 122 (288)
T ss_dssp HHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46779999999999999999999985 5679999999965 999998753 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ...++.++||||||+++|+|
T Consensus 123 H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l 194 (288)
T 1ob3_A 123 HRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEM 194 (288)
T ss_dssp CSCCCGGGEEECTT-SCEEECCTTHHHHHCC---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCC-CCEEEeECccccccCccccccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHHH
Confidence 99999999999955 46999999998754322 22234467999999998853 24578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
++|..||.+................+ .....+++++.+++.+||+.||.+|||
T Consensus 195 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 274 (288)
T 1ob3_A 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274 (288)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC
Confidence 99999998876554443332211110 112457899999999999999999999
Q ss_pred HHHHHHHHHhhhh
Q 022347 234 FSQIIRMLNAFLF 246 (298)
Q Consensus 234 ~~~l~~~l~~~~~ 246 (298)
+.++++ +.|+.
T Consensus 275 ~~e~l~--hp~f~ 285 (288)
T 1ob3_A 275 AKQALE--HAYFK 285 (288)
T ss_dssp HHHHHT--SGGGG
T ss_pred HHHHhc--Ccchh
Confidence 999998 55554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=276.86 Aligned_cols=217 Identities=18% Similarity=0.238 Sum_probs=176.8
Q ss_pred HHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+.+|+.+++++ +|+||+++++++. +...++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.||+
T Consensus 51 ~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 128 (298)
T 1csn_A 51 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLV 128 (298)
T ss_dssp CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 466899999999 7999999999985 55789999999 99999999863 34699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCC----ceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 102 HRDLKPDNLLLTPDQK----SLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 102 H~dik~~Nil~~~~~~----~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
||||||+||+++.++. .++|+|||++....... ......+++.|+|||.+.+ ..++.++|
T Consensus 129 H~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D 200 (298)
T 1csn_A 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDD 200 (298)
T ss_dssp CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHH
T ss_pred cCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC--------CCCChHHH
Confidence 9999999999985432 49999999997543322 1234568999999999864 56789999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHh----hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFK----HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
|||||+++|+|++|..||.+... .......... ...+.....+++++.+++.+||+.+|.+|||+.++++.|+.
T Consensus 201 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 201 LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 99999999999999999987432 1222221111 11122335789999999999999999999999999999999
Q ss_pred hhhccCC
Q 022347 244 FLFTLRP 250 (298)
Q Consensus 244 ~~~~~~~ 250 (298)
++..+..
T Consensus 281 ~~~~~~~ 287 (298)
T 1csn_A 281 VLERLNT 287 (298)
T ss_dssp HHHHTTC
T ss_pred HHHhcCC
Confidence 9887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=277.57 Aligned_cols=213 Identities=29% Similarity=0.440 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|
T Consensus 58 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ 135 (294)
T 2rku_A 58 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR 135 (294)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999985 45789999999999999998764 45999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++.+ +.++|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|
T Consensus 136 i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ 206 (294)
T 2rku_A 136 VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMY 206 (294)
T ss_dssp EECCCCCGGGEEECTT-CCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT--------SCBCTHHHHHHHHHHHH
T ss_pred ccccCCChHhEEEcCC-CCEEEEeccCceecccCccccccccCCCCcCCcchhcc--------CCCCchhhHHHHHHHHH
Confidence 9999999999999955 46999999999754322 22334568899999999864 56788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+|++|..||........... .......++..+++.+.+++.+||+.||.+|||+.++++ +.++...
T Consensus 207 ~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~~~ 272 (294)
T 2rku_A 207 TLLVGKPPFETSCLKETYLR--IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSG 272 (294)
T ss_dssp HHHHSSCTTCCSSHHHHHHH--HHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTS
T ss_pred HHHhCCCCCCCCCHHHHHHH--HhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh--ChheecC
Confidence 99999999987665433222 233445667789999999999999999999999999998 5565543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=297.24 Aligned_cols=214 Identities=25% Similarity=0.424 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. +...|+||||++||+|.+++... ..+++..++.++.|++.||.|||+.|
T Consensus 89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ 166 (504)
T 3q5i_A 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN 166 (504)
T ss_dssp THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999996 45789999999999999999764 45999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCC--ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|+||||||+||+++.++. .++|+|||++.............|++.|+|||++. ..++.++||||||+++
T Consensus 167 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il 237 (504)
T 3q5i_A 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIM 237 (504)
T ss_dssp EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHH
T ss_pred eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHH
Confidence 999999999999986543 69999999998766555555667999999999875 3578899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
|+|++|..||.+............ ....++ ..+++++.+|+.+||+.||.+|||+.++++ +.|+....
T Consensus 238 ~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~ 309 (504)
T 3q5i_A 238 YILLCGYPPFGGQNDQDIIKKVEK--GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKYA 309 (504)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHTC
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhch
Confidence 999999999988765443333222 222222 568999999999999999999999999998 66766543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=277.97 Aligned_cols=212 Identities=28% Similarity=0.436 Sum_probs=175.3
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec-----------------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD-----------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~ 86 (298)
.+.+|+.++++++||||+++++++.+ ...++||||+++++|.+++.......+++..++.++.
T Consensus 50 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ 129 (284)
T 2a19_B 50 KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129 (284)
T ss_dssp GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHH
Confidence 56689999999999999999998732 3479999999999999999875556799999999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCc
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 166 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 166 (298)
|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.............+++.|+|||.+.+ ..++.
T Consensus 130 qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~ 200 (284)
T 2a19_B 130 QITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--------QDYGK 200 (284)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC--------SCCCT
T ss_pred HHHHHHHHHHhCCeeeccCCHHHEEEcCC-CCEEECcchhheeccccccccccCCcccccChhhhcc--------CCCcc
Confidence 99999999999999999999999999954 5799999999876555444455678999999999864 56788
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 167 KVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 167 ~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++||||||+++|+|++|..|+.... ...... ....++..++..+.+++.+||+.||.+|||+.+++++|..+..
T Consensus 201 ~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 201 EVDLYALGLILAELLHVCDTAFETS---KFFTDL---RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHH---HTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hhhhHHHHHHHHHHHhcCCcchhHH---HHHHHh---hcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 9999999999999999998864321 111111 2233556789999999999999999999999999999998766
Q ss_pred ccCC
Q 022347 247 TLRP 250 (298)
Q Consensus 247 ~~~~ 250 (298)
..+.
T Consensus 275 ~~~~ 278 (284)
T 2a19_B 275 SPEK 278 (284)
T ss_dssp ----
T ss_pred CCCc
Confidence 5443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.35 Aligned_cols=217 Identities=21% Similarity=0.347 Sum_probs=175.8
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+++.+|+.++.++. ||||+++++++. ++..++||||++|++|.+++.......+++..++.++.|++.||+|||+.||
T Consensus 73 ~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~gi 152 (327)
T 3lm5_A 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152 (327)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 46779999999995 699999999985 4578999999999999999876555679999999999999999999999999
Q ss_pred eeecCCCCCEEEcC--CCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+||||||+||+++. ..+.++|+|||++.............+++.|+|||++.+ ..++.++||||||+++|
T Consensus 153 vH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 224 (327)
T 3lm5_A 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY--------DPITTATDMWNIGIIAY 224 (327)
T ss_dssp ECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred ecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC--------CCCCchhhHHHHHHHHH
Confidence 99999999999985 135799999999987655544455678999999999864 66888999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhh--cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+|++|..||................ ........+++.+.+++.+||+.||.+|||++++++ +.|+....
T Consensus 225 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--h~~~~~~~ 295 (327)
T 3lm5_A 225 MLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS--HSWLQQWD 295 (327)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--CGGGCCCC
T ss_pred HHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC--CHhhcccc
Confidence 9999999998876554433332222 222334568999999999999999999999999998 67765543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.34 Aligned_cols=204 Identities=25% Similarity=0.395 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|..++..+ +||||+++++++. .+..|+||||++||+|.+++... ..+++..++.++.|++.||.|||+.||
T Consensus 65 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gi 142 (353)
T 2i0e_A 65 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGI 142 (353)
T ss_dssp HHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 4677899999988 7999999999986 45799999999999999999864 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.++ .++|+|||++.... .........||+.|+|||++.+ ..++.++|+||||+++|+
T Consensus 143 vHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 213 (353)
T 2i0e_A 143 IYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYE 213 (353)
T ss_dssp BCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBSTHHHHHHHHHHHHH
T ss_pred EeccCCHHHEEEcCCC-cEEEEeCCcccccccCCcccccccCCccccChhhhcC--------CCcCCcccccchHHHHHH
Confidence 9999999999999654 69999999997532 2233445679999999999864 567899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~ 239 (298)
|++|..||.+.+.... .... ......+|..+++++.++|.+||..||.+||+ +.++++
T Consensus 214 ll~G~~Pf~~~~~~~~-~~~i-~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 214 MLAGQAPFEGEDEDEL-FQSI-MEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHSSCSSCCSSHHHH-HHHH-HHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHcCCCCCCCCCHHHH-HHHH-HhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999987655333 3332 33456678889999999999999999999995 577776
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=279.09 Aligned_cols=212 Identities=33% Similarity=0.587 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++.......+++..++.++.|++.||+|||+.|+
T Consensus 59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 138 (278)
T 1byg_A 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138 (278)
T ss_dssp HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 46889999999999999999999863 3478999999999999999986443348999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||||+||+++.+ +.++|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 139 ~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 207 (278)
T 1byg_A 139 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 207 (278)
T ss_dssp CCSCCSGGGEEECTT-SCEEECCCCC--------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred cccCCCcceEEEeCC-CcEEEeeccccccccccc--cCCCccccccCHHHhCC--------CCCCchhcHHHHHHHHHHH
Confidence 999999999999955 469999999987543322 23356788999999864 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++ |..||....... .............+..+++.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 208 ~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 208 YSFGRVPYPRIPLKD-VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HTTSCCSCTTSCGGG-HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHH-HHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 98 999998765432 333444455667778899999999999999999999999999999988654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.84 Aligned_cols=215 Identities=24% Similarity=0.395 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..++||||++ ++|.+++... ..+++..++.++.|++.||.|||+.|
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ 152 (329)
T 3gbz_A 76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR 152 (329)
T ss_dssp ----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4456779999999999999999999985 567999999996 5999999864 45999999999999999999999999
Q ss_pred CeeecCCCCCEEEcC----CCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTP----DQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~----~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|+|+||||+||+++. ....++|+|||++...... .......++..|+|||++.+ ...++.++||||||
T Consensus 153 ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG 225 (329)
T 3gbz_A 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIA 225 (329)
T ss_dssp CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHH
T ss_pred EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHH
Confidence 999999999999963 2335999999998754322 22334467899999999864 24578999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCC----------------------------CCCCcHHHHHHHHHhhhh
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL----------------------------PEDISPDLAFIVQSCWVE 226 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~ 226 (298)
+++|+|++|..||.+................+.. +..+++++.+||.+||+.
T Consensus 226 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 305 (329)
T 3gbz_A 226 CIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEM 305 (329)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCS
T ss_pred HHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccC
Confidence 9999999999999887765554443322111110 011678999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhc
Q 022347 227 DPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 227 ~p~~Rps~~~l~~~l~~~~~~ 247 (298)
||.+|||+.++++ +.|+..
T Consensus 306 dP~~R~t~~e~l~--hp~f~~ 324 (329)
T 3gbz_A 306 DPVKRISAKNALE--HPYFSH 324 (329)
T ss_dssp SGGGSCCHHHHHT--SGGGSS
T ss_pred ChhhCCCHHHHhC--CcccCC
Confidence 9999999999998 666654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.70 Aligned_cols=214 Identities=25% Similarity=0.386 Sum_probs=175.1
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|..+++.++||||+++++++. ++..|+||||++||+|.+++.. ..+++..++.++.|++.||+|||++||+|
T Consensus 115 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givH 191 (410)
T 3v8s_A 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIH 191 (410)
T ss_dssp THHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 4779999999999999999999996 4579999999999999999976 46999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+||+++.++ .++|+|||++....... ......||+.|+|||++.+.. ....++.++||||||+++|+|
T Consensus 192 rDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~~~~~~~DiwSlGvilyel 266 (410)
T 3v8s_A 192 RDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG----GDGYYGRECDWWSVGVFLYEM 266 (410)
T ss_dssp CCCSGGGEEECTTS-CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTT----TTCEEETHHHHHHHHHHHHHH
T ss_pred ccCCHHHeeECCCC-CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccC----CCcCCCCcceEecchHHHHHH
Confidence 99999999999654 69999999997544332 234567999999999986411 112378899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~--Rps~~~l~~~l~~~~~~ 247 (298)
++|..||.+.+................+ ...+++++.+||.+||..+|.+ ||+++++++ +.|+..
T Consensus 267 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--Hp~f~~ 335 (410)
T 3v8s_A 267 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--HLFFKN 335 (410)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--SGGGCC
T ss_pred HhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc--CccccC
Confidence 9999999876654443333222222223 3469999999999999988888 999999998 566543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=298.84 Aligned_cols=212 Identities=24% Similarity=0.398 Sum_probs=176.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++.... ...+++..++.++.||+.||.|||+.|
T Consensus 230 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g 309 (543)
T 3c4z_A 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309 (543)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC
Confidence 46789999999999999999999985 457999999999999999997643 346999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||||+||+++.++ .++|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 310 IvHrDLKP~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiwSlGvily 380 (543)
T 3c4z_A 310 IIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG--------EEYDFSVDYFALGVTLY 380 (543)
T ss_dssp EECCCCCGGGEEECTTS-CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT--------CCBCTHHHHHHHHHHHH
T ss_pred CcccCCChHHEEEeCCC-CEEEeecceeeeccCCCcccccccCCccccChhhhcC--------CCCChHHhcCcchHHHH
Confidence 99999999999999654 699999999976544332 234579999999999865 57889999999999999
Q ss_pred HHHhCCCCCCCCC---hHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMS---NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~~l~~~~~ 246 (298)
+|++|..||.... ....... ........++..+++++.++|.+||+.||.+||++ +++++ +.++.
T Consensus 381 elltG~~PF~~~~~~~~~~~~~~-~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~--Hpff~ 453 (543)
T 3c4z_A 381 EMIAARGPFRARGEKVENKELKQ-RVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT--HPLFR 453 (543)
T ss_dssp HHHHSSCSSCCTTCCCCHHHHHH-HHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT--SGGGT
T ss_pred HHHhCCCCCCCCccchhHHHHHH-HHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc--Ccccc
Confidence 9999999998653 2222222 23345566788899999999999999999999964 77776 45543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=274.32 Aligned_cols=217 Identities=24% Similarity=0.445 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceecee--e-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGAC--K-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~--~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++ . ....++||||++++ |.+++.......+++..++.++.|++.||.|||++
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 128 (305)
T 2wtk_C 50 EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128 (305)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 45788999999999999999999987 2 34789999999765 88888776667799999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcc---ccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|++|+||||+||+++.+ +.++|+|||++..... ........++..|+|||++.+ ....++.++||||||+
T Consensus 129 ~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~ 201 (305)
T 2wtk_C 129 GIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG------LDTFSGFKVDIWSAGV 201 (305)
T ss_dssp TEECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC------CSCEESHHHHHHHHHH
T ss_pred CeeecCCCcccEEEcCC-CcEEeeccccccccCccccccccccCCCCCCCcChhhccC------cccCCcchhhHHHHHH
Confidence 99999999999999955 5699999999975432 222334568999999998864 1233477999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++|+|++|..||.+...... .. ........++..+++.+.+++.+||+.||.+|||+.++++ +.++....+
T Consensus 202 il~~l~~g~~p~~~~~~~~~-~~-~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~ 272 (305)
T 2wtk_C 202 TLYNITTGLYPFEGDNIYKL-FE-NIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRKKHP 272 (305)
T ss_dssp HHHHHHHSSCSCCCSSHHHH-HH-HHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHSCCC
T ss_pred HHHHHHhCCCCCCCchHHHH-HH-HHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc--CcccccCCC
Confidence 99999999999987654332 22 2334455677889999999999999999999999999998 566665544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=295.30 Aligned_cols=211 Identities=25% Similarity=0.378 Sum_probs=176.5
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. .+..|+||||++||+|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 81 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iv 158 (494)
T 3lij_A 81 SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIV 158 (494)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 46789999999999999999999996 45789999999999999998764 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCC--CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+||+++.+ ...++|+|||++.............|++.|+|||++. ..++.++|||||||++|+
T Consensus 159 H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~~ 229 (494)
T 3lij_A 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILFI 229 (494)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHH
T ss_pred eccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHHH
Confidence 99999999999743 2359999999998766555556678999999999874 457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++|..||.+.................. ....+++.+.++|.+||+.+|.+|||+.++++ +.|+.
T Consensus 230 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--hp~~~ 296 (494)
T 3lij_A 230 LLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE--HPWIK 296 (494)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc--Ccccc
Confidence 9999999988765444333322222211 12468999999999999999999999999998 44443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=283.36 Aligned_cols=220 Identities=26% Similarity=0.431 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+++.+|+.++.++ +||||+++++++. ++..|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.||
T Consensus 55 ~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i 132 (316)
T 2ac3_A 55 SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGI 132 (316)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4677999999995 6999999999985 56799999999999999999874 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCC--ceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 101 IHRDLKPDNLLLTPDQK--SLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
+||||||+||+++.++. .++|+|||++....... ......+++.|+|||++.+... ....++.++||
T Consensus 133 vH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~Di 209 (316)
T 2ac3_A 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDL 209 (316)
T ss_dssp CCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHH
T ss_pred eeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc---cccCCCccccc
Confidence 99999999999986543 39999999987543211 1223458999999999853110 01346789999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChH-------------HHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNL-------------QAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~-------------~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
||||+++|+|++|..||.+.... ..............++ ..+++++.+++.+||+.||.+|||
T Consensus 210 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 289 (316)
T 2ac3_A 210 WSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289 (316)
T ss_dssp HHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC
Confidence 99999999999999999765321 1111222223333333 358899999999999999999999
Q ss_pred HHHHHHHHHhhhhccC
Q 022347 234 FSQIIRMLNAFLFTLR 249 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~~ 249 (298)
+.++++ +.|+....
T Consensus 290 ~~e~l~--hp~~~~~~ 303 (316)
T 2ac3_A 290 AAQVLQ--HPWVQGCA 303 (316)
T ss_dssp HHHHHH--STTCC---
T ss_pred HHHHhc--ChhhcCCC
Confidence 999998 66665543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=277.10 Aligned_cols=211 Identities=25% Similarity=0.404 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ..+++..++.++.|++.||.|||+.|++
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (304)
T 2jam_A 51 SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIV 128 (304)
T ss_dssp -HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46789999999999999999999985 45789999999999999999764 4589999999999999999999999999
Q ss_pred eecCCCCCEEEc--CCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLT--PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||++. .+.+.++|+|||++...... ......+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus 129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 199 (304)
T 2jam_A 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVITYI 199 (304)
T ss_dssp CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS--------CSCCHHHHHHHHHHHHHH
T ss_pred ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc--------CCCCchhhHHHHHHHHHH
Confidence 999999999993 14457999999998754332 2233468899999999864 568899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHA---RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|..||......... ....... .......+++++.+++.+||+.||.+|||+.++++ +.++..
T Consensus 200 l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~ 267 (304)
T 2jam_A 200 LLCGYPPFYEETESKLF-EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDG 267 (304)
T ss_dssp HHHSSCTTTTSCHHHHH-HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHS
T ss_pred HHHCCCCCCCCCHHHHH-HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccC
Confidence 99999999876654332 2222221 22344678999999999999999999999999998 566654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=275.90 Aligned_cols=213 Identities=24% Similarity=0.401 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|+
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i 129 (283)
T 3bhy_A 52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRI 129 (283)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 347889999999999999999999985 45789999999999999999764 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCC---ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+|+||+|+||+++.++. .++|+|||++.............+++.|+|||.+.+ ..++.++||||||+++
T Consensus 130 ~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 201 (283)
T 3bhy_A 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVIT 201 (283)
T ss_dssp ECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHH
T ss_pred cCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC--------CCCCcchhhhhHHHHH
Confidence 99999999999985542 699999999986555444455578999999998864 5678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|+|++|..||............. ...... ...++..+.+++.+||..||.+|||+.++++ +.++...
T Consensus 202 ~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~ 272 (283)
T 3bhy_A 202 YILLSGASPFLGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE--HSWIKAI 272 (283)
T ss_dssp HHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH--CHHHHHH
T ss_pred HHHHHCCCCCCCcchHHHHHHhH--hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh--CHHHHHH
Confidence 99999999998766543322221 222222 2468899999999999999999999999998 4454443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=295.28 Aligned_cols=212 Identities=26% Similarity=0.411 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al 92 (298)
...+++.+|+.+++.++||||+++++++.. ...|+||||+++ +|.+.+. ..+++..+..++.|++.||
T Consensus 103 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL 177 (464)
T 3ttj_A 103 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGI 177 (464)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHH
Confidence 344578899999999999999999999843 246999999965 6777665 3489999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
+|||+.||+||||||+||+++.+ +.++|+|||++.............+|+.|+|||++.+ ..++.++||||
T Consensus 178 ~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwS 248 (464)
T 3ttj_A 178 KHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWS 248 (464)
T ss_dssp HHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC-----CCCC----CCCTTCCHHHHTT--------CCCCTTHHHHH
T ss_pred HHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC--------CCCCHHHHHHH
Confidence 99999999999999999999965 4699999999987665555556789999999999975 56889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC--------------------CCC---------CC-----------C
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--------------------GLP---------ED-----------I 212 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~~~---------~~-----------~ 212 (298)
|||++|+|++|+.||.+.+..............+ ... .. .
T Consensus 249 lG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (464)
T 3ttj_A 249 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 328 (464)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccccccc
Confidence 9999999999999999877655443332211111 000 00 1
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 213 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 213 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++++.+||.+||+.||.+|||++++++ +.|+..
T Consensus 329 s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~~~~ 361 (464)
T 3ttj_A 329 ASQARDLLSKMLVIDPAKRISVDDALQ--HPYINV 361 (464)
T ss_dssp HHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTGG
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhc--Chhhhh
Confidence 567999999999999999999999998 666543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=271.58 Aligned_cols=212 Identities=25% Similarity=0.425 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|+
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i 132 (276)
T 2h6d_A 55 VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMV 132 (276)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 347889999999999999999999985 55789999999999999999864 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||+|+||+++.+ +.++|+|||++.............+++.|+|||.+.+ ....+.++||||||+++|+|
T Consensus 133 ~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l 204 (276)
T 2h6d_A 133 VHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYAL 204 (276)
T ss_dssp SCCCCCGGGEEECTT-SCEEECCCCGGGCCCC-------------CCTGGGTT-------SCCCHHHHHHHHHHHHHHHH
T ss_pred ccCCCChhhEEECCC-CCEEEeecccccccCCCcceecccCCccccCHHHHcC-------CCCCCccchHHHHHHHHHHH
Confidence 999999999999955 4699999999986655444445578899999999864 12336799999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||........ .. .........+..++..+.+++.+||+.||.+|||+.++++ +.++..
T Consensus 205 ~~g~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~ 267 (276)
T 2h6d_A 205 LCGTLPFDDEHVPTL-FK-KIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQ 267 (276)
T ss_dssp HHSSCSSCCSSHHHH-HH-HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHT
T ss_pred HhCCCCCCCCcHHHH-HH-HhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh--Chhhcc
Confidence 999999987654332 22 2334455567788999999999999999999999999998 555544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=275.37 Aligned_cols=222 Identities=24% Similarity=0.433 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ....+++..++.++.|++.||.|||+
T Consensus 75 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 154 (310)
T 2wqm_A 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154 (310)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3457889999999999999999999984 56799999999999999999752 34568999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
.|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||++
T Consensus 155 ~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i 225 (310)
T 2wqm_A 155 RRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCL 225 (310)
T ss_dssp TTCCCCCCCGGGEEECTT-SCEEECCC------------------CCSSCCHHHHTT--------CCCCHHHHHHHHHHH
T ss_pred CCeeCCCCcHHHEEEcCC-CCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC--------CCCCchhhHHHHHHH
Confidence 999999999999999955 469999999987543322 2233468899999998864 567889999999999
Q ss_pred HHHHHhCCCCCCCCC-hHHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 177 LWELLTNRLPFEGMS-NLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 177 l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
+|+|++|..||.+.. ..............+.. ...+++++.+++.+||+.||.+|||+.++++.|+.+......+
T Consensus 226 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 226 LYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 999999999997643 22233333333333333 3568999999999999999999999999999999987765543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=275.43 Aligned_cols=220 Identities=28% Similarity=0.488 Sum_probs=178.6
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|
T Consensus 63 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 142 (295)
T 2clq_A 63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142 (295)
T ss_dssp -HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 357889999999999999999999985 567899999999999999998743 235679999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
++|+||+|+||+++...+.++|+|||++....... ......++..|+|||++.+. ...++.++||||||+++|
T Consensus 143 i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~ 216 (295)
T 2clq_A 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG------PRGYGKAADIWSLGCTII 216 (295)
T ss_dssp EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHG------GGGCSHHHHHHHHHHHHH
T ss_pred EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCC------CCCCCcHHHHHHHHHHHH
Confidence 99999999999999646679999999997544322 23345689999999998641 134788999999999999
Q ss_pred HHHhCCCCCCCCChHHH-HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 179 ELLTNRLPFEGMSNLQA-AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+|++|..||........ ..........+.++..+++++.+++.+||+.||.+|||+.++++ +.++....
T Consensus 217 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~ 286 (295)
T 2clq_A 217 EMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV--DEFLKVSS 286 (295)
T ss_dssp HHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT--SGGGCC--
T ss_pred HHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhhhcc
Confidence 99999999976543332 22333344566778889999999999999999999999999988 66665433
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=289.74 Aligned_cols=211 Identities=30% Similarity=0.442 Sum_probs=167.9
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC--
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHAN-- 98 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~-- 98 (298)
++.+|+.++++++||||+++++++. .+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.
T Consensus 73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 152 (326)
T 3uim_A 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152 (326)
T ss_dssp HHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 6789999999999999999999985 5578999999999999999987432 3499999999999999999999999
Q ss_pred -CCeeecCCCCCEEEcCCCCceEEeccCCCccCccc--cccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 99 -GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 99 -givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
||+|+||||+||+++.+ +.++|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+
T Consensus 153 ~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~ 223 (326)
T 3uim_A 153 PKIIHRDVKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGV 223 (326)
T ss_dssp SCEECCCCSGGGEEECTT-CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH--------SEECHHHHHHHHHH
T ss_pred CCeEeCCCchhhEEECCC-CCEEeccCccccccCcccccccccccCCcCccCHHHhcc--------CCCCccccchhHHH
Confidence 99999999999999955 46999999999754322 22334458999999999865 56788999999999
Q ss_pred HHHHHHhCCCCCCCC-----C--hHHHHHHHHHhhc----------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 022347 176 VLWELLTNRLPFEGM-----S--NLQAAYAAAFKHA----------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238 (298)
Q Consensus 176 il~~ll~g~~p~~~~-----~--~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 238 (298)
++|+|++|..||... . ............. ....+...+..+.+++.+||+.+|.+|||+.+++
T Consensus 224 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 303 (326)
T 3uim_A 224 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303 (326)
T ss_dssp HHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred HHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHH
Confidence 999999999999521 0 0111100000000 0111222346799999999999999999999999
Q ss_pred HHHHh
Q 022347 239 RMLNA 243 (298)
Q Consensus 239 ~~l~~ 243 (298)
++|+.
T Consensus 304 ~~L~~ 308 (326)
T 3uim_A 304 RMLEG 308 (326)
T ss_dssp HHHHT
T ss_pred HHhcC
Confidence 99985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=284.30 Aligned_cols=217 Identities=26% Similarity=0.422 Sum_probs=170.8
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++. ++..++||||++ ++|.+++... ...+++..++.++.|++.||.|||+.||+|
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 123 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLH 123 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 4557999999999999999999985 567999999996 5999998763 356999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ...++.++||||||+++|+|+
T Consensus 124 ~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~ 195 (324)
T 3mtl_A 124 RDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMA 195 (324)
T ss_dssp SSCCGGGEEECTT-CCEEECSSSEEECC------------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHH
T ss_pred CCcCHHHEEECCC-CCEEEccCcccccccCCccccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999965 46999999998754432 22334467999999998864 256788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCC----------------------------CCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPG----------------------------LPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
+|..||.+................+. ....+++++.+|+.+||+.||.+|||
T Consensus 196 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 275 (324)
T 3mtl_A 196 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275 (324)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC
Confidence 99999988765444333222111110 11246889999999999999999999
Q ss_pred HHHHHHHHHhhhhccCCCC
Q 022347 234 FSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 234 ~~~l~~~l~~~~~~~~~~~ 252 (298)
++++++ +.|+.......
T Consensus 276 ~~e~l~--hp~f~~~~~~~ 292 (324)
T 3mtl_A 276 AEDAMK--HPFFLSLGERI 292 (324)
T ss_dssp HHHHTT--SGGGGGGCSTT
T ss_pred HHHHhc--Chhhhhccccc
Confidence 999999 78887765543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=287.81 Aligned_cols=200 Identities=27% Similarity=0.373 Sum_probs=163.0
Q ss_pred HHHHHHHHH-HHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNM-MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~-l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+.+|..+ ++.++||||+++++++. ++..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||
T Consensus 83 ~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gi 160 (373)
T 2r5t_A 83 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNI 160 (373)
T ss_dssp --------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 355677776 57789999999999985 45799999999999999999864 458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+||+++.++ .++|+|||++.... .........||+.|+|||++.+ ..++.++|+||||+++|+
T Consensus 161 vHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 231 (373)
T 2r5t_A 161 VYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYE 231 (373)
T ss_dssp CCCCCCGGGEEECTTS-CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT--------CCCCTHHHHHHHHHHHHH
T ss_pred eecCCCHHHEEECCCC-CEEEeeCccccccccCCCccccccCCccccCHHHhCC--------CCCCchhhhHHHHHHHHH
Confidence 9999999999999654 69999999997532 2333455679999999999865 568899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (298)
|++|..||.+.+.... .... ......++..++.++.++|.+||+.||.+||++.
T Consensus 232 ll~G~~Pf~~~~~~~~-~~~i-~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 232 MLYGLPPFYSRNTAEM-YDNI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHSSCTTCCSBHHHH-HHHH-HHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHcCCCCCCCCCHHHH-HHHH-HhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 9999999987665433 2332 2345567788999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=291.39 Aligned_cols=218 Identities=22% Similarity=0.343 Sum_probs=173.5
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|..++..++||||+++++++. ++..|+||||++||+|.+++.... ..+++..++.++.|++.||+|||+.||+|
T Consensus 107 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiH 185 (412)
T 2vd5_A 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVH 185 (412)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 4779999999999999999999996 457899999999999999997642 46999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccccc--cccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+|||++.++ .++|+|||++........ .....||+.|+|||++...... .....++.++|||||||++|+|
T Consensus 186 rDLKp~NILld~~g-~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~~~~~~~~~~DiwSlGvilyel 263 (412)
T 2vd5_A 186 RDIKPDNILLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG-PGTGSYGPECDWWALGVFAYEM 263 (412)
T ss_dssp CCCSGGGEEECTTS-CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTC-TTCSEECTHHHHHHHHHHHHHH
T ss_pred cccCHHHeeecCCC-CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccC-cCCCCCChHHhhhHHhHHHHHH
Confidence 99999999999654 699999999975443322 2345799999999998631100 0124678999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhh---cCCCCCCCCcHHHHHHHHHhhhhCCCCC---CCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKH---ARPGLPEDISPDLAFIVQSCWVEDPNLR---PSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~l~~~l~~~~~~ 247 (298)
++|..||.+.+............ ..+..+..+++++.+||.+||. +|.+| |+++++++ +.++..
T Consensus 264 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--Hpff~~ 333 (412)
T 2vd5_A 264 FYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--HPFFFG 333 (412)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--SGGGTT
T ss_pred HhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--CCCcCC
Confidence 99999998876544333332211 2233346799999999999999 99998 58999988 666543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=283.48 Aligned_cols=206 Identities=28% Similarity=0.384 Sum_probs=162.5
Q ss_pred HHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++..|+..+.++ +||||+++++++. ++..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||+.||+
T Consensus 102 ~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 179 (311)
T 3p1a_A 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLV 179 (311)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 444566655555 8999999999985 56799999999 77999998774 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
|+||||+||+++.+ +.++|+|||++.............|++.|+|||++. ..++.++||||||+++|+|+
T Consensus 180 H~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~el~ 249 (311)
T 3p1a_A 180 HLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ---------GSYGTAADVFSLGLTILEVA 249 (311)
T ss_dssp CCCCSGGGEEECGG-GCEEECCCTTCEECC------CCCCCGGGCCGGGGG---------TCCSTHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEECCC-CCEEEccceeeeecccCCCCcccCCCccccCHhHhc---------CCCCchhhHHHHHHHHHHHH
Confidence 99999999999855 469999999988765555555567899999999875 35788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|..++........ .......+.++..+++++.+++.+||+.||.+|||+.++++ +.|+.
T Consensus 250 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~~ 309 (311)
T 3p1a_A 250 CNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA--LPVLR 309 (311)
T ss_dssp HTCCCCSSHHHHHH---HTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGS
T ss_pred hCCCCCCCccHHHH---HhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh--Ccccc
Confidence 99776654322111 11111122344568999999999999999999999999998 55543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=297.40 Aligned_cols=214 Identities=25% Similarity=0.445 Sum_probs=178.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. .+..|+||||+.|++|.+++... ..+++..++.++.|++.||.|||++||+
T Consensus 71 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iv 148 (484)
T 3nyv_A 71 ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIV 148 (484)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46789999999999999999999996 45789999999999999998753 5699999999999999999999999999
Q ss_pred eecCCCCCEEEcC--CCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+||+++. ..+.++|+|||++.............+++.|+|||++. ..++.++||||||+++|+
T Consensus 149 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ 219 (484)
T 3nyv_A 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH---------GTYDEKCDVWSTGVILYI 219 (484)
T ss_dssp CSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH---------TCCCTHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeec---------CCCCCcceeHHHHHHHHH
Confidence 9999999999952 34579999999987655544445567999999999885 357889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
|++|..||.+.+.................+ ..+++++.+||.+||+.+|.+|||+.++++ +.|+....
T Consensus 220 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~~~ 289 (484)
T 3nyv_A 220 LLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQTYT 289 (484)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHHHT
T ss_pred HHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhcccc
Confidence 999999999876654443333222222222 468999999999999999999999999998 67766544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=275.36 Aligned_cols=224 Identities=24% Similarity=0.385 Sum_probs=181.2
Q ss_pred HHHHHHHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 17 ERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
......+.+.+|+.+++++. ||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||.|
T Consensus 62 ~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~ 139 (298)
T 1phk_A 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICA 139 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHH
Confidence 34456678899999999996 999999999985 45789999999999999999864 459999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+.|++|+||+|+||+++.+ +.++|+|||++.............+++.|+|||++.+... .....++.++||||||
T Consensus 140 lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG 216 (298)
T 1phk_A 140 LHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTG 216 (298)
T ss_dssp HHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHH
T ss_pred HHHCCcccCCCCcceEEEcCC-CcEEEecccchhhcCCCcccccccCCccccCHHHhccccc--cccccCCcccccHhHH
Confidence 999999999999999999955 4699999999986555444455678999999998853211 1124678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+++|+|++|..||.................... ....++..+.+++.+||+.||.+|||+.++++ +.++..
T Consensus 217 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 289 (298)
T 1phk_A 217 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQQ 289 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGCT
T ss_pred HHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh--ChHhhh
Confidence 999999999999987665443332222222211 12458899999999999999999999999987 566554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=278.49 Aligned_cols=220 Identities=26% Similarity=0.390 Sum_probs=172.5
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
...+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.
T Consensus 44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~ 121 (311)
T 4agu_A 44 VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH 121 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567889999999999999999999985 5578999999999999998875 35599999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++||||||+||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ...++.++||||||+++
T Consensus 122 ~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il 193 (311)
T 4agu_A 122 NCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVF 193 (311)
T ss_dssp TEECCCCSGGGEEECTT-SCEEECCCTTCEECC------------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHH
T ss_pred CCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCcccccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHH
Confidence 99999999999999955 46999999999764432 22344578999999998863 25678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhc-------------------CCCC----------CCCCcHHHHHHHHHhhhhCC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHA-------------------RPGL----------PEDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~----------~~~~~~~l~~li~~~l~~~p 228 (298)
|+|++|..||.+............... .... ...+++.+.+++.+||+.||
T Consensus 194 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 273 (311)
T 4agu_A 194 AELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDP 273 (311)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSST
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCCh
Confidence 999999999988765544332221100 0000 13578899999999999999
Q ss_pred CCCCCHHHHHHHHHhhhhccCCC
Q 022347 229 NLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 229 ~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
.+|||++++++ +.|+..++..
T Consensus 274 ~~Rpt~~ell~--hp~f~~~~~~ 294 (311)
T 4agu_A 274 TERLTCEQLLH--HPYFENIREI 294 (311)
T ss_dssp TTSCCHHHHHT--SGGGTTCC--
T ss_pred hhcCCHHHHhc--ChHHHhccCH
Confidence 99999999998 7777766543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=283.45 Aligned_cols=219 Identities=23% Similarity=0.434 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHHhCCC--Ccccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVKH--DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~h--p~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..+.+.+|+.++++++| |||+++++++. ++..|+|||+ .+++|.+++... ..+++..++.++.|++.||.|||+
T Consensus 50 ~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~ 126 (343)
T 3dbq_A 50 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ 126 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34578899999999987 99999999985 5678999995 488999999873 469999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceeccccccccccccC---CccCCCcchhHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQG---EKKHYNNKVDVY 171 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~---~~~~~~~~~Di~ 171 (298)
.||+||||||+||+++ + +.++|+|||++........ .....|++.|+|||++.+...... ....++.++|||
T Consensus 127 ~~iiHrDikp~NIll~-~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diw 204 (343)
T 3dbq_A 127 HGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204 (343)
T ss_dssp TTCCCCCCCGGGEEEE-T-TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHH
T ss_pred CCeecCCCCcceEEEE-C-CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHH
Confidence 9999999999999997 4 4699999999986543322 234578999999999864211110 125678899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHH-HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|||+++|+|++|..||....+........ .......++...+.++.+++.+||+.||.+|||+.++++ +.|+.
T Consensus 205 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~--hp~~~ 278 (343)
T 3dbq_A 205 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ 278 (343)
T ss_dssp HHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred HHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh--Ccccc
Confidence 99999999999999998765443333333 334445667778899999999999999999999999998 45544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=285.14 Aligned_cols=213 Identities=25% Similarity=0.463 Sum_probs=172.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN- 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~- 98 (298)
..+.+.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ..+++..+..++.|++.||.|||+.
T Consensus 74 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~ 151 (360)
T 3eqc_A 74 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 151 (360)
T ss_dssp HHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 4467889999999999999999999985 56799999999999999999874 4599999999999999999999996
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
||+|+||||+||+++.++ .++|+|||++...... ......+++.|+|||++.+ ..++.++||||||+++|
T Consensus 152 ~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 221 (360)
T 3eqc_A 152 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLV 221 (360)
T ss_dssp CCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT--------CCCSHHHHHHHHHHHHH
T ss_pred CEEcCCccHHHEEECCCC-CEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC--------CCCCchhhHHHHHHHHH
Confidence 999999999999999654 6999999998643222 2234578999999999865 56889999999999999
Q ss_pred HHHhCCCCCCCCChHHHH-----------------------------------------HHHHHhhcCCCCC-CCCcHHH
Q 022347 179 ELLTNRLPFEGMSNLQAA-----------------------------------------YAAAFKHARPGLP-EDISPDL 216 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~-~~~~~~l 216 (298)
+|++|..||......... .........+..+ ..++.++
T Consensus 222 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (360)
T 3eqc_A 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 301 (360)
T ss_dssp HHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHH
Confidence 999999999865532211 1111122222222 3478999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 217 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 217 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
.+|+.+||+.||.+|||+.++++ +.|+..
T Consensus 302 ~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 330 (360)
T 3eqc_A 302 QDFVNKCLIKNPAERADLKQLMV--HAFIKR 330 (360)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHT--SHHHHH
T ss_pred HHHHHHHhhcChhhCCCHHHHhh--ChHhhc
Confidence 99999999999999999999998 556544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=279.34 Aligned_cols=210 Identities=28% Similarity=0.403 Sum_probs=174.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.+.+.+|+.++++++||||+++++++. +...++||||+++++|.+++.... ...+++..++.++.|++.||.|||
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 128 (279)
T 2w5a_A 49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128 (279)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 457889999999999999999999872 457899999999999999997632 345999999999999999999999
Q ss_pred hCC-----CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 97 ANG-----IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 97 ~~g-----ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
+.| ++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||
T Consensus 129 ~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di 199 (279)
T 2w5a_A 129 RRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR--------MSYNEKSDI 199 (279)
T ss_dssp HHC------CCCCCSGGGEEECSS-SCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC--------C-CCHHHHH
T ss_pred cccCCCCeeEEeccchhhEEEcCC-CCEEEecCchheeeccccccccccCCCccccChHHhcc--------CCCCchhhH
Confidence 999 9999999999999955 469999999987543322 1223467889999999864 567889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 241 (298)
||||+++|+|++|..||...... ...........+.++..++.++.+++.+||+.+|.+|||+.++++++
T Consensus 200 ~slG~il~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 200 WSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHHHHHHHHHCCCCCcccCHH-HHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 99999999999999999876543 33344445556677788999999999999999999999999999843
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=287.05 Aligned_cols=219 Identities=23% Similarity=0.440 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHHhCC--CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVK--HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..+.+.+|+.++++++ ||||+++++++. ++..|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||+
T Consensus 97 ~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~ 173 (390)
T 2zmd_A 97 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ 173 (390)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3457889999999997 599999999884 5679999995 588999999864 468999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceecccccccccccc---CCccCCCcchhHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVY 171 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~---~~~~~~~~~~Di~ 171 (298)
.||+||||||+|||++ + +.++|+|||++....... ......|++.|+|||++.+..... .....++.++|||
T Consensus 174 ~~ivHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diw 251 (390)
T 2zmd_A 174 HGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251 (390)
T ss_dssp TTCCCCCCCGGGEEES-S-SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHH
T ss_pred CCeeecCCCHHHEEEE-C-CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHH
Confidence 9999999999999996 4 469999999998654322 223457999999999986421100 0124688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHH-hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
||||++|+|++|..||....+......... ......++...+.++.+++.+||+.||.+|||+.++++ +.|+.
T Consensus 252 SlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~~~ 325 (390)
T 2zmd_A 252 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ 325 (390)
T ss_dssp HHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred HHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh--CcCcc
Confidence 999999999999999987654333333333 23344566777899999999999999999999999998 45554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=275.18 Aligned_cols=214 Identities=27% Similarity=0.400 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|+
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i 126 (276)
T 2yex_A 49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126 (276)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 357889999999999999999999985 5578999999999999999875 2459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+|+||+|+||+++.+ +.++|+|||.+...... .......++..|+|||.+.+ ...++.++||||||+++
T Consensus 127 ~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il 198 (276)
T 2yex_A 127 THRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVL 198 (276)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC-------SSBCHHHHHHHHHHHHH
T ss_pred eccCCChHHEEEccC-CCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc-------CCCCCCcchHHHHHHHH
Confidence 999999999999955 46999999998754322 22334568999999999864 12346789999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+|++|..||................. .......+++.+.+++.+||+.||.+|||+.++++ +.++..
T Consensus 199 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~ 267 (276)
T 2yex_A 199 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNK 267 (276)
T ss_dssp HHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTC
T ss_pred HHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc--CccccC
Confidence 999999999987654332222222211 11223468899999999999999999999999988 455543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=284.52 Aligned_cols=208 Identities=25% Similarity=0.350 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHHhCC-----CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVK-----HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~-----hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..+.+..|+.+++.+. ||||+++++++. .+..|+||||+ +++|.+++.......+++..++.++.|++.||+|
T Consensus 74 ~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 152 (360)
T 3llt_A 74 YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152 (360)
T ss_dssp HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 3456778999999997 999999999985 56799999999 9999999988665679999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcC------------------------CCCceEEeccCCCccCccccccccccCccceecccc
Q 022347 95 LHANGIIHRDLKPDNLLLTP------------------------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 150 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 150 (298)
||+.||+||||||+||+++. ..+.++|+|||++...... .....+++.|+|||+
T Consensus 153 LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~ 230 (360)
T 3llt_A 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEV 230 (360)
T ss_dssp HHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHH
T ss_pred HHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHH
Confidence 99999999999999999974 2457999999999753332 234578999999999
Q ss_pred ccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC------------------------
Q 022347 151 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------------------------ 206 (298)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------------------ 206 (298)
+.+ ..++.++|||||||++|+|++|+.||...................
T Consensus 231 ~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 302 (360)
T 3llt_A 231 ILN--------LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302 (360)
T ss_dssp HTT--------CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEE
T ss_pred HcC--------CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCccccee
Confidence 865 568899999999999999999999998766544332221110000
Q ss_pred CCC--------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 207 GLP--------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 207 ~~~--------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
..+ ...++.+.+|+.+||+.||.+|||+.++++
T Consensus 303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 112367889999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.77 Aligned_cols=216 Identities=25% Similarity=0.362 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHhC------CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV------KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l------~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+.+|+.+++.+ .|+||+++++++. .+..|+||||+. ++|.+++.......+++..++.++.||+.||+|
T Consensus 137 ~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~ 215 (429)
T 3kvw_A 137 HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215 (429)
T ss_dssp HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 34666788888777 5789999999985 567999999994 699999988666679999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCC-ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
||+.||+||||||+|||++.++. .++|+|||++..... ......+++.|+|||++.+ ..++.++|||||
T Consensus 216 LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSl 285 (429)
T 3kvw_A 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILG--------ARYGMPIDMWSL 285 (429)
T ss_dssp HHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHT--------BCCCTHHHHHHH
T ss_pred HHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC--cccccCCCCCccChHHHhC--------CCCCchHHHHhH
Confidence 99999999999999999996543 399999999965432 2334578999999999875 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-----------------------------------------------
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP----------------------------------------------- 206 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------------- 206 (298)
||++|+|++|..||.+.+..............+
T Consensus 286 G~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (429)
T 3kvw_A 286 GCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLR 365 (429)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEE
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhcc
Confidence 999999999999998876554433322111000
Q ss_pred ----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 207 ----------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 207 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
.++...++.+.+||.+||+.||.+|||+.++++ +.|+....+
T Consensus 366 ~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~--Hpw~~~~~~ 417 (429)
T 3kvw_A 366 GPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR--HPWLRRRLP 417 (429)
T ss_dssp CSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT--STTTC----
T ss_pred CCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC--ChhhccCCC
Confidence 011234788999999999999999999999998 777765443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=272.94 Aligned_cols=217 Identities=21% Similarity=0.308 Sum_probs=174.9
Q ss_pred HHHHHHHHHHhCCCCcccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++.+|+.+++.++|++++..+..+ .++..++||||+ +++|.+++... ...+++..++.++.|++.||+|||++|++
T Consensus 50 ~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 127 (296)
T 3uzp_A 50 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFI 127 (296)
T ss_dssp HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 577999999999999988877766 355789999999 99999999752 35699999999999999999999999999
Q ss_pred eecCCCCCEEEc--CCCCceEEeccCCCccCccccc--------cccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 102 HRDLKPDNLLLT--PDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 102 H~dik~~Nil~~--~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
|+||||+||+++ .+++.++|+|||++........ .....++..|+|||.+.+ ..++.++|||
T Consensus 128 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~ 199 (296)
T 3uzp_A 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLE 199 (296)
T ss_dssp CSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--------CCCCHHHHHH
T ss_pred eCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC--------CCCCcchhhH
Confidence 999999999994 2445799999999975443221 234578999999999865 5688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 172 SFGIVLWELLTNRLPFEGMSN------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
|||+++|+|++|..||..... ...............++..+++++.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus 200 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 200 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 999999999999999976432 11111111111112233668999999999999999999999999999999998
Q ss_pred hccCC
Q 022347 246 FTLRP 250 (298)
Q Consensus 246 ~~~~~ 250 (298)
.....
T Consensus 280 ~~~~~ 284 (296)
T 3uzp_A 280 HRQGF 284 (296)
T ss_dssp HHTTC
T ss_pred HhcCC
Confidence 77654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=283.35 Aligned_cols=211 Identities=28% Similarity=0.474 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecC--------------------------------------------------
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDP-------------------------------------------------- 50 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-------------------------------------------------- 50 (298)
..+.+.+|+.++++++||||+++++++.+.
T Consensus 47 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (332)
T 3qd2_B 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126 (332)
T ss_dssp HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------------------------
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccc
Confidence 345788999999999999999999987321
Q ss_pred --------ceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEE
Q 022347 51 --------LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121 (298)
Q Consensus 51 --------~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l 121 (298)
..++||||++|++|.+++..... ...++..++.++.|++.||+|||+.||+||||||+||+++.+ +.++|
T Consensus 127 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL 205 (332)
T 3qd2_B 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKV 205 (332)
T ss_dssp -----CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEE
T ss_pred ccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEE
Confidence 27999999999999999987433 335677889999999999999999999999999999999955 46999
Q ss_pred eccCCCccCcccc-------------ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 022347 122 ADFGLAREETVTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 188 (298)
Q Consensus 122 ~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 188 (298)
+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..|+.
T Consensus 206 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG--------NNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp CCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC--------CCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred eecCcccccccchhhccccccccccccccccCCCcCccChHHhcC--------CCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999997544321 2233468999999999865 568899999999999999999877643
Q ss_pred CCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 189 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
. .............+......++.+.+++.+||+.||.+|||+.++++ +.++
T Consensus 278 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--~~~f 329 (332)
T 3qd2_B 278 E---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE--NAIF 329 (332)
T ss_dssp H---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH--STTC
T ss_pred H---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh--chhh
Confidence 2 11222222222222222345678899999999999999999999998 4444
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=280.21 Aligned_cols=204 Identities=24% Similarity=0.377 Sum_probs=171.8
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++.+|+.++++++||||+++++++. ++..++||||+.+| +|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 75 ~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iv 152 (335)
T 3dls_A 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDII 152 (335)
T ss_dssp EEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 5668999999999999999999995 55789999998766 999999763 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+||+++.+ +.++|+|||++.............+++.|+|||++.+ ...++.++||||||+++|+|+
T Consensus 153 H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~ 224 (335)
T 3dls_A 153 HRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-------NPYRGPELEMWSLGVTLYTLV 224 (335)
T ss_dssp CSCCSGGGEEECTT-SCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHH
T ss_pred EeccCHHHEEEcCC-CcEEEeecccceECCCCCceeccCCCccccChhhhcC-------CCCCCCcccchhHHHHHHHHH
Confidence 99999999999965 5699999999986655554455678999999999864 123378999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|..||...... .......+..+++++.+++.+||+.||.+|||+.++++ +.|+..
T Consensus 225 ~g~~pf~~~~~~--------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--hp~~~~ 280 (335)
T 3dls_A 225 FEENPFCELEET--------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT--DPWVTQ 280 (335)
T ss_dssp HSSCSCSSGGGG--------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH--CTTTTC
T ss_pred hCCCchhhHHHH--------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc--CccccC
Confidence 999999764321 12233445668999999999999999999999999998 566543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.87 Aligned_cols=216 Identities=25% Similarity=0.369 Sum_probs=173.5
Q ss_pred HHHHHHHhCCCCcccceeceee-cC------ceeEEEecCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 27 REVNMMSRVKHDNLVKFLGACK-DP------LMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 27 ~E~~~l~~l~hp~Iv~~~~~~~-~~------~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
+|+.+++.++||||+++++++. .+ +.++||||+++ ++.+.+.. .....+++..++.++.|++.||+|||+
T Consensus 81 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 7999999999999999999872 11 37899999976 44444432 224569999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
.||+||||||+||+++...+.++|+|||++.............+++.|+|||++.+ ...++.++|||||||++
T Consensus 160 ~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il 232 (394)
T 4e7w_A 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVM 232 (394)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHH
T ss_pred CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHH
Confidence 99999999999999995556799999999986655555556678999999998864 24588999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
|+|++|+.||.+.+..............+ .++..+++++.+|+.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (394)
T 4e7w_A 233 AELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312 (394)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhh
Confidence 99999999999877655444333211111 123457899999999999999999
Q ss_pred CCCHHHHHHHHHhhhhccCCCC
Q 022347 231 RPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 231 Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
|||+.++++ +.|+..++...
T Consensus 313 R~t~~e~l~--hp~f~~~~~~~ 332 (394)
T 4e7w_A 313 RLTAIEALC--HPFFDELRTGE 332 (394)
T ss_dssp SCCHHHHHT--SGGGSTTTSSC
T ss_pred CCCHHHHhc--Chhhhhhcccc
Confidence 999999998 77877665543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=275.53 Aligned_cols=209 Identities=29% Similarity=0.486 Sum_probs=177.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++
T Consensus 65 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 141 (303)
T 3a7i_A 65 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKI 141 (303)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 46789999999999999999999984 5678999999999999999875 5699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 142 H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 212 (303)
T 3a7i_A 142 HRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIEL 212 (303)
T ss_dssp CCCCSGGGEEECTT-SCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHH
T ss_pred cCCCChheEEECCC-CCEEEeecccceecCccccccCccCCCcCccCHHHHhc--------CCCCchhhhHHHHHHHHHH
Confidence 99999999999955 469999999997544332 2334568999999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++|..||........ .........+.++..++..+.+++.+||+.+|.+|||+.++++ +.++.
T Consensus 213 ~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~ 275 (303)
T 3a7i_A 213 ARGEPPHSELHPMKV-LFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFIL 275 (303)
T ss_dssp HHSSCTTTTSCHHHH-HHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT--CHHHH
T ss_pred ccCCCCCCCcCHHHH-HHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh--Chhhh
Confidence 999999987665433 3333445566677889999999999999999999999999998 44443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=279.65 Aligned_cols=215 Identities=29% Similarity=0.437 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
..+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.
T Consensus 73 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 152 (307)
T 2nru_A 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152 (307)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 4457889999999999999999999985 557899999999999999997532 34699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|++|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ .++.++||||||+
T Consensus 153 ~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~Dv~slG~ 222 (307)
T 2nru_A 153 HHIHRDIKSANILLDEA-FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---------EITPKSDIYSFGV 222 (307)
T ss_dssp TEECSCCCGGGEEECTT-CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---------EECTHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCC-CcEEEeecccccccccccccccccccCCCcCcCChHHhcC---------CCCccchhHHHHH
Confidence 99999999999999955 469999999987543321 2234468999999998753 4688999999999
Q ss_pred HHHHHHhCCCCCCCCChHH---HHHHHHH----------hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 176 VLWELLTNRLPFEGMSNLQ---AAYAAAF----------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++|+|++|..||....... ....... .......+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 223 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 223 VLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp HHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9999999999997654321 1111111 11112223345677999999999999999999999999998
Q ss_pred hhh
Q 022347 243 AFL 245 (298)
Q Consensus 243 ~~~ 245 (298)
.+.
T Consensus 303 ~l~ 305 (307)
T 2nru_A 303 EMT 305 (307)
T ss_dssp HHC
T ss_pred HHh
Confidence 764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.05 Aligned_cols=215 Identities=27% Similarity=0.414 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..+++.+|+.++++++||||+++++++.. ...|+||||++ ++|.+++.. ..+++..++.++.|++.||+|
T Consensus 68 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~ 143 (364)
T 3qyz_A 68 YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKY 143 (364)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999998843 35899999995 599999976 569999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
||+.||+||||||+||+++.+ +.++|+|||++........ .....+++.|+|||++.+ ...++.++||
T Consensus 144 LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di 215 (364)
T 3qyz_A 144 IHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDI 215 (364)
T ss_dssp HHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHH
T ss_pred HHHCCeecCCCChHhEEECCC-CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC-------CCCCCcchhH
Confidence 999999999999999999955 4699999999975443322 234478999999998753 2457899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-----------------------------CCCCCCcHHHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQ 221 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~ 221 (298)
||||+++|+|++|..||.+................+ .+...+++++.+|+.
T Consensus 216 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 295 (364)
T 3qyz_A 216 WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD 295 (364)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHH
Confidence 999999999999999998766544333222111100 012457899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+||+.||.+|||+.++++ +.|+....
T Consensus 296 ~~L~~dP~~R~t~~e~l~--hp~~~~~~ 321 (364)
T 3qyz_A 296 KMLTFNPHKRIEVEQALA--HPYLEQYY 321 (364)
T ss_dssp HHTCSSTTTSCCHHHHHT--SGGGTTTC
T ss_pred HHcCCChhhCCCHHHHhc--Ccchhhcc
Confidence 999999999999999998 77776543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.05 Aligned_cols=217 Identities=27% Similarity=0.413 Sum_probs=168.9
Q ss_pred HHHHHHHHHHhCCCCcccceeceeecC-----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+|+.++++++||||+++++++.+. ..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.
T Consensus 64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~ 140 (322)
T 3soc_A 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHED 140 (322)
T ss_dssp HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhh
Confidence 455799999999999999999998432 36999999999999999986 4599999999999999999999999
Q ss_pred ----------CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCC
Q 022347 99 ----------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN 165 (298)
Q Consensus 99 ----------givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 165 (298)
||+|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+... ....++
T Consensus 141 ~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~ 216 (322)
T 3soc_A 141 IPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN---FQRDAF 216 (322)
T ss_dssp EEEETTEEECEEECSCCSGGGEEECTT-CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC---CCHHHH
T ss_pred ccccccccCCCEEeCCCChHhEEECCC-CeEEEccCCcccccccccCccccccCccCccccCHhhcccccc---cCcCCC
Confidence 99999999999999955 569999999997543322 2233578999999999864110 113456
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHHHHHHh-hcCCCCCC-----CCcHHHHHHHHHhh
Q 022347 166 NKVDVYSFGIVLWELLTNRLPFEGMSN---------------LQAAYAAAFK-HARPGLPE-----DISPDLAFIVQSCW 224 (298)
Q Consensus 166 ~~~Di~slG~il~~ll~g~~p~~~~~~---------------~~~~~~~~~~-~~~~~~~~-----~~~~~l~~li~~~l 224 (298)
.++||||||+++|+|++|+.||.+... .......... ...+.++. ..++++.+++.+||
T Consensus 217 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (322)
T 3soc_A 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296 (322)
T ss_dssp HHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHT
T ss_pred ccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHc
Confidence 789999999999999999999965321 1111222211 12222222 12456999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhc
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+.||.+|||+.++++.|+.+...
T Consensus 297 ~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 297 DHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999987643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=281.66 Aligned_cols=219 Identities=21% Similarity=0.284 Sum_probs=176.9
Q ss_pred HHHHHHHHHHhCCCCcccc---------------eeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVK---------------FLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~---------------~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~ 86 (298)
.+.+|+.++++++||||++ +++++. +...|+||||+ +++|.+++.......+++..++.++.
T Consensus 88 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~ 166 (352)
T 2jii_A 88 RLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVAC 166 (352)
T ss_dssp THHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHH
Confidence 5779999999999999998 445543 46789999999 99999999875446799999999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCC-CceEEeccCCCccCccccc--------cccccCccceeccccccccccc
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQ-KSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLR 157 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~-~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~ 157 (298)
|++.||.|||+.||+||||||+||+++.++ ..++|+|||++........ .....+++.|+|||++.+
T Consensus 167 qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---- 242 (352)
T 2jii_A 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG---- 242 (352)
T ss_dssp HHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT----
T ss_pred HHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc----
Confidence 999999999999999999999999999654 1799999999975443221 123478999999999864
Q ss_pred cCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHH--HhhcCCCCC------CCCcHHHHHHHHHhhhhCC
Q 022347 158 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-NLQAAYAAA--FKHARPGLP------EDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 158 ~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~-~~~~~~~~~--~~~~~~~~~------~~~~~~l~~li~~~l~~~p 228 (298)
..++.++||||||+++|+|++|..||.... ......... .......+. ..+++++.+++.+||+.||
T Consensus 243 ----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 243 ----CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCT
T ss_pred ----CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCCh
Confidence 578899999999999999999999998754 222222211 122222222 2468999999999999999
Q ss_pred CCCCCHHHHHHHHHhhhhccCCC
Q 022347 229 NLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 229 ~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
.+|||+.++++.|+.++......
T Consensus 319 ~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 319 EEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hhCCCHHHHHHHHHHHHHhcCCC
Confidence 99999999999999998876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=274.25 Aligned_cols=211 Identities=26% Similarity=0.400 Sum_probs=155.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 56 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 134 (278)
T 3cok_A 56 QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGIL 134 (278)
T ss_dssp HHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 57889999999999999999999985 45789999999999999999863 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 135 H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 205 (278)
T 3cok_A 135 HRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR--------SAHGLESDVWSLGCMFYTL 205 (278)
T ss_dssp CSSCCGGGEEECTT-CCEEECCCTTCEECC------------------------------------CTHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCC-CCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC--------CCCCchhhHHHHHHHHHHH
Confidence 99999999999955 469999999987544322 2234468899999998864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||........... ........+..++.++.+++.+||+.||.+|||++++++ +.++..
T Consensus 206 ~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~ 268 (278)
T 3cok_A 206 LIGRPPFDTDTVKNTLNK--VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD--HPFMSR 268 (278)
T ss_dssp HHSSCSSCCCSCC-------CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--STTTC-
T ss_pred HhCCCCCCChhHHHHHHH--HhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc--CccccC
Confidence 999999986543322111 112233456778999999999999999999999999988 555543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=274.42 Aligned_cols=209 Identities=20% Similarity=0.335 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..++.+|+..+.++ +||||+++++++. ++..++||||++|++|.+++.... ...+++..++.++.|++.||.|||+
T Consensus 54 ~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 133 (289)
T 1x8b_A 54 EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133 (289)
T ss_dssp HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34677999999999 8999999999985 567999999999999999997642 2568999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCC------------------CceEEeccCCCccCccccccccccCccceeccccccccccccC
Q 022347 98 NGIIHRDLKPDNLLLTPDQ------------------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 159 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 159 (298)
.||+|+||||+||+++.++ ..++|+|||.+...... ....++..|+|||.+.+
T Consensus 134 ~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~------ 204 (289)
T 1x8b_A 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE------ 204 (289)
T ss_dssp TTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT------
T ss_pred CCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcC------
Confidence 9999999999999998432 36899999998765432 23358999999999864
Q ss_pred CccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 160 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 160 ~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
...++.++||||||+++|+|++|..++..... .........+.++..+++++.+++.+||+.||.+|||+.++++
T Consensus 205 -~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 205 -NYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 23566799999999999999999887754432 2334455666778889999999999999999999999999988
Q ss_pred HHHhhhh
Q 022347 240 MLNAFLF 246 (298)
Q Consensus 240 ~l~~~~~ 246 (298)
+.++.
T Consensus 280 --h~~~~ 284 (289)
T 1x8b_A 280 --HSVLL 284 (289)
T ss_dssp --CTTC-
T ss_pred --ChHhh
Confidence 55544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=277.20 Aligned_cols=219 Identities=26% Similarity=0.427 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
+.+.+|+.+++++ +||||+++++++. ++..++||||+++++|.+++.......+++..++.++.|++.||.|
T Consensus 65 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 144 (326)
T 2x7f_A 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144 (326)
T ss_dssp HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 4677999999999 7999999999984 3468999999999999999987555679999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
||+.|++|+||+|+||+++.+ +.++|+|||++...... .......+++.|+|||++.... .....++.++|||||
T Consensus 145 lH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~sl 220 (326)
T 2x7f_A 145 LHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSL 220 (326)
T ss_dssp HHHTTCCCCCCSGGGEEECTT-CCEEECCCTTTC-------------CCGGGCCHHHHC-----------CCTTHHHHHH
T ss_pred HHHCCccccCCcHHHEEEcCC-CCEEEeeCcCceecCcCccccccccCCccccChhhhcccc---ccCcCCCccchHHHH
Confidence 999999999999999999955 46999999998754332 2223446899999999986311 113567889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+++|+|++|..||.....................+..++..+.+++.+||..||.+|||+.++++ +.++..
T Consensus 221 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~~ 292 (326)
T 2x7f_A 221 GITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIRD 292 (326)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHHC
T ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHhh
Confidence 999999999999998776554443333333333345678999999999999999999999999998 555543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=281.75 Aligned_cols=209 Identities=23% Similarity=0.433 Sum_probs=169.2
Q ss_pred HHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 25 FIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 25 ~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
..+|+.++.++ +||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.||+|
T Consensus 62 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH 139 (342)
T 2qr7_A 62 PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVH 139 (342)
T ss_dssp CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence 34688888888 7999999999996 45789999999999999999753 45999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCC---ceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQK---SLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 103 ~dik~~Nil~~~~~~---~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|||||+||++..+.+ .++|+|||++...... .......+++.|+|||++.+ ..++.++||||||+++|
T Consensus 140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 211 (342)
T 2qr7_A 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER--------QGYDAACDIWSLGVLLY 211 (342)
T ss_dssp SCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH--------HHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC--------CCCCCccCeeeHhHHHH
Confidence 999999999854332 4999999999754332 23345578999999999865 45778999999999999
Q ss_pred HHHhCCCCCCCCC--hHHHHHHHHHhhcCCC----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMS--NLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|++|..||.... ........... .... .+..+++++.+++.+||..||.+|||+.++++ +.|+.
T Consensus 212 ell~g~~Pf~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~ 282 (342)
T 2qr7_A 212 TMLTGYTPFANGPDDTPEEILARIGS-GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR--HPWIV 282 (342)
T ss_dssp HHHHSSCSSCSSTTSCHHHHHHHHHH-CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHH
T ss_pred HHhcCCCCCCCCCcCCHHHHHHHHcc-CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CCeec
Confidence 9999999997632 22333333322 2222 23568999999999999999999999999998 55553
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=284.77 Aligned_cols=216 Identities=29% Similarity=0.426 Sum_probs=162.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+++.+|+.+++.++||||+++++++.. ...|+|+|++ +++|.+++.. ..+++..++.++.|++.||.
T Consensus 71 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~ 146 (367)
T 2fst_X 71 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLK 146 (367)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999998742 4579999999 7899998875 56999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||+.||+||||||+||+++.+ +.++|+|||++...... .....+++.|+|||++.+ ...++.++|||||
T Consensus 147 ~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diwsl 216 (367)
T 2fst_X 147 YIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTADE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSV 216 (367)
T ss_dssp HHHHTTCCCCCCCGGGEEECTT-CCEEECC-----------------CCCTTCCHHHHTT-------CCSCCTTHHHHHH
T ss_pred HHHHCCeeeCCCCHhhEEECCC-CCEEEeecccccccccc--CCCcCcCcCccChHHHcC-------CcCCCchhhHHHH
Confidence 9999999999999999999955 46999999999764332 334578999999998863 2567889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC---------------------CC--------CCCCCcHHHHHHHHHhh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---------------------PG--------LPEDISPDLAFIVQSCW 224 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~--------~~~~~~~~l~~li~~~l 224 (298)
||++|+|++|+.||.+.+.............. +. .....++.+.+||.+||
T Consensus 217 G~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL 296 (367)
T 2fst_X 217 GCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 296 (367)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhC
Confidence 99999999999999887654443332211111 00 11346788999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
..||.+|||+.++++ +.++.....+.
T Consensus 297 ~~dP~~R~t~~e~L~--hp~~~~~~~~~ 322 (367)
T 2fst_X 297 VLDSDKRITAAQALA--HAYFAQYHDPD 322 (367)
T ss_dssp CSSGGGSCCHHHHHT--SGGGTTTCCGG
T ss_pred CCCcccCcCHHHHhc--ChhhhhccCCC
Confidence 999999999999998 77777655433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=287.54 Aligned_cols=219 Identities=28% Similarity=0.379 Sum_probs=167.2
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..+++.+|+.++++++||||+++++++.. ...|+||||++ ++|.+++.. ...+++..++.++.||+.||.|
T Consensus 68 ~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~ 144 (432)
T 3n9x_A 68 DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENF 144 (432)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999999842 46899999995 699999975 3559999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----------------------ccccccCccceeccccc
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----------------------MMTAETGTYRWMAPELY 151 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----------------------~~~~~~~~~~y~aPE~~ 151 (298)
||+.||+||||||+||+++.+ +.++|+|||++....... ......+|+.|+|||++
T Consensus 145 LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 223 (432)
T 3n9x_A 145 IHESGIIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223 (432)
T ss_dssp HHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHH
T ss_pred HHHCCCCCCCCCHHHeEECCC-CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence 999999999999999999965 469999999997543321 12456789999999986
Q ss_pred cccccccCCccCCCcchhHHHHHHHHHHHHhCC-----------CCCCCCCh-----------------HHHHHHH----
Q 022347 152 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR-----------LPFEGMSN-----------------LQAAYAA---- 199 (298)
Q Consensus 152 ~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~-----------~p~~~~~~-----------------~~~~~~~---- 199 (298)
.. ...++.++|||||||++|+|++|. ++|.+... .......
T Consensus 224 ~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~ 296 (432)
T 3n9x_A 224 LL-------QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNII 296 (432)
T ss_dssp TT-------CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHH
T ss_pred hc-------CCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhc
Confidence 43 256899999999999999999844 33433220 0111000
Q ss_pred ------------------HHhhcCCCC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 200 ------------------AFKHARPGL-------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 200 ------------------~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
......... ...+++++.+||.+||+.||.+|||++++++ +.++.....+.
T Consensus 297 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~~~ 372 (432)
T 3n9x_A 297 GTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD--HPYLKDVRKKK 372 (432)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--CGGGTTTCCTT
T ss_pred CCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc--ChhhhhccCcc
Confidence 001111111 1357899999999999999999999999999 78887765543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=276.79 Aligned_cols=210 Identities=27% Similarity=0.397 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
..+.+|+.++++++||||+++++++.++..|+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|
T Consensus 60 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 137 (322)
T 2ycf_A 60 LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIH 137 (322)
T ss_dssp -CHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhHHHHHHHHHhCCCCCCceEeeEEcCCceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 3578999999999999999999999877799999999999999998753 56999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCC--ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||+||+++.++. .++|+|||++.............+++.|+|||++.+. ....++.++||||||+++|+|
T Consensus 138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~~l 212 (322)
T 2ycf_A 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFIC 212 (322)
T ss_dssp CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHT-----TTTTCTTHHHHHHHHHHHHHH
T ss_pred cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccC-----CCCCCCchhhHHHHHHHHHHH
Confidence 999999999985433 5999999999865544443445689999999987421 125678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++|..||................... .....+++.+.+++.+||+.||.+|||+.++++
T Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 213 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 99999997654322222222222221 122468899999999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=289.09 Aligned_cols=216 Identities=28% Similarity=0.413 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
.+++.+|+.++++++||||+++++++.. ...|+||||+ +++|.+++.. ...+++..++.++.||+.||.||
T Consensus 96 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~L 172 (458)
T 3rp9_A 96 CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYV 172 (458)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHH
Confidence 3578899999999999999999999821 3689999998 6799999975 35699999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----------------------------ccccccCccceec
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----------------------------MMTAETGTYRWMA 147 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----------------------------~~~~~~~~~~y~a 147 (298)
|+.||+||||||+|||++.++ .+||+|||++....... ......+|+.|+|
T Consensus 173 H~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 251 (458)
T 3rp9_A 173 HSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251 (458)
T ss_dssp HHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCC
T ss_pred HhCCcCCCCCChhhEEECCCC-CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccC
Confidence 999999999999999999654 69999999997543211 2234467999999
Q ss_pred cccccccccccCCccCCCcchhHHHHHHHHHHHHh-----------CCCCCCCCCh--------------------HHHH
Q 022347 148 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----------NRLPFEGMSN--------------------LQAA 196 (298)
Q Consensus 148 PE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~-----------g~~p~~~~~~--------------------~~~~ 196 (298)
||++.. ...++.++|||||||++|+|++ |..+|.+... ....
T Consensus 252 PE~~~~-------~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l 324 (458)
T 3rp9_A 252 PELILL-------QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL 324 (458)
T ss_dssp HHHHTT-------CCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHH
T ss_pred hHHhhC-------CCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHH
Confidence 998642 2568999999999999999998 6666655321 0110
Q ss_pred HHHH----------------------HhhcCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 197 YAAA----------------------FKHARP-------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 197 ~~~~----------------------~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
.... ...... ......++++.+||.+||..||.+|||++++++ +.|+..
T Consensus 325 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~~ 402 (458)
T 3rp9_A 325 NVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFKE 402 (458)
T ss_dssp HHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTT
T ss_pred HHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhhh
Confidence 0000 000000 012346899999999999999999999999999 888876
Q ss_pred cCC
Q 022347 248 LRP 250 (298)
Q Consensus 248 ~~~ 250 (298)
...
T Consensus 403 ~~~ 405 (458)
T 3rp9_A 403 VRI 405 (458)
T ss_dssp TCC
T ss_pred cCC
Confidence 654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=270.64 Aligned_cols=212 Identities=27% Similarity=0.461 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. .+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++
T Consensus 66 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 143 (287)
T 2wei_A 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIV 143 (287)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46789999999999999999999985 45789999999999999998764 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCC--CceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||+|+||+++.++ ..++|+|||++.............+++.|+|||.+.+ .++.++||||||+++|+
T Consensus 144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~Di~slG~~l~~ 214 (287)
T 2wei_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG---------TYDEKCDVWSAGVILYI 214 (287)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT---------CCCTHHHHHHHHHHHHH
T ss_pred ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC---------CCCCchhhHhHHHHHHH
Confidence 999999999997543 3699999999876544444344467889999998753 47889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|..||.+...................+ ..+++++.+++.+||..+|.+|||+.++++ +.++..
T Consensus 215 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~~~~ 282 (287)
T 2wei_A 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQK 282 (287)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--CHHHhc
Confidence 999999998876544332222222222222 468999999999999999999999999998 455443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=271.74 Aligned_cols=217 Identities=21% Similarity=0.304 Sum_probs=175.1
Q ss_pred HHHHHHHHHHHhCCCCcccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+++.+|+.+++.++|++++..+..+ .++..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.||
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i 126 (296)
T 4hgt_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNF 126 (296)
T ss_dssp CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3577899999999999988887776 355789999999 99999999752 3569999999999999999999999999
Q ss_pred eeecCCCCCEEE---cCCCCceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchh
Q 022347 101 IHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 101 vH~dik~~Nil~---~~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
+|+||||+||++ + +++.++|+|||++....... ......+++.|+|||.+.+ ..++.++|
T Consensus 127 vH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D 197 (296)
T 4hgt_A 127 IHRDVKPDNFLMGLGK-KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDD 197 (296)
T ss_dssp ECSCCSGGGEEECCGG-GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--------CCCCHHHH
T ss_pred ecCCCCHHHeeeeccC-CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC--------CCCCchhH
Confidence 999999999999 5 44569999999997543322 1234578999999999865 56889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSNL------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
|||||+++|+|++|+.||.+.... ..................+++++.+++.+||+.+|.+|||+.++++.|+.
T Consensus 198 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 198 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 999999999999999999764321 11111111111112235688999999999999999999999999999999
Q ss_pred hhhccCC
Q 022347 244 FLFTLRP 250 (298)
Q Consensus 244 ~~~~~~~ 250 (298)
++.+...
T Consensus 278 ~~~~~~~ 284 (296)
T 4hgt_A 278 LFHRQGF 284 (296)
T ss_dssp HHHHHTC
T ss_pred HHHHhCC
Confidence 9887654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=276.95 Aligned_cols=217 Identities=27% Similarity=0.480 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
.+.+.+|+.++++++||||+++++++.. ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 86 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~ 164 (326)
T 2w1i_A 86 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK 164 (326)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3478899999999999999999998732 3689999999999999999863 34699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----cccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||
T Consensus 165 ~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 235 (326)
T 2w1i_A 165 RYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFG 235 (326)
T ss_dssp TEECSCCCGGGEEEEET-TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--------CEEEHHHHHHHHH
T ss_pred CEeccCCCcceEEEcCC-CcEEEecCcchhhccccccccccccCCCCceeEECchhhcC--------CCCCchhhHHHHH
Confidence 99999999999999955 5799999999975433221 223356778999999865 4578899999999
Q ss_pred HHHHHHHhCCCCCCCCChH---------------HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNL---------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+++|+|++|..||...... ...............+..+++++.+++.+||+.+|.+|||+.++++
T Consensus 236 ~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 236 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999987642110 0111222334455667889999999999999999999999999999
Q ss_pred HHHhhhhcc
Q 022347 240 MLNAFLFTL 248 (298)
Q Consensus 240 ~l~~~~~~~ 248 (298)
.|+.+..++
T Consensus 316 ~L~~l~~~l 324 (326)
T 2w1i_A 316 RVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.37 Aligned_cols=215 Identities=26% Similarity=0.420 Sum_probs=175.0
Q ss_pred HHHHHHHHHHhC---CCCcccceeceee------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRV---KHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 24 ~~~~E~~~l~~l---~hp~Iv~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+|+.+++.+ +||||+++++++. +...++||||++ ++|.+++.......+++..++.++.|++.||.|
T Consensus 57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~ 135 (326)
T 1blx_A 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135 (326)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 344666666655 8999999999874 246899999996 699999987655669999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+.|++|+||||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++||||||
T Consensus 136 lH~~gi~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 206 (326)
T 1blx_A 136 LHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVG 206 (326)
T ss_dssp HHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHH
T ss_pred HHHCCceeccCCHHHeEEcCC-CCEEEecCcccccccCCCCccccccccceeCHHHHhc--------CCCCcchhHHHHH
Confidence 999999999999999999955 4699999999987655555556678999999999864 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcC-------------------------CCCCCCCcHHHHHHHHHhhhhCCC
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~ 229 (298)
+++|+|++|..||.+................ ..+...++..+.+++.+||+.||.
T Consensus 207 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (326)
T 1blx_A 207 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286 (326)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcc
Confidence 9999999999999887665443333221110 012356889999999999999999
Q ss_pred CCCCHHHHHHHHHhhhhccCC
Q 022347 230 LRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 230 ~Rps~~~l~~~l~~~~~~~~~ 250 (298)
+|||+.++++ +.++.....
T Consensus 287 ~Rpt~~e~l~--hp~~~~~~~ 305 (326)
T 1blx_A 287 KRISAYSALS--HPYFQDLER 305 (326)
T ss_dssp TSCCHHHHHT--SGGGTTCCC
T ss_pred cCCCHHHHhc--Cccccccch
Confidence 9999999998 777766543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=276.01 Aligned_cols=220 Identities=24% Similarity=0.345 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+.+.+|+.++++++||||+++++++. ....++||||+++++|.+++... ....+++..++.++.|++.||.
T Consensus 69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~ 148 (317)
T 2buj_A 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148 (317)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999874 23689999999999999999763 2356999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc----------cccccCccceeccccccccccccCCccC
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|||+.|++|+||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+. ....
T Consensus 149 ~LH~~~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ 222 (317)
T 2buj_A 149 AIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-----SHCV 222 (317)
T ss_dssp HHHHTTEECCCCCGGGEEECTT-SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-----SEEE
T ss_pred HHHhCCcccCCCCHHHEEEcCC-CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccC-----CCcC
Confidence 9999999999999999999855 4699999998865432111 1223568899999998641 1134
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++||||||+++|+|++|..||...... ...............+..+++++.+++.+||+.||.+|||+.++++.|+
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 688999999999999999999999532110 0111112222233444678999999999999999999999999999998
Q ss_pred hhhh
Q 022347 243 AFLF 246 (298)
Q Consensus 243 ~~~~ 246 (298)
.+..
T Consensus 303 ~~~~ 306 (317)
T 2buj_A 303 ALQP 306 (317)
T ss_dssp HTCC
T ss_pred hcCC
Confidence 7543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=280.10 Aligned_cols=215 Identities=28% Similarity=0.509 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
...+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.
T Consensus 66 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~ 143 (331)
T 4aaa_A 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH 143 (331)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34457889999999999999999999985 5578999999999999888664 35699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++|+||||+||+++.++ .++|+|||++...... .......++..|+|||.+.+ ...++.++||||||+++
T Consensus 144 ~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il 215 (331)
T 4aaa_A 144 NIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLV 215 (331)
T ss_dssp TCCCCCCCGGGEEECTTS-CEEECCCTTC------------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHH
T ss_pred CEEccCcChheEEEcCCC-cEEEEeCCCceeecCCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHH
Confidence 999999999999999554 6999999999754332 22344578999999998864 24678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcC--------------------CC---------CCCCCcHHHHHHHHHhhhhCC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHAR--------------------PG---------LPEDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~---------~~~~~~~~l~~li~~~l~~~p 228 (298)
|+|++|..||.................. +. ....+++.+.+|+.+||+.||
T Consensus 216 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 295 (331)
T 4aaa_A 216 TEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDP 295 (331)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCc
Confidence 9999999999887665444332211100 00 013578999999999999999
Q ss_pred CCCCCHHHHHHHHHhhhh
Q 022347 229 NLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 229 ~~Rps~~~l~~~l~~~~~ 246 (298)
.+|||+.++++ +.|+.
T Consensus 296 ~~Rpt~~ell~--hp~f~ 311 (331)
T 4aaa_A 296 DKRPFCAELLH--HDFFQ 311 (331)
T ss_dssp GGSCCGGGGGG--SHHHH
T ss_pred ccCCCHHHHhc--Cchhc
Confidence 99999999998 44443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=276.81 Aligned_cols=217 Identities=29% Similarity=0.476 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 61 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 139 (302)
T 2j7t_A 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRII 139 (302)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 47889999999999999999999985 56799999999999999998763 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++...... .......++..|+|||.+..... ....++.++||||||+++|+|
T Consensus 140 H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Di~slG~il~~l 215 (302)
T 2j7t_A 140 HRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIEM 215 (302)
T ss_dssp CCCCSGGGEEECTT-SCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHT---TSTTTTTHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEECCC-CCEEEEECCCCccccccccccccccCChhhcCCeeeccccC---CCCCCchhhhHHHHHHHHHHH
Confidence 99999999999955 46999999987532211 12234468899999998842110 125678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||...+......... ....+ ..+..++..+.+++.+||+.||.+|||+.++++ +.++..
T Consensus 216 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 281 (302)
T 2j7t_A 216 AQIEPPHHELNPMRVLLKIA-KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE--HPFVSS 281 (302)
T ss_dssp HHSSCTTTTSCHHHHHHHHH-HSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT--STTTTT
T ss_pred hcCCCCCccCCHHHHHHHHh-ccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc--ChHHhh
Confidence 99999998876544433322 22222 234568899999999999999999999999987 455543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=280.98 Aligned_cols=214 Identities=27% Similarity=0.410 Sum_probs=175.0
Q ss_pred HHHHHHHHhCCCCcccceeceeec---------------------------------------CceeEEEecCCCCCHHH
Q 022347 26 IREVNMMSRVKHDNLVKFLGACKD---------------------------------------PLMVIVTELLPGMSLRK 66 (298)
Q Consensus 26 ~~E~~~l~~l~hp~Iv~~~~~~~~---------------------------------------~~~~lv~e~~~~~sL~~ 66 (298)
.+|+.+++.++||||+++++++.. .+.++||||++ ++|.+
T Consensus 48 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 126 (383)
T 3eb0_A 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHK 126 (383)
T ss_dssp CHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHH
T ss_pred HHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHH
Confidence 379999999999999999998721 23889999996 58888
Q ss_pred HHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccc
Q 022347 67 YLVS--LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 144 (298)
Q Consensus 67 ~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 144 (298)
.+.. .....+++..++.++.|++.||.|||+.||+||||||+||+++.+.+.++|+|||++.............+++.
T Consensus 127 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~ 206 (383)
T 3eb0_A 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF 206 (383)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSS
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCC
Confidence 7764 23467999999999999999999999999999999999999985566899999999986655555556678999
Q ss_pred eeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC------------------
Q 022347 145 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------------------ 206 (298)
Q Consensus 145 y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 206 (298)
|+|||.+.+ ...++.++||||+||++|+|++|+.||.+....+...........+
T Consensus 207 y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 279 (383)
T 3eb0_A 207 YRAPELMLG-------ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279 (383)
T ss_dssp CCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCC
T ss_pred ccCHHHhcC-------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCC
Confidence 999998864 2458899999999999999999999999877655544433211111
Q ss_pred ---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 207 ---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 207 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
.++..+++++.+|+.+||+.||.+|||+.++++ +.++..++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 329 (383)
T 3eb0_A 280 TLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA--HPFFDHLR 329 (383)
T ss_dssp CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGHHHH
T ss_pred ccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--CHHHHHHH
Confidence 134568899999999999999999999999998 66665543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=281.40 Aligned_cols=219 Identities=24% Similarity=0.358 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
...+++.+|+.++++++||||+++++++.. ...|+||||++ ++|.+++.. ....+++..++.++.|++.||.
T Consensus 71 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~ 148 (362)
T 3pg1_A 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLH 148 (362)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHH
Confidence 344688899999999999999999998721 25799999996 689888875 3346999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||+.||+|+||||+||+++.+ +.++|+|||++.............+++.|+|||.+.+ ...++.++|||||
T Consensus 149 ~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diwsl 220 (362)
T 3pg1_A 149 VLHEAGVVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSA 220 (362)
T ss_dssp HHHHTTCCCCCCCGGGEEECTT-CCEEECCTTC---------------CGGGCCHHHHTT-------CTTCCTHHHHHHH
T ss_pred HHHHCcCEecCCChHHEEEcCC-CCEEEEecCcccccccccccceecccceecCcHHhcC-------CCCCCcHhHHHhH
Confidence 9999999999999999999955 4699999999986555555555678999999998863 2467889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC----------------------CC--------CCCCCcHHHHHHHHHh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----------------------PG--------LPEDISPDLAFIVQSC 223 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~--------~~~~~~~~l~~li~~~ 223 (298)
|+++|+|++|+.||.+................ .. .+..+++.+.+|+.+|
T Consensus 221 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 300 (362)
T 3pg1_A 221 GCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300 (362)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHH
Confidence 99999999999999886654433332211111 11 1235688899999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 224 WVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 224 l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
|+.||.+|||+.++++ +.++.....
T Consensus 301 L~~dP~~Rpt~~ell~--hp~f~~~~~ 325 (362)
T 3pg1_A 301 LEFNPQRRISTEQALR--HPYFESLFD 325 (362)
T ss_dssp TCSSGGGSCCHHHHHT--SGGGTTTCC
T ss_pred hcCChhhCCCHHHHHc--CchhhhccC
Confidence 9999999999999998 777776544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=278.63 Aligned_cols=223 Identities=27% Similarity=0.502 Sum_probs=173.4
Q ss_pred HHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
.+.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ...+++..++.++.|++.||+|||+.|++|
T Consensus 75 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H 153 (319)
T 2y4i_B 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153 (319)
T ss_dssp CCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5668999999999999999999985 55799999999999999999763 346899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcc------ccccccccCccceecccccccccccc-CCccCCCcchhHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETV------TEMMTAETGTYRWMAPELYSTVTLRQ-GEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~~~~Di~slG~ 175 (298)
+||||+||+++ + +.++|+|||++..... ........++..|+|||.+.+..... .....++.++||||||+
T Consensus 154 ~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 154 KDLKSKNVFYD-N-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp CCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred cCCChhhEEEe-C-CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 99999999998 4 4699999999764321 11223345889999999986422111 11245788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++|+|++|..||.......... .......+.. +..++.++.+++.+||..+|.+|||+.++++.|+.+......
T Consensus 232 il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 232 IWYELHAREWPFKTQPAEAIIW-QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHHHHHSSCSSSSCCHHHHHH-HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HHHHHHhCCCCCCCCCHHHHHH-HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 9999999999998766544333 3333333333 346889999999999999999999999999999988776544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.91 Aligned_cols=216 Identities=24% Similarity=0.367 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee---------------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK---------------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 86 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~---------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~ 86 (298)
.+++.+|+.++++++||||+++++++. ....|+||||++ ++|.+++.. ..+++..++.++.
T Consensus 52 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~ 127 (320)
T 2i6l_A 52 VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMY 127 (320)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHH
Confidence 457889999999999999999998762 246799999996 599999875 5699999999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc----cccccccCccceeccccccccccccCCcc
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
|++.||+|||+.|++|+||||+||+++.++..++|+|||++...... .......++..|+|||.+.+ ..
T Consensus 128 qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~ 200 (320)
T 2i6l_A 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------PN 200 (320)
T ss_dssp HHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------TT
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC-------cc
Confidence 99999999999999999999999999866678999999999764322 12233456889999998753 25
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc-----------------------CC-----CCCCCCcH
Q 022347 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-----------------------RP-----GLPEDISP 214 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------------------~~-----~~~~~~~~ 214 (298)
.++.++||||||+++|+|++|..||.+............... .+ .....++.
T Consensus 201 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (320)
T 2i6l_A 201 NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280 (320)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCH
T ss_pred cCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhH
Confidence 678899999999999999999999988765443222211100 00 11246889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 215 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 215 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++.+++.+||+.||.+|||+.++++ +.++.....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~~ 314 (320)
T 2i6l_A 281 EAVDFLEQILTFSPMDRLTAEEALS--HPYMSIYSF 314 (320)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHTTCC
T ss_pred HHHHHHHHHcCCCccccCCHHHHhC--CcccccccC
Confidence 9999999999999999999999998 666665443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=274.01 Aligned_cols=212 Identities=19% Similarity=0.338 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
+.+.+|+.++++++ ||||+++++++.+ ...++||||+++++|.+++.. +++..++.++.|++.||+|||+.
T Consensus 75 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~ 149 (330)
T 3nsz_A 75 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM 149 (330)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999997 9999999999853 468999999999999998853 88999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
||+||||||+||+++.++..++|+|||++.............++..|+|||.+.+ ...++.++||||||+++|
T Consensus 150 ~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ 222 (330)
T 3nsz_A 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLA 222 (330)
T ss_dssp TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHH
T ss_pred CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHH
Confidence 9999999999999997766899999999986555555556678999999998853 256788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHH------------hhcC------------------------CCCCCCCcHHHHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAF------------KHAR------------------------PGLPEDISPDLAFIVQS 222 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~------------~~~~------------------------~~~~~~~~~~l~~li~~ 222 (298)
+|++|..||.............. .... ...+..+++++.+||.+
T Consensus 223 ~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 302 (330)
T 3nsz_A 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302 (330)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHT
T ss_pred HHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHH
Confidence 99999999965433222111110 0000 01112378999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 223 CWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 223 ~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
||+.||.+|||++++++ +.|+...
T Consensus 303 ~L~~dP~~Rpta~e~l~--hp~f~~~ 326 (330)
T 3nsz_A 303 LLRYDHQSRLTAREAME--HPYFYTV 326 (330)
T ss_dssp TSCSSGGGSCCHHHHHT--SGGGTTC
T ss_pred HhcCCcccCCCHHHHhc--CccHhhh
Confidence 99999999999999998 6666543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.71 Aligned_cols=218 Identities=28% Similarity=0.418 Sum_probs=173.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
...++.+|+.++++++||||+++++++.. ...|+||||++ ++|.+++.. ..+++..++.++.|++.||+|
T Consensus 52 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~ 127 (353)
T 2b9h_A 52 FALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKV 127 (353)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHH
Confidence 34577899999999999999999998742 56899999995 699999986 569999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----------ccccccCccceeccccccccccccCCccC
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
||+.|++||||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.. ...
T Consensus 128 LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~ 199 (353)
T 2b9h_A 128 LHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAK 199 (353)
T ss_dssp HHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS-------CCC
T ss_pred HHHCCeecCCCCHHHeEEcCC-CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc-------CCC
Confidence 999999999999999999955 469999999997543211 1223467999999998753 256
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC------------------------------CCCCCCc
Q 022347 164 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------------------------------GLPEDIS 213 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~ 213 (298)
++.++||||||+++|+|++|..||.+.+..............+ .....++
T Consensus 200 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
T 2b9h_A 200 YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN 279 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred ccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCC
Confidence 7889999999999999999999998876543332221111100 0123678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 214 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 214 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+++.+++.+||+.||.+|||+.++++ +.|+.....+.
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~~~~ 316 (353)
T 2b9h_A 280 PKGIDLLQRMLVFDPAKRITAKEALE--HPYLQTYHDPN 316 (353)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCTT
T ss_pred HHHHHHHHHhcCcCcccCCCHHHHhc--CccccccCCcc
Confidence 99999999999999999999999998 77777665443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=298.67 Aligned_cols=208 Identities=25% Similarity=0.415 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.+..|..++..+ +||+|+.++++++ .+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+.||
T Consensus 386 ~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gI 463 (674)
T 3pfq_A 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGI 463 (674)
T ss_dssp HHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSE
T ss_pred HHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3577899999988 6999999999986 45789999999999999999874 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCc-cccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.++ .++|+|||++.... .........||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 464 iHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DvwSlGvilye 534 (674)
T 3pfq_A 464 IYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYE 534 (674)
T ss_dssp ECCCCCSTTEEECSSS-CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC--------CCBSTHHHHHHHHHHHHH
T ss_pred EeccCChhhEEEcCCC-cEEEeecceeeccccCCcccccccCCCcccCHhhhcC--------CCCCccceEechHHHHHH
Confidence 9999999999999654 69999999997532 2333455679999999999865 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHHhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIRMLNAFL 245 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~l~~~l~~~~ 245 (298)
|++|..||.+.+..+. ... +......+|..+++++.+||.+||+.||.+||++ +++++ +.++
T Consensus 535 lltG~~Pf~~~~~~~~-~~~-i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~--h~ff 601 (674)
T 3pfq_A 535 MLAGQAPFEGEDEDEL-FQS-IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE--HAFF 601 (674)
T ss_dssp HHHSSCSSCCSSHHHH-HHH-HHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS--SGGG
T ss_pred HHcCCCCCCCCCHHHH-HHH-HHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc--Cccc
Confidence 9999999988665433 333 2344567788899999999999999999999987 77776 4444
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.03 Aligned_cols=217 Identities=24% Similarity=0.355 Sum_probs=157.1
Q ss_pred HHHHHHHHHHHHhCC-CCcccceeceee---------cCceeEEEecCCCCCHHHHHhhh-CCCCCCHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVK-HDNLVKFLGACK---------DPLMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIAR 90 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~Iv~~~~~~~---------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~i~~qi~~ 90 (298)
.+.+.+|+.++.++. ||||+++++++. ....++||||+ +|+|.+++... ....+++..++.++.|++.
T Consensus 69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~ 147 (337)
T 3ll6_A 69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147 (337)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHH
Confidence 357889999999996 999999999872 12478999999 56999988652 3456999999999999999
Q ss_pred HHHHHHhCC--CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-------------cccccCccceeccccccccc
Q 022347 91 AMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-------------MTAETGTYRWMAPELYSTVT 155 (298)
Q Consensus 91 al~~LH~~g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~ 155 (298)
||.|||+.| |+|+||||+||+++.+ +.++|+|||++........ .....+++.|+|||++...
T Consensus 148 ~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~- 225 (337)
T 3ll6_A 148 AVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY- 225 (337)
T ss_dssp HHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCTTCBCCSSCC-------------------------------CC-
T ss_pred HHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-
Confidence 999999999 9999999999999955 4699999999975443221 1134588999999988321
Q ss_pred cccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 022347 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 235 (298)
Q Consensus 156 ~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 235 (298)
....++.++||||||+++|+|++|..||........ .........+...+..+.+++.+||+.+|.+|||+.
T Consensus 226 ----~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 297 (337)
T 3ll6_A 226 ----SNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA 297 (337)
T ss_dssp ----TTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHH
T ss_pred ----ccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHH
Confidence 135678899999999999999999999976443221 112223334456778899999999999999999999
Q ss_pred HHHHHHHhhhhccC
Q 022347 236 QIIRMLNAFLFTLR 249 (298)
Q Consensus 236 ~l~~~l~~~~~~~~ 249 (298)
+++++|+.+.....
T Consensus 298 e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 298 EVVHQLQEIAAARN 311 (337)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhccC
Confidence 99999999877544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=270.92 Aligned_cols=212 Identities=27% Similarity=0.430 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++
T Consensus 69 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 147 (314)
T 3com_A 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKI 147 (314)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence 46779999999999999999999984 56789999999999999999743 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 148 H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 218 (314)
T 3com_A 148 HRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNCVADIWSLGITAIEM 218 (314)
T ss_dssp CCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS--------SCBCTTHHHHHHHHHHHHH
T ss_pred CCCcCHHHEEECCC-CCEEEeecccchhhhhhccccCccCCCCCccChhhcCC--------CCCCccccHHHHHHHHHHH
Confidence 99999999999955 469999999997544322 2334568899999999864 5678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||............ .....+ ..+..++..+.+++.+||..||.+|||+.++++ +.++..
T Consensus 219 ~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~~ 284 (314)
T 3com_A 219 AEGKPPYADIHPMRAIFMI-PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVRS 284 (314)
T ss_dssp HHSSCTTTTSCHHHHHHHH-HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHT
T ss_pred HhCCCCCCCCChHHHHHHH-hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhc
Confidence 9999999877654443322 222222 234557899999999999999999999999998 556554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.01 Aligned_cols=224 Identities=25% Similarity=0.398 Sum_probs=176.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---CceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
+.+.+|+.++++++||||+++++++.+ ...++||||++|++|.+++..... ..+++..++.++.|++.||+|||+.
T Consensus 52 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 131 (396)
T 4eut_A 52 DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131 (396)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 467799999999999999999999843 267999999999999999976432 3399999999999999999999999
Q ss_pred CCeeecCCCCCEEE----cCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 99 GIIHRDLKPDNLLL----TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 99 givH~dik~~Nil~----~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||+||||||+||++ + +...++|+|||++.............++..|+|||++.+..........++.++||||||
T Consensus 132 ~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG 210 (396)
T 4eut_A 132 GIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG 210 (396)
T ss_dssp TEECCCCCGGGEEEEECTT-SCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHH
T ss_pred CEEECCcCHHHEEEeecCC-CceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHH
Confidence 99999999999998 4 334699999999987655555556679999999998864222111124567899999999
Q ss_pred HHHHHHHhCCCCCCCCC---hHHHHHHHHHhhcCC------------------------CCCCCCcHHHHHHHHHhhhhC
Q 022347 175 IVLWELLTNRLPFEGMS---NLQAAYAAAFKHARP------------------------GLPEDISPDLAFIVQSCWVED 227 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~---~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~~ 227 (298)
+++|+|++|..||.... .............++ .++..++..+.+++.+||+.|
T Consensus 211 ~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~d 290 (396)
T 4eut_A 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290 (396)
T ss_dssp HHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred HHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccC
Confidence 99999999999996432 222333333332221 111235567889999999999
Q ss_pred CCCCCCHHHHHHHHHhhhhc
Q 022347 228 PNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 228 p~~Rps~~~l~~~l~~~~~~ 247 (298)
|.+||++.++++.+...+..
T Consensus 291 P~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 291 QEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTTSCCHHHHHHHHHHHHTC
T ss_pred hhhhccHHHHHHHHHHHhhc
Confidence 99999999999999887653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=273.74 Aligned_cols=215 Identities=27% Similarity=0.500 Sum_probs=163.8
Q ss_pred HHHHHHHHHHh--CCCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSR--VKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 24 ~~~~E~~~l~~--l~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.+.+|.+++.. ++||||+++++++. ....++||||+++|+|.+++.. ..+++..++.++.|++.||+|||
T Consensus 46 ~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH 122 (301)
T 3q4u_A 46 SWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLH 122 (301)
T ss_dssp HHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHH
Confidence 45566666666 78999999999862 2358999999999999999965 56999999999999999999999
Q ss_pred --------hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-----cccccCccceeccccccccccccCCccC
Q 022347 97 --------ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 97 --------~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
+.||+||||||+||+++.+ +.++|+|||++........ .....+++.|+|||++.+.... ....
T Consensus 123 ~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~ 199 (301)
T 3q4u_A 123 IEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV--DCFD 199 (301)
T ss_dssp SCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT--TCHH
T ss_pred HhhhhccCCCCeecCCCChHhEEEcCC-CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCC--Cccc
Confidence 9999999999999999955 4699999999864332211 2234789999999998651100 0014
Q ss_pred CCcchhHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHH-HhhcCCCCCC-----CCcHHHHHHHHHh
Q 022347 164 YNNKVDVYSFGIVLWELLTN----------RLPFEGMSN----LQAAYAAA-FKHARPGLPE-----DISPDLAFIVQSC 223 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~g----------~~p~~~~~~----~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~~ 223 (298)
++.++||||||+++|+|++| ..||..... ........ .....+..+. ..++++.+++.+|
T Consensus 200 ~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 279 (301)
T 3q4u_A 200 SYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKEC 279 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHH
Confidence 45799999999999999999 888865321 12222221 1222333332 2557899999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhh
Q 022347 224 WVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 224 l~~~p~~Rps~~~l~~~l~~~ 244 (298)
|+.||.+|||+.++++.|+.+
T Consensus 280 l~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 280 WYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcChhhCCCHHHHHHHHhcc
Confidence 999999999999999999763
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=276.69 Aligned_cols=216 Identities=26% Similarity=0.486 Sum_probs=163.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh------CCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL------RPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+++.+|+.++++++||||+++++++. ++..++||||++|++|.+++... ....+++..++.++.|++.||.|
T Consensus 57 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 136 (303)
T 2vwi_A 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136 (303)
T ss_dssp ---------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 457889999999999999999999985 56799999999999999999752 23558999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc------ccccccCccceeccccccccccccCCccCCCcch
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~ 168 (298)
||+.|++|+||+|+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ...++.++
T Consensus 137 lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~ 208 (303)
T 2vwi_A 137 LHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKA 208 (303)
T ss_dssp HHHTTCCCCCCSGGGEEECTT-CCEEECCCHHHHHCC---------------CCCTTCCHHHHHH-------HHCCCTHH
T ss_pred HHhCCCCCCCCChhhEEEcCC-CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchh
Confidence 999999999999999999955 469999999886433221 1233468899999998853 13578899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 169 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 169 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
||||||+++|+|++|..||............. ....+ .....++.++.+++.+||+.||.+|||+.++++
T Consensus 209 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 99999999999999999998766544433222 22221 233568899999999999999999999999998
Q ss_pred HHHhhhhcc
Q 022347 240 MLNAFLFTL 248 (298)
Q Consensus 240 ~l~~~~~~~ 248 (298)
+.++...
T Consensus 288 --h~~~~~~ 294 (303)
T 2vwi_A 288 --HKFFQKA 294 (303)
T ss_dssp --STTC---
T ss_pred --ChhhhcC
Confidence 5565543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=277.99 Aligned_cols=214 Identities=27% Similarity=0.427 Sum_probs=169.6
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeecC-c------eeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L------MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al 92 (298)
...+++.+|+.++++++||||+++++++... . .|+||||+. ++|.+++. ..+++..++.++.|++.||
T Consensus 83 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL 157 (371)
T 4exu_A 83 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGL 157 (371)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999998532 2 399999995 68988774 4499999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
+|||+.||+||||||+||+++.+ +.++|+|||++...... .....+++.|+|||++.+ ...++.++||||
T Consensus 158 ~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diws 227 (371)
T 4exu_A 158 KYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWS 227 (371)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC----------CTTCCCTTSCHHHHSC-------CSCCCTTHHHHH
T ss_pred HHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCcccccccC--cCCcccCccccCHHHhcC-------CCCCCcHHhHHH
Confidence 99999999999999999999955 46999999999754332 234567999999998863 256788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-----------------------------CCCCCCcHHHHHHHHHh
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQSC 223 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~ 223 (298)
||+++|+|++|..||.+.+..+...........+ .....+++.+.+||.+|
T Consensus 228 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 307 (371)
T 4exu_A 228 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 307 (371)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHH
Confidence 9999999999999998876544433332211111 01235789999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 224 WVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 224 l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
|+.||.+|||+.++++ +.|+.....
T Consensus 308 L~~dP~~Rpt~~ell~--hp~f~~~~~ 332 (371)
T 4exu_A 308 LELDVDKRLTAAQALT--HPFFEPFRD 332 (371)
T ss_dssp SCSCTTTSCCHHHHHT--SGGGTTTCC
T ss_pred CCCChhhcCCHHHHhc--CcccccCCC
Confidence 9999999999999998 777765543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=277.95 Aligned_cols=212 Identities=23% Similarity=0.395 Sum_probs=175.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHH------HhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKY------LVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+.+.+|+.++++++||||+++++++. ++..++||||+++++|.++ +.......+++..++.++.|++.||.||
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999999999985 5578999999999999998 6553356799999999999999999999
Q ss_pred Hh-CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCc-chhHHHH
Q 022347 96 HA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN-KVDVYSF 173 (298)
Q Consensus 96 H~-~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~-~~Di~sl 173 (298)
|+ .|++|+||+|+||+++.++ .++|+|||++...... ......++..|+|||.+.+ ...++. ++|||||
T Consensus 168 H~~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~sl 238 (348)
T 2pml_X 168 HNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSL 238 (348)
T ss_dssp HHTSCEECCCCCGGGEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHH
T ss_pred hccCCEeecCCChHhEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHH
Confidence 99 9999999999999999554 6999999999764433 3345578999999999864 124555 9999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC-------------------CCCcHHHHHHHHHhhhhCCCCCCCH
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-------------------EDISPDLAFIVQSCWVEDPNLRPSF 234 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~ 234 (298)
|+++|+|++|..||.............. .....++ ..+++++.+++.+||+.||.+|||+
T Consensus 239 G~il~~l~~g~~pf~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~ 317 (348)
T 2pml_X 239 GICLYVMFYNVVPFSLKISLVELFNNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317 (348)
T ss_dssp HHHHHHHHHSSCSSCCSSCSHHHHHHHT-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHh-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH
Confidence 9999999999999987765333333332 2233334 5689999999999999999999999
Q ss_pred HHHHHHHHhhhh
Q 022347 235 SQIIRMLNAFLF 246 (298)
Q Consensus 235 ~~l~~~l~~~~~ 246 (298)
.++++ +.++.
T Consensus 318 ~e~l~--hp~f~ 327 (348)
T 2pml_X 318 EDALK--HEWLA 327 (348)
T ss_dssp HHHHT--SGGGT
T ss_pred HHHhc--Ccccc
Confidence 99998 55554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=270.33 Aligned_cols=216 Identities=25% Similarity=0.429 Sum_probs=163.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHAN- 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~- 98 (298)
+.+.++...++.++||||+++++++. ++..++||||++ ++|.+++... ....+++..++.++.|++.||.|||++
T Consensus 51 ~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 129 (290)
T 3fme_A 51 RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129 (290)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 34556666788899999999999985 557999999996 5998887652 345799999999999999999999998
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|++|+||||+||+++.+ +.++|+|||++.............+++.|+|||.+... .....++.++||||||+++|
T Consensus 130 ~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~ 204 (290)
T 3fme_A 130 SVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE----LNQKGYSVKSDIWSLGITMI 204 (290)
T ss_dssp CCCCCCCSGGGCEECTT-CCEEBCCC---------------CCCCCCSCHHHHSCC----TTC--CCHHHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEECCC-CCEEEeecCCcccccccccccccCCCccccChhhcChh----hcCcCCCcHHHHHHHHHHHH
Confidence 99999999999999955 46999999999865555444555789999999997320 12356788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|++|..||..................+..+ ..+++++.+++.+||+.+|.+|||+.++++ +.|+.
T Consensus 205 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~--hp~f~ 271 (290)
T 3fme_A 205 ELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ--HPFFT 271 (290)
T ss_dssp HHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHH
T ss_pred HHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh--Ccccc
Confidence 9999999998755544444444444444433 568999999999999999999999999998 45544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=273.41 Aligned_cols=221 Identities=21% Similarity=0.308 Sum_probs=175.7
Q ss_pred HHHHHHHHHHhCCCCcccceeceeec-C-------ceeEEEecCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACKD-P-------LMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~~-~-------~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
++.+++..+..++||||+++++++.. + ..++||||+++ +|.+.+.. .....+++..++.++.|++.||.
T Consensus 65 ~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 143 (360)
T 3e3p_A 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143 (360)
T ss_dssp HHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence 45578888999999999999998732 1 27899999966 66555443 23456899999999999999999
Q ss_pred HHH--hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 94 CLH--ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 94 ~LH--~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
||| +.||+||||||+||+++...+.++|+|||++.............+++.|+|||++.+ ...++.++|||
T Consensus 144 ~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~ 216 (360)
T 3e3p_A 144 CLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIW 216 (360)
T ss_dssp HHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHH
T ss_pred HHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHH
Confidence 999 999999999999999996466899999999987665555556678999999998854 24578999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhc------------------------------CCCCCCCCcHHHHHHHH
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA------------------------------RPGLPEDISPDLAFIVQ 221 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~ 221 (298)
|||+++|+|++|..||.+............... .+..+...++++.+|+.
T Consensus 217 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 296 (360)
T 3e3p_A 217 SVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296 (360)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHH
Confidence 999999999999999988765444333321111 11222336789999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 254 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 254 (298)
+||+.||.+|||+.++++ +.|+.....+...
T Consensus 297 ~~L~~dP~~Rpt~~e~l~--hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 297 ALLQYLPEERMKPYEALC--HPYFDELHDPATK 327 (360)
T ss_dssp HHTCSSGGGSCCHHHHTT--SGGGGGGGCTTCC
T ss_pred HHhccCccccCCHHHHhc--CccccccCCcccc
Confidence 999999999999999999 8888877655443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=279.86 Aligned_cols=211 Identities=27% Similarity=0.400 Sum_probs=159.7
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecC-------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+++.+|+.+++.++||||+++++++... ..|+||||++ ++|.+++. ..+++..+..++.|++.||.
T Consensus 67 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~ 141 (371)
T 2xrw_A 67 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIK 141 (371)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999998432 5799999996 58888886 35899999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||+.||+||||||+||+++.+ +.++|+|||++.............+++.|+|||++.+ ..++.++|||||
T Consensus 142 ~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Diwsl 212 (371)
T 2xrw_A 142 HLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSV 212 (371)
T ss_dssp HHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC----------------CTTCCHHHHTT--------CCCCTTHHHHHH
T ss_pred HHHHCCeecccCCHHHEEEcCC-CCEEEEEeecccccccccccCCceecCCccCHHHhcC--------CCCCchHhHHHH
Confidence 9999999999999999999955 4699999999986554444455678999999999865 568889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhc--------------------CCCCC--------------C------CCc
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--------------------RPGLP--------------E------DIS 213 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------------------~~~~~--------------~------~~~ 213 (298)
|+++|+|++|..||.+.+............. .+... . ..+
T Consensus 213 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (371)
T 2xrw_A 213 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 292 (371)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccccccccc
Confidence 9999999999999988765443332221100 11100 0 015
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 214 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 214 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+.+.+|+.+||+.||.+|||++++++ +.|+..
T Consensus 293 ~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~~ 324 (371)
T 2xrw_A 293 SQARDLLSKMLVIDASKRISVDEALQ--HPYINV 324 (371)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred HHHHHHHHHHCcCChhhCCCHHHHhC--Ccchhh
Confidence 67999999999999999999999998 566543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=277.66 Aligned_cols=207 Identities=26% Similarity=0.390 Sum_probs=170.4
Q ss_pred HHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+.+|+.+++++ +||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+
T Consensus 104 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iv 181 (355)
T 1vzo_A 104 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGII 181 (355)
T ss_dssp GCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 566899999999 6999999999985 56789999999999999999864 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc--cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||+||+++.+ +.++|+|||++...... .......+++.|+|||++.+ ....++.++||||||+++|+
T Consensus 182 H~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DvwslG~il~e 254 (355)
T 1vzo_A 182 YRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYE 254 (355)
T ss_dssp CCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEECCC-CcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcC------CCCCCCchhhHHHHHHHHHH
Confidence 99999999999955 46999999998754322 22334578999999999864 12457889999999999999
Q ss_pred HHhCCCCCCCCC--hHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 022347 180 LLTNRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 239 (298)
Q Consensus 180 ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~ 239 (298)
|++|..||.... ..............+..+..++..+.++|.+||..||.+|| ++.++++
T Consensus 255 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 255 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 999999997532 12222223334456677888999999999999999999999 9999988
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.77 Aligned_cols=215 Identities=22% Similarity=0.345 Sum_probs=170.4
Q ss_pred HHHHHHHHHHhCCCCcccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++.+|+.+++.++|++++..+.++ .+...++||||+ +++|.+++.. ....+++..++.|+.||+.||.|||++||+
T Consensus 48 ~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIv 125 (483)
T 3sv0_A 48 QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFL 125 (483)
T ss_dssp CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 467899999999986655555444 456789999999 9999999975 235699999999999999999999999999
Q ss_pred eecCCCCCEEEc--CCCCceEEeccCCCccCccccc--------cccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 102 HRDLKPDNLLLT--PDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 102 H~dik~~Nil~~--~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
||||||+|||++ .+.+.++|+|||++........ .....++..|+|||.+.+ ..++.++|||
T Consensus 126 HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDvw 197 (483)
T 3sv0_A 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG--------IEQSRRDDLE 197 (483)
T ss_dssp CCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHH
T ss_pred ecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC--------CCCChHHHHH
Confidence 999999999994 2445799999999975443221 124578999999999875 6688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCh--HHHHHHHH----HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 172 SFGIVLWELLTNRLPFEGMSN--LQAAYAAA----FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
||||++|+|++|..||.+... ........ .......+...++.++.+++..||+.+|.+||++.+|++.|+.++
T Consensus 198 SlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 198 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999987542 11111111 111112233568899999999999999999999999999999886
Q ss_pred hcc
Q 022347 246 FTL 248 (298)
Q Consensus 246 ~~~ 248 (298)
...
T Consensus 278 ~~~ 280 (483)
T 3sv0_A 278 IRE 280 (483)
T ss_dssp HHT
T ss_pred HHc
Confidence 543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=271.58 Aligned_cols=216 Identities=24% Similarity=0.361 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+.+|+.++++++||||+++++++.+ +..|+||||+++ +|.+.+... ...+++..++.++.|++.||+
T Consensus 61 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ 138 (351)
T 3mi9_A 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLY 138 (351)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHH
Confidence 356789999999999999999998843 358999999965 888877653 356999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcc-----ccccccccCccceeccccccccccccCCccCCCcch
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~ 168 (298)
|||+.||+||||||+||+++.+ +.++|+|||++..... ........+++.|+|||++.+ ...++.++
T Consensus 139 ~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~ 210 (351)
T 3mi9_A 139 YIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPI 210 (351)
T ss_dssp HHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHH
T ss_pred HHHHCCeeCCCCCHHHEEEcCC-CCEEEccchhcccccccccccccccCCcccccCccCchhhcC-------CCCCCcHh
Confidence 9999999999999999999955 4699999999975432 222334568999999998864 24578999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh--cCCCCCCC----------------------------CcHHHHH
Q 022347 169 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH--ARPGLPED----------------------------ISPDLAF 218 (298)
Q Consensus 169 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~----------------------------~~~~l~~ 218 (298)
||||||+++|+|++|..||.+.............. ..+..... .++.+.+
T Consensus 211 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (351)
T 3mi9_A 211 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 290 (351)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHH
Confidence 99999999999999999998876544333322211 11111111 2677999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 219 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 219 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
|+.+||+.||.+|||++++++ +.|+.....
T Consensus 291 li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~ 320 (351)
T 3mi9_A 291 LIDKLLVLDPAQRIDSDDALN--HDFFWSDPM 320 (351)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT--SGGGGSSSC
T ss_pred HHHHHhcCChhhCCCHHHHhC--CCCcCCCCC
Confidence 999999999999999999999 777765433
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.71 Aligned_cols=214 Identities=27% Similarity=0.411 Sum_probs=169.1
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceeecC-------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al 92 (298)
...+++.+|+.++++++||||+++++++... ..|+||||++ ++|.+++. ..+++..++.++.|++.||
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al 139 (353)
T 3coi_A 65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGL 139 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999998532 3599999996 58887764 3599999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
.|||+.|++|+||||+||+++.+ +.++|+|||++...... .....+++.|+|||.+.+ ...++.++||||
T Consensus 140 ~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~s 209 (353)
T 3coi_A 140 KYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWS 209 (353)
T ss_dssp HHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTTC----------CCSBCCSCHHHHSC-------CSCCCTTHHHHH
T ss_pred HHHHHCCcccCCCCHHHEeECCC-CcEEEeecccccCCCCC--ccccccCcCcCCHHHHhC-------cCCCCchhhHHH
Confidence 99999999999999999999955 46999999999764332 234467999999998753 246788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-----------------------------cCCCCCCCCcHHHHHHHHHh
Q 022347 173 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKH-----------------------------ARPGLPEDISPDLAFIVQSC 223 (298)
Q Consensus 173 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~ 223 (298)
||+++|+|++|..||.+.+............ ........+++++.+++.+|
T Consensus 210 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (353)
T 3coi_A 210 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 289 (353)
T ss_dssp HHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHH
Confidence 9999999999999998766543332221110 01123346789999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 224 WVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 224 l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
|+.||.+|||+.++++ +.++.....
T Consensus 290 L~~dp~~Rpt~~e~l~--hp~f~~~~~ 314 (353)
T 3coi_A 290 LELDVDKRLTAAQALT--HPFFEPFRD 314 (353)
T ss_dssp SCSCTTTSCCHHHHHT--SGGGTTTCC
T ss_pred cCCCcccCCCHHHHhc--CcchhhccC
Confidence 9999999999999998 777765544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=278.61 Aligned_cols=217 Identities=23% Similarity=0.340 Sum_probs=161.3
Q ss_pred HHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~ 93 (298)
.+.+|+.++++++||||+++++++. +...|+||||++ ++|.+++.... ...+++..++.++.||+.||.
T Consensus 64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~ 142 (405)
T 3rgf_A 64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142 (405)
T ss_dssp HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 5779999999999999999999983 457899999995 58888886421 234999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEc---CCCCceEEeccCCCccCccc----cccccccCccceeccccccccccccCCccCCCc
Q 022347 94 CLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 166 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~---~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 166 (298)
|||+.||+||||||+|||+. ...+.++|+|||++...... .......+++.|+|||++.+ ...++.
T Consensus 143 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~ 215 (405)
T 3rgf_A 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTK 215 (405)
T ss_dssp HHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTT-------CCSCCH
T ss_pred HHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccc
Confidence 99999999999999999993 23457999999999864432 22234578999999999864 245889
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHhhcCCC------------------------------
Q 022347 167 KVDVYSFGIVLWELLTNRLPFEGMSNL---------QAAYAAAFKHARPG------------------------------ 207 (298)
Q Consensus 167 ~~Di~slG~il~~ll~g~~p~~~~~~~---------~~~~~~~~~~~~~~------------------------------ 207 (298)
++|||||||++|+|++|..||...... ............+.
T Consensus 216 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (405)
T 3rgf_A 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 295 (405)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCH
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchh
Confidence 999999999999999999999754431 11111111111110
Q ss_pred ------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 208 ------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 208 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
.....++.+.+||.+||+.||.+|||++++++ +.|+.....
T Consensus 296 ~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~--hp~f~~~~~ 342 (405)
T 3rgf_A 296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ--DPYFLEDPL 342 (405)
T ss_dssp HHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTSSSC
T ss_pred hhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhccCCC
Confidence 00112678899999999999999999999999 788765443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.06 Aligned_cols=216 Identities=21% Similarity=0.285 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHHhCCCCc------ccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDN------LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~------Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+.+.+|+.+++.++|++ |+++++++. ++..++||||+ +++|.+++.......+++..++.++.|++.||+
T Consensus 54 ~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~ 132 (339)
T 1z57_A 54 YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 3457789999999987665 899999885 56899999999 889999998765567999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCC------------------CCceEEeccCCCccCccccccccccCccceeccccccccc
Q 022347 94 CLHANGIIHRDLKPDNLLLTPD------------------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 155 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 155 (298)
|||+.||+||||||+||+++.+ .+.++|+|||++...... .....+++.|+|||++.+
T Consensus 133 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-- 208 (339)
T 1z57_A 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-- 208 (339)
T ss_dssp HHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT--
T ss_pred HHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC--
Confidence 9999999999999999999853 346999999998753322 234578999999999865
Q ss_pred cccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC------------------------------
Q 022347 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------------------------------ 205 (298)
Q Consensus 156 ~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------------------------ 205 (298)
..++.++||||||+++|+|++|..||...+..............
T Consensus 209 ------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
T 1z57_A 209 ------LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282 (339)
T ss_dssp ------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHH
T ss_pred ------CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccc
Confidence 56889999999999999999999999876654332221110000
Q ss_pred ------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 206 ------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 206 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
...+...++++.+++.+||+.||.+|||+.++++ +.|+..++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~ 336 (339)
T 1z57_A 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK--HPFFDLLK 336 (339)
T ss_dssp HHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT--SGGGGGGG
T ss_pred hhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc--CHHHHHHh
Confidence 0011224577999999999999999999999998 66666543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=291.33 Aligned_cols=206 Identities=17% Similarity=0.254 Sum_probs=155.4
Q ss_pred HHHHHHH---HHHHhCCCCccccee-------ceeecC------------------ceeEEEecCCCCCHHHHHhhhCC-
Q 022347 23 GRFIREV---NMMSRVKHDNLVKFL-------GACKDP------------------LMVIVTELLPGMSLRKYLVSLRP- 73 (298)
Q Consensus 23 ~~~~~E~---~~l~~l~hp~Iv~~~-------~~~~~~------------------~~~lv~e~~~~~sL~~~l~~~~~- 73 (298)
+.+.+|+ .++++++||||++++ +++.+. ..|+||||+ +|+|.+++.....
T Consensus 118 ~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~ 196 (377)
T 3byv_A 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH 196 (377)
T ss_dssp HHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc
Confidence 5788999 556666899999998 444322 378999999 6799999986421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccc
Q 022347 74 ----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 149 (298)
Q Consensus 74 ----~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE 149 (298)
..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++..... ......| +.|+|||
T Consensus 197 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE 272 (377)
T 3byv_A 197 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPE 272 (377)
T ss_dssp TTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHH
T ss_pred ccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChh
Confidence 113358888999999999999999999999999999999965 4699999999985433 2234456 9999999
Q ss_pred ccccc---ccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhh
Q 022347 150 LYSTV---TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 226 (298)
Q Consensus 150 ~~~~~---~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 226 (298)
++.+. .........++.++||||||+++|+|++|..||.+....... .........+++++.+++.+||+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS------EWIFRSCKNIPQPVRALLEGFLRY 346 (377)
T ss_dssp HHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS------GGGGSSCCCCCHHHHHHHHHHTCS
T ss_pred hhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch------hhhhhhccCCCHHHHHHHHHHcCC
Confidence 98752 000001126889999999999999999999999764321110 011122357899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 022347 227 DPNLRPSFSQIIR 239 (298)
Q Consensus 227 ~p~~Rps~~~l~~ 239 (298)
||.+|||+.++++
T Consensus 347 dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 347 PKEDRLLPLQAME 359 (377)
T ss_dssp SGGGCCCHHHHHT
T ss_pred CchhCCCHHHHhh
Confidence 9999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=271.31 Aligned_cols=210 Identities=25% Similarity=0.433 Sum_probs=162.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee--------------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK--------------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~--------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~q 87 (298)
.+.+.+|+.++++++||||+++++++. .+..|+||||++|++|.+++.. ....+++..++.++.|
T Consensus 46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~q 124 (303)
T 1zy4_A 46 LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQ 124 (303)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHH
Confidence 357889999999999999999999863 2358999999999999999986 2345788999999999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc---------------cccccccCccceecccccc
Q 022347 88 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---------------EMMTAETGTYRWMAPELYS 152 (298)
Q Consensus 88 i~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~ 152 (298)
++.||+|||+.|++|+||||+||+++.+ +.++|+|||++...... .......++..|+|||.+.
T Consensus 125 i~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (303)
T 1zy4_A 125 ILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203 (303)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCCCSCTTC-------------------------CTTSCHHHHT
T ss_pred HHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccccc
Confidence 9999999999999999999999999955 46999999998754321 1223346888999999986
Q ss_pred ccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---hcCCCCCCCCcHHHHHHHHHhhhhCCC
Q 022347 153 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 153 ~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~ 229 (298)
+ ...++.++||||||+++|+|++ ||............... ..++.++...+..+.+++.+||+.||.
T Consensus 204 ~-------~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (303)
T 1zy4_A 204 G-------TGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273 (303)
T ss_dssp S-------CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGG
T ss_pred C-------CCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcc
Confidence 3 2467889999999999999998 55433222222222221 123344566788899999999999999
Q ss_pred CCCCHHHHHHHHHhhh
Q 022347 230 LRPSFSQIIRMLNAFL 245 (298)
Q Consensus 230 ~Rps~~~l~~~l~~~~ 245 (298)
+|||+.++++ +.|+
T Consensus 274 ~Rps~~~ll~--h~~~ 287 (303)
T 1zy4_A 274 KRPGARTLLN--SGWL 287 (303)
T ss_dssp GSCCHHHHHH--SSCS
T ss_pred cCcCHHHHhC--CCCc
Confidence 9999999998 4444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=269.15 Aligned_cols=218 Identities=26% Similarity=0.481 Sum_probs=163.5
Q ss_pred HHHHHHHHHh--CCCCcccceeceeec-----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 25 FIREVNMMSR--VKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 25 ~~~E~~~l~~--l~hp~Iv~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
+.+|..++.. ++||||+++++++.+ ...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+
T Consensus 76 ~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~ 152 (337)
T 3mdy_A 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHT 152 (337)
T ss_dssp HHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHS
T ss_pred hhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3445555554 489999999998743 468999999999999999976 469999999999999999999999
Q ss_pred C--------CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc-----cccccCccceeccccccccccccCCccCC
Q 022347 98 N--------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHY 164 (298)
Q Consensus 98 ~--------givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 164 (298)
. ||+||||||+||+++.+ +.++|+|||++........ .....|++.|+|||++.+..... ....
T Consensus 153 ~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~ 229 (337)
T 3mdy_A 153 EIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN--HFQS 229 (337)
T ss_dssp CBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTT--CTHH
T ss_pred hhhhhccCCCEEecccchHHEEECCC-CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCc--cccC
Confidence 9 99999999999999955 4699999999965433221 12447899999999986511100 0011
Q ss_pred CcchhHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHH-HhhcCCCCCC-----CCcHHHHHHHHHhh
Q 022347 165 NNKVDVYSFGIVLWELLTN----------RLPFEGMSN----LQAAYAAA-FKHARPGLPE-----DISPDLAFIVQSCW 224 (298)
Q Consensus 165 ~~~~Di~slG~il~~ll~g----------~~p~~~~~~----~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~~l 224 (298)
+.++||||||+++|+|++| ..||..... ........ .....+..+. .+++++.+++.+||
T Consensus 230 ~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 309 (337)
T 3mdy_A 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHS
T ss_pred ccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhh
Confidence 1249999999999999999 777754321 11111111 2223333332 45677999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+.||.+|||+.+++++|+.+....
T Consensus 310 ~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 310 AHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhChhhCCCHHHHHHHHHHHHhhc
Confidence 999999999999999999987754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=276.34 Aligned_cols=207 Identities=24% Similarity=0.374 Sum_probs=145.5
Q ss_pred HHHHhCCCCcccceeceeec-----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 022347 30 NMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104 (298)
Q Consensus 30 ~~l~~l~hp~Iv~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~d 104 (298)
..++.+.||||+++++++.. ...++||||++||+|.+++.......+++..++.++.|++.||.|||+.||+|||
T Consensus 74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~d 153 (336)
T 3fhr_A 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD 153 (336)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 34567789999999998842 3489999999999999999876556799999999999999999999999999999
Q ss_pred CCCCCEEEcCC--CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHh
Q 022347 105 LKPDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182 (298)
Q Consensus 105 ik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~ 182 (298)
|||+||+++.+ .+.++|+|||++...... ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~ 224 (336)
T 3fhr_A 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLC 224 (336)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCC--------CCCCchhhHHHHHHHHHHHHH
Confidence 99999999853 345999999999754432 2234567999999999854 567889999999999999999
Q ss_pred CCCCCCCCChHHHHH--HHHHh----hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 183 NRLPFEGMSNLQAAY--AAAFK----HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 183 g~~p~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|..||.......... ..... .........+++++.+++.+||+.||.+|||+.++++ +.|+..
T Consensus 225 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 293 (336)
T 3fhr_A 225 GFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQ 293 (336)
T ss_dssp SSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred CCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Cccccc
Confidence 999997654322110 11111 1112223568999999999999999999999999998 566654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=271.97 Aligned_cols=220 Identities=25% Similarity=0.448 Sum_probs=171.0
Q ss_pred HHHHHHHHHHHh--CCCCcccceeceeecC-----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSR--VKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~--l~hp~Iv~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+.+.+|.+++.. ++||||+++++++.+. ..++||||+++|+|.+++.. ..+++..++.++.|++.||.||
T Consensus 79 ~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~l 155 (342)
T 1b6c_B 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHL 155 (342)
T ss_dssp HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHH
Confidence 456788888887 7899999999998532 68999999999999999976 4699999999999999999999
Q ss_pred H--------hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCcc
Q 022347 96 H--------ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 96 H--------~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
| +.|++|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+.... ...
T Consensus 156 H~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~ 232 (342)
T 1b6c_B 156 HMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHF 232 (342)
T ss_dssp HCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCH
T ss_pred HHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc--ccc
Confidence 9 8999999999999999955 469999999997543322 22345789999999998641100 001
Q ss_pred CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCh----HHHHHHHHH-hhcCCCCCC-----CCcHHHHHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLTN----------RLPFEGMSN----LQAAYAAAF-KHARPGLPE-----DISPDLAFIVQS 222 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g----------~~p~~~~~~----~~~~~~~~~-~~~~~~~~~-----~~~~~l~~li~~ 222 (298)
.++.++||||||+++|+|++| ..||..... ......... ....+.++. ..++.+.+++.+
T Consensus 233 ~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 312 (342)
T 1b6c_B 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 312 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHH
T ss_pred ccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHH
Confidence 234689999999999999999 788865421 222222222 222333332 244679999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 223 CWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 223 ~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
||+.||.+|||+.+++++|+.+....
T Consensus 313 cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 313 CWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhccChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999887653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.98 Aligned_cols=212 Identities=23% Similarity=0.351 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHHHhCC--------CCcccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVK--------HDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 87 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~--------hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~q 87 (298)
..+.+.+|+.++++++ ||||+++++++. +...|+||||+ +++|.+++.......+++..++.++.|
T Consensus 76 ~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~q 154 (397)
T 1wak_A 76 YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQ 154 (397)
T ss_dssp HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHH
Confidence 3457889999999996 788999999874 23689999999 668877776655567999999999999
Q ss_pred HHHHHHHHHhC-CCeeecCCCCCEEEcCCC------------------------------------------------Cc
Q 022347 88 IARAMDCLHAN-GIIHRDLKPDNLLLTPDQ------------------------------------------------KS 118 (298)
Q Consensus 88 i~~al~~LH~~-givH~dik~~Nil~~~~~------------------------------------------------~~ 118 (298)
|+.||+|||++ ||+||||||+|||++.++ ..
T Consensus 155 i~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (397)
T 1wak_A 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234 (397)
T ss_dssp HHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCC
T ss_pred HHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccc
Confidence 99999999998 999999999999998654 26
Q ss_pred eEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-----H
Q 022347 119 LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-----L 193 (298)
Q Consensus 119 ~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-----~ 193 (298)
++|+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .
T Consensus 235 ~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 304 (397)
T 1wak_A 235 VKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG--------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304 (397)
T ss_dssp EEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHH
T ss_pred eEecccccccccccc--CccCCCCCcccCChhhcC--------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCch
Confidence 999999999764432 334578999999999875 5688899999999999999999999975432 1
Q ss_pred HHHHHHHHh-hcC----------------------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 194 QAAYAAAFK-HAR----------------------------------------PGLPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 194 ~~~~~~~~~-~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
......... ... ...+...++.+.+||.+||+.||.+||
T Consensus 305 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 384 (397)
T 1wak_A 305 EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384 (397)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC
T ss_pred HHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC
Confidence 111111110 000 011223456789999999999999999
Q ss_pred CHHHHHHHHHhhh
Q 022347 233 SFSQIIRMLNAFL 245 (298)
Q Consensus 233 s~~~l~~~l~~~~ 245 (298)
|+.++++ +.|+
T Consensus 385 t~~e~l~--hp~~ 395 (397)
T 1wak_A 385 TAAECLR--HPWL 395 (397)
T ss_dssp CHHHHHT--SGGG
T ss_pred CHHHHhh--Cccc
Confidence 9999998 5554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=275.97 Aligned_cols=217 Identities=21% Similarity=0.316 Sum_probs=169.0
Q ss_pred HHHHHHHHHHHHhCC-----------CCcccceeceeecC-----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVK-----------HDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-----------hp~Iv~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~ 85 (298)
.+.+.+|+.++++++ ||||+++++++... ..++|||++ +++|.+++.......+++..++.++
T Consensus 59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~ 137 (373)
T 1q8y_A 59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS 137 (373)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHH
Confidence 356778999999886 89999999998421 689999999 8999999987666679999999999
Q ss_pred HHHHHHHHHHHhC-CCeeecCCCCCEEEcCC-----CCceEEeccCCCccCccccccccccCccceeccccccccccccC
Q 022347 86 LDIARAMDCLHAN-GIIHRDLKPDNLLLTPD-----QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 159 (298)
Q Consensus 86 ~qi~~al~~LH~~-givH~dik~~Nil~~~~-----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 159 (298)
.|++.||+|||++ ||+|+||||+||+++.+ ...++|+|||++...... .....+++.|+|||++.+
T Consensus 138 ~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~------ 209 (373)
T 1q8y_A 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG------ 209 (373)
T ss_dssp HHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT------
T ss_pred HHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC------
Confidence 9999999999998 99999999999999532 236999999999754432 234478999999999865
Q ss_pred CccCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHh--------------------------------
Q 022347 160 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-----QAAYAAAFK-------------------------------- 202 (298)
Q Consensus 160 ~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~-------------------------------- 202 (298)
..++.++||||||+++|+|++|..||...... .........
T Consensus 210 --~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (373)
T 1q8y_A 210 --APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287 (373)
T ss_dssp --CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred --CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccc
Confidence 56789999999999999999999999754311 111111110
Q ss_pred ---------hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 203 ---------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 203 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
.....++..+++++.+||.+||+.||.+|||+.++++ +.++......
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~~ 343 (373)
T 1q8y_A 288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN--HPWLKDTLGM 343 (373)
T ss_dssp CBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT--CGGGTTCTTC
T ss_pred cccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh--ChhhhcccCc
Confidence 0111233445678999999999999999999999998 7777665433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=268.17 Aligned_cols=211 Identities=25% Similarity=0.421 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-gi 100 (298)
+.+..+..+++.++||||+++++++. ++..++||||+ ++.+..+... ....+++..++.++.|++.||.|||+. |+
T Consensus 69 ~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i 146 (318)
T 2dyl_A 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGV 146 (318)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 34556666788899999999999985 56789999999 6677666654 245699999999999999999999995 99
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+|+||||+||+++.+ +.++|+|||++.............+++.|+|||++..... ....++.++||||||+++|+|
T Consensus 147 ~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 147 IHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP---TKPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp CCCCCCGGGEEECTT-SCEEECCCTTC--------------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHH
T ss_pred EeCCCCHHHEEECCC-CCEEEEECCCchhccCCccccccCCCccccChhhcccccc---cccCCccccchhhHHHHHHHH
Confidence 999999999999955 4699999999976554444445578999999999853110 125678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
++|..||..................+.++ ..+++++.+++.+||+.||.+|||+.++++
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 223 ATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 99999998765555555555555554444 358999999999999999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=267.52 Aligned_cols=220 Identities=23% Similarity=0.432 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHHHhCC--CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 21 LEGRFIREVNMMSRVK--HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
..+.+.+|+.++.+++ ||||+++++++. ++..++|||+ .+++|.+++... ..+++..++.++.|++.||.|||+
T Consensus 69 ~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~ 145 (313)
T 3cek_A 69 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ 145 (313)
T ss_dssp HHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3457889999999998 599999999985 5578999995 588999999863 468999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceecccccccccccc---CCccCCCcchhHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVY 171 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~---~~~~~~~~~~Di~ 171 (298)
.|++|+||||+||+++ + +.++|+|||++....... ......+++.|+|||.+.+..... .....++.++|||
T Consensus 146 ~~ivH~dlkp~NIl~~-~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~ 223 (313)
T 3cek_A 146 HGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223 (313)
T ss_dssp TTCCCCCCCGGGEEEE-T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHH
T ss_pred CCceecCCCcccEEEE-C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHH
Confidence 9999999999999997 3 579999999997643322 123446899999999986421110 0124678899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHH-HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|||+++|+|++|..||............. .......++...+.++.+++.+||+.||.+|||+.++++ +.++..
T Consensus 224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~~ 298 (313)
T 3cek_A 224 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 298 (313)
T ss_dssp HHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHC
T ss_pred HHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc--CccccC
Confidence 99999999999999998765433333333 233444566778899999999999999999999999998 555543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=269.63 Aligned_cols=221 Identities=24% Similarity=0.425 Sum_probs=162.8
Q ss_pred HHHHHHHhCCCCcccceeceee------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 022347 27 REVNMMSRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-- 98 (298)
Q Consensus 27 ~E~~~l~~l~hp~Iv~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-- 98 (298)
.|+..+..++||||+++++.+. ....++||||+++|+|.+++.. ...++..++.++.|++.||.|||+.
T Consensus 56 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~ 132 (336)
T 3g2f_A 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELP 132 (336)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred HHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhc
Confidence 4444455689999999997542 2257899999999999999976 4468999999999999999999999
Q ss_pred -------CCeeecCCCCCEEEcCCCCceEEeccCCCccCccc---------cccccccCccceeccccccccccccCCcc
Q 022347 99 -------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---------EMMTAETGTYRWMAPELYSTVTLRQGEKK 162 (298)
Q Consensus 99 -------givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 162 (298)
||+||||||+||+++.+ +.++|+|||++...... .......|++.|+|||++.+.... ....
T Consensus 133 ~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~ 210 (336)
T 3g2f_A 133 RGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL-RDXE 210 (336)
T ss_dssp CGGGCBCCEECSSCSGGGEEECTT-SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCG-GGHH
T ss_pred cccccccceeecccccceEEEcCC-CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccc-cccc
Confidence 99999999999999955 46999999999754321 122344689999999998642110 0113
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCh-----------------HHHHHH-HHHhhcCCCCCCC------CcHHHHH
Q 022347 163 HYNNKVDVYSFGIVLWELLTNRLPFEGMSN-----------------LQAAYA-AAFKHARPGLPED------ISPDLAF 218 (298)
Q Consensus 163 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~-----------------~~~~~~-~~~~~~~~~~~~~------~~~~l~~ 218 (298)
.++.++||||||+++|+|++|..||..... ...... .......+.++.. +++.+.+
T Consensus 211 ~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (336)
T 3g2f_A 211 SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHH
Confidence 456789999999999999999766532111 011111 1112223344433 3457999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 219 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 219 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
+|.+||+.||.+|||+.++++.|+.++.......
T Consensus 291 li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999886655433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.80 Aligned_cols=210 Identities=19% Similarity=0.216 Sum_probs=169.3
Q ss_pred HHHHHHHHHHhCC---CCcccceeceee-cCceeEEEecCCCCCHHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRVK---HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL---RPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 24 ~~~~E~~~l~~l~---hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
++.+|+.++..++ |+||+.+++++. ++..|+||||++||+|.+++... ....+++..++.++.|++.||+|||
T Consensus 110 ~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH 189 (365)
T 3e7e_A 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189 (365)
T ss_dssp HHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh
Confidence 5667888888887 999999999984 56799999999999999999753 2356999999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCC----------CCceEEeccCCCccCc---cccccccccCccceeccccccccccccCCccC
Q 022347 97 ANGIIHRDLKPDNLLLTPD----------QKSLKLADFGLAREET---VTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~----------~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
+.||+||||||+|||++.+ .+.++|+|||++.... .........||+.|+|||++.+ ..
T Consensus 190 ~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~ 261 (365)
T 3e7e_A 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------KP 261 (365)
T ss_dssp TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------CC
T ss_pred hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--------CC
Confidence 9999999999999999851 4579999999996432 2333455679999999999865 56
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~~l~~~l~ 242 (298)
++.++||||||+++|+|++|+.||......... ....... ...++.+.+++..||+.+|.+| |++.++.+.|+
T Consensus 262 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHHHhCCCccccCCCCcee----echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 899999999999999999999998643221000 0001111 1246789999999999999999 58899999999
Q ss_pred hhhhc
Q 022347 243 AFLFT 247 (298)
Q Consensus 243 ~~~~~ 247 (298)
.++..
T Consensus 336 ~~l~~ 340 (365)
T 3e7e_A 336 KVFQQ 340 (365)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=269.29 Aligned_cols=210 Identities=27% Similarity=0.499 Sum_probs=145.8
Q ss_pred HHHHHHH-HHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 24 RFIREVN-MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVS---LRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 24 ~~~~E~~-~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
++..|+. +++.++||||+++++++. ++..++||||+++ +|.+++.. .....+++..++.++.|++.||.|||+.
T Consensus 66 ~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 144 (327)
T 3aln_A 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144 (327)
T ss_dssp HHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc
Confidence 4445555 778889999999999985 5678999999965 88888763 2246799999999999999999999999
Q ss_pred -CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 -GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 -givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
|++|+||||+||+++.+ +.++|+|||++.............++..|+|||.+.... ....++.++||||||+++
T Consensus 145 ~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il 219 (327)
T 3aln_A 145 LKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA----SRQGYDVRSDVWSLGITL 219 (327)
T ss_dssp HSCCCSCCCGGGEEEETT-TEEEECCCSSSCC----------------------------------CCSHHHHHHHHHHH
T ss_pred CCEeECCCCHHHEEEcCC-CCEEEccCCCceecccccccccCCCCccccCceeecccc----CcCCCCchhhHHHHHHHH
Confidence 99999999999999955 579999999998655444444457899999999984210 125678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|+|++|..||..................+.++ ..+++.+.+++.+||+.||.+|||+.++++
T Consensus 220 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 220 YELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 99999999998754332222222222222222 358999999999999999999999999988
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=267.45 Aligned_cols=206 Identities=26% Similarity=0.428 Sum_probs=168.5
Q ss_pred HHHHHHHHHHhC----CCCcccceeceee-cCceeEEEec-CCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 24 RFIREVNMMSRV----KHDNLVKFLGACK-DPLMVIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 24 ~~~~E~~~l~~l----~hp~Iv~~~~~~~-~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
.+.+|+.++.++ +||||+++++++. ++..++|+|+ +.+++|.+++... ..+++..++.++.|++.||.|||+
T Consensus 80 ~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~ 157 (312)
T 2iwi_A 80 TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHS 157 (312)
T ss_dssp CCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 566899999999 8999999999984 5678999999 7899999999874 459999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
.|++||||||+||+++.+.+.++|+|||++...... ......++..|+|||++.+ ....+.++||||||+++
T Consensus 158 ~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il 229 (312)
T 2iwi_A 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILL 229 (312)
T ss_dssp HTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHH
T ss_pred CCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeec-------CCCCCccchHHHHHHHH
Confidence 999999999999999855567999999998765433 2344568999999998864 12334589999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
|+|++|+.||..... .......++..++..+.+++.+||+.+|.+|||+.++++ +.++....
T Consensus 230 ~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--~~~~~~~~ 291 (312)
T 2iwi_A 230 YDMVCGDIPFERDQE--------ILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL--DPWMQTPA 291 (312)
T ss_dssp HHHHHSSCSCCSHHH--------HHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH--STTTCC--
T ss_pred HHHHHCCCCCCChHH--------HhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc--ChhhcCch
Confidence 999999999975321 122345567789999999999999999999999999998 56655443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=263.58 Aligned_cols=216 Identities=22% Similarity=0.275 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHHHhCCCCc------ccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDN------LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~------Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+.+.+|+.++++++|++ ++.+++++. ++..++||||+ ++++.+++.......+++..++.++.|++.||+
T Consensus 59 ~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~ 137 (355)
T 2eu9_A 59 YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence 3457789999999998766 888888874 56899999999 778888887755567999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcC------------------CCCceEEeccCCCccCccccccccccCccceeccccccccc
Q 022347 94 CLHANGIIHRDLKPDNLLLTP------------------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 155 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 155 (298)
|||+.||+||||||+||+++. ..+.++|+|||++...... .....+++.|+|||++.+
T Consensus 138 ~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-- 213 (355)
T 2eu9_A 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE-- 213 (355)
T ss_dssp HHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT--
T ss_pred HHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec--
Confidence 999999999999999999932 3457999999999753322 234578999999999865
Q ss_pred cccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-----------------------------
Q 022347 156 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP----------------------------- 206 (298)
Q Consensus 156 ~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------- 206 (298)
..++.++||||||+++|+|++|..||...................
T Consensus 214 ------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (355)
T 2eu9_A 214 ------LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR 287 (355)
T ss_dssp ------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHH
T ss_pred ------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhc
Confidence 568899999999999999999999998766543322221111000
Q ss_pred -------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 207 -------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 207 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
......+.++.+|+.+||+.||.+|||+.++++ +.|+....
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~ 341 (355)
T 2eu9_A 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL--HPFFAGLT 341 (355)
T ss_dssp HHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT--SGGGGGCC
T ss_pred cccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhcCCC
Confidence 001113457899999999999999999999998 67776654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=269.94 Aligned_cols=213 Identities=22% Similarity=0.305 Sum_probs=167.4
Q ss_pred HHHHHHHHHHHHhCC-CC-----cccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVK-HD-----NLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp-----~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+++.+|+.+++.++ |+ +|+++++++. ++..|+||||++ ++|.+++.......+++..+..++.|++.||.|
T Consensus 94 ~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 172 (382)
T 2vx3_A 94 LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172 (382)
T ss_dssp HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHH
Confidence 456778888888885 55 4888988884 568999999995 599999987655679999999999999999999
Q ss_pred HH--hCCCeeecCCCCCEEEcC-CCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 95 LH--ANGIIHRDLKPDNLLLTP-DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 95 LH--~~givH~dik~~Nil~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
|| +.||+||||||+||+++. +.+.++|+|||++..... ......+++.|+|||++.+ ..++.++|||
T Consensus 173 lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~--------~~~~~~~Diw 242 (382)
T 2vx3_A 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLG--------MPYDLAIDMW 242 (382)
T ss_dssp HTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTT--------CCCCTHHHHH
T ss_pred hccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcC--------CCCCcHHHHH
Confidence 99 579999999999999963 345699999999976533 2334578999999999875 5688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCC----------------CCC-------------------------
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG----------------LPE------------------------- 210 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----------------~~~------------------------- 210 (298)
||||++|+|++|..||.+.+..............+. ++.
T Consensus 243 SlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 322 (382)
T 2vx3_A 243 SLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHN 322 (382)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHH
Confidence 999999999999999998766544333222111100 000
Q ss_pred -----------------C----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 211 -----------------D----ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 211 -----------------~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
. .++++.+||.+||+.||.+|||+.++++ +.|+..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~--hp~f~~ 378 (382)
T 2vx3_A 323 ILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ--HSFFKK 378 (382)
T ss_dssp HHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT--SGGGCC
T ss_pred HhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc--Cccccc
Confidence 0 0147899999999999999999999998 666654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=275.49 Aligned_cols=213 Identities=13% Similarity=0.153 Sum_probs=149.3
Q ss_pred HHHHHHHHHHHHhC--CCCccccee-------ceee-c-----------------CceeEEEecCCCCCHHHHHhhhCCC
Q 022347 22 EGRFIREVNMMSRV--KHDNLVKFL-------GACK-D-----------------PLMVIVTELLPGMSLRKYLVSLRPN 74 (298)
Q Consensus 22 ~~~~~~E~~~l~~l--~hp~Iv~~~-------~~~~-~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~ 74 (298)
.+.+.+|+.++..+ +||||++++ +++. . ...|+||||++ ++|.+++.... .
T Consensus 106 ~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~ 183 (371)
T 3q60_A 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-F 183 (371)
T ss_dssp HHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-H
T ss_pred HHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-c
Confidence 44677785444444 699988755 3331 1 23799999997 79999998642 2
Q ss_pred CCCHHHH------HHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceecc
Q 022347 75 KLDLHVA------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 148 (298)
Q Consensus 75 ~~~~~~~------~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aP 148 (298)
.+++..+ +.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++........ ...+++.|+||
T Consensus 184 ~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aP 260 (371)
T 3q60_A 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD-GRLMLGDVSALWKVGTRGP--ASSVPVTYAPR 260 (371)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTT-SCEEECCGGGEEETTCEEE--GGGSCGGGCCH
T ss_pred ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCC-CCEEEEecceeeecCCCcc--CccCCcCCcCh
Confidence 3455555 6778999999999999999999999999999965 4699999999986543321 34566999999
Q ss_pred ccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-----HH--hhcCCCCCCCCcHHHHHHHH
Q 022347 149 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-----AF--KHARPGLPEDISPDLAFIVQ 221 (298)
Q Consensus 149 E~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-----~~--~~~~~~~~~~~~~~l~~li~ 221 (298)
|++.+ ....++.++||||||+++|+|++|+.||............ .. ..........+++.+.+++.
T Consensus 261 E~~~~------~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 334 (371)
T 3q60_A 261 EFLNA------STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334 (371)
T ss_dssp HHHTC------SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHH
T ss_pred hhccC------CCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHH
Confidence 99853 2256789999999999999999999999865321100000 00 01111222478999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 222 SCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 222 ~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+||+.||.+|||+.++++ +.|+..
T Consensus 335 ~~L~~dP~~Rpt~~e~l~--hp~f~~ 358 (371)
T 3q60_A 335 RFLNFDRRRRLLPLEAME--TPEFLQ 358 (371)
T ss_dssp HHTCSSTTTCCCHHHHTT--SHHHHH
T ss_pred HHcCCChhhCCCHHHHhc--CHHHHH
Confidence 999999999999999987 455443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=282.24 Aligned_cols=209 Identities=29% Similarity=0.380 Sum_probs=165.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-------cCceeEEEecCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAM 92 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-------~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al 92 (298)
..+++.+|+.++++++||||+++++++. ++..|+||||++|++|.+++..... ..+++..++.++.|++.||
T Consensus 55 ~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL 134 (676)
T 3qa8_A 55 NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134 (676)
T ss_dssp HHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHH
Confidence 3457889999999999999999999863 3468999999999999999986432 3589999999999999999
Q ss_pred HHHHhCCCeeecCCCCCEEEcCCCC--ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 93 DCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 93 ~~LH~~givH~dik~~Nil~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
+|||+.||+||||||+||+++.++. .++|+|||++.............++..|+|||.+.+ ..++.++||
T Consensus 135 ~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDI 206 (676)
T 3qa8_A 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ--------KKYTVTVDY 206 (676)
T ss_dssp HHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC--------SCCSTTHHH
T ss_pred HHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc--------CCCCchhHH
Confidence 9999999999999999999996543 489999999987665555556688999999999864 678899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHH-------H-H--h------------hcCCCCCCCCcHHHHHHHHHhhhhCC
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAA-------A-F--K------------HARPGLPEDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~-------~-~--~------------~~~~~~~~~~~~~l~~li~~~l~~~p 228 (298)
||||+++|+|++|..||............ . . . .....+...+++.+.+++.+||..||
T Consensus 207 wSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP 286 (676)
T 3qa8_A 207 WSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ 286 (676)
T ss_dssp HHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSC
T ss_pred HHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCH
Confidence 99999999999999999764322211000 0 0 0 00011223467899999999999999
Q ss_pred CCCCCHHHH
Q 022347 229 NLRPSFSQI 237 (298)
Q Consensus 229 ~~Rps~~~l 237 (298)
.+|||+.++
T Consensus 287 ~kRPTa~el 295 (676)
T 3qa8_A 287 RQRGTDPQN 295 (676)
T ss_dssp C---CCTTC
T ss_pred hhCcCHHHH
Confidence 999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=272.47 Aligned_cols=206 Identities=24% Similarity=0.368 Sum_probs=155.3
Q ss_pred HHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 25 FIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 25 ~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.+|+.+++++ +||||+++++++. +...|+||||+. |+|.+++.... ..+.+..++.++.|++.||.|||+.||+|
T Consensus 64 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 141 (432)
T 3p23_A 64 ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVH 141 (432)
T ss_dssp CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEe
Confidence 45899999999 7999999999985 457899999995 69999998633 34555567899999999999999999999
Q ss_pred ecCCCCCEEEcCCC----CceEEeccCCCccCccc----cccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 103 RDLKPDNLLLTPDQ----KSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 103 ~dik~~Nil~~~~~----~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|||||+||+++.++ ..++|+|||++...... .......||+.|+|||++.+. ....++.++||||||
T Consensus 142 rDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwSlG 216 (432)
T 3p23_A 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFSAG 216 (432)
T ss_dssp CCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC--------CCCTHHHHHHHH
T ss_pred CCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHHHH
Confidence 99999999996322 25789999999764432 223345789999999998631 125567899999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|+|++ |..||......... .......... +...+..+.+++.+||+.||.+|||+.++++
T Consensus 217 ~il~ellt~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 217 CVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHTTSCBTTBSTTTHHHH--HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCCCcchhhHHHHH--HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 99999999 99999765433221 1111111111 1224566899999999999999999999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.52 Aligned_cols=204 Identities=23% Similarity=0.407 Sum_probs=169.7
Q ss_pred HHHHHHHHHHhCC--CCcccceeceee-cCceeEEEecCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 24 RFIREVNMMSRVK--HDNLVKFLGACK-DPLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 24 ~~~~E~~~l~~l~--hp~Iv~~~~~~~-~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
++.+|+.++++++ ||||+++++++. ++..++|+|++.+ ++|.+++... ..+++..++.++.|++.||+|||+.|
T Consensus 92 ~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ 169 (320)
T 3a99_A 92 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG 169 (320)
T ss_dssp EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4568999999996 599999999985 4578999999976 8999999874 45899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||||+||+++.+.+.++|+|||++...... ......+++.|+|||++.+ ...++.++||||||+++|+
T Consensus 170 ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~e 241 (320)
T 3a99_A 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYD 241 (320)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHH
T ss_pred cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHH
Confidence 9999999999999865667999999998765432 2234568999999998864 1334678999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|..||..... .......++..+++++.+++.+||+.||.+|||++++++ +.++..
T Consensus 242 l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--hp~~~~ 299 (320)
T 3a99_A 242 MVCGDIPFEHDEE--------IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQD 299 (320)
T ss_dssp HHHSSCSCCSHHH--------HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSS
T ss_pred HHHCCCCCCChhh--------hhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc--CHhhcC
Confidence 9999999975321 122344566789999999999999999999999999988 555543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=268.73 Aligned_cols=213 Identities=22% Similarity=0.402 Sum_probs=155.8
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCC-----CCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNK-----LDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~-----~~~~~~~~i~~qi~~al~~L 95 (298)
+.+.+|+.++.++ +||||+++++++. ++..|+||||+. |+|.+++....... .++..++.++.|++.||+||
T Consensus 53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 131 (434)
T 2rio_A 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131 (434)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH
Confidence 3567899999886 8999999999985 457899999995 69999998633211 12334678999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCC------------CCceEEeccCCCccCccccc-----cccccCccceecccccccccccc
Q 022347 96 HANGIIHRDLKPDNLLLTPD------------QKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQ 158 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~------------~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~ 158 (298)
|+.||+||||||+||+++.+ ...++|+|||++........ .....|++.|+|||++.+....
T Consensus 132 H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~- 210 (434)
T 2rio_A 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL- 210 (434)
T ss_dssp HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT-
T ss_pred HHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc-
Confidence 99999999999999999743 24799999999975443221 2234689999999998642110
Q ss_pred CCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcC-CCC----CCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 159 GEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR-PGL----PEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 159 ~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
.....++.++|||||||++|+|++ |..||.+....... ....... +.. ...+++++.+++.+||+.||.+||
T Consensus 211 ~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 288 (434)
T 2rio_A 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288 (434)
T ss_dssp SCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred ccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCC
Confidence 112568899999999999999999 99999765443321 1111111 111 112467899999999999999999
Q ss_pred CHHHHHH
Q 022347 233 SFSQIIR 239 (298)
Q Consensus 233 s~~~l~~ 239 (298)
|+.++++
T Consensus 289 s~~eil~ 295 (434)
T 2rio_A 289 TAMKVLR 295 (434)
T ss_dssp CHHHHHT
T ss_pred CHHHHHh
Confidence 9999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=251.43 Aligned_cols=194 Identities=24% Similarity=0.447 Sum_probs=152.5
Q ss_pred HHHHHHHHH-HhCCCCcccceeceee-----cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 24 RFIREVNMM-SRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 24 ~~~~E~~~l-~~l~hp~Iv~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
.+.+|+.++ +..+||||+++++++. +...++||||++|++|.+++.......+++..++.++.|++.||.|||+
T Consensus 56 ~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (299)
T 3m2w_A 56 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135 (299)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456888887 5668999999999874 3468999999999999999988655679999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCC--CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
.|++|+||||+||+++.+ .+.++|+|||++.... ...++.++||||||+
T Consensus 136 ~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------------~~~~~~~~DiwslG~ 186 (299)
T 3m2w_A 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------------------GEKYDKSCDMWSLGV 186 (299)
T ss_dssp TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------------------TCGGGGHHHHHHHHH
T ss_pred CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------------------------cccCCchhhHHHHHH
Confidence 999999999999999963 4579999999884321 134577999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHH--HHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAA--AFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
++|+|++|..||............ .........+ ..+++++.+++.+||+.||.+|||+.++++ +.++...
T Consensus 187 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~~ 263 (299)
T 3m2w_A 187 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQS 263 (299)
T ss_dssp HHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHTG
T ss_pred HHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhccc
Confidence 999999999999765432211000 0001111122 468899999999999999999999999998 5666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=249.65 Aligned_cols=189 Identities=18% Similarity=0.193 Sum_probs=149.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.++.+++||||+++++++. ++..|+||||++|++|.+++.. + ....++..++.|++.||+|||++|
T Consensus 74 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~g 149 (286)
T 3uqc_A 74 VLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAG 149 (286)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999985 5679999999999999999964 2 456678999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||||+||+++.+ +.++|++++ |++ .++.++||||||+++|+
T Consensus 150 ivH~Dikp~NIll~~~-g~~kl~~~~-------------------~~~---------------~~~~~~Di~slG~il~e 194 (286)
T 3uqc_A 150 VALSIDHPSRVRVSID-GDVVLAYPA-------------------TMP---------------DANPQDDIRGIGASLYA 194 (286)
T ss_dssp CCCCCCSGGGEEEETT-SCEEECSCC-------------------CCT---------------TCCHHHHHHHHHHHHHH
T ss_pred CccCCCCcccEEEcCC-CCEEEEecc-------------------ccC---------------CCCchhHHHHHHHHHHH
Confidence 9999999999999955 458887443 222 24779999999999999
Q ss_pred HHhCCCCCCCCChHHHHHH--HHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 180 LLTNRLPFEGMSNLQAAYA--AAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
|++|+.||.+......... ........ .....+++++.+++.+||+.||.+| |+.++++.|+.......
T Consensus 195 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 195 LLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 9999999987543210000 00000000 1235688999999999999999999 99999999998765543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=276.77 Aligned_cols=198 Identities=24% Similarity=0.296 Sum_probs=156.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec-Cc-----eeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-PL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~-----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..+.+.+|+.++++++||||+++++++.+ +. .|+||||++|++|.+++.. .+++..++.++.||+.||.|
T Consensus 122 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~ 197 (681)
T 2pzi_A 122 AQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSY 197 (681)
T ss_dssp HHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999999843 33 6999999999999987753 69999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||++||+||||||+||+++.+ .++|+|||++...... ....||+.|+|||++.+ .++.++||||||
T Consensus 198 lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG 263 (681)
T 2pzi_A 198 LHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVG 263 (681)
T ss_dssp HHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHH
T ss_pred HHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC---CccCCCccccCHHHHcC---------CCCCceehhhhH
Confidence 999999999999999999854 6999999999764433 34568999999998853 347899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHhhh
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFL 245 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp-s~~~l~~~l~~~~ 245 (298)
+++|+|++|..||.+.... ...... ....++.+.++|.+||+.||.+|| +++++...|...+
T Consensus 264 ~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 264 RTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCcccccc---------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999887642110 000000 011356799999999999999999 5666766666554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=263.16 Aligned_cols=207 Identities=15% Similarity=0.159 Sum_probs=151.8
Q ss_pred HHHHHHHHHHHHhCCC-Cccccee---------------------ceee------cCceeEEEecCCCCCHHHHHhh---
Q 022347 22 EGRFIREVNMMSRVKH-DNLVKFL---------------------GACK------DPLMVIVTELLPGMSLRKYLVS--- 70 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~h-p~Iv~~~---------------------~~~~------~~~~~lv~e~~~~~sL~~~l~~--- 70 (298)
.+.+.+|+.+++.+.| +|+.... .++. ....+++|+++ +++|.+++..
T Consensus 122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~ 200 (413)
T 3dzo_A 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS 200 (413)
T ss_dssp CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence 3468899999999987 3222111 1111 12367788877 7899999852
Q ss_pred --hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceecc
Q 022347 71 --LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 148 (298)
Q Consensus 71 --~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aP 148 (298)
.....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++...... .....| +.|+||
T Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aP 276 (413)
T 3dzo_A 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPP 276 (413)
T ss_dssp HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCH
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCc
Confidence 1234478889999999999999999999999999999999999665 5999999998764443 334466 999999
Q ss_pred cccccccc--ccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhh
Q 022347 149 ELYSTVTL--RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 226 (298)
Q Consensus 149 E~~~~~~~--~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 226 (298)
|++.+... .......++.++|||||||++|+|++|+.||.......... . . ......+++++.+++.+||+.
T Consensus 277 E~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-~----~-~~~~~~~~~~~~~li~~~l~~ 350 (413)
T 3dzo_A 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE-W----I-FRSCKNIPQPVRALLEGFLRY 350 (413)
T ss_dssp HHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG-G----G-GSSCCCCCHHHHHHHHHHTCS
T ss_pred hhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH-H----H-HhhcccCCHHHHHHHHHHccC
Confidence 99843110 00023567889999999999999999999998754322111 0 0 111236889999999999999
Q ss_pred CCCCCCCHHHHHH
Q 022347 227 DPNLRPSFSQIIR 239 (298)
Q Consensus 227 ~p~~Rps~~~l~~ 239 (298)
||.+||++.++++
T Consensus 351 dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 351 PKEDRLLPLQAME 363 (413)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCcCHHHHHh
Confidence 9999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-33 Score=242.88 Aligned_cols=196 Identities=15% Similarity=0.138 Sum_probs=146.2
Q ss_pred HHHHHHHHHHHhCC--------------------------CCcccceeceee--------------cCceeEEEecCCCC
Q 022347 23 GRFIREVNMMSRVK--------------------------HDNLVKFLGACK--------------DPLMVIVTELLPGM 62 (298)
Q Consensus 23 ~~~~~E~~~l~~l~--------------------------hp~Iv~~~~~~~--------------~~~~~lv~e~~~~~ 62 (298)
+.+.+|+.+++.++ ||||+++++++. ++..|+||||+++|
T Consensus 68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g 147 (336)
T 2vuw_A 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence 35668888888776 555666665553 56899999999999
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeecCCCCCEEEcCCC-------------------CceEEe
Q 022347 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQ-------------------KSLKLA 122 (298)
Q Consensus 63 sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~givH~dik~~Nil~~~~~-------------------~~~~l~ 122 (298)
++.+.+.. ..+++..++.++.||+.||+||| +.||+||||||+|||++.++ ..+||+
T Consensus 148 ~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~ 224 (336)
T 2vuw_A 148 IDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224 (336)
T ss_dssp EETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEEC
T ss_pred ccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEe
Confidence 76666643 56899999999999999999999 99999999999999999654 179999
Q ss_pred ccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHH
Q 022347 123 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV-LWELLTNRLPFEGMSNLQAAYAAAF 201 (298)
Q Consensus 123 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i-l~~ll~g~~p~~~~~~~~~~~~~~~ 201 (298)
|||++...... ...||+.|+|||++.+ .. +.++|||||+++ .++++.|..||.+............
T Consensus 225 DFG~a~~~~~~----~~~gt~~y~aPE~~~g--------~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~ 291 (336)
T 2vuw_A 225 DYTLSRLERDG----IVVFCDVSMDEDLFTG--------DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML 291 (336)
T ss_dssp CCTTCBEEETT----EEECCCCTTCSGGGCC--------CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH
T ss_pred eccccEecCCC----cEEEeecccChhhhcC--------CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh
Confidence 99999764432 3378999999999864 22 779999998777 6678889999853211111111222
Q ss_pred hhcC-C-C----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH-H
Q 022347 202 KHAR-P-G----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII-R 239 (298)
Q Consensus 202 ~~~~-~-~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~-~ 239 (298)
.... . . .+..+++++.+||.+||+.+ |+++++ +
T Consensus 292 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 292 KQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHH
T ss_pred hhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhc
Confidence 1111 1 1 11247788999999999976 999998 6
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-33 Score=252.85 Aligned_cols=153 Identities=18% Similarity=0.205 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 16 DERALLEGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 16 ~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
...+.-.++|.+|+++|+++ .|+||++++++++ ++..||||||++|++|.+++... +.++.. +|+.||+.||+
T Consensus 279 ~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ 353 (569)
T 4azs_A 279 EESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLA 353 (569)
T ss_dssp HHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHH
Confidence 34455566899999999999 6999999999996 45799999999999999999863 446664 57899999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 172 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 172 (298)
|+|++||+||||||+|||++.+ +.+||+|||+++..... ......+||+.|+|||++.+ .+..++|+|+
T Consensus 354 ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g---------~~~~~~d~~s 423 (569)
T 4azs_A 354 ALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE---------NKSWNGFWRS 423 (569)
T ss_dssp HHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC---------------------
T ss_pred HHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCccccCceechhhccHHHhCC---------CCCCcccccc
Confidence 9999999999999999999965 46999999999754432 23345579999999999864 3566899999
Q ss_pred HHHHHHHHHhC
Q 022347 173 FGIVLWELLTN 183 (298)
Q Consensus 173 lG~il~~ll~g 183 (298)
+|++++.+.++
T Consensus 424 ~g~~~~~l~~~ 434 (569)
T 4azs_A 424 APVHPFNLPQP 434 (569)
T ss_dssp -----CCCCTT
T ss_pred cccchhhhccc
Confidence 99998776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-25 Score=204.06 Aligned_cols=149 Identities=21% Similarity=0.259 Sum_probs=121.4
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceecee-ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
...+++.+|+.++++++||||+++..++ ..+..|+||||++|++|.+++.. +..++.|++.||.|||++
T Consensus 381 ~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~ 450 (540)
T 3en9_A 381 IRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN 450 (540)
T ss_dssp HHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC
Confidence 3456789999999999999999554444 45567999999999999999874 568999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc--------cccccCccceeccccccccccccCCccCCCcchhH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
||+||||||+||+++. .++|+|||++........ .....||+.|+|||++... ...|+..+|+
T Consensus 451 gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~------~~~Y~~~~d~ 521 (540)
T 3en9_A 451 DVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERF------LEGYKSVYDR 521 (540)
T ss_dssp TEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH------HHHHHHHCTT
T ss_pred cCccCCCCHHHEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHH------HHHHHHHHhH
Confidence 9999999999999995 699999999986554322 1245789999999998642 1456778899
Q ss_pred HHHHHHHHHHHhCCCCC
Q 022347 171 YSFGIVLWELLTNRLPF 187 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~ 187 (298)
|+..+-.++-..++.+|
T Consensus 522 ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 522 WEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHHHHHHhcccc
Confidence 99888877776666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=6e-19 Score=147.23 Aligned_cols=106 Identities=15% Similarity=0.123 Sum_probs=86.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
....+.+|+.++++++ | +++.+++..+..|+||||++|++|.+ +.. .....++.|++.||.|||+.||
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~gi 214 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGI 214 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCC
Confidence 4567889999999999 5 66777666667899999999999988 421 2345799999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceecccccc
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 152 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 152 (298)
+||||||+||+++ + +.++|+|||++.. +..+.|||.+.
T Consensus 215 iHrDlkp~NILl~-~-~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 215 VHGDLSQYNVLVS-E-EGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp ECSCCSTTSEEEE-T-TEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred EeCCCCHHHEEEE-C-CcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 9999999999999 4 5799999999853 33456788763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=5.6e-16 Score=127.63 Aligned_cols=99 Identities=16% Similarity=0.117 Sum_probs=78.4
Q ss_pred HHHHHHHHHHHHHHhCCCCcc--cceeceeecCceeEEEecCCC-C----CHHHHHhhhCCCCCCHHHHHHHHHHHHHHH
Q 022347 20 LLEGRFIREVNMMSRVKHDNL--VKFLGACKDPLMVIVTELLPG-M----SLRKYLVSLRPNKLDLHVALNFALDIARAM 92 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~I--v~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~i~~qi~~al 92 (298)
.....+.+|+..+.++.|++| +.+++ ....++||||+.+ | +|.++... .++..+..++.|++.||
T Consensus 112 ~~~~~~~~E~~~l~~l~~~~i~~p~~~~---~~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l 183 (258)
T 1zth_A 112 KVFIWTEKEFRNLERAKEAGVSVPQPYT---YMKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENV 183 (258)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCEEE---EETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCeEEE---cCCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHH
Confidence 344578899999999998865 33333 2356899999932 3 78876543 23456788999999999
Q ss_pred HHHH-hCCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 93 DCLH-ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 93 ~~LH-~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.||| +.||+||||||+|||++. .++|+|||++..
T Consensus 184 ~~lH~~~givHrDlkp~NILl~~---~~~liDFG~a~~ 218 (258)
T 1zth_A 184 KRLYQEAELVHADLSEYNIMYID---KVYFIDMGQAVT 218 (258)
T ss_dssp HHHHHTSCEECSSCSTTSEEESS---SEEECCCTTCEE
T ss_pred HHHHHHCCEEeCCCCHHHEEEcC---cEEEEECccccc
Confidence 9999 999999999999999985 699999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.32 E-value=9.1e-13 Score=113.26 Aligned_cols=96 Identities=17% Similarity=0.244 Sum_probs=68.2
Q ss_pred HHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~d 104 (298)
..+|...|.++.+.++.- ...+.....++||||++|++|.++.. . .....++.|++.+|.+||+.||||||
T Consensus 160 A~kE~~nL~rL~~~gv~v-p~p~~~~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrD 230 (397)
T 4gyi_A 160 AIKEFAFMKALYEEGFPV-PEPIAQSRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGD 230 (397)
T ss_dssp HHHHHHHHHHHHHTTCSC-CCEEEEETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHHHHhcCCCC-CeeeeccCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 445666777765444322 11121123479999999988865432 1 23456889999999999999999999
Q ss_pred CCCCCEEEcCCCC---------ceEEeccCCCcc
Q 022347 105 LKPDNLLLTPDQK---------SLKLADFGLARE 129 (298)
Q Consensus 105 ik~~Nil~~~~~~---------~~~l~dfg~~~~ 129 (298)
|||.|||++.++. .+.|+||+.+..
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999999985542 378999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=7.2e-10 Score=91.08 Aligned_cols=96 Identities=19% Similarity=0.162 Sum_probs=75.6
Q ss_pred HHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh----
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA---- 97 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~---- 97 (298)
++.+|+.+++.+. +..+.++++++. ++..|+||||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 55 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~ 127 (263)
T 3tm0_A 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDIS 127 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcc
Confidence 4668999999885 677888888874 4578999999999999875321 12234678899999999998
Q ss_pred -------------------------------------------------------CCCeeecCCCCCEEEcCCCCceEEe
Q 022347 98 -------------------------------------------------------NGIIHRDLKPDNLLLTPDQKSLKLA 122 (298)
Q Consensus 98 -------------------------------------------------------~givH~dik~~Nil~~~~~~~~~l~ 122 (298)
..++|||+++.||+++ ++..+.|+
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lI 206 (263)
T 3tm0_A 128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFI 206 (263)
T ss_dssp TCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEEC
T ss_pred cCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEE
Confidence 4489999999999998 44445699
Q ss_pred ccCCC
Q 022347 123 DFGLA 127 (298)
Q Consensus 123 dfg~~ 127 (298)
||+.+
T Consensus 207 Dwe~a 211 (263)
T 3tm0_A 207 DLGRS 211 (263)
T ss_dssp CCTTC
T ss_pred Echhc
Confidence 99866
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=4.1e-09 Score=90.70 Aligned_cols=103 Identities=20% Similarity=0.348 Sum_probs=81.3
Q ss_pred HHHHHHHHHHHhCC--CCcccceeceeecC----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVK--HDNLVKFLGACKDP----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 23 ~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
..+.+|..+++.+. +..+++++.++.+. ..|+||||++|.++.+. ....++......++.+++..|..||
T Consensus 81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH 156 (359)
T 3dxp_A 81 HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMH 156 (359)
T ss_dssp -CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHh
Confidence 36778999999997 45577888887543 47899999999877531 1134778888899999999999999
Q ss_pred h----------------------------------------------------------CCCeeecCCCCCEEEcCCCC-
Q 022347 97 A----------------------------------------------------------NGIIHRDLKPDNLLLTPDQK- 117 (298)
Q Consensus 97 ~----------------------------------------------------------~givH~dik~~Nil~~~~~~- 117 (298)
+ .+++|||+++.||+++.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~ 236 (359)
T 3dxp_A 157 TVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPR 236 (359)
T ss_dssp HSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSC
T ss_pred CCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCc
Confidence 7 36899999999999986653
Q ss_pred ceEEeccCCCcc
Q 022347 118 SLKLADFGLARE 129 (298)
Q Consensus 118 ~~~l~dfg~~~~ 129 (298)
.+.|+||+.+..
T Consensus 237 v~~viDwe~a~~ 248 (359)
T 3dxp_A 237 VLAVLDWELSTL 248 (359)
T ss_dssp EEEECCCTTCEE
T ss_pred EEEEECcccccc
Confidence 358999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=4.1e-09 Score=88.54 Aligned_cols=162 Identities=19% Similarity=0.242 Sum_probs=98.3
Q ss_pred HHHHHHHHHHHHhCC-CCc--ccceeceeecC----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVK-HDN--LVKFLGACKDP----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-hp~--Iv~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..++.+|..+++.+. +.. +..++....++ ..|+||++++|.++.+... ..++..+...++.+++..|..
T Consensus 54 ~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~ 129 (304)
T 3sg8_A 54 STNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSE 129 (304)
T ss_dssp HHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHH
Confidence 346779999998884 333 33444443222 3589999999998875432 236777788888888888888
Q ss_pred HHh----------------------------------------------------------CCCeeecCCCCCEEEcCC-
Q 022347 95 LHA----------------------------------------------------------NGIIHRDLKPDNLLLTPD- 115 (298)
Q Consensus 95 LH~----------------------------------------------------------~givH~dik~~Nil~~~~- 115 (298)
||+ ..++|||+++.||+++.+
T Consensus 130 LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 209 (304)
T 3sg8_A 130 LHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK 209 (304)
T ss_dssp HHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT
T ss_pred HHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC
Confidence 886 137999999999999964
Q ss_pred CCceEEeccCCCccCccccccccccCccceeccccccc----ccccc--CCccCCCcchhHHHHHHHHHHHHhCCCCC
Q 022347 116 QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST----VTLRQ--GEKKHYNNKVDVYSFGIVLWELLTNRLPF 187 (298)
Q Consensus 116 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~--~~~~~~~~~~Di~slG~il~~ll~g~~p~ 187 (298)
+..+.|+||+.+.................-..|+.... ..... ..........+.|+++.++|.+.+|..+|
T Consensus 210 ~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 210 NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 45678999998864222111000000000011111100 00000 00011122368999999999999998765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.77 E-value=6e-09 Score=85.24 Aligned_cols=93 Identities=18% Similarity=0.150 Sum_probs=68.2
Q ss_pred HHHHHHHHHHhCCCCc--ccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 022347 24 RFIREVNMMSRVKHDN--LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG- 99 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~--Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g- 99 (298)
.+.+|+.+++.+.+.+ +.+++++.. ++..++||||++|.+|. ... ... ..++.+++..|..||+..
T Consensus 59 ~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~ 128 (264)
T 1nd4_A 59 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDP 128 (264)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCG
T ss_pred hhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCC
Confidence 4668999998886544 455777764 45689999999998884 211 121 256677778888888643
Q ss_pred ---------------------------------------------------------CeeecCCCCCEEEcCCCCceEEe
Q 022347 100 ---------------------------------------------------------IIHRDLKPDNLLLTPDQKSLKLA 122 (298)
Q Consensus 100 ---------------------------------------------------------ivH~dik~~Nil~~~~~~~~~l~ 122 (298)
++|||++|.||+++. +..+.|+
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~li 207 (264)
T 1nd4_A 129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFI 207 (264)
T ss_dssp GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEEC
T ss_pred CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEE
Confidence 999999999999984 3445699
Q ss_pred ccCCC
Q 022347 123 DFGLA 127 (298)
Q Consensus 123 dfg~~ 127 (298)
||+.+
T Consensus 208 D~~~a 212 (264)
T 1nd4_A 208 DCGRL 212 (264)
T ss_dssp CCTTC
T ss_pred cchhc
Confidence 99976
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.1e-06 Score=70.96 Aligned_cols=104 Identities=23% Similarity=0.248 Sum_probs=71.1
Q ss_pred HHHHHHHHHHHHhCCCC---cccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHD---NLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp---~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
...+.+|..+|+.+.+. .|.+++.+.. ++..++|||+++|.++.+..- ..++......++.++...|..||
T Consensus 53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHh
Confidence 35778999999999753 3455565553 456789999999988876321 12344455555555555555555
Q ss_pred hC------------------------------------------------------------CCeeecCCCCCEEEcC--
Q 022347 97 AN------------------------------------------------------------GIIHRDLKPDNLLLTP-- 114 (298)
Q Consensus 97 ~~------------------------------------------------------------givH~dik~~Nil~~~-- 114 (298)
+. .++|||+++.||+++.
T Consensus 129 ~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 208 (306)
T 3tdw_A 129 AFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS 208 (306)
T ss_dssp HSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC
T ss_pred cCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC
Confidence 32 3599999999999986
Q ss_pred -CCCceEEeccCCCcc
Q 022347 115 -DQKSLKLADFGLARE 129 (298)
Q Consensus 115 -~~~~~~l~dfg~~~~ 129 (298)
++..+.|+||+.+..
T Consensus 209 ~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 209 RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SSCCEEEECCCTTCEE
T ss_pred CCCceEEEEehhhcCC
Confidence 244458999997753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.24 E-value=2.1e-05 Score=61.37 Aligned_cols=141 Identities=16% Similarity=0.181 Sum_probs=91.3
Q ss_pred CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccccccccc
Q 022347 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 140 (298)
Q Consensus 62 ~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 140 (298)
-||.+.++.. +.++++.++|.++.|.+.+|.-+-. ..-...=+.|..|++..+|. |-+.+ +.+ ..
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-V~f~~-~~s-----------~~ 98 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-VTLAP-AAD-----------DA 98 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-EEECC-C---------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-eeccc-ccc-----------cc
Confidence 3899998874 4789999999999999999887622 22112333468889887764 54432 111 01
Q ss_pred CccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 022347 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 220 (298)
Q Consensus 141 ~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 220 (298)
....+.|||... ...+.+.=|||||+++|..+.-..| ...+..+|+.|.+||
T Consensus 99 ~~~~~~~pe~~~---------~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL 150 (229)
T 2yle_A 99 GEPPPVAGKLGY---------SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLI 150 (229)
T ss_dssp --------CCSS---------SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHH
T ss_pred cccCCCChhhcc---------ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHH
Confidence 233567888652 2446788999999999998863333 122356889999999
Q ss_pred HHhhhh-------------------------CCCCCCCHHHHHHHHHhh
Q 022347 221 QSCWVE-------------------------DPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 221 ~~~l~~-------------------------~p~~Rps~~~l~~~l~~~ 244 (298)
..|..- .+..|+++.+|++....-
T Consensus 151 ~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 151 DHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp HHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred HHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 999765 245778888888766543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-05 Score=65.80 Aligned_cols=99 Identities=18% Similarity=0.172 Sum_probs=68.7
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-- 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-- 98 (298)
..+.+|...|+.+. +--+.+++.++. ++..|+|||+++|.++.+..... ......+..++...|..||+.
T Consensus 64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~ 137 (272)
T 4gkh_A 64 NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPV 137 (272)
T ss_dssp HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCG
T ss_pred hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCc
Confidence 35668999888885 323566777774 45789999999999988765431 112234555666666666632
Q ss_pred --------------------------------------------------------CCeeecCCCCCEEEcCCCCceEEe
Q 022347 99 --------------------------------------------------------GIIHRDLKPDNLLLTPDQKSLKLA 122 (298)
Q Consensus 99 --------------------------------------------------------givH~dik~~Nil~~~~~~~~~l~ 122 (298)
.++|||+++.||+++. ++.+-|+
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~vi 216 (272)
T 4gkh_A 138 CNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCI 216 (272)
T ss_dssp GGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEEC
T ss_pred ccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEE
Confidence 1689999999999984 4456699
Q ss_pred ccCCCc
Q 022347 123 DFGLAR 128 (298)
Q Consensus 123 dfg~~~ 128 (298)
||+.+.
T Consensus 217 Dwe~a~ 222 (272)
T 4gkh_A 217 DVGRVG 222 (272)
T ss_dssp CCTTCE
T ss_pred ECcccc
Confidence 998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=3.1e-05 Score=66.18 Aligned_cols=31 Identities=16% Similarity=0.317 Sum_probs=25.3
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
...++|||+++.||+++ ++..+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~-~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYR-DFQPVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEE-TTEEEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEe-CCcEEEEEcccccc
Confidence 34699999999999998 44457899998763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00084 Score=58.15 Aligned_cols=30 Identities=27% Similarity=0.377 Sum_probs=25.0
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
...++|||+++.||+++.+ .+.++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~--~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH--ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS--CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC--CeEEEeCcccc
Confidence 3579999999999999854 38999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0018 Score=53.85 Aligned_cols=29 Identities=21% Similarity=0.232 Sum_probs=23.4
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.++|+|+.+.||+.+ ++ .+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~~-~~-~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLDT-GE-RMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEEC-SS-CEEECCCTTCEE
T ss_pred eeeccCCCcCCEEEC-CC-CEEEEecccccC
Confidence 489999999999944 43 589999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0022 Score=54.09 Aligned_cols=32 Identities=31% Similarity=0.484 Sum_probs=26.4
Q ss_pred CCCeeecCCCCCEEEcCC---CCceEEeccCCCcc
Q 022347 98 NGIIHRDLKPDNLLLTPD---QKSLKLADFGLARE 129 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~---~~~~~l~dfg~~~~ 129 (298)
..++|||+++.||+++.+ .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999853 14689999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0053 Score=52.76 Aligned_cols=102 Identities=18% Similarity=0.295 Sum_probs=60.9
Q ss_pred HHHHHHHHHHhCCCCc-ccceeceeecCceeEEEecCCCCCHHH--------------HHhh-h-C----CCCCC--HHH
Q 022347 24 RFIREVNMMSRVKHDN-LVKFLGACKDPLMVIVTELLPGMSLRK--------------YLVS-L-R----PNKLD--LHV 80 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~-Iv~~~~~~~~~~~~lv~e~~~~~sL~~--------------~l~~-~-~----~~~~~--~~~ 80 (298)
.+.+|..+++.+.--+ ..++++.+.++ +||||++|.+|.. .+.. + . .+... +..
T Consensus 99 ~~~rE~~vl~~L~~~gv~P~ll~~~~~g---~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~ 175 (379)
T 3feg_A 99 SLVLESVMFAILAERSLGPQLYGVFPEG---RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGT 175 (379)
T ss_dssp HHHHHHHHHHHHHHTTSSCCEEEEETTE---EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEcCCc---cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHH
Confidence 3447888888775222 35566666543 9999999866531 1111 0 1 11122 345
Q ss_pred HHHHHHHHHH-------------------HHHHH----HhC----CCeeecCCCCCEEEcCC---CCceEEeccCCCc
Q 022347 81 ALNFALDIAR-------------------AMDCL----HAN----GIIHRDLKPDNLLLTPD---QKSLKLADFGLAR 128 (298)
Q Consensus 81 ~~~i~~qi~~-------------------al~~L----H~~----givH~dik~~Nil~~~~---~~~~~l~dfg~~~ 128 (298)
+.++..++-. .+..| ... .++|+|+.+.||+++.+ .+.+.++||..+.
T Consensus 176 i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 176 MERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 5555544422 12333 222 59999999999999865 2468999999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.95 E-value=0.0098 Score=49.99 Aligned_cols=30 Identities=20% Similarity=0.343 Sum_probs=25.2
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
.+++|||+++.||+++.+ +.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-CcEEEEehhhcc
Confidence 579999999999999744 458999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.018 Score=47.96 Aligned_cols=42 Identities=14% Similarity=0.102 Sum_probs=31.6
Q ss_pred HHHHHHHHHHHhCC---CCcccceeceee-cCceeEEEecCCCCCH
Q 022347 23 GRFIREVNMMSRVK---HDNLVKFLGACK-DPLMVIVTELLPGMSL 64 (298)
Q Consensus 23 ~~~~~E~~~l~~l~---hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL 64 (298)
..+..|...|+.+. ...+++++.+.. ++..++||||++|.++
T Consensus 73 ~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 73 SMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 45778888888874 356777877764 4568999999999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.014 Score=50.85 Aligned_cols=32 Identities=25% Similarity=0.402 Sum_probs=27.2
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
+...++|||+++.||+++.++ +.|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC--EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC--CEEEeCccccc
Confidence 456899999999999998543 99999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=93.71 E-value=0.15 Score=41.66 Aligned_cols=24 Identities=33% Similarity=0.313 Sum_probs=19.4
Q ss_pred CCeeecCCCCCEEEcCCCCceEEecc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADF 124 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~df 124 (298)
.++|||+++.|++++.++ ..++|.
T Consensus 189 ~LvHGDlw~gNvl~~~~g--~~~iDp 212 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDDG--AVVIDP 212 (288)
T ss_dssp EEECSCCSGGGEEEETTE--EEECSC
T ss_pred eeeecCCCCCcEEEcCCC--eEEEec
Confidence 599999999999999654 456664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.37 E-value=0.064 Score=44.73 Aligned_cols=29 Identities=28% Similarity=0.312 Sum_probs=24.5
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
..++|||+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 4589999999999998 4 589999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.24 E-value=0.037 Score=46.06 Aligned_cols=30 Identities=40% Similarity=0.546 Sum_probs=24.2
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
.+++|||+++.||+++.+ ..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCC-ceEEEecchhcc
Confidence 369999999999999843 335799998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.90 E-value=0.13 Score=43.26 Aligned_cols=31 Identities=19% Similarity=0.334 Sum_probs=25.4
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 98 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
..++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 369999999999999844 3589999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.97 E-value=0.13 Score=43.84 Aligned_cols=28 Identities=32% Similarity=0.528 Sum_probs=23.6
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
+++|+|+++.||+++.+ .+.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~--~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK--CLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC---CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCC--cEEEEEecCCC
Confidence 59999999999999743 38999998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=89.11 E-value=0.14 Score=44.61 Aligned_cols=38 Identities=18% Similarity=0.348 Sum_probs=24.4
Q ss_pred HHHHHHHHHHhCCCCcc-cceeceeecCceeEEEecCCCCCH
Q 022347 24 RFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELLPGMSL 64 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~I-v~~~~~~~~~~~~lv~e~~~~~sL 64 (298)
.+.+|..+++.+...++ .++++.+.++ +|+||++|.++
T Consensus 121 ~li~E~~~l~~L~~~g~~P~l~~~~~~g---~v~e~l~G~~l 159 (429)
T 1nw1_A 121 HLVAESVIFTLLSERHLGPKLYGIFSGG---RLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETTE---EEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCcEEEEeCCC---EEEEEeCCccc
Confidence 34468888887753334 5566655432 89999987443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=88.86 E-value=0.33 Score=42.71 Aligned_cols=36 Identities=19% Similarity=0.246 Sum_probs=24.7
Q ss_pred HHHHHHHHhCCCCcc-cceeceeecCceeEEEecCCCCCH
Q 022347 26 IREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELLPGMSL 64 (298)
Q Consensus 26 ~~E~~~l~~l~hp~I-v~~~~~~~~~~~~lv~e~~~~~sL 64 (298)
.+|..++..+...++ .++++.+.+ .+|+||++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~~---G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFTN---GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEETT---EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeCC---eEEEEeeCCccC
Confidence 378888888875555 456666643 259999988544
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.68 E-value=1.2 Score=34.61 Aligned_cols=115 Identities=12% Similarity=0.115 Sum_probs=72.9
Q ss_pred CCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCC
Q 022347 36 KHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 115 (298)
Q Consensus 36 ~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~ 115 (298)
.||+.++.--.-.++.+.+.++.-+ +...|-.- ...+....++++.+|+....+++ .-+|--++|+|++++.+
T Consensus 43 ~~~~Fl~~~I~e~eD~v~~~y~~~~--~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDAELTELRDSFQIHYDIND--NHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCEEEEECSSEEEEEECCCT--TSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTT
T ss_pred cCCcccceEEEEcccEEEEEEEcCc--ccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCC
Confidence 5788887732223444444455432 23332222 34788999999999999885443 45888999999999965
Q ss_pred CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHH-HHHHHHHHHHhCCCCCC
Q 022347 116 QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY-SFGIVLWELLTNRLPFE 188 (298)
Q Consensus 116 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~-slG~il~~ll~g~~p~~ 188 (298)
. .+++.-.|+... ++|.- .+ ..|.| .+=|++..++.++..|+
T Consensus 116 ~-~p~i~~RGik~~----------------l~P~~-------------~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 116 G-LPIAKTRGLQNV----------------VDPLP-------------VS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp S-CEEESCCEETTT----------------BSCCC-------------CC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred C-CEEEEEccCccC----------------CCCCC-------------CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 4 577776554311 23321 12 33444 58888999999988875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.98 E-value=0.35 Score=41.66 Aligned_cols=30 Identities=30% Similarity=0.490 Sum_probs=24.5
Q ss_pred CeeecCCCCCEEEcC-----CCCceEEeccCCCcc
Q 022347 100 IIHRDLKPDNLLLTP-----DQKSLKLADFGLARE 129 (298)
Q Consensus 100 ivH~dik~~Nil~~~-----~~~~~~l~dfg~~~~ 129 (298)
++|+|+.+.||++.. +...+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 789999999999942 345699999998853
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.60 E-value=1.6 Score=33.97 Aligned_cols=113 Identities=10% Similarity=0.134 Sum_probs=72.4
Q ss_pred CCCcccceeceeecCceeEEEecCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCeeecCCCCCEEEc
Q 022347 36 KHDNLVKFLGACKDPLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMD-CLHANGIIHRDLKPDNLLLT 113 (298)
Q Consensus 36 ~hp~Iv~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~-~LH~~givH~dik~~Nil~~ 113 (298)
.||+. +.--...++.+.+.++.-++ -++.. + ..++....++++.+|+.... ++ ..-+|--++|+|++++
T Consensus 48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~-i-----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAA-I-----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-EEEEEECSSEEEEEEECCTTCEEHHH-H-----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHH-H-----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 57777 33322344555566665433 34443 3 23788999999999888665 44 4468889999999999
Q ss_pred CCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHH-HHHHHHHHHHhCCCCCC
Q 022347 114 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY-SFGIVLWELLTNRLPFE 188 (298)
Q Consensus 114 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~-slG~il~~ll~g~~p~~ 188 (298)
.+ +.+++.-.|+. .-++|.-+ + ..|.| .+=|++..++.++..|+
T Consensus 119 ~~-~~p~i~hRGi~----------------~~lpP~e~-------------~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 119 RA-LEPFFLHVGVK----------------ESLPPDEW-------------D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp TT-CCEEESCCEET----------------TTBSSCSC-------------C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CC-CcEEEEEcCCc----------------ccCCCCCC-------------C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 55 45887766643 22344322 1 34554 57888888888887764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 298 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-70
Identities = 69/232 (29%), Positives = 117/232 (50%), Gaps = 14/232 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
F EV ++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++
Sbjct: 50 AFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLID 108
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAET 140
A A+ MD LHA IIHRDLK +N+ L D ++K+ DFGLA + + +
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
G+ WMAPE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N
Sbjct: 168 GSILWMAPEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
Query: 201 FKHAR----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248
+ + + + ++ C + + RP F QI+ + +L
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-62
Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 17/240 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY 67
L +GS S + F+ E N+M +++H LV+ + I+TE + SL +
Sbjct: 44 SLKQGSMSPDA------FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDF 97
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
L + KL ++ L+ A IA M + IHRDL+ N+L+ D S K+ADFGLA
Sbjct: 98 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV-SDTLSCKIADFGLA 156
Query: 128 R--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
R E+ +W APE + + K DV+SFGI+L E++T+
Sbjct: 157 RLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGR 208
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ R P++ +L +++ CW E P RP+F + +L F
Sbjct: 209 IPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-62
Identities = 68/243 (27%), Positives = 116/243 (47%), Gaps = 24/243 (9%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-----MVIVTELL 59
E+ +R T ER RF E M+ ++H N+V+F + + + +V+VTEL+
Sbjct: 39 WCELQDRKLTKSERQ----RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94
Query: 60 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK 117
+L+ YL R + + V ++ I + + LH IIHRDLK DN+ +T
Sbjct: 95 TSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 152
Query: 118 SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
S+K+ D GLA + A GT +MAPE+Y ++ Y+ VDVY+FG+ +
Sbjct: 153 SVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY---------EEKYDESVDVYAFGMCM 202
Query: 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
E+ T+ P+ N Y +P + P++ I++ C ++ + R S
Sbjct: 203 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 262
Query: 237 IIR 239
++
Sbjct: 263 LLN 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-62
Identities = 56/246 (22%), Positives = 116/246 (47%), Gaps = 20/246 (8%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY 67
VL +G+ + +RE +M ++ + +V+ +G C+ +++V E+ G L K+
Sbjct: 43 VLKQGTEKADTE----EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKF 98
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
LV + ++ + ++ M L +HRDL N+LL K++DFGL+
Sbjct: 99 LVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLS 156
Query: 128 R----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
+ +++ +A +W APE + + ++++ DV+S+G+ +WE L+
Sbjct: 157 KALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSY 208
Query: 184 -RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
+ P++ M + A + R P + P+L ++ CW+ RP F + + +
Sbjct: 209 GQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
Query: 243 AFLFTL 248
A ++L
Sbjct: 268 ACYYSL 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-61
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 13/220 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
F+ E ++M++++H NLV+ LG + + IVTE + SL YL S + L
Sbjct: 46 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 105
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 141
L F+LD+ AM+ L N +HRDL N+L++ D K++DFGL +E +
Sbjct: 106 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKE--ASSTQDTGKL 162
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
+W APE K ++ K DV+SFGI+LWE+ + L+
Sbjct: 163 PVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
K + P+ P + ++++CW D +RPSF Q+ L
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 7e-60
Identities = 54/233 (23%), Positives = 106/233 (45%), Gaps = 17/233 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
VL + +E + REV + S ++H N+++ G D + ++ E P ++ +
Sbjct: 38 VLFKAQLEKAG--VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
L + +K D + ++A A+ H+ +IHRD+KP+NLLL LK+ADFG
Sbjct: 96 ELQ--KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGW 152
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
+ + T GT ++ PE+ + ++ KVD++S G++ +E L + P
Sbjct: 153 SVHAPSSRRTT-LCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPP 203
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
FE + + P+ ++ ++ +P+ RP +++
Sbjct: 204 FEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-59
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 8/219 (3%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
++ E+++++ H N+VK L A + I+ E G ++ ++ L L
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQ 113
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETG 141
A++ LH N IIHRDLK N+L T D +KLADFG++ + T T + + G
Sbjct: 114 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIG 172
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AA 200
T WMAPE+ T + + Y+ K DV+S GI L E+ P ++ ++ A
Sbjct: 173 TPYWMAPEVVMCETSKD---RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ P S + ++ C ++ + R + SQ+++
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 5e-59
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 17/228 (7%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+ E N+M ++ + +V+ +G C+ ++V E+ L KYL R + +
Sbjct: 54 ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIE 111
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAE 139
++ M L + +HRDL N+LL K++DFGL++ +E + T
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHG 170
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 198
+W APE + +++K DV+SFG+++WE + + P+ GM + A
Sbjct: 171 KWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTA 221
Query: 199 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246
K R G P ++ ++ CW D RP F+ + L + +
Sbjct: 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 1e-58
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 17/253 (6%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMS 63
+K++ G S+E+ I+EV + +++H N +++ G +V E G +
Sbjct: 45 IKKMSYSGKQSNEK---WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
V +P L + + LH++ +IHRD+K N+LL+ +KL D
Sbjct: 102 SDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGD 158
Query: 124 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
FG A GT WMAPE+ + ++ Y+ KVDV+S GI EL
Sbjct: 159 FGSASIMAPANSFV---GTPYWMAPEV-----ILAMDEGQYDGKVDVWSLGITCIELAER 210
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243
+ P M+ + A Y A + S V SC + P RP+ +++ +
Sbjct: 211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HR 268
Query: 244 FLFTLRPPSPSVP 256
F+ RPP+ +
Sbjct: 269 FVLRERPPTVIMD 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-58
Identities = 72/239 (30%), Positives = 103/239 (43%), Gaps = 17/239 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY 67
L S A+ FIREVN M + H NL++ G P M +VTEL P SL
Sbjct: 43 CLKPDVLSQPEAM--DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR 100
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
L L +A+ +A M L + IHRDL NLLL +K+ DFGL
Sbjct: 101 LRK-HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLM 158
Query: 128 R----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
R + M + W APE T + +++ D + FG+ LWE+ T
Sbjct: 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTY 210
Query: 184 -RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
+ P+ G++ Q + + R PED D+ ++ CW P RP+F + L
Sbjct: 211 GQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 7e-58
Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 25/246 (10%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LMVIVTELLPG 61
KE+ T E+ + EVN++ +KH N+V++ D + IV E G
Sbjct: 34 WKELDYGSMTEAEKQ----MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89
Query: 62 MSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH-----ANGIIHRDLKPDNLLLTP 114
L + + LD L + A+ H + ++HRDLKP N+ L
Sbjct: 90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149
Query: 115 DQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173
Q ++KL DFGLAR T A GT +M+PE + YN K D++S
Sbjct: 150 KQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDIWSL 200
Query: 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
G +L+EL PF S + + +P S +L I+ RPS
Sbjct: 201 GCLLYELCALMPPFTAFSQKE-LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 259
Query: 234 FSQIIR 239
+I+
Sbjct: 260 VEEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-57
Identities = 64/246 (26%), Positives = 102/246 (41%), Gaps = 17/246 (6%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY 67
L G+ S E F++E +M +++H+ LV+ + + IVTE + SL +
Sbjct: 48 TLKPGTMSPEA------FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDF 101
Query: 68 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 127
L L L ++ A IA M + +HRDL+ N+L+ + K+ADFGLA
Sbjct: 102 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLA 160
Query: 128 R--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
R E+ +W APE + K DV+SFGI+L EL T
Sbjct: 161 RLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGR 212
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ + R P + L ++ CW ++P RP+F + L +
Sbjct: 213 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
Query: 246 FTLRPP 251
+ P
Sbjct: 273 TSTEPQ 278
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 8e-57
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 12/224 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
+F++E M + H ++VK +G + + I+ EL LR +L R LDL +
Sbjct: 54 KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLIL 112
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETG 141
+A ++ A+ L + +HRD+ N+L++ +KL DFGL+R E++ +
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
+WMAPE + + + + DV+ FG+ +WE+L + +
Sbjct: 172 PIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223
Query: 202 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
R +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-56
Identities = 61/238 (25%), Positives = 109/238 (45%), Gaps = 21/238 (8%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
++ GS S++ FI E +M + H+ LV+ G C + I+TE + L
Sbjct: 35 MIKEGSMSEDE------FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
YL ++ L D+ AM+ L + +HRDL N L+ +K++DFGL
Sbjct: 89 YLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGL 146
Query: 127 ARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN- 183
+R + RW PE+ +++K D+++FG+++WE+ +
Sbjct: 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLG 198
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
++P+E +N + A A + R P S + I+ SCW E + RP+F ++ +
Sbjct: 199 KMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-56
Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 40/270 (14%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELLP 60
+ ++L + S ER + E+ MM+++ H+N+V LGAC + ++ E
Sbjct: 69 QVAVKMLKEKADSSERE----ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 61 GMSLRKYLVSLRP---------------------NKLDLHVALNFALDIARAMDCLHANG 99
L YL S R N L L FA +A+ M+ L
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184
Query: 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTL 156
+HRDL N+L+T K +K+ DFGLAR ++ + +WMAPE
Sbjct: 185 CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--- 240
Query: 157 RQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 215
Y K DV+S+GI+LWE+ + P+ G+ Y + P + +
Sbjct: 241 -----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEE 295
Query: 216 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ I+QSCW D RPSF + L L
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-56
Identities = 68/236 (28%), Positives = 108/236 (45%), Gaps = 17/236 (7%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
I E+ +M K+ N+V +L + + +V E L G SL + +D
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIA 119
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETG 141
+ +A++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + G
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T WMAPE+ + K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 179 TPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
Query: 202 KHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
PE +S + C D R S ++++ + FL +P S P
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (455), Expect = 1e-55
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 12/225 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
F++E +M +KH NLV+ LG C ++P I+TE + +L YL ++ V L
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAET 140
A I+ AM+ L IHRDL N L+ + +K+ADFGL+R
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 141 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 200
+W APE + ++ K DV++FG++LWE+ T + +L Y
Sbjct: 178 FPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
Query: 201 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
K R PE + ++++CW +P+ RPSF++I +
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-55
Identities = 66/245 (26%), Positives = 106/245 (43%), Gaps = 21/245 (8%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLR 65
LNR + E + +F+ E +M H N++ LG C + ++V + LR
Sbjct: 62 SLNRITDIGEVS----QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
++ + + + + F L +A+ M L + +HRDL N +L +K+ADFG
Sbjct: 118 NFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFG 175
Query: 126 LAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
LAR E T +WMA E T + + K DV+SFG++LWEL
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWEL 227
Query: 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240
+T P N + R PE L ++ CW +RPSFS+++
Sbjct: 228 MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 241 LNAFL 245
++A
Sbjct: 288 ISAIF 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 8e-55
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 13/229 (5%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPN 74
E A+ E FI E +M ++ H LV+ G C + + +V E + L YL + +
Sbjct: 38 REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRG 96
Query: 75 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETV 132
L LD+ M L +IHRDL N L+ + + +K++DFG+ R +
Sbjct: 97 LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ 155
Query: 133 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 192
T +W +PE++S Y++K DV+SFG+++WE+ + +
Sbjct: 156 YTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 193 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 241
R P S + I+ CW E P RP+FS+++R L
Sbjct: 208 NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 176 bits (446), Expect = 2e-54
Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 9/241 (3%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDPLMV-IVTELLP 60
K + +++E L ++EV+++ +V H N+++ + +V +L+
Sbjct: 34 KIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK 93
Query: 61 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 120
L YL L + + LH I+HRDLKP+N+LL D +K
Sbjct: 94 KGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IK 150
Query: 121 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
L DFG + + E + GT ++APE+ Y +VD++S G++++ L
Sbjct: 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE--CSMNDNHPGYGKEVDMWSTGVIMYTL 208
Query: 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQII 238
L PF + + + G PE D S + +V V P R + + +
Sbjct: 209 LAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
Query: 239 R 239
Sbjct: 269 A 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 2e-54
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 13/220 (5%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+E+ MS ++H LV A +D MV++ E + G L + + NK+ A+
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAV 127
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETG 141
+ + + + +H N +H DLKP+N++ T + + LKL DFGL + + TG
Sbjct: 128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--A 199
T + APE+ K D++S G++ + LL+ PF G ++ + +
Sbjct: 188 TAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239
Query: 200 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ IS D ++ + DPN R + Q +
Sbjct: 240 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-54
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+E+ + + H+N+VKF G ++ + + E G L + + A
Sbjct: 49 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQ 106
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAE 139
F + + LH GI HRD+KP+NLLL +LK++DFGLA ++
Sbjct: 107 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKM 165
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
GT ++APEL ++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 166 CGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218
Query: 200 A-FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
K + I ++ VE+P+ R + I +
Sbjct: 219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 7e-54
Identities = 48/236 (20%), Positives = 102/236 (43%), Gaps = 18/236 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
+N D+ E+++M+++ H L+ A +D MV++ E L G L
Sbjct: 61 FINTPYPLDKY-----TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFG 125
+ + K+ +N+ + +H + I+H D+KP+N++ + S+K+ DFG
Sbjct: 116 RIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174
Query: 126 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
LA + E++ T T + APE+ +++ D+++ G++ + LL+
Sbjct: 175 LATKLNPDEIVKVTTATAEFAAPEIV--------DREPVGFYTDMWAIGVLGYVLLSGLS 226
Query: 186 PFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
PF G +L+ +SP+ +++ ++P R + +
Sbjct: 227 PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 1e-52
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 23/246 (9%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
L G T +R F+ E ++M + H N++ G ++I+TE + SL
Sbjct: 61 TLKSGYTEKQRR----DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L + + + IA M L +HRDL N+L+ + K++DFGL
Sbjct: 117 FLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGL 174
Query: 127 AR------EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+R + RW APE + + + DV+S+GIV+WE+
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYGIVMWEV 226
Query: 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
++ P+ M+N Q A + R P D L ++ CW +D N RP F QI+
Sbjct: 227 MSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 240 MLNAFL 245
L+ +
Sbjct: 286 TLDKMI 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-52
Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 19/243 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
L G T +R F+ E +M + H N+++ G M+I+TE + +L K
Sbjct: 43 TLKAGYTEKQRV----DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 98
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L + + + + IA M L +HRDL N+L+ + K++DFGL
Sbjct: 99 FLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGL 156
Query: 127 AR----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
+R + T + RW APE S + + + DV+SFGIV+WE++T
Sbjct: 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMT 208
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242
+ A R P D + ++ CW ++ RP F+ I+ +L+
Sbjct: 209 YGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
Query: 243 AFL 245
+
Sbjct: 269 KLI 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-52
Identities = 39/222 (17%), Positives = 101/222 (45%), Gaps = 13/222 (5%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
+ +E+++++ +H N++ + + +V++ E + G+ + + + + +L+
Sbjct: 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNERE 103
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAE 139
+++ + A+ LH++ I H D++P+N++ + S +K+ +FG AR+ +
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
+ APE++ + + D++S G +++ LL+ PF +N Q
Sbjct: 164 FTAPEYYAPEVH--------QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 200 AFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
++IS + V V++ R + S+ ++
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-52
Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 32/258 (12%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGM 62
+K + S D R F E+ ++ ++ H N++ LGAC+ + + E P
Sbjct: 42 IKRMKEYASKDDHR-----DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 96
Query: 63 SLRKYL--------------VSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 108
+L +L + + L L+FA D+AR MD L IHRDL
Sbjct: 97 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156
Query: 109 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168
N+L+ + K+ADFGL+R + V T RWMA E + Y
Sbjct: 157 NILVGENYV-AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNS 207
Query: 169 DVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVED 227
DV+S+G++LWE+++ P+ GM Y + R P + ++ +++ CW E
Sbjct: 208 DVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREK 266
Query: 228 PNLRPSFSQIIRMLNAFL 245
P RPSF+QI+ LN L
Sbjct: 267 PYERPSFAQILVSLNRML 284
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-52
Identities = 58/247 (23%), Positives = 109/247 (44%), Gaps = 19/247 (7%)
Query: 3 KFMKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGM 62
+ L ++ + E +M+ V + ++ + LG C + ++T+L+P
Sbjct: 40 PVAIKELREATSPKANK----EILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFG 95
Query: 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 122
L Y+ + + LN+ + IA+ M+ L ++HRDL N+L+ + +K+
Sbjct: 96 CLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKIT 153
Query: 123 DFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
DFGLA+ E +WMA E + Y ++ DV+S+G+ +WE
Sbjct: 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWE 205
Query: 180 LLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
L+T P++G+ + K R P + D+ I+ CW+ D + RP F ++I
Sbjct: 206 LMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264
Query: 239 RMLNAFL 245
+
Sbjct: 265 IEFSKMA 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 2e-51
Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 41/261 (15%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
+L +++D +A F RE +M+ + N+VK LG C M ++ E + L +
Sbjct: 50 MLKEEASADMQA----DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 105
Query: 67 YLVSLRPN----------------------KLDLHVALNFALDIARAMDCLHANGIIHRD 104
+L S+ P+ L L A +A M L +HRD
Sbjct: 106 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165
Query: 105 LKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 161
L N L+ + +K+ADFGL+R + + RWM PE
Sbjct: 166 LATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------- 216
Query: 162 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 220
Y + DV+++G+VLWE+ + P+ GM++ + Y PE+ +L ++
Sbjct: 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLM 275
Query: 221 QSCWVEDPNLRPSFSQIIRML 241
+ CW + P RPSF I R+L
Sbjct: 276 RLCWSKLPADRPSFCSIHRIL 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-51
Identities = 51/260 (19%), Positives = 95/260 (36%), Gaps = 56/260 (21%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ IRE+ ++ +V F GA + I E + G SL + L + ++ +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 107
Query: 83 NFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 141
++ + + + L + I+HRD+KP N+L+ + +KL DFG++ + + M + G
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQ-LIDSMANSFVG 165
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--------- 192
T +M+PE HY+ + D++S G+ L E+ R P
Sbjct: 166 TRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 193 --------------------------------LQAAYAAAFKHARPGLPED-ISPDLAFI 219
+ P LP S +
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 220 VQSCWVEDPNLRPSFSQIIR 239
V C +++P R Q++
Sbjct: 278 VNKCLIKNPAERADLKQLMV 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 4e-51
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 19/234 (8%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
+L + E + RE ++MSR+ H VK +D + L K
Sbjct: 40 ILEKRHIIKENKVP--YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
Y+ + D + +I A++ LH GIIHRDLKP+N+LL D +++ DFG
Sbjct: 98 YIR--KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGT 154
Query: 127 AR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
A+ E+ + GT ++++PEL + K D+++ G ++++L+
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAG 206
Query: 184 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
PF + PE P +V+ V D R ++
Sbjct: 207 LPPFRAGNEYLIFQ--KIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-50
Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 35/256 (13%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVIVTELLPGMSLR 65
+L + ER + E+ ++S + H N+V LGAC +++TE L
Sbjct: 60 MLKPSAHLTERE----ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 66 KYLVSLRPN----------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 109
+L R + LDL L+F+ +A+ M L + IHRDL N
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175
Query: 110 LLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 166
+LLT + + K+ DFGLAR ++ + +WMAPE Y
Sbjct: 176 ILLTHGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTF 226
Query: 167 KVDVYSFGIVLWELLTNRLP-FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 225
+ DV+S+GI LWEL + + GM Y + R PE ++ I+++CW
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
Query: 226 EDPNLRPSFSQIIRML 241
DP RP+F QI++++
Sbjct: 287 ADPLKRPTFKQIVQLI 302
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-49
Identities = 69/247 (27%), Positives = 112/247 (45%), Gaps = 27/247 (10%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRK 66
+N ++ ER F+ E ++M ++V+ LG + +++ EL+ L+
Sbjct: 57 TVNEAASMRERI----EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 112
Query: 67 YLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 118
YL SLRP L + A +IA M L+AN +HRDL N ++ D +
Sbjct: 113 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FT 171
Query: 119 LKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175
+K+ DFG+ R E RWM+PE + DV+SFG+
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGV 223
Query: 176 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 234
VLWE+ T P++G+SN Q + P++ L +++ CW +P +RPSF
Sbjct: 224 VLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282
Query: 235 SQIIRML 241
+II +
Sbjct: 283 LEIISSI 289
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 2e-49
Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 15/223 (6%)
Query: 22 EGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHV 80
EG E+ ++ ++KH N+V + + ++ +L+ G L +V
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERD 108
Query: 81 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLAREETVTEMMTA 138
A + A+ LH GI+HRDLKP+NLL + + ++DFGL++ E +++
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 168
Query: 139 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 198
GT ++APE+ + K Y+ VD +S G++ + LL PF ++ +
Sbjct: 169 ACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
Query: 199 AAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
P +DIS ++ +DP R + Q ++
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-49
Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 22/230 (9%)
Query: 24 RFIREVNMMSRV-KHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLD 77
+ REV + R + ++V+ + ++ ++IV E L G L +
Sbjct: 50 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 109
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREETVTEM 135
A I A+ LH+ I HRD+KP+NLL T LKL DFG A+E T
Sbjct: 110 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
Query: 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
+T T ++APE+ + Y+ D++S G++++ LL PF L
Sbjct: 170 LTTPCYTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
Query: 196 AYA--AAFKHARPGLPE----DISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ + + P ++S ++ ++++ +P R + ++ +
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 9e-49
Identities = 49/238 (20%), Positives = 98/238 (41%), Gaps = 20/238 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVK--HDNLVKFLGACKDP-LMVIVTELLPG 61
+K V + R EV ++ +V +++ L + P V++ E
Sbjct: 34 IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 93
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
+ ++ L +A +F + A+ H G++HRD+K +N+L+ ++ LKL
Sbjct: 94 VQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 152
Query: 122 ADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
DFG T + T GT + PE +++ V+S GI+L++++
Sbjct: 153 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMV 204
Query: 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+PFE + + + +S + +++ C P+ RP+F +I
Sbjct: 205 CGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-48
Identities = 55/265 (20%), Positives = 98/265 (36%), Gaps = 44/265 (16%)
Query: 16 DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVS 70
R E+ ++H+N++ F+ A + +V++ SL YL
Sbjct: 35 SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-- 92
Query: 71 LRPNKLDLHVALNFALDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLA 122
+ + + AL A + LH I HRDLK N+L+ + + +A
Sbjct: 93 -NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA 150
Query: 123 DFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177
D GLA +T+ GT R+MAPE+ + + + D+Y+ G+V
Sbjct: 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE--SFKRADIYAMGLVF 208
Query: 178 WELLTNRLPFEGMSNLQAAY---------------AAAFKHARPGLPE-----DISPDLA 217
WE+ + Q Y + RP +P + +A
Sbjct: 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268
Query: 218 FIVQSCWVEDPNLRPSFSQIIRMLN 242
I++ CW + R + +I + L+
Sbjct: 269 KIMRECWYANGAARLTALRIKKTLS 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-48
Identities = 53/241 (21%), Positives = 100/241 (41%), Gaps = 16/241 (6%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMS 63
K + R + S R + REV+++ ++H N++ ++ ++++ EL+ G
Sbjct: 40 AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE 99
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD---QKSLK 120
L +L L A F I + LH+ I H DLKP+N++L + +K
Sbjct: 100 LFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157
Query: 121 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180
+ DFGLA + GT ++APE+ + + D++S G++ + L
Sbjct: 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--------NYEPLGLEADMWSIGVITYIL 209
Query: 181 LTNRLPFEGMSNLQAAYA--AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 238
L+ PF G + + A + S ++ V+DP R + +
Sbjct: 210 LSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 239 R 239
+
Sbjct: 270 Q 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-47
Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 32/257 (12%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDPLMV-IVTELLPGMSLR 65
+L +T + + I E+ MM + KH N++ LGAC + ++ E +LR
Sbjct: 52 MLKSDATEKDLS----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 66 KYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 111
+YL + RP +L ++ A +AR M+ L + IHRDL N+L
Sbjct: 108 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167
Query: 112 LTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168
+T D K+ADFGLAR + T +WMAPE + Y ++
Sbjct: 168 VTEDNVM-KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQS 218
Query: 169 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 228
DV+SFG++LWE+ T ++ + + R P + + +L +++ CW P
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 278
Query: 229 NLRPSFSQIIRMLNAFL 245
+ RP+F Q++ L+ +
Sbjct: 279 SQRPTFKQLVEDLDRIV 295
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (397), Expect = 4e-47
Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 22/242 (9%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGM 62
VL D L RF RE + + H +V + PL IV E + G+
Sbjct: 39 VLRADLARDPSFYL--RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96
Query: 63 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SL 119
+LR + + A+ D +A++ H NGIIHRD+KP N++++
Sbjct: 97 TLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 154
Query: 120 KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179
+A A GT ++++PE + + DVYS G VL+E
Sbjct: 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYE 206
Query: 180 LLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 237
+LT PF G S + AY + P E +S DL +V ++P R +
Sbjct: 207 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 266
Query: 238 IR 239
+R
Sbjct: 267 MR 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-47
Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 17/237 (7%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMS 63
+K + D+ +E + + + +H L + + V E L G
Sbjct: 32 IKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 89
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L ++ +K DL A +A +I + LH+ GI++RDLK DN+LL D K+AD
Sbjct: 90 LMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI-KIAD 146
Query: 124 FGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
FG+ +E GT ++APE+ + YN+ VD +SFG++L+E+L
Sbjct: 147 FGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLI 198
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ PF G + + + + P P + + ++ +V +P R IR
Sbjct: 199 GQSPFHGQDEEELFH--SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 3e-45
Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 34/259 (13%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDP--LMVIVTELLPGMSL 64
+L G+T E + E+ ++ + H N+V LGAC P ++++ E +L
Sbjct: 50 MLKEGATHSEHR----ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 105
Query: 65 RKYLVS--------------LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 110
YL S L + L L + ++ +A+ M+ L + IHRDL N+
Sbjct: 106 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165
Query: 111 LLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 167
LL+ +K+ DFGLAR ++ +WMAPE + Y +
Sbjct: 166 LLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQ 216
Query: 168 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVE 226
DV+SFG++LWE+ + P+ G+ + + R P+ +P++ + CW
Sbjct: 217 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 276
Query: 227 DPNLRPSFSQIIRMLNAFL 245
+P+ RP+FS+++ L L
Sbjct: 277 EPSQRPTFSELVEHLGNLL 295
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 4e-45
Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 18/230 (7%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
VL + + + E M+S V H +++ G +D + ++ + + G L
Sbjct: 36 VLKKEIVVRLKQV--EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
L + + VA +A ++ A++ LH+ II+RDLKP+N+LL + +K+ DFG
Sbjct: 94 LLR--KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGF 150
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ V ++ GT ++APE+ ST K YN +D +SFGI+++E+L P
Sbjct: 151 AKY--VPDVTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTP 200
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
F + ++ +A P + D+ ++ D + R Q
Sbjct: 201 FYDSNTMKTYE--KILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ 248
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (383), Expect = 5e-44
Identities = 58/273 (21%), Positives = 106/273 (38%), Gaps = 24/273 (8%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMS 63
MK + + + L ++++S +V A P + + +L+ G
Sbjct: 34 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 93
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L +L +A +I ++ +H +++RDLKP N+LL + ++++D
Sbjct: 94 LHYHLSQHGVFSEAD--MRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISD 150
Query: 124 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
GLA + + A GT+ +MAPE+ Y++ D +S G +L++LL
Sbjct: 151 LGLAC-DFSKKKPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRG 202
Query: 184 RLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI----- 237
PF + LP+ SP+L +++ D N R
Sbjct: 203 HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262
Query: 238 -----IRMLN-AFLFTLRPPSPSVPESDTNEAA 264
R L+ +F + P P +P AA
Sbjct: 263 KESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAA 295
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 2e-42
Identities = 44/243 (18%), Positives = 83/243 (34%), Gaps = 28/243 (11%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 81
+ E + ++ + + C + V+V ELL + K L
Sbjct: 48 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTV 105
Query: 82 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL--ADFGLAR--------EET 131
L A + ++ +H+ IHRD+KPDN L+ +K + DFGLA+ +
Sbjct: 106 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165
Query: 132 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 191
TGT R+ + + + + D+ S G VL LP++G+
Sbjct: 166 PYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
Query: 192 NLQAAYAAAFKHAR------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245
+ L + + A + C + +P +S + ++
Sbjct: 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
Query: 246 FTL 248
Sbjct: 278 HRQ 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-41
Identities = 52/231 (22%), Positives = 93/231 (40%), Gaps = 18/231 (7%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMS 63
MK + + + + E ++ +H L A + + V E G
Sbjct: 35 MKILRKEVIIAKDE---VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91
Query: 64 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 123
L +L R A + +I A++ LH+ +++RD+K +NL+L D +K+ D
Sbjct: 92 LFFHLS--RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITD 148
Query: 124 FGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 182
FGL +E + M GT ++APE+ Y VD + G+V++E++
Sbjct: 149 FGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMC 200
Query: 183 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
RLPF + + P +SP+ ++ +DP R
Sbjct: 201 GRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-41
Identities = 60/268 (22%), Positives = 99/268 (36%), Gaps = 44/268 (16%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNK- 75
RE+ +M ++ H N+V+ + +V + +P R R +
Sbjct: 59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 76 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 135
L + + + R++ +H+ GI HRD+KP NLLL PD LKL DFG A++ E
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 136 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 195
+ + + APEL Y + +DV+S G VL ELL + F G S +
Sbjct: 179 NVSYICSRYYRAPELIF-------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
Query: 196 AYA---------------AAFKHARPGLPE------------DISPDLAFIVQSCWVEDP 228
+ P+ P+ + P
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 229 NLRPSFSQIIRMLNAFLFTLRPPSPSVP 256
R + + ++F LR P+ +P
Sbjct: 292 TARLTPLEACA--HSFFDELRDPNVKLP 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 40/275 (14%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRK 66
+ G S+ + + +RE+ ++ + H N++ L A + +V + +
Sbjct: 30 KIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV- 88
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
++ L + L + ++ LH + I+HRDLKP+NLLL + LKLADFGL
Sbjct: 89 -IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGL 146
Query: 127 AREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 185
A+ T + T + APEL + Y VD+++ G +L ELL
Sbjct: 147 AKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVP 199
Query: 186 PFEGMSNLQAAYAAAFKHARPGLPE--------------------------DISPDLAFI 219
G S+L P + DL +
Sbjct: 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
Query: 220 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 254
+Q ++ +P R + +Q ++M + P+P
Sbjct: 260 IQGLFLFNPCARITATQALKM--KYFSNRPGPTPG 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-39
Identities = 54/263 (20%), Positives = 94/263 (35%), Gaps = 41/263 (15%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------LMVIVTELLPG 61
+ + + L R + + + +H N+V+ C + +V E +
Sbjct: 40 RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ 99
Query: 62 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 121
YL + + + + R +D LH++ ++HRDLKP N+L+T +KL
Sbjct: 100 DLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKL 157
Query: 122 ADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181
ADFGLAR + +T+ T + APE+ Y VD++S G + E+
Sbjct: 158 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMF 209
Query: 182 TNRLPFEGMSNLQAAYAAAFKHARPG-------------------------LPEDISPDL 216
+ F G S++ PG DI
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269
Query: 217 AFIVQSCWVEDPNLRPSFSQIIR 239
++ C +P R S +
Sbjct: 270 KDLLLKCLTFNPAKRISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-39
Identities = 60/260 (23%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 83
IRE++++ + H N+VK L + + L+K++ + + L + +
Sbjct: 47 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS 106
Query: 84 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGT 142
+ + + + H++ ++HRDLKP NLL+ + ++KLADFGLAR V T E T
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 143 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA---- 198
+ APE+ K+Y+ VD++S G + E++T R F G S + +
Sbjct: 166 LWYRAPEILL-------GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218
Query: 199 ------------AAFKHARPGLPE-----------DISPDLAFIVQSCWVEDPNLRPSFS 235
+ +P P+ + D ++ DPN R S
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
Query: 236 QIIRMLNAFLFTLRPPSPSV 255
+ F + P P +
Sbjct: 279 AALAH--PFFQDVTKPVPHL 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-39
Identities = 60/254 (23%), Positives = 94/254 (37%), Gaps = 49/254 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDL 78
R +RE+ ++ R +H+N++ + P + V + L G L K L + L
Sbjct: 52 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSN 108
Query: 79 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTE 134
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR + T
Sbjct: 109 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTG 167
Query: 135 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 194
+T T + APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 168 FLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 195 AAYAAAFKHARPG-----------------------------LPEDISPDLAFIVQSCWV 225
P L + ++
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280
Query: 226 EDPNLRPSFSQIIR 239
+P+ R Q +
Sbjct: 281 FNPHKRIEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (342), Expect = 8e-39
Identities = 35/245 (14%), Positives = 76/245 (31%), Gaps = 28/245 (11%)
Query: 24 RFIREVNMMSRVKH-DNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+ E + + ++ L ++ L G SL L K +
Sbjct: 46 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL-CGRKFSVKTVA 104
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLT----PDQKSLKLADFGLAR--------EE 130
A + + +H +++RD+KPDN L+ + + + DFG+ + +
Sbjct: 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 131 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 190
+GT R+M+ + + + + D+ + G V L LP++G+
Sbjct: 165 IPYREKKNLSGTARYMSINTH--------LGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216
Query: 191 SNLQAAYA------AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244
L + + + P + + + +
Sbjct: 217 KAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
Query: 245 LFTLR 249
L L
Sbjct: 277 LERLN 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-38
Identities = 58/235 (24%), Positives = 106/235 (45%), Gaps = 16/235 (6%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKH-DNLVKFLGACKDP-LMVIVTELLPGMSLR 65
VL + + + E E ++ ++ LV A + + ++ + + G L
Sbjct: 59 VLKKATIVQKAKTTE-HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 66 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 125
+L + + H + +I A++ LH GII+RD+K +N+LL + + L DFG
Sbjct: 118 THLS--QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFG 174
Query: 126 LARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 183
L++E TE GT +MAP++ +G ++ VD +S G++++ELLT
Sbjct: 175 LSKEFVADETERAYDFCGTIEYMAPDIV------RGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 184 RLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 236
PF N QA + + P P+++S ++Q ++DP R
Sbjct: 229 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (330), Expect = 4e-37
Identities = 56/245 (22%), Positives = 91/245 (37%), Gaps = 39/245 (15%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
IRE++++ +KH N+VK +V+V E L + V L+ A
Sbjct: 46 TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAK 103
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 142
+F L + + H ++HRDLKP NLL+ + LK+ADFGLAR +
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIV 162
Query: 143 YRW-MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ------- 194
W AP++ K Y+ +D++S G + E++ F G+S
Sbjct: 163 TLWYRAPDVLM-------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
Query: 195 ----------------AAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSF 234
Y F P + + ++ DPN R +
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
Query: 235 SQIIR 239
Q +
Sbjct: 276 KQALE 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (334), Expect = 5e-37
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 23/238 (9%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI-VTELLPGMSLRK 66
+L++ + + + E ++ V LVK + KD + V E + G +
Sbjct: 73 ILDKQKVVKLKQIE--HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 67 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 126
+L R + A +A I + LH+ +I+RDLKP+NLL+ +++ DFG
Sbjct: 131 HLR--RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGF 187
Query: 127 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 186
A+ GT +APE+ + K YN VD ++ G++++E+ P
Sbjct: 188 AKRV--KGRTWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 187 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP-----NLRPSFSQIIR 239
F +Q + P S DL ++++ D NL+ + I
Sbjct: 238 FFADQPIQIYE--KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (324), Expect = 7e-36
Identities = 42/256 (16%), Positives = 89/256 (34%), Gaps = 52/256 (20%)
Query: 24 RFIREVNMMSRVK-HDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLH 79
+ RE+ ++ ++ N++ KDP +V E + ++ L +
Sbjct: 75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDY 129
Query: 80 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 139
+ +I +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA +
Sbjct: 130 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 189
Query: 140 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 199
+ + PEL + + Y+ +D++S G +L ++ + PF +
Sbjct: 190 VASRYFKGPELLV-------DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
Query: 200 AFK------------------------------------HARPGLPEDISPDLAFIVQSC 223
K +SP+ +
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302
Query: 224 WVEDPNLRPSFSQIIR 239
D R + + +
Sbjct: 303 LRYDHQSRLTAREAME 318
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-35
Identities = 55/293 (18%), Positives = 99/293 (33%), Gaps = 60/293 (20%)
Query: 5 MKEVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---------LMVIV 55
+K+VL +RE+ ++ +KH+N+V + C+ + +V
Sbjct: 40 LKKVLMENEKEGFPI----TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95
Query: 56 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 115
+ L K L + + +H N I+HRD+K N+L+T D
Sbjct: 96 FDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD 153
Query: 116 QKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170
LKLADFGLAR + + T T + PEL ++ Y +D+
Sbjct: 154 G-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDL 205
Query: 171 YSFGIVLWELLTNRLPFEGMSNLQA-------------------------AYAAAFKHAR 205
+ G ++ E+ T +G + K +
Sbjct: 206 WGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 265
Query: 206 PGLPEDI-----SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 253
+ + + P ++ V DP R + + F ++ PS
Sbjct: 266 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSDPMPSD 316
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-34
Identities = 46/258 (17%), Positives = 97/258 (37%), Gaps = 42/258 (16%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 82
+RE+ ++ +KH N+V+ + +V E + + + +
Sbjct: 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVK 104
Query: 83 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETG 141
+F + + + H+ ++HRDLKP NLL+ + + KLA+FGLAR + +AE
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVV 163
Query: 142 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 201
T + P++ K Y+ +D++S G + EL P +++ F
Sbjct: 164 TLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 202 K----------------------------HARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233
+ + + ++ ++Q+ +P R S
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 234 FSQIIRMLNAFLFTLRPP 251
+ ++ + + PP
Sbjct: 277 AEEALQ--HPYFSDFCPP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-32
Identities = 60/276 (21%), Positives = 105/276 (38%), Gaps = 54/276 (19%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKL 76
R RE+ ++ ++H+N++ L +V + + ++ KL
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL----MKHEKL 118
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
+ + + +HA GIIHRDLKP NL + D + K+ DFGLAR+ M
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQ--ADSEM 175
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
T T + APE+ Y VD++S G ++ E++T + F+G +L
Sbjct: 176 TGYVVTRWYRAPEVIL-------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228
Query: 197 Y------------------AAAFKHARPGLPE-----------DISPDLAFIVQSCWVED 227
+ K+ GLPE + SP +++ V D
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288
Query: 228 PNLRPSFSQIIRMLNAFLFTLRPPS--PSVPESDTN 261
R + + + + +L P V + D +
Sbjct: 289 AEQRVTAGEALAH--PYFESLHDTEDEPQVQKYDDS 322
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-28
Identities = 63/265 (23%), Positives = 101/265 (38%), Gaps = 50/265 (18%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLD 77
R RE+ ++ +KH+N++ L V + L G L + + KL
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLT 119
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 137
I R + +H+ IIHRDLKP NL + LK+ DFGLAR + MT
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA-VNEDCELKILDFGLARH--TDDEMT 176
Query: 138 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 197
T + APE+ HYN VD++S G ++ ELLT R F G ++
Sbjct: 177 GYVATRWYRAPEIML-------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 198 ---------------------AAAFKHARPGLPE--------DISPDLAFIVQSCWVEDP 228
A + + +P+ +P +++ V D
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289
Query: 229 NLRPSFSQIIRMLNAFLFTLRPPSP 253
+ R + +Q + +A+ P
Sbjct: 290 DKRITAAQALA--HAYFAQYHDPDD 312
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-27
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 22/223 (9%)
Query: 24 RFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKL 76
R RE+ +M V H N++ L + +V EL+ + +L
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MEL 116
Query: 77 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 136
D + + LH+ GIIHRDLKP N+++ D K+ DFGLAR + MM
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMM 175
Query: 137 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 196
T T + APE+ Y VD++S G ++ E++ +++ F G +
Sbjct: 176 TPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-Q 226
Query: 197 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+ + PE + + +F ++
Sbjct: 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.1 bits (209), Expect = 2e-19
Identities = 43/291 (14%), Positives = 90/291 (30%), Gaps = 67/291 (23%)
Query: 8 VLNRGSTSDERALLEGRFIREVNMMSRVK-----HDNLVKFLGAC----KDPLMVIVTEL 58
++ E A E + ++ VN K ++++K L + + V++
Sbjct: 45 IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104
Query: 59 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQK 117
+ G +L + + L + + +D +H GIIH D+KP+N+L+
Sbjct: 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164
Query: 118 SLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174
L +A E T T + +PE+ + D++S
Sbjct: 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG--------APWGCGADIWSTA 216
Query: 175 IVLWELLTNRLPFEG--------------------------------------------- 189
+++EL+T FE
Sbjct: 217 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 276
Query: 190 -MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239
+S L+ + +D + +++ + DP R ++
Sbjct: 277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.2 bits (171), Expect = 3e-15
Identities = 23/157 (14%), Positives = 48/157 (30%), Gaps = 20/157 (12%)
Query: 18 RALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD 77
R + F +R + L K G + V L + + + ++
Sbjct: 46 RDYGDLHFSVLAIRSARNEFRALQKLQGLA----VPKVYAWEGNAVLMELIDAKELYRVR 101
Query: 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 137
+ I + + GI+H DL N+L++ + + + DF + E
Sbjct: 102 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVE-------- 151
Query: 138 AETGTYRWMAPELY--STVTLRQGEKKHYNNKVDVYS 172
E+ + + Y + D+ S
Sbjct: 152 ----VGEEGWREILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 298 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 91.76 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=341.72 Aligned_cols=219 Identities=31% Similarity=0.536 Sum_probs=182.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.|.+|+.++++++||||+++++++.++..++||||++||+|.+++... ...+++..++.++.|++.||+|||++||+|
T Consensus 49 ~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivH 127 (276)
T d1uwha_ 49 QAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127 (276)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEec
Confidence 5788999999999999999999999888899999999999999999753 356999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|||||+|||++.+ +.+||+|||++...... .......||+.|+|||++.+. ....++.++|||||||++||
T Consensus 128 rDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l~e 201 (276)
T d1uwha_ 128 RDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVLYE 201 (276)
T ss_dssp SCCCGGGEEEETT-SSEEECCCCCSCC------------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHHHH
T ss_pred cccCHHHEEEcCC-CCEEEccccceeeccccCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHHHH
Confidence 9999999999955 56999999999754332 223445789999999998641 12467899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|++|+.||.+..+.............. ..+..+++++.+++.+||+.||.+|||+.++++.|+.+..++
T Consensus 202 l~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 202 LMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 999999999877665555554444332 345678999999999999999999999999999998877653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=341.47 Aligned_cols=215 Identities=26% Similarity=0.511 Sum_probs=185.3
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..++|.+|+.++++++||||+++++++.++..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++||
T Consensus 51 ~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~i 128 (277)
T d1xbba_ 51 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 128 (277)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCc
Confidence 456899999999999999999999999877889999999999999999863 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc----cccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+||||||+||+++.+ +.++|+|||++...... .......|++.|+|||.+.+ ..++.++||||||++
T Consensus 129 iHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv~ 199 (277)
T d1xbba_ 129 VHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVL 199 (277)
T ss_dssp ECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred ccCCCcchhhccccc-CcccccchhhhhhccccccccccccccCCCceecCchhhcC--------CCCCchhhhccchhh
Confidence 999999999999955 57999999999754322 12233468899999999865 568899999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|||++ |..||.+.... ........+.++..|..+|+++.+|+.+||+.||.+|||++++.+.|+.+..+
T Consensus 200 l~ellt~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 200 MWEAFSYGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred hhHHhhCCCCCCCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 999998 89999987654 34445556677888899999999999999999999999999999999887654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=342.27 Aligned_cols=216 Identities=25% Similarity=0.541 Sum_probs=187.4
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.++|.+|+.++++++||||+++++++.++..|+||||++||+|.+++.. ....+++..++.++.|++.||+|||++||+
T Consensus 53 ~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~ii 131 (285)
T d1u59a_ 53 TEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFV 131 (285)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4578999999999999999999999988889999999999999999865 235699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
||||||+||+++.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++
T Consensus 132 HrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gv~l 202 (285)
T d1u59a_ 132 HRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTM 202 (285)
T ss_dssp CCCCSGGGEEEEET-TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHH
T ss_pred cCcCchhheeeccC-CceeeccchhhhcccccccccccccccccCccccChHHHhC--------CCCCccchhhcchHHH
Confidence 99999999999955 579999999998543322 2233467899999999865 5688999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 178 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|||++ |..||.+.... ........+.++..|..+|+++.+|+.+||+.+|++|||+.++.+.|+....++
T Consensus 203 ~E~lt~G~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 203 WEALSYGQKPYKKMKGP-EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHTTSCCTTTTCCTH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99998 99999887654 344555667778888999999999999999999999999999999998876654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=336.62 Aligned_cols=210 Identities=25% Similarity=0.499 Sum_probs=180.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.||+.||+|||++|
T Consensus 49 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ 126 (263)
T d2j4za1 49 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR 126 (263)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457889999999999999999999996 45799999999999999999864 45999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||||+|||++.+ +.+||+|||++....... .....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 127 ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilye 196 (263)
T d2j4za1 127 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYE 196 (263)
T ss_dssp CCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHH
T ss_pred eeeeeeccccceecCC-CCEeecccceeeecCCCc-ccccCCCCcccCHHHHcC--------CCCCchhhhhhHhHHHHH
Confidence 9999999999999965 469999999997654332 344579999999999975 668899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++|+.||.+.+.... ... .......+|..+++++.+|+.+||+.||.+|||++++++ +.|+.
T Consensus 197 ll~G~~Pf~~~~~~~~-~~~-i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~--hp~~~ 259 (263)
T d2j4za1 197 FLVGKPPFEANTYQET-YKR-ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWIT 259 (263)
T ss_dssp HHHSSCTTCCSSHHHH-HHH-HHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--CHHHH
T ss_pred HhcCCCCCCCCCHHHH-HHH-HHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc--CcCcC
Confidence 9999999987654333 222 334556678889999999999999999999999999998 45543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=342.92 Aligned_cols=216 Identities=29% Similarity=0.448 Sum_probs=186.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.|.+|+.++++++||||+++++++.++..|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+|
T Consensus 53 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivH 132 (272)
T d1qpca_ 53 DAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132 (272)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 46889999999999999999999998888899999999999999887655456999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+||+++.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|||
T Consensus 133 rDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwS~Gvvl~el 203 (272)
T d1qpca_ 133 RDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEI 203 (272)
T ss_dssp SCCSGGGEEECTT-SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHH
T ss_pred Cccchhheeeecc-cceeeccccceEEccCCccccccccCCcccccChHHHhC--------CCCCchhhhhhhHHHHHHH
Confidence 9999999999955 569999999998654322 2334568889999999865 5688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..|+.................++..|..+++++.+|+.+||+.||++|||++++++.|+.+..+
T Consensus 204 lt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 204 VTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9965555444445555666667777888899999999999999999999999999999999988754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=342.00 Aligned_cols=211 Identities=31% Similarity=0.463 Sum_probs=180.4
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++.. +.+++..++.++.||+.||+|||++||+
T Consensus 62 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~ii 138 (293)
T d1yhwa1 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVI 138 (293)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 46889999999999999999999985 5679999999999999998876 4699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+|||++.+ +.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 139 HrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyem 209 (293)
T d1yhwa1 139 HRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEM 209 (293)
T ss_dssp CCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS--------SCBCTHHHHHHHHHHHHHH
T ss_pred ccCCcHHHeEECCC-CcEeeccchhheeeccccccccccccCCCccChhhhcC--------CCCCchhceehHhHHHHHH
Confidence 99999999999965 46999999999865433 33455679999999999865 6788999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
++|..||.+.+............. ....+..+++++.+||.+||+.||.+|||+.++++ +.|+..
T Consensus 210 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~~ 275 (293)
T d1yhwa1 210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKI 275 (293)
T ss_dssp HHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGGG
T ss_pred hhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhCC
Confidence 999999988776555444333222 23445678999999999999999999999999988 677654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-51 Score=340.73 Aligned_cols=216 Identities=27% Similarity=0.489 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..++|.+|+.+|++++|||||++++++. ++..|+||||++||+|.+++... ...+++..++.++.|++.||+|||++|
T Consensus 70 ~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T d1jpaa_ 70 QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMN 148 (299)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 3457899999999999999999999985 56799999999999999988763 346999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccc------cccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|+||||||+|||++.+ +.+||+|||++........ .....+++.|+|||.+.+ ..++.++|||||
T Consensus 149 iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~sDvwS~ 219 (299)
T d1jpaa_ 149 YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSY 219 (299)
T ss_dssp CCCSCCCGGGEEECTT-CCEEECCC-----------------------CGGGSCHHHHHS--------CCCCHHHHHHHH
T ss_pred CccCccccceEEECCC-CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--------CCCCcccccccc
Confidence 9999999999999955 4699999999975433221 122356889999999864 678999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 174 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 174 G~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
||++|||++ |..||.+.... ..........+++.+..+++++.+++.+||+.||.+|||+.++++.|+.++..
T Consensus 220 Gvvl~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 220 GIVMWEVMSYGERPYWDMTNQ-DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 999999998 89999887654 34445556667778888999999999999999999999999999999988764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-51 Score=342.35 Aligned_cols=215 Identities=31% Similarity=0.534 Sum_probs=185.9
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++|.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.......+++..++.++.|++.||+|||++||+
T Consensus 58 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~ii 137 (287)
T d1opja_ 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 137 (287)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46889999999999999999999985 56799999999999999999876667799999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+|||++.+ +.+||+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+
T Consensus 138 HrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~k~DiwS~Gv~l~e 208 (287)
T d1opja_ 138 HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWE 208 (287)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHH
T ss_pred cCccccCeEEECCC-CcEEEccccceeecCCCCceeeccccccccccChHHHcC--------CCCCchhhhhhHHHHHHH
Confidence 99999999999955 469999999998654322 2233357889999999875 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++|..||....+.............+..+..+++++.+|+.+||+.||++|||++++++.|+.+..
T Consensus 209 ll~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 209 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9997777655555555666666677788888999999999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=334.52 Aligned_cols=206 Identities=30% Similarity=0.574 Sum_probs=176.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeec-----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.++|.+|++++++++||||+++++++.+ ..+|+||||++||+|.+++... ..+++..+..++.||+.||+|||
T Consensus 52 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH 129 (270)
T d1t4ha_ 52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH 129 (270)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHH
Confidence 4578899999999999999999999742 3579999999999999999864 45999999999999999999999
Q ss_pred hCC--CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 97 ANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 97 ~~g--ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
++| |+||||||+|||++.+.+.+||+|||++...... ......||+.|+|||++. ..++.++||||||
T Consensus 130 ~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~---------~~~~~~~DIwSlG 199 (270)
T d1t4ha_ 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFG 199 (270)
T ss_dssp TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHH
T ss_pred HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhC---------CCCCCcCchhhHH
Confidence 998 9999999999999754567999999999753332 234557999999999875 3588999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|++|+|++|+.||.+..+.............+ .++..+++++.+++.+||+.||++|||++|+++
T Consensus 200 vilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 200 MCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 99999999999998877666665555444333 345678899999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=335.48 Aligned_cols=213 Identities=29% Similarity=0.547 Sum_probs=173.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++|.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.||+
T Consensus 45 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~ii 123 (263)
T d1sm2a_ 45 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVI 123 (263)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcccee
Confidence 47889999999999999999999985 5679999999999999999876 335689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+||+++.+ +.+||+|||++....... ......|+..|+|||++.+ ..++.++||||||+++||
T Consensus 124 HrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvil~e 194 (263)
T d1sm2a_ 124 HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWE 194 (263)
T ss_dssp CTTCSGGGEEECGG-GCEEECSCC------------------CTTSCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred ecccchhheeecCC-CCeEecccchheeccCCCceeecceecCcccCChHHhcC--------CCCCchhhhcchHHHHHH
Confidence 99999999999955 469999999997544332 2233468899999999865 678999999999999999
Q ss_pred HHhC-CCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|+++ ..||... .............++..|..+++++.+++.+||+.||.+|||+++++++|+.+..
T Consensus 195 l~t~~~~~~~~~-~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 195 VFSEGKIPYENR-SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHTTSCCTTCSC-CHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHCCCCCCCCC-CHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 9995 5555544 4445555666667777888899999999999999999999999999999988754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=335.50 Aligned_cols=213 Identities=27% Similarity=0.402 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++||
T Consensus 47 ~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~I 124 (271)
T d1nvra_ 47 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGI 124 (271)
T ss_dssp --CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence 357889999999999999999999985 5678999999999999999875 3569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+||||||+|||++.+ +.+||+|||++...... .......||+.|+|||++.+ ...++.++|||||||++
T Consensus 125 iHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~~~~~~DiwSlGvil 196 (271)
T d1nvra_ 125 THRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVL 196 (271)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC-------SSBCHHHHHHHHHHHHH
T ss_pred ccCcccHHHEEECCC-CCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC-------CCCCCCceeeeHhHHHH
Confidence 999999999999955 46999999999854332 22345579999999999864 12346789999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|+|++|+.||................. .......+++++.+|+.+||+.||.+|||++++++ +.|+.
T Consensus 197 yeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hpwf~ 264 (271)
T d1nvra_ 197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYN 264 (271)
T ss_dssp HHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTT
T ss_pred HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhC
Confidence 999999999987654433333332222 22223568999999999999999999999999987 55654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-50 Score=336.88 Aligned_cols=214 Identities=27% Similarity=0.406 Sum_probs=179.6
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+.+.+|+.++++++||||+++++++. ++..|+||||++||+|..++... ..+++..++.++.||+.||.|||++|
T Consensus 58 ~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~ 135 (309)
T d1u5ra_ 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN 135 (309)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457889999999999999999999985 56799999999999998776653 56999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||||+|||++.+ +.+||+|||++...... ....||+.|+|||++.+. ....|+.++|||||||++|+
T Consensus 136 iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~-----~~~~y~~~~DiwSlGvilye 206 (309)
T d1u5ra_ 136 MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIE 206 (309)
T ss_dssp CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTT-----TSCCBCTHHHHHHHHHHHHH
T ss_pred EeccCCCcceEEECCC-CCEEEeecccccccCCC---CccccCccccCHHHHhcc-----CCCCcCchhhhhhHHHHHHH
Confidence 9999999999999954 57999999999764432 345799999999998641 12468899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|++|..||.+...................+..+|+++.+||.+||+.||.+|||++++++ +.|+..
T Consensus 207 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~~ 272 (309)
T d1u5ra_ 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (309)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh--CHHhcC
Confidence 999999998877655544444333333445568999999999999999999999999998 566654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=342.60 Aligned_cols=214 Identities=32% Similarity=0.540 Sum_probs=183.1
Q ss_pred HHHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC---------------------CCCC
Q 022347 21 LEGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---------------------NKLD 77 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~ 77 (298)
..+.+.+|+.++.++ +|||||++++++. .+..|+||||++||+|.+++..... ..++
T Consensus 83 ~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 162 (325)
T d1rjba_ 83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162 (325)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CC
T ss_pred HHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCC
Confidence 345788999999998 8999999999995 5679999999999999999976431 3488
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccc---cccccCccceecccccccc
Q 022347 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTV 154 (298)
Q Consensus 78 ~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~ 154 (298)
+..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++........ .....+|+.|+|||++.+
T Consensus 163 ~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~- 240 (325)
T d1rjba_ 163 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE- 240 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-
Confidence 99999999999999999999999999999999999955 5799999999975443322 234457899999999865
Q ss_pred ccccCCccCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 155 TLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 155 ~~~~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
..++.++|||||||++|||++ |..||.+...............++..|..+|+++.+||.+||+.||++|||
T Consensus 241 -------~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt 313 (325)
T d1rjba_ 241 -------GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313 (325)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC
Confidence 678999999999999999998 899998876656666666666777888899999999999999999999999
Q ss_pred HHHHHHHHHh
Q 022347 234 FSQIIRMLNA 243 (298)
Q Consensus 234 ~~~l~~~l~~ 243 (298)
+++|+++|..
T Consensus 314 ~~ei~~~L~~ 323 (325)
T d1rjba_ 314 FPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhC
Confidence 9999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=333.98 Aligned_cols=208 Identities=28% Similarity=0.418 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee---cCceeEEEecCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
.+.+.+|+.++++++||||+++++++. ++.+|+||||++||+|.+++... ....+++..++.++.|++.||+|||
T Consensus 47 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH 126 (269)
T d2java1 47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126 (269)
T ss_dssp HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357889999999999999999999884 34689999999999999998653 2356999999999999999999999
Q ss_pred hCC-----CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 97 ANG-----IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 97 ~~g-----ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
++| |+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++||
T Consensus 127 ~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DI 197 (269)
T d2java1 127 RRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDI 197 (269)
T ss_dssp HHCC---------CCGGGEEECTT-SCEEECCHHHHHHC-----------CCCSCCCHHHHTT--------CCCCHHHHH
T ss_pred HhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC--------CCCChHHHH
Confidence 976 9999999999999965 469999999998654332 3345678999999999864 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 171 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 171 ~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
|||||++|+|++|+.||.+.+.. ...........+.++..+|+++.+|+.+||+.||.+|||++++++
T Consensus 198 wSlGvilyel~tg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 198 WSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhCHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 99999999999999999876653 344445555666788889999999999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-50 Score=336.02 Aligned_cols=213 Identities=25% Similarity=0.418 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||
T Consensus 51 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~i 128 (307)
T d1a06a_ 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGI 128 (307)
T ss_dssp ----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhcee
Confidence 356789999999999999999999985 5579999999999999999976 3569999999999999999999999999
Q ss_pred eeecCCCCCEEEcC--CCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+||||||+||++.. +.+.+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|
T Consensus 129 iHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~--------~~~~~~~DiwSlGvily 200 (307)
T d1a06a_ 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAY 200 (307)
T ss_dssp CCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTT--------CCCCTHHHHHHHHHHHH
T ss_pred eeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC--------CCCCcHHHhhhhhHHHH
Confidence 99999999999963 345799999999987665555566789999999999865 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
+|++|..||.+................ .+.+..+|+++.+|+.+||+.||.+|||++|+++ +.|+.
T Consensus 201 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 268 (307)
T d1a06a_ 201 ILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIA 268 (307)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhC
Confidence 999999999887654433333222222 2344679999999999999999999999999998 56664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=330.23 Aligned_cols=219 Identities=27% Similarity=0.411 Sum_probs=185.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 102 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH 102 (298)
+.|.+|+.++++++||||+++++++.++..++||||+++|+|..++.......+++..++.++.||+.||+|||+.||+|
T Consensus 57 ~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH 136 (285)
T d1fmka3 57 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 136 (285)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheec
Confidence 47889999999999999999999998778899999999999999987655566999999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccCCCccCccc--cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 103 RDLKPDNLLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 103 ~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
|||||+|||++.+ +.+||+|||++...... .......+++.|+|||.+.. ..++.++||||||+++|||
T Consensus 137 ~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~S~Giil~el 207 (285)
T d1fmka3 137 RDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTEL 207 (285)
T ss_dssp SCCSGGGEEECGG-GCEEECCCCTTC--------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred ccccceEEEECCC-CcEEEcccchhhhccCCCceeeccccccccccChHHHhC--------CCCCcHHhhhcchHHHHHH
Confidence 9999999999955 46999999999754332 22334568899999999865 6788999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
++|..||...................+.+..+++++.+++.+||+.||++|||+++|++.|+.++....+
T Consensus 208 ~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 208 TTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp HTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 9976666555555656666666777788899999999999999999999999999999999998877654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=328.49 Aligned_cols=216 Identities=26% Similarity=0.447 Sum_probs=179.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.++|.+|+.++++++||||+++++++. .+..++||||+.++++.+++.. ....+++..++.++.|++.||+|||+.||
T Consensus 53 ~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~i 131 (283)
T d1mqba_ 53 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNY 131 (283)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccccc
Confidence 457889999999999999999999985 5678999999999999998876 34569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+||||||+|||++.+ +.+||+|||++....... ......||..|+|||++.+ ..++.++||||||++
T Consensus 132 iHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 132 VHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIV 202 (283)
T ss_dssp CCSCCCGGGEEECTT-CCEEECCCCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHH
T ss_pred ccCccccceEEECCC-CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc--------CCCCCcccccccHHH
Confidence 999999999999965 469999999997543321 2223457899999998864 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|||++|..|+.................++..+..+++++.+++.+||+.+|++|||+.++++.|+.++..
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 99999966665554455566666777778888889999999999999999999999999999999887753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=329.38 Aligned_cols=218 Identities=28% Similarity=0.546 Sum_probs=178.4
Q ss_pred HHHHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 19 ALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 19 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
....+.|.+|+.++++++||||+++++++.++..|+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.
T Consensus 49 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~ 127 (273)
T d1mp8a_ 49 DSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK 127 (273)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc
Confidence 3345689999999999999999999999988889999999999999998765 345699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
|++||||||+||+++.+ +.+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||++
T Consensus 128 ~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~--------~~~~~~~DiwSlGvi 198 (273)
T d1mp8a_ 128 RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVC 198 (273)
T ss_dssp TCCCSCCSGGGEEEEET-TEEEECC-------------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHH
T ss_pred CeeccccchhheeecCC-CcEEEccchhheeccCCcceeccceecCcccchhhHhcc--------CCCCCccccccchHH
Confidence 99999999999999955 579999999997644322 2334567899999999865 678999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|||++ |..||.+....+ ..........++.+..+|+++.+||.+||+.||.+|||+.+|++.|+.++..
T Consensus 199 l~e~lt~g~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 199 MWEILMHGVKPFQGVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHTTSCCTTTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999998 899998766543 3444556667788899999999999999999999999999999999887653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=334.56 Aligned_cols=216 Identities=29% Similarity=0.463 Sum_probs=179.0
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.++++++||||+++++++. ++..|+||||++||+|.+++... .+.+++..+..++.||+.||.|||++||+
T Consensus 54 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~iv 132 (288)
T d2jfla1 54 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKII 132 (288)
T ss_dssp GGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 36779999999999999999999985 56799999999999999998763 35699999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+|||++.++ .+||+|||++...... .......||+.|+|||++.+.. .....++.++|||||||++|+|
T Consensus 133 HrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~y~~k~DiwSlGvilyem 208 (288)
T d2jfla1 133 HRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEM 208 (288)
T ss_dssp CCCCSGGGEEECTTS-CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCS---TTTSSTTTHHHHHHHHHHHHHH
T ss_pred EeecChhheeECCCC-CEEEEechhhhccCCCcccccccccccccCCHHHHhhcc---cCCCCCChhhhHHHHHHHHHHH
Confidence 999999999999654 6999999999754433 2334567999999999985421 1235688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++|+.||.+.+..+..... .....+ ..+..+++++.+||.+||+.||.+|||++|+++ +.|+.
T Consensus 209 ltg~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~--hp~~~ 273 (288)
T d2jfla1 209 AEIEPPHHELNPMRVLLKI-AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVT 273 (288)
T ss_dssp HHSSCTTTTSCGGGHHHHH-HHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGC
T ss_pred hhCCCCCCCCCHHHHHHHH-HcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 9999999887665544333 333332 334678999999999999999999999999987 45553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-49 Score=337.88 Aligned_cols=216 Identities=26% Similarity=0.389 Sum_probs=181.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++... .+.+++..+..++.||+.||.|||++||
T Consensus 67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~i 145 (350)
T d1koaa2 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNY 145 (350)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 357889999999999999999999985 56899999999999999999652 3569999999999999999999999999
Q ss_pred eeecCCCCCEEEcCC-CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.+ ++.+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 146 iHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~--------~~~~~~~DiwSlGvilye 217 (350)
T d1koaa2 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYI 217 (350)
T ss_dssp ECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT--------CCBCHHHHHHHHHHHHHH
T ss_pred eeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC--------CCCChhHhhhhhhHHHHH
Confidence 999999999999743 45799999999987666666666789999999999865 678899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|++|+.||.+.+..+........... ......+++++.+||.+||..||.+|||++++++ +.|+...
T Consensus 218 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hp~~~~~ 286 (350)
T d1koaa2 218 LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPG 286 (350)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH--STTTSCT
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCCC
Confidence 99999999877654443333322222 1223468999999999999999999999999998 6666544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=332.12 Aligned_cols=214 Identities=22% Similarity=0.365 Sum_probs=180.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+.+.+|+.++++++|||||++++++. ++..|+||||++||+|.+++... +.+++..++.++.|++.||+|||+.||
T Consensus 57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~i 134 (293)
T d1jksa_ 57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQI 134 (293)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcce
Confidence 457889999999999999999999996 45789999999999999999875 459999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCC---ceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+||||||+||+++.++. .+||+|||++.............+++.|+|||++.+ ..++.++|||||||++
T Consensus 135 vHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVIT 206 (293)
T ss_dssp ECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT--------CCBCTHHHHHHHHHHH
T ss_pred eecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC--------CCCCCcccchhhhHHH
Confidence 99999999999986543 599999999987666556666789999999999865 6788999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
|+|++|+.||.+.+..+........... ...+..+|+++.+||.+||+.||.+|||++++++ +.|+..
T Consensus 207 yell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~ 276 (293)
T d1jksa_ 207 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIKP 276 (293)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTCC
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCC
Confidence 9999999999886654443332221111 1123578999999999999999999999999998 666643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=330.76 Aligned_cols=204 Identities=25% Similarity=0.419 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ++..|+||||++||+|.+++... +.+++..++.++.|++.||+|||+.||+
T Consensus 53 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~ii 130 (288)
T d1uu3a_ 53 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGII 130 (288)
T ss_dssp HHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEE
Confidence 46889999999999999999999985 45789999999999999998864 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
||||||+||+++.++ .++|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 131 HrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~DiwSlGvily 201 (288)
T d1uu3a_ 131 HRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIY 201 (288)
T ss_dssp CSCCSGGGEEECTTS-CEEECCCTTCEECC----------CCCCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHH
T ss_pred cCcCCccccccCCCc-eEEecccccceecccCCcccccccccCCccccCceeecc--------CCCCcccceehhhHHHH
Confidence 999999999999554 6999999999765432 22344579999999999875 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 239 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 239 (298)
+|++|..||.+.+.... .... ......+|..+++++.+||.+||+.||.+|||++|+++
T Consensus 202 ell~g~~Pf~~~~~~~~-~~~i-~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 202 QLVAGLPPFRAGNEYLI-FQKI-IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHSSCSSCCSSHHHH-HHHH-HTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHhhCCCCCCCcCHHHH-HHHH-HcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 99999999987665433 2322 34456678889999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=323.27 Aligned_cols=210 Identities=27% Similarity=0.542 Sum_probs=181.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++|.+|+.++++++||||+++++++. ++..++||||+++|+|.+++... ...+++..++.++.|+++||.|||+.||+
T Consensus 44 ~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~ii 122 (258)
T d1k2pa_ 44 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFL 122 (258)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcc
Confidence 47889999999999999999999985 56799999999999999997653 35689999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcccc--ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
||||||+||+++.+ +.+||+|||++....... ......++..|+|||.+.+ ..++.++||||||+++||
T Consensus 123 H~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~ksDiwS~G~~l~e 193 (258)
T d1k2pa_ 123 HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWE 193 (258)
T ss_dssp CSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred cccccceeEEEcCC-CcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC--------CCCCcceeecccchhhHh
Confidence 99999999999955 569999999997543322 2233568899999999875 678999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 180 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 180 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
|++ |+.||.+.... +.........++..|...++++.+|+.+||+.||++|||+.+++++|..
T Consensus 194 l~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 194 IYSLGKMPYERFTNS-ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTSCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHhcCCCCCCCCCHH-HHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 998 89999887754 4455556667778888999999999999999999999999999998854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.6e-49 Score=335.33 Aligned_cols=214 Identities=21% Similarity=0.383 Sum_probs=181.1
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
++.+.+|+.++++++||||+++++++. ++.+|+||||++||+|.+++.. ....+++.+++.++.||+.||+|||++||
T Consensus 70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~i 148 (352)
T d1koba_ 70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSI 148 (352)
T ss_dssp HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 346789999999999999999999985 5578999999999999998765 33469999999999999999999999999
Q ss_pred eeecCCCCCEEEcC-CCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTP-DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++. +.+.+||+|||++.............+++.|+|||++.+ ..++.++|||||||++|+
T Consensus 149 iHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilye 220 (352)
T d1koba_ 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYV 220 (352)
T ss_dssp ECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHH
T ss_pred eecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC--------CCCCCccchHHHHHHHHH
Confidence 99999999999973 345799999999987766666666789999999999865 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++|..||.+.+............. .......+++++.+||.+||+.||.+|||+.++++ +.|+.
T Consensus 221 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--Hp~~~ 287 (352)
T d1koba_ 221 LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLK 287 (352)
T ss_dssp HHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTS
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 9999999988776554433332222 22344679999999999999999999999999988 45553
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=324.42 Aligned_cols=213 Identities=32% Similarity=0.551 Sum_probs=182.0
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..++|.+|+.++++++||||+++++++.++..++||||+++|++.+++... ...+++..++.++.|++.||.|||++||
T Consensus 54 ~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~i 132 (273)
T d1u46a_ 54 AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRF 132 (273)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEeecchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 445799999999999999999999999888889999999999999988763 3469999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
+||||||+||+++.+ +.+||+|||++....... ......++..|+|||.+.+ ..++.++||||||++
T Consensus 133 iHrDikp~NIll~~~-~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~S~Gvi 203 (273)
T d1u46a_ 133 IHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVT 203 (273)
T ss_dssp ECSCCCGGGEEEEET-TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHH
T ss_pred eeeeecHHHhccccc-cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC--------CCCCcchhhhhhHHH
Confidence 999999999999965 479999999998543322 1223356789999999875 678889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 177 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 177 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
+|||++ |..||.+.+..+...........++.+..+|+++.+++.+||+.||++|||+.+|++.|.+
T Consensus 204 l~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 204 LWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 999998 8999998776665555555556677788899999999999999999999999999988875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.4e-48 Score=318.67 Aligned_cols=223 Identities=24% Similarity=0.374 Sum_probs=184.9
Q ss_pred HHHHHHHHHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 17 ERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 17 ~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
..+...+++.+|+.++++++ ||||+++++++. ++..|+||||++||+|.+++... +.+++..++.++.||+.||+|
T Consensus 48 ~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~ 125 (277)
T d1phka_ 48 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICA 125 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence 34556678999999999997 999999999996 45789999999999999999874 459999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||++||+||||||+||+++.+ +.+||+|||++.............||..|.|||.+.+.... ....++.++||||+|
T Consensus 126 lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~--~~~~~~~~~DiwslG 202 (277)
T d1phka_ 126 LHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND--NHPGYGKEVDMWSTG 202 (277)
T ss_dssp HHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCT--TSCCBCTHHHHHHHH
T ss_pred HHHcCCcccccccceEEEcCC-CCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccc--cCCCCCchheEcccc
Confidence 999999999999999999955 46999999999876665555667899999999998753221 234678899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|++|+|++|+.||.+.+............... .....+|+++.+|+.+||+++|.+|||++++++ +.|+.
T Consensus 203 vilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~--h~~~~ 274 (277)
T d1phka_ 203 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQ 274 (277)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGC
T ss_pred hhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHHH
Confidence 99999999999999877654433333322222 223469999999999999999999999999987 44543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=324.19 Aligned_cols=208 Identities=24% Similarity=0.427 Sum_probs=179.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+++.+|+.+|++++||||+++++++. ++.+|+||||++||+|.+++... +.+++..++.++.|++.||+|||++||+
T Consensus 50 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~ii 127 (337)
T d1o6la_ 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVV 127 (337)
T ss_dssp HHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence 46789999999999999999999996 45799999999999999999874 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCcc-ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+|||++.++ .+||+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 128 HRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~--------~~y~~~~DiwSlGvilyem 198 (337)
T d1o6la_ 128 YRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEM 198 (337)
T ss_dssp CCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHH
T ss_pred ccccCHHHeEecCCC-CEEEeecccccccccCCcccccceeCHHHhhhhhccC--------CCCChhhcccchhhHHHHH
Confidence 999999999999664 699999999986443 334455679999999999875 6789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhh
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFL 245 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~~l~~~~ 245 (298)
++|+.||.+.+.... .. ........+|..+|+++.+||.+||+.||.+|++ +.++++ +.|+
T Consensus 199 l~G~~pf~~~~~~~~-~~-~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~--Hp~f 264 (337)
T d1o6la_ 199 MCGRLPFYNQDHERL-FE-LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--HRFF 264 (337)
T ss_dssp HHSSCSSCCSSHHHH-HH-HHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGG
T ss_pred HHCCCCCCCcCHHHH-HH-HHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc--Cccc
Confidence 999999988765333 22 3344567788899999999999999999999994 888887 4444
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=329.16 Aligned_cols=212 Identities=25% Similarity=0.460 Sum_probs=171.8
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-G 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-g 99 (298)
.+++.+|+.+|++++|||||++++++. ++..|+||||++||+|.+++... +.+++..+..++.|++.||.|||++ |
T Consensus 48 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~ 125 (322)
T d1s9ja_ 48 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK 125 (322)
T ss_dssp HHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457889999999999999999999995 55799999999999999999864 4599999999999999999999975 9
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||||+|||++.+ +.+||+|||++...... ......||+.|+|||++.+ ..++.++||||+||++|+
T Consensus 126 IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvil~e 195 (322)
T d1s9ja_ 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVE 195 (322)
T ss_dssp CCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC--------SCCCTTHHHHHHHHHHHH
T ss_pred EEccccCHHHeeECCC-CCEEEeeCCCccccCCC-ccccccCCccccCchHHcC--------CCCCcHHHHHHHHHHHHH
Confidence 9999999999999955 46999999999854332 2345689999999999975 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHH-----------------------------------------HHHHhhcCCCCC-CCCcHHHH
Q 022347 180 LLTNRLPFEGMSNLQAAY-----------------------------------------AAAFKHARPGLP-EDISPDLA 217 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~-~~~~~~l~ 217 (298)
|++|+.||.+.+...... ........+..+ ..++.++.
T Consensus 196 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 275 (322)
T d1s9ja_ 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275 (322)
T ss_dssp HHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHH
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHH
Confidence 999999997654321110 111111222222 23688999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 218 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 218 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
+|+.+||+.||.+|||++|+++ +.|+.+
T Consensus 276 dli~~~L~~dP~~R~ta~e~L~--Hpf~~~ 303 (322)
T d1s9ja_ 276 DFVNKCLIKNPAERADLKQLMV--HAFIKR 303 (322)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHT--SHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhh--CHhhCc
Confidence 9999999999999999999998 455543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=325.14 Aligned_cols=217 Identities=32% Similarity=0.558 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhh--------------CCCCCCHHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFA 85 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~~i~ 85 (298)
.++|.+|+.+|+++ +||||+++++++. ++..++||||++||+|.+++... ....+++..++.++
T Consensus 54 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 133 (309)
T d1fvra_ 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133 (309)
T ss_dssp -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHH
Confidence 45789999999999 6999999999985 56799999999999999999753 23569999999999
Q ss_pred HHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCC
Q 022347 86 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 165 (298)
Q Consensus 86 ~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 165 (298)
.|++.||.|||+.||+||||||+|||++.++ .+||+|||++.............++..|+|||.+.+ ..++
T Consensus 134 ~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~ 204 (309)
T d1fvra_ 134 ADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYT 204 (309)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEEC
T ss_pred HHHHHHHHhhhcCCccccccccceEEEcCCC-ceEEccccccccccccccccceecCCcccchHHhcc--------CCCC
Confidence 9999999999999999999999999999654 699999999986655555555678999999999865 6788
Q ss_pred cchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 022347 166 NKVDVYSFGIVLWELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 244 (298)
Q Consensus 166 ~~~Di~slG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 244 (298)
.++||||||+++|||++|. .||.+.+. .........+.++..+..+++++.+||.+||+.||++|||++++++.|+.+
T Consensus 205 ~~sDvwSfGvil~ell~~~~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccceeehhHHHHHHHHhcCCCCCCCCCH-HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999965 56766544 444555566677888889999999999999999999999999999999998
Q ss_pred hhcc
Q 022347 245 LFTL 248 (298)
Q Consensus 245 ~~~~ 248 (298)
+...
T Consensus 284 ~~~~ 287 (309)
T d1fvra_ 284 LEER 287 (309)
T ss_dssp HHSS
T ss_pred HhcC
Confidence 7653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=326.40 Aligned_cols=215 Identities=27% Similarity=0.519 Sum_probs=182.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
..++|.+|+.++++++||||+++++++.++..++++|++.+++|.+++.. ....+++..++.++.|++.||+|||++||
T Consensus 54 ~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~i 132 (317)
T d1xkka_ 54 ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132 (317)
T ss_dssp THHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 34578999999999999999999999988888999999999999998876 34679999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
+||||||+||+++.+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++
T Consensus 133 iHrDlKp~NIll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 133 VHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTV 203 (317)
T ss_dssp CCSCCCGGGEEEEET-TEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCcchhhcceeCCC-CCeEeeccccceecccccccccccccccCccccChHHHhc--------CCCChhhhhhhHHHHH
Confidence 999999999999955 579999999997543322 2233467899999999875 6789999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 178 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 178 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
|||++ |..||.+.... ........+.++..|..+++++.+++.+||+.||.+|||+.+++++|..+..
T Consensus 204 ~el~t~g~~p~~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPAS-EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHTTSCCTTTTSCGG-GHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 99998 88999876543 3344555667778888999999999999999999999999999999887654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=322.31 Aligned_cols=217 Identities=29% Similarity=0.549 Sum_probs=177.5
Q ss_pred HHHHHHHHHHHHhC-CCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHH
Q 022347 22 EGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNF 84 (298)
Q Consensus 22 ~~~~~~E~~~l~~l-~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i 84 (298)
.+.+.+|...+.++ +||||+.+++++. +...++||||+++|+|.+++.... ...+++..++.+
T Consensus 60 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (299)
T d1ywna1 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139 (299)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHH
Confidence 34677888888777 5899999999873 346899999999999999997532 234889999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCc
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEK 161 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~ 161 (298)
+.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||++.+
T Consensus 140 ~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------- 210 (299)
T d1ywna1 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------- 210 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--------
T ss_pred HHHHHHHHHHHHhCCCcCCcCCccceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc--------
Confidence 9999999999999999999999999999955 469999999997543322 2334578999999999875
Q ss_pred cCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 162 KHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 162 ~~~~~~~Di~slG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
..++.++|||||||++|||++| ..||.+.............+..+..+..+++++.+++.+||+.||++|||+++++++
T Consensus 211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6789999999999999999986 568887766666666667777888889999999999999999999999999999999
Q ss_pred HHhhhhc
Q 022347 241 LNAFLFT 247 (298)
Q Consensus 241 l~~~~~~ 247 (298)
|+.++..
T Consensus 291 L~~ilq~ 297 (299)
T d1ywna1 291 LGNLLQA 297 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHhC
Confidence 9987653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=321.35 Aligned_cols=218 Identities=29% Similarity=0.485 Sum_probs=182.9
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
.++|.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.|
T Consensus 72 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~ 150 (311)
T d1r0pa_ 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK 150 (311)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC
Confidence 357999999999999999999999873 4578999999999999999876 3456788999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
|+||||||+|||++.+ ..+||+|||++....... ......++..|+|||.+.. ..++.++||||||
T Consensus 151 iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~SfG 221 (311)
T d1r0pa_ 151 FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFG 221 (311)
T ss_dssp CCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH--------CCCCHHHHHHHHH
T ss_pred cccCCccHHhEeECCC-CCEEEecccchhhccccccccceecccccccccccChHHHhc--------CCCCChhHhhhhH
Confidence 9999999999999954 569999999997543322 1223467899999999865 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhccC
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 249 (298)
+++|||++|..||...............+.++..|..+++++.+|+.+||+.||++|||+.+|+++|+.++....
T Consensus 222 ivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 222 VLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp HHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 999999998888776555555555666677788888999999999999999999999999999999999876543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=320.67 Aligned_cols=221 Identities=25% Similarity=0.335 Sum_probs=177.4
Q ss_pred HHHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 20 LLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 20 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
...+++.+|+.++++++||||+++++++. ++..|+||||+.|+++..+... ...+++..+..++.||+.||+|||++
T Consensus 42 ~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~ 119 (299)
T d1ua2a_ 42 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH 119 (299)
T ss_dssp --CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc
Confidence 34457889999999999999999999995 5679999999988777666543 45699999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 177 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il 177 (298)
||+||||||+|||++.+ +.+||+|||++....... ......+|+.|+|||++.. ...++.++|||||||++
T Consensus 120 ~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil 191 (299)
T d1ua2a_ 120 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCIL 191 (299)
T ss_dssp TCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHH
T ss_pred ceecccCCcceEEecCC-CccccccCccccccCCCcccccceecChhhccHHHHcc-------CCCCChhhhhhhcchHH
Confidence 99999999999999955 569999999997654433 3344578999999998863 25678999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhcCCC--------------------------CCCCCcHHHHHHHHHhhhhCCCCC
Q 022347 178 WELLTNRLPFEGMSNLQAAYAAAFKHARPG--------------------------LPEDISPDLAFIVQSCWVEDPNLR 231 (298)
Q Consensus 178 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~R 231 (298)
|+|++|..||.+..+.+...........+. ....+++++.+|+.+||+.||++|
T Consensus 192 ~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R 271 (299)
T d1ua2a_ 192 AELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 271 (299)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTS
T ss_pred HHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhC
Confidence 999999999988776554443322111110 012467899999999999999999
Q ss_pred CCHHHHHHHHHhhhhccCCCC
Q 022347 232 PSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 232 ps~~~l~~~l~~~~~~~~~~~ 252 (298)
||++|+++ +.|+.+...+.
T Consensus 272 ~sa~e~L~--Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 272 ITATQALK--MKYFSNRPGPT 290 (299)
T ss_dssp CCHHHHHT--SGGGTSSSCCC
T ss_pred cCHHHHhC--CHhhCCCCCCC
Confidence 99999998 77776554433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=329.43 Aligned_cols=213 Identities=25% Similarity=0.450 Sum_probs=173.5
Q ss_pred HHHHHHHHHHhC-CCCcccceeceeec-----CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022347 24 RFIREVNMMSRV-KHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 97 (298)
Q Consensus 24 ~~~~E~~~l~~l-~hp~Iv~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 97 (298)
.+.+|+.++.++ +||||+++++++++ ..+|+|||||+||+|.+++.......+++.+++.++.|++.||+|||+
T Consensus 50 ~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~ 129 (335)
T d2ozaa1 50 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129 (335)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 566899887654 79999999998843 468999999999999999987555679999999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCC--CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 98 NGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 98 ~givH~dik~~Nil~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
.||+||||||+|||++.+ .+.+||+|||++.............||+.|+|||++.+ ..++.++|||||||
T Consensus 130 ~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~y~~~~DiwSlGv 201 (335)
T d2ozaa1 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGV 201 (335)
T ss_dssp TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG--------GGGSHHHHHHHHHH
T ss_pred cCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC--------CCCCHHHHHHhhch
Confidence 999999999999999853 34699999999987666666667789999999999865 67889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHH--HHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAA--AFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
++|+|++|+.||.+.......... ........++ ..+|+++.+||.+||+.||.+|||+.++++ +.|+.
T Consensus 202 ily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 276 (335)
T d2ozaa1 202 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIM 276 (335)
T ss_dssp HHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SHHHH
T ss_pred hHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHhh
Confidence 999999999999765433221111 1111122222 247899999999999999999999999998 45554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-47 Score=318.72 Aligned_cols=215 Identities=30% Similarity=0.528 Sum_probs=180.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC----------------------CCCCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR----------------------PNKLD 77 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~ 77 (298)
..++|.+|+.++++++||||+++++++. .+..+++|||+++|+|.+++.... ...++
T Consensus 59 ~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 138 (301)
T d1lufa_ 59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138 (301)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred HHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCC
Confidence 4568899999999999999999999985 567999999999999999996532 13488
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc---cccccccCccceecccccccc
Q 022347 78 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTV 154 (298)
Q Consensus 78 ~~~~~~i~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~ 154 (298)
+..++.++.|++.||+|||+.|++||||||+|||++.+ +.+||+|||++...... .......+++.|+|||.+.+
T Consensus 139 ~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 216 (301)
T d1lufa_ 139 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY- 216 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-
T ss_pred HHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-
Confidence 99999999999999999999999999999999999965 46999999998743222 22234567889999999975
Q ss_pred ccccCCccCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 022347 155 TLRQGEKKHYNNKVDVYSFGIVLWELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 233 (298)
Q Consensus 155 ~~~~~~~~~~~~~~Di~slG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 233 (298)
..++.++||||||+++|||++|. .||.+.+.. +..........+..+..+++++.+|+.+||+.+|.+|||
T Consensus 217 -------~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~-e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 217 -------NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -------CCCChhhhhccchhhHHHHHccCCCCCCCCCHH-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcC
Confidence 67899999999999999999985 577766554 444556666777888899999999999999999999999
Q ss_pred HHHHHHHHHhhh
Q 022347 234 FSQIIRMLNAFL 245 (298)
Q Consensus 234 ~~~l~~~l~~~~ 245 (298)
+.+|++.|+.+.
T Consensus 289 ~~ev~~~L~~i~ 300 (301)
T d1lufa_ 289 FCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHHhc
Confidence 999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=323.67 Aligned_cols=210 Identities=19% Similarity=0.341 Sum_probs=177.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.+|++++||||+++++++. ++.+|+||||++||+|.+++... ...+++.+++.++.||+.||+|||++||+
T Consensus 46 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~ii 124 (321)
T d1tkia_ 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIG 124 (321)
T ss_dssp HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 35779999999999999999999985 56899999999999999999763 34699999999999999999999999999
Q ss_pred eecCCCCCEEEcCC-CCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+|||++.+ ...++|+|||++.............+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 125 HrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~--------~~~~~~~DiWSlGvily~l 196 (321)
T d1tkia_ 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVL 196 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHH
T ss_pred cccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccC--------CCCCchhhcccHHHHHHHH
Confidence 99999999999853 34699999999987665555556678999999998865 6788999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
++|..||.+.+......... . ....++ ..+++++.+||.+||..||.+|||+.++++ +.|+
T Consensus 197 l~G~~Pf~~~~~~~~~~~i~-~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~ 261 (321)
T d1tkia_ 197 LSGINPFLAETNQQIIENIM-N-AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWL 261 (321)
T ss_dssp HHSSCTTCCSSHHHHHHHHH-H-TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHH
T ss_pred HhCCCCCCCCCHHHHHHHHH-h-CCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhh
Confidence 99999998876544333322 2 222222 368999999999999999999999999998 4444
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-46 Score=317.91 Aligned_cols=207 Identities=26% Similarity=0.421 Sum_probs=177.3
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..|+||||++||+|..++... ..+++..+..++.||+.||+|||++||
T Consensus 48 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i 125 (316)
T d1fota_ 48 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDI 125 (316)
T ss_dssp HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred HHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcE
Confidence 357889999999999999999999985 56799999999999999998864 458899999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+|||++.+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 126 iHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~--------~~y~~~~DiwSlGvilyem 194 (316)
T d1fota_ 126 IYRDLKPENILLDKN-GHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEM 194 (316)
T ss_dssp ECCCCCGGGEEECTT-SCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHH
T ss_pred EccccCchheeEcCC-CCEEEecCccceEeccc--cccccCcccccCHHHHcC--------CCCCchhhccccchhHHHH
Confidence 999999999999965 46999999999765432 234679999999999865 6788999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhh
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 245 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~ 245 (298)
++|+.||.+.+....... .......+|..+++++.+++.+||..||.+|+ |++++++ +.|+
T Consensus 195 ltG~~Pf~~~~~~~~~~~--i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~--Hp~f 260 (316)
T d1fota_ 195 LAGYTPFYDSNTMKTYEK--ILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWF 260 (316)
T ss_dssp HHSSCTTCCSSHHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGG
T ss_pred HhCCCCCCCcCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc--Cccc
Confidence 999999988765443333 23345567788999999999999999999996 8999988 4444
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-46 Score=313.17 Aligned_cols=213 Identities=30% Similarity=0.468 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeec-C----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKD-P----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
..++|.+|+.++++++||||+++++++.. + ..|+||||++|++|.+++... +.+++.+++.++.|++.||+||
T Consensus 50 ~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~l 127 (277)
T d1o6ya_ 50 FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFS 127 (277)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 44578999999999999999999998842 2 378999999999999998764 4599999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc----cccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
|+.||+||||||+||+++.+ +..+++|||.+...... .......||+.|+|||++.+ ..++.++|||
T Consensus 128 H~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~Diw 198 (277)
T d1o6ya_ 128 HQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVY 198 (277)
T ss_dssp HHTTEECCCCSGGGEEEETT-SCEEECCCTTCEECC----------------TTCCHHHHTT--------CCCCHHHHHH
T ss_pred HhCCccCccccCcccccCcc-ccceeehhhhhhhhccccccccccccccCcccccCHHHHcC--------CCCCcceecc
Confidence 99999999999999999955 46999999988643322 23344578999999999864 6788999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHhh
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAF 244 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~l~~~l~~~ 244 (298)
||||++|+|++|+.||.+.+..+...........+ .....+|+++.++|.+||+.||.+|| |+++++..|...
T Consensus 199 SlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 199 SLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 99999999999999999877655544443332222 23467899999999999999999999 899998877654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-46 Score=321.56 Aligned_cols=208 Identities=23% Similarity=0.325 Sum_probs=173.0
Q ss_pred HHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 022347 26 IREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 104 (298)
Q Consensus 26 ~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~givH~d 104 (298)
.+|+.+++.++||||+++++++. ++..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+|||
T Consensus 55 ~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrD 132 (364)
T d1omwa3 55 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRD 132 (364)
T ss_dssp HHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCcccee
Confidence 34577888889999999999985 45799999999999999999874 4589999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHHhCC
Q 022347 105 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 184 (298)
Q Consensus 105 ik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll~g~ 184 (298)
|||+|||++.+ +.+||+|||++...... ......||+.|+|||++.. ...++.++|||||||++|+|++|+
T Consensus 133 lKP~NILl~~~-g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyemltG~ 203 (364)
T d1omwa3 133 LKPANILLDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGH 203 (364)
T ss_dssp CSGGGEEECSS-SCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eccceeEEcCC-CcEEEeeeceeeecCCC-cccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHHHhCC
Confidence 99999999955 46999999999865443 2345579999999999853 256889999999999999999999
Q ss_pred CCCCCCChH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhhh
Q 022347 185 LPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 246 (298)
Q Consensus 185 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~l~~~l~~~~~ 246 (298)
.||.+.... ..............++..+++++.+||.+||+.||.+||| ++++++ +.|+.
T Consensus 204 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~--Hp~f~ 269 (364)
T d1omwa3 204 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 269 (364)
T ss_dssp CSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT--SGGGT
T ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc--Ccccc
Confidence 999865432 2222223334455677889999999999999999999998 799988 55543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=311.13 Aligned_cols=211 Identities=33% Similarity=0.587 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee--cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+.|.+|+.++++++||||+++++++. ++.+|+||||+++|+|.+++.......+++..++.|+.||+.||.|||+.+|
T Consensus 45 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~i 124 (262)
T d1byga_ 45 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 124 (262)
T ss_dssp HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCce
Confidence 57889999999999999999999883 3468999999999999999976444458999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
+||||||+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||
T Consensus 125 vH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~--------~~~t~~sDIwSfG~il~el 193 (262)
T d1byga_ 125 VHRDLAARNVLVSED-NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEI 193 (262)
T ss_dssp CCSCCSGGGEEECTT-SCEEECCCCC--------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred eccccchHhheecCC-CCEeecccccceecCCC--CccccccccCCChHHHhC--------CCCChHHHHHhHHHHHHHH
Confidence 999999999999965 46999999999864433 233467889999999865 6789999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 181 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 181 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
++ |..||...... ..........+++++..+++++.+|+.+||+.||.+|||+.+++++|+.+.
T Consensus 194 ~t~~~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 194 YSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HTTSCCSCTTSCGG-GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 98 78888765443 344455566788889999999999999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-46 Score=319.36 Aligned_cols=206 Identities=24% Similarity=0.361 Sum_probs=176.8
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
+.+.+|+.++++++||||+++++++. ....++||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+
T Consensus 86 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~ii 163 (350)
T d1rdqe_ 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLI 163 (350)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 46889999999999999999999985 45689999999999999999765 4599999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 181 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ll 181 (298)
||||||+|||++.+ +.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 164 HRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 164 YRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp CCCCSGGGEEECTT-SCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHcccCCC-CCEEeeeceeeeecccc--cccccCccccCCHHHHcC--------CCCCccccccchhHHHHHHH
Confidence 99999999999965 46999999999865432 234578999999999975 67889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhh
Q 022347 182 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 245 (298)
Q Consensus 182 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~ 245 (298)
+|+.||.+.+...... . ........+..+++++.++|.+||+.||.+|+ |++++++ +.|+
T Consensus 233 tG~~Pf~~~~~~~~~~-~-i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~--Hp~f 297 (350)
T d1rdqe_ 233 AGYPPFFADQPIQIYE-K-IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWF 297 (350)
T ss_dssp HSSCSSCCSSHHHHHH-H-HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGG
T ss_pred hCCCCCCCcCHHHHHH-H-HhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc--Cccc
Confidence 9999998766443322 2 33445667788999999999999999999994 8999988 4443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=310.10 Aligned_cols=214 Identities=33% Similarity=0.627 Sum_probs=184.4
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFAL 86 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~ 86 (298)
.++.+|...+.++ +||||+++++++. ++..++||||+++|+|.+++.... ...+++..++.++.
T Consensus 63 ~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 142 (299)
T d1fgka_ 63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 142 (299)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHH
Confidence 4678899999888 7999999999995 567999999999999999997643 24589999999999
Q ss_pred HHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccC
Q 022347 87 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKH 163 (298)
Q Consensus 87 qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 163 (298)
|++.||+|||+.||+||||||+|||++.++ .+||+|||++....... ......+++.|+|||.+.+ ..
T Consensus 143 qi~~al~ylH~~~ivHrDiKp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~ 213 (299)
T d1fgka_ 143 QVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RI 213 (299)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------CC
T ss_pred HHHHHHHHhhhCCEEeeeecccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC--------CC
Confidence 999999999999999999999999999664 69999999998654432 2334568899999999865 67
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 022347 164 YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 242 (298)
Q Consensus 164 ~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 242 (298)
++.++||||||+++|+|++ |..||.+... .........+..+..+..+++++.+|+.+||+.||.+|||+.+|++.|+
T Consensus 214 y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 214 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCchhhhHHhHHHHHHhccCCCCCCCCCCH-HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 8999999999999999998 7888877654 4445556667778888999999999999999999999999999999998
Q ss_pred hhhh
Q 022347 243 AFLF 246 (298)
Q Consensus 243 ~~~~ 246 (298)
.+++
T Consensus 293 ~i~a 296 (299)
T d1fgka_ 293 RIVA 296 (299)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 8765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=310.96 Aligned_cols=221 Identities=28% Similarity=0.468 Sum_probs=178.7
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..|+||||+.+ ++.+++.......+++..+..++.|++.||+|||++||
T Consensus 45 ~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~I 123 (298)
T d1gz8a_ 45 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123 (298)
T ss_dssp CHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence 457889999999999999999999995 5579999999954 66666655455679999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.++ .++|+|||.+...... .......+++.|+|||.+.. ...++.++|||||||++|+
T Consensus 124 iHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~ 195 (298)
T d1gz8a_ 124 LHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAE 195 (298)
T ss_dssp CCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHH
T ss_pred EccccCchheeecccC-cceeccCCcceeccCCcccceeecccceeeehhhhcc-------ccCCCccccccccchhhhH
Confidence 9999999999999654 6999999999754332 33344578999999998764 2456789999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCC----------------C-----------CCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPG----------------L-----------PEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~----------------~-----------~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
|++|+.||.+.+..............+. . ...+++++.+|+.+||+.||.+||
T Consensus 196 m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (298)
T d1gz8a_ 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275 (298)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc
Confidence 9999999998776554444332111110 0 124678899999999999999999
Q ss_pred CHHHHHHHHHhhhhccCCCCC
Q 022347 233 SFSQIIRMLNAFLFTLRPPSP 253 (298)
Q Consensus 233 s~~~l~~~l~~~~~~~~~~~~ 253 (298)
|++|+++ +.|+.++..|.|
T Consensus 276 t~~ell~--H~ff~~~~~p~p 294 (298)
T d1gz8a_ 276 SAKAALA--HPFFQDVTKPVP 294 (298)
T ss_dssp CHHHHHT--SGGGTTCCCCCC
T ss_pred CHHHHhC--CHhhccCCCCCC
Confidence 9999998 788877766543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=314.68 Aligned_cols=203 Identities=29% Similarity=0.466 Sum_probs=172.4
Q ss_pred HHHHHHHHHH-hCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMS-RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~-~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+.+|..++. .++||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+
T Consensus 48 ~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~ii 125 (320)
T d1xjda_ 48 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIV 125 (320)
T ss_dssp HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4556666655 789999999999996 55799999999999999999874 4589999999999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCccc-cccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHHH
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 180 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~l 180 (298)
||||||+|||++.+ +.++|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 126 HrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyem 196 (320)
T d1xjda_ 126 YRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEM 196 (320)
T ss_dssp CCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHH
T ss_pred eccCcccceeecCC-CceeccccchhhhcccccccccccCCCCCcCCHHHHcC--------CCCCchhhhhhhhHHHHHH
Confidence 99999999999955 56999999999854433 33344579999999999975 6789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 022347 181 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 239 (298)
Q Consensus 181 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~ 239 (298)
++|+.||.+.+..... .. .....+.+|..+|+++.+||.+||+.||.+|||+. ++++
T Consensus 197 ltG~~PF~~~~~~~~~-~~-i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 197 LIGQSPFHGQDEEELF-HS-IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHSSCSSCCSSHHHHH-HH-HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HhCCCCCCCCCHHHHH-HH-HHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 9999999876654432 22 23456778888999999999999999999999985 7876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=310.70 Aligned_cols=216 Identities=32% Similarity=0.543 Sum_probs=184.7
Q ss_pred HHHHHHHHHHHhC-CCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCC----------------CCCCHHHHHHH
Q 022347 23 GRFIREVNMMSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP----------------NKLDLHVALNF 84 (298)
Q Consensus 23 ~~~~~E~~~l~~l-~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~~~i 84 (298)
.+|.+|+.+++++ +||||+++++++. .+..++||||+++|+|.+++..... ..+++..+..+
T Consensus 71 ~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 150 (311)
T d1t46a_ 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHH
Confidence 4788999999999 6999999999995 4578999999999999999976431 25889999999
Q ss_pred HHHHHHHHHHHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCc
Q 022347 85 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEK 161 (298)
Q Consensus 85 ~~qi~~al~~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~ 161 (298)
+.||+.||+|||++|++||||||+||+++.+ +.++++|||.+....... ......+++.|+|||.+..
T Consensus 151 ~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------- 221 (311)
T d1t46a_ 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------- 221 (311)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------
T ss_pred HHHHHHHHHHHHhCCeeeccccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--------
Confidence 9999999999999999999999999999955 579999999998644322 2233467899999999865
Q ss_pred cCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 022347 162 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 240 (298)
Q Consensus 162 ~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 240 (298)
..++.++||||||+++|+|++ |.+||...............+.++..+..+++++.+||.+||+.||.+|||++++++.
T Consensus 222 ~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 678999999999999999998 6777777666555556666677777888899999999999999999999999999999
Q ss_pred HHhhhhc
Q 022347 241 LNAFLFT 247 (298)
Q Consensus 241 l~~~~~~ 247 (298)
|+..+.+
T Consensus 302 L~~~i~~ 308 (311)
T d1t46a_ 302 IEKQISE 308 (311)
T ss_dssp HHHHHHH
T ss_pred HHHhhcc
Confidence 9987765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=311.57 Aligned_cols=205 Identities=23% Similarity=0.408 Sum_probs=172.5
Q ss_pred HHHHHHHHHHhCC--CCcccceeceee-cCceeEEEecCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 24 RFIREVNMMSRVK--HDNLVKFLGACK-DPLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 24 ~~~~E~~~l~~l~--hp~Iv~~~~~~~-~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
++.+|+.++++++ ||||+++++++. ++..|+||||+.+ +++.+++... ..+++..++.++.|++.||+|||+.|
T Consensus 53 ~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ 130 (273)
T d1xwsa_ 53 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG 130 (273)
T ss_dssp EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4568999999997 899999999996 4578999999976 6888888764 46999999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
|+||||||+||+++.+.+.++|+|||++...... ......||+.|+|||++.+ ...++.++|||||||++|+
T Consensus 131 iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilye 202 (273)
T d1xwsa_ 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYD 202 (273)
T ss_dssp EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHH
T ss_pred CccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehh
Confidence 9999999999999977678999999999754332 2345679999999999865 1334678999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
|++|+.||...+. .......++..+|+++.+||.+||+.||.+|||++++++ +.|+...
T Consensus 203 ll~g~~Pf~~~~~--------i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~~~ 261 (273)
T d1xwsa_ 203 MVCGDIPFEHDEE--------IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDV 261 (273)
T ss_dssp HHHSSCSCCSHHH--------HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSSC
T ss_pred HhhCCCCCCCchH--------HhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhCCC
Confidence 9999999976321 223445677889999999999999999999999999998 5666543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=305.36 Aligned_cols=214 Identities=30% Similarity=0.530 Sum_probs=181.7
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------PNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~ 93 (298)
..|.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.... ...+++..+..++.|++.||.
T Consensus 68 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~ 147 (308)
T d1p4oa_ 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147 (308)
T ss_dssp HHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 47889999999999999999999984 567999999999999999986532 134789999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc---ccccccCccceeccccccccccccCCccCCCcchhH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 170 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 170 (298)
|||+++|+||||||+|||++.+ ..+||+|||++....... ......+++.|+|||.+.+ ..++.++||
T Consensus 148 ~LH~~~ivHrDlk~~NiLld~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--------~~~~~~~Dv 218 (308)
T d1p4oa_ 148 YLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDV 218 (308)
T ss_dssp HHHHTTCBCSCCSGGGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHH
T ss_pred HHhhCCeeeceEcCCceeecCC-ceEEEeecccceeccCCcceeeccceecccccCCHHHHcc--------CCCCccccc
Confidence 9999999999999999999955 569999999997543322 2333467899999999865 678889999
Q ss_pred HHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 022347 171 YSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 246 (298)
Q Consensus 171 ~slG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 246 (298)
||||+++|||++| ..||.+.+. ............+..+..+++.+.+++.+||+.+|++|||+.+|++.|+..+.
T Consensus 219 ~S~G~il~El~t~~~~p~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 219 WSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ccHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 9999999999997 577776554 44455566677788888999999999999999999999999999999887543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=312.56 Aligned_cols=218 Identities=26% Similarity=0.340 Sum_probs=174.6
Q ss_pred HHHHHHHHHhCCCCcccceeceeec-------CceeEEEecCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~-------~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+.+|+.++++++||||+++++++.. .++|+||||++++ +.+.+.. .....+++..+..++.||+.||+||
T Consensus 60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL 138 (350)
T d1q5ka_ 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138 (350)
T ss_dssp CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3479999999999999999998721 2478999999765 4444332 2345699999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|++||+||||||+|||++.++..+||+|||++.............++..|+|||.+.+ ...++.++||||+||
T Consensus 139 H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~ 211 (350)
T d1q5ka_ 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGC 211 (350)
T ss_dssp HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHH
T ss_pred HhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhc-------ccCCCcceeecccce
Confidence 9999999999999999997776799999999987666556666789999999998764 356899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcC---------------C------------CCCCCCcHHHHHHHHHhhhhCC
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHAR---------------P------------GLPEDISPDLAFIVQSCWVEDP 228 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---------------~------------~~~~~~~~~l~~li~~~l~~~p 228 (298)
++|+|++|+.||......+........... . ......++++.+|+.+||+.||
T Consensus 212 il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 291 (350)
T d1q5ka_ 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291 (350)
T ss_dssp HHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSG
T ss_pred EEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCCh
Confidence 999999999999877655443332211000 0 0123478899999999999999
Q ss_pred CCCCCHHHHHHHHHhhhhccCCCC
Q 022347 229 NLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 229 ~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
.+|||+.|+++ +.|+.++..+.
T Consensus 292 ~~R~ta~e~L~--Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 292 TARLTPLEACA--HSFFDELRDPN 313 (350)
T ss_dssp GGSCCHHHHHT--SGGGGGGGCTT
T ss_pred hHCcCHHHHhc--CHhhccccCCC
Confidence 99999999998 67777665543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=296.18 Aligned_cols=214 Identities=25% Similarity=0.383 Sum_probs=173.1
Q ss_pred HHHHHHHHHHhC---CCCcccceeceee------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 022347 24 RFIREVNMMSRV---KHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 94 (298)
Q Consensus 24 ~~~~E~~~l~~l---~hp~Iv~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 94 (298)
.+.+|+.+++.+ +||||+++++++. +...+++|||++++++.... ......+++..++.++.|++.||+|
T Consensus 53 ~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~y 131 (305)
T d1blxa_ 53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDF 131 (305)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHH
Confidence 344666666555 8999999999873 23689999999776665443 3345679999999999999999999
Q ss_pred HHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHH
Q 022347 95 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 174 (298)
Q Consensus 95 LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 174 (298)
||++||+||||||+|||++.+ +.++|+|||++.............||+.|+|||++.+ ..++.++||||||
T Consensus 132 LH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~--------~~y~~~~DiwSlG 202 (305)
T d1blxa_ 132 LHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVG 202 (305)
T ss_dssp HHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHH
T ss_pred HHhCCEEecCCCccEEEEcCC-CCeeecchhhhhhhcccccCCCcccChhhcCcchhcC--------CCCChhehhhchH
Confidence 999999999999999999955 4699999999987766666677789999999999865 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhhcC-------------------------CCCCCCCcHHHHHHHHHhhhhCCC
Q 022347 175 IVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPN 229 (298)
Q Consensus 175 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~ 229 (298)
|++|+|++|+.||.+.+..+........... ..++..+++.+.+||.+||+.||.
T Consensus 203 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 282 (305)
T d1blxa_ 203 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282 (305)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChh
Confidence 9999999999999987765544433221111 012346789999999999999999
Q ss_pred CCCCHHHHHHHHHhhhhccC
Q 022347 230 LRPSFSQIIRMLNAFLFTLR 249 (298)
Q Consensus 230 ~Rps~~~l~~~l~~~~~~~~ 249 (298)
+|||+.|+++ +.|+.++.
T Consensus 283 ~R~sa~e~L~--Hpff~~i~ 300 (305)
T d1blxa_ 283 KRISAYSALS--HPYFQDLE 300 (305)
T ss_dssp TSCCHHHHHT--SGGGTTCC
T ss_pred HCcCHHHHhc--ChhhcCch
Confidence 9999999998 67776554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=301.21 Aligned_cols=217 Identities=28% Similarity=0.417 Sum_probs=171.9
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecC-----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
..+++.+|+.+|++++||||+++++++... ..+++++++.||+|.+++.. ..+++..+..++.|++.||+||
T Consensus 49 ~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yL 125 (345)
T d1pmea_ 49 YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYI 125 (345)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999998432 23455556669999999976 4699999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc----ccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
|++||+||||||+|||++.+ +.+||+|||++....... ......+++.|+|||++.. ...++.++|||
T Consensus 126 H~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~Diw 197 (345)
T d1pmea_ 126 HSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIW 197 (345)
T ss_dssp HHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHH
T ss_pred HHCCCcCCCCCcceEEECCC-CCEEEcccCceeeccCCCccceeeccccccceechHHHhhc-------CCCCCchhhhh
Confidence 99999999999999999955 569999999997543322 2344568999999999853 25678899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC-----------------------------CCCCCCcHHHHHHHHH
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQS 222 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~ 222 (298)
|+||++|+|++|+.||.+................+ .....+++++.+|+.+
T Consensus 198 SlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 277 (345)
T d1pmea_ 198 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277 (345)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred ccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHH
Confidence 99999999999999998776544333322111111 0123577899999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHhhhhccCC
Q 022347 223 CWVEDPNLRPSFSQIIRMLNAFLFTLRP 250 (298)
Q Consensus 223 ~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 250 (298)
||+.||.+|||+.++++ +.++.....
T Consensus 278 ~L~~dP~~R~ta~e~L~--hpf~~~~~~ 303 (345)
T d1pmea_ 278 MLTFNPHKRIEVEQALA--HPYLEQYYD 303 (345)
T ss_dssp HSCSSTTTSCCHHHHHT--SGGGTTTCC
T ss_pred HccCChhHCcCHHHHhc--CHhhccCCC
Confidence 99999999999999998 666665444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-44 Score=299.75 Aligned_cols=213 Identities=27% Similarity=0.400 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
.+++.+|+.++++++||||+++++++. ++..++++|++.++.+..+... .+.+++..+..++.||+.||+|||+.||
T Consensus 44 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~I 121 (286)
T d1ob3a_ 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (286)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcE
Confidence 357889999999999999999999985 5679999999977666665543 3669999999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 179 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~~ 179 (298)
+||||||+|||++.+ +.+||+|||.+....... ......+++.|+|||.+.+ ...++.++|||||||++|+
T Consensus 122 vHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~e 193 (286)
T d1ob3a_ 122 LHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAE 193 (286)
T ss_dssp CCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHH
T ss_pred EecCCCCceeeEcCC-CCEEecccccceecccCccccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHH
Confidence 999999999999966 469999999987544322 2334468899999999864 3567899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhcCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 022347 180 LLTNRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRP 232 (298)
Q Consensus 180 ll~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp 232 (298)
|++|+.||.+.+..+...........+ .....+++.+.+|+.+||+.||++||
T Consensus 194 l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 273 (286)
T d1ob3a_ 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273 (286)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc
Confidence 999999998876655444332211111 12345788999999999999999999
Q ss_pred CHHHHHHHHHhhhh
Q 022347 233 SFSQIIRMLNAFLF 246 (298)
Q Consensus 233 s~~~l~~~l~~~~~ 246 (298)
|++|+++ +.|+.
T Consensus 274 s~~ell~--Hp~f~ 285 (286)
T d1ob3a_ 274 TAKQALE--HAYFK 285 (286)
T ss_dssp CHHHHHT--SGGGG
T ss_pred CHHHHhc--CcccC
Confidence 9999987 45543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=298.60 Aligned_cols=215 Identities=26% Similarity=0.426 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceeecC-------ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
..+++.+|+.+|++++|||||+++++|... .+|+||||+ +.+|..++.. ..+++..++.++.|++.||.
T Consensus 60 ~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~ 135 (346)
T d1cm8a_ 60 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLR 135 (346)
T ss_dssp HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHH
Confidence 345788999999999999999999998432 479999999 7789888765 56999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHH
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 173 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 173 (298)
|||++||+||||||+|||++.+ +.++++|||++...... .....+++.|+|||.+.+ ...++.++||||+
T Consensus 136 ~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 136 YIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSV 205 (346)
T ss_dssp HHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHH
T ss_pred HHHhCCCcccccCcchhhcccc-cccccccccceeccCCc--cccccccccccCHHHHcC-------CCCCCccchhhcc
Confidence 9999999999999999999965 46999999999765432 345678999999999864 2457889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhcC-----------------------------CCCCCCCcHHHHHHHHHhh
Q 022347 174 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-----------------------------PGLPEDISPDLAFIVQSCW 224 (298)
Q Consensus 174 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l 224 (298)
||++|+|++|+.||.+.+.............. .......++++.+||.+||
T Consensus 206 Gvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL 285 (346)
T d1cm8a_ 206 GCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285 (346)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHS
T ss_pred hHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHC
Confidence 99999999999999887654443322211111 1123467899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhccCCC
Q 022347 225 VEDPNLRPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 225 ~~~p~~Rps~~~l~~~l~~~~~~~~~~ 251 (298)
..||.+|||+.++++ +.|+..+..+
T Consensus 286 ~~dP~~R~ta~eiL~--Hp~f~~~~~~ 310 (346)
T d1cm8a_ 286 VLDAEQRVTAGEALA--HPYFESLHDT 310 (346)
T ss_dssp CSSTTTSCCHHHHHH--SGGGTTTC--
T ss_pred cCChhHCcCHHHHhc--ChhhCcCCCc
Confidence 999999999999999 7777766543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-43 Score=300.05 Aligned_cols=211 Identities=19% Similarity=0.339 Sum_probs=171.5
Q ss_pred HHHHHHHHHHHhCC-CCcccceeceee---cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022347 23 GRFIREVNMMSRVK-HDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 98 (298)
Q Consensus 23 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 98 (298)
+++.+|+.+|++++ ||||+++++++. +...++||||+++++|..+. +.+++..+..++.||+.||.|||++
T Consensus 74 ~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~ 148 (328)
T d3bqca1 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM 148 (328)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 46779999999996 999999999984 34689999999999987653 4599999999999999999999999
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
||+||||||+|||++.++..++|+|||++.............+|+.|+|||.+.+ ...++.++||||+||++|
T Consensus 149 gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~ 221 (328)
T d3bqca1 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLA 221 (328)
T ss_dssp TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHH
T ss_pred ccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhH
Confidence 9999999999999997777799999999987665555666788999999998864 245788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHh------------h------------------------cCCCCCCCCcHHHHHHHHH
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFK------------H------------------------ARPGLPEDISPDLAFIVQS 222 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~------------~------------------------~~~~~~~~~~~~l~~li~~ 222 (298)
++++|..||....+.......... . ........+++++.+||.+
T Consensus 222 e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 301 (328)
T d3bqca1 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301 (328)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHH
T ss_pred HhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHH
Confidence 999999999765543222111100 0 0001113478899999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHhhhhc
Q 022347 223 CWVEDPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 223 ~l~~~p~~Rps~~~l~~~l~~~~~~ 247 (298)
||+.||.+|||++|+++ +.|+..
T Consensus 302 mL~~dP~~R~ta~e~L~--Hp~F~~ 324 (328)
T d3bqca1 302 LLRYDHQSRLTAREAME--HPYFYT 324 (328)
T ss_dssp HSCSSGGGSCCHHHHHT--SGGGTT
T ss_pred HccCChhHCcCHHHHhc--CcccCC
Confidence 99999999999999998 666554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=295.98 Aligned_cols=217 Identities=24% Similarity=0.367 Sum_probs=164.5
Q ss_pred HHHHHHHHHhCCCCcccceeceeec-C----ceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh--
Q 022347 25 FIREVNMMSRVKHDNLVKFLGACKD-P----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-- 97 (298)
Q Consensus 25 ~~~E~~~l~~l~hp~Iv~~~~~~~~-~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-- 97 (298)
+..|+..+++++||||+++++++.+ + .+|+||||+++|+|.++++. ..+++..++.++.|++.||+|||+
T Consensus 44 ~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~ 120 (303)
T d1vjya_ 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred HHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhh
Confidence 3356777778999999999999842 2 57999999999999999986 469999999999999999999996
Q ss_pred ------CCCeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-----ccccccCccceeccccccccccccCCccCCCc
Q 022347 98 ------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 166 (298)
Q Consensus 98 ------~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 166 (298)
.||+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||++.+... .....++.
T Consensus 121 ~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~ 197 (303)
T d1vjya_ 121 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFK 197 (303)
T ss_dssp CSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC--TTCHHHHH
T ss_pred hhhccCCCeeccccCccceEEcCC-CCeEEEecCccccccCCCcceeccccceecccCcCChhhcccccc--ccCCCcCc
Confidence 599999999999999955 569999999997543322 2234578999999999864211 01124677
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHHH-hhcCCCCCCC-----CcHHHHHHHHHhhhh
Q 022347 167 KVDVYSFGIVLWELLTNRLPFEGMS--------------NLQAAYAAAF-KHARPGLPED-----ISPDLAFIVQSCWVE 226 (298)
Q Consensus 167 ~~Di~slG~il~~ll~g~~p~~~~~--------------~~~~~~~~~~-~~~~~~~~~~-----~~~~l~~li~~~l~~ 226 (298)
++|||||||++|||++|..||.... .......... ...++.++.. .+..+.+++.+||+.
T Consensus 198 k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T d1vjya_ 198 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCS
T ss_pred chhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHccc
Confidence 9999999999999999987763211 1122222222 2233444332 234688999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhc
Q 022347 227 DPNLRPSFSQIIRMLNAFLFT 247 (298)
Q Consensus 227 ~p~~Rps~~~l~~~l~~~~~~ 247 (298)
||.+|||+.+|++.|+.+..+
T Consensus 278 dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 278 NGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999887654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-42 Score=291.26 Aligned_cols=215 Identities=21% Similarity=0.305 Sum_probs=168.3
Q ss_pred HHHHHHHHHHhCCCCcccceecee--ecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
++.+|++++++++|+|++..+..+ .++..++||||+ ++++.+.+.. ....+++..+..++.|++.||+|||++||+
T Consensus 48 ~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii 125 (299)
T d1ckia_ 48 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFI 125 (299)
T ss_dssp CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCee
Confidence 567899999999988877666554 456788999999 6677777654 346799999999999999999999999999
Q ss_pred eecCCCCCEEEcC--CCCceEEeccCCCccCcccc--------ccccccCccceeccccccccccccCCccCCCcchhHH
Q 022347 102 HRDLKPDNLLLTP--DQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 171 (298)
Q Consensus 102 H~dik~~Nil~~~--~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 171 (298)
||||||+||+++. .+..++|+|||++....... ......||+.|+|||.+.+ ..++.++|||
T Consensus 126 HrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Diw 197 (299)
T d1ckia_ 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLE 197 (299)
T ss_dssp CSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--------BCCCHHHHHH
T ss_pred eccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC--------CCCCChhhEE
Confidence 9999999999863 23469999999998543321 2234479999999999865 6789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHH------HHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 022347 172 SFGIVLWELLTNRLPFEGMSNLQAAYAA------AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 245 (298)
Q Consensus 172 slG~il~~ll~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 245 (298)
||||++|+|++|..||............ ......+.....+|+++.+++..||+.+|++||+++++.+.|+.++
T Consensus 198 SlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 198 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999765432221111 1111112334678999999999999999999999999999998876
Q ss_pred hcc
Q 022347 246 FTL 248 (298)
Q Consensus 246 ~~~ 248 (298)
...
T Consensus 278 ~~~ 280 (299)
T d1ckia_ 278 HRQ 280 (299)
T ss_dssp HHH
T ss_pred HHc
Confidence 543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=288.23 Aligned_cols=219 Identities=23% Similarity=0.387 Sum_probs=176.4
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 022347 21 LEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 99 (298)
Q Consensus 21 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~g 99 (298)
..+++.+|+.++++++||||+++++++. ....+++++++.|++|..++.. .+.+++..+..++.|++.||+|||++|
T Consensus 44 ~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~ 121 (292)
T d1unla_ 44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCC
Confidence 3457889999999999999999999985 4578999999999998888765 356899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCCccCcccc-ccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
|+||||||+|||++.+ +.++|+|||.+....... ......++..|.|||.+.. ...++.++|||||||++|
T Consensus 122 IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~ 193 (292)
T d1unla_ 122 VLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFA 193 (292)
T ss_dssp EECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHH
T ss_pred EeeecccCcccccccC-CceeeeecchhhcccCCCccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHH
Confidence 9999999999999965 469999999998654433 2334456788999998764 245688999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhhcC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCC
Q 022347 179 ELLTNRLPFEGMSNLQAAYAAAFKHAR----------------------------PGLPEDISPDLAFIVQSCWVEDPNL 230 (298)
Q Consensus 179 ~ll~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~ 230 (298)
+|++|+.||....+............. ......+++.+.+|+.+||+.||.+
T Consensus 194 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 273 (292)
T d1unla_ 194 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273 (292)
T ss_dssp HHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhH
Confidence 999999997655554444443321111 1123457889999999999999999
Q ss_pred CCCHHHHHHHHHhhhhccCCC
Q 022347 231 RPSFSQIIRMLNAFLFTLRPP 251 (298)
Q Consensus 231 Rps~~~l~~~l~~~~~~~~~~ 251 (298)
|||++|+++ +.|+.+..+|
T Consensus 274 R~sa~e~L~--Hp~f~~~~~~ 292 (292)
T d1unla_ 274 RISAEEALQ--HPYFSDFCPP 292 (292)
T ss_dssp SCCHHHHTT--SGGGSSCSCC
T ss_pred CcCHHHHhc--ChhhcCCCCC
Confidence 999999998 6777665543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=290.06 Aligned_cols=214 Identities=22% Similarity=0.311 Sum_probs=167.6
Q ss_pred HHHHHHHHHHHhCCCCcccceeceeec---------CceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 93 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 93 (298)
+++.+|+.+|++++||||+++++++.. +..|+||||++++.+..+.. ....+++..++.++.|++.||.
T Consensus 54 ~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~ 131 (318)
T d3blha1 54 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLY 131 (318)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHH
Confidence 467899999999999999999998732 35899999997766654443 2456999999999999999999
Q ss_pred HHHhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccc-----cccccccCccceeccccccccccccCCccCCCcch
Q 022347 94 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 168 (298)
Q Consensus 94 ~LH~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~ 168 (298)
|||+.||+||||||+|||++.+ +.++|+|||++...... .......+|+.|+|||++.+ ...++.++
T Consensus 132 ~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~ 203 (318)
T d3blha1 132 YIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPI 203 (318)
T ss_dssp HHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHH
T ss_pred HhccCCEEecCcCchheeecCC-CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcC-------CCCCCcHH
Confidence 9999999999999999999965 46999999999744322 22233468999999999864 24688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhcCC--CCCC----------------------------CCcHHHHH
Q 022347 169 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPE----------------------------DISPDLAF 218 (298)
Q Consensus 169 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~----------------------------~~~~~l~~ 218 (298)
|||||||++|+|++|+.||.+.++.............. .... ..++++.+
T Consensus 204 DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 283 (318)
T d3blha1 204 DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283 (318)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHH
T ss_pred HcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHH
Confidence 99999999999999999998776544433322211111 1000 12567889
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 219 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 219 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
||.+||++||++|||+.|+++ +.|+...
T Consensus 284 Ll~~mL~~dP~~R~sa~elL~--Hpff~~~ 311 (318)
T d3blha1 284 LIDKLLVLDPAQRIDSDDALN--HDFFWSD 311 (318)
T ss_dssp HHHHHSCSSTTTSCCHHHHHH--SGGGSSS
T ss_pred HHHHHCcCChhHCcCHHHHHc--ChhhccC
Confidence 999999999999999999998 7777653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=289.65 Aligned_cols=215 Identities=29% Similarity=0.420 Sum_probs=170.3
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 96 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 96 (298)
+++.+|+.+|++++||||+++++++. +...+++++++.||+|.+++.. +.+++..+..++.||+.||+|||
T Consensus 62 ~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH 138 (348)
T d2gfsa1 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH 138 (348)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999999999873 2345677777889999999965 56999999999999999999999
Q ss_pred hCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHHH
Q 022347 97 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 176 (298)
Q Consensus 97 ~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 176 (298)
++||+||||||+||+++.+ +.++++|||.+...... .....|++.|+|||.+.+ ...++.++|||||||+
T Consensus 139 ~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~ 208 (348)
T d2gfsa1 139 SADIIHRDLKPSNLAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCI 208 (348)
T ss_dssp HTTCCCCCCCGGGEEECTT-CCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHH
T ss_pred hCCCcccccCCcccccccc-ccccccccchhcccCcc--cccccccccccCchhhcC-------CccCCcccchhhhhHH
Confidence 9999999999999999965 46999999998764432 344578899999998754 2456889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhcCC---------------------C--------CCCCCcHHHHHHHHHhhhhC
Q 022347 177 LWELLTNRLPFEGMSNLQAAYAAAFKHARP---------------------G--------LPEDISPDLAFIVQSCWVED 227 (298)
Q Consensus 177 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~l~~li~~~l~~~ 227 (298)
+|+|++|..||.+.+..............+ . ....+++++.+||.+||+.|
T Consensus 209 l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 288 (348)
T d2gfsa1 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288 (348)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCC
Confidence 999999999998876544433322211111 0 11357889999999999999
Q ss_pred CCCCCCHHHHHHHHHhhhhccCCCC
Q 022347 228 PNLRPSFSQIIRMLNAFLFTLRPPS 252 (298)
Q Consensus 228 p~~Rps~~~l~~~l~~~~~~~~~~~ 252 (298)
|.+|||+.|+++ +.|+.....+.
T Consensus 289 P~~R~ta~elL~--Hp~f~~~~~~~ 311 (348)
T d2gfsa1 289 SDKRITAAQALA--HAYFAQYHDPD 311 (348)
T ss_dssp GGGSCCHHHHHT--SGGGTTTCCTT
T ss_pred hhhCcCHHHHhc--CHhhCCCCCCc
Confidence 999999999998 67877665433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=288.00 Aligned_cols=212 Identities=26% Similarity=0.397 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHhCCC-Ccccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 022347 23 GRFIREVNMMSRVKH-DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 100 (298)
Q Consensus 23 ~~~~~E~~~l~~l~h-p~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~gi 100 (298)
+++.+|+.++++++| |||+++++++. ....+++|||+.||+|.+++... +.+++..+..++.|++.||+|||+.||
T Consensus 73 ~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~i 150 (322)
T d1vzoa_ 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGI 150 (322)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence 467799999999977 89999999985 55799999999999999999875 457899999999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEeccCCCccCcc--ccccccccCccceeccccccccccccCCccCCCcchhHHHHHHHHH
Q 022347 101 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 178 (298)
Q Consensus 101 vH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~il~ 178 (298)
+||||||+||+++.+ +.++|+|||++..... ........+++.|++||.+.+ ....++.++|||||||++|
T Consensus 151 vHrDiKp~Nill~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~------~~~~~~~ksDIWSlG~iLy 223 (322)
T d1vzoa_ 151 IYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMY 223 (322)
T ss_dssp CCCCCCGGGEEECTT-SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHH
T ss_pred EeccCCccceeecCC-CCEEEeeccchhhhcccccccccccccccccchhHHhhc------CCcCCCchhhhHHHHHHHH
Confidence 999999999999966 4699999999975433 223345678999999999864 2245788999999999999
Q ss_pred HHHhCCCCCCCCCh--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhh
Q 022347 179 ELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 245 (298)
Q Consensus 179 ~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~~l~~~~ 245 (298)
+|++|+.||.+... .............+.++..+++++.+|+.+||++||.+|| |++|+++ +.|+
T Consensus 224 elltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~--Hpff 295 (322)
T d1vzoa_ 224 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--HLFF 295 (322)
T ss_dssp HHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--SGGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc--CHhh
Confidence 99999999976532 2222233334556677788999999999999999999999 4888887 4454
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.1e-40 Score=274.28 Aligned_cols=217 Identities=18% Similarity=0.248 Sum_probs=174.0
Q ss_pred HHHHHHHHHHhCCC-Ccccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 24 RFIREVNMMSRVKH-DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 24 ~~~~E~~~l~~l~h-p~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
.+.+|++.++.++| +||+.+++++. +...++||||+ +++|.+++.. ....++...+..++.|++.||+|||+.||+
T Consensus 46 ~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~gii 123 (293)
T d1csna_ 46 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123 (293)
T ss_dssp CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCce
Confidence 46688999999975 89999999885 56789999999 7899999875 345699999999999999999999999999
Q ss_pred eecCCCCCEEEcC----CCCceEEeccCCCccCccc--------cccccccCccceeccccccccccccCCccCCCcchh
Q 022347 102 HRDLKPDNLLLTP----DQKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 169 (298)
Q Consensus 102 H~dik~~Nil~~~----~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~D 169 (298)
||||||+||+++. ..+.++|+|||++...... .......||+.|+|||++.+ ..++.++|
T Consensus 124 HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------~~~~~~~D 195 (293)
T d1csna_ 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDD 195 (293)
T ss_dssp CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHH
T ss_pred eccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC--------CCCChHHH
Confidence 9999999999974 2346999999999753321 12234469999999999865 67899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH----HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 022347 170 VYSFGIVLWELLTNRLPFEGMSN--LQAAYAAA----FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 243 (298)
Q Consensus 170 i~slG~il~~ll~g~~p~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 243 (298)
|||||+++|+|++|..||.+... ........ .......+...+|+++.+++..|+..+|++||+++.+.+.|+.
T Consensus 196 iwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 196 LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 99999999999999999975432 11111111 1111122345688999999999999999999999999999999
Q ss_pred hhhccCC
Q 022347 244 FLFTLRP 250 (298)
Q Consensus 244 ~~~~~~~ 250 (298)
++.+...
T Consensus 276 ~~~~~~~ 282 (293)
T d1csna_ 276 VLERLNT 282 (293)
T ss_dssp HHHHTTC
T ss_pred HHHHcCC
Confidence 8876544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=286.05 Aligned_cols=210 Identities=27% Similarity=0.411 Sum_probs=159.2
Q ss_pred HHHHHHHHHHHhCCCCcccceeceee-------cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 022347 23 GRFIREVNMMSRVKHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 95 (298)
Q Consensus 23 ~~~~~E~~~l~~l~hp~Iv~~~~~~~-------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 95 (298)
+++.+|+.++++++||||+++++++. ....|+||||+.++ +.+.+. ..+++..++.++.|++.||.||
T Consensus 61 ~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~L 135 (355)
T d2b1pa1 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHL 135 (355)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHh
Confidence 47889999999999999999999983 24689999999664 544443 4589999999999999999999
Q ss_pred HhCCCeeecCCCCCEEEcCCCCceEEeccCCCccCccccccccccCccceeccccccccccccCCccCCCcchhHHHHHH
Q 022347 96 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 175 (298)
Q Consensus 96 H~~givH~dik~~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 175 (298)
|+.||+||||||+|||++.++ .++++|||++.............+|+.|+|||++.+ ..++.++||||+||
T Consensus 136 H~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~DiwSlG~ 206 (355)
T d2b1pa1 136 HSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGC 206 (355)
T ss_dssp HHTTCCCSCCCGGGEEECTTC-CEEECCCCC---------------CCTTCCHHHHTT--------CCCCTTHHHHHHHH
T ss_pred hhcccccccCCcccccccccc-ceeeechhhhhccccccccccccccccccChhhhcC--------CCCCCCcccccccc
Confidence 999999999999999999664 599999999987766666666789999999999865 67889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhhcC--------------------CCC--------------C------CCCcHH
Q 022347 176 VLWELLTNRLPFEGMSNLQAAYAAAFKHAR--------------------PGL--------------P------EDISPD 215 (298)
Q Consensus 176 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~~--------------~------~~~~~~ 215 (298)
++++|++|+.||.+.+.............. +.. + ...+++
T Consensus 207 ~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 286 (355)
T d2b1pa1 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 286 (355)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHH
T ss_pred hHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHH
Confidence 999999999999877654433322111100 000 0 113567
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 216 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 216 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
+.+||.+||..||.+|||++|+++ +.|+...
T Consensus 287 ~~dll~~mL~~dP~~R~ta~elL~--Hpw~~~~ 317 (355)
T d2b1pa1 287 ARDLLSKMLVIDPAKRISVDDALQ--HPYINVW 317 (355)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT--STTTGGG
T ss_pred HHHHHHHHCcCChhHCcCHHHHhc--CcccCCC
Confidence 899999999999999999999998 6777653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-34 Score=249.68 Aligned_cols=215 Identities=19% Similarity=0.258 Sum_probs=156.6
Q ss_pred HHHHHHHHHHHHhCC-----------CCcccceeceeec---CceeEEEecCCCC-CHHHHHhhhCCCCCCHHHHHHHHH
Q 022347 22 EGRFIREVNMMSRVK-----------HDNLVKFLGACKD---PLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFAL 86 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~-----------hp~Iv~~~~~~~~---~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~ 86 (298)
.+.+.+|+.+++.+. ||||+++++++.. ...+++++++.++ +............+++..+..++.
T Consensus 53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~ 132 (362)
T d1q8ya_ 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132 (362)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHH
Confidence 346778888888775 5789999988732 3455566554443 444444554557799999999999
Q ss_pred HHHHHHHHHHh-CCCeeecCCCCCEEEcCCCC-----ceEEeccCCCccCccccccccccCccceeccccccccccccCC
Q 022347 87 DIARAMDCLHA-NGIIHRDLKPDNLLLTPDQK-----SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 160 (298)
Q Consensus 87 qi~~al~~LH~-~givH~dik~~Nil~~~~~~-----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 160 (298)
|++.||+|||+ .||+||||||+|||++.++. .++++|||.+..... ......+++.|+|||++..
T Consensus 133 qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~------- 203 (362)
T d1q8ya_ 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG------- 203 (362)
T ss_dssp HHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-------
T ss_pred HHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccc-------
Confidence 99999999998 89999999999999985432 489999999875433 2345578999999998865
Q ss_pred ccCCCcchhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHhh-------------------------------
Q 022347 161 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL------QAAYAAAFKH------------------------------- 203 (298)
Q Consensus 161 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~------~~~~~~~~~~------------------------------- 203 (298)
..++.++||||+||++++|++|+.||...... ..........
T Consensus 204 -~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
T d1q8ya_ 204 -APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 282 (362)
T ss_dssp -CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC
T ss_pred -cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhcccccc
Confidence 66889999999999999999999999753321 1111100000
Q ss_pred ---------cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhcc
Q 022347 204 ---------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 248 (298)
Q Consensus 204 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 248 (298)
.....+...++++.+|+.+||+.||.+|||++|+++ +.|+.+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~--Hp~f~~~ 334 (362)
T d1q8ya_ 283 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN--HPWLKDT 334 (362)
T ss_dssp BCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT--CGGGTTC
T ss_pred CCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc--CcccCCC
Confidence 001112234678999999999999999999999998 7776643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=2.2e-20 Score=145.18 Aligned_cols=96 Identities=17% Similarity=0.181 Sum_probs=78.0
Q ss_pred HHHHHHHHHHHHhCCCCcccceeceeecCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 022347 22 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 101 (298)
Q Consensus 22 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~giv 101 (298)
...+.+|...+.++.|++++..+++.. .+++|||+++..+.+ ++...+..++.|++.+|+|||++||+
T Consensus 58 ~~~~~~e~~~l~~l~~~~v~~~~~~~~---~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~gii 125 (191)
T d1zara2 58 IRSARNEFRALQKLQGLAVPKVYAWEG---NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIV 125 (191)
T ss_dssp HHHHHHHHHHHHHTTTSSSCCEEEEET---TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHccCCCcceEEEecC---CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEE
Confidence 345667999999999999998876542 379999998765432 44455678999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEeccCCCccCc
Q 022347 102 HRDLKPDNLLLTPDQKSLKLADFGLAREET 131 (298)
Q Consensus 102 H~dik~~Nil~~~~~~~~~l~dfg~~~~~~ 131 (298)
||||||+|||++.+ .++|+|||.+....
T Consensus 126 HrDiKP~NILv~~~--~~~liDFG~a~~~~ 153 (191)
T d1zara2 126 HGDLSQYNVLVSEE--GIWIIDFPQSVEVG 153 (191)
T ss_dssp CSCCSTTSEEEETT--EEEECCCTTCEETT
T ss_pred EccCChhheeeeCC--CEEEEECCCcccCC
Confidence 99999999999943 38999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.73 E-value=3.6e-05 Score=60.72 Aligned_cols=97 Identities=18% Similarity=0.147 Sum_probs=61.6
Q ss_pred HHHHHHHHHHhCC-CCcccceeceee-cCceeEEEecCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Q 022347 24 RFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--- 98 (298)
Q Consensus 24 ~~~~E~~~l~~l~-hp~Iv~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--- 98 (298)
.+.+|...+..+. +--+.+++.+.. ++..++||++++|.++.+.... . .. ...++.++...++.||+.
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~---~-~~---~~~~~~~l~~~l~~lH~~~~~ 127 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---E-QS---PEKIIELYAECIRLFHSIDIS 127 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT---C-SC---HHHHHHHHHHHHHHHHTSCCT
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc---c-cc---HHHHHHHHHHHHHHHhccCcc
Confidence 3457888877764 333566676664 5678999999999888654321 0 11 122333444444444421
Q ss_pred --------------------------------------------------------CCeeecCCCCCEEEcCCCCceEEe
Q 022347 99 --------------------------------------------------------GIIHRDLKPDNLLLTPDQKSLKLA 122 (298)
Q Consensus 99 --------------------------------------------------------givH~dik~~Nil~~~~~~~~~l~ 122 (298)
.++|||+.|.||+++. ++..-|+
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~-~~~~~lI 206 (263)
T d1j7la_ 128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFI 206 (263)
T ss_dssp TCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEET-TEEEEEC
T ss_pred ccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecC-CceEEEe
Confidence 2789999999999984 4445699
Q ss_pred ccCCCc
Q 022347 123 DFGLAR 128 (298)
Q Consensus 123 dfg~~~ 128 (298)
||+.+.
T Consensus 207 Dwe~a~ 212 (263)
T d1j7la_ 207 DLGRSG 212 (263)
T ss_dssp CCTTCE
T ss_pred echhcc
Confidence 998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.21 E-value=0.00047 Score=53.72 Aligned_cols=27 Identities=19% Similarity=0.255 Sum_probs=22.6
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccCCC
Q 022347 100 IIHRDLKPDNLLLTPDQKSLKLADFGLA 127 (298)
Q Consensus 100 ivH~dik~~Nil~~~~~~~~~l~dfg~~ 127 (298)
++|||+.|.||+++.+ ..+-|+||+.+
T Consensus 177 liHgD~~~~Nvl~~~~-~~~~iID~~~~ 203 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENG-RFSGFIDCGRL 203 (255)
T ss_dssp EECSSCCGGGEEEETT-EEEEECCCTTC
T ss_pred EEeCCCCCcceEEeCC-ceEEEEEchhc
Confidence 7999999999999843 44679999866
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.90 E-value=0.00073 Score=56.43 Aligned_cols=29 Identities=24% Similarity=0.321 Sum_probs=24.6
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
.++|||+++.|||++.+ .++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS--CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC--ceEEechhhccc
Confidence 58999999999999854 389999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.79 E-value=0.0029 Score=52.71 Aligned_cols=37 Identities=19% Similarity=0.317 Sum_probs=24.8
Q ss_pred HHHHHHHHhCCCCcc-cceeceeecCceeEEEecCCCCCHH
Q 022347 26 IREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELLPGMSLR 65 (298)
Q Consensus 26 ~~E~~~l~~l~hp~I-v~~~~~~~~~~~~lv~e~~~~~sL~ 65 (298)
.+|..+++.+.--++ .++++++.+ .+|+||++|.++.
T Consensus 92 ~~E~~i~~~ls~~gl~Pkll~~~~~---g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 92 VAESVIFTLLSERHLGPKLYGIFSG---GRLEEYIPSRPLS 129 (395)
T ss_dssp HHHHHHHHHHHHTTSSSCEEEEETT---EEEECCCCEEECC
T ss_pred HHHHHHHHHHHhCCCCCeEEEEcCC---ceEEEEeccccCC
Confidence 368888887753344 467777654 4889999886543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.35 E-value=0.0054 Score=49.17 Aligned_cols=29 Identities=41% Similarity=0.568 Sum_probs=24.4
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 128 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~ 128 (298)
|++|||+.++|++++.+ ...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccc-cceeEecccccc
Confidence 79999999999999954 445799999774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=91.76 E-value=0.069 Score=42.68 Aligned_cols=28 Identities=29% Similarity=0.332 Sum_probs=23.0
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccCCCcc
Q 022347 99 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 129 (298)
Q Consensus 99 givH~dik~~Nil~~~~~~~~~l~dfg~~~~ 129 (298)
+++|||+++.||+++ ++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~-~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWR-DG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEES-SS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEe-CC--ceEEechhccc
Confidence 689999999999997 33 45899997753
|